data_2b0f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2b0f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.47 0.126 0 N-CA-C 113.907 0.695 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 11.1 t30 -68.77 -48.27 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.374 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 m -70.23 -29.02 65.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.714 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.56 -50.0 74.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.52 -47.31 84.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.475 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.36 58.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.533 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.79 -23.68 64.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -76.94 -51.23 11.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.591 0.71 . . . . 0.0 109.853 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.4 tp -57.13 -44.51 83.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.254 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.517 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 69.6 tp -53.86 -49.91 67.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.203 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -78.02 -28.38 49.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -86.54 -52.57 5.49 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.86 1.98 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 40.2 mm -106.25 133.02 51.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.435 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 50' ' ' ASN . 46.2 ttm -150.55 144.04 25.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.799 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 104' ' ' HIS . 22.0 m -69.23 113.59 6.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.59 108.77 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 14.0 m -93.91 122.5 36.47 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.8 0.81 . . . . 0.0 109.994 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 -163.9 1.45 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.44 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.37 -44.4 62.11 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 55.1 tttm -85.36 1.2 49.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.877 0.762 . . . . 0.0 111.863 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.67 -149.76 17.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.31 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.26 129.66 35.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.055 -0.573 . . . . 0.0 111.584 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -131.85 157.26 44.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.109 0.957 . . . . 0.0 111.96 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 80.5 m -72.66 107.53 5.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.332 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.24 107.24 3.16 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.399 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.37 99.06 11.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.37 123.01 7.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.681 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.93 -56.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 117.179 0.489 . . . . 0.0 110.03 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.95 153.31 5.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.605 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.06 -89.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.999 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.1 ptp180 -132.02 10.25 4.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -110.69 131.82 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.931 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 p -133.13 156.68 47.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.51 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.45 139.82 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.469 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.8 tt -143.54 141.58 19.27 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.367 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.16 153.06 13.43 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 C-N-CA 121.313 1.342 . . . . 0.0 112.243 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 39.5 m -77.61 -37.45 50.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -66.91 -13.08 61.35 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.63 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.72 -21.18 64.41 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.024 0.916 . . . . 0.0 109.224 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.415 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 45.1 mt-30 61.12 69.07 1.12 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.311 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 12.3 Cg_exo -75.25 131.23 13.78 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.806 2.337 . . . . 0.0 107.97 175.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.84 -134.37 7.6 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.417 -1.373 . . . . 0.0 114.602 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.39 -26.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.685 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 53' ' ' LYS . 13.0 p-10 -144.67 133.69 22.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.96 158.67 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.892 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 45.6 mt -101.8 98.71 8.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 HG13 ' SD ' ' A' ' 16' ' ' MET . 41.0 t -91.81 103.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 65.8 t30 66.47 24.78 10.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.699 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.57 -20.1 52.01 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.35 115.57 18.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.362 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 87.7 tttt -74.74 109.49 8.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.759 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.17 139.89 46.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.435 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.28 153.77 22.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.963 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 59' ' ' LYS . 14.6 p -73.81 141.59 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -99.9 -42.85 6.62 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 37.9 t70 -159.13 118.35 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.304 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.542 ' HB2' HG23 ' A' ' 56' ' ' VAL . 28.5 ttpp -111.47 106.41 15.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -115.87 110.41 18.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.764 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.11 105.59 6.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 60.0 tp -75.69 114.74 14.63 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-O 122.243 1.02 . . . . 0.0 111.89 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.25 159.9 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.434 -1.712 . . . . 0.0 107.852 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 20.4 t70 -74.84 149.04 85.36 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 64' ' ' ASP . 6.3 Cg_endo -49.28 -23.84 7.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.75 2.3 . . . . 0.0 113.666 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 68' ' ' ILE . 7.6 mm-40 -86.37 25.04 1.26 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.604 0.716 . . . . 0.0 109.805 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.289 0.3 OUTLIER 39.99 61.98 1.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.495 1.118 . . . . 0.0 113.202 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 66' ' ' GLU . 25.2 mm -138.62 155.59 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.492 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' N ' HG22 ' A' ' 68' ' ' ILE . 51.6 t30 -57.5 131.33 49.84 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.783 -0.573 . . . . 0.0 111.761 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.545 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.7 tp -103.89 -22.94 13.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 22.7 tp10 80.61 7.89 1.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.403 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.85 109.62 22.01 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.397 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 99.8 m -85.27 107.44 17.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.79 101.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.02 100.32 11.46 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.05 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 21.5 m -96.77 121.84 39.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.665 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mm? -120.34 158.54 26.9 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.63 82.15 6.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -79.64 117.37 20.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.492 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.82 -53.81 13.9 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.5 89.86 7.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.27 143.44 52.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.127 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -82.88 148.68 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.058 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.63 144.35 51.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.75 83.24 1.17 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -87.45 12.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.756 -0.59 . . . . 0.0 109.577 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.08 -19.8 65.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.791 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.91 73.86 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.559 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -84.49 -21.12 30.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.704 -0.248 . . . . 0.0 110.474 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.12 121.69 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 13.7 m -113.06 148.48 35.1 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.67 -33.42 12.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.7 105.63 15.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.705 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 17.4 mt -68.33 -57.16 6.35 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.705 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 5.6 pt-20 55.75 13.48 1.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 0.0 111.247 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 98' ' ' ASP . . . -115.87 67.3 0.29 Allowed Glycine 0 C--N 1.334 0.459 0 CA-C-O 121.603 0.557 . . . . 0.0 112.838 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 97' ' ' VAL . 14.6 p -60.87 -3.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.071 0.462 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 96' ' ' GLY . 24.7 t70 -117.94 111.89 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.58 160.43 34.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.849 0.833 . . . . 0.0 112.865 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.1 m -125.63 137.0 53.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.337 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 tp -102.33 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.016 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 t -104.05 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.62 129.91 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.674 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -138.86 35.07 2.17 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -108.54 -170.05 1.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -44.15 -51.93 7.7 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.18 -29.41 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.812 0.733 . . . . 0.0 112.355 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -140.02 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.887 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 m -96.83 119.35 35.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.46 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 96.1 m-20 69.39 70.4 0.25 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.039 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 m -141.71 107.99 5.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.068 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.0 mt -86.32 108.3 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.053 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.1 mt -116.64 107.53 14.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.342 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -73.59 125.43 27.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.49 -25.18 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 89.5 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.504 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 5.8 Cg_exo -75.52 122.36 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.284 1.989 . . . . 0.0 112.974 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.21 132.87 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.307 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -134.95 -169.64 2.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.759 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.3 ptm -129.47 149.7 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.428 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.16 -4.68 21.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.134 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.44 -108.07 2.73 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.14 128.48 54.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.073 -0.563 . . . . 0.0 111.099 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.6 pt -150.63 -178.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 120.679 0.276 . . . . 0.0 110.346 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 30.4 m-80 -96.19 136.42 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 40.6 tp -120.72 105.68 10.99 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t 60.23 42.76 14.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m 66.69 8.92 6.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.883 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.5 m -112.03 112.63 52.63 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.63 124.08 15.27 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.233 1.288 . . . . 0.0 111.204 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.0 m -130.33 141.32 50.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.84 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -99.42 151.87 20.61 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 57.64 62.82 2.0 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.945 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.554 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 8.0 mmt -93.63 134.45 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.715 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 57.4 mt -94.97 141.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.905 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.537 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 18.3 ttp180 -125.43 125.39 43.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.578 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.491 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.9 OUTLIER -127.6 130.83 49.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.349 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 87.36 3.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.621 0.724 . . . . 0.0 109.202 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.06 114.7 1.5 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.094 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.8 116.51 3.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 112.236 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.67 160.02 37.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.956 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 142' ' ' LYS . 53.2 mtpt -136.97 177.24 8.01 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.349 1.071 . . . . 0.0 112.101 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.537 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 1.5 p -45.03 155.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.126 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.37 13.26 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.67 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -90.9 -6.31 54.32 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.138 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.625 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 26.6 p -73.3 133.87 44.02 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.889 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.84 -21.18 18.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.0 149.07 38.79 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.095 -0.552 . . . . 0.0 112.976 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.47 121.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 112.46 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.1 tp -93.66 107.72 19.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.8 p -149.19 172.29 15.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.081 0.943 . . . . 0.0 113.325 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 167.61 24.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.273 -1.785 . . . . 0.0 107.437 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.9 t -65.1 101.21 0.5 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.944 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.61 -12.95 39.13 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -134.46 121.53 21.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.6 mt -101.48 117.09 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -88.48 -33.64 17.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.124 0.487 . . . . 0.0 111.806 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.485 ' CA ' HD13 ' A' ' 173' ' ' LEU . . . 152.18 -150.73 22.63 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.538 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.1 pt -129.54 145.95 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.046 0.927 . . . . 0.0 112.024 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.42 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 6.6 t60 -60.99 123.75 18.53 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.603 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.479 HG23 ' HG2' ' A' ' 71' ' ' GLU . 9.8 p -111.84 -29.11 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.351 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -177.13 -147.51 6.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.229 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.54 160.32 29.62 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.77 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 15.3 t-20 -137.23 105.02 5.58 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.58 -115.26 5.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.263 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -104.79 -0.28 27.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.19 0.519 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.18 125.14 48.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.21 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.66 149.59 23.59 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.537 ' CZ ' ' HG3' ' A' ' 136' ' ' ARG . 49.3 m-85 -125.71 129.52 49.7 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.88 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 160' ' ' HIS . 39.5 m -121.6 165.16 16.11 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.987 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.19 132.42 38.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.36 106.27 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.868 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.485 HD13 ' CA ' ' A' ' 158' ' ' GLY . 11.0 mp -85.28 85.73 7.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.98 129.1 37.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.837 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -43.1 -38.55 2.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.477 0.656 . . . . 0.0 111.489 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -49.75 -41.74 44.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.689 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 121.253 0.549 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.9 tt0 -115.66 81.44 1.59 Allowed 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 171.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -80.97 149.14 29.46 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 35.8 tp -103.81 152.98 21.25 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.55 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.8 m-85 -61.2 145.03 52.57 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.625 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.8 mt-30 . . . . . 0 N--CA 1.443 -0.806 0 C-N-CA 118.836 -1.145 . . . . 0.0 . -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 CA--C 1.537 0.652 0 N-CA-C 114.117 0.776 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -52.4 -47.87 66.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.842 0.83 . . . . 0.0 110.934 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -56.28 -52.74 63.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.881 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.26 -30.23 63.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.81 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.28 -50.41 70.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.74 96.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.374 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.5 tt -54.54 -46.31 73.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -79.82 -32.7 40.71 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.933 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.28 -43.43 98.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.026 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 4.6 pp -67.14 -26.89 66.89 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 65.5 mtp180 -73.69 -27.82 61.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.72 0.295 . . . . 0.0 111.101 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -97.55 -50.94 4.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -114.59 13.67 17.52 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 57.6 mt -122.29 117.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.034 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.1 mtp -128.99 146.89 50.85 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.788 0.804 . . . . 0.0 110.128 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.24 99.08 2.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.32 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.24 98.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.664 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 73.0 p -74.67 98.08 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.97 179.37 4.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.43 -176.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.546 ' H ' HG23 ' A' ' 20' ' ' THR . 4.8 m -62.48 -25.49 68.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.167 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -93.7 -39.17 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.99 -154.02 14.24 Favored Glycine 0 C--O 1.234 0.126 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -93.67 117.25 29.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -117.12 151.28 37.17 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.025 0.917 . . . . 0.0 112.978 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 21.3 m -79.06 100.21 7.25 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.06 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.09 101.15 2.17 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -96.41 111.38 23.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 131.7 11.07 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG13 ' CE1' ' A' ' 178' ' ' PHE . 43.2 mm -98.84 -56.59 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 117.518 0.659 . . . . 0.0 111.097 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -145.45 129.55 17.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.908 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 m-20 55.12 -90.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.824 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.4 ptp180 -128.32 7.41 5.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.4 0.619 . . . . 0.0 111.397 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.7 t -87.65 111.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.938 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.2 m -119.3 159.14 24.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.68 144.52 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.576 0.703 . . . . 0.0 111.098 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -152.68 140.55 13.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.631 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.19 148.31 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.052 1.168 . . . . 0.0 111.234 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.708 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 77.7 m -68.86 -40.33 79.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.633 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -68.42 4.02 1.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.68 -25.53 53.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.885 0.85 . . . . 0.0 108.88 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 57.99 70.97 1.13 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.854 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.89 131.12 10.9 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.087 2.525 . . . . 0.0 111.318 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.18 -161.29 32.45 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.554 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.12 -21.39 50.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.767 0.784 . . . . 0.0 109.383 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.5 p-10 -133.03 133.79 43.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.93 163.67 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.796 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -103.01 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.301 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.64 92.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 68.38 19.72 8.82 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.285 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.4 32.9 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.841 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 112.98 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 2.2 pptp? -76.51 134.18 39.55 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.43 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.8 tp -144.35 137.55 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.084 -1.417 . . . . 0.0 108.488 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 39.0 mtt180 -93.69 138.54 31.8 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.614 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.51 138.26 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.87 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -83.39 -49.55 9.22 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.841 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.06 137.56 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.001 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -124.7 85.55 2.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -90.94 123.1 34.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.321 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.48 127.41 32.09 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.678 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.595 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 83.5 mt -90.13 116.77 28.39 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.372 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.19 159.55 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.609 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 27.6 t70 -76.64 144.86 74.12 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 15.9 Cg_endo -55.88 -5.16 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.395 2.063 . . . . 0.0 113.123 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.68 17.8 19.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.033 0.921 . . . . 0.0 109.939 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t30 74.5 0.02 3.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.814 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.34 155.01 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -67.4 146.62 53.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 0.0 111.742 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.4 tp -108.75 -22.8 12.06 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.708 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 24.4 tp10 78.96 11.8 1.44 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.397 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.9 mm? -102.25 151.25 22.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.218 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.8 m -124.47 120.38 31.85 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.308 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.4 100.82 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.1 93.42 9.14 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.583 0.706 . . . . 0.0 109.996 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -87.15 109.82 19.71 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.134 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 69.7 mt -106.77 151.73 24.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.648 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.92 102.45 6.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.443 ' NH2' ' HG2' ' A' ' 81' ' ' GLU . 22.5 mmm180 -119.29 108.13 14.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -83.28 -29.58 28.27 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -101.25 91.38 4.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 174.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 52.3 pttt -97.86 178.96 4.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.48 171.85 8.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.787 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.46 138.23 31.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.67 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.44 92.09 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.67 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.6 pt -88.13 21.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.057 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.44 -30.39 64.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.57 -20.28 77.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.074 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 77.5 m-85 -93.19 -8.84 41.28 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.8 mm -76.97 134.04 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -81.41 112.88 19.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -77.03 -27.03 54.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -143.44 131.75 22.07 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.991 -1.913 . . . . 0.0 106.219 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.2 mt -74.82 -80.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.26 71.38 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.466 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.23 80.41 0.14 Allowed Glycine 0 C--N 1.331 0.262 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 9.3 p -70.3 9.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 20.7 t70 -138.75 124.53 19.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.44 155.54 47.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.19 0.995 . . . . 0.0 112.958 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 m -107.76 143.13 36.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.154 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -115.73 111.94 21.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.76 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.23 99.54 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.42 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.03 122.69 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.431 0.634 . . . . 0.0 111.197 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.586 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 66.0 t60 -135.42 57.09 1.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -121.63 -163.91 1.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 112.996 -1.911 . . . . 0.0 112.379 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.05 -44.52 88.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.528 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -70.82 -60.84 2.02 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.679 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -113.11 108.63 17.57 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.856 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 15.7 m -96.48 97.62 9.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.446 0.641 . . . . 0.0 109.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.586 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 16.6 t30 74.44 71.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.584 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 m -143.51 121.47 12.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.698 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.43 115.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.141 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.15 157.52 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.93 140.09 40.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.07 -23.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.807 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.34 -125.92 7.13 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.881 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.5 Cg_endo -67.61 113.91 3.12 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.596 2.197 . . . . 0.0 114.187 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 157.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -145.45 158.75 43.78 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.104 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.21 140.14 48.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.897 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.99 -28.35 12.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.647 0.261 . . . . 0.0 111.671 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.99 -121.46 7.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.282 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.05 113.94 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.627 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.2 pt -132.46 176.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 38.4 m-80 -94.66 102.97 14.9 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.399 0.619 . . . . 0.0 110.804 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 57.0 tp -83.75 104.93 14.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.2 m 63.34 31.03 15.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.288 0.566 . . . . 0.0 109.657 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.4 m 81.41 0.58 1.62 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.545 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.9 m -108.51 117.48 54.3 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.5 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.26 119.93 6.55 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.336 2.024 . . . . 0.0 112.88 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -132.27 134.12 44.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.881 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.6 t30 -104.53 161.19 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.993 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.609 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 1.9 mpt_? 69.12 43.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.514 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 6.3 mmt -90.95 116.35 28.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 70.6 mt -85.44 130.65 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -110.75 136.04 50.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -148.48 113.55 5.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 6.7 p-10 -74.59 97.99 3.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.566 1.174 . . . . 0.0 110.526 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -149.02 139.26 22.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 111.873 -2.421 . . . . 0.0 107.69 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.85 90.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -106.17 158.56 16.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -139.24 159.64 41.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.198 0.999 . . . . 0.0 111.747 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.491 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 2.8 m -44.3 158.92 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.852 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.81 -17.75 57.23 Favored Glycine 0 N--CA 1.462 0.401 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.912 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -94.22 8.57 41.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.708 -0.246 . . . . 0.0 111.575 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.78 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 16.8 m -63.2 122.0 15.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.208 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 118.61 -20.87 10.02 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.71 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.91 130.24 23.04 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.12 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.94 115.55 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.2 tp -88.76 108.51 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.7 p -147.6 176.95 9.67 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.992 0.901 . . . . 0.0 112.785 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.97 173.09 14.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.529 -1.668 . . . . 0.0 107.765 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.8 m -64.49 108.75 1.74 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.191 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.27 -7.19 59.96 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.922 -0.656 . . . . 0.0 114.291 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 18.3 ptpt -155.89 137.32 14.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.02 126.79 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -88.06 -34.34 17.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.208 0.527 . . . . 0.0 111.49 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 160.37 -159.08 30.51 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.288 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.0 pt -129.97 149.75 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.669 0.747 . . . . 0.0 111.671 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -61.77 120.27 10.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.862 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.8 t -114.55 -26.83 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.377 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.09 -149.24 7.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.169 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.32 148.43 7.5 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.491 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 9.0 t-20 -118.27 105.69 12.02 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.08 -102.95 0.98 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -121.75 19.03 11.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.302 0.572 . . . . 0.0 110.601 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 0.5 OUTLIER -111.94 109.03 18.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -71.07 146.95 42.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.1 m-85 -127.53 119.45 26.06 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.2 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.4 m -110.6 156.0 21.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.627 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.478 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.05 131.85 37.01 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -71.31 105.17 3.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.645 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 72' ' ' LEU . 73.0 mt -87.98 91.26 8.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.522 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -79.68 127.0 31.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.599 0.714 . . . . 0.0 109.54 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -42.25 -34.83 0.84 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.853 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.52 -38.92 64.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -67.42 -13.44 62.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.402 ' CE1' HG13 ' A' ' 30' ' ' ILE . 83.9 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.164 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.442 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 41.0 tt0 -106.08 81.59 1.65 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -85.32 127.86 34.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.183 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 28.5 tp -89.78 151.12 21.97 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -58.27 139.77 54.51 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.78 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.6 mt-30 . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 120.183 -0.607 . . . . 0.0 . 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 CA--C 1.53 0.275 0 N-CA-C 112.655 0.214 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.461 ' HA ' ' HG1' ' A' ' 153' ' ' THR . 41.1 t-20 -62.57 -40.05 95.62 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.866 0.841 . . . . 0.0 109.177 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -43.83 87.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.41 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -64.43 -42.65 95.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.196 0.522 . . . . 0.0 109.708 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.14 -47.19 86.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 109.758 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.82 92.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.13 -48.59 80.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -70.69 -38.83 73.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.256 0.55 . . . . 0.0 110.113 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.41 -42.88 96.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.425 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 8.4 tt -60.33 -51.46 69.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.611 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -67.55 -28.76 68.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 4.7 mmpt? -99.86 -26.27 14.07 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.156 0.889 . . . . 0.0 113.088 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -123.58 -12.43 7.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.5 mt -107.07 120.88 59.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.726 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 22.4 mmt -127.45 145.69 50.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.065 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -76.52 105.69 7.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.404 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 43.2 mm -95.3 111.82 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.338 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 13.5 m -91.44 114.43 26.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.896 0.855 . . . . 0.0 110.468 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.44 ' OG1' ' HB1' ' A' ' 41' ' ' ALA . 9.0 p -118.05 -162.95 0.91 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.186 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 13.0 m -69.76 -38.08 76.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HE3' ' HZ ' ' A' ' 25' ' ' PHE . 26.0 ttpp -83.0 -19.79 36.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.328 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.38 -156.93 27.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.412 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -109.39 117.82 35.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.922 0.867 . . . . 0.0 109.952 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HZ ' ' HE3' ' A' ' 22' ' ' LYS . 41.3 m-85 -109.91 171.75 7.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.629 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 73.1 m -86.89 108.94 19.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -94.01 126.88 8.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -101.31 104.63 15.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.087 0.47 . . . . 0.0 111.236 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 111.07 3.23 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.9 mm -75.4 -58.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 122.561 -0.376 . . . . 0.0 112.007 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -166.41 164.11 17.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.557 0.694 . . . . 0.0 112.79 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.99 -101.37 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.389 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -129.19 20.85 5.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.421 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.87 124.69 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.232 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 75' ' ' LEU . 6.3 p -124.27 141.12 52.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.202 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.87 121.52 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.371 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.09 133.56 24.39 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.646 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.83 139.04 78.12 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 N-CA-C 109.013 -1.187 . . . . 0.0 109.013 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.557 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.9 m -63.84 -35.38 80.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.753 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -69.3 -3.52 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.44 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -71.8 -28.66 63.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 72.2 mm-40 62.51 71.38 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.771 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -75.32 142.7 27.22 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.075 2.517 . . . . 0.0 111.496 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.03 -157.02 30.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.001 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.52 -21.94 28.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.595 0.712 . . . . 0.0 110.354 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.36 117.59 19.98 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.58 145.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 69.8 mt -85.23 103.47 14.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.659 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.27 90.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 12.4 t30 59.03 58.36 3.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.241 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.59 -32.64 1.87 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.659 -1.155 . . . . 0.0 114.391 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' OE1' HG12 ' A' ' 54' ' ' ILE . 25.0 tm0? -83.52 142.42 30.91 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.759 -0.26 . . . . 0.0 110.542 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.08 127.4 38.61 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 77' ' ' LEU . 21.3 mm -137.39 133.45 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.358 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -91.5 142.46 27.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 110.838 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.44 136.18 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.333 -176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -88.64 -42.74 11.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -171.96 132.23 0.68 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.337 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.42 119.39 36.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.45 126.48 50.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.466 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 49.9 mtpt -79.57 128.29 33.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 26.6 mt -95.58 127.25 41.46 Favored 'General case' 0 C--O 1.254 1.327 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 156.16 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 66' ' ' GLU . 24.4 t70 -72.73 142.19 83.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.407 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.0 -10.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.54 1.493 . . . . 0.0 112.096 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 64' ' ' ASP . 4.0 tp10 -76.92 -3.2 37.49 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 108.704 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 64' ' ' ASP . 24.9 m120 75.44 16.71 2.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.002 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.29 147.71 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -59.9 135.93 57.85 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -99.79 -22.81 15.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.557 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 28.3 tp10 76.28 14.96 2.35 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.119 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 78.6 mt -98.81 114.11 26.52 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.438 0.461 . . . . 0.0 112.013 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.5 m -93.5 111.48 23.15 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.04 100.05 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.4 tp -83.28 94.32 7.89 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.959 0.885 . . . . 0.0 110.958 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.8 m -85.37 105.96 16.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -108.37 152.9 24.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.31 -177.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -84.56 94.62 8.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.839 0.828 . . . . 0.0 109.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -144.35 128.07 17.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.384 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.03 -21.89 29.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.92 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -79.93 87.06 5.38 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -72.86 157.05 38.2 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.583 -175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -93.9 147.33 23.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.38 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -55.92 135.88 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 85' ' ' ASP . 3.3 p-10 -81.95 89.56 6.39 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.454 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 28' ' ' LEU . 32.8 pt -86.74 15.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.504 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -61.8 -23.66 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.91 -19.23 80.03 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.574 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 97.8 m-85 -86.34 -22.38 26.72 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 59.4 mt -71.98 136.8 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -125.12 142.47 51.47 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.1 pm0 -80.91 -15.34 56.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.42 153.56 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -100.07 -68.09 0.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.493 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 41.7 73.87 0.12 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.83 88.85 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.2 -13.61 16.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.968 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -106.85 125.68 51.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.92 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.63 149.66 39.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.878 0.847 . . . . 0.0 112.179 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -112.62 142.01 45.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -115.63 109.67 18.09 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.59 114.65 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.295 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.8 133.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.749 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -140.0 31.94 1.98 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 20.2 p -109.77 -160.67 0.73 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.385 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.411 ' H ' ' HB2' ' A' ' 105' ' ' SER . 4.4 t-20 -52.09 -61.74 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.99 -34.85 71.78 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -137.84 122.47 18.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.725 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 8.4 m -119.34 128.77 54.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.95 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 109' ' ' THR . 88.5 m-20 65.95 28.51 10.57 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.501 0.667 . . . . 0.0 110.095 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 m -99.87 103.36 14.95 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.906 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -90.55 100.08 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.37 117.98 30.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.35 120.78 18.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.52 -36.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.885 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.67 -128.56 8.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.859 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.67 113.43 3.49 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.023 1.815 . . . . 0.0 112.542 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.1 p -107.82 147.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.468 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 t -155.88 167.03 31.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.4 ttm -93.05 141.83 27.97 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.804 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.24 -33.75 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.517 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.52 -101.99 2.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.324 -0.853 . . . . 0.0 114.307 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp -125.24 122.24 36.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.729 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 48.3 pt -143.02 -176.53 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 10.0 m120 -106.55 85.76 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 23.4 tp -70.54 111.15 5.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.616 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.6 p 64.07 25.25 13.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.421 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 m 85.65 -3.68 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.222 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.1 m -99.89 125.97 38.43 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.797 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.62 120.23 7.76 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.334 2.022 . . . . 0.0 113.879 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 p -123.97 137.74 54.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.862 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -110.39 160.5 16.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 16.0 mmm180 64.76 29.31 12.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.097 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.445 ' SD ' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -73.05 121.73 20.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.017 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.76 144.19 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.048 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 13.8 ptt180 -129.38 143.15 50.73 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.904 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -129.36 131.43 46.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.82 103.49 1.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.198 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -178.42 133.75 0.14 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.496 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.18 110.35 4.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.372 0.606 . . . . 0.0 110.1 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.417 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 21.2 p -111.25 148.6 32.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.029 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -133.24 151.46 51.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.067 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.3 161.46 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.129 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.53 -13.42 67.4 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.532 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -102.08 8.22 40.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.863 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.774 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 7.6 m -64.75 141.63 58.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.127 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.678 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.61 -6.7 74.39 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.058 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.28 38.75 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.18 110.78 17.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.71 105.06 15.22 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.2 p -144.45 178.07 8.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.397 1.094 . . . . 0.0 113.639 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.43 176.1 9.62 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.605 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.461 ' HG1' ' HA ' ' A' ' 3' ' ' ASN . 2.9 m -71.21 100.52 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.24 12.16 60.31 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.831 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 40.3 ttmt -155.33 134.58 12.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.306 0.574 . . . . 0.0 111.124 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.11 131.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.766 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.79 -43.01 7.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA2' HD11 ' A' ' 173' ' ' LEU . . . 169.17 -152.65 20.46 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.938 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.9 pt -135.22 150.18 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 122.077 0.942 . . . . 0.0 113.147 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.33 118.7 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.907 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.47 -21.73 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.049 0.452 . . . . 0.0 110.857 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.28 -147.75 8.13 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.927 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 169' ' ' PHE . . . 171.51 161.12 21.57 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.575 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 55.2 t30 -128.23 82.17 2.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.495 0.664 . . . . 0.0 109.248 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.28 -107.22 2.1 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.869 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -90.59 7.55 38.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -124.75 110.77 14.75 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -77.8 142.55 26.78 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.501 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 49.2 m-85 -118.83 127.16 53.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.852 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -125.3 163.48 22.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.157 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -99.35 141.11 32.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.275 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 8.3 tt0 -77.39 106.91 9.44 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.986 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.494 HD11 ' HA2' ' A' ' 158' ' ' GLY . 11.1 mp -94.52 85.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.225 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.91 135.13 37.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 7.4 ttpm? -54.38 -35.95 63.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.719 0.771 . . . . 0.0 109.813 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -53.06 -34.56 57.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.633 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -71.92 -25.9 62.09 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.257 -0.277 . . . . 0.0 111.08 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.517 0.675 . . . . 0.0 110.357 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.426 ' N ' HD12 ' B' ' 2' ' ' LEU . 6.6 mp . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 120.991 0.424 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -96.48 74.77 2.84 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.575 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -76.51 146.75 38.24 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.9 tp -106.05 148.69 27.48 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.573 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 19.1 m-85 -57.74 135.64 56.8 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.774 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 81.7 mt-30 . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 . 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo . . . . . 0 N--CA 1.464 -0.219 0 N-CA-C 113.488 0.534 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.04 -35.64 66.79 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -65.19 -44.97 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.154 0.978 . . . . 0.0 108.584 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.86 -47.03 83.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.634 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.75 -46.3 79.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.276 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.03 93.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.21 -44.8 94.29 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 122.165 -0.334 . . . . 0.0 110.796 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -65.38 -40.12 93.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 109.893 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.5 tp -64.54 -44.81 89.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.169 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.422 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 5.4 tt -55.14 -46.64 75.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.251 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.13 -45.46 66.8 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.56 -2.21 20.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 115.635 1.716 . . . . 0.0 115.635 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -135.55 -12.24 2.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.265 -0.974 . . . . 0.0 113.294 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 49.2 mm -106.83 101.82 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.81 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -120.22 135.89 54.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.542 0.687 . . . . 0.0 110.261 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.13 102.25 2.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.09 100.0 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.325 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' A' ' 48' ' ' LEU . 8.9 t -94.94 130.2 41.67 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.105 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.5 t -146.4 -157.55 0.82 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 m -51.54 -50.74 59.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.71 -16.25 39.63 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.73 -157.69 28.41 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 119.608 -1.282 . . . . 0.0 114.727 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -112.48 114.36 27.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.394 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.37 159.78 25.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.58 0.705 . . . . 0.0 111.674 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.2 m -72.64 106.01 4.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.613 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.62 106.68 3.34 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -87.53 106.55 18.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.336 0.589 . . . . 0.0 111.957 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 117.72 8.01 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 47.9 mm -89.08 -64.21 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 117.099 0.45 . . . . 0.0 112.077 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 58.36 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.237 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.9 ptp180 -129.78 15.22 5.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 110.678 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.93 122.66 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.788 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -122.37 156.03 34.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.804 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -114.82 135.16 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.478 0.656 . . . . 0.0 109.847 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' HB ' ' A' ' 73' ' ' THR . 12.3 tt -144.94 142.06 18.13 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.614 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.47 149.66 23.02 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 120.888 1.059 . . . . 0.0 110.579 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.558 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 33.0 m -73.27 -36.74 66.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -66.94 -1.26 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -22.14 59.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.541 0.686 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.31 71.96 1.09 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.56 127.06 18.05 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.932 2.421 . . . . 0.0 112.374 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.58 -169.15 29.32 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.451 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 56' ' ' VAL . 2.6 p-10 -78.15 -16.31 58.05 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -143.18 137.61 29.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.69 156.12 37.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB2' ' CG2' ' A' ' 19' ' ' THR . 7.5 mp -97.41 103.08 14.98 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.301 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 49' ' ' VAL . 7.7 p -84.66 102.42 10.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.542 0.686 . . . . 0.0 110.154 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.6 t30 66.66 19.17 10.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.644 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.12 -22.11 11.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.583 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -92.1 115.66 28.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.318 0.559 . . . . 0.0 111.89 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.58 128.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -139.27 137.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.878 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -65.18 139.61 58.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.474 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 45' ' ' ASP . 14.4 p -87.06 136.75 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 76' ' ' THR . 57.1 tptt -78.36 -47.04 18.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.82 0.819 . . . . 0.0 108.833 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.06 133.46 1.46 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -106.99 92.76 4.22 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -86.22 106.21 17.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.754 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.77 121.08 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.906 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mt -89.88 113.34 24.93 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.704 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -94.02 165.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' HH21 ' A' ' 133' ' ' ARG . 15.7 t70 -71.58 137.42 83.29 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.632 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HG2' ' NH2' ' A' ' 133' ' ' ARG . 7.0 Cg_endo -52.36 -15.68 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.857 1.705 . . . . 0.0 112.771 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.48 16.48 8.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.894 0.854 . . . . 0.0 109.059 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.0 t30 72.21 10.43 5.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.92 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 69' ' ' ASN . 15.9 mt -92.66 176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.51 ' H ' HG22 ' A' ' 68' ' ' ILE . 51.4 t30 -81.75 143.4 31.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 118.514 0.597 . . . . 0.0 111.22 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.565 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 26.5 tp -118.54 -27.49 5.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.558 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 26.5 tp10 70.55 10.62 7.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.666 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 10.9 tp -96.11 103.11 14.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.866 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 78.0 m -90.92 115.42 27.94 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.565 0.698 . . . . 0.0 111.616 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.73 94.17 3.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.3 tp -81.47 104.51 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.797 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 8.7 m -98.59 115.09 27.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.572 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mp -117.47 150.01 39.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.718 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.73 91.49 7.97 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.438 ' HE ' ' HA ' ' A' ' 79' ' ' ARG . 2.2 tpm_? -112.51 110.33 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.58 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.31 -54.0 51.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.783 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -74.73 92.59 2.48 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -70.74 147.3 49.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.221 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -88.06 146.96 25.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.991 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -58.41 120.62 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.103 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 7.4 p-10 -77.37 94.24 4.18 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 121.709 0.766 . . . . 0.0 112.408 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.2 17.13 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.95 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 88' ' ' GLY . 5.0 ppt_? -59.03 -23.95 62.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.16 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 87' ' ' ARG . . . -84.08 -13.63 73.99 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.642 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.53 -3.36 46.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.1 mt -82.55 127.31 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.449 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 6.5 m -83.69 110.89 18.66 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.19 -49.95 31.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 91' ' ' SER . 23.8 t70 -97.78 115.66 28.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 173.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.1 mt -60.75 -72.23 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.88 67.41 0.93 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -146.49 75.38 0.28 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.344 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 p -97.38 0.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 10.9 t70 -149.88 125.72 10.48 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.115 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -153.6 176.7 11.77 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.473 1.13 . . . . 0.0 114.041 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -115.4 138.78 50.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.783 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -115.55 110.66 19.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.09 124.78 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.096 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.6 139.82 38.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 122.035 0.921 . . . . 0.0 113.063 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -149.35 71.79 1.13 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.045 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.4 p -125.55 -174.01 2.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.637 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -59.85 -44.68 93.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.866 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.85 -41.05 15.33 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -115.96 98.15 6.49 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.4 m -105.59 122.78 46.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.581 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 66.73 73.36 0.36 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.8 m -142.25 102.85 4.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.731 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.93 108.92 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.11 120.98 32.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -72.54 118.1 15.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 137' ' ' TYR . 13.8 p -92.14 -26.29 4.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.707 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.57 -125.84 7.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.593 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.87 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.345 2.03 . . . . 0.0 113.453 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.615 HG11 ' O ' ' A' ' 96' ' ' GLY . 2.8 p -136.61 141.89 39.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.589 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 m -153.08 139.37 18.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 27.3 ptt? -74.01 140.2 45.28 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.822 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.07 -66.24 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.48 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.32 -122.35 1.78 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.885 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt -103.06 117.79 35.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.448 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 36.0 pt -138.52 -176.38 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.6 m120 -105.18 83.95 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.982 0.42 . . . . 0.0 111.198 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 59.3 tp -65.93 108.03 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.212 0.529 . . . . 0.0 110.048 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 128' ' ' SER . 3.5 m 61.24 33.48 19.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 127' ' ' SER . 22.7 t 76.97 8.97 2.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.472 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -112.12 113.45 51.83 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.819 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.67 113.37 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.847 1.698 . . . . 0.0 111.649 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 126' ' ' LEU . 29.5 m -124.69 139.65 53.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.103 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -113.4 159.66 19.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' NH2' ' HG2' ' A' ' 65' ' ' PRO . 8.2 mtm180 56.37 61.45 2.7 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.319 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.404 ' HE2' HD13 ' A' ' 126' ' ' LEU . 58.0 mtp -109.6 132.67 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.156 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 50.2 mt -86.1 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ttp180 -132.27 147.01 52.39 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.16 0.505 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.498 ' CD1' HG22 ' A' ' 115' ' ' VAL . 23.2 p90 -143.16 134.97 26.71 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.35 94.52 7.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.248 1.023 . . . . 0.0 110.555 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -155.86 133.63 11.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.942 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.11 105.56 0.42 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.394 0.616 . . . . 0.0 111.22 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 p -119.17 141.97 48.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -129.29 164.39 23.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.095 0.95 . . . . 0.0 112.03 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.549 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 1.0 OUTLIER -43.1 150.25 0.18 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.405 174.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.51 9.36 Favored Glycine 0 N--CA 1.463 0.44 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -68.55 -7.81 35.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.814 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.803 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 22.5 m -58.75 137.86 57.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 99.39 -17.87 57.19 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.734 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.26 126.86 37.78 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.242 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.15 117.49 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.07 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.25 110.45 17.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.0 p -147.03 -177.25 5.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.056 0.931 . . . . 0.0 112.704 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.76 30.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 t -62.93 108.28 1.17 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.831 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.1 75.51 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.923 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -141.55 121.01 13.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.2 mm -102.87 130.1 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.56 -52.92 2.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.505 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -176.89 -174.09 43.03 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.792 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 pt -118.97 139.07 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.414 0.626 . . . . 0.0 110.586 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -69.52 122.27 18.69 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.28 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.76 -9.58 11.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.8 -161.78 29.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.167 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.36 158.46 26.9 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.061 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.525 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 3.7 t-20 -129.75 89.62 2.85 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.909 0.385 . . . . 0.0 110.336 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 -107.88 2.33 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.408 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -96.04 1.67 52.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.238 0.542 . . . . 0.0 110.173 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -107.95 109.3 20.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.314 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -80.26 137.67 18.72 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.02 125.48 46.39 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.571 -0.852 . . . . 0.0 113.069 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.4 m -120.92 151.82 39.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.106 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.44 130.91 39.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.448 ' HB3' HD12 ' A' ' 135' ' ' ILE . 20.0 pt20 -87.79 110.99 20.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 118.468 -1.293 . . . . 0.0 112.722 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.505 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -88.76 94.78 10.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.88 139.79 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.952 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -45.6 -35.41 4.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.05 -26.45 37.66 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.42 -15.74 54.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 173' ' ' LEU . 25.3 m-85 . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.589 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.1 mm? . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.5 tt0 -114.59 71.85 0.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.88 133.71 39.2 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.397 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 15.9 tp -95.73 152.17 18.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.574 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 27.8 m-85 -56.98 137.7 55.24 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.803 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.5 mt-30 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 . 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--O 1.231 0.157 0 N-CA-C 114.085 0.763 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.589 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.7 t-20 -68.53 -45.14 73.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.709 0.766 . . . . 0.0 110.528 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.4 m -57.54 -43.59 84.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.143 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.02 -24.29 52.13 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.8 -43.54 58.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.35 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.175 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 8' ' ' LEU . 2.8 tm? -59.53 -39.44 83.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.279 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -69.53 -47.34 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.794 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.42 -38.5 84.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.7 tp -55.57 -49.14 73.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -68.49 -28.12 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.266 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -86.78 -63.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.11 -3.6 12.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -173.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 54.6 mt -99.99 131.45 47.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.872 -1.131 . . . . 0.0 113.008 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -151.62 146.42 25.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.923 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 m -68.88 117.86 11.09 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.488 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mt -98.64 98.69 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.901 0.858 . . . . 0.0 110.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 58.5 m -70.9 99.22 1.72 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.018 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -175.53 3.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.45 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 m -70.54 -28.8 65.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.613 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -88.17 -45.81 9.79 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.083 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.27 -168.07 26.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.492 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 34.3 mt-10 -108.22 103.03 12.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.798 0.808 . . . . 0.0 109.228 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 41' ' ' ALA . 40.6 m-85 -97.75 165.39 11.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.853 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 97.7 m -83.24 108.17 16.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.97 136.49 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.93 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 28' ' ' LEU . 2.5 pt? -124.61 135.72 53.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.582 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.64 142.69 27.12 Favored Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.83 -54.2 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.978 0.889 . . . . 0.0 110.066 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -167.83 138.77 2.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 82' ' ' LYS . 31.2 m-20 57.18 -88.74 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.508 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -125.49 5.78 7.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.405 0.622 . . . . 0.0 111.175 -178.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -88.18 120.67 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.034 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -131.48 141.25 49.74 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.009 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.59 151.13 34.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.56 167.8 12.6 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 113.043 -1.889 . . . . 0.0 106.303 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.78 175.47 2.3 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 121.289 1.326 . . . . 0.0 112.147 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.497 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 99.5 m -80.56 -36.81 32.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.544 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -72.3 4.99 3.14 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -69.21 -28.49 66.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.791 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 60.58 72.83 0.68 Allowed Pre-proline 0 CA--C 1.514 -0.43 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.27 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.28 123.52 6.66 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.013 2.475 . . . . 0.0 112.843 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.36 -172.01 46.04 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.19 -17.12 38.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.888 0.844 . . . . 0.0 109.71 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 18.9 t70 -134.85 109.77 8.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.55 154.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 95.3 mt -99.42 99.6 10.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.494 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -83.06 93.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.415 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 t30 66.19 17.96 10.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.708 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.12 -21.81 8.15 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.523 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.87 118.02 23.14 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.741 -0.27 . . . . 0.0 110.278 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.633 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -81.98 119.34 23.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.706 0.765 . . . . 0.0 110.508 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.49 130.7 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.026 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.2 mtp-105 -85.83 126.48 34.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.264 0.554 . . . . 0.0 110.069 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.01 143.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.281 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -77.99 -52.79 8.25 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.763 0.792 . . . . 0.0 109.237 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -141.73 126.71 18.3 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.406 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -109.29 104.44 13.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -104.29 120.11 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.875 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.88 125.1 28.12 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 29.8 mt -90.7 111.85 23.37 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 122.0 0.905 . . . . 0.0 111.545 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.1 m -113.85 159.11 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 67' ' ' ASN . 14.7 t70 -67.72 138.42 93.23 Favored Pre-proline 0 C--N 1.311 -1.101 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.47 -21.99 32.64 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.532 1.488 . . . . 0.0 112.815 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.71 -0.04 55.55 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' ASP . 63.9 m-80 71.76 72.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.134 -1.848 . . . . 0.0 115.454 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.6 mm -137.41 151.96 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.516 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.465 ' O ' HG21 ' A' ' 131' ' ' THR . 22.8 t30 -62.87 111.83 2.3 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.883 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 15.0 tp -87.36 -27.11 23.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 71.62 31.14 2.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.898 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 94.1 mt -123.42 151.55 42.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 25.3 m -132.64 127.07 34.11 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.373 0.606 . . . . 0.0 110.516 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG22 ' HG ' ' A' ' 62' ' ' LEU . 85.7 t -87.63 107.38 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.974 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.31 92.24 8.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -74.36 90.51 2.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.043 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.25 91.48 5.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' ARG . 18.7 p-10 -78.82 61.57 3.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.376 0.608 . . . . 0.0 109.866 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -82.55 160.32 22.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.34 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -61.31 -51.66 67.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -78.64 110.72 14.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 61.2 mttp -77.08 152.2 35.13 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.782 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -80.33 141.4 35.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.109 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.12 138.14 58.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.682 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 87' ' ' ARG . 11.4 p-10 -73.96 88.12 1.85 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.128 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.8 pt -88.0 12.11 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 85' ' ' ASP . 45.2 ttt180 -53.7 -38.4 64.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.838 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.74 76.75 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.709 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -87.49 -12.7 45.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.62 129.98 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 13.5 m -120.5 122.39 40.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.633 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.5 mp0 -64.66 -48.41 74.87 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 91' ' ' SER . 30.0 t70 -95.48 120.06 35.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -76.5 -54.83 6.17 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 41.05 66.15 0.7 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.306 0.574 . . . . 0.0 109.928 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.14 80.93 0.1 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.863 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -70.53 -7.59 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.82 121.49 45.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.81 40.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.599 0.714 . . . . 0.0 112.176 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 96.0 m -116.03 135.22 54.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.256 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -92.06 116.85 29.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.392 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.06 103.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 22.1 t -100.38 124.11 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.446 0.641 . . . . 0.0 110.98 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -137.37 50.3 1.98 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.8 m -107.93 -172.54 2.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.333 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 13.4 p30 -62.05 -35.37 78.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -55.61 -50.5 69.97 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.824 -0.547 . . . . 0.0 112.215 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -158.79 132.97 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.317 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 23.2 m -84.39 114.55 21.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.603 0.716 . . . . 0.0 110.969 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 109' ' ' THR . 5.6 m-20 77.24 72.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 2.0 m -116.73 109.29 16.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.5 pt -107.99 99.56 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.051 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.8 mt -97.29 117.64 31.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.892 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.03 98.93 9.54 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.92 -16.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.098 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.34 -128.99 9.04 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.535 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 22.9 Cg_endo -65.11 119.11 6.07 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.193 1.929 . . . . 0.0 114.816 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 137' ' ' TYR . 34.3 m -111.87 148.63 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.512 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 m -150.39 144.4 25.43 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.0 ptp -82.01 142.96 31.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.193 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.53 -42.46 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.093 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.27 -128.92 8.45 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.067 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 48.1 tp -99.26 110.52 23.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.84 0.352 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.62 175.33 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.996 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.677 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.8 m-20 -87.54 126.13 34.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 46.5 tp -111.58 107.51 16.69 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.44 ' HG ' ' C ' ' A' ' 126' ' ' LEU . 95.6 p 57.86 32.07 21.42 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.006 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.0 m 76.73 29.75 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.929 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -140.36 120.85 9.03 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.14 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.38 117.94 4.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.502 2.135 . . . . 0.0 114.123 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 69' ' ' ASN . 82.9 m -127.31 131.68 50.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.549 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 29.8 p-10 -102.67 169.38 8.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER 57.7 42.13 24.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.846 175.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.8 mmt -86.32 136.75 33.02 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.38 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.8 mm -101.07 137.63 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.093 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -127.84 148.32 50.46 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.502 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.452 ' HB3' HG11 ' A' ' 118' ' ' VAL . 25.0 p90 -143.03 151.74 41.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.263 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.89 113.51 22.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.832 0.825 . . . . 0.0 111.43 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -176.12 133.19 0.25 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.327 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -68.32 100.82 1.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.818 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.1 p -93.39 171.4 8.94 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.749 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -161.44 145.63 13.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.56 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.583 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.24 158.72 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.706 175.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.77 -24.33 15.64 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.003 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -85.76 4.49 36.6 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.769 0.428 . . . . 0.0 112.009 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.814 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 13.4 m -62.18 140.96 58.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.674 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 107.02 -20.69 32.99 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.77 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.76 130.45 26.92 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.532 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.36 124.18 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 110.73 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.7 tp -101.56 106.7 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.4 p -149.74 176.4 10.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.972 0.891 . . . . 0.0 112.922 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.589 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -137.28 172.73 12.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.591 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.3 t -61.31 108.76 0.97 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.066 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.56 -4.2 86.37 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -141.47 116.78 10.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.729 0.764 . . . . 0.0 111.836 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -93.99 126.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.73 -44.13 6.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.79 -165.01 34.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.7 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -129.63 144.5 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.437 0.637 . . . . 0.0 110.797 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -66.82 115.37 6.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.438 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.0 t -107.16 -27.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.169 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.19 -147.86 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.082 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.32 164.69 29.69 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.221 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.426 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 8.8 t30 -128.23 88.37 2.74 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.67 -109.62 2.78 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.636 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 18.1 ttt180 -88.54 3.84 48.91 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 113.37 19.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.295 0.569 . . . . 0.0 109.977 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -78.41 143.21 26.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 44.6 m-85 -121.86 124.42 44.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.352 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -123.11 142.38 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.008 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.37 125.45 31.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.689 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.539 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 50.2 tt0 -72.03 119.86 16.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.123 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.453 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.6 mp -88.19 92.83 9.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.83 132.56 33.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.633 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 ttpm? -58.48 -17.32 20.12 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.24 -29.99 67.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -81.11 -28.15 35.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.66 0.267 . . . . 0.0 111.569 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.468 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.561 0.696 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 34.5 tt0 -126.24 77.47 1.69 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.83 152.51 26.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.6 tp -107.69 154.87 20.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -63.69 141.28 58.83 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.814 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.6 mt-30 . . . . . 0 C--N 1.295 -1.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 . 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 N--CA 1.464 -0.264 0 N-CA-C 113.134 0.398 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.36 -42.65 78.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.293 -0.163 . . . . 0.0 110.897 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -72.2 -27.59 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.44 -45.5 75.86 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.87 -45.71 89.5 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.315 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.38 83.57 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.8 tp -68.1 -38.92 82.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -67.66 -38.08 83.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.002 0.429 . . . . 0.0 110.028 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.46 -40.45 93.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.528 0.68 . . . . 0.0 109.567 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 HD11 ' C ' ' A' ' 11' ' ' LEU . 3.1 tm? -50.59 -48.69 57.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.218 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -70.01 -29.61 66.72 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.39 -58.85 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.2 7.24 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.15 106.7 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.969 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.3 mtp -121.6 147.73 45.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -76.29 111.23 11.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.088 -178.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.407 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.7 mm -92.84 106.15 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.601 0.715 . . . . 0.0 110.463 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 6.7 m -75.96 98.35 4.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.628 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.469 HG21 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -103.47 -178.08 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.521 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.469 ' H ' HG21 ' A' ' 20' ' ' THR . 16.4 m -59.47 -32.24 70.06 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -88.97 -1.63 58.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.03 0.832 . . . . 0.0 111.253 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.24 -163.7 23.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.844 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 105' ' ' SER . 25.3 mt-10 -96.85 128.37 43.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.407 0.622 . . . . 0.0 110.902 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -123.22 166.94 14.4 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.804 0.812 . . . . 0.0 111.325 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 2.7 m -68.64 100.43 1.13 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.875 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -81.2 109.54 3.01 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.637 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.46 94.47 9.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.902 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.44 122.41 8.62 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.5 -50.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 117.678 0.739 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -161.25 153.64 20.24 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.963 0.887 . . . . 0.0 113.117 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 42.8 m-20 51.65 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.615 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.1 ptt180 -140.15 16.36 2.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.702 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.9 115.42 39.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.154 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -120.18 148.7 43.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.21 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.69 130.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.498 0.666 . . . . 0.0 112.141 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.39 165.42 28.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.85 163.62 36.68 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 121.647 1.565 . . . . 0.0 112.61 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.705 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 44.8 m -81.11 -38.95 26.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.161 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -71.31 2.27 5.02 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -12.9 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.663 0.744 . . . . 0.0 109.156 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 68.8 mt-30 62.44 73.23 0.55 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.341 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.88 159.54 47.97 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 122.537 2.158 . . . . 0.0 111.873 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.14 178.96 17.0 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.047 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HA ' HG11 ' A' ' 56' ' ' VAL . 24.0 m-20 -81.89 -19.7 40.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.889 0.844 . . . . 0.0 109.467 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -137.37 113.17 9.62 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.86 173.07 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.829 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 6.2 mp -112.3 138.16 49.4 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.765 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.33 83.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 2.4 t-20 62.23 27.0 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.12 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.39 -44.79 1.16 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.159 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.16 115.77 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -76.4 122.02 23.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -125.43 149.01 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.227 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.607 ' HD2' ' N ' ' A' ' 55' ' ' ARG . 7.8 mpt_? -96.61 145.51 25.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.221 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 45' ' ' ASP . 8.5 p -86.99 138.88 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.998 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.18 -42.23 17.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -158.81 132.12 7.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -117.44 116.38 27.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.55 120.54 39.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.256 0.55 . . . . 0.0 111.095 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.12 121.71 27.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.791 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 76.9 mt -85.91 123.51 31.34 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.331 0.586 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m -122.01 171.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.185 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 16.8 t70 -78.73 143.08 62.09 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -48.54 -26.13 8.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.829 2.353 . . . . 0.0 113.618 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.34 22.74 4.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 111.09 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.11 11.6 5.09 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.107 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 69' ' ' ASN . 25.4 mm -88.16 163.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.423 ' N ' HG23 ' A' ' 68' ' ' ILE . 54.9 t30 -73.33 139.27 45.92 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.548 HD11 ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.79 -36.68 6.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.705 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.8 tp10 84.07 22.0 0.14 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.34 -1.754 . . . . 0.0 114.498 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 173' ' ' LEU . 2.8 mm? -111.4 146.04 37.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.21 0.529 . . . . 0.0 110.834 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 26.3 m -117.33 114.48 23.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.564 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -80.93 100.08 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.32 100.67 12.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.71 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.4 m -92.38 93.88 8.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.066 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 96.0 mt -85.62 159.16 19.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.371 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -78.76 92.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -128.61 123.21 32.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.084 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -80.8 -57.3 3.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.61 114.79 5.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.1 ptpt -76.1 145.78 39.8 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.68 145.98 42.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -56.93 122.81 13.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.031 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 90.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.106 0.479 . . . . 0.0 111.072 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -96.27 32.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.033 0.444 . . . . 0.0 110.111 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.3 -30.72 71.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.237 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.59 -19.22 79.95 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.939 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -80.14 -16.39 55.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.614 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 52.7 m -94.69 122.41 37.27 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.063 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.585 ' O ' ' HE2' ' A' ' 174' ' ' LYS . 5.0 pt-20 -61.5 -29.65 70.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.031 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.451 ' HA ' ' CE ' ' A' ' 174' ' ' LYS . 37.8 t70 -131.05 163.35 27.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 95' ' ' GLU . 43.6 mt -74.47 -81.1 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 94' ' ' LEU . 12.8 pt-20 33.32 74.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.253 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' HA3' ' CZ ' ' A' ' 157' ' ' PHE . . . -157.7 92.25 0.12 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.462 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 61.5 t -62.15 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -124.36 132.45 53.54 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.58 174.6 10.81 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.738 0.78 . . . . 0.0 112.752 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.9 m -131.06 146.26 52.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.593 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.5 tp -105.98 113.91 27.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.34 110.92 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 109.994 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -112.08 117.33 54.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.275 0.56 . . . . 0.0 111.365 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -130.9 83.09 2.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 71.1 p -129.57 -164.56 1.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.891 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.76 -13.95 57.1 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -90.52 -66.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.347 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.573 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 56.2 m-85 -108.48 120.97 43.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.704 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.4 p -100.0 110.66 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.891 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.56 32.38 16.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 39.9 m -81.91 102.11 10.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.697 0.761 . . . . 0.0 110.905 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 112' ' ' ILE . 9.5 tt -100.13 92.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -101.22 113.15 25.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.139 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.69 112.0 6.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.832 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.15 -33.94 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.05 -123.68 7.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.323 -0.942 . . . . 0.0 114.165 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 35.1 Cg_endo -64.58 124.52 13.38 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.533 2.156 . . . . 0.0 113.85 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -106.21 137.43 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.063 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 p -132.27 171.01 14.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 59.6 ttp -120.13 139.66 52.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.938 0.399 . . . . 0.0 112.05 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.42 -43.66 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.693 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.43 -111.75 4.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.094 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.54 116.68 32.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 pt -144.8 -176.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 m-20 -101.95 123.05 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.257 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.3 mm? -102.13 111.69 24.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' SER . 17.3 t 60.46 30.88 20.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.453 0.644 . . . . 0.0 109.933 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 127' ' ' SER . 45.4 m 83.37 2.34 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.377 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.4 m -112.01 116.47 49.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.063 0.227 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.49 123.35 11.14 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 122.413 2.075 . . . . 0.0 112.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.434 ' HB ' HD22 ' A' ' 126' ' ' LEU . 70.6 m -131.94 138.42 48.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.903 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -101.93 169.59 8.68 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 13.5 mmt180 63.29 34.77 12.97 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.05 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.605 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 31.7 mmt -82.17 128.43 34.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.734 0.778 . . . . 0.0 112.058 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 19.9 mm -95.21 144.07 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 33.0 ptt180 -131.6 139.46 49.17 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.506 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.1 130.97 24.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.361 0.6 . . . . 0.0 109.928 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.2 96.71 0.66 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.246 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -175.09 121.25 0.21 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.093 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.56 108.17 2.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.849 0.833 . . . . 0.0 112.286 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.67 148.48 43.87 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.151 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -133.67 176.99 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.881 0.848 . . . . 0.0 112.81 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.9 OUTLIER -44.08 150.2 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.357 176.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.33 -22.69 31.19 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.352 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.84 3.7 47.35 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.776 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 1.8 m -58.93 134.88 57.33 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.954 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.65 8.35 59.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.523 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.91 135.93 20.97 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.239 -1.458 . . . . 0.0 109.571 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.4 t -86.32 117.45 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.666 0.733 . . . . 0.0 111.32 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.14 105.06 17.37 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.1 p -141.3 165.42 27.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.951 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.58 179.26 6.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -60.24 101.1 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.484 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.5 22.43 78.96 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.614 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 32.5 ttmt -147.92 108.72 4.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -94.36 123.1 46.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.468 ' CZ ' ' HA3' ' A' ' 96' ' ' GLY . 91.6 m-85 -91.57 -39.09 12.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.474 0.655 . . . . 0.0 110.755 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 157.4 -155.17 26.16 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.935 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.79 150.16 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.541 0.686 . . . . 0.0 110.903 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -69.15 122.22 18.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.016 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.07 -23.08 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.49 -156.54 12.0 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.855 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.64 157.9 25.61 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.1 t-20 -128.65 92.32 3.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.575 0.703 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.72 -104.99 1.49 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.741 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -95.85 2.27 53.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -127.25 129.55 47.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.308 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.1 146.52 22.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.483 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.9 m-85 -123.78 131.5 53.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.778 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.5 m -125.3 159.48 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.289 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.569 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -97.77 141.04 31.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.317 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 77.0 mt-30 -79.85 117.24 20.54 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.549 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 66.9 mt -96.74 71.75 2.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.585 ' HE2' ' O ' ' A' ' 92' ' ' GLU . 38.6 mtpt -79.75 135.3 36.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -56.38 -15.62 4.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.652 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -67.73 -16.91 64.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.15 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.36 -9.98 34.11 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.119 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 120.99 0.424 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.8 tt0 -110.99 78.94 1.15 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.64 137.75 34.39 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 39.2 tp -95.62 144.63 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.573 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.0 m-85 -59.87 137.86 57.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.776 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.9 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.226 -0.443 . . . . 0.0 . -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 CA--C 1.532 0.412 0 N-CA-C 115.255 1.213 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -66.35 -59.58 3.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 0.0 112.026 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 m -56.87 -42.22 79.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.89 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.41 -25.8 57.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.949 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -67.62 -46.44 72.51 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.69 99.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.26 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.62 -46.29 90.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -65.94 -44.96 83.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -62.83 -41.94 99.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.828 0.823 . . . . 0.0 110.811 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 31.0 tp -51.81 -51.48 56.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.01 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -63.02 -28.16 69.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -108.28 -49.26 3.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.43 -6.81 22.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 41.8 mt -102.18 108.44 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.415 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.1 mmt -119.17 148.32 43.22 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.953 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 m -76.83 117.17 18.17 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.147 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.78 95.79 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 28.1 m -84.07 108.57 17.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -129.73 -170.6 2.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.538 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -56.81 -49.1 76.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.43 ' HD2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 tmtt? -71.02 -27.71 63.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.64 -156.99 28.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.677 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.02 117.1 32.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.43 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 43.6 m-85 -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.154 0.978 . . . . 0.0 112.295 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 75.4 m -88.68 95.77 10.39 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 113.399 -1.728 . . . . 0.0 107.93 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.23 116.94 4.36 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.184 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.88 101.02 13.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.357 0.599 . . . . 0.0 110.998 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -68.36 127.32 23.6 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.482 ' CG2' ' HG2' ' A' ' 87' ' ' ARG . 36.2 mm -97.18 -47.4 12.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 118.07 0.935 . . . . 0.0 110.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 33' ' ' ARG . 6.7 p80 -165.75 166.81 17.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 40.99 -84.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.759 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' HIS . 16.4 ptp180 -143.92 21.51 1.78 Allowed 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 122.273 -0.267 . . . . 0.0 111.388 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 74' ' ' VAL . 7.2 p -119.03 134.18 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 60.4 m -119.59 159.21 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.639 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.88 131.84 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.551 0.691 . . . . 0.0 111.571 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.72 165.17 29.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.98 170.69 18.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.216 1.277 . . . . 0.0 111.438 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 35.5 m -82.18 -33.27 29.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.043 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -72.8 2.01 7.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.823 0.344 . . . . 0.0 110.731 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -72.1 -19.55 61.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 53.68 70.3 1.83 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.599 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.35 124.98 10.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.692 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 -164.25 14.0 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.375 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.34 -31.0 16.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 108.837 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.15 118.65 18.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.28 159.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.986 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 85.3 mt -90.46 107.65 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.644 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.95 100.84 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.012 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.92 32.76 12.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.615 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.72 -14.93 64.21 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.828 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -100.92 126.36 47.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.507 0.654 . . . . 0.0 111.479 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.64 112.35 5.35 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 35.8 mm -114.62 118.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.379 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.54 157.91 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.94 -45.04 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.781 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 20.0 t70 -142.56 94.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.834 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 17.6 ptpt -93.0 90.26 6.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -97.19 115.11 26.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.406 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.88 129.36 37.53 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.916 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 20.0 mt -88.51 101.28 13.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -108.2 144.21 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 171.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' C ' ' N ' ' A' ' 66' ' ' GLU . 15.2 t70 -80.18 150.59 71.54 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.23 -20.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.618 0.879 . . . . 0.0 110.258 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 6.4 tp10 -63.12 -14.69 51.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.686 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 20.6 t30 80.43 3.36 1.84 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.372 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.07 155.16 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.584 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.77 126.35 29.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.0 tp -93.9 -15.58 24.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 17.2 tp10 70.24 14.25 7.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.728 -1.578 . . . . 0.0 113.152 175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mp -101.63 159.22 15.5 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -135.81 117.09 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 HG21 ' HG ' ' A' ' 62' ' ' LEU . 69.2 t -78.57 96.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.33 85.35 7.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.437 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 3.2 m -80.35 104.63 11.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.028 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 65.9 mt -95.55 159.75 14.84 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.786 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.65 86.35 7.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -117.72 126.27 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.565 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -84.36 -48.76 9.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.26 116.04 15.56 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -82.32 150.17 27.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 122.018 0.913 . . . . 0.0 112.644 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.797 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -82.76 129.74 35.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.8 p-10 -75.61 97.8 3.86 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.429 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.5 pt -96.25 29.38 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.777 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 57.3 mtm180 -66.7 -27.0 67.29 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.032 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.7 -1.86 22.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.63 141.57 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 19.1 m -93.7 119.9 33.28 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.87 -47.14 60.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 91' ' ' SER . 19.2 t0 -114.28 144.1 43.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 173.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.0 mt -66.98 -71.19 0.21 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 59.23 70.88 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.718 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -143.31 92.41 0.17 Allowed Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 114.153 -1.385 . . . . 0.0 113.616 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.8 p -101.42 -8.35 9.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 6.1 t70 -144.46 135.67 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.756 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.61 155.13 38.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.528 0.68 . . . . 0.0 111.868 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 23.8 m -120.62 139.81 52.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.48 120.86 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.231 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.2 p -114.87 121.81 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.154 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.17 135.62 45.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.824 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -137.9 85.0 2.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 106' ' ' ASN . 37.2 t -135.89 -159.08 0.92 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.223 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.423 ' N ' ' OG ' ' A' ' 105' ' ' SER . 9.4 t30 -46.41 -64.45 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.01 -45.01 5.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 0.0 111.68 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.71 106.94 14.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.687 0.756 . . . . 0.0 112.929 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 p -116.43 138.74 51.12 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.868 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 51.8 28.13 4.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.821 0.448 . . . . 0.0 111.83 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 20.6 m -74.81 90.04 2.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.489 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.79 97.47 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 120.22 32.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.571 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.9 pt-20 -80.11 144.85 32.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.012 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.0 m -101.65 -20.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.59 -123.03 5.89 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.562 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 20.7 Cg_endo -61.8 114.25 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.294 1.996 . . . . 0.0 112.882 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -118.52 151.39 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.776 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.2 p -146.83 -177.54 5.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.427 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 21.2 ptt? -120.4 163.63 17.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.781 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.07 -2.55 8.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 -121.7 6.05 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.481 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.18 120.86 39.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.178 0.514 . . . . 0.0 109.69 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 26.4 pt -138.16 -171.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.922 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 33.7 m-80 -102.22 135.18 44.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.269 0.557 . . . . 0.0 109.923 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 45.6 tp -119.23 103.79 9.82 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.452 ' OG ' HD13 ' B' ' 5' ' ' LEU . 2.8 m 63.75 32.56 13.54 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 110.32 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.8 m 82.76 1.6 1.18 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 126' ' ' LEU . 12.8 t -114.35 124.76 30.19 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.07 125.41 18.49 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.338 2.025 . . . . 0.0 113.215 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.03 138.78 54.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.479 ' ND2' ' HG3' ' A' ' 133' ' ' ARG . 7.2 p-10 -111.76 152.13 28.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.656 0.741 . . . . 0.0 112.652 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.479 ' HG3' ' ND2' ' A' ' 132' ' ' ASN . 59.9 mtt-85 66.37 53.28 1.01 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.015 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.9 mmm -93.06 134.91 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.712 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 170' ' ' SER . 14.2 tt -108.85 142.5 21.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.542 ' HD2' ' OE1' ' A' ' 167' ' ' GLN . 19.4 ptt85 -127.23 139.75 52.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.546 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.3 OUTLIER -122.72 135.15 54.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.431 0.634 . . . . 0.0 110.941 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.5 87.78 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.41 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -171.89 127.27 0.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.374 -1.739 . . . . 0.0 107.268 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.35 100.19 1.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.704 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 137.79 52.57 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 96.2 mttt -127.96 176.63 7.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.37 152.99 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 111.107 -2.77 . . . . 0.0 111.664 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.07 -15.13 57.06 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.455 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -115.02 9.84 16.09 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.663 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 21.1 p -78.41 135.88 37.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 117.959 -1.496 . . . . 0.0 110.026 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 126.63 -16.88 6.53 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.84 153.88 44.06 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.14 129.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.338 0.589 . . . . 0.0 112.366 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.88 111.42 23.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.2 p -147.62 179.01 8.0 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 112.744 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.34 -178.5 6.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.041 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.9 t -60.92 101.76 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.63 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.93 31.07 77.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.889 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -153.35 111.2 3.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.708 0.289 . . . . 0.0 111.007 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.5 mt -96.78 129.38 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.54 -49.16 5.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.156 0.503 . . . . 0.0 112.017 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.589 ' HA2' HD21 ' A' ' 173' ' ' LEU . . . 175.92 -166.55 37.82 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.191 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.431 ' C ' ' HG ' ' A' ' 170' ' ' SER . 45.9 pt -120.83 142.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.739 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -63.23 113.76 3.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.38 -27.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.05 -147.74 6.18 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.882 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 179.37 164.72 32.37 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.494 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.3 t-20 -137.56 96.68 3.29 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.206 0.527 . . . . 0.0 109.861 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.85 -119.26 5.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.997 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -97.29 19.66 12.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.202 0.525 . . . . 0.0 110.815 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.542 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 8.8 tt0 -134.36 115.86 14.54 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.875 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.59 148.94 34.41 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.245 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 46.7 m-85 -124.67 121.53 34.93 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.848 0.832 . . . . 0.0 111.129 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.555 ' HB3' HG23 ' A' ' 135' ' ' ILE . 15.2 t -117.5 156.44 28.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.145 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.78 134.19 39.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.515 ' OE1' ' HE2' ' A' ' 174' ' ' LYS . 76.1 mt-30 -71.03 122.49 20.13 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.589 HD21 ' HA2' ' A' ' 158' ' ' GLY . 2.5 mm? -85.52 93.9 8.89 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.515 ' HE2' ' OE1' ' A' ' 172' ' ' GLN . 51.2 mttm -93.21 128.03 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.668 0.747 . . . . 0.0 111.462 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -50.21 -31.12 13.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.388 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -37.3 -56.64 0.95 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.33 -9.71 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.88 179.625 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.5 mm? . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.366 0.603 . . . . 0.0 111.663 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.9 tt0 -113.35 81.06 1.44 Allowed 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -83.18 153.73 24.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -109.35 151.92 25.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.1 m-85 -60.3 133.98 56.62 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.663 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.7 mt-30 . . . . . 0 N--CA 1.439 -0.996 0 C-N-CA 119.219 -0.993 . . . . 0.0 . -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 CA--C 1.533 0.444 0 N-CA-C 113.745 0.633 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -60.18 -50.53 73.31 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.948 0.88 . . . . 0.0 110.98 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -43.24 99.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.901 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -60.45 -55.58 31.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.175 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.7 -45.55 86.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.51 82.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 8' ' ' LEU . 3.0 tm? -67.82 -40.08 83.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.699 0.285 . . . . 0.0 110.925 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -66.77 -42.37 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.64 -37.5 82.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.309 0.576 . . . . 0.0 109.916 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.559 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 3.4 tm? -51.41 -56.81 11.18 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.572 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.38 -27.84 66.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.367 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.53 -69.97 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.54 3.7 14.07 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 43.1 mm -97.86 96.39 5.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.5 mtm -126.91 144.12 51.08 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.715 0.769 . . . . 0.0 110.974 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 7.3 m -74.27 116.84 15.38 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.0 mt -111.2 108.28 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.34 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 25.0 m -76.12 114.02 14.3 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.93 0.872 . . . . 0.0 109.86 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 p -95.8 -161.16 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.419 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -71.98 -31.71 66.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -76.09 -47.04 26.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.191 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.97 -153.6 24.58 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.621 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 47.7 mt-10 -75.35 116.46 16.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.952 -0.624 . . . . 0.0 112.381 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -124.4 151.93 43.86 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.706 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 47.2 m -75.7 108.36 8.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.76 116.98 5.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.464 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 103.64 16.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.081 0.467 . . . . 0.0 110.746 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.11 132.55 12.93 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.83 -59.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 118.262 1.031 . . . . 0.0 111.3 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -170.36 163.23 8.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.714 0.768 . . . . 0.0 112.75 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m-20 44.7 -90.02 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -127.36 6.91 6.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.099 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 p -133.18 149.75 52.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.326 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 72' ' ' LEU . 33.5 m -110.5 135.69 48.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.827 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.01 139.4 31.92 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.232 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.75 141.58 97.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.336 1.357 . . . . 0.0 111.1 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.704 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 99.4 m -60.84 -43.42 98.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.374 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.35 -11.03 28.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.78 -15.07 60.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.857 0.837 . . . . 0.0 109.235 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 60.25 70.72 0.97 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.94 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.2 115.75 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 N-CA-C 107.702 -1.691 . . . . 0.0 107.702 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.75 -124.38 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.23 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 56' ' ' VAL . 21.0 t70 -95.31 -32.07 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.939 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -144.5 144.42 31.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.724 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 m -128.1 155.25 39.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.828 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 16.1 tp -97.75 100.66 12.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.3 t -89.95 107.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.087 0.946 . . . . 0.0 111.308 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 p30 56.7 12.57 1.16 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.485 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.13 -6.65 13.05 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.507 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -103.64 117.35 34.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.02 114.1 6.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.068 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 tp -120.64 131.63 72.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -88.02 147.77 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 111.295 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 45' ' ' ASP . 8.0 p -73.09 136.5 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -87.03 -50.11 6.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -169.17 151.96 4.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.147 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -128.38 132.36 48.53 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -115.62 117.48 30.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.365 0.603 . . . . 0.0 112.285 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -66.19 106.7 1.72 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.661 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 65.9 tp -85.98 104.74 15.89 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 122.558 1.171 . . . . 0.0 109.782 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 31.6 m -113.67 164.53 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 113.572 -1.649 . . . . 0.0 106.665 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.5 134.92 78.98 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.538 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.71 -10.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 114.941 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.92 19.67 12.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.965 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.2 m120 71.03 29.08 3.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.916 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 37.5 mt -108.79 147.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.968 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t-20 -64.59 131.01 45.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.823 0.344 . . . . 0.0 111.548 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.661 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 6.7 tt -111.87 -27.02 8.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.704 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 34.8 tp10 78.8 8.78 1.97 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 36' ' ' VAL . 15.4 tp -99.41 133.12 44.18 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.239 0.542 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.4 m -106.93 112.62 25.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.41 101.2 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.7 tp -85.25 108.01 17.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.767 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -93.33 116.62 29.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.181 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.7 mt -116.75 124.33 49.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.778 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.87 103.9 11.02 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.915 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.28 136.19 41.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -62.24 -39.72 93.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.19 117.92 19.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 32' ' ' ASP . 72.1 mmtt -71.64 140.98 49.93 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.01 149.2 49.05 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 1.1 tpm_? -61.19 126.31 26.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.324 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.496 ' OD2' ' HD2' ' A' ' 87' ' ' ARG . 14.5 t70 -67.42 81.56 0.15 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -97.88 20.86 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.496 ' HD2' ' OD2' ' A' ' 85' ' ' ASP . 6.7 ptm180 -63.46 -28.71 70.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.4 -6.38 86.06 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.104 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -91.17 -7.01 52.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.61 142.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 48.8 m -100.5 134.73 43.01 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER -76.17 -41.57 49.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 91' ' ' SER . 26.6 t70 -119.47 129.3 54.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.441 HD12 ' NE2' ' A' ' 172' ' ' GLN . 26.6 mt -65.23 -73.16 0.13 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 57.29 68.71 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.43 87.82 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.126 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 11.6 p -81.19 -0.73 4.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.114 0.483 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 9.3 t70 -125.27 129.88 50.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.805 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.43 165.1 31.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.679 0.752 . . . . 0.0 112.438 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.2 m -134.81 141.65 46.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.435 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.544 HD13 ' OH ' ' A' ' 137' ' ' TYR . 78.9 mt -96.18 119.93 35.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.556 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.56 100.22 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.85 129.4 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.726 0.774 . . . . 0.0 112.206 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.19 49.38 1.65 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 m -106.49 -163.15 0.9 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.731 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -56.61 -48.17 78.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.121 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -88.16 -62.72 1.43 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.888 -0.507 . . . . 0.0 112.288 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.61 112.37 21.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -100.95 108.49 20.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.661 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 m120 58.97 72.33 0.54 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.736 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 m -140.56 130.85 25.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 112' ' ' ILE . 23.9 pt -105.37 99.46 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.7 mp -91.66 103.79 16.33 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.948 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -69.77 107.68 3.6 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.064 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.7 -121.05 5.32 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.34 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.7 Cg_endo -65.75 116.51 3.99 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.535 2.157 . . . . 0.0 114.719 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 137' ' ' TYR . 32.4 m -120.74 136.84 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.311 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -138.37 160.05 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -89.16 139.8 30.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.824 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.64 -56.78 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.001 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.11 -128.83 6.54 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 5.0 tt -99.66 113.47 25.94 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.5 pt -133.16 -159.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 20.3 m120 -125.99 125.9 43.43 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 2.7 mm? -100.48 113.36 26.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.497 ' OG ' HD12 ' B' ' 5' ' ' LEU . 4.0 m 57.23 29.31 16.5 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.317 0.58 . . . . 0.0 111.262 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 127' ' ' SER . 42.6 m 87.18 7.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 126' ' ' LEU . 6.0 t -111.03 139.68 22.02 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 21.3 Cg_exo -64.67 111.82 1.79 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 126' ' ' LEU . 26.3 m -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.864 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 133' ' ' ARG . 19.0 t-20 -119.3 163.25 17.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 37.7 ttm-85 68.41 35.45 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.937 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mmt -92.93 139.37 30.6 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.803 0.811 . . . . 0.0 113.004 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.6 mt -95.41 137.93 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.453 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -117.47 141.27 48.55 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.544 ' OH ' HD13 ' A' ' 101' ' ' LEU . 33.2 p90 -148.63 145.07 27.6 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.201 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.73 92.96 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.736 0.779 . . . . 0.0 112.112 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -161.43 137.18 7.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.59 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.78 87.01 5.29 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.486 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.1 p -89.91 151.04 21.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.081 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -130.27 151.57 50.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.045 0.926 . . . . 0.0 113.007 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.555 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.7 OUTLIER -45.35 152.3 0.3 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.225 175.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.58 -14.52 63.77 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.001 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 22.2 tt0 -99.33 7.2 45.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.317 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.776 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 6.9 m -60.56 136.11 57.96 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.37 -10.48 36.17 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 123.654 0.596 . . . . 0.0 111.952 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -51.1 121.01 10.26 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.086 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.36 108.54 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.529 0.68 . . . . 0.0 111.212 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.5 tp -81.63 103.84 11.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.988 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -143.38 177.68 8.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.744 0.783 . . . . 0.0 111.998 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.13 -178.55 6.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.753 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.8 t -64.17 98.31 0.22 Allowed 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.802 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.42 29.05 54.28 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.162 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.432 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 33.4 ttmt -156.2 129.36 8.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.471 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.2 mt -112.77 129.14 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.23 -41.22 7.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 162.99 -156.09 27.7 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.82 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -127.89 151.16 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.923 0.868 . . . . 0.0 111.822 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.5 123.16 19.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -114.2 -28.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.55 -152.35 9.07 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.177 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.68 153.96 16.32 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.851 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.524 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 34.1 t30 -131.42 100.94 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.84 -121.88 6.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.404 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -102.21 22.92 12.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.675 0.75 . . . . 0.0 109.611 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -127.61 115.53 18.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.365 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.42 148.75 28.25 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.86 132.65 54.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.217 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.1 t -133.48 141.95 48.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.581 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.41 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -80.61 127.64 32.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 27.5 tt0 -74.6 109.2 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.895 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.482 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 55.2 mt -87.69 94.43 9.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.401 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.67 129.82 34.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.865 0.841 . . . . 0.0 111.379 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.35 -29.5 10.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.939 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -44.76 -43.16 8.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.659 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -79.81 -47.04 15.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 112.263 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.715 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.453 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.2 tt0 -101.64 83.96 2.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -88.75 141.06 28.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.6 tp -94.94 148.17 22.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.53 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 20.4 m-85 -61.32 139.59 58.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.776 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.8 mt-30 . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.971 -0.559 . . . . 0.0 . 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.46 -0.465 0 CA-C-O 121.016 0.34 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 22.8 t-20 -63.14 -53.25 56.38 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.389 1.09 . . . . 0.0 109.699 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 m -50.43 -53.71 27.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.073 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -57.49 -51.53 69.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.801 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.74 -50.58 72.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.171 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -44.95 95.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' HD22 ' A' ' 8' ' ' LEU . 2.7 tt -68.0 -35.06 77.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.571 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -70.05 -38.55 75.83 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.65 -40.76 93.19 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.196 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 29.7 mt -50.43 -57.66 7.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.431 1.11 . . . . 0.0 111.175 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -60.92 -28.0 68.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.719 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.59 -61.63 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.27 -7.26 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.6 mm -92.7 126.8 45.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.968 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtm -133.77 148.37 51.37 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -82.31 111.81 18.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.718 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.07 134.06 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 20.9 m -120.6 101.18 7.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.461 0.648 . . . . 0.0 109.941 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 p -105.74 -163.48 0.94 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.232 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -60.98 -18.57 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.0 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.684 ' HE2' ' OE1' ' A' ' 42' ' ' GLN . 6.3 mptp? -95.19 -59.05 1.98 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.06 0.457 . . . . 0.0 110.007 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . 172.2 -143.34 7.37 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.917 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -85.1 121.92 28.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.164 0.507 . . . . 0.0 111.327 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -125.88 161.57 27.14 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.395 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 37.8 m -89.26 112.03 22.99 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.485 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.73 109.11 3.38 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -87.62 98.47 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 111.672 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.13 10.35 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.68 -56.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.357 0.578 . . . . 0.0 109.858 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -154.82 144.07 21.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.987 0.899 . . . . 0.0 112.858 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 4.1 p30 46.78 -86.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.684 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 37.6 ptt180 -134.23 14.16 3.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.5 0.667 . . . . 0.0 110.595 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -94.67 113.05 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.1 m -118.87 154.07 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.842 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.33 133.1 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.14 143.58 25.27 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.662 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.7 153.04 52.11 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 120.849 1.033 . . . . 0.0 111.069 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.547 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 97.0 m -73.68 -39.55 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -65.11 -1.8 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.51 54.71 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.288 0.566 . . . . 0.0 110.802 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.684 ' OE1' ' HE2' ' A' ' 22' ' ' LYS . 42.5 mt-30 65.22 72.15 0.49 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.046 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.38 123.92 2.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.608 2.872 . . . . 0.0 109.949 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.25 -133.14 6.07 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.544 -0.836 . . . . 0.0 114.262 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.602 ' O ' HG11 ' A' ' 56' ' ' VAL . 28.0 t70 -83.84 -44.92 13.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 3.2 p30 -127.75 144.17 51.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.7 153.97 27.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.156 0.503 . . . . 0.0 111.146 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.84 103.71 16.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.7 m -89.36 93.85 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.054 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 69.87 13.1 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.64 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.84 -29.83 5.7 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.94 120.91 19.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -84.73 114.98 22.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.851 0.834 . . . . 0.0 110.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.39 141.83 44.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.018 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 34.4 ttt180 -90.54 151.06 21.51 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.47 0.652 . . . . 0.0 112.058 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.602 HG11 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -92.38 145.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -89.09 -41.94 12.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.733 0.778 . . . . 0.0 109.018 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -160.07 129.79 5.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.206 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.54 112.41 22.17 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -104.89 107.07 17.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.731 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.84 126.29 28.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.079 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.603 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -90.42 103.87 16.51 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.91 141.08 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 172.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 66' ' ' GLU . 11.8 t70 -72.95 135.89 80.14 Favored Pre-proline 0 C--N 1.31 -1.15 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.631 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.59 -8.16 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.835 1.69 . . . . 0.0 112.217 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 64' ' ' ASP . 28.6 tt0 -81.54 3.24 25.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 73.48 25.22 2.15 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.863 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.28 152.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 131' ' ' THR . 52.7 t30 -63.84 134.86 55.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 41.7 tp -102.99 -22.13 13.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.547 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.1 tp10 72.04 13.29 5.91 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.071 175.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 62' ' ' LEU . 6.5 mp -106.86 158.94 16.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.937 0.399 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.6 m -135.88 120.8 18.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.208 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.05 102.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' HD11 ' A' ' 77' ' ' LEU . 15.7 tp -93.09 97.68 10.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.992 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 m -92.12 90.66 7.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 75' ' ' LEU . 4.8 mp -74.21 152.5 39.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.513 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.37 75.49 10.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 79' ' ' ARG . 5.0 tpt180 -106.92 128.28 54.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.007 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.5 -12.74 51.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.56 117.86 29.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.612 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -93.5 111.29 22.93 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.258 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -81.98 165.85 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.482 0.658 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -50.93 126.52 16.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.864 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -81.79 98.75 8.61 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.45 0.643 . . . . 0.0 109.859 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.5 pt -91.04 21.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 122.054 0.931 . . . . 0.0 109.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -55.28 -33.4 63.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.484 -1.689 . . . . 0.0 113.239 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.11 -7.74 88.16 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.864 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.81 2.05 51.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.44 131.85 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -93.28 105.12 17.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 174' ' ' LYS . 0.1 OUTLIER -62.43 -54.77 35.32 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 176.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.41 135.2 45.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 95' ' ' GLU . 25.6 mt -61.03 -55.44 32.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 15.0 pt-20 36.61 71.8 0.13 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.591 . . . . 0.0 111.147 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.39 105.69 0.21 Allowed Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.651 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -91.97 9.98 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.083 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -111.62 118.33 35.38 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.09 151.54 37.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.044 0.926 . . . . 0.0 112.423 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.5 m -122.03 135.92 54.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.262 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.9 105.41 17.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.294 0.569 . . . . 0.0 110.222 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.63 ' HB ' ' CG2' ' A' ' 149' ' ' VAL . 35.3 t -80.38 102.16 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 108' ' ' PHE . 14.7 t -89.35 108.24 18.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.426 0.631 . . . . 0.0 111.71 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 29.6 t60 -129.9 39.35 3.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 97.2 p -108.9 -161.18 0.75 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.177 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -73.9 -17.25 61.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.704 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -78.01 -76.69 0.18 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 103' ' ' VAL . 79.8 m-85 -117.99 147.85 42.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.096 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 6.4 m -124.63 124.97 43.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.269 0.557 . . . . 0.0 110.794 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.731 ' HB3' ' O ' ' A' ' 109' ' ' THR . 12.3 t-20 80.82 -2.2 1.82 Allowed 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.658 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.0 m -92.67 119.38 32.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.26 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.25 126.62 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.0 110.53 20.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.54 122.13 18.44 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.58 -32.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.729 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.07 -105.12 2.04 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.879 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 88.5 Cg_endo -84.5 128.85 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.208 1.939 . . . . 0.0 114.145 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.81 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.6 p -132.14 163.77 27.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.726 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.15 153.92 20.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.46 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.51 0.13 11.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.871 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.93 -116.04 4.14 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.214 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 123' ' ' LEU . 7.3 tt -121.16 127.24 51.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.001 0.429 . . . . 0.0 111.239 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.7 pt -136.91 179.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 19.9 m120 -95.81 84.04 3.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.233 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 55.3 tp -65.49 105.86 1.28 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.0 m 62.52 32.67 16.45 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.373 0.606 . . . . 0.0 109.615 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 127' ' ' SER . 38.0 m 81.84 -10.46 1.14 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.378 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -91.49 120.98 68.08 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.518 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.34 114.59 2.04 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.493 1.462 . . . . 0.0 110.762 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 69' ' ' ASN . 23.3 m -134.34 134.88 42.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.016 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -113.42 -177.62 3.18 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.909 -0.717 . . . . 0.0 112.714 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 65.91 26.96 10.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.459 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 74.0 mt -92.34 135.5 27.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -117.26 130.99 56.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.627 0.727 . . . . 0.0 111.873 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.487 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.8 p90 -142.9 112.12 6.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.12 105.71 2.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.728 0.775 . . . . 0.0 109.246 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -167.59 135.4 2.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.75 102.7 0.97 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.825 0.821 . . . . 0.0 111.655 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 t -140.26 147.07 39.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.386 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 26.4 mtpp -141.51 -179.13 5.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.339 1.066 . . . . 0.0 111.962 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -37.6 150.2 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.986 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.69 -28.33 13.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.876 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -87.17 10.49 16.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.0 0.429 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.808 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 4.8 m -63.37 135.14 56.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.771 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.644 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 102.96 -21.37 40.41 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.488 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.24 133.72 24.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.942 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.63 ' CG2' ' HB ' ' A' ' 102' ' ' VAL . 17.7 m -92.16 112.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 0.0 111.719 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.66 109.66 18.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.63 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -146.12 172.68 13.06 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.176 0.988 . . . . 0.0 113.231 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.549 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -130.91 172.58 11.88 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.682 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 153' ' ' THR . 4.3 t -68.62 103.25 1.66 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.773 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.54 -0.48 77.5 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.581 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -139.18 109.35 6.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.5 mm -90.49 111.55 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.33 -48.65 12.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 170.0 -160.54 33.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.621 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.4 pt -122.41 143.37 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.838 0.828 . . . . 0.0 112.583 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.24 118.72 10.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.152 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 17.1 m -113.24 -23.01 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.748 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.37 -152.2 8.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.522 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.81 153.81 12.01 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.766 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.465 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 16.0 t30 -126.36 105.68 8.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.175 0.512 . . . . 0.0 110.399 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.96 -106.66 1.93 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.322 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 29.7 ttm180 -116.73 20.45 13.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -122.62 116.54 24.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.164 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.53 149.61 35.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.864 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 51.5 m-85 -130.51 115.38 16.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.45 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 69.5 m -109.45 172.64 6.73 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.676 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -115.0 132.25 56.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.9 pt20 -86.42 133.98 33.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.0 mt -85.92 88.92 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.297 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.544 ' HB3' ' HZ2' ' A' ' 174' ' ' LYS . 9.6 mtpm? -79.1 111.26 15.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.087 0.946 . . . . 0.0 108.799 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -35.71 -36.23 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.488 ' HG2' ' CG ' ' A' ' 92' ' ' GLU . 17.0 mm100 -56.34 -27.95 57.51 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -68.46 -18.39 64.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.489 0.662 . . . . 0.0 109.245 177.871 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 4.5 mp . . . . . 0 CA--C 1.512 -0.509 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.4 tt0 -89.31 77.42 7.43 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.624 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.35 118.55 22.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.136 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 21.0 tp -83.6 152.11 25.0 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.591 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.9 m-85 -58.22 141.01 52.02 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.808 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.2 mt-30 . . . . . 0 C--N 1.307 -1.243 0 C-N-CA 120.708 -0.397 . . . . 0.0 . 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 N-CA-C 115.679 1.377 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.442 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 64.2 t30 -57.12 -48.77 77.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -68.39 -42.54 78.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.891 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -61.7 -43.98 97.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.264 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.17 -49.0 76.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.128 0.489 . . . . 0.0 110.387 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 -46.04 85.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.577 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.95 -42.72 99.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -68.07 -44.84 75.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.585 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.73 -45.79 91.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.738 0.78 . . . . 0.0 110.16 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 57.5 tp -55.99 -49.89 72.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.408 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.39 -28.57 56.77 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.64 -34.05 10.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -121.33 -9.81 9.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 50.8 mm -97.8 114.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.627 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.466 ' HA ' ' HE3' ' A' ' 16' ' ' MET . 2.1 mmt -122.24 146.18 47.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.323 0.582 . . . . 0.0 110.355 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.52 86.32 4.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 47.4 mm -75.61 94.33 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.0 109.765 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.3 m -86.62 96.12 10.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.741 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.19 179.65 4.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.932 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -55.92 -35.97 67.2 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -89.25 -31.7 17.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.9 -169.9 42.44 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 119.495 -1.336 . . . . 0.0 115.054 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -95.52 109.05 21.32 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 114.84 -0.68 . . . . 0.0 110.066 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 41' ' ' ALA . 86.7 m-85 -112.04 158.68 19.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.74 0.781 . . . . 0.0 112.245 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.0 m -83.05 106.66 15.05 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.559 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -89.64 119.99 5.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.938 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -93.99 100.68 12.77 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 0.0 110.186 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.38 106.99 1.9 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.0 -55.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -163.02 144.12 9.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 34.0 t70 54.02 -94.27 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.786 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -133.17 23.51 4.14 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.633 -0.667 . . . . 0.0 110.604 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.8 t -102.27 119.42 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.747 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -123.71 142.5 51.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.6 t -109.55 131.88 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 122.227 1.013 . . . . 0.0 112.111 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 pt -141.75 165.53 27.55 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.44 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -66.28 170.0 12.85 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 120.757 0.972 . . . . 0.0 111.098 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.544 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 62.6 m -76.44 -37.47 56.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.97 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -69.06 9.41 0.41 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.456 ' HA ' ' CE1' ' A' ' 25' ' ' PHE . . . -75.64 -29.98 59.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.3 mm-40 61.37 72.9 0.63 Allowed Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.928 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.54 132.4 33.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.642 2.228 . . . . 0.0 111.263 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.53 -129.17 5.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.635 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.29 -30.73 12.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 109.188 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.468 ' OD1' ' HA ' ' A' ' 55' ' ' ARG . 16.2 m-20 -132.38 155.62 48.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -129.7 134.38 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.54 104.84 13.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.423 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 51' ' ' GLY . 62.9 t -82.44 91.14 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.119 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 70.75 -9.57 0.81 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.104 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 152.55 -26.73 0.85 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -74.77 113.55 12.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.55 -0.825 . . . . 0.0 110.425 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.58 93.96 2.58 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.97 142.78 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.766 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.468 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 1.7 mmp_? -63.26 133.03 53.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.73 108.65 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -68.3 -40.51 81.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.122 0.963 . . . . 0.0 109.281 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -171.48 147.83 2.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.617 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.657 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -117.87 139.31 51.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.755 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -141.47 106.34 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.573 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -71.81 135.95 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 38.2 tp -104.18 109.17 20.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.379 1.085 . . . . 0.0 113.293 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.57 160.21 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 136.95 60.41 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -43.42 -26.13 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.473 2.115 . . . . 0.0 113.65 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.75 -9.37 57.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.75 0.786 . . . . 0.0 109.332 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.65 66.27 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.792 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 63.0 mt -144.38 150.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 112.442 -2.163 . . . . 0.0 105.935 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -65.65 135.06 54.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.263 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 29.0 tp -108.62 -29.32 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.544 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 18.0 tp10 74.92 23.88 1.63 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.123 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.06 157.13 18.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 47.3 m -132.26 120.14 21.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.124 0.488 . . . . 0.0 109.796 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.9 t -86.4 88.52 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.8 tp -84.26 110.86 18.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.93 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -98.06 101.67 13.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.868 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.96 155.25 16.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.88 76.29 9.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -104.35 104.55 14.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.25 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.54 -38.03 74.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -82.62 82.25 8.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 20.4 ptmt -61.52 154.3 25.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.595 -1.184 . . . . 0.0 113.944 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.2 169.93 10.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.215 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -71.97 137.31 47.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.266 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -86.82 87.31 7.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.423 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -85.45 14.62 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -63.13 -16.13 59.01 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.792 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.79 -20.49 79.78 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.194 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -93.41 -0.37 56.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.7 mt -74.99 144.53 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 12.8 m -91.56 123.87 35.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.2 pm0 -78.96 -31.51 45.02 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 91' ' ' SER . 41.2 t0 -136.31 148.09 47.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 32.2 mt -71.41 -55.53 7.76 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 94' ' ' LEU . 1.9 pt-20 38.2 72.0 0.14 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.453 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.42 99.22 0.14 Allowed Glycine 0 N--CA 1.444 -0.784 0 O-C-N 124.0 0.813 . . . . 0.0 111.781 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.6 p -74.89 -21.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.87 0.366 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -92.3 119.36 31.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.596 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.96 154.31 48.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.105 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -120.71 137.47 54.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.176 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -107.98 127.02 53.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.38 113.98 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.62 123.44 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.916 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 39.7 t60 -150.49 71.96 1.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -143.16 -150.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.325 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.02 -54.79 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.177 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.406 ' HB2' ' OE1' ' A' ' 145' ' ' GLN . 66.3 m-80 -74.36 -68.53 0.52 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -116.36 157.09 25.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -136.61 147.47 46.96 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.277 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.32 13.14 6.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.0 0.428 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.0 m -93.02 104.51 16.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.436 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.98 111.95 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.315 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.11 129.23 51.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.328 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.53 122.75 30.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.466 HG23 ' CD1' ' A' ' 137' ' ' TYR . 9.1 p -89.26 -32.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.036 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.67 -130.69 10.31 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.642 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 76.3 Cg_endo -78.27 134.41 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.878 1.719 . . . . 0.0 112.891 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.33 165.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.159 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 p -132.79 -178.78 5.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.1 mtt -115.4 149.62 37.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.753 0.311 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 -31.08 5.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.41 -112.62 4.26 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.073 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 tt -123.31 112.08 17.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.8 pt -130.26 175.75 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.018 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 53.0 m-80 -86.9 87.32 7.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.51 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.58 HD12 ' O ' ' B' ' 4' ' ' ALA . 49.8 tp -75.45 106.42 6.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.3 t 61.67 36.55 16.49 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.8 m 74.18 -0.07 3.46 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.516 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 m -104.23 113.69 64.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.912 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.74 111.78 0.87 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.989 1.792 . . . . 0.0 111.493 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 m -124.04 136.63 54.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.16 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -103.84 164.16 11.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 67.13 45.89 1.62 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.983 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 10.7 mmt -91.66 127.35 37.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.281 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' A' ' 170' ' ' SER . 28.9 mm -93.9 147.18 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -134.18 140.2 46.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 111.757 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.466 ' CD1' HG23 ' A' ' 115' ' ' VAL . 36.4 p90 -149.04 140.98 23.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.13 117.63 25.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.409 1.099 . . . . 0.0 110.15 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -174.08 137.96 0.57 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.242 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.38 96.2 0.08 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.322 0.582 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.9 p -107.96 144.37 35.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.333 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.3 158.25 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.516 1.15 . . . . 0.0 112.79 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.48 152.1 0.1 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.289 173.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.51 -14.51 50.84 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.406 ' OE1' ' HB2' ' A' ' 107' ' ' ASN . 11.2 mm-40 -99.86 -0.27 40.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 119.792 -0.147 . . . . 0.0 110.872 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.644 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 10.5 p -78.3 135.26 37.48 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.309 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 119.78 -23.12 8.44 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.929 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.52 138.01 19.27 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.399 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.78 125.33 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.775 0.798 . . . . 0.0 112.911 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.17 109.07 21.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.384 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -149.29 -174.5 4.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.106 0.955 . . . . 0.0 113.326 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.35 172.85 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.212 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.1 t -60.52 108.8 0.88 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.572 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.18 63.44 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.344 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -162.66 113.75 1.52 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.83 119.9 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -83.98 -41.11 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 164.08 -156.45 28.33 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.605 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.4 pt -126.62 147.5 31.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.21 0.528 . . . . 0.0 111.05 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.1 133.13 48.46 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.43 -28.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.61 -155.91 11.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.08 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.71 154.27 25.0 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.029 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.562 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 10.3 t-20 -135.16 116.14 14.17 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.69 -112.59 4.71 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.06 -1.066 . . . . 0.0 111.06 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -118.08 19.45 13.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.481 . . . . 0.0 109.828 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -111.0 135.17 51.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.316 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.77 138.28 14.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 44.9 m-85 -116.72 132.92 56.56 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 18.5 m -124.86 165.35 18.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.546 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -106.91 143.03 35.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -81.95 110.75 17.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -88.55 93.02 9.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 91' ' ' SER . 86.4 mttt -87.3 135.22 33.4 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 122.643 1.211 . . . . 0.0 113.45 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 16.1 tptm -42.78 -43.08 3.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.537 -2.12 . . . . 0.0 112.78 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -41.51 -46.41 3.5 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.74 -23.02 55.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 . . . . . 0 C--N 1.321 -0.661 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.679 -178.583 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.9 mm? . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 121.326 0.584 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.0 tt0 -114.68 85.77 2.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.58 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -91.09 130.5 36.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 23.2 tp -88.55 154.71 20.12 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.583 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 24.3 m-85 -62.64 145.64 54.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.644 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 95.2 mt-30 . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 118.702 -1.199 . . . . 0.0 . 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--O 1.229 0.061 0 N-CA-C 114.609 0.965 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 66.6 t30 -79.83 -49.54 11.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.209 0.528 . . . . 0.0 111.932 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -68.38 -42.29 79.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.738 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.42 -29.54 63.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.097 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -65.58 -46.32 79.87 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.59 75.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.432 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.13 -43.63 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.603 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 m -69.85 -41.74 74.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.179 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.85 -42.07 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.716 0.77 . . . . 0.0 109.945 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.631 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -56.41 -53.5 56.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.882 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.7 -25.99 66.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -83.42 -55.58 4.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -118.06 -2.42 11.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.631 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 40.5 mm -101.94 114.24 40.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.31 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtm -128.03 155.05 44.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.506 0.669 . . . . 0.0 111.434 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -85.3 109.15 18.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.9 mt -103.08 110.69 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.678 0.751 . . . . 0.0 110.224 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 11.3 m -85.5 114.22 22.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.37 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -106.52 -176.3 3.04 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -75.83 -15.83 60.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.112 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -82.62 -42.34 18.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.052 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.94 38.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.98 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HG2' ' HG1' ' A' ' 19' ' ' THR . 45.9 mt-10 -96.99 116.14 28.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.75 166.33 13.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.969 0.89 . . . . 0.0 111.333 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 19.0 m -73.55 105.01 4.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.51 105.53 3.23 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.602 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -107.07 130.1 54.72 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.794 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.43 126.08 7.22 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.17 -56.76 5.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.125 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -158.43 151.09 22.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.259 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.646 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 8.1 t70 56.25 -94.36 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.52 20.25 1.86 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.877 0.846 . . . . 0.0 108.885 177.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.0 106.73 18.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 m -115.29 152.6 32.46 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.34 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.73 144.69 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -146.98 140.39 14.94 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.757 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.36 145.39 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.772 1.648 . . . . 0.0 111.981 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 67.0 m -75.29 -34.86 61.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.293 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -65.01 -11.97 45.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.38 -23.26 46.89 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.563 0.697 . . . . 0.0 109.888 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 48.27 72.1 1.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.81 130.57 28.16 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.41 -155.07 4.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.374 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -82.22 -35.98 27.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.188 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.29 121.53 22.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.2 m -117.28 150.94 19.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.369 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 34.4 mt -83.34 107.12 15.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.348 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -92.45 89.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 58.49 36.27 25.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.107 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.95 -15.06 57.09 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.156 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 15.8 mm-40 -106.09 108.71 20.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.91 139.46 30.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.722 -179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.0 tp -135.85 135.54 50.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -84.91 128.0 34.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.38 142.58 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -77.14 -49.73 14.58 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -150.76 120.33 6.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.817 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -97.59 98.21 9.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -100.49 123.79 45.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.017 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 3.4 mppt? -94.53 108.2 20.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 47.2 tp -86.12 118.22 25.44 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.07 172.75 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.98 140.94 86.26 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 117.723 0.238 . . . . 0.0 111.637 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.55 -29.02 9.77 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.267 1.311 . . . . 0.0 111.954 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.0 8.87 16.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.274 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 64.02 68.36 0.57 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.681 0.753 . . . . 0.0 110.469 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.0 mt -142.97 164.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.985 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -69.0 116.54 9.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 118.298 0.499 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.56 -32.93 10.53 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 30.3 tp10 77.38 15.11 1.76 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.995 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 80.4 mt -103.37 111.68 24.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.038 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 98.7 m -90.11 107.54 19.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.3 t -79.04 97.16 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.658 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 tp -78.21 94.57 4.79 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.102 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.2 m -83.95 98.63 9.9 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.691 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -103.4 144.13 31.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.064 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.35 96.82 7.98 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.18 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -117.52 150.01 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -82.09 -44.82 16.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 110.08 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.79 76.11 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 59.6 pttt -67.76 172.31 5.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.491 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -93.65 160.89 14.57 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -71.83 143.61 49.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.479 -1.692 . . . . 0.0 112.299 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.47 91.77 2.81 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.371 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.0 pt -89.89 11.49 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -70.07 -27.06 64.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.305 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.26 -20.69 73.47 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 67.4 m-85 -92.54 -16.91 25.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.34 121.76 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.8 m -101.6 107.65 18.98 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.296 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' HE3' ' A' ' 174' ' ' LYS . 12.5 pt-20 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -94.79 112.88 24.59 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.34 -71.36 0.09 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 49.97 67.98 0.82 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.08 92.52 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.264 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 60.7 t -83.79 -4.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.825 0.345 . . . . 0.0 111.515 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -114.21 110.4 19.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 165.69 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 112.739 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 m -119.97 141.62 49.51 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.723 -1.581 . . . . 0.0 109.69 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.8 tp -109.85 120.02 41.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 102' ' ' VAL . 31.3 m -116.31 108.38 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 120.214 -0.595 . . . . 0.0 110.05 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.91 136.98 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.755 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -142.28 75.73 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.57 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.9 p -124.24 -162.68 1.09 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -45.34 -67.63 0.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -94.15 -34.78 12.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.309 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.74 83.51 7.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 112.545 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.3 p -92.73 123.39 35.98 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.599 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER 38.61 62.9 0.95 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -99.02 103.13 15.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.642 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.8 mt -93.08 109.11 21.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.868 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.64 123.51 50.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.28 107.81 9.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.488 HG22 ' CD1' ' A' ' 137' ' ' TYR . 8.7 p -86.35 -24.76 6.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.307 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.21 -122.41 5.97 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.461 -0.876 . . . . 0.0 115.03 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.5 Cg_endo -66.24 117.59 4.82 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.407 2.072 . . . . 0.0 115.629 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 137' ' ' TYR . 30.9 m -108.3 151.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.6 m -151.41 135.55 16.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.606 0.241 . . . . 0.0 110.928 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.1 ttm -66.71 122.44 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.695 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.43 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.14 -115.81 5.34 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.34 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.78 119.1 32.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.22 -170.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.875 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.558 ' HB3' ' HA ' ' A' ' 128' ' ' SER . 5.7 m-20 -110.38 109.42 19.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.8 mm? -87.57 112.1 21.91 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 128' ' ' SER . 26.7 t 65.21 10.33 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.568 0.699 . . . . 0.0 110.643 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.558 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 4.8 m 82.99 66.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.001 1.32 . . . . 0.0 112.823 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 126' ' ' LEU . 15.2 t -163.3 131.49 2.77 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.778 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.35 109.96 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 121.361 1.374 . . . . 0.0 113.84 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.475 ' HB ' HD22 ' A' ' 126' ' ' LEU . 7.3 m -111.67 132.89 54.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.479 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -111.22 160.89 16.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.1 mtt180 65.36 43.37 3.51 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.078 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 85.1 mmm -92.24 136.6 33.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.3 tt -117.91 137.52 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -105.37 150.14 25.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 115' ' ' VAL . 1.5 p90 -144.68 152.8 40.97 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.368 0.604 . . . . 0.0 110.226 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.2 99.96 7.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.862 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.406 ' HB2' HG23 ' A' ' 115' ' ' VAL . 47.2 t80 -178.2 119.93 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.755 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.68 120.63 16.58 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.6 t -143.01 151.85 41.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.752 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.9 174.21 10.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.701 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HA ' ' CA ' ' B' ' 7' ' ' GLN . 17.8 p -38.91 155.47 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.318 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.3 -29.9 8.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -86.69 -4.87 59.23 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.636 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 26.3 p -78.1 144.57 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.508 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.42 -22.59 17.27 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.46 34.52 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.984 -0.608 . . . . 0.0 112.217 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.26 126.8 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.417 0.627 . . . . 0.0 112.297 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.73 106.6 18.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.2 p -149.24 -176.33 5.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.093 0.949 . . . . 0.0 112.306 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.68 174.69 13.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.816 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 8.8 t -62.02 115.75 4.34 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.794 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.05 90.67 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 19.2 ptmt -156.82 142.04 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.488 1.144 . . . . 0.0 112.772 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.43 138.85 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.614 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -106.53 -39.41 5.87 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.943 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.483 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 175.59 -167.77 39.83 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.441 ' C ' ' HG ' ' A' ' 170' ' ' SER . 20.0 pt -129.48 141.8 45.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.699 0.762 . . . . 0.0 110.604 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 6.1 t60 -65.57 107.44 1.71 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.471 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 27.2 m -95.3 -21.03 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.759 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 175.8 -146.75 8.34 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.125 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.56 163.4 32.5 Favored Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.336 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.472 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 2.9 t30 -123.49 94.8 4.36 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.85 0.833 . . . . 0.0 109.765 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.65 -104.87 1.31 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.393 -1.276 . . . . 0.0 114.223 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.449 ' HD2' ' O ' ' A' ' 166' ' ' ARG . 1.0 OUTLIER -97.55 -8.25 29.51 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.56 -0.82 . . . . 0.0 111.972 -177.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -108.99 133.04 53.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.282 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -85.68 149.94 23.88 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.2 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 49.8 m-85 -133.11 122.68 24.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.702 0.763 . . . . 0.0 112.022 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.441 ' HG ' ' C ' ' A' ' 159' ' ' ILE . 27.1 t -117.99 150.64 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.987 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.1 128.26 36.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -63.01 118.82 8.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.415 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.483 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 42.5 mt -87.66 85.19 7.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.503 ' HE3' ' O ' ' A' ' 92' ' ' GLU . 55.7 mtpt -89.56 133.89 34.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.752 0.787 . . . . 0.0 109.538 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -50.29 -19.64 0.86 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.639 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -9.09 58.79 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 . . . . . 0 C--N 1.312 -1.032 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.099 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 37.4 tt0 -108.07 76.37 1.04 Allowed 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 172.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.44 140.58 33.33 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.0 tp -104.97 145.84 29.86 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 31.2 m-85 -57.61 142.09 45.94 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.636 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 81.9 mt-30 . . . . . 0 N--CA 1.436 -1.171 0 C-N-CA 119.344 -0.942 . . . . 0.0 . -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 CA--C 1.529 0.253 0 N-CA-C 113.375 0.49 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.78 -53.8 19.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.1 0.476 . . . . 0.0 110.585 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -63.49 -35.52 80.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.779 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -61.82 -51.65 67.4 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -57.87 -48.43 79.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.269 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.78 -49.14 73.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.328 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.13 -43.73 98.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -71.34 -39.61 71.22 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.91 -41.34 95.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 122.182 0.991 . . . . 0.0 108.6 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.586 HD22 ' ND2' ' A' ' 110' ' ' ASN . 53.4 tp -59.49 -56.32 23.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.879 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 12' ' ' ARG . 2.1 mmp_? -69.71 -28.87 66.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -103.23 -29.19 11.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.48 -19.25 8.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 11' ' ' LEU . 47.9 mt -93.35 117.99 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.075 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -125.87 156.77 39.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.186 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.421 HG23 ' CD2' ' A' ' 104' ' ' HIS . 1.9 p -86.73 106.11 17.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.515 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.8 mp -93.38 110.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 89.3 m -72.07 114.34 10.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.881 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 58.6 p -109.27 -163.57 0.88 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.7 t -77.53 -29.2 52.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -90.38 -33.15 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.95 -167.2 39.95 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.423 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.89 115.36 21.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -121.5 159.22 26.76 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.944 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -72.71 113.2 9.48 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.573 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -114.76 129.91 8.92 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.247 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.36 104.49 16.83 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.44 90.97 0.94 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.414 HD11 HD13 ' A' ' 90' ' ' ILE . 24.5 mm -59.18 -50.98 77.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 111.35 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -166.94 164.24 16.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.307 1.051 . . . . 0.0 113.328 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 82' ' ' LYS . 1.6 m-20 45.97 -92.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.997 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 31.5 ptt180 -142.55 19.87 2.03 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.037 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.36 119.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.543 0.687 . . . . 0.0 110.765 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 m -117.33 139.98 50.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.047 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -99.84 124.69 53.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.574 . . . . 0.0 109.847 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 pt -136.84 163.89 46.35 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.66 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.18 150.43 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.549 1.499 . . . . 0.0 111.615 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 94.9 m -81.19 -42.52 20.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.355 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -63.17 -17.12 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -67.29 -19.21 65.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 109.422 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.3 mt-30 68.01 72.87 0.36 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.28 133.05 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.454 2.769 . . . . 0.0 110.657 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.82 26.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.613 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -103.07 -5.89 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.205 1.002 . . . . 0.0 109.355 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.623 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 10.7 t70 -139.72 107.43 5.63 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.44 148.01 15.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.108 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.756 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 7.3 mp -96.9 103.7 15.65 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.736 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.87 106.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 64.22 23.99 13.26 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.955 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.38 -17.54 46.96 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.733 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -83.47 105.67 14.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.859 -0.201 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 15.0 ptpt -71.9 114.23 9.77 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 78' ' ' ASP . 4.6 tt -127.22 143.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.53 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.623 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 20.2 mmm180 -66.35 142.99 57.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.73 150.68 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.36 -49.76 5.31 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.53 114.54 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.351 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -107.21 132.11 53.43 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.497 ' CE2' HD23 ' A' ' 62' ' ' LEU . 24.0 t80 -130.13 118.29 21.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.42 104.44 10.03 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.456 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 96.1 mt -62.52 109.49 1.39 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.992 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.8 m -91.96 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.552 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 22.3 t70 -89.04 132.68 37.21 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.66 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.61 -18.49 2.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.0 2.467 . . . . 0.0 114.551 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 44.2 mt-10 -89.82 19.58 4.69 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 111.133 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 25.0 t-20 77.32 15.38 1.75 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.142 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.566 HG23 ' H ' ' A' ' 69' ' ' ASN . 25.8 mm -109.26 179.1 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.79 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.566 ' H ' HG23 ' A' ' 68' ' ' ILE . 52.8 t30 -92.14 146.16 23.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.192 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.765 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 27.4 tp -108.33 -22.39 12.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.545 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 19.4 tp10 68.89 13.0 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.476 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 76.1 mt -105.47 110.48 22.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.96 0.163 . . . . 0.0 110.951 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.0 m -91.98 116.51 28.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.044 0.449 . . . . 0.0 111.493 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.31 105.93 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.158 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -84.44 93.13 8.23 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 13.0 tp -93.59 155.79 17.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.772 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 54' ' ' ILE . 28.7 t70 -89.48 67.36 7.6 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 11.2 tpt180 -117.07 101.88 8.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -89.32 -6.0 57.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.831 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -87.03 107.14 18.29 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 32' ' ' ASP . 20.5 ptmt -78.21 157.7 29.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -88.04 167.09 13.98 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 111.989 -2.369 . . . . 0.0 108.262 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -64.03 130.54 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.395 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' OD1' ' HD2' ' A' ' 87' ' ' ARG . 10.3 m-20 -68.56 95.16 0.62 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -96.38 25.96 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 9.7 mtp180 -63.17 -36.07 82.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.645 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.08 -11.75 85.28 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.433 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -90.15 -17.71 27.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.562 0.681 . . . . 0.0 109.287 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.414 HD13 HD11 ' A' ' 30' ' ' ILE . 30.0 mt -69.02 130.8 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 21.1 m -107.61 129.0 55.04 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.3 -43.23 52.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 91' ' ' SER . 10.2 t70 -106.05 124.81 50.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.167 175.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.66 -71.49 0.37 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 49.47 72.16 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 82.92 0.12 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.754 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.56 3.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.12 0.486 . . . . 0.0 111.304 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.1 t70 -143.8 119.17 10.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.187 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.5 172.2 13.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.085 0.945 . . . . 0.0 112.337 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -120.64 144.6 48.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.115 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -111.0 124.51 52.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.775 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.17 120.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.467 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 t -113.38 133.41 59.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.53 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.421 ' CD2' HG23 ' A' ' 17' ' ' THR . 74.1 t60 -140.77 75.24 1.49 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.9 p -118.4 -166.98 1.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -68.82 -38.43 79.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.234 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.43 -60.84 1.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.637 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.613 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 46.4 m-85 -96.68 108.94 21.66 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.239 0.543 . . . . 0.0 110.063 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 15.2 m -113.36 117.7 32.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.423 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 11' ' ' LEU . 14.4 m120 70.4 34.54 2.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.49 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.613 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 2.6 m -87.26 122.4 30.98 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.3 tt -119.96 109.28 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.6 mt -115.03 128.54 56.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.85 106.0 17.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.5 m -78.95 -38.47 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 98.15 -123.17 7.76 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.899 -1.143 . . . . 0.0 114.499 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.7 Cg_exo -61.35 108.89 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.804 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.427 ' C ' ' HG1' ' A' ' 119' ' ' THR . 90.4 t -106.27 139.54 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 4.4 m -153.09 151.71 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.81 151.07 26.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.243 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 136' ' ' ARG . . . -114.5 -35.93 4.76 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.64 -97.52 1.63 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.729 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.97 125.26 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.095 0.474 . . . . 0.0 111.492 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 124' ' ' ILE . 45.0 pt -141.58 179.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 36.9 m-80 -100.47 93.83 5.83 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.297 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.574 HD13 ' O ' ' B' ' 4' ' ' ALA . 31.4 tp -72.74 97.18 2.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 128' ' ' SER . 5.1 m 62.59 35.22 14.5 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.749 0.785 . . . . 0.0 110.267 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 127' ' ' SER . 74.7 m 79.14 0.91 2.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.29 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.9 m -103.82 107.11 55.63 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.91 123.07 12.22 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 121.833 1.688 . . . . 0.0 112.99 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 144.91 49.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.401 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.9 t30 -117.43 168.02 10.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.582 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.552 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 3.2 mpt_? 65.58 31.46 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.5 mmm -82.21 130.33 35.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.936 0.874 . . . . 0.0 113.031 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.0 mt -98.7 142.66 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.143 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 119' ' ' THR . 6.6 ptm180 -122.76 157.17 32.94 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 167' ' ' GLN . 20.2 p90 -157.75 141.8 15.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.534 0.683 . . . . 0.0 109.997 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.09 98.32 5.73 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.755 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -171.49 134.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.08 114.17 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.311 0.577 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.8 p -121.3 162.05 20.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 143' ' ' THR . 58.6 tttm -157.28 150.47 23.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.22 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 142' ' ' LYS . 57.1 p -37.58 158.83 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.88 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.74 -25.61 8.32 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.4 -0.86 57.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.625 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 9.8 p -76.68 142.53 40.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.58 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.57 -20.36 20.64 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.08 144.71 41.84 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.744 -0.728 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.02 124.25 46.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.302 0.573 . . . . 0.0 112.11 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -90.84 111.61 23.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -146.94 177.27 9.26 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.901 0.858 . . . . 0.0 112.681 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.08 177.54 10.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.944 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.6 t -60.93 111.65 1.75 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.208 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.1 77.77 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.157 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -151.98 121.14 6.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.17 0.485 . . . . 0.0 112.182 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.95 128.68 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -93.82 -41.16 9.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.237 0.541 . . . . 0.0 111.248 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.1 -158.47 29.49 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.537 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.92 143.54 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.558 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 162' ' ' GLY . 83.8 t60 -72.8 102.75 3.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.495 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.2 m -91.19 -19.37 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.549 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 160' ' ' HIS . . . -176.88 -152.75 10.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.929 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 176.39 168.31 36.32 Favored Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.544 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 22.0 t-20 -127.92 84.05 2.21 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.622 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.09 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.806 -1.543 . . . . 0.0 115.654 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -102.73 4.54 38.16 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 63.0 mt-30 -126.73 126.59 43.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.426 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.56 143.6 22.69 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 24.7 m-85 -122.54 109.44 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.918 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.8 t -108.5 146.56 33.0 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.541 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.64 125.07 38.05 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.6 pt20 -69.17 116.17 9.3 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.881 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 90' ' ' ILE . 18.8 tp -83.24 91.91 7.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.918 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -83.67 142.95 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.552 0.691 . . . . 0.0 112.263 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -66.09 -16.43 63.94 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -48.42 -50.98 28.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.733 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -70.91 -29.48 65.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.444 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.218 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.486 ' N ' HD13 ' B' ' 2' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.503 -0.862 0 CA-C-O 120.613 0.244 . . . . 0.0 111.636 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.3 tt0 -94.77 79.17 3.71 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 173.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.574 ' O ' HD13 ' A' ' 126' ' ' LEU . . . -72.42 135.77 45.88 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' B' ' 6' ' ' PHE . 0.4 OUTLIER -91.18 134.45 34.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.55 ' N ' HD12 ' B' ' 5' ' ' LEU . 25.1 m-85 -50.04 137.02 17.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.625 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 72.1 mt-30 . . . . . 0 N--CA 1.439 -1.024 0 C-N-CA 117.098 -1.841 . . . . 0.0 . -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 112.703 0.232 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.87 -44.35 55.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.431 0.634 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -55.19 -57.32 12.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.758 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.5 -34.31 75.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.6 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.47 -53.83 30.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.258 0.551 . . . . 0.0 110.625 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.38 98.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.947 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.6 tt -62.79 -42.95 99.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.696 0.284 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -69.93 -43.21 72.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.21 -40.68 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.352 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.655 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 8.3 tt -60.64 -45.0 95.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.013 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 41.7 mtp180 -73.73 -29.8 62.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 1.9 tpmt? -94.87 -51.61 4.61 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.92 -17.31 14.23 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.0 mm -88.05 123.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.65 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.474 ' HA ' ' HE3' ' A' ' 16' ' ' MET . 3.7 mmt -123.53 130.23 52.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.455 ' HG1' ' CD2' ' A' ' 104' ' ' HIS . 0.2 OUTLIER -71.96 103.98 3.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.196 178.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 56.6 mt -89.83 107.86 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 122.123 0.963 . . . . 0.0 111.607 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 m -80.41 110.66 16.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.334 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 21' ' ' SER . 6.2 t -134.11 -171.6 2.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.68 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' N ' ' OG1' ' A' ' 20' ' ' THR . 15.7 m -60.9 -28.47 68.93 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 40' ' ' HIS . 74.3 mmtt -92.78 -4.55 52.86 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.853 -0.53 . . . . 0.0 111.302 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 -151.75 19.1 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 29.1 mt-10 -112.34 129.33 56.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -118.12 167.27 11.64 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.134 0.968 . . . . 0.0 112.428 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 27.0 m -78.75 99.34 6.62 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.931 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 136.39 12.86 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 28' ' ' LEU . 1.6 pt? -121.32 129.74 53.26 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 118.389 -1.325 . . . . 0.0 112.597 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.9 109.64 2.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 90' ' ' ILE . 45.8 mm -67.9 -43.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.276 0.56 . . . . 0.0 110.611 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -171.88 146.78 2.1 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.474 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 50.28 -86.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.2 ptt180 -133.85 9.58 3.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.62 -174.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.95 113.78 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.524 0.678 . . . . 0.0 112.06 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.0 m -117.96 144.21 45.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.343 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.21 143.78 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.291 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.8 tt -148.13 144.84 19.37 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.921 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.94 149.14 15.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.153 1.235 . . . . 0.0 110.879 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.481 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 28.4 m -70.79 -37.11 73.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 42.8 p-80 -64.34 -7.96 11.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.74 61.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 55.71 72.5 1.02 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.76 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.86 135.24 25.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.866 2.377 . . . . 0.0 111.873 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.71 -160.05 36.09 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.087 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.1 p-10 -76.03 -23.78 55.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.206 0.527 . . . . 0.0 110.148 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 1.4 p-10 -139.81 132.96 29.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.81 148.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.511 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.0 mt -96.86 104.36 16.36 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.812 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' OD1' ' A' ' 50' ' ' ASN . 7.6 p -93.9 109.21 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 122.182 0.992 . . . . 0.0 109.962 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 9.4 p-10 45.74 28.36 0.55 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.954 -1.476 . . . . 0.0 113.12 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.45 -20.49 12.3 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.449 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.12 132.41 33.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -85.59 118.41 25.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -138.62 119.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.045 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 36.4 ptt180 -72.57 151.79 42.19 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.82 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 45' ' ' ASP . 11.1 p -74.54 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.056 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -98.36 -40.56 8.25 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 27.4 t0 -155.43 134.68 12.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.482 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.515 ' HZ2' ' HB3' ' A' ' 59' ' ' LYS . 6.2 ttpm? -136.34 115.32 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.414 . . . . 0.0 110.633 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -122.97 125.9 46.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -84.48 112.45 20.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.631 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 39.9 mt -75.47 109.08 8.72 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 m -101.55 148.79 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.45 140.93 95.24 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.326 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -45.9 -24.78 2.32 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.526 2.151 . . . . 0.0 113.851 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 9.81 3.62 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.374 0.607 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 73.11 30.97 1.53 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.61 155.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -64.93 129.17 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 37.2 tp -104.07 -22.49 13.43 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 37.3 tp10 75.09 8.45 4.04 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.47 107.61 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.971 0.351 . . . . 0.0 111.09 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 93.1 m -89.62 112.53 23.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.516 . . . . 0.0 109.72 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.53 106.22 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -101.28 100.9 11.48 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.175 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 17.6 m -91.49 110.33 21.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.426 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 31.0 mt -117.81 120.24 37.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.605 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.64 101.89 0.85 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 117.729 -1.588 . . . . 0.0 109.46 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -102.41 129.69 48.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.65 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -76.49 -25.65 54.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.024 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.15 120.78 38.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -73.6 129.33 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -77.2 137.57 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -44.78 131.56 6.91 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.274 -0.266 . . . . 0.0 111.041 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.25 92.66 3.88 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.282 0.563 . . . . 0.0 112.12 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.4 pt -93.48 20.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 87' ' ' ARG . 10.3 ttm180 -61.64 -39.13 90.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.079 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.35 -11.32 85.14 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.104 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 47.2 m-85 -87.82 -20.58 25.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 117.77 0.785 . . . . 0.0 109.652 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 30' ' ' ILE . 45.4 mt -74.06 146.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 p -120.2 139.61 52.39 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.495 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.01 -42.63 31.98 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.27 120.53 42.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 172' ' ' GLN . 26.7 mt -58.87 -68.18 0.29 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 56.57 70.87 0.61 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.46 93.42 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.13 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -87.84 3.42 5.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.889 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 13.5 t70 -131.05 124.34 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.368 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.79 163.85 31.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.227 1.013 . . . . 0.0 113.115 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.1 m -116.19 143.32 45.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.638 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -116.22 122.11 44.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 -177.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.43 113.03 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.304 0.573 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -99.37 139.75 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.631 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.491 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.8 t60 -146.36 59.62 1.22 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.1 m -108.88 -179.5 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.118 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.8 p-10 -68.39 -38.91 81.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.436 1.016 . . . . 0.0 111.765 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.499 HD21 ' HA2' ' A' ' 144' ' ' GLY . 79.3 m-20 -70.08 -60.12 2.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.087 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -108.06 92.9 4.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 m -91.83 110.64 21.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.514 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.491 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 41.2 t30 64.01 71.8 0.48 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.608 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.3 m -130.98 103.47 6.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.124 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.7 113.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.591 0.71 . . . . 0.0 110.414 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.1 mt -122.53 134.31 54.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.754 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.67 104.45 16.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.24 -41.09 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 96.54 -119.06 6.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.716 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.5 Cg_exo -60.42 100.41 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 115.684 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 137' ' ' TYR . 6.4 m -108.05 126.09 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -142.28 146.78 35.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -77.88 135.27 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.546 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.82 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.19 -116.11 3.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.283 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.93 106.99 14.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.888 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.1 pt -125.17 -172.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.154 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.8 m120 -113.14 95.39 5.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.35 0.595 . . . . 0.0 110.653 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.489 HD22 ' CG1' ' A' ' 161' ' ' VAL . 43.9 tp -81.62 106.85 13.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.4 m 64.77 25.74 12.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.2 m 86.1 -11.24 0.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.824 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.8 m -87.07 119.42 71.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.404 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.19 117.39 4.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.199 1.932 . . . . 0.0 112.36 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -117.46 132.87 56.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.178 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.76 141.04 32.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.707 0.765 . . . . 0.0 112.152 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 64.09 47.08 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.713 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.41 ' SD ' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.78 130.42 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.666 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 61.4 mt -89.44 134.54 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.493 0.663 . . . . 0.0 111.61 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -109.17 130.64 55.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.565 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' HB3' HG13 ' A' ' 118' ' ' VAL . 2.4 p90 -139.19 127.83 23.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.61 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.66 110.61 5.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.991 0.9 . . . . 0.0 111.251 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -179.71 132.05 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.799 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.49 106.68 0.68 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.4 p -112.38 140.18 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.531 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -130.44 152.61 49.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.267 1.032 . . . . 0.0 112.001 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.493 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.18 153.68 0.06 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.759 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 107' ' ' ASN . . . 92.66 -18.2 55.83 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -94.24 -4.57 48.66 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.529 -0.836 . . . . 0.0 112.155 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.658 ' SG ' ' CA ' ' B' ' 7' ' ' GLN 0.265 29.2 p -85.55 151.82 23.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 116.575 -2.05 . . . . 0.0 113.763 -174.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.697 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 106.59 -20.56 34.24 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -53.47 146.83 19.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.735 -0.732 . . . . 0.0 111.697 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.48 125.96 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.821 0.819 . . . . 0.0 113.162 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.8 tp -90.78 108.99 20.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.617 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.9 p -145.48 -179.72 6.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.031 0.919 . . . . 0.0 113.381 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.24 -172.71 4.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.642 -1.617 . . . . 0.0 108.568 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 153' ' ' THR . 9.8 t -66.93 101.75 0.88 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.012 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.9 83.99 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.302 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 79.3 mttt -140.43 140.08 35.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.415 0.626 . . . . 0.0 111.816 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.92 123.54 71.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -97.75 -31.89 12.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.934 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 167.53 -163.12 36.88 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.423 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.5 144.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.701 0.762 . . . . 0.0 111.413 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.433 ' HB2' HD23 ' A' ' 101' ' ' LEU . 6.1 t60 -62.72 114.11 3.41 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.454 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.489 ' CG1' HD22 ' A' ' 126' ' ' LEU . 47.8 t -103.6 -33.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.563 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.42 -147.13 5.54 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.646 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.37 166.3 32.18 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.306 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.497 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 5.3 t30 -132.91 89.67 2.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 109.812 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.52 -102.25 0.42 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.097 -0.956 . . . . 0.0 114.491 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -94.29 4.81 53.37 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -131.98 114.75 14.98 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.27 39.44 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.838 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.0 m-85 -129.01 118.16 22.11 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.021 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.478 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 27.0 t -111.64 159.83 17.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.252 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.87 131.54 44.26 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.439 ' HG3' HD23 ' A' ' 94' ' ' LEU . 47.3 tt0 -68.88 104.49 2.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.086 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.586 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 19.0 tp -80.16 92.87 5.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -87.67 119.94 28.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.994 0.902 . . . . 0.0 112.614 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -53.47 -31.16 44.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.537 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -60.71 -17.74 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.98 -14.66 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.089 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.269 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.417 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.682 0.277 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.7 tt0 -109.99 74.21 0.88 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 171.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -74.94 153.68 38.47 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 23.4 tp -113.42 152.4 30.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 23.2 m-85 -56.99 146.98 25.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.658 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.6 mt-30 . . . . . 0 N--CA 1.436 -1.174 0 C-N-CA 119.891 -0.723 . . . . 0.0 . 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 N--CA 1.462 -0.329 0 N-CA-C 113.363 0.486 . . . . 0.0 113.363 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' HA ' ' OG1' ' A' ' 153' ' ' THR . 17.7 m120 -66.27 -44.17 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.131 0.491 . . . . 0.0 112.136 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -46.35 83.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.214 0.53 . . . . 0.0 111.869 -178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -55.01 -55.08 34.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.316 0.579 . . . . 0.0 111.659 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -63.47 -47.33 82.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.94 90.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.462 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 6.4 tt -67.36 -39.44 85.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 p -69.75 -41.49 75.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.184 -0.323 . . . . 0.0 111.201 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.8 -39.84 76.32 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.043 0.449 . . . . 0.0 110.963 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' C ' HD21 ' A' ' 11' ' ' LEU . 7.0 tt -54.76 -55.76 26.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 8' ' ' LEU . 12.4 mpt_? -61.2 -27.82 68.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.1 -52.98 4.56 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -106.44 -9.64 16.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -100.3 109.15 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.548 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt -121.96 155.54 35.3 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.845 0.831 . . . . 0.0 110.72 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.87 101.13 5.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.985 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.47 107.39 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.433 0.635 . . . . 0.0 110.544 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.6 m -76.82 99.91 5.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.089 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.8 p -95.33 -177.59 4.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.538 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m -75.28 -14.94 60.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.167 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -105.5 -8.11 18.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.415 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 -179.66 22.07 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -79.15 121.18 24.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' HZ ' ' HZ3' ' A' ' 22' ' ' LYS . 75.1 m-85 -127.1 164.73 20.95 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.789 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.4 m -74.86 95.27 2.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.182 -1.826 . . . . 0.0 111.018 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.05 104.87 2.38 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 tp -88.73 104.89 17.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.0 112.162 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.58 126.64 12.87 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.3 mm -89.34 -51.57 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 117.417 0.608 . . . . 0.0 110.399 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -171.95 149.17 2.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.614 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.06 -87.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -135.86 16.06 3.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.494 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.51 119.83 49.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.302 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -125.39 147.16 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.506 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.66 136.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.859 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.405 ' O ' ' HB ' ' A' ' 73' ' ' THR . 15.5 mm -141.04 142.68 28.48 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.34 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.37 148.04 91.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.277 1.318 . . . . 0.0 111.657 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.57 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 52.2 m -68.23 -35.52 78.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.837 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' B' ' 6' ' ' PHE . 54.6 p-80 -74.02 -3.96 32.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -20.7 38.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.581 0.705 . . . . 0.0 109.366 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 59.14 71.64 0.92 Allowed Pre-proline 0 CA--C 1.517 -0.311 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.052 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.67 125.44 10.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.59 1.526 . . . . 0.0 108.963 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.15 178.88 50.94 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.372 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 56' ' ' VAL . 19.7 t70 -70.07 -31.2 68.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -120.18 140.94 50.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.13 161.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.407 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -98.22 114.48 26.75 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.678 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -91.9 92.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.165 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 66.78 5.25 3.84 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.339 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -31.88 2.34 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.976 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.406 ' CD ' HH12 ' A' ' 79' ' ' ARG . 50.3 tt0 -81.72 137.3 35.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 110.449 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -78.45 128.97 34.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.44 154.44 13.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.611 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -106.33 153.39 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.944 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 45' ' ' ASP . 7.7 p -94.96 118.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.49 -33.11 68.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.17 107.83 4.13 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.863 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.47 95.88 6.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -109.31 123.35 49.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.589 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -76.4 124.27 27.28 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -89.51 103.86 16.46 Favored 'General case' 0 C--O 1.259 1.596 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 29.6 m -110.82 173.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.844 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -72.5 139.64 81.32 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.55 -27.58 41.63 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.936 1.758 . . . . 0.0 111.788 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -85.54 8.39 19.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.459 0.647 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.5 t30 64.06 68.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.457 1.123 . . . . 0.0 111.183 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.9 mt -139.93 170.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 112.313 -2.221 . . . . 0.0 105.32 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' H ' HG23 ' A' ' 68' ' ' ILE . 65.7 t30 -86.43 135.72 33.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.342 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 20.4 mt -108.0 -26.94 10.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 25.0 tp10 79.09 3.6 2.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.132 -1.394 . . . . 0.0 113.169 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 17.7 mt -89.88 126.05 35.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.406 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 39.8 m -103.96 118.8 37.52 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.063 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.2 102.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.9 tp -95.42 94.95 8.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.85 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -84.17 94.95 8.49 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.958 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.29 122.57 42.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.213 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.26 84.7 5.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.406 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.406 HH12 ' CD ' ' A' ' 52' ' ' GLN . 27.9 tpt180 -95.56 133.01 40.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.661 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.22 -44.42 79.51 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 118.11 17.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -87.14 134.51 33.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.331 0.586 . . . . 0.0 111.945 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -68.92 137.47 53.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.438 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -72.91 131.4 42.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.946 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.86 86.07 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 18.5 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -63.56 -28.44 69.94 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.698 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.74 -18.65 74.94 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.531 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 92.5 m-85 -77.43 -22.78 50.96 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.9 mt -72.58 123.66 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.6 t -123.37 136.35 54.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -65.92 -42.14 90.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.96 107.01 18.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.72 -76.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HB3' ' HZ3' ' A' ' 155' ' ' LYS . 39.2 tt0 51.43 70.82 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.82 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.02 86.84 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.573 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.61 2.14 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.453 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.666 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.9 t70 -139.35 124.4 18.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.557 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.36 168.57 19.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.644 0.735 . . . . 0.0 112.545 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 34.2 m -119.67 136.42 54.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.381 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 160' ' ' HIS . 3.1 tm? -99.48 114.11 26.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.12 120.49 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.161 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -113.99 119.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.425 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -129.32 72.8 1.48 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.2 p -121.36 -171.95 2.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.632 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.44 -35.76 71.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.27 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.58 -55.81 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.04 125.35 12.27 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.392 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 1.6 p -88.15 112.58 22.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' THR . 84.0 m-20 76.29 74.48 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -142.22 136.37 29.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.195 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.47 137.24 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 109.651 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.78 108.72 13.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.624 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.7 pt-20 -75.65 108.2 8.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.08 -29.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.547 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.62 -115.81 4.61 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.945 -1.121 . . . . 0.0 115.735 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.19 109.35 0.61 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.95 2.434 . . . . 0.0 115.448 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.88 134.94 35.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -134.64 -172.27 2.98 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.86 147.55 48.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.07 -14.19 11.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.49 -111.69 3.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.974 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.2 118.73 32.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.51 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 134' ' ' MET . 49.3 pt -135.32 -179.27 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 5.4 m-20 -96.29 123.7 40.02 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.967 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 53.7 tp -106.12 104.22 13.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.1 t 63.47 28.57 15.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.4 p 80.16 1.23 2.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.873 1.669 . . . . 0.0 112.011 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 m -95.3 114.45 63.85 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.291 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.23 114.06 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.11 1.873 . . . . 0.0 112.718 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -121.3 130.01 53.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.615 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -105.59 164.46 11.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 55.18 50.07 15.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.352 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' HD11 ' A' ' 124' ' ' ILE . 35.2 ttm -101.85 134.65 44.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.061 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 70.0 mt -86.78 152.07 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.296 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -129.58 151.03 50.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.45 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.421 ' HH ' ' CE1' ' A' ' 160' ' ' HIS . 42.9 p90 -156.32 142.95 18.6 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.584 175.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.44 99.36 6.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.505 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -171.02 127.9 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.062 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 110.94 3.25 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.529 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.1 p -109.62 156.54 20.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.855 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 143' ' ' THR . 51.0 tttm -143.36 152.41 41.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.016 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.502 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 6.3 p -40.59 161.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.481 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.65 -28.58 7.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.502 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -83.09 -11.58 57.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.64 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 25.2 p -72.08 111.95 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.634 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 137.23 -14.71 3.74 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.615 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.75 151.72 52.21 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 124.32 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 112.039 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.0 tp -91.98 109.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.3 p -144.59 178.25 8.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.97 0.89 . . . . 0.0 112.13 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.7 174.65 10.46 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.766 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 3' ' ' ASN . 27.9 m -72.45 94.44 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.04 -24.61 9.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.584 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 95' ' ' GLU . 94.0 mttt -134.65 146.52 49.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.73 0.776 . . . . 0.0 112.507 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 mm -110.1 130.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -101.69 -45.39 5.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.46 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.584 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.0 -170.17 43.0 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.651 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.403 HG23 HD13 ' A' ' 173' ' ' LEU . 30.5 pt -116.68 143.63 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.464 ' HB2' HD22 ' A' ' 101' ' ' LEU . 67.0 t60 -73.52 114.98 12.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.321 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.77 -21.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.63 -157.01 16.75 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.886 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.96 165.96 35.82 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.578 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.451 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 28.1 t-20 -136.62 85.99 2.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.778 0.799 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.31 -106.99 1.61 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.563 -1.198 . . . . 0.0 115.178 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.14 -17.11 57.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.93 127.31 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.48 142.4 17.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.462 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 66.6 m-85 -119.5 122.06 40.81 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.236 1.018 . . . . 0.0 111.994 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 32.3 t -119.83 149.71 41.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.38 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.39 136.29 35.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -67.46 123.99 21.95 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.584 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 29.6 mt -90.61 84.96 5.97 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -80.75 135.72 36.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.999 0.428 . . . . 0.0 110.37 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.09 -29.14 68.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.401 0.619 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -55.14 -32.12 61.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.536 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.3 -11.64 51.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 . . . . . 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.489 -179.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.514 -0.438 0 CA-C-O 121.457 0.646 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.2 tt0 -122.49 79.67 1.64 Allowed 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 171.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.59 145.63 30.53 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 33.2 tp -98.59 153.58 18.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.561 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.5 m-85 -59.15 142.35 51.82 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.64 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.3 mt-30 . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 118.203 -1.399 . . . . 0.0 . -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo . . . . . 0 CA--C 1.543 0.929 0 N-CA-C 115.186 1.187 . . . . 0.0 115.186 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.632 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.1 t-20 -57.01 -51.07 70.72 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.828 -0.545 . . . . 0.0 112.206 -177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -56.28 -45.29 80.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.698 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.12 -28.35 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 111.224 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.05 -44.66 83.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.82 90.76 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.485 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.33 -49.81 74.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.987 0.423 . . . . 0.0 110.193 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.24 -39.55 82.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.972 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.8 tp -62.09 -49.57 75.4 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.509 0.671 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.8 tt -54.6 -43.72 72.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.155 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -64.91 -29.69 70.65 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.6 6.15 13.38 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.953 0.797 . . . . 0.0 112.982 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.8 -38.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.1 mt -86.39 115.89 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.353 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.4 mtt -119.72 161.74 20.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.925 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -92.8 123.67 36.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.92 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -112.84 105.57 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.931 0.872 . . . . 0.0 111.448 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.681 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.1 m -78.0 123.04 26.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.619 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.1 p -126.26 -173.48 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 m -81.03 -9.47 59.83 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -91.46 -43.47 9.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.6 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.66 -169.05 42.18 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.268 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 19' ' ' THR . 31.4 mt-10 -106.02 107.32 18.26 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -101.98 171.13 7.69 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.423 1.106 . . . . 0.0 113.516 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.7 m -79.9 113.77 18.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.534 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.02 112.49 4.48 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.781 -1.199 . . . . 0.0 110.877 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 tp -94.98 120.0 34.46 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.25 129.86 9.88 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.476 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -90.61 -56.85 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.72 0.76 . . . . 0.0 110.426 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -160.33 127.56 4.42 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 12.5 t0 56.89 -78.35 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.486 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 15.2 mmt-85 -120.46 -11.24 9.14 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.851 -0.531 . . . . 0.0 110.666 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.19 99.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.331 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -114.23 141.84 47.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.838 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.84 137.64 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.712 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.7 tt -142.24 141.7 22.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.36 142.53 16.91 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.253 1.302 . . . . 0.0 111.351 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.512 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 83.7 m -70.82 -34.84 72.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.132 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -65.62 -7.22 13.91 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.389 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.95 60.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.48 0.657 . . . . 0.0 109.672 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.6 mm-40 50.1 72.83 1.12 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.893 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.03 156.06 60.94 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.96 2.44 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -153.46 26.14 Favored Glycine 0 N--CA 1.455 -0.062 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.835 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.24 -15.58 35.51 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 2.2 p30 -139.27 156.56 46.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.223 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.23 161.06 17.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.681 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 77.3 mt -104.38 108.51 19.96 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' THR . 80.2 t -84.6 85.07 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.352 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 73.82 -10.1 1.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.091 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 156.82 -33.33 0.57 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.91 111.08 1.16 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.802 -1.199 . . . . 0.0 111.557 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -75.12 96.48 3.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 tt -123.92 148.02 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.661 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 55' ' ' ARG . 8.4 mpt_? -97.44 165.05 12.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.326 0.584 . . . . 0.0 111.526 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.4 t -90.45 120.65 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.725 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' ' HB2' ' A' ' 78' ' ' ASP . 75.9 tttt -79.86 -38.67 32.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.385 0.612 . . . . 0.0 110.152 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -159.29 132.63 7.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.395 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.97 114.57 26.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.185 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.551 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -118.06 105.73 12.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.319 -178.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.09 110.11 18.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 71.2 mt -79.32 120.86 24.38 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HA ' ' H ' ' A' ' 70' ' ' LEU . 33.5 m -116.01 154.87 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.621 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 12.6 t70 -87.1 143.45 34.85 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 119.034 0.834 . . . . 0.0 112.91 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 67' ' ' ASN . 61.0 Cg_exo -43.72 -17.13 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.52 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.621 ' HG2' ' OD1' ' A' ' 64' ' ' ASP . 52.7 mm-40 -71.34 0.9 7.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.316 0.579 . . . . 0.0 109.827 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 64.4 m-80 72.75 18.82 4.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -116.98 145.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.858 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -51.6 135.58 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.106 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.533 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.0 tp -104.56 -16.69 14.96 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.512 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 68.3 14.76 9.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.122 -1.399 . . . . 0.0 113.648 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 82.1 mt -105.91 105.29 15.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.061 0.457 . . . . 0.0 111.499 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -89.54 110.19 21.06 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.434 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 95.5 t -81.51 108.86 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 tp -101.49 100.34 10.77 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.815 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 m -74.41 102.76 4.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.625 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' ARG . 86.5 mt -104.71 127.81 52.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.619 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 57' ' ' LYS . 14.1 t70 -87.79 89.46 8.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -93.61 133.89 36.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.61 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.91 -28.75 58.21 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.34 118.36 36.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 19.0 pttp -59.89 129.21 40.71 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.211 -0.995 . . . . 0.0 108.842 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -78.97 161.53 26.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.593 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -49.08 122.84 6.33 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -175.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.22 93.76 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.841 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 156' ' ' ILE . 49.0 pt -96.81 19.11 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -56.16 -35.31 67.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.312 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.76 -16.28 79.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.062 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -87.61 -13.13 43.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.55 133.37 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 7.1 m -96.25 130.94 43.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -77.97 -55.1 5.57 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 91' ' ' SER . 29.0 t70 -100.94 131.68 46.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.4 mt -79.39 -67.64 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.827 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 47.04 71.68 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -167.26 78.32 0.11 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.2 p -71.83 12.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 27.8 t70 -150.31 121.55 7.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.833 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.76 12.6 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.866 0.841 . . . . 0.0 111.591 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 m -120.06 145.96 46.36 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.585 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 9.6 tt -120.56 121.94 39.5 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' THR . 24.2 m -111.21 121.92 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.061 0.458 . . . . 0.0 111.04 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 4.0 t -100.5 134.48 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.08 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -135.7 70.97 1.42 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 m -127.18 175.43 8.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.764 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 25.8 p-10 -71.42 -20.05 62.16 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.359 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -84.97 -34.16 22.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.423 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.47 97.29 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.421 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 102.85 15.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 60.55 70.83 0.6 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.839 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 28.6 m -117.75 111.87 19.69 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.855 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.36 105.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 tt -116.56 127.24 54.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.658 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.71 128.51 34.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.17 -24.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.03 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 79.13 -124.12 6.43 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.852 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 27.9 Cg_endo -62.66 105.11 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.52 2.147 . . . . 0.0 114.495 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 90.6 t -97.2 118.32 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.694 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 p -138.07 167.58 21.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.971 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -104.53 126.04 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.61 -49.79 6.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.88 -115.89 4.13 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.476 -0.868 . . . . 0.0 115.114 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 123' ' ' LEU . 3.8 mp -95.96 107.8 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.061 -0.569 . . . . 0.0 112.096 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 42.2 pt -138.98 -177.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.274 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 60.0 m-80 -102.1 136.53 41.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.008 0.432 . . . . 0.0 110.598 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.657 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 4.1 mm? -115.07 103.81 11.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 128' ' ' SER . 10.3 t 60.8 31.13 20.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.768 -0.582 . . . . 0.0 109.751 -177.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 127' ' ' SER . 67.0 m 79.96 2.94 2.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.444 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -99.59 115.68 65.45 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.777 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.05 115.37 2.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.947 1.765 . . . . 0.0 112.368 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' HD23 ' A' ' 126' ' ' LEU . 19.7 m -128.69 141.84 51.21 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.014 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.608 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 60.3 t30 -117.91 162.8 17.54 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 3.2 mpt_? 77.84 22.94 0.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.659 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.48 129.27 37.62 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.146 0.974 . . . . 0.0 113.303 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 79.6 mt -92.3 132.66 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.278 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -107.25 129.22 54.9 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.515 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 1.3 p90 -133.29 143.44 49.05 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.96 99.49 9.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.636 0.732 . . . . 0.0 112.009 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.405 ' O ' HG23 ' A' ' 141' ' ' THR . 88.8 t80 -170.11 126.16 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.023 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.12 110.97 1.76 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.451 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 36.8 p -112.52 151.68 29.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -143.16 151.52 40.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.334 1.064 . . . . 0.0 110.916 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -38.86 156.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.363 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.81 -20.74 45.41 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 121.726 0.625 . . . . 0.0 111.648 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -87.33 2.94 48.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.459 -0.871 . . . . 0.0 112.228 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.79 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 16.6 m -64.8 142.62 58.37 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 104.5 -23.54 31.24 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.866 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 103' ' ' VAL . . . -49.74 135.92 24.3 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.562 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 47.3 t -88.78 122.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 111.847 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -93.46 108.83 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -146.65 166.18 27.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.193 0.997 . . . . 0.0 113.418 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.632 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -128.74 173.25 10.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.485 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -67.53 106.26 2.1 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.885 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.99 6.47 89.44 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.24 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -137.96 112.98 9.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.409 ' CD1' HD13 ' A' ' 86' ' ' ILE . 65.7 mt -103.59 134.73 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.362 0.601 . . . . 0.0 110.596 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -99.53 -55.13 2.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.931 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.576 ' HA2' HD12 ' A' ' 173' ' ' LEU . . . 176.64 -156.97 21.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.55 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.1 pt -125.94 148.04 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.334 0.588 . . . . 0.0 112.089 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.01 116.55 6.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.195 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.48 -28.88 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.625 0.726 . . . . 0.0 109.901 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' B' ' 7' ' ' GLN . . . 174.44 -145.84 8.26 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.589 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.62 174.11 44.56 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.4 t-20 -135.26 86.26 2.23 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.733 0.778 . . . . 0.0 109.769 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.05 -103.52 0.73 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.545 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -82.85 -11.49 58.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.68 -177.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.463 ' OE1' ' HB3' ' A' ' 166' ' ' ARG . 1.1 mp0 -112.8 145.99 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.851 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -105.13 150.8 17.11 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.7 m-85 -132.8 119.69 20.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.217 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.7 t -113.59 152.66 30.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.579 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.98 135.19 33.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 9.0 tt0 -74.93 113.48 12.28 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.576 HD12 ' HA2' ' A' ' 158' ' ' GLY . 8.4 mp -82.9 83.04 7.92 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -81.06 121.14 25.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.122 0.963 . . . . 0.0 111.249 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -39.67 -39.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.253 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -45.56 -51.21 12.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -69.45 -19.99 63.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.704 -179.367 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.8 mm? . . . . . 0 CA--C 1.508 -0.637 0 CA-C-O 121.273 0.559 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.8 tt0 -121.89 77.32 1.36 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -77.51 147.2 35.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.495 HD11 ' H ' ' B' ' 6' ' ' PHE . 55.1 tp -103.24 142.85 33.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.495 ' H ' HD11 ' B' ' 5' ' ' LEU . 24.6 m-85 -57.78 125.39 22.81 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.06 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.79 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 83.2 mt-30 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 116.525 -0.307 . . . . 0.0 . 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo . . . . . 0 CA--C 1.529 0.266 0 N-CA-C 113.913 0.697 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.3 -51.81 53.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.296 0.57 . . . . 0.0 110.834 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -67.63 -36.15 80.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.941 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.19 -50.53 73.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 110.578 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.19 -48.75 79.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.05 83.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.438 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.3 tt -64.28 -40.39 95.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.596 0.236 . . . . 0.0 110.666 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -63.95 -43.71 94.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.38 . . . . 0.0 110.678 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.3 tp -67.51 -43.17 81.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.682 0.754 . . . . 0.0 110.58 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.3 tp -49.77 -50.54 44.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.436 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 78.4 mtp180 -56.9 -40.05 75.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.74 -15.49 8.9 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.9 5.56 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.8 mm -119.12 109.48 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.4 mmt -124.78 150.84 45.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.654 0.74 . . . . 0.0 111.211 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -76.33 95.36 3.76 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.7 mp -87.86 104.5 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 m -95.88 113.57 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.199 1.0 . . . . 0.0 109.987 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 69.4 p -94.44 -162.84 0.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.863 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.6 m -80.15 -7.25 58.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.68 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -100.74 -56.21 2.39 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.255 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.46 -163.59 26.55 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -83.49 123.39 29.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.267 -0.466 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -126.41 159.28 33.72 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 121.189 0.519 . . . . 0.0 109.709 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 14.2 m -90.16 109.23 20.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.141 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -88.23 110.18 3.6 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.368 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.1 120.4 36.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.27 138.84 15.66 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.63 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG21 ' CD2' ' A' ' 31' ' ' HIS . 4.1 mp -120.57 -39.8 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 118.447 1.124 . . . . 0.0 110.911 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 36.0 m-70 -135.43 128.61 31.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 18.8 t70 43.72 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 14.3 ptt180 -127.08 21.54 6.78 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.963 0.887 . . . . 0.0 109.253 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.38 112.46 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.064 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.2 m -116.76 156.7 26.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.65 139.52 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.176 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 pt -142.01 162.86 43.64 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.0 152.45 71.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 121.212 1.275 . . . . 0.0 111.52 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.616 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 61.0 m -70.69 -33.1 70.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -79.13 3.89 16.3 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.64 59.67 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 20' ' ' THR . 12.7 mm100 68.41 72.32 0.36 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.44 117.01 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.985 2.457 . . . . 0.0 110.086 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.35 -138.11 2.81 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.812 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.403 ' O ' HG11 ' A' ' 56' ' ' VAL . 24.8 t70 -77.55 -24.67 49.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.501 ' HB3' HH11 ' A' ' 55' ' ' ARG . 4.9 p-10 -142.83 162.63 34.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.881 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -140.79 149.04 21.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 84.6 mt -82.99 99.99 10.17 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.731 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -86.16 96.1 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.156 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 63.91 18.91 11.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.39 -17.81 21.09 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.338 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -90.64 123.54 34.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.11 113.31 14.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.181 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.2 mt -116.75 122.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.5 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.501 HH11 ' HB3' ' A' ' 46' ' ' ASP . 2.7 mpt_? -66.84 152.0 46.43 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.368 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -94.4 137.25 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HE3' ' CZ ' ' A' ' 33' ' ' ARG . 67.7 mttm -92.56 -55.52 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -128.26 140.14 52.05 Favored 'General case' 0 N--CA 1.46 0.049 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.622 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -132.44 78.93 1.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.535 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 90.6 t80 -88.01 131.33 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.591 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 10.6 mptt -90.1 116.13 27.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.98 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 17.2 mt -82.93 119.08 23.96 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-O 121.608 0.718 . . . . 0.0 110.549 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 29.8 m -128.62 158.22 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.147 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.05 145.26 88.57 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.261 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.11 -19.12 3.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.809 1.673 . . . . 0.0 113.218 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.06 5.57 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 109.81 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.76 61.59 0.97 Allowed 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.808 0.813 . . . . 0.0 109.641 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.47 HG23 HD12 ' A' ' 123' ' ' LEU . 35.9 mm -133.44 145.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.026 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 131' ' ' THR . 64.2 t30 -59.57 128.87 39.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -105.1 -24.36 12.79 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 174.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.616 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 75.22 10.31 3.67 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.452 -1.703 . . . . 0.0 113.607 175.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 10.5 mp -95.13 122.2 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.4 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 92.4 m -98.26 112.45 24.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.485 0.659 . . . . 0.0 109.883 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 98.9 t -76.2 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.7 tp -94.25 102.02 14.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.388 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.1 m -89.36 100.84 13.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 122.091 0.948 . . . . 0.0 109.178 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.8 mt -74.63 141.25 44.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 19.5 t70 -82.88 72.63 9.95 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.09 133.67 46.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.148 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -81.05 -32.13 34.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.97 98.44 2.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -88.46 150.18 23.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.139 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.21 -163.9 1.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.528 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -83.86 117.58 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.598 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 31' ' ' HIS . 4.8 m-20 -66.57 99.46 0.59 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -91.56 27.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 122.037 -0.414 . . . . 0.0 111.544 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -65.1 -15.46 62.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.463 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.6 -16.42 75.66 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.764 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -91.7 -14.41 30.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.06 127.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.9 m -125.95 132.85 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.474 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.3 pm0 -81.93 -27.29 33.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.75 149.08 26.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.4 mt -103.4 -68.61 0.83 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 41.75 37.66 0.8 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.433 0.635 . . . . 0.0 112.31 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.57 73.62 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 118' ' ' VAL . 1.2 p -73.5 20.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.138 -1.531 . . . . 0.0 114.818 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -121.59 130.12 53.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.43 166.32 25.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.476 -0.89 . . . . 0.0 113.1 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 96.4 m -121.55 142.54 49.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.49 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.13 113.41 26.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.6 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.95 97.57 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -87.93 123.01 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.6 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.0 t60 -137.64 33.31 2.47 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.1 p -109.51 -162.44 0.81 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.024 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -53.35 -56.58 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.15 -44.25 80.24 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.557 -0.714 . . . . 0.0 112.055 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.55 106.28 7.74 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.416 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 23.9 m -93.91 105.72 17.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.6 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 9.9 t30 79.18 72.42 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.275 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.3 m -141.15 107.86 5.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.37 100.37 11.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.801 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD21 ' OH ' ' A' ' 139' ' ' TYR . 58.1 tp -127.55 128.24 45.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.327 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 8.6 pt-20 -79.19 142.53 36.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.83 -20.07 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.55 -124.78 7.96 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.958 -1.115 . . . . 0.0 114.846 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.25 128.62 12.26 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 114.833 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 97' ' ' VAL . 86.8 t -104.91 157.58 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.764 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 m -160.21 114.89 2.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -78.01 115.94 18.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 118.668 -1.213 . . . . 0.0 108.059 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.9 -11.88 46.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.612 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.08 -120.64 5.26 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.788 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 68' ' ' ILE . 48.5 tp -94.17 113.66 25.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.4 pt -138.42 177.83 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.1 m-20 -94.64 128.35 41.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.657 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 68.4 tp -115.36 105.05 12.41 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.5 t 62.24 30.57 17.61 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.7 m 82.1 -1.55 1.48 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.151 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 39.3 m -100.22 123.09 47.98 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.874 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.71 116.37 3.21 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.04 1.827 . . . . 0.0 111.739 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 69' ' ' ASN . 33.6 m -126.82 134.25 50.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.279 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -108.93 163.2 13.51 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HG3' ' OH ' ' A' ' 177' ' ' TYR . 15.8 mmt180 66.37 24.0 10.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.022 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 tpt -72.24 128.86 36.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.143 0.973 . . . . 0.0 112.034 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 38.2 mm -92.43 126.61 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.899 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -104.75 137.27 42.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.33 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.4 p90 -145.63 109.51 4.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -74.01 99.3 3.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.829 1.3 . . . . 0.0 110.914 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' OH ' HD21 ' A' ' 113' ' ' LEU . 85.4 t80 -160.21 137.95 9.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 111.497 -2.592 . . . . 0.0 106.32 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 86.18 1.95 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -101.01 161.84 13.31 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -141.99 168.29 20.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.849 1.309 . . . . 0.0 113.093 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.579 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.03 152.61 0.17 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.763 175.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.5 -19.81 50.38 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -94.22 7.21 46.12 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.205 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.796 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 13.7 m -62.47 136.97 58.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.0 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 103.91 -16.98 50.01 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.829 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.5 142.28 43.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.505 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.13 114.9 29.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.439 0.638 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.7 tp -89.54 106.56 18.53 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.016 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.0 p -149.85 -177.17 5.74 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.039 0.923 . . . . 0.0 111.447 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.99 163.96 35.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.734 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 t -61.12 120.94 11.28 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.717 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.87 -19.39 45.85 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -144.41 124.59 13.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.878 0.839 . . . . 0.0 111.537 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.33 135.34 38.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.413 ' HA ' HE22 ' A' ' 172' ' ' GLN . 93.1 m-85 -103.06 -71.21 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 173' ' ' LEU . . . -152.56 -169.13 17.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.387 -1.387 . . . . 0.0 114.719 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 161' ' ' VAL . 27.4 pt -119.36 140.67 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.457 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -61.09 120.33 10.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 159' ' ' ILE . 73.2 t -117.08 -28.35 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.491 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.09 -151.28 8.4 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.345 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.48 161.16 27.6 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.0 t-20 -135.29 107.91 7.43 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.34 -110.18 3.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.872 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -113.06 25.82 11.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.248 1.023 . . . . 0.0 109.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -126.07 135.99 52.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.447 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -94.38 148.39 18.98 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.282 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.2 m-85 -128.96 123.42 32.44 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.822 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 159' ' ' ILE . 30.8 t -116.07 155.5 28.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.511 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.91 123.8 42.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.475 ' HG3' ' HG3' ' A' ' 174' ' ' LYS . 55.8 tp60 -72.27 124.85 25.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 158' ' ' GLY . 11.0 mp -88.87 84.17 6.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 172' ' ' GLN . 66.4 mttm -78.43 132.72 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.474 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 8.1 ttpm? -52.12 -30.81 28.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -53.61 -29.44 37.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.407 ' OH ' ' HG3' ' A' ' 133' ' ' ARG . 7.8 m-85 -72.18 -32.3 66.7 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.722 -0.611 . . . . 0.0 111.362 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.519 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 90.7 m-85 . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.212 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.445 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.9 mm? . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 121.185 0.517 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.6 tt0 -119.43 78.05 1.27 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 171.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.74 143.61 31.71 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 24.2 tp -99.89 153.34 19.23 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.554 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 25.4 m-85 -60.07 130.31 46.08 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.796 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.8 mt-30 . . . . . 0 C--N 1.315 -0.928 0 C-N-CA 120.623 -0.431 . . . . 0.0 . 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 CA--C 1.535 0.564 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.517 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 12.2 t30 -61.71 -55.64 28.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 m -74.37 -33.6 63.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.91 -24.81 58.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.75 -42.69 97.8 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.48 85.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.76 -50.28 72.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.955 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -71.23 -37.17 72.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.993 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.85 -44.72 95.37 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.725 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.5 pp -63.69 -29.95 71.11 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -76.23 -28.53 57.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.13 -45.7 6.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -120.25 6.64 10.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.725 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 46.1 mm -106.22 106.0 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.0 mtp -111.84 147.58 35.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.216 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 101.66 12.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.143 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.72 98.87 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 32.5 m -80.66 100.0 8.45 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.34 -170.79 2.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.905 -177.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.412 ' H ' HG23 ' A' ' 20' ' ' THR . 65.4 m -74.01 -29.75 62.11 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.586 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.82 -23.71 22.76 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.212 -0.305 . . . . 0.0 111.516 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.27 -164.99 37.54 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.644 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -97.86 107.82 20.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.634 0.731 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -108.97 164.14 12.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.904 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.3 m -89.34 118.18 28.83 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.64 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.23 99.1 2.49 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.652 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.92 104.89 14.38 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.51 120.83 5.65 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.446 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.0 mp -81.75 -58.91 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 117.576 0.688 . . . . 0.0 110.581 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -155.04 148.82 25.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 26.0 m-20 51.71 -91.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.776 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -137.22 22.5 3.0 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.29 119.58 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 110.41 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.0 m -114.31 159.17 20.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.2 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.14 140.97 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' O ' ' HB ' ' A' ' 73' ' ' THR . 14.0 tt -148.36 141.89 15.85 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.13 143.25 25.81 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 120.604 0.869 . . . . 0.0 110.167 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.587 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 71.5 m -67.74 -35.03 78.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -68.41 -7.57 32.82 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.42 68.24 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.636 0.732 . . . . 0.0 109.663 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 59.46 69.68 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.198 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -77.62 146.24 23.92 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.27 2.647 . . . . 0.0 110.549 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.41 -140.42 8.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.982 -1.104 . . . . 0.0 114.079 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.83 -24.38 38.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.732 -0.734 . . . . 0.0 110.324 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.62 139.83 34.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 27.6 m -124.55 153.47 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.246 0.546 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.3 mt -94.52 101.87 13.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.179 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.99 87.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.61 16.02 8.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.522 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.63 -25.07 6.64 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.034 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.08 108.47 17.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 76.5 mttt -73.8 142.38 46.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.715 0.769 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -136.53 142.17 39.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.85 140.12 33.08 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.854 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.45 155.56 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.408 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -113.72 -46.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.54 134.5 8.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.474 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -124.1 116.01 22.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.416 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 87.5 t80 -133.65 123.85 25.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.778 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -83.9 112.9 20.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . 6.7 tt -96.49 115.13 26.92 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.174 0.988 . . . . 0.0 109.876 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 27.7 m -111.35 178.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.165 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.6 t70 -70.93 136.56 85.09 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.92 -28.55 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.363 2.042 . . . . 0.0 113.948 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -90.12 20.21 4.48 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.6 0.714 . . . . 0.0 110.742 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.75 62.06 1.56 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.887 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 54.9 mt -133.13 158.29 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -77.94 144.58 36.7 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.14 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.704 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.4 tp -127.48 -35.65 2.14 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.704 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 55.4 mm-40 85.96 7.26 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.466 HD11 ' HG ' ' A' ' 70' ' ' LEU . 11.3 mp -78.97 93.66 5.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.164 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 45.7 m -84.01 106.25 15.52 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 70.0 t -71.16 96.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.5 tp -103.04 98.74 8.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 111.304 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -92.26 125.51 36.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.463 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.1 mt -114.02 153.43 29.39 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.938 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.62 68.5 8.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.266 -1.373 . . . . 0.0 108.475 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -78.82 117.58 20.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.877 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -76.31 -52.18 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.947 0.403 . . . . 0.0 109.982 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.92 82.98 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 19.5 pttp -73.27 139.16 45.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.641 0.734 . . . . 0.0 112.139 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -82.1 -178.32 6.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -69.64 147.87 50.07 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.565 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 6.6 t70 -88.69 95.98 10.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.848 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 90' ' ' ILE . 39.1 pt -91.49 15.66 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 13.9 ttp180 -62.7 -29.56 70.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.833 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.32 -16.47 80.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.679 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -92.46 -20.17 21.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 56.9 mt -68.74 124.35 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 19.0 m -103.52 120.54 41.06 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.33 -38.07 36.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 91' ' ' SER . 22.1 t70 -101.04 130.62 47.07 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 172.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 mt -90.57 -78.82 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 49.7 70.31 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.42 86.82 0.11 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.6 p -79.41 15.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.123 -0.539 . . . . 0.0 112.272 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 15.2 t70 -141.03 132.14 26.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.965 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.57 31.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.025 0.917 . . . . 0.0 111.031 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.05 135.85 51.37 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.329 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.93 117.97 34.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.256 0.55 . . . . 0.0 111.879 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.31 93.77 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.04 122.06 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.457 0.646 . . . . 0.0 110.236 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.482 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 72.5 t60 -145.71 41.65 1.22 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.7 p -108.35 -164.9 0.99 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.18 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.37 -48.92 79.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.79 -17.58 53.04 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -150.94 101.39 2.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.507 -0.746 . . . . 0.0 110.742 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 p -85.65 110.02 18.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.482 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 t30 66.43 71.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.564 0.697 . . . . 0.0 111.655 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 m -139.81 109.31 6.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.08 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.0 tp -82.39 120.87 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 116.05 20.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.579 -176.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.15 128.3 35.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.35 -27.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.067 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.45 -131.23 10.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.912 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 39.5 Cg_exo -61.38 115.93 3.07 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.842 2.362 . . . . 0.0 114.19 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -92.46 116.51 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.295 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -123.53 172.08 9.02 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 67.2 mtt -115.75 154.33 29.8 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.0 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.82 -22.92 10.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.02 -111.05 3.23 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.064 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -109.66 111.98 23.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.848 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 46.2 pt -139.35 -177.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 84.5 m-20 -101.43 127.7 47.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.823 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 34.7 tp -107.75 106.58 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 128' ' ' SER . 60.6 p 60.84 30.27 19.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.297 0.57 . . . . 0.0 109.951 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 127' ' ' SER . 63.4 m 85.67 0.52 0.7 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.282 1.033 . . . . 0.0 112.431 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.9 m -110.1 115.27 55.03 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 75.6 Cg_exo -52.05 128.09 25.75 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.529 2.153 . . . . 0.0 114.365 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 p -125.46 145.35 50.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.098 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 65.9 t30 -115.68 160.82 19.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.322 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 5.2 mpt_? 65.83 32.72 8.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.074 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.4 mmm -77.91 127.28 32.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.565 0.698 . . . . 0.0 112.807 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 71.7 mt -85.41 145.39 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.843 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.85 134.0 44.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 111.675 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -152.94 148.41 27.08 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.54 120.03 36.11 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 122.65 1.214 . . . . 0.0 111.502 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -175.06 129.84 0.3 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.811 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.04 0.79 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.151 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.8 t -119.55 138.45 53.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.112 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.43 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 113.455 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.19 153.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.276 174.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.16 -20.11 31.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.429 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -90.68 -7.84 51.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.327 -0.437 . . . . 0.0 111.495 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.621 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 25.8 p -73.61 135.13 43.81 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.024 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.662 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 124.03 -24.14 6.39 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.053 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.48 148.82 25.27 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.142 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.95 121.61 50.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 112.38 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.8 tp -92.41 113.42 25.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.283 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -149.26 169.9 19.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.752 0.787 . . . . 0.0 112.823 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.6 169.95 16.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.132 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 1.6 t -62.69 106.11 0.75 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.87 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.12 70.43 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.402 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.87 106.92 9.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.4 mt -95.08 115.96 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.09 -65.37 1.02 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.894 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.501 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -177.39 -155.6 14.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.103 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.4 pt -119.52 142.76 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.374 0.607 . . . . 0.0 111.236 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.15 115.62 7.83 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.35 -25.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.42 -154.84 10.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.564 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.31 161.77 31.89 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.516 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 48.3 t30 -136.2 98.54 3.88 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.86 -119.78 6.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.657 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HD2' ' H ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -103.03 17.38 24.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.821 0.81 . . . . 0.0 111.015 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -113.01 124.65 53.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.74 139.03 15.17 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.406 ' CZ ' ' HG ' ' B' ' 2' ' ' LEU . 73.4 m-85 -119.09 118.03 30.3 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.088 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 40.4 t -110.94 154.12 24.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.249 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -101.49 136.21 41.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.991 0.424 . . . . 0.0 110.078 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.92 117.03 18.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.501 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 92.6 mt -89.85 87.19 6.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HB2' ' CD2' ' A' ' 177' ' ' TYR . 92.5 mttt -80.52 126.5 31.31 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.325 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 63.0 tttm -43.07 -43.78 4.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.226 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -57.71 -23.52 52.21 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.475 ' CD2' ' HB2' ' A' ' 174' ' ' LYS . 54.4 m-85 -75.63 -25.99 57.37 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.644 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.203 0.525 . . . . 0.0 110.921 -179.13 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.406 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.2 mm? . . . . . 0 CA--C 1.509 -0.62 0 CA-C-O 121.505 0.669 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.4 tt0 -119.74 84.85 2.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 172.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -89.58 146.39 24.6 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 45.9 tp -102.14 151.7 21.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.539 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 22.3 m-85 -57.78 140.87 50.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.621 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 93.8 mt-30 . . . . . 0 N--CA 1.441 -0.892 0 C-N-CA 118.353 -1.339 . . . . 0.0 . 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 CA--C 1.526 0.09 0 N-CA-C 114.073 0.759 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -70.78 -46.8 62.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.914 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -62.72 -33.65 75.55 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.812 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.15 -47.01 88.2 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.389 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -62.1 -44.38 96.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.233 0.54 . . . . 0.0 109.835 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.71 87.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.705 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 1.6 tt -64.68 -40.07 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.653 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -67.6 -48.1 67.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 -39.72 87.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.879 0.847 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.418 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 67.1 tp -54.9 -49.86 70.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.115 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 16.8 mtm180 -72.33 -29.6 63.97 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -91.12 -48.98 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -175.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -118.49 0.06 11.51 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 55.0 mt -106.44 122.99 60.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.6 mtp -133.98 165.6 24.66 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.991 0.901 . . . . 0.0 110.584 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.74 111.79 12.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.958 -1.474 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -104.53 110.38 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 2.0 m -87.31 112.86 22.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.175 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -122.35 -171.93 2.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.32 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.472 ' H ' HG22 ' A' ' 20' ' ' THR . 14.9 m -55.28 -37.09 66.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' A' ' 25' ' ' PHE . 23.9 ttpp -91.02 0.43 57.54 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.78 -160.16 21.69 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.466 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -89.91 122.85 33.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.136 0.493 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 22' ' ' LYS . 66.9 m-85 -113.45 177.6 4.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.233 1.016 . . . . 0.0 112.003 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 49.4 m -91.94 107.18 19.02 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.742 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.3 112.1 4.23 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.191 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 tp -95.6 103.9 15.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.418 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.68 125.58 13.63 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.99 -46.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 117.199 0.5 . . . . 0.0 111.106 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -171.83 149.93 2.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.99 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.641 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 31.6 t70 46.49 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.641 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 10.2 ptp85 -125.44 18.86 8.15 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.811 -0.556 . . . . 0.0 111.074 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.51 122.92 58.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.625 0.726 . . . . 0.0 111.71 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.44 141.68 50.97 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.377 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.67 135.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.562 0.696 . . . . 0.0 109.785 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' A' ' 73' ' ' THR . 8.1 tp -141.04 137.78 17.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.798 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.52 151.53 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.775 0.983 . . . . 0.0 111.196 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 92.0 m -78.35 -34.84 48.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.936 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -72.2 3.8 4.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.759 0.314 . . . . 0.0 111.111 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.33 -24.62 50.78 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.0 0.905 . . . . 0.0 109.336 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 56.9 70.18 1.48 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.817 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.95 152.12 24.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.875 2.383 . . . . 0.0 109.41 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.57 -134.78 7.04 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.91 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.83 -9.14 24.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 11.6 t70 -136.91 124.43 22.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.082 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.95 172.58 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.697 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.598 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.6 mp -117.03 121.92 42.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.76 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.24 98.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 55.9 58.14 4.64 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.793 -176.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -38.07 1.9 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 118.7 15.63 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG2' ' HG ' ' A' ' 48' ' ' LEU . 4.6 mtmp? -80.71 146.02 31.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.638 0.732 . . . . 0.0 112.166 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -144.58 146.32 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.076 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.497 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 24.8 mmm180 -79.89 145.35 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.67 0.271 . . . . 0.0 110.466 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.29 150.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HE3' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -94.65 -58.25 2.24 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.36 117.53 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.277 -1.328 . . . . 0.0 110.454 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 59' ' ' LYS . 38.1 ttpt -107.56 115.67 30.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -121.66 117.46 26.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -77.28 109.36 11.1 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 57.4 tp -85.45 114.36 22.43 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-O 122.475 1.131 . . . . 0.0 110.877 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 34.6 m -123.52 168.36 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 113.092 -1.867 . . . . 0.0 108.786 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 13.3 t70 -63.99 144.16 98.16 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.945 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.75 -19.71 8.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.248 1.965 . . . . 0.0 113.682 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.94 15.75 19.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 109.112 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t30 60.65 64.12 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.08 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -130.87 142.16 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 131' ' ' THR . 65.2 t30 -64.4 127.13 30.18 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 29.0 mt -98.43 -29.21 13.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 32.5 tp10 85.81 7.94 0.35 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.785 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 10.8 mp -91.93 107.48 19.24 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.736 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 51.7 m -90.27 105.37 17.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.09 99.78 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.56 100.94 13.6 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.486 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -94.58 98.42 10.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.367 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 pt? -122.62 127.93 50.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.457 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.79 86.14 1.7 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.568 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -79.96 141.08 36.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.12 -1.4 . . . . 0.0 107.943 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -68.96 -38.6 79.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -90.59 96.7 10.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.2 152.9 28.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -85.42 159.06 20.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.116 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -72.49 156.54 38.92 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.877 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.41 67.47 8.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.1 11.41 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.198 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -58.29 -25.94 62.41 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 120.623 0.249 . . . . 0.0 111.255 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.14 -17.68 74.11 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.805 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -95.34 -4.32 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 109.956 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.8 mt -82.11 131.9 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 2.5 m -91.6 122.77 34.47 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -174.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -71.18 -63.33 1.13 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.86 135.17 34.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 172.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.13 -54.91 41.65 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.979 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 46.58 71.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.176 0.512 . . . . 0.0 110.965 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.21 93.25 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 5.9 p -78.04 6.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -119.17 124.81 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.57 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.328 1.061 . . . . 0.0 113.745 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 m -124.28 139.18 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.37 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.89 117.77 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.008 0.432 . . . . 0.0 112.033 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -104.24 105.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.841 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.63 121.74 54.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 111.713 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -126.5 76.99 1.67 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.47 -170.28 2.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.444 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -56.4 -47.29 79.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -98.64 -56.65 2.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.903 0.774 . . . . 0.0 110.099 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.46 90.82 5.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 3.1 m -106.87 114.61 28.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.822 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 109' ' ' THR . 3.5 m-20 71.5 26.85 3.14 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.166 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -84.52 111.66 19.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.375 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.58 99.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.336 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 113' ' ' LEU . 3.6 mp -95.39 137.19 34.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.08 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.59 114.81 26.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -97.82 -19.56 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.422 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.33 -135.81 14.69 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.453 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.717 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 19.3 Cg_exo -67.23 142.15 59.66 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.02 2.48 . . . . 0.0 114.063 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.83 171.29 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.639 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 m -148.61 157.68 43.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.13 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 73.9 mtm -100.58 129.26 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 136' ' ' ARG . . . -97.63 -17.42 19.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.31 -118.85 4.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.48 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.4 tt -107.5 120.3 41.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.204 0.526 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.3 pt -140.68 -166.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 17.5 m120 -117.17 131.55 56.85 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.235 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 1.6 mm? -110.08 108.1 18.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' SER . 7.2 t 61.39 29.14 18.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 55.3 m 84.31 -10.49 0.88 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.571 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 m -81.64 126.31 76.13 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.05 117.4 4.51 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.828 1.685 . . . . 0.0 112.14 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.482 ' HG1' HD23 ' A' ' 126' ' ' LEU . 15.0 p -120.25 142.89 48.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.553 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.11 164.29 15.77 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.358 0.599 . . . . 0.0 111.538 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 62.61 34.27 15.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.527 ' HE1' ' HA ' ' A' ' 134' ' ' MET . 10.7 mmt -79.32 137.2 37.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.505 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 65.6 mt -96.25 133.69 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.584 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 37.5 ttt180 -120.43 125.23 47.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.762 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -142.9 139.08 30.63 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.92 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -80.44 96.52 6.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.145 0.974 . . . . 0.0 110.982 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -165.56 131.74 2.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.521 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.67 83.62 0.87 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -89.42 140.24 29.71 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.24 157.63 39.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.996 1.379 . . . . 0.0 114.315 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.77 150.0 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.292 175.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.38 -27.35 10.69 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -93.15 7.37 44.5 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.627 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 12.6 p -79.58 125.7 29.94 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.181 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 127.93 -16.66 6.1 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.303 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 151.67 33.6 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.653 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.37 119.13 45.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.332 0.587 . . . . 0.0 112.039 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.64 110.04 19.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -152.85 -170.4 3.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.024 0.916 . . . . 0.0 113.129 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -166.1 178.6 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.989 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.0 t -55.44 107.98 0.38 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.471 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 60.11 30.24 70.01 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.541 ' HE2' ' OG ' ' A' ' 91' ' ' SER . 2.5 tpmt? -145.3 91.67 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.713 -0.743 . . . . 0.0 111.453 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -93.75 122.52 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -92.32 -46.79 7.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.054 0.454 . . . . 0.0 110.351 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.555 ' CA ' HD11 ' A' ' 173' ' ' LEU . . . 163.85 -154.73 25.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.125 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.36 146.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.53 0.681 . . . . 0.0 111.234 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -78.9 115.05 18.34 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.644 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.24 -28.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.65 -151.5 8.99 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.209 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -173.18 167.09 39.76 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.489 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 24.8 t-20 -136.76 94.43 2.98 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.4 -96.43 0.49 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.398 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -108.96 9.88 26.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.19 0.519 . . . . 0.0 110.879 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -121.29 135.67 55.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.98 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.19 139.29 14.41 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 60.9 m-85 -120.59 121.52 38.55 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.93 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.6 m -121.17 167.94 12.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.617 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.511 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.49 143.2 37.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.06 116.17 18.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.555 HD11 ' CA ' ' A' ' 158' ' ' GLY . 8.7 mp -93.58 86.3 5.15 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 91' ' ' SER . 28.6 mttm -76.3 146.67 38.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.446 ' HB3' ' HZ3' ' A' ' 175' ' ' LYS . 7.3 ttpm? -58.34 -31.94 68.04 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 111.695 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -50.9 -42.23 59.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.402 ' CG ' HD22 ' A' ' 62' ' ' LEU . 9.0 m-85 -64.01 -38.54 91.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -174.619 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.4 tt0 -118.22 77.11 1.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -78.65 155.37 29.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 51.0 tp -110.46 142.9 41.56 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 21.3 m-85 -57.16 136.08 56.4 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.627 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.1 mt-30 . . . . . 0 N--CA 1.44 -0.938 0 C-N-CA 119.665 -0.814 . . . . 0.0 . -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 CA-C-O 120.851 0.271 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 152' ' ' ALA . 38.6 t30 -62.1 -50.99 69.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.547 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -56.86 -53.38 58.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.175 -1.375 . . . . 0.0 112.935 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.547 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.2 mp0 -71.33 -26.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.309 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.56 -45.71 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' HB3' HG11 ' A' ' 102' ' ' VAL . . . -56.89 -45.39 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.403 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.61 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 7.5 tt -59.76 -42.33 93.02 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 m -70.3 -36.49 74.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.256 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -70.26 -47.41 61.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.0 pp -64.81 -25.02 67.73 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 69.6 mtp180 -70.0 -50.07 45.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.31 -23.99 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -108.51 -4.55 17.15 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 43.4 mm -114.59 117.08 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.816 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -120.79 137.31 54.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.313 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 m -76.71 103.28 6.59 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.97 102.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.686 0.755 . . . . 0.0 111.575 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 63.4 m -71.13 100.01 1.97 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.791 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -107.4 175.7 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.954 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.509 ' H ' HG23 ' A' ' 20' ' ' THR . 3.4 m -55.15 -47.31 75.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 7.7 mmpt? -89.83 2.11 55.35 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.71 -175.97 27.73 Favored Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.853 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.6 ' O ' ' HB3' ' A' ' 105' ' ' SER . 30.2 mt-10 -101.48 112.6 25.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -106.93 162.59 13.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.951 0.881 . . . . 0.0 112.951 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 86.3 m -80.73 106.8 13.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.847 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.27 116.48 4.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.694 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -94.42 108.95 20.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 110.795 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.8 108.08 2.41 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -75.43 -55.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.891 0.377 . . . . 0.0 111.802 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -162.96 138.92 7.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.617 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 13.0 t70 57.32 -94.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.069 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 76' ' ' THR . 79.2 mtt85 -126.28 8.74 7.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.802 0.81 . . . . 0.0 110.163 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.9 t -92.71 113.18 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.866 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 p -124.06 142.8 50.87 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.11 137.09 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.023 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 tt -144.95 139.95 15.72 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.525 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.2 144.1 72.06 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.457 1.438 . . . . 0.0 112.439 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.78 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 89.7 m -63.9 -37.6 87.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -72.52 6.54 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.17 -19.1 30.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.668 0.747 . . . . 0.0 109.937 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 64.98 69.51 0.66 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.196 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.81 110.49 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.638 1.559 . . . . 0.0 109.48 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -141.84 1.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.546 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.01 -28.32 15.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.952 0.882 . . . . 0.0 109.227 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -136.88 132.4 34.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.039 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.81 153.15 36.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 mp -97.01 104.01 15.98 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.118 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 49' ' ' VAL . 7.2 p -82.02 96.03 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.34 10.53 7.3 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.47 -28.76 3.96 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.461 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -78.88 118.38 20.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.127 0.489 . . . . 0.0 110.741 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 6.9 mtpm? -72.55 107.79 5.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.9 mt -119.39 126.4 75.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.257 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -77.56 146.22 36.42 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 110.084 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.27 138.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -84.46 -45.56 12.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.78 144.48 15.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -136.67 112.67 9.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -112.95 129.35 56.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.339 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.43 110.79 16.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 36.9 tp -81.19 115.1 20.44 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.44 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.59 167.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.673 -1.603 . . . . 0.0 108.218 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 17.9 t70 -87.0 143.32 34.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.59 -17.05 6.25 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.367 2.045 . . . . 0.0 113.513 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.89 7.18 9.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.86 39.99 2.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.938 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 150.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.846 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -66.4 137.39 56.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 18.6 mt -105.38 -28.38 10.91 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.78 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 35.8 tp10 80.7 9.03 1.18 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.948 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.473 ' HG ' HD21 ' A' ' 173' ' ' LEU . 2.3 mm? -95.54 133.41 39.58 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.904 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.8 m -105.61 115.56 30.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.61 96.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -93.28 103.55 15.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.928 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 19.9 m -94.44 100.5 12.49 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.22 156.63 16.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.758 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -83.87 103.53 13.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -129.96 143.1 50.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.459 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -87.34 -59.02 2.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.77 90.64 4.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 55.6 pttt -68.07 163.66 21.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -79.23 145.91 33.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.343 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -62.45 130.82 46.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.717 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.94 80.93 0.47 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 122.173 -0.329 . . . . 0.0 111.437 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.36 19.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 O-C-N 121.448 -0.782 . . . . 0.0 110.403 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.48 -13.38 62.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.614 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.84 67.43 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.873 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.28 -10.15 50.52 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.86 131.84 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.9 m -105.43 133.68 49.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -81.97 -23.82 35.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -127.31 111.49 13.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.6 mt -52.74 -64.55 0.78 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.7 69.25 0.69 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.28 96.9 0.1 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.5 p -86.55 17.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.333 0.587 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -140.35 132.92 28.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.034 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.18 16.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.236 1.017 . . . . 0.0 113.38 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.3 m -128.23 142.1 51.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.389 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.76 110.97 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.142 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 7' ' ' ALA . 27.1 m -103.74 136.19 37.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.16 0.505 . . . . 0.0 110.999 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -122.54 133.87 67.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.909 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.586 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 64.5 t60 -138.64 45.03 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 m -108.78 -165.42 1.02 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.413 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -83.34 -18.52 38.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.619 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 11.9 p30 -67.49 -50.3 59.55 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -138.49 113.83 9.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.4 m -92.55 96.84 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.808 0.813 . . . . 0.0 112.22 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.586 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 8.0 t30 74.03 70.45 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.054 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 m -134.85 136.67 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.819 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.58 117.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.8 mp -111.91 113.16 25.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.49 120.58 24.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -97.06 -25.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.956 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.73 -129.12 9.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.838 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 25.1 Cg_exo -62.43 130.51 30.37 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.3 2.0 . . . . 0.0 113.231 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.45 131.66 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.0 p -122.98 144.98 48.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 72.8 mtm -81.31 114.28 19.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.51 -50.27 7.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.864 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.19 -119.95 5.86 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.785 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 123' ' ' LEU . 3.4 tm? -95.68 118.1 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.304 0.574 . . . . 0.0 112.53 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.8 pt -139.98 -174.46 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.1 m-20 -113.26 104.28 12.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.735 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.6 mm? -79.52 113.36 17.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.426 ' HB3' HD12 ' B' ' 5' ' ' LEU . 59.0 p 52.27 30.81 8.39 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.969 -0.457 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m 70.56 62.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -160.8 115.27 1.35 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.315 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.21 112.12 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.349 1.366 . . . . 0.0 111.6 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.498 ' HB ' HD22 ' A' ' 126' ' ' LEU . 17.7 m -125.79 128.86 48.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.854 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.517 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 57.7 t30 -106.86 162.79 13.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 19.6 ttm-85 70.88 34.82 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.286 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.3 mmm -87.37 139.44 30.55 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 111.68 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.4 mm -97.94 134.49 36.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.442 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -111.82 125.42 54.0 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -137.36 125.82 23.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.67 99.81 3.78 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 122.232 1.015 . . . . 0.0 110.773 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -166.7 128.19 1.71 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.47 91.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.1 p -90.72 162.42 14.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.336 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -132.17 150.33 52.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.971 0.891 . . . . 0.0 111.865 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.639 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.22 154.22 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.275 175.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -33.14 5.43 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.468 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 70.8 mt-30 -77.52 9.99 2.92 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.823 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 23.6 m -65.54 139.6 58.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.678 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.88 -14.96 34.31 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.951 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.68 145.1 40.11 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.532 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.42 122.19 50.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.645 0.736 . . . . 0.0 112.249 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.38 108.91 20.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.347 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 178.85 8.68 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.904 0.859 . . . . 0.0 112.802 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.408 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . . . -153.12 179.25 8.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.628 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 2.0 t -60.63 102.63 0.2 Allowed 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.794 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.95 88.01 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.608 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.08 119.36 16.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.641 0.721 . . . . 0.0 112.768 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -99.31 124.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -94.57 -35.03 12.42 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 161.05 -163.15 34.14 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.769 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.5 pt -129.85 152.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.842 0.829 . . . . 0.0 112.11 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -62.27 122.73 16.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.756 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.13 -30.98 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.183 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.21 -146.12 5.5 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.583 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -179.42 158.11 21.76 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.322 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.505 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 21.4 t30 -131.22 86.56 2.37 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.977 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.13 -99.74 0.81 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 114.995 -1.002 . . . . 0.0 114.973 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -94.25 -2.43 52.39 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 111.929 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -121.46 131.39 54.13 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.759 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.01 151.3 25.83 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -129.28 114.11 15.84 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.765 -1.174 . . . . 0.0 113.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.0 m -108.92 159.27 16.94 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.46 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.494 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -96.26 132.35 41.81 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.587 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.598 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 51.8 tt0 -70.96 107.86 4.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.12 0.486 . . . . 0.0 110.283 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 80.4 mt -85.59 93.83 8.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.556 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.75 125.56 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.726 0.774 . . . . 0.0 109.548 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -40.18 -39.86 1.0 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.4 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.48 -46.23 37.91 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -64.06 -17.0 62.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 110.626 179.472 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -86.55 79.54 8.9 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.492 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.735 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.41 125.08 30.64 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 37.7 tp -86.02 146.75 26.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.505 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 16.2 m-85 -60.17 130.2 45.5 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.823 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.3 mt-30 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.647 -0.706 . . . . 0.0 . 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 CA--C 1.535 0.532 0 N-CA-C 114.451 0.904 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.67 -40.49 76.39 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.58 0.705 . . . . 0.0 110.694 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -49.78 68.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.535 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.28 -33.82 72.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.388 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -68.81 -58.52 4.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 tp -70.46 -33.02 70.8 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -79.79 -34.55 39.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.42 -36.43 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.1 tp -54.94 -59.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.027 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.61 -27.04 61.92 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.71 -46.34 14.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.53 -6.06 9.24 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 65.2 mt -110.25 121.19 62.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.96 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.4 mtt -127.73 147.23 50.4 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.639 0.733 . . . . 0.0 109.817 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -64.92 110.98 2.63 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.009 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 39.7 mm -95.57 105.18 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -92.21 96.52 10.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.507 0.67 . . . . 0.0 109.301 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.402 HG21 HG22 ' A' ' 18' ' ' ILE . 1.3 p -102.81 -169.73 1.7 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.341 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -67.32 -32.04 72.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.703 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -83.03 -35.29 25.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.395 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.43 -151.57 22.64 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 119.479 -1.343 . . . . 0.0 115.34 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.42 120.28 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.306 -0.947 . . . . 0.0 110.531 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -126.44 159.58 32.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.184 0.992 . . . . 0.0 113.018 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.646 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 32.9 m -79.65 100.91 8.07 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.384 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -90.42 112.29 4.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.69 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -101.81 105.72 16.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.28 116.58 5.27 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.53 -60.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.223 0.512 . . . . 0.0 111.946 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -145.51 152.65 40.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.875 0.845 . . . . 0.0 112.678 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.499 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 41.6 m-20 45.14 -92.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.781 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 16.9 ptt180 -141.59 25.75 1.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.88 0.848 . . . . 0.0 109.661 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.53 118.61 53.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.548 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 m -117.48 146.07 43.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.869 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.89 122.91 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.062 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -134.76 141.11 37.39 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.243 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.6 144.3 97.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 121.583 1.522 . . . . 0.0 109.915 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.524 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 49.7 m -74.11 -32.44 63.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -71.53 -7.27 46.51 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.89 -29.44 66.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.952 0.882 . . . . 0.0 108.754 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 66.61 70.95 0.47 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.662 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.73 118.56 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.223 2.615 . . . . 0.0 108.64 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.52 -111.42 0.74 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.559 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.18 -35.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.558 0.694 . . . . 0.0 109.172 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -117.78 148.64 41.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.561 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 HG22 HD22 ' A' ' 75' ' ' LEU . 86.8 t -131.3 123.81 53.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.744 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.0 mt -74.41 88.32 2.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.198 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.24 98.98 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.5 23.04 12.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 -7.6 56.93 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.597 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -93.76 130.37 39.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.122 0.487 . . . . 0.0 111.665 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -74.35 88.62 2.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.925 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.94 136.07 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -100.67 154.75 18.34 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 117.956 -1.498 . . . . 0.0 113.889 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 59' ' ' LYS . 78.2 t -71.49 133.53 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.522 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.438 ' HD3' ' C ' ' A' ' 57' ' ' LYS . 11.0 tmtt? -100.95 -56.24 2.37 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -128.02 115.88 19.17 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.649 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.56 ' HB2' HG12 ' A' ' 56' ' ' VAL . 54.0 tttp -106.88 92.16 3.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -113.22 123.76 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.455 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -86.12 103.19 14.54 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 56.2 tp -69.19 114.75 7.74 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 123.376 1.56 . . . . 0.0 112.302 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.62 153.42 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' A' ' 66' ' ' GLU . 12.3 t70 -74.33 139.92 75.69 Favored Pre-proline 0 C--N 1.306 -1.291 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 67' ' ' ASN . 31.2 Cg_exo -44.72 -17.62 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.576 1.517 . . . . 0.0 112.086 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 64' ' ' ASP . 12.9 tp10 -68.42 -1.39 6.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.566 0.698 . . . . 0.0 109.161 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 65' ' ' PRO . 10.7 t30 72.21 30.21 2.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.052 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.3 mt -123.39 143.41 36.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.789 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.84 145.26 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.758 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 59.2 mt -126.26 -30.72 2.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.183 0.516 . . . . 0.0 109.833 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.758 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.4 mm-40 87.13 4.35 0.36 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.975 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 66.6 mt -87.92 98.12 11.32 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.014 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 m -76.46 103.45 6.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.033 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 62' ' ' LEU . 99.2 t -77.57 88.05 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.48 HD22 HG22 ' A' ' 47' ' ' VAL . 15.2 tp -93.76 115.01 27.41 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.109 -175.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -98.32 109.86 22.55 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.632 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.44 151.41 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.92 86.93 6.87 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.353 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 33' ' ' ARG . 29.2 mmm180 -103.81 146.96 27.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.009 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.96 -51.63 3.99 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -76.22 114.02 14.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.58 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 32' ' ' ASP . 11.7 ptpt -84.57 -179.48 7.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.729 0.776 . . . . 0.0 111.938 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.47 163.57 12.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.214 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -67.27 117.04 8.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -66.26 91.55 0.17 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.4 pt -90.18 20.0 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -62.85 -21.48 65.99 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.43 -18.4 71.28 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.542 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 96.7 m-85 -87.88 -1.98 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.103 0.478 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.4 mt -84.78 125.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.6 m -85.08 129.05 34.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.683 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -55.95 13.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.68 132.99 42.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.9 mt -55.62 -70.18 0.12 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 50.61 71.27 0.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.021 0.439 . . . . 0.0 110.046 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.08 88.27 0.07 OUTLIER Glycine 0 C--N 1.333 0.408 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.447 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 -0.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.355 0.597 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 12.5 t70 -128.91 114.69 16.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.687 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.03 165.12 20.92 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.961 0.886 . . . . 0.0 111.363 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.9 m -119.12 140.53 49.98 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.261 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.7 tp -109.83 124.81 51.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.479 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.43 111.36 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.478 HG13 ' H ' ' A' ' 105' ' ' SER . 10.5 t -103.52 137.85 30.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.34 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.445 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 86.5 t60 -136.41 42.05 2.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.478 ' H ' HG13 ' A' ' 103' ' ' VAL . 54.6 m -107.29 -176.59 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.209 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -44.41 -57.91 3.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -79.83 -47.94 14.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.047 0.839 . . . . 0.0 112.26 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -108.99 96.08 6.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.651 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 3.1 m -98.08 103.58 15.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.808 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 109' ' ' THR . 16.9 t30 73.36 72.2 0.13 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.978 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -140.09 125.09 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.193 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.1 tt -113.07 126.19 70.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 tt -143.0 127.87 18.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -81.01 108.02 14.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.23 -33.21 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.958 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.72 -118.96 5.84 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.513 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 26.6 Cg_endo -58.02 107.29 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 116.03 -175.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.8 t -96.47 118.93 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.59 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 24.5 m -137.66 141.23 41.16 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.501 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -81.92 130.19 35.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.313 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.31 -18.38 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.52 -130.18 9.53 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.403 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 123' ' ' LEU . 2.9 tm? -93.5 112.38 24.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 47.9 pt -135.83 -174.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 1.0 OUTLIER -108.33 106.44 16.58 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.857 -179.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.625 HD12 ' O ' ' B' ' 4' ' ' ALA . 56.3 tp -82.57 111.21 18.35 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.431 ' HG ' ' C ' ' A' ' 126' ' ' LEU . 92.1 p 56.42 37.31 28.72 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.076 0.465 . . . . 0.0 110.991 -177.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.4 m 77.73 11.14 2.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.892 0.877 . . . . 0.0 112.992 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -118.2 118.19 34.4 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.622 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.05 116.62 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.245 1.964 . . . . 0.0 113.825 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 p -125.09 145.4 49.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.839 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -112.9 163.26 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.909 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.605 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 80.2 mtt180 58.94 41.86 20.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.642 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -77.63 127.87 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.54 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.517 ' HB ' ' OG ' ' A' ' 170' ' ' SER . 39.4 mm -87.38 120.84 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 24.8 ttt180 -104.88 124.65 49.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.613 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.549 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.6 OUTLIER -117.19 115.86 26.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.879 -1.896 . . . . 0.0 105.879 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -71.55 90.42 1.01 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.016 0.912 . . . . 0.0 112.059 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -166.96 132.12 2.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.328 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.41 0.54 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.518 0.675 . . . . 0.0 111.582 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 131.79 54.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.491 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 7.2 mtpm? -122.29 179.3 4.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.7 150.75 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.773 177.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.08 -20.22 41.39 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.039 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.28 5.87 40.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.648 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 14.5 p -78.53 140.98 38.49 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.182 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 116.96 -19.29 12.11 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.16 150.44 29.13 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.098 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.96 124.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.44 0.638 . . . . 0.0 111.967 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.36 108.96 20.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -144.99 -178.72 6.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.927 0.87 . . . . 0.0 112.453 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.2 179.74 7.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.397 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 t -65.17 117.23 7.46 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.559 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.7 76.91 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.618 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 8.7 ptpp? -159.32 138.91 11.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.776 0.788 . . . . 0.0 112.602 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 63.6 mt -113.41 135.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.635 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.03 -39.61 6.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.798 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.508 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 175.08 -171.1 44.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.5 pt -125.54 142.83 41.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.871 0.843 . . . . 0.0 111.111 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.537 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.0 t-160 -61.7 112.75 2.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.234 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.87 -25.17 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.265 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.36 -145.94 5.46 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.402 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 175.43 164.11 29.43 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.3 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 31.1 t30 -136.88 99.98 4.18 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.477 0.656 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 60.56 -110.03 2.71 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 115.014 0.765 . . . . 0.0 115.014 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -92.93 18.96 8.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.447 0.642 . . . . 0.0 111.337 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.426 HE21 ' HB2' ' A' ' 167' ' ' GLN . 14.2 mt-30 -135.1 128.56 32.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -91.05 145.28 17.7 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 136' ' ' ARG . 44.9 m-85 -127.18 126.98 43.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.672 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.517 ' OG ' ' HB ' ' A' ' 135' ' ' ILE . 19.8 p -124.92 169.61 11.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.178 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.88 140.21 41.33 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.6 pt20 -70.3 118.5 13.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.508 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.0 mp -97.78 75.9 2.44 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.449 ' HB3' ' HZ2' ' A' ' 174' ' ' LYS . 9.1 mtpm? -83.74 142.1 30.96 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -50.98 -22.97 2.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -54.63 -22.54 13.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -97.82 -16.22 19.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -173.582 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.8 mm? . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 120.828 0.347 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.2 tt0 -106.96 90.1 3.2 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . 0.625 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -96.42 126.51 41.67 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.117 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -87.03 158.68 19.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.717 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.568 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.0 m-85 -62.58 147.45 49.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . 0.648 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.1 mt-30 . . . . . 0 N--CA 1.434 -1.258 0 C-N-CA 118.402 -1.319 . . . . 0.0 . 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 120.465 -0.075 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 123.123 2.549 . . . . 0.0 113.907 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 11.1 t30 -68.77 -48.27 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.374 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 m -70.23 -29.02 65.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.714 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.56 -50.0 74.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.52 -47.31 84.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.475 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.36 58.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.533 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.79 -23.68 64.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -76.94 -51.23 11.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.591 0.71 . . . . 0.0 109.853 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.4 tp -57.13 -44.51 83.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.254 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.517 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 69.6 tp -53.86 -49.91 67.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.203 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -78.02 -28.38 49.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -86.54 -52.57 5.49 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.86 1.98 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 40.2 mm -106.25 133.02 51.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.435 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 50' ' ' ASN . 46.2 ttm -150.55 144.04 25.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.799 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 104' ' ' HIS . 22.0 m -69.23 113.59 6.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.59 108.77 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 14.0 m -93.91 122.5 36.47 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.8 0.81 . . . . 0.0 109.994 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 -163.9 1.45 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.44 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.37 -44.4 62.11 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.917 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 55.1 tttm -85.36 1.2 49.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.877 0.762 . . . . 0.0 111.863 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.67 -149.76 17.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.31 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.26 129.66 35.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.055 -0.573 . . . . 0.0 111.584 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -131.85 157.26 44.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.109 0.957 . . . . 0.0 111.96 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 80.5 m -72.66 107.53 5.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.332 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.24 107.24 3.16 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.399 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.37 99.06 11.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.37 123.01 7.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.681 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.93 -56.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 117.179 0.489 . . . . 0.0 110.03 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.95 153.31 5.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.605 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.06 -89.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.999 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.1 ptp180 -132.02 10.25 4.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -110.69 131.82 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.931 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 p -133.13 156.68 47.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.51 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.45 139.82 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.469 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.8 tt -143.54 141.58 19.27 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.367 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.16 153.06 13.43 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 C-N-CA 121.313 1.342 . . . . 0.0 112.243 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 39.5 m -77.61 -37.45 50.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -66.91 -13.08 61.35 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.63 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.72 -21.18 64.41 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.024 0.916 . . . . 0.0 109.224 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 45.1 mt-30 61.12 69.07 1.12 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.311 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 12.3 Cg_exo -75.25 131.23 13.78 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.806 2.337 . . . . 0.0 107.97 175.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.84 -134.37 7.6 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.417 -1.373 . . . . 0.0 114.602 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.39 -26.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.685 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 53' ' ' LYS . 13.0 p-10 -144.67 133.69 22.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.96 158.67 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.892 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 45.6 mt -101.8 98.71 8.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG13 ' SD ' ' A' ' 16' ' ' MET . 41.0 t -91.81 103.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 65.8 t30 66.47 24.78 10.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.699 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.57 -20.1 52.01 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.35 115.57 18.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.362 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 87.7 tttt -74.74 109.49 8.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.759 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.17 139.89 46.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.435 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.28 153.77 22.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.963 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 59' ' ' LYS . 14.6 p -73.81 141.59 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -99.9 -42.85 6.62 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 37.9 t70 -159.13 118.35 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.304 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.542 ' HB2' HG23 ' A' ' 56' ' ' VAL . 28.5 ttpp -111.47 106.41 15.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -115.87 110.41 18.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.764 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.11 105.59 6.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 60.0 tp -75.69 114.74 14.63 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-O 122.243 1.02 . . . . 0.0 111.89 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.25 159.9 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.434 -1.712 . . . . 0.0 107.852 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 20.4 t70 -74.84 149.04 85.36 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 64' ' ' ASP . 6.3 Cg_endo -49.28 -23.84 7.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.75 2.3 . . . . 0.0 113.666 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 68' ' ' ILE . 7.6 mm-40 -86.37 25.04 1.26 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.604 0.716 . . . . 0.0 109.805 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.289 0.3 OUTLIER 39.99 61.98 1.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.495 1.118 . . . . 0.0 113.202 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 66' ' ' GLU . 25.2 mm -138.62 155.59 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.492 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' N ' HG22 ' A' ' 68' ' ' ILE . 51.6 t30 -57.5 131.33 49.84 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.783 -0.573 . . . . 0.0 111.761 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.545 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.7 tp -103.89 -22.94 13.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 22.7 tp10 80.61 7.89 1.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.403 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.85 109.62 22.01 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.397 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 99.8 m -85.27 107.44 17.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.79 101.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.02 100.32 11.46 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.05 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 21.5 m -96.77 121.84 39.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.665 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mm? -120.34 158.54 26.9 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.63 82.15 6.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -79.64 117.37 20.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.492 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.82 -53.81 13.9 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.5 89.86 7.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.27 143.44 52.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.127 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -82.88 148.68 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.058 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.63 144.35 51.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.75 83.24 1.17 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -87.45 12.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.756 -0.59 . . . . 0.0 109.577 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.08 -19.8 65.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.791 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.91 73.86 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.559 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -84.49 -21.12 30.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.704 -0.248 . . . . 0.0 110.474 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.12 121.69 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 13.7 m -113.06 148.48 35.1 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.67 -33.42 12.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.7 105.63 15.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.705 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 17.4 mt -68.33 -57.16 6.35 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.705 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 5.6 pt-20 55.75 13.48 1.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 0.0 111.247 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 98' ' ' ASP . . . -115.87 67.3 0.29 Allowed Glycine 0 C--N 1.334 0.459 0 CA-C-O 121.603 0.557 . . . . 0.0 112.838 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 97' ' ' VAL . 14.6 p -60.87 -3.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.071 0.462 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 96' ' ' GLY . 24.7 t70 -117.94 111.89 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.58 160.43 34.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.849 0.833 . . . . 0.0 112.865 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.1 m -125.63 137.0 53.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.337 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 tp -102.33 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.016 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 t -104.05 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.62 129.91 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.674 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -138.86 35.07 2.17 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -108.54 -170.05 1.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -44.15 -51.93 7.7 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.18 -29.41 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.812 0.733 . . . . 0.0 112.355 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -140.02 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.887 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 m -96.83 119.35 35.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.46 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 96.1 m-20 69.39 70.4 0.25 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.039 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 m -141.71 107.99 5.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.068 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.0 mt -86.32 108.3 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.053 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.1 mt -116.64 107.53 14.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.342 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -73.59 125.43 27.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.49 -25.18 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 89.5 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.504 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 5.8 Cg_exo -75.52 122.36 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.284 1.989 . . . . 0.0 112.974 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.21 132.87 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.307 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -134.95 -169.64 2.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.759 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.3 ptm -129.47 149.7 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.428 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.16 -4.68 21.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.134 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.44 -108.07 2.73 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.14 128.48 54.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.073 -0.563 . . . . 0.0 111.099 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.6 pt -150.63 -178.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 120.679 0.276 . . . . 0.0 110.346 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 30.4 m-80 -96.19 136.42 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 40.6 tp -120.72 105.68 10.99 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t 60.23 42.76 14.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m 66.69 8.92 6.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.883 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.5 m -112.03 112.63 52.63 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.63 124.08 15.27 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.233 1.288 . . . . 0.0 111.204 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.0 m -130.33 141.32 50.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.84 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -99.42 151.87 20.61 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 57.64 62.82 2.0 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.945 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.554 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 8.0 mmt -93.63 134.45 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.715 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 57.4 mt -94.97 141.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.905 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.537 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 18.3 ttp180 -125.43 125.39 43.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.578 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.491 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.9 OUTLIER -127.6 130.83 49.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.349 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 87.36 3.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.621 0.724 . . . . 0.0 109.202 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.06 114.7 1.5 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.094 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.8 116.51 3.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 112.236 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.67 160.02 37.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.956 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 142' ' ' LYS . 53.2 mtpt -136.97 177.24 8.01 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.349 1.071 . . . . 0.0 112.101 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.537 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 1.5 p -45.03 155.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.126 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.503 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 90.52 -25.37 13.26 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.67 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -90.9 -6.31 54.32 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.138 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 133.87 44.02 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.889 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.84 -21.18 18.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.0 149.07 38.79 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.095 -0.552 . . . . 0.0 112.976 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.47 121.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 112.46 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.1 tp -93.66 107.72 19.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.8 p -149.19 172.29 15.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.081 0.943 . . . . 0.0 113.325 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 167.61 24.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.273 -1.785 . . . . 0.0 107.437 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.9 t -65.1 101.21 0.5 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.944 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.61 -12.95 39.13 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -134.46 121.53 21.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.6 mt -101.48 117.09 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -88.48 -33.64 17.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.124 0.487 . . . . 0.0 111.806 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.485 ' CA ' HD13 ' A' ' 173' ' ' LEU . . . 152.18 -150.73 22.63 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.538 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.1 pt -129.54 145.95 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.046 0.927 . . . . 0.0 112.024 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.42 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 6.6 t60 -60.99 123.75 18.53 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.603 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.479 HG23 ' HG2' ' A' ' 71' ' ' GLU . 9.8 p -111.84 -29.11 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.351 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -177.13 -147.51 6.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.229 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.54 160.32 29.62 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.77 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 15.3 t-20 -137.23 105.02 5.58 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.58 -115.26 5.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.263 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -104.79 -0.28 27.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.19 0.519 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.18 125.14 48.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.21 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.66 149.59 23.59 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.537 ' CZ ' ' HG3' ' A' ' 136' ' ' ARG . 49.3 m-85 -125.71 129.52 49.7 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.88 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 160' ' ' HIS . 39.5 m -121.6 165.16 16.11 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.987 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.19 132.42 38.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.36 106.27 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.868 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.485 HD13 ' CA ' ' A' ' 158' ' ' GLY . 11.0 mp -85.28 85.73 7.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.98 129.1 37.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.837 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -43.1 -38.55 2.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.477 0.656 . . . . 0.0 111.489 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 180' ' ' GLU . 79.3 mt-30 -49.75 -41.74 44.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -105.32 -35.2 7.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.7 p -62.12 -28.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.665 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 176' ' ' GLN . 5.0 pt-20 -77.39 -24.35 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -84.02 140.56 31.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.091 0.948 . . . . 0.0 113.273 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.364 -178.172 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.149 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? -129.65 147.35 51.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.253 0.549 . . . . 0.0 110.476 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.9 tt0 -115.66 81.44 1.59 Allowed 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 171.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -80.97 149.14 29.46 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 35.8 tp -103.81 152.98 21.25 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.55 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.8 m-85 -61.2 145.03 52.57 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 94.8 mt-30 . . . . . 0 N--CA 1.443 -0.806 0 C-N-CA 118.836 -1.145 . . . . 0.0 . -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.917 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 CA-C-O 120.964 0.202 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.69 -55.18 4.37 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.612 2.208 . . . . 0.0 114.117 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -52.4 -47.87 66.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.842 0.83 . . . . 0.0 110.934 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -56.28 -52.74 63.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.881 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.26 -30.23 63.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.81 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.28 -50.41 70.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.74 96.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.374 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.5 tt -54.54 -46.31 73.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -79.82 -32.7 40.71 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.933 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.28 -43.43 98.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.026 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 4.6 pp -67.14 -26.89 66.89 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 65.5 mtp180 -73.69 -27.82 61.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.72 0.295 . . . . 0.0 111.101 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -97.55 -50.94 4.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -114.59 13.67 17.52 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 57.6 mt -122.29 117.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.034 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.1 mtp -128.99 146.89 50.85 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.788 0.804 . . . . 0.0 110.128 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.24 99.08 2.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.32 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.24 98.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.664 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 73.0 p -74.67 98.08 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.97 179.37 4.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.43 -176.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.546 ' H ' HG23 ' A' ' 20' ' ' THR . 4.8 m -62.48 -25.49 68.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.167 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -93.7 -39.17 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.99 -154.02 14.24 Favored Glycine 0 C--O 1.234 0.126 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -93.67 117.25 29.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -117.12 151.28 37.17 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.025 0.917 . . . . 0.0 112.978 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 21.3 m -79.06 100.21 7.25 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.06 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.09 101.15 2.17 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -96.41 111.38 23.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 131.7 11.07 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG13 ' CE1' ' A' ' 178' ' ' PHE . 43.2 mm -98.84 -56.59 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 117.518 0.659 . . . . 0.0 111.097 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -145.45 129.55 17.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.908 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 m-20 55.12 -90.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.824 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.4 ptp180 -128.32 7.41 5.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.4 0.619 . . . . 0.0 111.397 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.7 t -87.65 111.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.938 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.2 m -119.3 159.14 24.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.68 144.52 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.576 0.703 . . . . 0.0 111.098 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -152.68 140.55 13.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.631 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.19 148.31 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.052 1.168 . . . . 0.0 111.234 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.708 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 77.7 m -68.86 -40.33 79.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.633 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -68.42 4.02 1.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.68 -25.53 53.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.885 0.85 . . . . 0.0 108.88 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 57.99 70.97 1.13 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.854 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.89 131.12 10.9 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.087 2.525 . . . . 0.0 111.318 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.18 -161.29 32.45 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.554 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.12 -21.39 50.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.767 0.784 . . . . 0.0 109.383 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.5 p-10 -133.03 133.79 43.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.93 163.67 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.796 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -103.01 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.301 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.64 92.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 68.38 19.72 8.82 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.285 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.4 32.9 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.841 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 112.98 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 2.2 pptp? -76.51 134.18 39.55 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.43 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.8 tp -144.35 137.55 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.084 -1.417 . . . . 0.0 108.488 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 39.0 mtt180 -93.69 138.54 31.8 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.614 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.51 138.26 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.87 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -83.39 -49.55 9.22 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.841 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.06 137.56 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.001 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -124.7 85.55 2.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -90.94 123.1 34.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.321 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.48 127.41 32.09 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.678 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.595 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 83.5 mt -90.13 116.77 28.39 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.372 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.19 159.55 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.609 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 27.6 t70 -76.64 144.86 74.12 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 15.9 Cg_endo -55.88 -5.16 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.395 2.063 . . . . 0.0 113.123 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.68 17.8 19.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.033 0.921 . . . . 0.0 109.939 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t30 74.5 0.02 3.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.814 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.34 155.01 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -67.4 146.62 53.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 0.0 111.742 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.4 tp -108.75 -22.8 12.06 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.708 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 24.4 tp10 78.96 11.8 1.44 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.397 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.9 mm? -102.25 151.25 22.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.218 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.8 m -124.47 120.38 31.85 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.308 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.4 100.82 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.1 93.42 9.14 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.583 0.706 . . . . 0.0 109.996 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -87.15 109.82 19.71 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.134 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 69.7 mt -106.77 151.73 24.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.648 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.92 102.45 6.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.443 ' NH2' ' HG2' ' A' ' 81' ' ' GLU . 22.5 mmm180 -119.29 108.13 14.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -83.28 -29.58 28.27 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -101.25 91.38 4.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 174.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 52.3 pttt -97.86 178.96 4.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.48 171.85 8.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.787 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.46 138.23 31.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.67 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.44 92.09 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.67 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.6 pt -88.13 21.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.057 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.44 -30.39 64.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.57 -20.28 77.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.074 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 77.5 m-85 -93.19 -8.84 41.28 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.8 mm -76.97 134.04 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -81.41 112.88 19.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -77.03 -27.03 54.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -143.44 131.75 22.07 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.991 -1.913 . . . . 0.0 106.219 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.2 mt -74.82 -80.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.26 71.38 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.466 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.23 80.41 0.14 Allowed Glycine 0 C--N 1.331 0.262 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 9.3 p -70.3 9.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 20.7 t70 -138.75 124.53 19.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.44 155.54 47.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.19 0.995 . . . . 0.0 112.958 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 m -107.76 143.13 36.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.154 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -115.73 111.94 21.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.76 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.23 99.54 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.42 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.03 122.69 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.431 0.634 . . . . 0.0 111.197 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.586 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 66.0 t60 -135.42 57.09 1.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -121.63 -163.91 1.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 112.996 -1.911 . . . . 0.0 112.379 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.05 -44.52 88.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.528 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -70.82 -60.84 2.02 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.679 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -113.11 108.63 17.57 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.856 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 15.7 m -96.48 97.62 9.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.446 0.641 . . . . 0.0 109.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.586 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 16.6 t30 74.44 71.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.584 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 m -143.51 121.47 12.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.698 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.43 115.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.141 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.15 157.52 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.93 140.09 40.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.07 -23.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.807 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.34 -125.92 7.13 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.881 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.5 Cg_endo -67.61 113.91 3.12 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.596 2.197 . . . . 0.0 114.187 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 157.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -145.45 158.75 43.78 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.104 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.21 140.14 48.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.897 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.99 -28.35 12.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.647 0.261 . . . . 0.0 111.671 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.99 -121.46 7.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.282 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.05 113.94 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.627 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.2 pt -132.46 176.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 38.4 m-80 -94.66 102.97 14.9 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.399 0.619 . . . . 0.0 110.804 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 57.0 tp -83.75 104.93 14.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.2 m 63.34 31.03 15.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.288 0.566 . . . . 0.0 109.657 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.4 m 81.41 0.58 1.62 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.545 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.9 m -108.51 117.48 54.3 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.5 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.26 119.93 6.55 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.336 2.024 . . . . 0.0 112.88 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -132.27 134.12 44.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.881 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.6 t30 -104.53 161.19 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.993 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.609 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 1.9 mpt_? 69.12 43.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.514 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 6.3 mmt -90.95 116.35 28.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 70.6 mt -85.44 130.65 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -110.75 136.04 50.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -148.48 113.55 5.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 6.7 p-10 -74.59 97.99 3.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.566 1.174 . . . . 0.0 110.526 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -149.02 139.26 22.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 111.873 -2.421 . . . . 0.0 107.69 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.85 90.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -106.17 158.56 16.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -139.24 159.64 41.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.198 0.999 . . . . 0.0 111.747 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.491 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 2.8 m -44.3 158.92 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.852 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.81 -17.75 57.23 Favored Glycine 0 N--CA 1.462 0.401 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.912 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -94.22 8.57 41.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.708 -0.246 . . . . 0.0 111.575 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.569 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 16.8 m -63.2 122.0 15.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.208 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 118.61 -20.87 10.02 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.71 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.91 130.24 23.04 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.12 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.94 115.55 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.2 tp -88.76 108.51 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.7 p -147.6 176.95 9.67 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.992 0.901 . . . . 0.0 112.785 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.97 173.09 14.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.529 -1.668 . . . . 0.0 107.765 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.8 m -64.49 108.75 1.74 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.191 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.27 -7.19 59.96 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.922 -0.656 . . . . 0.0 114.291 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 18.3 ptpt -155.89 137.32 14.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.02 126.79 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -88.06 -34.34 17.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.208 0.527 . . . . 0.0 111.49 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 160.37 -159.08 30.51 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.288 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.0 pt -129.97 149.75 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.669 0.747 . . . . 0.0 111.671 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -61.77 120.27 10.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.862 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.8 t -114.55 -26.83 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.377 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.09 -149.24 7.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.169 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.32 148.43 7.5 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.491 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 9.0 t-20 -118.27 105.69 12.02 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.08 -102.95 0.98 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -121.75 19.03 11.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.302 0.572 . . . . 0.0 110.601 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 0.5 OUTLIER -111.94 109.03 18.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -71.07 146.95 42.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.1 m-85 -127.53 119.45 26.06 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.2 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.4 m -110.6 156.0 21.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.627 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.478 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.05 131.85 37.01 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -71.31 105.17 3.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.645 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 72' ' ' LEU . 73.0 mt -87.98 91.26 8.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.522 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -79.68 127.0 31.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.599 0.714 . . . . 0.0 109.54 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -42.25 -34.83 0.84 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.853 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.52 -38.92 64.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -67.42 -13.44 62.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.402 ' CE1' HG13 ' A' ' 30' ' ' ILE . 83.9 m-85 -97.77 -34.23 10.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.22 -1.85 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.027 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.43 -27.4 66.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 109.253 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -107.83 133.06 52.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.982 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.199 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.234 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.442 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? -141.33 144.69 34.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 41.0 tt0 -106.08 81.59 1.65 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -85.32 127.86 34.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.183 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 28.5 tp -89.78 151.12 21.97 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -58.27 139.77 54.51 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.491 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 97.6 mt-30 . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 120.183 -0.607 . . . . 0.0 . 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.569 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.684 0 N-CA-C 112.599 -0.2 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.15 -37.21 96.49 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 122.076 1.85 . . . . 0.0 112.655 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' HA ' ' HG1' ' A' ' 153' ' ' THR . 41.1 t-20 -62.57 -40.05 95.62 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.866 0.841 . . . . 0.0 109.177 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -43.83 87.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.41 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -64.43 -42.65 95.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.196 0.522 . . . . 0.0 109.708 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.14 -47.19 86.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 109.758 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.82 92.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.13 -48.59 80.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -70.69 -38.83 73.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.256 0.55 . . . . 0.0 110.113 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.41 -42.88 96.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.425 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 8.4 tt -60.33 -51.46 69.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.611 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -67.55 -28.76 68.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 4.7 mmpt? -99.86 -26.27 14.07 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.156 0.889 . . . . 0.0 113.088 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -123.58 -12.43 7.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.5 mt -107.07 120.88 59.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.726 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 22.4 mmt -127.45 145.69 50.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.065 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -76.52 105.69 7.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.404 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 43.2 mm -95.3 111.82 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.338 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 13.5 m -91.44 114.43 26.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.896 0.855 . . . . 0.0 110.468 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.44 ' OG1' ' HB1' ' A' ' 41' ' ' ALA . 9.0 p -118.05 -162.95 0.91 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.186 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 13.0 m -69.76 -38.08 76.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HE3' ' HZ ' ' A' ' 25' ' ' PHE . 26.0 ttpp -83.0 -19.79 36.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.328 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.38 -156.93 27.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.412 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -109.39 117.82 35.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.922 0.867 . . . . 0.0 109.952 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HZ ' ' HE3' ' A' ' 22' ' ' LYS . 41.3 m-85 -109.91 171.75 7.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.629 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 73.1 m -86.89 108.94 19.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -94.01 126.88 8.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -101.31 104.63 15.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.087 0.47 . . . . 0.0 111.236 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 111.07 3.23 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.9 mm -75.4 -58.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 122.561 -0.376 . . . . 0.0 112.007 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -166.41 164.11 17.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.557 0.694 . . . . 0.0 112.79 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.99 -101.37 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.389 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -129.19 20.85 5.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.421 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.87 124.69 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.232 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 75' ' ' LEU . 6.3 p -124.27 141.12 52.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.202 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.87 121.52 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.371 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.09 133.56 24.39 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.646 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.83 139.04 78.12 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 N-CA-C 109.013 -1.187 . . . . 0.0 109.013 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.557 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.9 m -63.84 -35.38 80.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.753 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -69.3 -3.52 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.44 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -71.8 -28.66 63.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 72.2 mm-40 62.51 71.38 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.771 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -75.32 142.7 27.22 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.075 2.517 . . . . 0.0 111.496 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.03 -157.02 30.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.001 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.52 -21.94 28.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.595 0.712 . . . . 0.0 110.354 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.36 117.59 19.98 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.58 145.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 69.8 mt -85.23 103.47 14.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.659 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.27 90.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 12.4 t30 59.03 58.36 3.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.241 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.59 -32.64 1.87 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.659 -1.155 . . . . 0.0 114.391 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' OE1' HG12 ' A' ' 54' ' ' ILE . 25.0 tm0? -83.52 142.42 30.91 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.759 -0.26 . . . . 0.0 110.542 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.08 127.4 38.61 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 77' ' ' LEU . 21.3 mm -137.39 133.45 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.358 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -91.5 142.46 27.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 110.838 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.44 136.18 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.333 -176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -88.64 -42.74 11.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -171.96 132.23 0.68 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.337 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.42 119.39 36.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.45 126.48 50.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.466 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 49.9 mtpt -79.57 128.29 33.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 26.6 mt -95.58 127.25 41.46 Favored 'General case' 0 C--O 1.254 1.327 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 156.16 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 66' ' ' GLU . 24.4 t70 -72.73 142.19 83.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.407 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.0 -10.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.54 1.493 . . . . 0.0 112.096 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 64' ' ' ASP . 4.0 tp10 -76.92 -3.2 37.49 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 108.704 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 64' ' ' ASP . 24.9 m120 75.44 16.71 2.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.002 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.29 147.71 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -59.9 135.93 57.85 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -99.79 -22.81 15.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.557 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 28.3 tp10 76.28 14.96 2.35 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.119 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 78.6 mt -98.81 114.11 26.52 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.438 0.461 . . . . 0.0 112.013 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.5 m -93.5 111.48 23.15 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.04 100.05 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.4 tp -83.28 94.32 7.89 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.959 0.885 . . . . 0.0 110.958 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.8 m -85.37 105.96 16.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -108.37 152.9 24.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.31 -177.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -84.56 94.62 8.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.839 0.828 . . . . 0.0 109.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -144.35 128.07 17.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.384 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.03 -21.89 29.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.92 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -79.93 87.06 5.38 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -72.86 157.05 38.2 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.583 -175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -93.9 147.33 23.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.38 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -55.92 135.88 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 85' ' ' ASP . 3.3 p-10 -81.95 89.56 6.39 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.454 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 28' ' ' LEU . 32.8 pt -86.74 15.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.504 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -61.8 -23.66 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.91 -19.23 80.03 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.574 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 97.8 m-85 -86.34 -22.38 26.72 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 59.4 mt -71.98 136.8 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -125.12 142.47 51.47 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.1 pm0 -80.91 -15.34 56.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.42 153.56 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -100.07 -68.09 0.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.493 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 41.7 73.87 0.12 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.83 88.85 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.2 -13.61 16.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.968 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -106.85 125.68 51.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.92 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.63 149.66 39.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.878 0.847 . . . . 0.0 112.179 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -112.62 142.01 45.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -115.63 109.67 18.09 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.59 114.65 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.295 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.8 133.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.749 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -140.0 31.94 1.98 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 20.2 p -109.77 -160.67 0.73 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.385 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.411 ' H ' ' HB2' ' A' ' 105' ' ' SER . 4.4 t-20 -52.09 -61.74 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.99 -34.85 71.78 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -137.84 122.47 18.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.725 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 8.4 m -119.34 128.77 54.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.95 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 109' ' ' THR . 88.5 m-20 65.95 28.51 10.57 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.501 0.667 . . . . 0.0 110.095 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 m -99.87 103.36 14.95 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.906 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -90.55 100.08 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.37 117.98 30.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.35 120.78 18.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.52 -36.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.885 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.67 -128.56 8.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.859 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.67 113.43 3.49 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.023 1.815 . . . . 0.0 112.542 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.1 p -107.82 147.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.468 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 t -155.88 167.03 31.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.4 ttm -93.05 141.83 27.97 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.804 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.24 -33.75 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.517 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.52 -101.99 2.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.324 -0.853 . . . . 0.0 114.307 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp -125.24 122.24 36.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.729 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 48.3 pt -143.02 -176.53 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 10.0 m120 -106.55 85.76 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 23.4 tp -70.54 111.15 5.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.616 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.6 p 64.07 25.25 13.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.421 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 m 85.65 -3.68 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.222 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.1 m -99.89 125.97 38.43 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.797 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.62 120.23 7.76 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.334 2.022 . . . . 0.0 113.879 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 p -123.97 137.74 54.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.862 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -110.39 160.5 16.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 16.0 mmm180 64.76 29.31 12.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.097 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.445 ' SD ' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -73.05 121.73 20.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.017 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.76 144.19 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.048 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 13.8 ptt180 -129.38 143.15 50.73 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.904 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -129.36 131.43 46.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.82 103.49 1.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.198 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -178.42 133.75 0.14 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.496 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.18 110.35 4.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.372 0.606 . . . . 0.0 110.1 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.417 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 21.2 p -111.25 148.6 32.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.029 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -133.24 151.46 51.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.067 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.3 161.46 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.129 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.465 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.53 -13.42 67.4 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.532 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -102.08 8.22 40.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.863 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.6 m -64.75 141.63 58.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.127 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.678 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.61 -6.7 74.39 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.058 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.28 38.75 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.18 110.78 17.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.71 105.06 15.22 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.2 p -144.45 178.07 8.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.397 1.094 . . . . 0.0 113.639 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.43 176.1 9.62 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.605 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.461 ' HG1' ' HA ' ' A' ' 3' ' ' ASN . 2.9 m -71.21 100.52 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.24 12.16 60.31 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.831 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 40.3 ttmt -155.33 134.58 12.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.306 0.574 . . . . 0.0 111.124 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.11 131.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.766 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.79 -43.01 7.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA2' HD11 ' A' ' 173' ' ' LEU . . . 169.17 -152.65 20.46 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.938 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.9 pt -135.22 150.18 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 122.077 0.942 . . . . 0.0 113.147 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.33 118.7 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.907 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.47 -21.73 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.049 0.452 . . . . 0.0 110.857 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.28 -147.75 8.13 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.927 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 169' ' ' PHE . . . 171.51 161.12 21.57 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.575 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 55.2 t30 -128.23 82.17 2.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.495 0.664 . . . . 0.0 109.248 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.28 -107.22 2.1 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.869 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -90.59 7.55 38.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -124.75 110.77 14.75 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -77.8 142.55 26.78 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.501 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 49.2 m-85 -118.83 127.16 53.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.852 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -125.3 163.48 22.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.157 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -99.35 141.11 32.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.275 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 8.3 tt0 -77.39 106.91 9.44 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.986 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.494 HD11 ' HA2' ' A' ' 158' ' ' GLY . 11.1 mp -94.52 85.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.225 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.91 135.13 37.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 7.4 ttpm? -54.38 -35.95 63.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.719 0.771 . . . . 0.0 109.813 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -53.06 -34.56 57.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.633 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -71.92 -25.9 62.09 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.257 -0.277 . . . . 0.0 111.08 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.11 -4.45 59.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.517 0.675 . . . . 0.0 110.357 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.35 -30.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.38 -47.32 81.99 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.88 136.57 34.03 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 . . . . . 0 C--N 1.316 -0.858 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.024 -179.432 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.426 ' N ' HD12 ' B' ' 2' ' ' LEU . 6.6 mp -114.64 120.48 40.29 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -96.48 74.77 2.84 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.575 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -76.51 146.75 38.24 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.9 tp -106.05 148.69 27.48 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.573 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 19.1 m-85 -57.74 135.64 56.8 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.417 ' OE1' ' HB ' ' A' ' 141' ' ' THR . 81.7 mt-30 . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 . 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.465 ' CX7' ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 112.974 -0.05 . . . . 0.0 112.974 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.5 -35.74 95.09 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.873 2.382 . . . . 0.0 113.488 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.04 -35.64 66.79 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -65.19 -44.97 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.154 0.978 . . . . 0.0 108.584 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.86 -47.03 83.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.634 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.75 -46.3 79.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.276 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.03 93.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.21 -44.8 94.29 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 122.165 -0.334 . . . . 0.0 110.796 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -65.38 -40.12 93.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 109.893 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.5 tp -64.54 -44.81 89.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.169 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.422 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 5.4 tt -55.14 -46.64 75.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.251 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.13 -45.46 66.8 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.56 -2.21 20.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 115.635 1.716 . . . . 0.0 115.635 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -135.55 -12.24 2.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.265 -0.974 . . . . 0.0 113.294 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 49.2 mm -106.83 101.82 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.81 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -120.22 135.89 54.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.542 0.687 . . . . 0.0 110.261 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.13 102.25 2.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.09 100.0 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.325 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' A' ' 48' ' ' LEU . 8.9 t -94.94 130.2 41.67 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.105 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.5 t -146.4 -157.55 0.82 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 m -51.54 -50.74 59.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.71 -16.25 39.63 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.73 -157.69 28.41 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 119.608 -1.282 . . . . 0.0 114.727 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -112.48 114.36 27.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.394 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.37 159.78 25.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.58 0.705 . . . . 0.0 111.674 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.2 m -72.64 106.01 4.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.613 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.62 106.68 3.34 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -87.53 106.55 18.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.336 0.589 . . . . 0.0 111.957 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 117.72 8.01 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 47.9 mm -89.08 -64.21 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 117.099 0.45 . . . . 0.0 112.077 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 58.36 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.237 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.9 ptp180 -129.78 15.22 5.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 110.678 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.93 122.66 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.788 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -122.37 156.03 34.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.804 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -114.82 135.16 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.478 0.656 . . . . 0.0 109.847 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' HB ' ' A' ' 73' ' ' THR . 12.3 tt -144.94 142.06 18.13 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.614 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.47 149.66 23.02 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 120.888 1.059 . . . . 0.0 110.579 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.558 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 33.0 m -73.27 -36.74 66.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -66.94 -1.26 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -22.14 59.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.541 0.686 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.31 71.96 1.09 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.56 127.06 18.05 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.932 2.421 . . . . 0.0 112.374 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.58 -169.15 29.32 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.451 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 56' ' ' VAL . 2.6 p-10 -78.15 -16.31 58.05 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -143.18 137.61 29.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.69 156.12 37.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB2' ' CG2' ' A' ' 19' ' ' THR . 7.5 mp -97.41 103.08 14.98 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.301 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 49' ' ' VAL . 7.7 p -84.66 102.42 10.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.542 0.686 . . . . 0.0 110.154 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.6 t30 66.66 19.17 10.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.644 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.12 -22.11 11.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.583 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -92.1 115.66 28.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.318 0.559 . . . . 0.0 111.89 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.58 128.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -139.27 137.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.878 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -65.18 139.61 58.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.474 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 45' ' ' ASP . 14.4 p -87.06 136.75 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 76' ' ' THR . 57.1 tptt -78.36 -47.04 18.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.82 0.819 . . . . 0.0 108.833 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.06 133.46 1.46 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -106.99 92.76 4.22 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -86.22 106.21 17.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.754 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.77 121.08 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.906 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mt -89.88 113.34 24.93 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.704 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -94.02 165.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' HH21 ' A' ' 133' ' ' ARG . 15.7 t70 -71.58 137.42 83.29 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.632 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HG2' ' NH2' ' A' ' 133' ' ' ARG . 7.0 Cg_endo -52.36 -15.68 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.857 1.705 . . . . 0.0 112.771 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.48 16.48 8.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.894 0.854 . . . . 0.0 109.059 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.0 t30 72.21 10.43 5.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.92 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 69' ' ' ASN . 15.9 mt -92.66 176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.51 ' H ' HG22 ' A' ' 68' ' ' ILE . 51.4 t30 -81.75 143.4 31.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 118.514 0.597 . . . . 0.0 111.22 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.565 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 26.5 tp -118.54 -27.49 5.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.558 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 26.5 tp10 70.55 10.62 7.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.666 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 10.9 tp -96.11 103.11 14.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.866 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 78.0 m -90.92 115.42 27.94 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.565 0.698 . . . . 0.0 111.616 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.73 94.17 3.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.3 tp -81.47 104.51 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.797 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 8.7 m -98.59 115.09 27.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.572 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mp -117.47 150.01 39.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.718 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.73 91.49 7.97 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.438 ' HE ' ' HA ' ' A' ' 79' ' ' ARG . 2.2 tpm_? -112.51 110.33 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.58 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.31 -54.0 51.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.783 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -74.73 92.59 2.48 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -70.74 147.3 49.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.221 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -88.06 146.96 25.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.991 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -58.41 120.62 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.103 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 7.4 p-10 -77.37 94.24 4.18 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 121.709 0.766 . . . . 0.0 112.408 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.2 17.13 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.95 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 88' ' ' GLY . 5.0 ppt_? -59.03 -23.95 62.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.16 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 87' ' ' ARG . . . -84.08 -13.63 73.99 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.642 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.53 -3.36 46.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.1 mt -82.55 127.31 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.449 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 6.5 m -83.69 110.89 18.66 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.19 -49.95 31.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 91' ' ' SER . 23.8 t70 -97.78 115.66 28.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 173.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.1 mt -60.75 -72.23 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.88 67.41 0.93 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -146.49 75.38 0.28 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.344 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 p -97.38 0.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 10.9 t70 -149.88 125.72 10.48 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.115 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -153.6 176.7 11.77 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.473 1.13 . . . . 0.0 114.041 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -115.4 138.78 50.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.783 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -115.55 110.66 19.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.09 124.78 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.096 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.6 139.82 38.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 122.035 0.921 . . . . 0.0 113.063 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -149.35 71.79 1.13 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.045 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.4 p -125.55 -174.01 2.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.637 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -59.85 -44.68 93.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.866 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.85 -41.05 15.33 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -115.96 98.15 6.49 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.4 m -105.59 122.78 46.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.581 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 66.73 73.36 0.36 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.8 m -142.25 102.85 4.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.731 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.93 108.92 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.11 120.98 32.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -72.54 118.1 15.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 137' ' ' TYR . 13.8 p -92.14 -26.29 4.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.707 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.57 -125.84 7.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.593 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.87 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.345 2.03 . . . . 0.0 113.453 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.615 HG11 ' O ' ' A' ' 96' ' ' GLY . 2.8 p -136.61 141.89 39.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.589 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 m -153.08 139.37 18.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 27.3 ptt? -74.01 140.2 45.28 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.822 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.07 -66.24 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.48 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.32 -122.35 1.78 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.885 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt -103.06 117.79 35.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.448 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 36.0 pt -138.52 -176.38 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.6 m120 -105.18 83.95 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.982 0.42 . . . . 0.0 111.198 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 59.3 tp -65.93 108.03 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.212 0.529 . . . . 0.0 110.048 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 128' ' ' SER . 3.5 m 61.24 33.48 19.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 127' ' ' SER . 22.7 t 76.97 8.97 2.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.472 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -112.12 113.45 51.83 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.819 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.67 113.37 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.847 1.698 . . . . 0.0 111.649 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 126' ' ' LEU . 29.5 m -124.69 139.65 53.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.103 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -113.4 159.66 19.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' NH2' ' HG2' ' A' ' 65' ' ' PRO . 8.2 mtm180 56.37 61.45 2.7 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.319 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.404 ' HE2' HD13 ' A' ' 126' ' ' LEU . 58.0 mtp -109.6 132.67 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.156 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 50.2 mt -86.1 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ttp180 -132.27 147.01 52.39 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.16 0.505 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.498 ' CD1' HG22 ' A' ' 115' ' ' VAL . 23.2 p90 -143.16 134.97 26.71 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.35 94.52 7.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.248 1.023 . . . . 0.0 110.555 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -155.86 133.63 11.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.942 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.11 105.56 0.42 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.394 0.616 . . . . 0.0 111.22 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 p -119.17 141.97 48.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -129.29 164.39 23.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.095 0.95 . . . . 0.0 112.03 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.549 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 1.0 OUTLIER -43.1 150.25 0.18 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.405 174.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.51 9.36 Favored Glycine 0 N--CA 1.463 0.44 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -68.55 -7.81 35.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.814 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.569 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 22.5 m -58.75 137.86 57.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 99.39 -17.87 57.19 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.734 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.26 126.86 37.78 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.242 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.15 117.49 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.07 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.25 110.45 17.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.0 p -147.03 -177.25 5.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.056 0.931 . . . . 0.0 112.704 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.76 30.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 t -62.93 108.28 1.17 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.831 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.1 75.51 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.923 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -141.55 121.01 13.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.2 mm -102.87 130.1 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.56 -52.92 2.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.505 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -176.89 -174.09 43.03 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.792 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 pt -118.97 139.07 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.414 0.626 . . . . 0.0 110.586 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -69.52 122.27 18.69 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.28 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.76 -9.58 11.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.8 -161.78 29.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.167 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.36 158.46 26.9 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.061 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.525 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 3.7 t-20 -129.75 89.62 2.85 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.909 0.385 . . . . 0.0 110.336 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 -107.88 2.33 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.408 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -96.04 1.67 52.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.238 0.542 . . . . 0.0 110.173 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -107.95 109.3 20.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.314 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -80.26 137.67 18.72 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.02 125.48 46.39 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.571 -0.852 . . . . 0.0 113.069 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.4 m -120.92 151.82 39.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.106 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.44 130.91 39.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.448 ' HB3' HD12 ' A' ' 135' ' ' ILE . 20.0 pt20 -87.79 110.99 20.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 118.468 -1.293 . . . . 0.0 112.722 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.505 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -88.76 94.78 10.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.88 139.79 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.952 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -45.6 -35.41 4.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.05 -26.45 37.66 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.42 -15.74 54.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.495 ' C ' ' H ' ' A' ' 180' ' ' GLU . 25.3 m-85 -107.93 -38.06 5.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 179' ' ' VAL . 55.4 t -77.63 6.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 178' ' ' PHE . 10.1 tt0 -65.1 -35.77 82.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.168 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -88.73 89.7 8.1 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.745 -1.571 . . . . 0.0 114.825 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.251 176.098 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.074 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.589 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.1 mm? -121.28 154.75 35.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.5 tt0 -114.59 71.85 0.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.88 133.71 39.2 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.397 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 15.9 tp -95.73 152.17 18.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.574 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 27.8 m-85 -56.98 137.7 55.24 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.549 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 97.5 mt-30 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 . 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.569 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.069 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.7 -51.66 10.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.427 2.085 . . . . 0.0 114.085 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.589 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.7 t-20 -68.53 -45.14 73.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.709 0.766 . . . . 0.0 110.528 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.4 m -57.54 -43.59 84.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.143 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.02 -24.29 52.13 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.8 -43.54 58.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.35 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.175 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 8' ' ' LEU . 2.8 tm? -59.53 -39.44 83.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.279 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -69.53 -47.34 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.794 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.42 -38.5 84.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.7 tp -55.57 -49.14 73.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -68.49 -28.12 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.266 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -86.78 -63.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.11 -3.6 12.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -173.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 54.6 mt -99.99 131.45 47.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.872 -1.131 . . . . 0.0 113.008 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -151.62 146.42 25.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.923 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 m -68.88 117.86 11.09 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.488 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mt -98.64 98.69 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.901 0.858 . . . . 0.0 110.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 58.5 m -70.9 99.22 1.72 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.018 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -175.53 3.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.45 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 m -70.54 -28.8 65.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.613 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -88.17 -45.81 9.79 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.083 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.27 -168.07 26.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.492 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 34.3 mt-10 -108.22 103.03 12.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.798 0.808 . . . . 0.0 109.228 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 41' ' ' ALA . 40.6 m-85 -97.75 165.39 11.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.853 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 97.7 m -83.24 108.17 16.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.97 136.49 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.93 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 28' ' ' LEU . 2.5 pt? -124.61 135.72 53.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.582 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.64 142.69 27.12 Favored Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.83 -54.2 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.978 0.889 . . . . 0.0 110.066 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -167.83 138.77 2.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 82' ' ' LYS . 31.2 m-20 57.18 -88.74 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.508 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -125.49 5.78 7.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.405 0.622 . . . . 0.0 111.175 -178.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -88.18 120.67 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.034 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -131.48 141.25 49.74 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.009 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.59 151.13 34.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.56 167.8 12.6 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 113.043 -1.889 . . . . 0.0 106.303 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.78 175.47 2.3 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 121.289 1.326 . . . . 0.0 112.147 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.497 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 99.5 m -80.56 -36.81 32.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.544 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -72.3 4.99 3.14 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -69.21 -28.49 66.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.791 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 60.58 72.83 0.68 Allowed Pre-proline 0 CA--C 1.514 -0.43 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.27 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.28 123.52 6.66 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.013 2.475 . . . . 0.0 112.843 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.36 -172.01 46.04 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.19 -17.12 38.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.888 0.844 . . . . 0.0 109.71 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 18.9 t70 -134.85 109.77 8.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.55 154.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 95.3 mt -99.42 99.6 10.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.494 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -83.06 93.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.415 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 t30 66.19 17.96 10.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.708 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.12 -21.81 8.15 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.523 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.87 118.02 23.14 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.741 -0.27 . . . . 0.0 110.278 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.633 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -81.98 119.34 23.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.706 0.765 . . . . 0.0 110.508 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.49 130.7 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.026 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.2 mtp-105 -85.83 126.48 34.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.264 0.554 . . . . 0.0 110.069 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.01 143.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.281 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -77.99 -52.79 8.25 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.763 0.792 . . . . 0.0 109.237 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -141.73 126.71 18.3 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.406 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -109.29 104.44 13.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -104.29 120.11 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.875 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.88 125.1 28.12 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 29.8 mt -90.7 111.85 23.37 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 122.0 0.905 . . . . 0.0 111.545 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.1 m -113.85 159.11 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 67' ' ' ASN . 14.7 t70 -67.72 138.42 93.23 Favored Pre-proline 0 C--N 1.311 -1.101 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.47 -21.99 32.64 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.532 1.488 . . . . 0.0 112.815 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.71 -0.04 55.55 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' ASP . 63.9 m-80 71.76 72.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.134 -1.848 . . . . 0.0 115.454 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.6 mm -137.41 151.96 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.516 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.465 ' O ' HG21 ' A' ' 131' ' ' THR . 22.8 t30 -62.87 111.83 2.3 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.883 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 15.0 tp -87.36 -27.11 23.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 71.62 31.14 2.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.898 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 94.1 mt -123.42 151.55 42.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 25.3 m -132.64 127.07 34.11 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.373 0.606 . . . . 0.0 110.516 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG22 ' HG ' ' A' ' 62' ' ' LEU . 85.7 t -87.63 107.38 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.974 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.31 92.24 8.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -74.36 90.51 2.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.043 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.25 91.48 5.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' ARG . 18.7 p-10 -78.82 61.57 3.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.376 0.608 . . . . 0.0 109.866 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -82.55 160.32 22.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.34 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -61.31 -51.66 67.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -78.64 110.72 14.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 61.2 mttp -77.08 152.2 35.13 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.782 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -80.33 141.4 35.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.109 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.12 138.14 58.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.682 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 87' ' ' ARG . 11.4 p-10 -73.96 88.12 1.85 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.128 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.8 pt -88.0 12.11 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 179' ' ' VAL . 45.2 ttt180 -53.7 -38.4 64.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.838 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.74 76.75 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.709 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -87.49 -12.7 45.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.62 129.98 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 13.5 m -120.5 122.39 40.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.633 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.5 mp0 -64.66 -48.41 74.87 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 91' ' ' SER . 30.0 t70 -95.48 120.06 35.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -76.5 -54.83 6.17 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 41.05 66.15 0.7 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.306 0.574 . . . . 0.0 109.928 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.14 80.93 0.1 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.863 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -70.53 -7.59 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.82 121.49 45.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.81 40.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.599 0.714 . . . . 0.0 112.176 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 96.0 m -116.03 135.22 54.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.256 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -92.06 116.85 29.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.392 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.06 103.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 22.1 t -100.38 124.11 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.446 0.641 . . . . 0.0 110.98 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -137.37 50.3 1.98 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.8 m -107.93 -172.54 2.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.333 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 13.4 p30 -62.05 -35.37 78.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -55.61 -50.5 69.97 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.824 -0.547 . . . . 0.0 112.215 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -158.79 132.97 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.317 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 23.2 m -84.39 114.55 21.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.603 0.716 . . . . 0.0 110.969 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 109' ' ' THR . 5.6 m-20 77.24 72.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 2.0 m -116.73 109.29 16.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.5 pt -107.99 99.56 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.051 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.8 mt -97.29 117.64 31.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.892 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.03 98.93 9.54 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.92 -16.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.098 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.34 -128.99 9.04 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.535 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 22.9 Cg_endo -65.11 119.11 6.07 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.193 1.929 . . . . 0.0 114.816 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 137' ' ' TYR . 34.3 m -111.87 148.63 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.512 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 m -150.39 144.4 25.43 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.0 ptp -82.01 142.96 31.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.193 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.53 -42.46 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.093 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.27 -128.92 8.45 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.067 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 48.1 tp -99.26 110.52 23.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.84 0.352 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.62 175.33 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.996 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.677 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.8 m-20 -87.54 126.13 34.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 46.5 tp -111.58 107.51 16.69 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.44 ' HG ' ' C ' ' A' ' 126' ' ' LEU . 95.6 p 57.86 32.07 21.42 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.006 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.0 m 76.73 29.75 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.929 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -140.36 120.85 9.03 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.14 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.38 117.94 4.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.502 2.135 . . . . 0.0 114.123 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 69' ' ' ASN . 82.9 m -127.31 131.68 50.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.549 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 29.8 p-10 -102.67 169.38 8.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER 57.7 42.13 24.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.846 175.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.8 mmt -86.32 136.75 33.02 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.38 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.8 mm -101.07 137.63 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.093 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -127.84 148.32 50.46 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.502 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.452 ' HB3' HG11 ' A' ' 118' ' ' VAL . 25.0 p90 -143.03 151.74 41.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.263 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.89 113.51 22.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.832 0.825 . . . . 0.0 111.43 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -176.12 133.19 0.25 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.327 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -68.32 100.82 1.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.818 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.1 p -93.39 171.4 8.94 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.749 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -161.44 145.63 13.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.56 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.583 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.24 158.72 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.706 175.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' N ' ' OX8' ' B' ' 8' ' ' CA1 . . . 89.77 -24.33 15.64 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.003 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -85.76 4.49 36.6 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.769 0.428 . . . . 0.0 112.009 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 13.4 m -62.18 140.96 58.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.674 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 107.02 -20.69 32.99 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.77 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.76 130.45 26.92 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.532 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.36 124.18 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 110.73 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.7 tp -101.56 106.7 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.4 p -149.74 176.4 10.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.972 0.891 . . . . 0.0 112.922 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.589 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -137.28 172.73 12.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.591 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.3 t -61.31 108.76 0.97 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.066 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.56 -4.2 86.37 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -141.47 116.78 10.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.729 0.764 . . . . 0.0 111.836 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -93.99 126.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.73 -44.13 6.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.79 -165.01 34.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.7 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -129.63 144.5 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.437 0.637 . . . . 0.0 110.797 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -66.82 115.37 6.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.438 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.0 t -107.16 -27.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.169 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.19 -147.86 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.082 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.32 164.69 29.69 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.221 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.426 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 8.8 t30 -128.23 88.37 2.74 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.67 -109.62 2.78 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.636 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 18.1 ttt180 -88.54 3.84 48.91 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 113.37 19.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.295 0.569 . . . . 0.0 109.977 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -78.41 143.21 26.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 44.6 m-85 -121.86 124.42 44.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.352 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -123.11 142.38 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.008 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.37 125.45 31.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.689 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.539 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 50.2 tt0 -72.03 119.86 16.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.123 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.453 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.6 mp -88.19 92.83 9.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.83 132.56 33.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.633 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 ttpm? -58.48 -17.32 20.12 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.24 -29.99 67.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -81.11 -28.15 35.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.66 0.267 . . . . 0.0 111.569 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -86.37 -32.55 20.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.454 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 12.5 p -65.63 -21.99 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 110.344 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -38.14 86.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.748 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.591 ' HZ3' ' HB3' ' A' ' 181' ' ' LYS . 0.6 OUTLIER -98.91 120.13 38.84 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.854 177.544 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.099 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -135.25 164.43 27.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.561 0.696 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 34.5 tt0 -126.24 77.47 1.69 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.83 152.51 26.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.6 tp -107.69 154.87 20.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -63.69 141.28 58.83 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.6 mt-30 . . . . . 0 C--N 1.295 -1.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 . 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.413 ' OX8' ' N ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.35 -42.16 29.66 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.368 2.046 . . . . 0.0 113.134 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.36 -42.65 78.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.293 -0.163 . . . . 0.0 110.897 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -72.2 -27.59 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.44 -45.5 75.86 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.87 -45.71 89.5 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.315 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.38 83.57 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.8 tp -68.1 -38.92 82.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -67.66 -38.08 83.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.002 0.429 . . . . 0.0 110.028 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.46 -40.45 93.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.528 0.68 . . . . 0.0 109.567 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 HD11 ' C ' ' A' ' 11' ' ' LEU . 3.1 tm? -50.59 -48.69 57.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.218 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -70.01 -29.61 66.72 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.39 -58.85 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.2 7.24 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.15 106.7 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.969 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.3 mtp -121.6 147.73 45.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -76.29 111.23 11.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.088 -178.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.407 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.7 mm -92.84 106.15 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.601 0.715 . . . . 0.0 110.463 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 6.7 m -75.96 98.35 4.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.628 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.469 HG21 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -103.47 -178.08 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.521 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.469 ' H ' HG21 ' A' ' 20' ' ' THR . 16.4 m -59.47 -32.24 70.06 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.657 ' HZ1' ' CX7' ' B' ' 8' ' ' CA1 . 5.8 mtmp? -88.97 -1.63 58.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.03 0.832 . . . . 0.0 111.253 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.24 -163.7 23.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.844 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 105' ' ' SER . 25.3 mt-10 -96.85 128.37 43.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.407 0.622 . . . . 0.0 110.902 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -123.22 166.94 14.4 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.804 0.812 . . . . 0.0 111.325 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 2.7 m -68.64 100.43 1.13 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.875 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -81.2 109.54 3.01 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.637 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.46 94.47 9.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.902 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.44 122.41 8.62 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.5 -50.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 117.678 0.739 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -161.25 153.64 20.24 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.963 0.887 . . . . 0.0 113.117 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 42.8 m-20 51.65 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.615 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.1 ptt180 -140.15 16.36 2.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.702 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.9 115.42 39.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.154 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -120.18 148.7 43.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.21 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.69 130.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.498 0.666 . . . . 0.0 112.141 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.39 165.42 28.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.85 163.62 36.68 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 121.647 1.565 . . . . 0.0 112.61 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.705 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 44.8 m -81.11 -38.95 26.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.161 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -71.31 2.27 5.02 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -12.9 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.663 0.744 . . . . 0.0 109.156 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 68.8 mt-30 62.44 73.23 0.55 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.341 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.88 159.54 47.97 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 122.537 2.158 . . . . 0.0 111.873 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.14 178.96 17.0 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.047 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HA ' HG11 ' A' ' 56' ' ' VAL . 24.0 m-20 -81.89 -19.7 40.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.889 0.844 . . . . 0.0 109.467 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -137.37 113.17 9.62 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.86 173.07 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.829 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 6.2 mp -112.3 138.16 49.4 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.765 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.33 83.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 2.4 t-20 62.23 27.0 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.12 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.39 -44.79 1.16 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.159 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.16 115.77 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -76.4 122.02 23.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -125.43 149.01 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.227 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.607 ' HD2' ' N ' ' A' ' 55' ' ' ARG . 7.8 mpt_? -96.61 145.51 25.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.221 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 45' ' ' ASP . 8.5 p -86.99 138.88 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.998 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.18 -42.23 17.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -158.81 132.12 7.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -117.44 116.38 27.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.55 120.54 39.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.256 0.55 . . . . 0.0 111.095 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.12 121.71 27.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.791 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 76.9 mt -85.91 123.51 31.34 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.331 0.586 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m -122.01 171.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.185 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 16.8 t70 -78.73 143.08 62.09 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -48.54 -26.13 8.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.829 2.353 . . . . 0.0 113.618 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.34 22.74 4.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 111.09 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.11 11.6 5.09 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.107 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 69' ' ' ASN . 25.4 mm -88.16 163.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.423 ' N ' HG23 ' A' ' 68' ' ' ILE . 54.9 t30 -73.33 139.27 45.92 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.548 HD11 ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.79 -36.68 6.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.705 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.8 tp10 84.07 22.0 0.14 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.34 -1.754 . . . . 0.0 114.498 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 173' ' ' LEU . 2.8 mm? -111.4 146.04 37.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.21 0.529 . . . . 0.0 110.834 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 26.3 m -117.33 114.48 23.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.564 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -80.93 100.08 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.32 100.67 12.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.71 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.4 m -92.38 93.88 8.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.066 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 96.0 mt -85.62 159.16 19.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.371 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -78.76 92.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -128.61 123.21 32.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.084 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -80.8 -57.3 3.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.61 114.79 5.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.1 ptpt -76.1 145.78 39.8 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.68 145.98 42.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -56.93 122.81 13.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.031 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 90.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.106 0.479 . . . . 0.0 111.072 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -96.27 32.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.033 0.444 . . . . 0.0 110.111 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.566 HH22 ' HA ' ' A' ' 182' ' ' GLN . 13.0 mtp180 -65.3 -30.72 71.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.237 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.59 -19.22 79.95 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.939 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -80.14 -16.39 55.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.614 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 52.7 m -94.69 122.41 37.27 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.063 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.585 ' O ' ' HE2' ' A' ' 174' ' ' LYS . 5.0 pt-20 -61.5 -29.65 70.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.031 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.451 ' HA ' ' CE ' ' A' ' 174' ' ' LYS . 37.8 t70 -131.05 163.35 27.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 95' ' ' GLU . 43.6 mt -74.47 -81.1 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 94' ' ' LEU . 12.8 pt-20 33.32 74.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.253 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' HA3' ' CZ ' ' A' ' 157' ' ' PHE . . . -157.7 92.25 0.12 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.462 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 61.5 t -62.15 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -124.36 132.45 53.54 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.58 174.6 10.81 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.738 0.78 . . . . 0.0 112.752 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.9 m -131.06 146.26 52.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.593 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.5 tp -105.98 113.91 27.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.34 110.92 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 109.994 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -112.08 117.33 54.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.275 0.56 . . . . 0.0 111.365 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -130.9 83.09 2.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 71.1 p -129.57 -164.56 1.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.891 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.76 -13.95 57.1 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -90.52 -66.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.347 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.573 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 56.2 m-85 -108.48 120.97 43.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.704 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.4 p -100.0 110.66 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.891 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.56 32.38 16.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 39.9 m -81.91 102.11 10.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.697 0.761 . . . . 0.0 110.905 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 112' ' ' ILE . 9.5 tt -100.13 92.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -101.22 113.15 25.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.139 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.69 112.0 6.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.832 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.15 -33.94 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.05 -123.68 7.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.323 -0.942 . . . . 0.0 114.165 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 35.1 Cg_endo -64.58 124.52 13.38 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.533 2.156 . . . . 0.0 113.85 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -106.21 137.43 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.063 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 p -132.27 171.01 14.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 59.6 ttp -120.13 139.66 52.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.938 0.399 . . . . 0.0 112.05 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.42 -43.66 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.693 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.43 -111.75 4.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.094 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.54 116.68 32.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 pt -144.8 -176.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 m-20 -101.95 123.05 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.257 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.3 mm? -102.13 111.69 24.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' SER . 17.3 t 60.46 30.88 20.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.453 0.644 . . . . 0.0 109.933 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 127' ' ' SER . 45.4 m 83.37 2.34 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.377 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.4 m -112.01 116.47 49.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.063 0.227 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.49 123.35 11.14 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 122.413 2.075 . . . . 0.0 112.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.434 ' HB ' HD22 ' A' ' 126' ' ' LEU . 70.6 m -131.94 138.42 48.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.903 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -101.93 169.59 8.68 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 13.5 mmt180 63.29 34.77 12.97 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.05 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.605 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 31.7 mmt -82.17 128.43 34.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.734 0.778 . . . . 0.0 112.058 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 19.9 mm -95.21 144.07 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 33.0 ptt180 -131.6 139.46 49.17 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.506 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.1 130.97 24.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.361 0.6 . . . . 0.0 109.928 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.2 96.71 0.66 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.246 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -175.09 121.25 0.21 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.093 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.56 108.17 2.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.849 0.833 . . . . 0.0 112.286 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.67 148.48 43.87 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.151 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -133.67 176.99 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.881 0.848 . . . . 0.0 112.81 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.9 OUTLIER -44.08 150.2 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.357 176.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.33 -22.69 31.19 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.352 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.84 3.7 47.35 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 m -58.93 134.88 57.33 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.954 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.65 8.35 59.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.523 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.91 135.93 20.97 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.239 -1.458 . . . . 0.0 109.571 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.4 t -86.32 117.45 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.666 0.733 . . . . 0.0 111.32 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.14 105.06 17.37 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.1 p -141.3 165.42 27.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.951 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.58 179.26 6.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -60.24 101.1 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.484 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.5 22.43 78.96 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.614 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 32.5 ttmt -147.92 108.72 4.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -94.36 123.1 46.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.468 ' CZ ' ' HA3' ' A' ' 96' ' ' GLY . 91.6 m-85 -91.57 -39.09 12.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.474 0.655 . . . . 0.0 110.755 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 157.4 -155.17 26.16 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.935 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.79 150.16 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.541 0.686 . . . . 0.0 110.903 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -69.15 122.22 18.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.016 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.07 -23.08 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.49 -156.54 12.0 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.855 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.64 157.9 25.61 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.1 t-20 -128.65 92.32 3.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.575 0.703 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.72 -104.99 1.49 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.741 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -95.85 2.27 53.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -127.25 129.55 47.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.308 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.1 146.52 22.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.483 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.9 m-85 -123.78 131.5 53.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.778 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.5 m -125.3 159.48 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.289 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.569 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -97.77 141.04 31.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.317 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 77.0 mt-30 -79.85 117.24 20.54 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.549 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 66.9 mt -96.74 71.75 2.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.585 ' HE2' ' O ' ' A' ' 92' ' ' GLU . 38.6 mtpt -79.75 135.3 36.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -56.38 -15.62 4.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.652 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 179' ' ' VAL . 3.9 pt20 -67.73 -16.91 64.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.15 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.36 -9.98 34.11 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.06 11.35 23.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.119 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 176' ' ' GLN . 8.2 p -96.61 -6.39 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.487 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -86.87 -52.43 5.48 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -71.34 125.88 28.15 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.566 ' HA ' HH22 ' A' ' 87' ' ' ARG . 21.7 tt0 . . . . . 0 C--N 1.317 -0.826 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.125 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -144.18 149.58 36.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.99 0.424 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.8 tt0 -110.99 78.94 1.15 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.64 137.75 34.39 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 39.2 tp -95.62 144.63 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.573 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.0 m-85 -59.87 137.86 57.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 97.9 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.226 -0.443 . . . . 0.0 . -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.657 ' CX7' ' HZ1' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.674 0 N-CA-C 112.376 -0.29 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -47.42 -41.93 28.65 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.009 2.472 . . . . 0.0 115.255 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -66.35 -59.58 3.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 0.0 112.026 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 m -56.87 -42.22 79.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.89 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.41 -25.8 57.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.949 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -67.62 -46.44 72.51 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.69 99.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.26 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.62 -46.29 90.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -65.94 -44.96 83.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -62.83 -41.94 99.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.828 0.823 . . . . 0.0 110.811 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 31.0 tp -51.81 -51.48 56.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.01 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -63.02 -28.16 69.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -108.28 -49.26 3.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.43 -6.81 22.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 41.8 mt -102.18 108.44 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.415 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.1 mmt -119.17 148.32 43.22 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.953 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 m -76.83 117.17 18.17 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.147 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.78 95.79 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 28.1 m -84.07 108.57 17.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -129.73 -170.6 2.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.538 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -56.81 -49.1 76.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.646 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 10.8 tmtt? -71.02 -27.71 63.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.64 -156.99 28.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.677 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.02 117.1 32.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.43 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 43.6 m-85 -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.154 0.978 . . . . 0.0 112.295 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 75.4 m -88.68 95.77 10.39 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 113.399 -1.728 . . . . 0.0 107.93 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.23 116.94 4.36 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.184 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.88 101.02 13.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.357 0.599 . . . . 0.0 110.998 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -68.36 127.32 23.6 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.482 ' CG2' ' HG2' ' A' ' 87' ' ' ARG . 36.2 mm -97.18 -47.4 12.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 118.07 0.935 . . . . 0.0 110.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 33' ' ' ARG . 6.7 p80 -165.75 166.81 17.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 40.99 -84.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.759 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' HIS . 16.4 ptp180 -143.92 21.51 1.78 Allowed 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 122.273 -0.267 . . . . 0.0 111.388 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 74' ' ' VAL . 7.2 p -119.03 134.18 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 60.4 m -119.59 159.21 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.639 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.88 131.84 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.551 0.691 . . . . 0.0 111.571 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.72 165.17 29.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.98 170.69 18.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.216 1.277 . . . . 0.0 111.438 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 35.5 m -82.18 -33.27 29.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.043 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -72.8 2.01 7.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.823 0.344 . . . . 0.0 110.731 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -72.1 -19.55 61.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 53.68 70.3 1.83 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.599 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.35 124.98 10.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.692 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 -164.25 14.0 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.375 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.34 -31.0 16.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 108.837 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.15 118.65 18.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.28 159.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.986 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 85.3 mt -90.46 107.65 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.644 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.95 100.84 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.012 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.92 32.76 12.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.615 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.72 -14.93 64.21 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.828 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -100.92 126.36 47.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.507 0.654 . . . . 0.0 111.479 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.64 112.35 5.35 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 35.8 mm -114.62 118.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.379 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.54 157.91 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.94 -45.04 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.781 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 20.0 t70 -142.56 94.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.834 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 17.6 ptpt -93.0 90.26 6.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -97.19 115.11 26.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.406 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.88 129.36 37.53 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.916 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 20.0 mt -88.51 101.28 13.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -108.2 144.21 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 171.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' C ' ' N ' ' A' ' 66' ' ' GLU . 15.2 t70 -80.18 150.59 71.54 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.23 -20.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.618 0.879 . . . . 0.0 110.258 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 6.4 tp10 -63.12 -14.69 51.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.686 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 20.6 t30 80.43 3.36 1.84 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.372 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.07 155.16 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.584 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.77 126.35 29.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.0 tp -93.9 -15.58 24.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 17.2 tp10 70.24 14.25 7.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.728 -1.578 . . . . 0.0 113.152 175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mp -101.63 159.22 15.5 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -135.81 117.09 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 HG21 ' HG ' ' A' ' 62' ' ' LEU . 69.2 t -78.57 96.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.33 85.35 7.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.437 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 3.2 m -80.35 104.63 11.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.028 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 65.9 mt -95.55 159.75 14.84 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.786 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.65 86.35 7.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -117.72 126.27 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.565 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -84.36 -48.76 9.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.26 116.04 15.56 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -82.32 150.17 27.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 122.018 0.913 . . . . 0.0 112.644 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.797 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -82.76 129.74 35.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.8 p-10 -75.61 97.8 3.86 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.429 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.5 pt -96.25 29.38 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.777 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 57.3 mtm180 -66.7 -27.0 67.29 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.032 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.7 -1.86 22.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.63 141.57 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 19.1 m -93.7 119.9 33.28 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.87 -47.14 60.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 91' ' ' SER . 19.2 t0 -114.28 144.1 43.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 173.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.0 mt -66.98 -71.19 0.21 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 59.23 70.88 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.718 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -143.31 92.41 0.17 Allowed Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 114.153 -1.385 . . . . 0.0 113.616 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.8 p -101.42 -8.35 9.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 6.1 t70 -144.46 135.67 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.756 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.61 155.13 38.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.528 0.68 . . . . 0.0 111.868 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 23.8 m -120.62 139.81 52.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.48 120.86 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.231 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.2 p -114.87 121.81 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.154 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.17 135.62 45.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.824 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -137.9 85.0 2.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 106' ' ' ASN . 37.2 t -135.89 -159.08 0.92 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.223 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.423 ' N ' ' OG ' ' A' ' 105' ' ' SER . 9.4 t30 -46.41 -64.45 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.01 -45.01 5.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 0.0 111.68 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.71 106.94 14.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.687 0.756 . . . . 0.0 112.929 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 p -116.43 138.74 51.12 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.868 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 51.8 28.13 4.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.821 0.448 . . . . 0.0 111.83 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 20.6 m -74.81 90.04 2.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.489 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.79 97.47 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 120.22 32.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.571 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.9 pt-20 -80.11 144.85 32.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.012 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.0 m -101.65 -20.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.59 -123.03 5.89 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.562 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 20.7 Cg_endo -61.8 114.25 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.294 1.996 . . . . 0.0 112.882 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -118.52 151.39 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.776 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.2 p -146.83 -177.54 5.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.427 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 21.2 ptt? -120.4 163.63 17.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.781 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.07 -2.55 8.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 -121.7 6.05 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.481 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.18 120.86 39.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.178 0.514 . . . . 0.0 109.69 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 26.4 pt -138.16 -171.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.922 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 33.7 m-80 -102.22 135.18 44.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.269 0.557 . . . . 0.0 109.923 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 45.6 tp -119.23 103.79 9.82 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.452 ' OG ' HD13 ' B' ' 5' ' ' LEU . 2.8 m 63.75 32.56 13.54 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 110.32 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.8 m 82.76 1.6 1.18 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 126' ' ' LEU . 12.8 t -114.35 124.76 30.19 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.07 125.41 18.49 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.338 2.025 . . . . 0.0 113.215 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.03 138.78 54.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.479 ' ND2' ' HG3' ' A' ' 133' ' ' ARG . 7.2 p-10 -111.76 152.13 28.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.656 0.741 . . . . 0.0 112.652 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.479 ' HG3' ' ND2' ' A' ' 132' ' ' ASN . 59.9 mtt-85 66.37 53.28 1.01 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.015 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.9 mmm -93.06 134.91 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.712 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 170' ' ' SER . 14.2 tt -108.85 142.5 21.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.542 ' HD2' ' OE1' ' A' ' 167' ' ' GLN . 19.4 ptt85 -127.23 139.75 52.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.546 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.3 OUTLIER -122.72 135.15 54.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.431 0.634 . . . . 0.0 110.941 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.5 87.78 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.41 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -171.89 127.27 0.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.374 -1.739 . . . . 0.0 107.268 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.35 100.19 1.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.704 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 137.79 52.57 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 96.2 mttt -127.96 176.63 7.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.37 152.99 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 111.107 -2.77 . . . . 0.0 111.664 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 88.07 -15.13 57.06 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.455 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -115.02 9.84 16.09 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 21.1 p -78.41 135.88 37.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 117.959 -1.496 . . . . 0.0 110.026 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 126.63 -16.88 6.53 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.84 153.88 44.06 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.14 129.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.338 0.589 . . . . 0.0 112.366 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.88 111.42 23.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.2 p -147.62 179.01 8.0 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 112.744 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.34 -178.5 6.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.041 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.9 t -60.92 101.76 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.63 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.93 31.07 77.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.889 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -153.35 111.2 3.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.708 0.289 . . . . 0.0 111.007 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.5 mt -96.78 129.38 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.54 -49.16 5.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.156 0.503 . . . . 0.0 112.017 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.589 ' HA2' HD21 ' A' ' 173' ' ' LEU . . . 175.92 -166.55 37.82 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.191 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.431 ' C ' ' HG ' ' A' ' 170' ' ' SER . 45.9 pt -120.83 142.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.739 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -63.23 113.76 3.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.38 -27.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.05 -147.74 6.18 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.882 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 179.37 164.72 32.37 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.494 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.3 t-20 -137.56 96.68 3.29 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.206 0.527 . . . . 0.0 109.861 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.85 -119.26 5.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.997 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -97.29 19.66 12.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.202 0.525 . . . . 0.0 110.815 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.542 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 8.8 tt0 -134.36 115.86 14.54 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.875 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.59 148.94 34.41 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.245 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 46.7 m-85 -124.67 121.53 34.93 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.848 0.832 . . . . 0.0 111.129 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.555 ' HB3' HG23 ' A' ' 135' ' ' ILE . 15.2 t -117.5 156.44 28.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.145 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.78 134.19 39.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.515 ' OE1' ' HE2' ' A' ' 174' ' ' LYS . 76.1 mt-30 -71.03 122.49 20.13 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.589 HD21 ' HA2' ' A' ' 158' ' ' GLY . 2.5 mm? -85.52 93.9 8.89 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.515 ' HE2' ' OE1' ' A' ' 172' ' ' GLN . 51.2 mttm -93.21 128.03 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.668 0.747 . . . . 0.0 111.462 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -50.21 -31.12 13.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.388 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 180' ' ' GLU . 1.6 mp0 -37.3 -56.64 0.95 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.33 -9.71 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.76 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 13.1 tp10 -63.53 -50.76 68.28 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.813 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.05 131.67 46.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.343 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.089 -179.299 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.19 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.5 mm? -118.24 139.47 51.26 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.663 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.9 tt0 -113.35 81.06 1.44 Allowed 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -83.18 153.73 24.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -109.35 151.92 25.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.1 m-85 -60.3 133.98 56.62 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.7 mt-30 . . . . . 0 N--CA 1.439 -0.996 0 C-N-CA 119.219 -0.993 . . . . 0.0 . -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.646 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.696 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.548 0 CA-C-O 120.424 -0.098 . . . . 0.0 113.285 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -38.38 -51.05 2.2 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.197 1.932 . . . . 0.0 113.745 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -60.18 -50.53 73.31 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.948 0.88 . . . . 0.0 110.98 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -43.24 99.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.901 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.696 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 22.9 mm-40 -60.45 -55.58 31.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.175 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.7 -45.55 86.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.51 82.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 8' ' ' LEU . 3.0 tm? -67.82 -40.08 83.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.699 0.285 . . . . 0.0 110.925 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -66.77 -42.37 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.64 -37.5 82.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.309 0.576 . . . . 0.0 109.916 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 3.4 tm? -51.41 -56.81 11.18 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.572 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.38 -27.84 66.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.367 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.53 -69.97 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.54 3.7 14.07 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 43.1 mm -97.86 96.39 5.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.5 mtm -126.91 144.12 51.08 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.715 0.769 . . . . 0.0 110.974 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 7.3 m -74.27 116.84 15.38 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.0 mt -111.2 108.28 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.34 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 25.0 m -76.12 114.02 14.3 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.93 0.872 . . . . 0.0 109.86 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 p -95.8 -161.16 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.419 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -71.98 -31.71 66.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -76.09 -47.04 26.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.191 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.97 -153.6 24.58 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.621 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 47.7 mt-10 -75.35 116.46 16.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.952 -0.624 . . . . 0.0 112.381 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -124.4 151.93 43.86 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.706 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 47.2 m -75.7 108.36 8.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.76 116.98 5.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.464 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 103.64 16.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.081 0.467 . . . . 0.0 110.746 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.11 132.55 12.93 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.83 -59.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 118.262 1.031 . . . . 0.0 111.3 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -170.36 163.23 8.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.714 0.768 . . . . 0.0 112.75 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m-20 44.7 -90.02 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -127.36 6.91 6.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.099 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 p -133.18 149.75 52.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.326 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 72' ' ' LEU . 33.5 m -110.5 135.69 48.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.827 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.01 139.4 31.92 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.232 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.75 141.58 97.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.336 1.357 . . . . 0.0 111.1 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.704 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 99.4 m -60.84 -43.42 98.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.374 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.35 -11.03 28.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.78 -15.07 60.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.857 0.837 . . . . 0.0 109.235 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 60.25 70.72 0.97 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.94 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.2 115.75 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 N-CA-C 107.702 -1.691 . . . . 0.0 107.702 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.75 -124.38 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.23 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 56' ' ' VAL . 21.0 t70 -95.31 -32.07 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.939 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -144.5 144.42 31.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.724 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 m -128.1 155.25 39.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.828 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 16.1 tp -97.75 100.66 12.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.3 t -89.95 107.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.087 0.946 . . . . 0.0 111.308 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 p30 56.7 12.57 1.16 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.485 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.13 -6.65 13.05 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.507 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -103.64 117.35 34.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.02 114.1 6.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.068 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 tp -120.64 131.63 72.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -88.02 147.77 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 111.295 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 45' ' ' ASP . 8.0 p -73.09 136.5 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -87.03 -50.11 6.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -169.17 151.96 4.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.147 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -128.38 132.36 48.53 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -115.62 117.48 30.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.365 0.603 . . . . 0.0 112.285 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -66.19 106.7 1.72 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.661 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 65.9 tp -85.98 104.74 15.89 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 122.558 1.171 . . . . 0.0 109.782 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 31.6 m -113.67 164.53 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 113.572 -1.649 . . . . 0.0 106.665 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.5 134.92 78.98 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.538 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.71 -10.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 114.941 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.92 19.67 12.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.965 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.2 m120 71.03 29.08 3.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.916 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 37.5 mt -108.79 147.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.968 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t-20 -64.59 131.01 45.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.823 0.344 . . . . 0.0 111.548 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.661 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 6.7 tt -111.87 -27.02 8.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.704 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 34.8 tp10 78.8 8.78 1.97 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 36' ' ' VAL . 15.4 tp -99.41 133.12 44.18 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.239 0.542 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.4 m -106.93 112.62 25.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.41 101.2 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.7 tp -85.25 108.01 17.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.767 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -93.33 116.62 29.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.181 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.7 mt -116.75 124.33 49.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.778 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.87 103.9 11.02 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.915 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.28 136.19 41.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -62.24 -39.72 93.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.19 117.92 19.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 32' ' ' ASP . 72.1 mmtt -71.64 140.98 49.93 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.01 149.2 49.05 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 1.1 tpm_? -61.19 126.31 26.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.324 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.496 ' OD2' ' HD2' ' A' ' 87' ' ' ARG . 14.5 t70 -67.42 81.56 0.15 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -97.88 20.86 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.496 ' HD2' ' OD2' ' A' ' 85' ' ' ASP . 6.7 ptm180 -63.46 -28.71 70.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.4 -6.38 86.06 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.104 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -91.17 -7.01 52.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.61 142.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 48.8 m -100.5 134.73 43.01 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER -76.17 -41.57 49.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 91' ' ' SER . 26.6 t70 -119.47 129.3 54.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.441 HD12 ' NE2' ' A' ' 172' ' ' GLN . 26.6 mt -65.23 -73.16 0.13 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 57.29 68.71 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.43 87.82 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.126 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 11.6 p -81.19 -0.73 4.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.114 0.483 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 9.3 t70 -125.27 129.88 50.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.805 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.43 165.1 31.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.679 0.752 . . . . 0.0 112.438 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.2 m -134.81 141.65 46.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.435 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.544 HD13 ' OH ' ' A' ' 137' ' ' TYR . 78.9 mt -96.18 119.93 35.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.556 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.56 100.22 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.85 129.4 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.726 0.774 . . . . 0.0 112.206 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.19 49.38 1.65 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 m -106.49 -163.15 0.9 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.731 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -56.61 -48.17 78.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.121 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -88.16 -62.72 1.43 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.888 -0.507 . . . . 0.0 112.288 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.61 112.37 21.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -100.95 108.49 20.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.661 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 m120 58.97 72.33 0.54 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.736 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 m -140.56 130.85 25.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 112' ' ' ILE . 23.9 pt -105.37 99.46 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.7 mp -91.66 103.79 16.33 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.948 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -69.77 107.68 3.6 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.064 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.7 -121.05 5.32 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.34 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.7 Cg_endo -65.75 116.51 3.99 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.535 2.157 . . . . 0.0 114.719 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 137' ' ' TYR . 32.4 m -120.74 136.84 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.311 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -138.37 160.05 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -89.16 139.8 30.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.824 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.64 -56.78 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.001 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.11 -128.83 6.54 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 5.0 tt -99.66 113.47 25.94 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.5 pt -133.16 -159.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 20.3 m120 -125.99 125.9 43.43 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 2.7 mm? -100.48 113.36 26.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.497 ' OG ' HD12 ' B' ' 5' ' ' LEU . 4.0 m 57.23 29.31 16.5 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.317 0.58 . . . . 0.0 111.262 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 127' ' ' SER . 42.6 m 87.18 7.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 126' ' ' LEU . 6.0 t -111.03 139.68 22.02 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 21.3 Cg_exo -64.67 111.82 1.79 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 126' ' ' LEU . 26.3 m -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.864 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 133' ' ' ARG . 19.0 t-20 -119.3 163.25 17.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 37.7 ttm-85 68.41 35.45 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.937 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mmt -92.93 139.37 30.6 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.803 0.811 . . . . 0.0 113.004 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.6 mt -95.41 137.93 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.453 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -117.47 141.27 48.55 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.544 ' OH ' HD13 ' A' ' 101' ' ' LEU . 33.2 p90 -148.63 145.07 27.6 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.201 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.73 92.96 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.736 0.779 . . . . 0.0 112.112 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -161.43 137.18 7.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.59 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.78 87.01 5.29 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.486 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.1 p -89.91 151.04 21.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.081 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -130.27 151.57 50.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.045 0.926 . . . . 0.0 113.007 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.555 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.7 OUTLIER -45.35 152.3 0.3 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.225 175.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.58 -14.52 63.77 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.001 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 22.2 tt0 -99.33 7.2 45.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.317 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.524 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 6.9 m -60.56 136.11 57.96 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.37 -10.48 36.17 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 123.654 0.596 . . . . 0.0 111.952 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -51.1 121.01 10.26 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.086 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.36 108.54 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.529 0.68 . . . . 0.0 111.212 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.5 tp -81.63 103.84 11.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.988 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -143.38 177.68 8.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.744 0.783 . . . . 0.0 111.998 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.13 -178.55 6.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.753 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.8 t -64.17 98.31 0.22 Allowed 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.802 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.42 29.05 54.28 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.162 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 33.4 ttmt -156.2 129.36 8.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.471 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.2 mt -112.77 129.14 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.23 -41.22 7.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 162.99 -156.09 27.7 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.82 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -127.89 151.16 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.923 0.868 . . . . 0.0 111.822 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.5 123.16 19.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -114.2 -28.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.55 -152.35 9.07 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.177 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.68 153.96 16.32 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.851 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.524 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 34.1 t30 -131.42 100.94 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.84 -121.88 6.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.404 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -102.21 22.92 12.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.675 0.75 . . . . 0.0 109.611 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -127.61 115.53 18.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.365 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.42 148.75 28.25 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.86 132.65 54.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.217 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.1 t -133.48 141.95 48.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.581 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.41 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -80.61 127.64 32.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 27.5 tt0 -74.6 109.2 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.895 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.482 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 55.2 mt -87.69 94.43 9.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.401 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.67 129.82 34.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.865 0.841 . . . . 0.0 111.379 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.35 -29.5 10.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.939 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -44.76 -43.16 8.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.659 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -79.81 -47.04 15.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 112.263 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.03 -16.63 61.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.23 -29.33 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 O-C-N 121.386 -0.821 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.76 -36.68 11.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.833 0.349 . . . . 0.0 111.15 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.61 119.7 17.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.091 -178.107 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . 0.494 ' O ' HD11 ' B' ' 2' ' ' LEU . . . . . . . . 0 C--O 1.225 -0.227 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.494 HD11 ' O ' ' B' ' 1' ' ' ACE . 2.3 mm? -140.45 132.25 27.47 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.309 0.381 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.2 tt0 -101.64 83.96 2.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -88.75 141.06 28.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.6 tp -94.94 148.17 22.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.53 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 20.4 m-85 -61.32 139.59 58.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.8 mt-30 . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.971 -0.559 . . . . 0.0 . 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.524 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.627 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.49 -30.38 52.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.504 1.469 . . . . 0.0 111.57 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 22.8 t-20 -63.14 -53.25 56.38 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.389 1.09 . . . . 0.0 109.699 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 m -50.43 -53.71 27.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.073 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -57.49 -51.53 69.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.801 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.74 -50.58 72.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.171 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -44.95 95.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' HD22 ' A' ' 8' ' ' LEU . 2.7 tt -68.0 -35.06 77.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.571 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -70.05 -38.55 75.83 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.65 -40.76 93.19 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.196 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 29.7 mt -50.43 -57.66 7.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.431 1.11 . . . . 0.0 111.175 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -60.92 -28.0 68.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.719 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.59 -61.63 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.27 -7.26 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.6 mm -92.7 126.8 45.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.968 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtm -133.77 148.37 51.37 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -82.31 111.81 18.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.718 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.07 134.06 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 20.9 m -120.6 101.18 7.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.461 0.648 . . . . 0.0 109.941 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 p -105.74 -163.48 0.94 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.232 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -60.98 -18.57 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.0 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.684 ' HE2' ' OE1' ' A' ' 42' ' ' GLN . 6.3 mptp? -95.19 -59.05 1.98 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.06 0.457 . . . . 0.0 110.007 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . 172.2 -143.34 7.37 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.917 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -85.1 121.92 28.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.164 0.507 . . . . 0.0 111.327 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -125.88 161.57 27.14 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.395 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 37.8 m -89.26 112.03 22.99 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.485 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.73 109.11 3.38 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -87.62 98.47 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 111.672 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.13 10.35 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.68 -56.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.357 0.578 . . . . 0.0 109.858 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -154.82 144.07 21.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.987 0.899 . . . . 0.0 112.858 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 4.1 p30 46.78 -86.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.684 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 37.6 ptt180 -134.23 14.16 3.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.5 0.667 . . . . 0.0 110.595 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -94.67 113.05 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.1 m -118.87 154.07 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.842 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.33 133.1 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.14 143.58 25.27 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.662 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.7 153.04 52.11 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 120.849 1.033 . . . . 0.0 111.069 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.547 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 97.0 m -73.68 -39.55 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -65.11 -1.8 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.51 54.71 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.288 0.566 . . . . 0.0 110.802 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.684 ' OE1' ' HE2' ' A' ' 22' ' ' LYS . 42.5 mt-30 65.22 72.15 0.49 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.046 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.38 123.92 2.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.608 2.872 . . . . 0.0 109.949 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.25 -133.14 6.07 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.544 -0.836 . . . . 0.0 114.262 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.602 ' O ' HG11 ' A' ' 56' ' ' VAL . 28.0 t70 -83.84 -44.92 13.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 3.2 p30 -127.75 144.17 51.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.7 153.97 27.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.156 0.503 . . . . 0.0 111.146 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.84 103.71 16.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.7 m -89.36 93.85 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.054 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 69.87 13.1 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.64 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.84 -29.83 5.7 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.94 120.91 19.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -84.73 114.98 22.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.851 0.834 . . . . 0.0 110.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.39 141.83 44.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.018 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 34.4 ttt180 -90.54 151.06 21.51 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.47 0.652 . . . . 0.0 112.058 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.602 HG11 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -92.38 145.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -89.09 -41.94 12.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.733 0.778 . . . . 0.0 109.018 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -160.07 129.79 5.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.206 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.54 112.41 22.17 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -104.89 107.07 17.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.731 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.84 126.29 28.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.079 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.603 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -90.42 103.87 16.51 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.91 141.08 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 172.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 66' ' ' GLU . 11.8 t70 -72.95 135.89 80.14 Favored Pre-proline 0 C--N 1.31 -1.15 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.631 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.59 -8.16 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.835 1.69 . . . . 0.0 112.217 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 64' ' ' ASP . 28.6 tt0 -81.54 3.24 25.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 73.48 25.22 2.15 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.863 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.28 152.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 131' ' ' THR . 52.7 t30 -63.84 134.86 55.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 41.7 tp -102.99 -22.13 13.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.547 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.1 tp10 72.04 13.29 5.91 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.071 175.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 62' ' ' LEU . 6.5 mp -106.86 158.94 16.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.937 0.399 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.6 m -135.88 120.8 18.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.208 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.05 102.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' HD11 ' A' ' 77' ' ' LEU . 15.7 tp -93.09 97.68 10.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.992 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 m -92.12 90.66 7.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 75' ' ' LEU . 4.8 mp -74.21 152.5 39.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.513 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.37 75.49 10.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 79' ' ' ARG . 5.0 tpt180 -106.92 128.28 54.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.007 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.5 -12.74 51.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.56 117.86 29.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.612 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -93.5 111.29 22.93 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.258 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -81.98 165.85 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.482 0.658 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -50.93 126.52 16.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.864 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -81.79 98.75 8.61 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.45 0.643 . . . . 0.0 109.859 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.5 pt -91.04 21.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 122.054 0.931 . . . . 0.0 109.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -55.28 -33.4 63.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.484 -1.689 . . . . 0.0 113.239 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.11 -7.74 88.16 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.864 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.81 2.05 51.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.44 131.85 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -93.28 105.12 17.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 174' ' ' LYS . 0.1 OUTLIER -62.43 -54.77 35.32 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 176.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.41 135.2 45.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 95' ' ' GLU . 25.6 mt -61.03 -55.44 32.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 15.0 pt-20 36.61 71.8 0.13 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.591 . . . . 0.0 111.147 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.39 105.69 0.21 Allowed Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.651 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -91.97 9.98 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.083 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -111.62 118.33 35.38 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.09 151.54 37.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.044 0.926 . . . . 0.0 112.423 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.5 m -122.03 135.92 54.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.262 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.9 105.41 17.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.294 0.569 . . . . 0.0 110.222 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.63 ' HB ' ' CG2' ' A' ' 149' ' ' VAL . 35.3 t -80.38 102.16 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 108' ' ' PHE . 14.7 t -89.35 108.24 18.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.426 0.631 . . . . 0.0 111.71 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 29.6 t60 -129.9 39.35 3.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 97.2 p -108.9 -161.18 0.75 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.177 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -73.9 -17.25 61.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.704 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -78.01 -76.69 0.18 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 103' ' ' VAL . 79.8 m-85 -117.99 147.85 42.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.096 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 6.4 m -124.63 124.97 43.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.269 0.557 . . . . 0.0 110.794 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.731 ' HB3' ' O ' ' A' ' 109' ' ' THR . 12.3 t-20 80.82 -2.2 1.82 Allowed 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.658 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.0 m -92.67 119.38 32.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.26 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.25 126.62 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.0 110.53 20.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.54 122.13 18.44 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.58 -32.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.729 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.07 -105.12 2.04 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.879 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 88.5 Cg_endo -84.5 128.85 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.208 1.939 . . . . 0.0 114.145 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.81 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.6 p -132.14 163.77 27.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.726 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.15 153.92 20.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.46 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.51 0.13 11.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.871 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.93 -116.04 4.14 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.214 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 123' ' ' LEU . 7.3 tt -121.16 127.24 51.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.001 0.429 . . . . 0.0 111.239 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.7 pt -136.91 179.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 19.9 m120 -95.81 84.04 3.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.233 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 55.3 tp -65.49 105.86 1.28 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.0 m 62.52 32.67 16.45 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.373 0.606 . . . . 0.0 109.615 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 127' ' ' SER . 38.0 m 81.84 -10.46 1.14 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.378 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -91.49 120.98 68.08 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.518 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.34 114.59 2.04 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.493 1.462 . . . . 0.0 110.762 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 69' ' ' ASN . 23.3 m -134.34 134.88 42.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.016 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -113.42 -177.62 3.18 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.909 -0.717 . . . . 0.0 112.714 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 65.91 26.96 10.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.459 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 74.0 mt -92.34 135.5 27.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -117.26 130.99 56.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.627 0.727 . . . . 0.0 111.873 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.487 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.8 p90 -142.9 112.12 6.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.12 105.71 2.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.728 0.775 . . . . 0.0 109.246 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -167.59 135.4 2.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.75 102.7 0.97 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.825 0.821 . . . . 0.0 111.655 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 t -140.26 147.07 39.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.386 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 26.4 mtpp -141.51 -179.13 5.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.339 1.066 . . . . 0.0 111.962 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -37.6 150.2 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.986 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.69 -28.33 13.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.876 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -87.17 10.49 16.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.0 0.429 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.647 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 4.8 m -63.37 135.14 56.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.771 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.644 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 102.96 -21.37 40.41 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.488 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.24 133.72 24.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.942 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.63 ' CG2' ' HB ' ' A' ' 102' ' ' VAL . 17.7 m -92.16 112.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 0.0 111.719 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.66 109.66 18.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.63 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -146.12 172.68 13.06 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.176 0.988 . . . . 0.0 113.231 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.549 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -130.91 172.58 11.88 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.682 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 153' ' ' THR . 4.3 t -68.62 103.25 1.66 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.773 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.54 -0.48 77.5 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.581 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -139.18 109.35 6.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.5 mm -90.49 111.55 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.33 -48.65 12.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 170.0 -160.54 33.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.621 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.4 pt -122.41 143.37 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.838 0.828 . . . . 0.0 112.583 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.24 118.72 10.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.152 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 17.1 m -113.24 -23.01 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.748 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.37 -152.2 8.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.522 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.81 153.81 12.01 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.766 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.465 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 16.0 t30 -126.36 105.68 8.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.175 0.512 . . . . 0.0 110.399 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.96 -106.66 1.93 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.322 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 29.7 ttm180 -116.73 20.45 13.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -122.62 116.54 24.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.164 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.53 149.61 35.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.864 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 51.5 m-85 -130.51 115.38 16.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.45 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 69.5 m -109.45 172.64 6.73 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.676 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -115.0 132.25 56.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.9 pt20 -86.42 133.98 33.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.0 mt -85.92 88.92 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.297 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.544 ' HB3' ' HZ2' ' A' ' 174' ' ' LYS . 9.6 mtpm? -79.1 111.26 15.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.087 0.946 . . . . 0.0 108.799 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -35.71 -36.23 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.488 ' HG2' ' CG ' ' A' ' 92' ' ' GLU . 17.0 mm100 -56.34 -27.95 57.51 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -68.46 -18.39 64.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.42 -12.1 26.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.489 0.662 . . . . 0.0 109.245 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -89.96 -44.93 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.195 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -27.66 56.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.561 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -80.38 108.16 13.77 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.583 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.435 177.425 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.038 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 4.5 mp -108.79 106.96 17.2 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.069 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.4 tt0 -89.31 77.42 7.43 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.624 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.35 118.55 22.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.136 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 21.0 tp -83.6 152.11 25.0 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.591 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.9 m-85 -58.22 141.01 52.02 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 98.2 mt-30 . . . . . 0 C--N 1.307 -1.243 0 C-N-CA 120.708 -0.397 . . . . 0.0 . 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.647 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.832 -0.107 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.91 -58.53 1.53 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.827 2.351 . . . . 0.0 115.679 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.442 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 64.2 t30 -57.12 -48.77 77.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -68.39 -42.54 78.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.891 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -61.7 -43.98 97.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.264 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.17 -49.0 76.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.128 0.489 . . . . 0.0 110.387 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 -46.04 85.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.577 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.95 -42.72 99.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -68.07 -44.84 75.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.585 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.73 -45.79 91.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.738 0.78 . . . . 0.0 110.16 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 57.5 tp -55.99 -49.89 72.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.408 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.39 -28.57 56.77 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.64 -34.05 10.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -121.33 -9.81 9.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 50.8 mm -97.8 114.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.627 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.466 ' HA ' ' HE3' ' A' ' 16' ' ' MET . 2.1 mmt -122.24 146.18 47.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.323 0.582 . . . . 0.0 110.355 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.52 86.32 4.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 47.4 mm -75.61 94.33 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.0 109.765 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.3 m -86.62 96.12 10.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.741 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.19 179.65 4.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.932 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -55.92 -35.97 67.2 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.625 ' HZ2' ' CX7' ' B' ' 8' ' ' CA1 . 13.8 tmtt? -89.25 -31.7 17.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.9 -169.9 42.44 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 119.495 -1.336 . . . . 0.0 115.054 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -95.52 109.05 21.32 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 114.84 -0.68 . . . . 0.0 110.066 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 41' ' ' ALA . 86.7 m-85 -112.04 158.68 19.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.74 0.781 . . . . 0.0 112.245 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.0 m -83.05 106.66 15.05 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.559 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -89.64 119.99 5.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.938 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -93.99 100.68 12.77 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 0.0 110.186 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.38 106.99 1.9 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.0 -55.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -163.02 144.12 9.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 34.0 t70 54.02 -94.27 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.786 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -133.17 23.51 4.14 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.633 -0.667 . . . . 0.0 110.604 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.8 t -102.27 119.42 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.747 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -123.71 142.5 51.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.6 t -109.55 131.88 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 122.227 1.013 . . . . 0.0 112.111 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 pt -141.75 165.53 27.55 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.44 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -66.28 170.0 12.85 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 120.757 0.972 . . . . 0.0 111.098 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.544 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 62.6 m -76.44 -37.47 56.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.97 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -69.06 9.41 0.41 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.456 ' HA ' ' CE1' ' A' ' 25' ' ' PHE . . . -75.64 -29.98 59.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.3 mm-40 61.37 72.9 0.63 Allowed Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.928 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.54 132.4 33.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.642 2.228 . . . . 0.0 111.263 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.53 -129.17 5.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.635 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.29 -30.73 12.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 109.188 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.468 ' OD1' ' HA ' ' A' ' 55' ' ' ARG . 16.2 m-20 -132.38 155.62 48.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -129.7 134.38 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.54 104.84 13.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.423 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 51' ' ' GLY . 62.9 t -82.44 91.14 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.119 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 70.75 -9.57 0.81 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.104 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 152.55 -26.73 0.85 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -74.77 113.55 12.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.55 -0.825 . . . . 0.0 110.425 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.58 93.96 2.58 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.97 142.78 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.766 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.468 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 1.7 mmp_? -63.26 133.03 53.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.73 108.65 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -68.3 -40.51 81.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.122 0.963 . . . . 0.0 109.281 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -171.48 147.83 2.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.617 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.657 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -117.87 139.31 51.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.755 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -141.47 106.34 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.573 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -71.81 135.95 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 38.2 tp -104.18 109.17 20.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.379 1.085 . . . . 0.0 113.293 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.57 160.21 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 136.95 60.41 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -43.42 -26.13 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.473 2.115 . . . . 0.0 113.65 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.75 -9.37 57.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.75 0.786 . . . . 0.0 109.332 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.65 66.27 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.792 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 63.0 mt -144.38 150.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 112.442 -2.163 . . . . 0.0 105.935 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -65.65 135.06 54.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.263 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 29.0 tp -108.62 -29.32 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.544 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 18.0 tp10 74.92 23.88 1.63 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.123 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.06 157.13 18.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 47.3 m -132.26 120.14 21.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.124 0.488 . . . . 0.0 109.796 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.9 t -86.4 88.52 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.8 tp -84.26 110.86 18.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.93 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -98.06 101.67 13.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.868 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.96 155.25 16.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.88 76.29 9.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -104.35 104.55 14.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.25 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.54 -38.03 74.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -82.62 82.25 8.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 20.4 ptmt -61.52 154.3 25.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.595 -1.184 . . . . 0.0 113.944 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.2 169.93 10.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.215 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -71.97 137.31 47.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.266 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -86.82 87.31 7.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.423 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -85.45 14.62 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -63.13 -16.13 59.01 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.792 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.79 -20.49 79.78 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.194 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -93.41 -0.37 56.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.7 mt -74.99 144.53 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 12.8 m -91.56 123.87 35.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.2 pm0 -78.96 -31.51 45.02 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 91' ' ' SER . 41.2 t0 -136.31 148.09 47.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 32.2 mt -71.41 -55.53 7.76 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 94' ' ' LEU . 1.9 pt-20 38.2 72.0 0.14 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.453 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.42 99.22 0.14 Allowed Glycine 0 N--CA 1.444 -0.784 0 O-C-N 124.0 0.813 . . . . 0.0 111.781 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.6 p -74.89 -21.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.87 0.366 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -92.3 119.36 31.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.596 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.96 154.31 48.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.105 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -120.71 137.47 54.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.176 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -107.98 127.02 53.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.38 113.98 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.62 123.44 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.916 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 39.7 t60 -150.49 71.96 1.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -143.16 -150.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.325 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.02 -54.79 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.177 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.406 ' HB2' ' OE1' ' A' ' 145' ' ' GLN . 66.3 m-80 -74.36 -68.53 0.52 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -116.36 157.09 25.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -136.61 147.47 46.96 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.277 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.32 13.14 6.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.0 0.428 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.0 m -93.02 104.51 16.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.436 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.98 111.95 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.315 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.11 129.23 51.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.328 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.53 122.75 30.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.466 HG23 ' CD1' ' A' ' 137' ' ' TYR . 9.1 p -89.26 -32.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.036 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.67 -130.69 10.31 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.642 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 76.3 Cg_endo -78.27 134.41 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.878 1.719 . . . . 0.0 112.891 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.33 165.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.159 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 p -132.79 -178.78 5.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.1 mtt -115.4 149.62 37.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.753 0.311 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 -31.08 5.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.41 -112.62 4.26 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.073 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 tt -123.31 112.08 17.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.8 pt -130.26 175.75 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.018 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 53.0 m-80 -86.9 87.32 7.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.51 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.58 HD12 ' O ' ' B' ' 4' ' ' ALA . 49.8 tp -75.45 106.42 6.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.3 t 61.67 36.55 16.49 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.8 m 74.18 -0.07 3.46 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.516 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 m -104.23 113.69 64.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.912 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.74 111.78 0.87 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.989 1.792 . . . . 0.0 111.493 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 m -124.04 136.63 54.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.16 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -103.84 164.16 11.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 67.13 45.89 1.62 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.983 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 10.7 mmt -91.66 127.35 37.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.281 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' A' ' 170' ' ' SER . 28.9 mm -93.9 147.18 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -134.18 140.2 46.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 111.757 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.466 ' CD1' HG23 ' A' ' 115' ' ' VAL . 36.4 p90 -149.04 140.98 23.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.13 117.63 25.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.409 1.099 . . . . 0.0 110.15 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -174.08 137.96 0.57 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.242 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.38 96.2 0.08 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.322 0.582 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.9 p -107.96 144.37 35.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.333 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.3 158.25 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.516 1.15 . . . . 0.0 112.79 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.581 ' CG2' ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -42.48 152.1 0.1 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.289 173.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.569 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 85.51 -14.51 50.84 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.269 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.406 ' OE1' ' HB2' ' A' ' 107' ' ' ASN . 11.2 mm-40 -99.86 -0.27 40.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 119.792 -0.147 . . . . 0.0 110.872 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.5 p -78.3 135.26 37.48 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.309 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 119.78 -23.12 8.44 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.929 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.52 138.01 19.27 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.399 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.78 125.33 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.775 0.798 . . . . 0.0 112.911 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.17 109.07 21.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.384 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -149.29 -174.5 4.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.106 0.955 . . . . 0.0 113.326 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.35 172.85 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.212 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.1 t -60.52 108.8 0.88 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.572 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.18 63.44 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.344 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -162.66 113.75 1.52 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.83 119.9 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -83.98 -41.11 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 164.08 -156.45 28.33 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.605 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.4 pt -126.62 147.5 31.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.21 0.528 . . . . 0.0 111.05 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.1 133.13 48.46 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.43 -28.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.61 -155.91 11.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.08 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.71 154.27 25.0 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.029 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.562 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 10.3 t-20 -135.16 116.14 14.17 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.69 -112.59 4.71 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.06 -1.066 . . . . 0.0 111.06 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -118.08 19.45 13.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.481 . . . . 0.0 109.828 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -111.0 135.17 51.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.316 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.77 138.28 14.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 44.9 m-85 -116.72 132.92 56.56 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 18.5 m -124.86 165.35 18.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.546 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -106.91 143.03 35.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -81.95 110.75 17.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -88.55 93.02 9.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 91' ' ' SER . 86.4 mttt -87.3 135.22 33.4 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 122.643 1.211 . . . . 0.0 113.45 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 179' ' ' VAL . 16.1 tptm -42.78 -43.08 3.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.537 -2.12 . . . . 0.0 112.78 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -41.51 -46.41 3.5 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.74 -23.02 55.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.679 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 175' ' ' LYS . 92.1 t -74.27 -24.21 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.5 -19.8 61.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.819 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -79.91 119.68 23.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.608 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.491 -179.557 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.202 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.9 mm? -131.19 150.55 52.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.326 0.584 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.0 tt0 -114.68 85.77 2.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.58 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -91.09 130.5 36.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 23.2 tp -88.55 154.71 20.12 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.583 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 24.3 m-85 -62.64 145.64 54.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 118.702 -1.199 . . . . 0.0 . 179.198 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.625 ' CX7' ' HZ2' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.657 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.495 2.611 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.419 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 12.2 Cg_endo -52.68 -32.02 53.04 Favored 'Trans proline' 0 C--N 1.334 -0.188 0 C-N-CA 122.574 2.183 . . . . 0.0 114.609 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 66.6 t30 -79.83 -49.54 11.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.209 0.528 . . . . 0.0 111.932 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -68.38 -42.29 79.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.738 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 13.5 pt-20 -72.42 -29.54 63.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.097 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -65.58 -46.32 79.87 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.59 75.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.432 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.13 -43.63 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.603 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 m -69.85 -41.74 74.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.179 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.85 -42.07 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.716 0.77 . . . . 0.0 109.945 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.631 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -56.41 -53.5 56.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.882 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.7 -25.99 66.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -83.42 -55.58 4.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -118.06 -2.42 11.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.631 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 40.5 mm -101.94 114.24 40.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.31 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtm -128.03 155.05 44.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.506 0.669 . . . . 0.0 111.434 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -85.3 109.15 18.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.9 mt -103.08 110.69 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.678 0.751 . . . . 0.0 110.224 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 11.3 m -85.5 114.22 22.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.37 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -106.52 -176.3 3.04 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -75.83 -15.83 60.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.112 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -82.62 -42.34 18.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.052 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.94 38.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.98 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HG2' ' HG1' ' A' ' 19' ' ' THR . 45.9 mt-10 -96.99 116.14 28.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.75 166.33 13.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.969 0.89 . . . . 0.0 111.333 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 19.0 m -73.55 105.01 4.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.51 105.53 3.23 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.602 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -107.07 130.1 54.72 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.794 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.43 126.08 7.22 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.17 -56.76 5.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.125 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -158.43 151.09 22.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.259 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.646 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 8.1 t70 56.25 -94.36 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.52 20.25 1.86 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.877 0.846 . . . . 0.0 108.885 177.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.0 106.73 18.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 m -115.29 152.6 32.46 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.34 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.73 144.69 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -146.98 140.39 14.94 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.757 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.36 145.39 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.772 1.648 . . . . 0.0 111.981 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 67.0 m -75.29 -34.86 61.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.293 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -65.01 -11.97 45.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.38 -23.26 46.89 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.563 0.697 . . . . 0.0 109.888 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 48.27 72.1 1.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.81 130.57 28.16 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.41 -155.07 4.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.374 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -82.22 -35.98 27.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.188 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.29 121.53 22.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.2 m -117.28 150.94 19.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.369 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 34.4 mt -83.34 107.12 15.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.348 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -92.45 89.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 58.49 36.27 25.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.107 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.95 -15.06 57.09 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.156 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 15.8 mm-40 -106.09 108.71 20.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.91 139.46 30.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.722 -179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.0 tp -135.85 135.54 50.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -84.91 128.0 34.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.38 142.58 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -77.14 -49.73 14.58 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -150.76 120.33 6.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.817 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -97.59 98.21 9.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -100.49 123.79 45.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.017 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 3.4 mppt? -94.53 108.2 20.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 47.2 tp -86.12 118.22 25.44 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.07 172.75 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.98 140.94 86.26 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 117.723 0.238 . . . . 0.0 111.637 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.55 -29.02 9.77 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.267 1.311 . . . . 0.0 111.954 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.0 8.87 16.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.274 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 64.02 68.36 0.57 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.681 0.753 . . . . 0.0 110.469 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.0 mt -142.97 164.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.985 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -69.0 116.54 9.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 118.298 0.499 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.56 -32.93 10.53 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 30.3 tp10 77.38 15.11 1.76 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.995 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 80.4 mt -103.37 111.68 24.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.038 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 98.7 m -90.11 107.54 19.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.3 t -79.04 97.16 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.658 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 tp -78.21 94.57 4.79 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.102 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.2 m -83.95 98.63 9.9 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.691 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -103.4 144.13 31.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.064 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.35 96.82 7.98 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.18 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -117.52 150.01 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -82.09 -44.82 16.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 110.08 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.79 76.11 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 59.6 pttt -67.76 172.31 5.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.491 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -93.65 160.89 14.57 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -71.83 143.61 49.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.479 -1.692 . . . . 0.0 112.299 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.47 91.77 2.81 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.371 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.0 pt -89.89 11.49 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -70.07 -27.06 64.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.305 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.26 -20.69 73.47 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 67.4 m-85 -92.54 -16.91 25.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.34 121.76 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.8 m -101.6 107.65 18.98 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.296 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' HE3' ' A' ' 174' ' ' LYS . 12.5 pt-20 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -94.79 112.88 24.59 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.34 -71.36 0.09 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 49.97 67.98 0.82 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.08 92.52 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.264 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 60.7 t -83.79 -4.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.825 0.345 . . . . 0.0 111.515 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -114.21 110.4 19.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 165.69 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 112.739 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 m -119.97 141.62 49.51 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.723 -1.581 . . . . 0.0 109.69 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.8 tp -109.85 120.02 41.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 102' ' ' VAL . 31.3 m -116.31 108.38 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 120.214 -0.595 . . . . 0.0 110.05 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.91 136.98 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.755 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -142.28 75.73 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.57 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.9 p -124.24 -162.68 1.09 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -45.34 -67.63 0.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -94.15 -34.78 12.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.309 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.74 83.51 7.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 112.545 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.3 p -92.73 123.39 35.98 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.599 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER 38.61 62.9 0.95 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -99.02 103.13 15.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.642 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.8 mt -93.08 109.11 21.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.868 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.64 123.51 50.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.28 107.81 9.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.488 HG22 ' CD1' ' A' ' 137' ' ' TYR . 8.7 p -86.35 -24.76 6.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.307 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.21 -122.41 5.97 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.461 -0.876 . . . . 0.0 115.03 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.5 Cg_endo -66.24 117.59 4.82 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.407 2.072 . . . . 0.0 115.629 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 137' ' ' TYR . 30.9 m -108.3 151.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.6 m -151.41 135.55 16.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.606 0.241 . . . . 0.0 110.928 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.1 ttm -66.71 122.44 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.695 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.43 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.14 -115.81 5.34 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.34 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.78 119.1 32.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.22 -170.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.875 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.558 ' HB3' ' HA ' ' A' ' 128' ' ' SER . 5.7 m-20 -110.38 109.42 19.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.8 mm? -87.57 112.1 21.91 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 128' ' ' SER . 26.7 t 65.21 10.33 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.568 0.699 . . . . 0.0 110.643 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.558 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 4.8 m 82.99 66.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.001 1.32 . . . . 0.0 112.823 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 126' ' ' LEU . 15.2 t -163.3 131.49 2.77 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.778 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.35 109.96 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 121.361 1.374 . . . . 0.0 113.84 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.475 ' HB ' HD22 ' A' ' 126' ' ' LEU . 7.3 m -111.67 132.89 54.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.479 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -111.22 160.89 16.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.1 mtt180 65.36 43.37 3.51 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.078 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 85.1 mmm -92.24 136.6 33.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.3 tt -117.91 137.52 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -105.37 150.14 25.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 115' ' ' VAL . 1.5 p90 -144.68 152.8 40.97 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.368 0.604 . . . . 0.0 110.226 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.2 99.96 7.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.862 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.406 ' HB2' HG23 ' A' ' 115' ' ' VAL . 47.2 t80 -178.2 119.93 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.755 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.68 120.63 16.58 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.6 t -143.01 151.85 41.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.752 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.9 174.21 10.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.701 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.433 ' HA ' ' CA ' ' B' ' 7' ' ' GLN . 17.8 p -38.91 155.47 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.318 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.446 ' H ' ' H1 ' ' B' ' 8' ' ' CA1 . . . 94.3 -29.9 8.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -86.69 -4.87 59.23 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 26.3 p -78.1 144.57 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.508 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.42 -22.59 17.27 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.46 34.52 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.984 -0.608 . . . . 0.0 112.217 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.26 126.8 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.417 0.627 . . . . 0.0 112.297 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.73 106.6 18.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.2 p -149.24 -176.33 5.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.093 0.949 . . . . 0.0 112.306 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.68 174.69 13.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.816 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 8.8 t -62.02 115.75 4.34 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.794 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.05 90.67 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 19.2 ptmt -156.82 142.04 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.488 1.144 . . . . 0.0 112.772 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.43 138.85 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.614 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -106.53 -39.41 5.87 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.943 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.483 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 175.59 -167.77 39.83 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.441 ' C ' ' HG ' ' A' ' 170' ' ' SER . 20.0 pt -129.48 141.8 45.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.699 0.762 . . . . 0.0 110.604 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 6.1 t60 -65.57 107.44 1.71 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.471 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 27.2 m -95.3 -21.03 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.759 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 175.8 -146.75 8.34 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.125 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.56 163.4 32.5 Favored Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.336 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.472 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 2.9 t30 -123.49 94.8 4.36 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.85 0.833 . . . . 0.0 109.765 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.65 -104.87 1.31 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.393 -1.276 . . . . 0.0 114.223 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.449 ' HD2' ' O ' ' A' ' 166' ' ' ARG . 1.0 OUTLIER -97.55 -8.25 29.51 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.56 -0.82 . . . . 0.0 111.972 -177.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -108.99 133.04 53.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.282 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -85.68 149.94 23.88 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.2 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 49.8 m-85 -133.11 122.68 24.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.702 0.763 . . . . 0.0 112.022 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.441 ' HG ' ' C ' ' A' ' 159' ' ' ILE . 27.1 t -117.99 150.64 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.987 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.1 128.26 36.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -63.01 118.82 8.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.415 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.483 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 42.5 mt -87.66 85.19 7.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.503 ' HE3' ' O ' ' A' ' 92' ' ' GLU . 55.7 mtpt -89.56 133.89 34.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.752 0.787 . . . . 0.0 109.538 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -50.29 -19.64 0.86 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.639 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -9.09 58.79 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -108.99 13.25 24.8 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 p -88.48 -42.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.31 -11.63 37.44 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.966 0.803 . . . . 0.0 112.064 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -73.45 137.44 44.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 112.569 -2.105 . . . . 0.0 108.094 176.16 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.174 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -137.03 149.45 47.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 37.4 tt0 -108.07 76.37 1.04 Allowed 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 172.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.44 140.58 33.33 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.0 tp -104.97 145.84 29.86 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 31.2 m-85 -57.61 142.09 45.94 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 81.9 mt-30 . . . . . 0 N--CA 1.436 -1.171 0 C-N-CA 119.344 -0.942 . . . . 0.0 . -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.446 ' H1 ' ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.643 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.88 -25.2 74.34 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.4 2.066 . . . . 0.0 113.375 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.78 -53.8 19.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.1 0.476 . . . . 0.0 110.585 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -63.49 -35.52 80.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.779 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -61.82 -51.65 67.4 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -57.87 -48.43 79.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.269 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.78 -49.14 73.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.328 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.13 -43.73 98.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -71.34 -39.61 71.22 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.91 -41.34 95.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 122.182 0.991 . . . . 0.0 108.6 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.586 HD22 ' ND2' ' A' ' 110' ' ' ASN . 53.4 tp -59.49 -56.32 23.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.879 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 12' ' ' ARG . 2.1 mmp_? -69.71 -28.87 66.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -103.23 -29.19 11.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.48 -19.25 8.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 11' ' ' LEU . 47.9 mt -93.35 117.99 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.075 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -125.87 156.77 39.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.186 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.421 HG23 ' CD2' ' A' ' 104' ' ' HIS . 1.9 p -86.73 106.11 17.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.515 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.8 mp -93.38 110.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 89.3 m -72.07 114.34 10.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.881 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 58.6 p -109.27 -163.57 0.88 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.7 t -77.53 -29.2 52.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -90.38 -33.15 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.95 -167.2 39.95 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.423 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.89 115.36 21.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -121.5 159.22 26.76 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.944 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -72.71 113.2 9.48 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.573 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -114.76 129.91 8.92 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.247 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.36 104.49 16.83 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.44 90.97 0.94 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.414 HD11 HD13 ' A' ' 90' ' ' ILE . 24.5 mm -59.18 -50.98 77.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 111.35 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -166.94 164.24 16.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.307 1.051 . . . . 0.0 113.328 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 82' ' ' LYS . 1.6 m-20 45.97 -92.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.997 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 31.5 ptt180 -142.55 19.87 2.03 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.037 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.36 119.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.543 0.687 . . . . 0.0 110.765 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 m -117.33 139.98 50.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.047 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -99.84 124.69 53.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.574 . . . . 0.0 109.847 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 pt -136.84 163.89 46.35 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.66 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.18 150.43 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.549 1.499 . . . . 0.0 111.615 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 94.9 m -81.19 -42.52 20.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.355 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -63.17 -17.12 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -67.29 -19.21 65.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 109.422 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.3 mt-30 68.01 72.87 0.36 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.28 133.05 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.454 2.769 . . . . 0.0 110.657 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.82 26.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.613 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -103.07 -5.89 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.205 1.002 . . . . 0.0 109.355 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.623 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 10.7 t70 -139.72 107.43 5.63 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.44 148.01 15.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.108 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.756 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 7.3 mp -96.9 103.7 15.65 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.736 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.87 106.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 64.22 23.99 13.26 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.955 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.38 -17.54 46.96 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.733 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -83.47 105.67 14.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.859 -0.201 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 15.0 ptpt -71.9 114.23 9.77 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 78' ' ' ASP . 4.6 tt -127.22 143.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.53 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.623 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 20.2 mmm180 -66.35 142.99 57.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.73 150.68 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.36 -49.76 5.31 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.53 114.54 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.351 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -107.21 132.11 53.43 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.497 ' CE2' HD23 ' A' ' 62' ' ' LEU . 24.0 t80 -130.13 118.29 21.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.42 104.44 10.03 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.456 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 96.1 mt -62.52 109.49 1.39 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.992 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.8 m -91.96 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.552 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 22.3 t70 -89.04 132.68 37.21 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.66 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.61 -18.49 2.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.0 2.467 . . . . 0.0 114.551 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 44.2 mt-10 -89.82 19.58 4.69 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 111.133 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 25.0 t-20 77.32 15.38 1.75 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.142 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.566 HG23 ' H ' ' A' ' 69' ' ' ASN . 25.8 mm -109.26 179.1 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.79 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.566 ' H ' HG23 ' A' ' 68' ' ' ILE . 52.8 t30 -92.14 146.16 23.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.192 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.765 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 27.4 tp -108.33 -22.39 12.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.545 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 19.4 tp10 68.89 13.0 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.476 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 76.1 mt -105.47 110.48 22.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.96 0.163 . . . . 0.0 110.951 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.0 m -91.98 116.51 28.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.044 0.449 . . . . 0.0 111.493 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.31 105.93 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.158 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -84.44 93.13 8.23 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 13.0 tp -93.59 155.79 17.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.772 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 54' ' ' ILE . 28.7 t70 -89.48 67.36 7.6 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 11.2 tpt180 -117.07 101.88 8.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -89.32 -6.0 57.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.831 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -87.03 107.14 18.29 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 32' ' ' ASP . 20.5 ptmt -78.21 157.7 29.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -88.04 167.09 13.98 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 111.989 -2.369 . . . . 0.0 108.262 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -64.03 130.54 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.395 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' OD1' ' HD2' ' A' ' 87' ' ' ARG . 10.3 m-20 -68.56 95.16 0.62 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -96.38 25.96 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 9.7 mtp180 -63.17 -36.07 82.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.645 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.08 -11.75 85.28 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.433 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -90.15 -17.71 27.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.562 0.681 . . . . 0.0 109.287 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.414 HD13 HD11 ' A' ' 30' ' ' ILE . 30.0 mt -69.02 130.8 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 21.1 m -107.61 129.0 55.04 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.3 -43.23 52.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 91' ' ' SER . 10.2 t70 -106.05 124.81 50.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.167 175.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.66 -71.49 0.37 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 49.47 72.16 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 82.92 0.12 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.754 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.56 3.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.12 0.486 . . . . 0.0 111.304 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.1 t70 -143.8 119.17 10.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.187 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.5 172.2 13.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.085 0.945 . . . . 0.0 112.337 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -120.64 144.6 48.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.115 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -111.0 124.51 52.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.775 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.17 120.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.467 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 t -113.38 133.41 59.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.53 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.421 ' CD2' HG23 ' A' ' 17' ' ' THR . 74.1 t60 -140.77 75.24 1.49 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.9 p -118.4 -166.98 1.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -68.82 -38.43 79.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.234 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.43 -60.84 1.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.637 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.613 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 46.4 m-85 -96.68 108.94 21.66 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.239 0.543 . . . . 0.0 110.063 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 15.2 m -113.36 117.7 32.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.423 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 11' ' ' LEU . 14.4 m120 70.4 34.54 2.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.49 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.613 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 2.6 m -87.26 122.4 30.98 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.3 tt -119.96 109.28 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.6 mt -115.03 128.54 56.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.85 106.0 17.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.5 m -78.95 -38.47 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 98.15 -123.17 7.76 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.899 -1.143 . . . . 0.0 114.499 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.7 Cg_exo -61.35 108.89 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.804 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.427 ' C ' ' HG1' ' A' ' 119' ' ' THR . 90.4 t -106.27 139.54 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 4.4 m -153.09 151.71 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.81 151.07 26.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.243 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 136' ' ' ARG . . . -114.5 -35.93 4.76 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.64 -97.52 1.63 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.729 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.97 125.26 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.095 0.474 . . . . 0.0 111.492 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 124' ' ' ILE . 45.0 pt -141.58 179.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 36.9 m-80 -100.47 93.83 5.83 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.297 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.574 HD13 ' O ' ' B' ' 4' ' ' ALA . 31.4 tp -72.74 97.18 2.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 128' ' ' SER . 5.1 m 62.59 35.22 14.5 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.749 0.785 . . . . 0.0 110.267 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 127' ' ' SER . 74.7 m 79.14 0.91 2.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.29 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.9 m -103.82 107.11 55.63 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.91 123.07 12.22 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 121.833 1.688 . . . . 0.0 112.99 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 144.91 49.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.401 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.9 t30 -117.43 168.02 10.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.582 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.552 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 3.2 mpt_? 65.58 31.46 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.5 mmm -82.21 130.33 35.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.936 0.874 . . . . 0.0 113.031 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.0 mt -98.7 142.66 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.143 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 119' ' ' THR . 6.6 ptm180 -122.76 157.17 32.94 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 167' ' ' GLN . 20.2 p90 -157.75 141.8 15.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.534 0.683 . . . . 0.0 109.997 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.09 98.32 5.73 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.755 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -171.49 134.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.08 114.17 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.311 0.577 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.8 p -121.3 162.05 20.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 143' ' ' THR . 58.6 tttm -157.28 150.47 23.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.22 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 142' ' ' LYS . 57.1 p -37.58 158.83 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.88 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.568 ' H ' ' H1 ' ' B' ' 8' ' ' CA1 . . . 87.74 -25.61 8.32 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.4 -0.86 57.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 9.8 p -76.68 142.53 40.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.58 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.57 -20.36 20.64 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.08 144.71 41.84 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.744 -0.728 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.02 124.25 46.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.302 0.573 . . . . 0.0 112.11 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -90.84 111.61 23.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -146.94 177.27 9.26 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.901 0.858 . . . . 0.0 112.681 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.08 177.54 10.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.944 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.6 t -60.93 111.65 1.75 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.208 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.1 77.77 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.157 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -151.98 121.14 6.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.17 0.485 . . . . 0.0 112.182 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.95 128.68 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -93.82 -41.16 9.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.237 0.541 . . . . 0.0 111.248 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.1 -158.47 29.49 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.537 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.92 143.54 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.558 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 162' ' ' GLY . 83.8 t60 -72.8 102.75 3.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.495 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.2 m -91.19 -19.37 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.549 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 160' ' ' HIS . . . -176.88 -152.75 10.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.929 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 176.39 168.31 36.32 Favored Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.544 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 22.0 t-20 -127.92 84.05 2.21 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.622 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.09 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.806 -1.543 . . . . 0.0 115.654 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -102.73 4.54 38.16 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 63.0 mt-30 -126.73 126.59 43.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.426 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.56 143.6 22.69 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 24.7 m-85 -122.54 109.44 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.918 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.8 t -108.5 146.56 33.0 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.541 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.64 125.07 38.05 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.6 pt20 -69.17 116.17 9.3 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.881 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 90' ' ' ILE . 18.8 tp -83.24 91.91 7.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.918 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -83.67 142.95 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.552 0.691 . . . . 0.0 112.263 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -66.09 -16.43 63.94 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -48.42 -50.98 28.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.733 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -70.91 -29.48 65.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.444 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.0 0.63 57.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -17.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.15 -25.96 18.47 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.173 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -117.39 120.92 39.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.289 -179.698 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.164 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.486 ' N ' HD13 ' B' ' 2' ' ' LEU . 4.8 mp -118.52 116.5 26.79 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.636 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.3 tt0 -94.77 79.17 3.71 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 173.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.574 ' O ' HD13 ' A' ' 126' ' ' LEU . . . -72.42 135.77 45.88 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' B' ' 6' ' ' PHE . 0.4 OUTLIER -91.18 134.45 34.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.55 ' N ' HD12 ' B' ' 5' ' ' LEU . 25.1 m-85 -50.04 137.02 17.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 72.1 mt-30 . . . . . 0 N--CA 1.439 -1.024 0 C-N-CA 117.098 -1.841 . . . . 0.0 . -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.568 ' H1 ' ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 112.887 -0.085 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.91 -40.51 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.232 1.955 . . . . 0.0 112.703 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.87 -44.35 55.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.431 0.634 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -55.19 -57.32 12.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.758 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.5 -34.31 75.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.6 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.47 -53.83 30.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.258 0.551 . . . . 0.0 110.625 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.38 98.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.947 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.6 tt -62.79 -42.95 99.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.696 0.284 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -69.93 -43.21 72.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.21 -40.68 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.352 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.655 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 8.3 tt -60.64 -45.0 95.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.013 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 41.7 mtp180 -73.73 -29.8 62.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 1.9 tpmt? -94.87 -51.61 4.61 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.92 -17.31 14.23 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.0 mm -88.05 123.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.65 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.474 ' HA ' ' HE3' ' A' ' 16' ' ' MET . 3.7 mmt -123.53 130.23 52.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' HG1' ' CD2' ' A' ' 104' ' ' HIS . 0.2 OUTLIER -71.96 103.98 3.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.196 178.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 56.6 mt -89.83 107.86 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 122.123 0.963 . . . . 0.0 111.607 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 m -80.41 110.66 16.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.334 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 21' ' ' SER . 6.2 t -134.11 -171.6 2.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.68 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' N ' ' OG1' ' A' ' 20' ' ' THR . 15.7 m -60.9 -28.47 68.93 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 40' ' ' HIS . 74.3 mmtt -92.78 -4.55 52.86 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.853 -0.53 . . . . 0.0 111.302 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 -151.75 19.1 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 29.1 mt-10 -112.34 129.33 56.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -118.12 167.27 11.64 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.134 0.968 . . . . 0.0 112.428 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 27.0 m -78.75 99.34 6.62 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.931 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 136.39 12.86 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 28' ' ' LEU . 1.6 pt? -121.32 129.74 53.26 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 118.389 -1.325 . . . . 0.0 112.597 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.9 109.64 2.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 90' ' ' ILE . 45.8 mm -67.9 -43.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.276 0.56 . . . . 0.0 110.611 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -171.88 146.78 2.1 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.474 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 50.28 -86.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.2 ptt180 -133.85 9.58 3.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.62 -174.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.95 113.78 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.524 0.678 . . . . 0.0 112.06 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.0 m -117.96 144.21 45.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.343 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.21 143.78 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.291 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.8 tt -148.13 144.84 19.37 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.921 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.94 149.14 15.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.153 1.235 . . . . 0.0 110.879 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.481 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 28.4 m -70.79 -37.11 73.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 42.8 p-80 -64.34 -7.96 11.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.74 61.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 55.71 72.5 1.02 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.76 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.86 135.24 25.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.866 2.377 . . . . 0.0 111.873 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.71 -160.05 36.09 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.087 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.1 p-10 -76.03 -23.78 55.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.206 0.527 . . . . 0.0 110.148 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 1.4 p-10 -139.81 132.96 29.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.81 148.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.511 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.0 mt -96.86 104.36 16.36 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.812 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' OD1' ' A' ' 50' ' ' ASN . 7.6 p -93.9 109.21 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 122.182 0.992 . . . . 0.0 109.962 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 9.4 p-10 45.74 28.36 0.55 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.954 -1.476 . . . . 0.0 113.12 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.45 -20.49 12.3 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.449 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.12 132.41 33.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -85.59 118.41 25.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -138.62 119.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.045 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 36.4 ptt180 -72.57 151.79 42.19 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.82 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 45' ' ' ASP . 11.1 p -74.54 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.056 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -98.36 -40.56 8.25 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 27.4 t0 -155.43 134.68 12.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.482 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.515 ' HZ2' ' HB3' ' A' ' 59' ' ' LYS . 6.2 ttpm? -136.34 115.32 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.414 . . . . 0.0 110.633 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -122.97 125.9 46.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -84.48 112.45 20.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.631 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 39.9 mt -75.47 109.08 8.72 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 m -101.55 148.79 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.45 140.93 95.24 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.326 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -45.9 -24.78 2.32 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.526 2.151 . . . . 0.0 113.851 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 9.81 3.62 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.374 0.607 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 73.11 30.97 1.53 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.61 155.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -64.93 129.17 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 37.2 tp -104.07 -22.49 13.43 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 37.3 tp10 75.09 8.45 4.04 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.47 107.61 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.971 0.351 . . . . 0.0 111.09 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 93.1 m -89.62 112.53 23.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.516 . . . . 0.0 109.72 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.53 106.22 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -101.28 100.9 11.48 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.175 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 17.6 m -91.49 110.33 21.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.426 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 31.0 mt -117.81 120.24 37.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.605 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.64 101.89 0.85 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 117.729 -1.588 . . . . 0.0 109.46 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -102.41 129.69 48.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.65 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -76.49 -25.65 54.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.024 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.15 120.78 38.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -73.6 129.33 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -77.2 137.57 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -44.78 131.56 6.91 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.274 -0.266 . . . . 0.0 111.041 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.25 92.66 3.88 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.282 0.563 . . . . 0.0 112.12 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.4 pt -93.48 20.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 87' ' ' ARG . 10.3 ttm180 -61.64 -39.13 90.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.079 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.35 -11.32 85.14 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.104 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 47.2 m-85 -87.82 -20.58 25.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 117.77 0.785 . . . . 0.0 109.652 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 30' ' ' ILE . 45.4 mt -74.06 146.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 p -120.2 139.61 52.39 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.495 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.01 -42.63 31.98 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.27 120.53 42.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 172' ' ' GLN . 26.7 mt -58.87 -68.18 0.29 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 56.57 70.87 0.61 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.46 93.42 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.13 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -87.84 3.42 5.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.889 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 13.5 t70 -131.05 124.34 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.368 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.79 163.85 31.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.227 1.013 . . . . 0.0 113.115 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.1 m -116.19 143.32 45.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.638 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -116.22 122.11 44.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 -177.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.43 113.03 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.304 0.573 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -99.37 139.75 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.631 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.491 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.8 t60 -146.36 59.62 1.22 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.1 m -108.88 -179.5 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.118 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.8 p-10 -68.39 -38.91 81.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.436 1.016 . . . . 0.0 111.765 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.499 HD21 ' HA2' ' A' ' 144' ' ' GLY . 79.3 m-20 -70.08 -60.12 2.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.087 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -108.06 92.9 4.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 m -91.83 110.64 21.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.514 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.491 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 41.2 t30 64.01 71.8 0.48 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.608 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.3 m -130.98 103.47 6.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.124 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.7 113.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.591 0.71 . . . . 0.0 110.414 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.1 mt -122.53 134.31 54.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.754 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.67 104.45 16.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.24 -41.09 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 96.54 -119.06 6.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.716 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.5 Cg_exo -60.42 100.41 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 115.684 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 137' ' ' TYR . 6.4 m -108.05 126.09 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -142.28 146.78 35.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -77.88 135.27 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.546 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.82 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.19 -116.11 3.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.283 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.93 106.99 14.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.888 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.1 pt -125.17 -172.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.154 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.8 m120 -113.14 95.39 5.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.35 0.595 . . . . 0.0 110.653 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.489 HD22 ' CG1' ' A' ' 161' ' ' VAL . 43.9 tp -81.62 106.85 13.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.4 m 64.77 25.74 12.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.2 m 86.1 -11.24 0.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.824 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.8 m -87.07 119.42 71.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.404 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.19 117.39 4.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.199 1.932 . . . . 0.0 112.36 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -117.46 132.87 56.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.178 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.76 141.04 32.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.707 0.765 . . . . 0.0 112.152 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 64.09 47.08 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.713 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.41 ' SD ' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.78 130.42 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.666 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 61.4 mt -89.44 134.54 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.493 0.663 . . . . 0.0 111.61 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -109.17 130.64 55.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.565 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' HB3' HG13 ' A' ' 118' ' ' VAL . 2.4 p90 -139.19 127.83 23.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.61 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.66 110.61 5.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.991 0.9 . . . . 0.0 111.251 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -179.71 132.05 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.799 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.49 106.68 0.68 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.4 p -112.38 140.18 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.531 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -130.44 152.61 49.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.267 1.032 . . . . 0.0 112.001 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.493 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.18 153.68 0.06 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.759 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 107' ' ' ASN . . . 92.66 -18.2 55.83 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -94.24 -4.57 48.66 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.529 -0.836 . . . . 0.0 112.155 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.471 ' H ' ' H1 ' ' B' ' 8' ' ' CA1 0.265 29.2 p -85.55 151.82 23.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 116.575 -2.05 . . . . 0.0 113.763 -174.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.697 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 106.59 -20.56 34.24 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -53.47 146.83 19.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.735 -0.732 . . . . 0.0 111.697 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.48 125.96 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.821 0.819 . . . . 0.0 113.162 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.8 tp -90.78 108.99 20.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.617 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.9 p -145.48 -179.72 6.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.031 0.919 . . . . 0.0 113.381 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.24 -172.71 4.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.642 -1.617 . . . . 0.0 108.568 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 153' ' ' THR . 9.8 t -66.93 101.75 0.88 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.012 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.9 83.99 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.302 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 79.3 mttt -140.43 140.08 35.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.415 0.626 . . . . 0.0 111.816 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.92 123.54 71.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -97.75 -31.89 12.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.934 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 167.53 -163.12 36.88 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.423 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.5 144.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.701 0.762 . . . . 0.0 111.413 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.433 ' HB2' HD23 ' A' ' 101' ' ' LEU . 6.1 t60 -62.72 114.11 3.41 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.454 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.489 ' CG1' HD22 ' A' ' 126' ' ' LEU . 47.8 t -103.6 -33.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.563 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.42 -147.13 5.54 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.646 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.37 166.3 32.18 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.306 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.497 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 5.3 t30 -132.91 89.67 2.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 109.812 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.52 -102.25 0.42 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.097 -0.956 . . . . 0.0 114.491 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -94.29 4.81 53.37 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -131.98 114.75 14.98 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.27 39.44 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.838 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.0 m-85 -129.01 118.16 22.11 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.021 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.478 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 27.0 t -111.64 159.83 17.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.252 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.87 131.54 44.26 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.439 ' HG3' HD23 ' A' ' 94' ' ' LEU . 47.3 tt0 -68.88 104.49 2.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.086 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.586 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 19.0 tp -80.16 92.87 5.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -87.67 119.94 28.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.994 0.902 . . . . 0.0 112.614 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -53.47 -31.16 44.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.537 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.47 ' HA ' HG11 ' A' ' 179' ' ' VAL . 4.9 pt20 -60.71 -17.74 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.98 -14.66 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.089 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -105.06 -30.91 9.45 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 176' ' ' GLN . 12.7 p -83.22 -2.95 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.57 -25.51 57.14 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.487 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -122.57 170.2 10.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.413 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.15 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.417 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? -133.77 139.89 46.6 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.443 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.7 tt0 -109.99 74.21 0.88 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 171.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -74.94 153.68 38.47 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 23.4 tp -113.42 152.4 30.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 23.2 m-85 -56.99 146.98 25.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.6 mt-30 . . . . . 0 N--CA 1.436 -1.174 0 C-N-CA 119.891 -0.723 . . . . 0.0 . 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.471 ' H1 ' ' H ' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 112.392 -0.283 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.74 -60.6 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.876 1.717 . . . . 0.0 113.363 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' HA ' ' OG1' ' A' ' 153' ' ' THR . 17.7 m120 -66.27 -44.17 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.131 0.491 . . . . 0.0 112.136 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -46.35 83.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.214 0.53 . . . . 0.0 111.869 -178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -55.01 -55.08 34.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.316 0.579 . . . . 0.0 111.659 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -63.47 -47.33 82.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.94 90.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.462 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 6.4 tt -67.36 -39.44 85.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 p -69.75 -41.49 75.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.184 -0.323 . . . . 0.0 111.201 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.8 -39.84 76.32 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.043 0.449 . . . . 0.0 110.963 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' C ' HD21 ' A' ' 11' ' ' LEU . 7.0 tt -54.76 -55.76 26.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 8' ' ' LEU . 12.4 mpt_? -61.2 -27.82 68.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.1 -52.98 4.56 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -106.44 -9.64 16.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -100.3 109.15 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.548 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt -121.96 155.54 35.3 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.845 0.831 . . . . 0.0 110.72 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.87 101.13 5.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.985 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.47 107.39 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.433 0.635 . . . . 0.0 110.544 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.6 m -76.82 99.91 5.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.089 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.8 p -95.33 -177.59 4.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.538 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m -75.28 -14.94 60.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.167 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.812 ' HZ2' ' CX7' ' B' ' 8' ' ' CA1 . 0.8 OUTLIER -105.5 -8.11 18.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.415 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 -179.66 22.07 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -79.15 121.18 24.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' HZ ' ' HZ3' ' A' ' 22' ' ' LYS . 75.1 m-85 -127.1 164.73 20.95 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.789 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.4 m -74.86 95.27 2.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.182 -1.826 . . . . 0.0 111.018 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.05 104.87 2.38 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 tp -88.73 104.89 17.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.0 112.162 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.58 126.64 12.87 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.3 mm -89.34 -51.57 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 117.417 0.608 . . . . 0.0 110.399 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -171.95 149.17 2.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.614 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.06 -87.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -135.86 16.06 3.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.494 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.51 119.83 49.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.302 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -125.39 147.16 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.506 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.66 136.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.859 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.405 ' O ' ' HB ' ' A' ' 73' ' ' THR . 15.5 mm -141.04 142.68 28.48 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.34 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.37 148.04 91.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.277 1.318 . . . . 0.0 111.657 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.57 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 52.2 m -68.23 -35.52 78.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.837 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' B' ' 6' ' ' PHE . 54.6 p-80 -74.02 -3.96 32.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -20.7 38.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.581 0.705 . . . . 0.0 109.366 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 59.14 71.64 0.92 Allowed Pre-proline 0 CA--C 1.517 -0.311 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.052 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.67 125.44 10.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.59 1.526 . . . . 0.0 108.963 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.15 178.88 50.94 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.372 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 56' ' ' VAL . 19.7 t70 -70.07 -31.2 68.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -120.18 140.94 50.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.13 161.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.407 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -98.22 114.48 26.75 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.678 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -91.9 92.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.165 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 66.78 5.25 3.84 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.339 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -31.88 2.34 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.976 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.406 ' CD ' HH12 ' A' ' 79' ' ' ARG . 50.3 tt0 -81.72 137.3 35.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 110.449 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -78.45 128.97 34.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.44 154.44 13.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.611 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -106.33 153.39 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.944 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 45' ' ' ASP . 7.7 p -94.96 118.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.49 -33.11 68.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.17 107.83 4.13 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.863 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.47 95.88 6.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -109.31 123.35 49.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.589 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -76.4 124.27 27.28 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -89.51 103.86 16.46 Favored 'General case' 0 C--O 1.259 1.596 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 29.6 m -110.82 173.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.844 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -72.5 139.64 81.32 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.55 -27.58 41.63 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.936 1.758 . . . . 0.0 111.788 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -85.54 8.39 19.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.459 0.647 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.5 t30 64.06 68.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.457 1.123 . . . . 0.0 111.183 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.9 mt -139.93 170.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 112.313 -2.221 . . . . 0.0 105.32 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' H ' HG23 ' A' ' 68' ' ' ILE . 65.7 t30 -86.43 135.72 33.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.342 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 20.4 mt -108.0 -26.94 10.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 25.0 tp10 79.09 3.6 2.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.132 -1.394 . . . . 0.0 113.169 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 17.7 mt -89.88 126.05 35.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.406 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 39.8 m -103.96 118.8 37.52 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.063 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.2 102.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.9 tp -95.42 94.95 8.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.85 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -84.17 94.95 8.49 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.958 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.29 122.57 42.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.213 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.26 84.7 5.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.406 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.406 HH12 ' CD ' ' A' ' 52' ' ' GLN . 27.9 tpt180 -95.56 133.01 40.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.661 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.22 -44.42 79.51 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 118.11 17.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -87.14 134.51 33.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.331 0.586 . . . . 0.0 111.945 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -68.92 137.47 53.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.438 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -72.91 131.4 42.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.946 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.86 86.07 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 18.5 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -63.56 -28.44 69.94 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.698 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.74 -18.65 74.94 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.531 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 92.5 m-85 -77.43 -22.78 50.96 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.9 mt -72.58 123.66 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.6 t -123.37 136.35 54.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -65.92 -42.14 90.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.96 107.01 18.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.72 -76.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HB3' ' HZ3' ' A' ' 155' ' ' LYS . 39.2 tt0 51.43 70.82 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.82 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.02 86.84 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.573 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.61 2.14 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.453 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.666 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.9 t70 -139.35 124.4 18.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.557 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.36 168.57 19.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.644 0.735 . . . . 0.0 112.545 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 34.2 m -119.67 136.42 54.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.381 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 160' ' ' HIS . 3.1 tm? -99.48 114.11 26.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.12 120.49 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.161 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -113.99 119.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.425 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -129.32 72.8 1.48 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.2 p -121.36 -171.95 2.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.632 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.44 -35.76 71.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.27 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.58 -55.81 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.04 125.35 12.27 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.392 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 1.6 p -88.15 112.58 22.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' THR . 84.0 m-20 76.29 74.48 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -142.22 136.37 29.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.195 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.47 137.24 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 109.651 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.78 108.72 13.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.624 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.7 pt-20 -75.65 108.2 8.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.08 -29.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.547 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.62 -115.81 4.61 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.945 -1.121 . . . . 0.0 115.735 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.19 109.35 0.61 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.95 2.434 . . . . 0.0 115.448 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.88 134.94 35.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -134.64 -172.27 2.98 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.86 147.55 48.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.07 -14.19 11.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.49 -111.69 3.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.974 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.2 118.73 32.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.51 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 134' ' ' MET . 49.3 pt -135.32 -179.27 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 5.4 m-20 -96.29 123.7 40.02 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.967 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 53.7 tp -106.12 104.22 13.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.1 t 63.47 28.57 15.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.4 p 80.16 1.23 2.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.873 1.669 . . . . 0.0 112.011 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 m -95.3 114.45 63.85 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.291 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.23 114.06 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.11 1.873 . . . . 0.0 112.718 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -121.3 130.01 53.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.615 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -105.59 164.46 11.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 55.18 50.07 15.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.352 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' HD11 ' A' ' 124' ' ' ILE . 35.2 ttm -101.85 134.65 44.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.061 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 70.0 mt -86.78 152.07 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.296 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -129.58 151.03 50.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.45 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.421 ' HH ' ' CE1' ' A' ' 160' ' ' HIS . 42.9 p90 -156.32 142.95 18.6 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.584 175.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.44 99.36 6.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.505 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -171.02 127.9 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.062 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 110.94 3.25 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.529 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.1 p -109.62 156.54 20.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.855 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 143' ' ' THR . 51.0 tttm -143.36 152.41 41.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.016 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.502 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 6.3 p -40.59 161.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.481 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.503 ' H ' ' H1 ' ' B' ' 8' ' ' CA1 . . . 90.65 -28.58 7.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.502 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -83.09 -11.58 57.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 25.2 p -72.08 111.95 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.634 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 137.23 -14.71 3.74 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.615 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.75 151.72 52.21 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 124.32 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 112.039 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.0 tp -91.98 109.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.3 p -144.59 178.25 8.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.97 0.89 . . . . 0.0 112.13 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.7 174.65 10.46 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.766 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 3' ' ' ASN . 27.9 m -72.45 94.44 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.04 -24.61 9.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.584 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 95' ' ' GLU . 94.0 mttt -134.65 146.52 49.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.73 0.776 . . . . 0.0 112.507 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 mm -110.1 130.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -101.69 -45.39 5.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.46 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.584 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.0 -170.17 43.0 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.651 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.403 HG23 HD13 ' A' ' 173' ' ' LEU . 30.5 pt -116.68 143.63 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.464 ' HB2' HD22 ' A' ' 101' ' ' LEU . 67.0 t60 -73.52 114.98 12.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.321 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.77 -21.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.63 -157.01 16.75 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.886 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.96 165.96 35.82 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.578 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.451 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 28.1 t-20 -136.62 85.99 2.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.778 0.799 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.31 -106.99 1.61 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.563 -1.198 . . . . 0.0 115.178 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.14 -17.11 57.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.93 127.31 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.48 142.4 17.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 66.6 m-85 -119.5 122.06 40.81 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.236 1.018 . . . . 0.0 111.994 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 32.3 t -119.83 149.71 41.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.38 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.39 136.29 35.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -67.46 123.99 21.95 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.584 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 29.6 mt -90.61 84.96 5.97 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -80.75 135.72 36.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.999 0.428 . . . . 0.0 110.37 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.09 -29.14 68.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.401 0.619 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -55.14 -32.12 61.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.536 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.3 -11.64 51.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -111.1 -18.76 12.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.489 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.01 -8.46 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' OE2' ' HB2' ' A' ' 181' ' ' LYS . 0.7 OUTLIER -72.85 -17.68 61.52 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.43 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.702 ' HZ1' ' HB2' ' A' ' 181' ' ' LYS . 4.4 ttmp? -94.87 89.32 5.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.713 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.381 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -139.27 151.55 46.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.457 0.646 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.2 tt0 -122.49 79.67 1.64 Allowed 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 171.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.59 145.63 30.53 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 33.2 tp -98.59 153.58 18.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.561 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.5 m-85 -59.15 142.35 51.82 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.502 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 94.3 mt-30 . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 118.203 -1.399 . . . . 0.0 . -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.812 ' CX7' ' HZ2' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.693 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.69 -60.79 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.564 2.176 . . . . 0.0 115.186 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.632 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.1 t-20 -57.01 -51.07 70.72 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.828 -0.545 . . . . 0.0 112.206 -177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -56.28 -45.29 80.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.698 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.12 -28.35 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 111.224 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.05 -44.66 83.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.82 90.76 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.485 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.33 -49.81 74.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.987 0.423 . . . . 0.0 110.193 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.24 -39.55 82.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.972 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.8 tp -62.09 -49.57 75.4 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.509 0.671 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.8 tt -54.6 -43.72 72.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.155 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -64.91 -29.69 70.65 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.6 6.15 13.38 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.953 0.797 . . . . 0.0 112.982 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.8 -38.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.1 mt -86.39 115.89 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.353 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.4 mtt -119.72 161.74 20.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.925 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -92.8 123.67 36.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.92 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -112.84 105.57 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.931 0.872 . . . . 0.0 111.448 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.681 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.1 m -78.0 123.04 26.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.619 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.1 p -126.26 -173.48 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 m -81.03 -9.47 59.83 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -91.46 -43.47 9.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.6 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.66 -169.05 42.18 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.268 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 19' ' ' THR . 31.4 mt-10 -106.02 107.32 18.26 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -101.98 171.13 7.69 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.423 1.106 . . . . 0.0 113.516 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.7 m -79.9 113.77 18.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.534 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.02 112.49 4.48 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.781 -1.199 . . . . 0.0 110.877 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 tp -94.98 120.0 34.46 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.25 129.86 9.88 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.476 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -90.61 -56.85 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.72 0.76 . . . . 0.0 110.426 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -160.33 127.56 4.42 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 12.5 t0 56.89 -78.35 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.486 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 15.2 mmt-85 -120.46 -11.24 9.14 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.851 -0.531 . . . . 0.0 110.666 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.19 99.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.331 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -114.23 141.84 47.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.838 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.84 137.64 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.712 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.7 tt -142.24 141.7 22.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.36 142.53 16.91 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.253 1.302 . . . . 0.0 111.351 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.512 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 83.7 m -70.82 -34.84 72.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.132 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -65.62 -7.22 13.91 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.389 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.95 60.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.48 0.657 . . . . 0.0 109.672 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.6 mm-40 50.1 72.83 1.12 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.893 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.03 156.06 60.94 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.96 2.44 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -153.46 26.14 Favored Glycine 0 N--CA 1.455 -0.062 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.835 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.24 -15.58 35.51 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 2.2 p30 -139.27 156.56 46.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.223 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.23 161.06 17.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.681 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 77.3 mt -104.38 108.51 19.96 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' THR . 80.2 t -84.6 85.07 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.352 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 73.82 -10.1 1.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.091 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 156.82 -33.33 0.57 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.91 111.08 1.16 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.802 -1.199 . . . . 0.0 111.557 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -75.12 96.48 3.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 tt -123.92 148.02 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.661 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 55' ' ' ARG . 8.4 mpt_? -97.44 165.05 12.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.326 0.584 . . . . 0.0 111.526 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.4 t -90.45 120.65 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.725 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' ' HB2' ' A' ' 78' ' ' ASP . 75.9 tttt -79.86 -38.67 32.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.385 0.612 . . . . 0.0 110.152 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -159.29 132.63 7.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.395 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.97 114.57 26.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.185 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.551 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -118.06 105.73 12.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.319 -178.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.09 110.11 18.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 71.2 mt -79.32 120.86 24.38 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HA ' ' H ' ' A' ' 70' ' ' LEU . 33.5 m -116.01 154.87 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.621 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 12.6 t70 -87.1 143.45 34.85 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 119.034 0.834 . . . . 0.0 112.91 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 67' ' ' ASN . 61.0 Cg_exo -43.72 -17.13 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.52 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.621 ' HG2' ' OD1' ' A' ' 64' ' ' ASP . 52.7 mm-40 -71.34 0.9 7.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.316 0.579 . . . . 0.0 109.827 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 64.4 m-80 72.75 18.82 4.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -116.98 145.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.858 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -51.6 135.58 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.106 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.533 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.0 tp -104.56 -16.69 14.96 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.512 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 68.3 14.76 9.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.122 -1.399 . . . . 0.0 113.648 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 82.1 mt -105.91 105.29 15.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.061 0.457 . . . . 0.0 111.499 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -89.54 110.19 21.06 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.434 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 95.5 t -81.51 108.86 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 tp -101.49 100.34 10.77 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.815 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 m -74.41 102.76 4.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.625 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' ARG . 86.5 mt -104.71 127.81 52.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.619 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 57' ' ' LYS . 14.1 t70 -87.79 89.46 8.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -93.61 133.89 36.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.61 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.91 -28.75 58.21 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.34 118.36 36.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 19.0 pttp -59.89 129.21 40.71 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.211 -0.995 . . . . 0.0 108.842 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -78.97 161.53 26.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.593 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -49.08 122.84 6.33 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -175.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.22 93.76 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.841 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 156' ' ' ILE . 49.0 pt -96.81 19.11 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -56.16 -35.31 67.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.312 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.76 -16.28 79.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.062 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -87.61 -13.13 43.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.55 133.37 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 7.1 m -96.25 130.94 43.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -77.97 -55.1 5.57 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 91' ' ' SER . 29.0 t70 -100.94 131.68 46.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.4 mt -79.39 -67.64 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.827 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 47.04 71.68 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -167.26 78.32 0.11 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.2 p -71.83 12.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 27.8 t70 -150.31 121.55 7.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.833 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.76 12.6 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.866 0.841 . . . . 0.0 111.591 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 m -120.06 145.96 46.36 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.585 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 9.6 tt -120.56 121.94 39.5 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' THR . 24.2 m -111.21 121.92 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.061 0.458 . . . . 0.0 111.04 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 4.0 t -100.5 134.48 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.08 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -135.7 70.97 1.42 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 m -127.18 175.43 8.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.764 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 25.8 p-10 -71.42 -20.05 62.16 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.359 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -84.97 -34.16 22.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.423 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.47 97.29 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.421 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 102.85 15.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 60.55 70.83 0.6 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.839 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 28.6 m -117.75 111.87 19.69 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.855 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.36 105.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 tt -116.56 127.24 54.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.658 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.71 128.51 34.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.17 -24.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.03 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 79.13 -124.12 6.43 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.852 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 27.9 Cg_endo -62.66 105.11 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.52 2.147 . . . . 0.0 114.495 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 90.6 t -97.2 118.32 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.694 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 p -138.07 167.58 21.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.971 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -104.53 126.04 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.61 -49.79 6.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.88 -115.89 4.13 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.476 -0.868 . . . . 0.0 115.114 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 123' ' ' LEU . 3.8 mp -95.96 107.8 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.061 -0.569 . . . . 0.0 112.096 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 42.2 pt -138.98 -177.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.274 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 60.0 m-80 -102.1 136.53 41.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.008 0.432 . . . . 0.0 110.598 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.657 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 4.1 mm? -115.07 103.81 11.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 128' ' ' SER . 10.3 t 60.8 31.13 20.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.768 -0.582 . . . . 0.0 109.751 -177.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 127' ' ' SER . 67.0 m 79.96 2.94 2.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.444 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -99.59 115.68 65.45 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.777 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.05 115.37 2.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.947 1.765 . . . . 0.0 112.368 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' HD23 ' A' ' 126' ' ' LEU . 19.7 m -128.69 141.84 51.21 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.014 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.608 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 60.3 t30 -117.91 162.8 17.54 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 3.2 mpt_? 77.84 22.94 0.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.659 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.48 129.27 37.62 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.146 0.974 . . . . 0.0 113.303 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 79.6 mt -92.3 132.66 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.278 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -107.25 129.22 54.9 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.515 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 1.3 p90 -133.29 143.44 49.05 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.96 99.49 9.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.636 0.732 . . . . 0.0 112.009 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.405 ' O ' HG23 ' A' ' 141' ' ' THR . 88.8 t80 -170.11 126.16 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.023 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.12 110.97 1.76 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.451 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 36.8 p -112.52 151.68 29.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -143.16 151.52 40.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.334 1.064 . . . . 0.0 110.916 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -38.86 156.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.363 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.81 -20.74 45.41 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 121.726 0.625 . . . . 0.0 111.648 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -87.33 2.94 48.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.459 -0.871 . . . . 0.0 112.228 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.545 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 16.6 m -64.8 142.62 58.37 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 104.5 -23.54 31.24 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.866 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 103' ' ' VAL . . . -49.74 135.92 24.3 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.562 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 47.3 t -88.78 122.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 111.847 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -93.46 108.83 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -146.65 166.18 27.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.193 0.997 . . . . 0.0 113.418 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.632 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -128.74 173.25 10.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.485 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -67.53 106.26 2.1 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.885 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.99 6.47 89.44 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.24 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -137.96 112.98 9.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.409 ' CD1' HD13 ' A' ' 86' ' ' ILE . 65.7 mt -103.59 134.73 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.362 0.601 . . . . 0.0 110.596 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -99.53 -55.13 2.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.931 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.576 ' HA2' HD12 ' A' ' 173' ' ' LEU . . . 176.64 -156.97 21.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.55 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.1 pt -125.94 148.04 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.334 0.588 . . . . 0.0 112.089 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.01 116.55 6.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.195 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.48 -28.88 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.625 0.726 . . . . 0.0 109.901 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' B' ' 7' ' ' GLN . . . 174.44 -145.84 8.26 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.589 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.62 174.11 44.56 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.4 t-20 -135.26 86.26 2.23 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.733 0.778 . . . . 0.0 109.769 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.05 -103.52 0.73 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.545 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -82.85 -11.49 58.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.68 -177.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.463 ' OE1' ' HB3' ' A' ' 166' ' ' ARG . 1.1 mp0 -112.8 145.99 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.851 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -105.13 150.8 17.11 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.7 m-85 -132.8 119.69 20.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.217 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.7 t -113.59 152.66 30.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.579 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.98 135.19 33.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 9.0 tt0 -74.93 113.48 12.28 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.576 HD12 ' HA2' ' A' ' 158' ' ' GLY . 8.4 mp -82.9 83.04 7.92 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -81.06 121.14 25.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.122 0.963 . . . . 0.0 111.249 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -39.67 -39.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.253 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -45.56 -51.21 12.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -69.45 -19.99 63.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -97.59 -29.62 13.33 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.704 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.41 -20.89 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.165 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.24 -23.95 18.35 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.442 ' HZ2' ' C ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -81.47 114.36 20.15 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.442 ' C ' ' HZ2' ' A' ' 181' ' ' LYS . 25.3 mt-30 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.377 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.089 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.8 mm? -136.63 155.19 50.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.273 0.559 . . . . 0.0 109.792 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.8 tt0 -121.89 77.32 1.36 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -77.51 147.2 35.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.495 HD11 ' H ' ' B' ' 6' ' ' PHE . 55.1 tp -103.24 142.85 33.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.495 ' H ' HD11 ' B' ' 5' ' ' LEU . 24.6 m-85 -57.78 125.39 22.81 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.06 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.468 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 83.2 mt-30 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 116.525 -0.307 . . . . 0.0 . 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.545 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 112.594 -0.203 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.49 -35.62 81.39 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 121.907 1.738 . . . . 0.0 113.913 -178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.3 -51.81 53.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.296 0.57 . . . . 0.0 110.834 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -67.63 -36.15 80.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.941 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 7.2 tp10 -58.19 -50.53 73.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 110.578 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.19 -48.75 79.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.05 83.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.438 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.3 tt -64.28 -40.39 95.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.596 0.236 . . . . 0.0 110.666 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -63.95 -43.71 94.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.38 . . . . 0.0 110.678 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.3 tp -67.51 -43.17 81.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.682 0.754 . . . . 0.0 110.58 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.3 tp -49.77 -50.54 44.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.436 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 78.4 mtp180 -56.9 -40.05 75.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.74 -15.49 8.9 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.9 5.56 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.8 mm -119.12 109.48 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.4 mmt -124.78 150.84 45.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.654 0.74 . . . . 0.0 111.211 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -76.33 95.36 3.76 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.7 mp -87.86 104.5 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 m -95.88 113.57 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.199 1.0 . . . . 0.0 109.987 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 69.4 p -94.44 -162.84 0.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.863 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.6 m -80.15 -7.25 58.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.68 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -100.74 -56.21 2.39 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.255 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.46 -163.59 26.55 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -83.49 123.39 29.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.267 -0.466 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -126.41 159.28 33.72 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 121.189 0.519 . . . . 0.0 109.709 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 14.2 m -90.16 109.23 20.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.141 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -88.23 110.18 3.6 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.368 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.1 120.4 36.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.27 138.84 15.66 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.63 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG21 ' CD2' ' A' ' 31' ' ' HIS . 4.1 mp -120.57 -39.8 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 118.447 1.124 . . . . 0.0 110.911 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 36.0 m-70 -135.43 128.61 31.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 18.8 t70 43.72 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 14.3 ptt180 -127.08 21.54 6.78 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.963 0.887 . . . . 0.0 109.253 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.38 112.46 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.064 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.2 m -116.76 156.7 26.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.65 139.52 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.176 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 pt -142.01 162.86 43.64 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.0 152.45 71.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 121.212 1.275 . . . . 0.0 111.52 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.616 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 61.0 m -70.69 -33.1 70.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -79.13 3.89 16.3 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.64 59.67 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 20' ' ' THR . 12.7 mm100 68.41 72.32 0.36 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.44 117.01 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.985 2.457 . . . . 0.0 110.086 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.35 -138.11 2.81 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.812 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.403 ' O ' HG11 ' A' ' 56' ' ' VAL . 24.8 t70 -77.55 -24.67 49.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.501 ' HB3' HH11 ' A' ' 55' ' ' ARG . 4.9 p-10 -142.83 162.63 34.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.881 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -140.79 149.04 21.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 84.6 mt -82.99 99.99 10.17 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.731 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -86.16 96.1 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.156 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 63.91 18.91 11.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.39 -17.81 21.09 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.338 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -90.64 123.54 34.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.11 113.31 14.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.181 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.2 mt -116.75 122.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.5 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.501 HH11 ' HB3' ' A' ' 46' ' ' ASP . 2.7 mpt_? -66.84 152.0 46.43 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.368 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -94.4 137.25 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HE3' ' CZ ' ' A' ' 33' ' ' ARG . 67.7 mttm -92.56 -55.52 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -128.26 140.14 52.05 Favored 'General case' 0 N--CA 1.46 0.049 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.622 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -132.44 78.93 1.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.535 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 90.6 t80 -88.01 131.33 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.591 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 10.6 mptt -90.1 116.13 27.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.98 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 17.2 mt -82.93 119.08 23.96 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-O 121.608 0.718 . . . . 0.0 110.549 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 29.8 m -128.62 158.22 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.147 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.05 145.26 88.57 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.261 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.11 -19.12 3.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.809 1.673 . . . . 0.0 113.218 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.06 5.57 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 109.81 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.76 61.59 0.97 Allowed 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.808 0.813 . . . . 0.0 109.641 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.47 HG23 HD12 ' A' ' 123' ' ' LEU . 35.9 mm -133.44 145.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.026 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 131' ' ' THR . 64.2 t30 -59.57 128.87 39.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -105.1 -24.36 12.79 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 174.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.616 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 75.22 10.31 3.67 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.452 -1.703 . . . . 0.0 113.607 175.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 10.5 mp -95.13 122.2 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.4 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 92.4 m -98.26 112.45 24.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.485 0.659 . . . . 0.0 109.883 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 98.9 t -76.2 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.7 tp -94.25 102.02 14.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.388 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.1 m -89.36 100.84 13.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 122.091 0.948 . . . . 0.0 109.178 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.8 mt -74.63 141.25 44.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 19.5 t70 -82.88 72.63 9.95 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.09 133.67 46.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.148 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -81.05 -32.13 34.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.97 98.44 2.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -88.46 150.18 23.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.139 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.21 -163.9 1.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.528 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -83.86 117.58 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.598 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 31' ' ' HIS . 4.8 m-20 -66.57 99.46 0.59 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -91.56 27.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 122.037 -0.414 . . . . 0.0 111.544 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -65.1 -15.46 62.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.463 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.6 -16.42 75.66 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.764 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -91.7 -14.41 30.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.06 127.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.9 m -125.95 132.85 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.474 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.3 pm0 -81.93 -27.29 33.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.75 149.08 26.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.4 mt -103.4 -68.61 0.83 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 41.75 37.66 0.8 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.433 0.635 . . . . 0.0 112.31 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.57 73.62 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 118' ' ' VAL . 1.2 p -73.5 20.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.138 -1.531 . . . . 0.0 114.818 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -121.59 130.12 53.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.43 166.32 25.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.476 -0.89 . . . . 0.0 113.1 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 96.4 m -121.55 142.54 49.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.49 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.13 113.41 26.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.6 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.95 97.57 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -87.93 123.01 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.6 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.0 t60 -137.64 33.31 2.47 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.1 p -109.51 -162.44 0.81 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.024 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -53.35 -56.58 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.15 -44.25 80.24 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.557 -0.714 . . . . 0.0 112.055 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.55 106.28 7.74 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.416 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 23.9 m -93.91 105.72 17.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.6 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 9.9 t30 79.18 72.42 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.275 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.3 m -141.15 107.86 5.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.37 100.37 11.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.801 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.462 HD21 ' OH ' ' A' ' 139' ' ' TYR . 58.1 tp -127.55 128.24 45.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.327 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 8.6 pt-20 -79.19 142.53 36.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.83 -20.07 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.55 -124.78 7.96 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.958 -1.115 . . . . 0.0 114.846 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.25 128.62 12.26 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 114.833 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 97' ' ' VAL . 86.8 t -104.91 157.58 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.764 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 m -160.21 114.89 2.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -78.01 115.94 18.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 118.668 -1.213 . . . . 0.0 108.059 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.9 -11.88 46.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.612 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.08 -120.64 5.26 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.788 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 68' ' ' ILE . 48.5 tp -94.17 113.66 25.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.4 pt -138.42 177.83 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.1 m-20 -94.64 128.35 41.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.657 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 68.4 tp -115.36 105.05 12.41 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.5 t 62.24 30.57 17.61 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.7 m 82.1 -1.55 1.48 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.151 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 39.3 m -100.22 123.09 47.98 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.874 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.71 116.37 3.21 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.04 1.827 . . . . 0.0 111.739 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 69' ' ' ASN . 33.6 m -126.82 134.25 50.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.279 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -108.93 163.2 13.51 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HG3' ' OH ' ' A' ' 177' ' ' TYR . 15.8 mmt180 66.37 24.0 10.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.022 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 tpt -72.24 128.86 36.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.143 0.973 . . . . 0.0 112.034 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 38.2 mm -92.43 126.61 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.899 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -104.75 137.27 42.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.33 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.4 p90 -145.63 109.51 4.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -74.01 99.3 3.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.829 1.3 . . . . 0.0 110.914 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' OH ' HD21 ' A' ' 113' ' ' LEU . 85.4 t80 -160.21 137.95 9.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 111.497 -2.592 . . . . 0.0 106.32 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 86.18 1.95 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -101.01 161.84 13.31 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -141.99 168.29 20.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.849 1.309 . . . . 0.0 113.093 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.579 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.03 152.61 0.17 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.763 175.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 93.5 -19.81 50.38 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.51 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -94.22 7.21 46.12 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.205 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.684 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 13.7 m -62.47 136.97 58.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.0 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 103.91 -16.98 50.01 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.829 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.5 142.28 43.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.505 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.13 114.9 29.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.439 0.638 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.7 tp -89.54 106.56 18.53 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.016 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.0 p -149.85 -177.17 5.74 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.039 0.923 . . . . 0.0 111.447 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.99 163.96 35.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.734 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 t -61.12 120.94 11.28 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.717 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.87 -19.39 45.85 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -144.41 124.59 13.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.878 0.839 . . . . 0.0 111.537 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.33 135.34 38.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.413 ' HA ' HE22 ' A' ' 172' ' ' GLN . 93.1 m-85 -103.06 -71.21 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 173' ' ' LEU . . . -152.56 -169.13 17.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.387 -1.387 . . . . 0.0 114.719 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 161' ' ' VAL . 27.4 pt -119.36 140.67 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.457 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -61.09 120.33 10.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 159' ' ' ILE . 73.2 t -117.08 -28.35 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.491 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.09 -151.28 8.4 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.345 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.48 161.16 27.6 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.0 t-20 -135.29 107.91 7.43 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.34 -110.18 3.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.872 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -113.06 25.82 11.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.248 1.023 . . . . 0.0 109.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -126.07 135.99 52.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.447 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -94.38 148.39 18.98 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.282 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.2 m-85 -128.96 123.42 32.44 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.822 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 159' ' ' ILE . 30.8 t -116.07 155.5 28.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.511 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.91 123.8 42.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.475 ' HG3' ' HG3' ' A' ' 174' ' ' LYS . 55.8 tp60 -72.27 124.85 25.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 158' ' ' GLY . 11.0 mp -88.87 84.17 6.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 172' ' ' GLN . 66.4 mttm -78.43 132.72 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 179' ' ' VAL . 8.1 ttpm? -52.12 -30.81 28.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -53.61 -29.44 37.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.407 ' OH ' ' HG3' ' A' ' 133' ' ' ARG . 7.8 m-85 -72.18 -32.3 66.7 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.722 -0.611 . . . . 0.0 111.362 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.519 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 90.7 m-85 -87.81 -13.72 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.212 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 175' ' ' LYS . 57.4 t -67.15 -11.64 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.5 -24.61 62.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.133 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -111.28 170.54 8.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.519 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.548 178.507 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.054 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.445 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.9 mm? -138.93 149.21 44.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.185 0.517 . . . . 0.0 110.712 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.6 tt0 -119.43 78.05 1.27 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 171.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.74 143.61 31.71 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 24.2 tp -99.89 153.34 19.23 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.554 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 25.4 m-85 -60.07 130.31 46.08 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.579 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 98.8 mt-30 . . . . . 0 C--N 1.315 -0.928 0 C-N-CA 120.623 -0.431 . . . . 0.0 . 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.684 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.9 -40.51 85.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.795 2.33 . . . . 0.0 115.29 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 12.2 t30 -61.71 -55.64 28.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 m -74.37 -33.6 63.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.91 -24.81 58.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.75 -42.69 97.8 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.48 85.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.76 -50.28 72.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.955 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -71.23 -37.17 72.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.993 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.85 -44.72 95.37 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.725 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.5 pp -63.69 -29.95 71.11 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -76.23 -28.53 57.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.13 -45.7 6.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -120.25 6.64 10.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.725 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 46.1 mm -106.22 106.0 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.0 mtp -111.84 147.58 35.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.216 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 101.66 12.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.143 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.72 98.87 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 32.5 m -80.66 100.0 8.45 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.34 -170.79 2.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.905 -177.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.412 ' H ' HG23 ' A' ' 20' ' ' THR . 65.4 m -74.01 -29.75 62.11 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.586 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.503 ' HZ3' ' H3 ' ' B' ' 8' ' ' CA1 . 58.4 tttm -88.82 -23.71 22.76 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.212 -0.305 . . . . 0.0 111.516 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.27 -164.99 37.54 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.644 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -97.86 107.82 20.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.634 0.731 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -108.97 164.14 12.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.904 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.3 m -89.34 118.18 28.83 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.64 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.23 99.1 2.49 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.652 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.92 104.89 14.38 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.51 120.83 5.65 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.446 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.0 mp -81.75 -58.91 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 117.576 0.688 . . . . 0.0 110.581 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -155.04 148.82 25.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 26.0 m-20 51.71 -91.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.776 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -137.22 22.5 3.0 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.29 119.58 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 110.41 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.0 m -114.31 159.17 20.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.2 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.14 140.97 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' O ' ' HB ' ' A' ' 73' ' ' THR . 14.0 tt -148.36 141.89 15.85 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.13 143.25 25.81 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 120.604 0.869 . . . . 0.0 110.167 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.587 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 71.5 m -67.74 -35.03 78.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -68.41 -7.57 32.82 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.42 68.24 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.636 0.732 . . . . 0.0 109.663 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 59.46 69.68 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.198 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -77.62 146.24 23.92 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.27 2.647 . . . . 0.0 110.549 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.41 -140.42 8.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.982 -1.104 . . . . 0.0 114.079 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.83 -24.38 38.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.732 -0.734 . . . . 0.0 110.324 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.62 139.83 34.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 27.6 m -124.55 153.47 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.246 0.546 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.3 mt -94.52 101.87 13.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.179 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.99 87.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.61 16.02 8.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.522 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.63 -25.07 6.64 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.034 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.08 108.47 17.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 76.5 mttt -73.8 142.38 46.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.715 0.769 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -136.53 142.17 39.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.85 140.12 33.08 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.854 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.45 155.56 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.408 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -113.72 -46.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.54 134.5 8.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.474 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -124.1 116.01 22.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.416 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 87.5 t80 -133.65 123.85 25.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.778 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -83.9 112.9 20.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . 6.7 tt -96.49 115.13 26.92 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.174 0.988 . . . . 0.0 109.876 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 27.7 m -111.35 178.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.165 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.6 t70 -70.93 136.56 85.09 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.92 -28.55 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.363 2.042 . . . . 0.0 113.948 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -90.12 20.21 4.48 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.6 0.714 . . . . 0.0 110.742 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.75 62.06 1.56 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.887 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 54.9 mt -133.13 158.29 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -77.94 144.58 36.7 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.14 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.704 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.4 tp -127.48 -35.65 2.14 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.704 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 55.4 mm-40 85.96 7.26 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.466 HD11 ' HG ' ' A' ' 70' ' ' LEU . 11.3 mp -78.97 93.66 5.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.164 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 45.7 m -84.01 106.25 15.52 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 70.0 t -71.16 96.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.5 tp -103.04 98.74 8.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 111.304 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.448 ' OG1' ' HE2' ' A' ' 181' ' ' LYS . 3.8 m -92.26 125.51 36.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.463 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.1 mt -114.02 153.43 29.39 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.938 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.62 68.5 8.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.266 -1.373 . . . . 0.0 108.475 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -78.82 117.58 20.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.877 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -76.31 -52.18 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.947 0.403 . . . . 0.0 109.982 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.92 82.98 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 19.5 pttp -73.27 139.16 45.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.641 0.734 . . . . 0.0 112.139 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -82.1 -178.32 6.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -69.64 147.87 50.07 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.565 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 6.6 t70 -88.69 95.98 10.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.848 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 90' ' ' ILE . 39.1 pt -91.49 15.66 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 13.9 ttp180 -62.7 -29.56 70.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.833 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.32 -16.47 80.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.679 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -92.46 -20.17 21.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 56.9 mt -68.74 124.35 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 19.0 m -103.52 120.54 41.06 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.33 -38.07 36.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 91' ' ' SER . 22.1 t70 -101.04 130.62 47.07 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 172.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 mt -90.57 -78.82 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 49.7 70.31 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.42 86.82 0.11 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.6 p -79.41 15.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.123 -0.539 . . . . 0.0 112.272 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 15.2 t70 -141.03 132.14 26.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.965 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.57 31.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.025 0.917 . . . . 0.0 111.031 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.05 135.85 51.37 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.329 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.93 117.97 34.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.256 0.55 . . . . 0.0 111.879 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.31 93.77 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.04 122.06 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.457 0.646 . . . . 0.0 110.236 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.482 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 72.5 t60 -145.71 41.65 1.22 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.7 p -108.35 -164.9 0.99 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.18 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.37 -48.92 79.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.79 -17.58 53.04 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -150.94 101.39 2.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.507 -0.746 . . . . 0.0 110.742 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 p -85.65 110.02 18.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.482 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 t30 66.43 71.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.564 0.697 . . . . 0.0 111.655 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 m -139.81 109.31 6.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.08 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.0 tp -82.39 120.87 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 116.05 20.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.579 -176.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.15 128.3 35.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.35 -27.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.067 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.45 -131.23 10.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.912 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 39.5 Cg_exo -61.38 115.93 3.07 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.842 2.362 . . . . 0.0 114.19 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -92.46 116.51 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.295 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -123.53 172.08 9.02 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 67.2 mtt -115.75 154.33 29.8 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.0 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.82 -22.92 10.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.02 -111.05 3.23 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.064 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -109.66 111.98 23.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.848 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 46.2 pt -139.35 -177.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 84.5 m-20 -101.43 127.7 47.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.823 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 34.7 tp -107.75 106.58 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 128' ' ' SER . 60.6 p 60.84 30.27 19.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.297 0.57 . . . . 0.0 109.951 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 127' ' ' SER . 63.4 m 85.67 0.52 0.7 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.282 1.033 . . . . 0.0 112.431 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.9 m -110.1 115.27 55.03 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 75.6 Cg_exo -52.05 128.09 25.75 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.529 2.153 . . . . 0.0 114.365 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 p -125.46 145.35 50.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.098 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 65.9 t30 -115.68 160.82 19.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.322 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 5.2 mpt_? 65.83 32.72 8.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.074 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.4 mmm -77.91 127.28 32.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.565 0.698 . . . . 0.0 112.807 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 71.7 mt -85.41 145.39 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.843 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.85 134.0 44.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 111.675 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -152.94 148.41 27.08 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.54 120.03 36.11 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 122.65 1.214 . . . . 0.0 111.502 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -175.06 129.84 0.3 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.811 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.04 0.79 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.151 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.8 t -119.55 138.45 53.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.112 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.43 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 113.455 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.529 ' CG2' ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -41.19 153.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.276 174.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.499 ' H ' ' H1 ' ' B' ' 8' ' ' CA1 . . . 88.16 -20.11 31.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.429 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -90.68 -7.84 51.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.327 -0.437 . . . . 0.0 111.495 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 25.8 p -73.61 135.13 43.81 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.024 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.662 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 124.03 -24.14 6.39 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.053 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.48 148.82 25.27 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.142 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.95 121.61 50.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 112.38 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.8 tp -92.41 113.42 25.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.283 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -149.26 169.9 19.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.752 0.787 . . . . 0.0 112.823 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.6 169.95 16.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.132 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 1.6 t -62.69 106.11 0.75 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.87 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.12 70.43 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.402 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.87 106.92 9.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.4 mt -95.08 115.96 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.09 -65.37 1.02 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.894 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.501 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -177.39 -155.6 14.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.103 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.4 pt -119.52 142.76 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.374 0.607 . . . . 0.0 111.236 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.15 115.62 7.83 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.35 -25.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.42 -154.84 10.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.564 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.31 161.77 31.89 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.516 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 48.3 t30 -136.2 98.54 3.88 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.86 -119.78 6.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.657 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HD2' ' H ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -103.03 17.38 24.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.821 0.81 . . . . 0.0 111.015 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -113.01 124.65 53.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.74 139.03 15.17 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.406 ' CZ ' ' HG ' ' B' ' 2' ' ' LEU . 73.4 m-85 -119.09 118.03 30.3 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.088 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 40.4 t -110.94 154.12 24.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.249 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -101.49 136.21 41.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.991 0.424 . . . . 0.0 110.078 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.92 117.03 18.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 92.6 mt -89.85 87.19 6.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HB2' ' CD2' ' A' ' 177' ' ' TYR . 92.5 mttt -80.52 126.5 31.31 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.325 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 63.0 tttm -43.07 -43.78 4.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.226 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -57.71 -23.52 52.21 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.475 ' CD2' ' HB2' ' A' ' 174' ' ' LYS . 54.4 m-85 -75.63 -25.99 57.37 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.644 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -84.43 3.66 35.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.203 0.525 . . . . 0.0 110.921 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.08 -3.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.012 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -78.75 -51.35 9.91 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.448 ' HE2' ' OG1' ' A' ' 76' ' ' THR . 63.1 tttp -71.37 136.59 47.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.168 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.603 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.22 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.406 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.2 mm? -135.11 149.39 50.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.4 tt0 -119.74 84.85 2.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 172.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -89.58 146.39 24.6 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 45.9 tp -102.14 151.7 21.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.539 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 22.3 m-85 -57.78 140.87 50.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 93.8 mt-30 . . . . . 0 N--CA 1.441 -0.892 0 C-N-CA 118.353 -1.339 . . . . 0.0 . 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.529 ' H2 ' ' CG2' ' A' ' 143' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.641 ' O ' ' HG3' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.499 2.85 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -59.61 -33.92 96.7 Favored 'Trans proline' 0 CA--C 1.526 0.09 0 C-N-CA 122.559 2.173 . . . . 0.0 114.073 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -70.78 -46.8 62.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.914 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -62.72 -33.65 75.55 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.812 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.641 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 44.9 mt-10 -61.15 -47.01 88.2 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.389 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -62.1 -44.38 96.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.233 0.54 . . . . 0.0 109.835 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.71 87.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.705 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 1.6 tt -64.68 -40.07 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.653 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -67.6 -48.1 67.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 -39.72 87.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.879 0.847 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 67.1 tp -54.9 -49.86 70.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.115 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 16.8 mtm180 -72.33 -29.6 63.97 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -91.12 -48.98 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -175.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -118.49 0.06 11.51 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 55.0 mt -106.44 122.99 60.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.6 mtp -133.98 165.6 24.66 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.991 0.901 . . . . 0.0 110.584 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.74 111.79 12.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.958 -1.474 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -104.53 110.38 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 2.0 m -87.31 112.86 22.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.175 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -122.35 -171.93 2.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.32 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.472 ' H ' HG22 ' A' ' 20' ' ' THR . 14.9 m -55.28 -37.09 66.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.963 ' HZ2' ' CX7' ' B' ' 8' ' ' CA1 . 23.9 ttpp -91.02 0.43 57.54 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.78 -160.16 21.69 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.466 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -89.91 122.85 33.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.136 0.493 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 22' ' ' LYS . 66.9 m-85 -113.45 177.6 4.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.233 1.016 . . . . 0.0 112.003 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 49.4 m -91.94 107.18 19.02 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.742 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.3 112.1 4.23 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.191 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 tp -95.6 103.9 15.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.418 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.68 125.58 13.63 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.99 -46.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 117.199 0.5 . . . . 0.0 111.106 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -171.83 149.93 2.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.99 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.641 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 31.6 t70 46.49 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.641 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 10.2 ptp85 -125.44 18.86 8.15 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.811 -0.556 . . . . 0.0 111.074 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.51 122.92 58.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.625 0.726 . . . . 0.0 111.71 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.44 141.68 50.97 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.377 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.67 135.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.562 0.696 . . . . 0.0 109.785 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' A' ' 73' ' ' THR . 8.1 tp -141.04 137.78 17.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.798 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.52 151.53 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.775 0.983 . . . . 0.0 111.196 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 92.0 m -78.35 -34.84 48.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.936 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -72.2 3.8 4.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.759 0.314 . . . . 0.0 111.111 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.33 -24.62 50.78 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.0 0.905 . . . . 0.0 109.336 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 56.9 70.18 1.48 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.817 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.95 152.12 24.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.875 2.383 . . . . 0.0 109.41 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.57 -134.78 7.04 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.91 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.83 -9.14 24.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 11.6 t70 -136.91 124.43 22.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.082 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.95 172.58 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.697 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.598 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.6 mp -117.03 121.92 42.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.76 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.24 98.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 55.9 58.14 4.64 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.793 -176.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -38.07 1.9 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 118.7 15.63 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG2' ' HG ' ' A' ' 48' ' ' LEU . 4.6 mtmp? -80.71 146.02 31.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.638 0.732 . . . . 0.0 112.166 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -144.58 146.32 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.076 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.497 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 24.8 mmm180 -79.89 145.35 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.67 0.271 . . . . 0.0 110.466 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.29 150.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HE3' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -94.65 -58.25 2.24 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.36 117.53 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.277 -1.328 . . . . 0.0 110.454 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 59' ' ' LYS . 38.1 ttpt -107.56 115.67 30.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -121.66 117.46 26.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -77.28 109.36 11.1 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 57.4 tp -85.45 114.36 22.43 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-O 122.475 1.131 . . . . 0.0 110.877 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 34.6 m -123.52 168.36 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 113.092 -1.867 . . . . 0.0 108.786 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 13.3 t70 -63.99 144.16 98.16 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.945 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.75 -19.71 8.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.248 1.965 . . . . 0.0 113.682 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.94 15.75 19.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 109.112 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t30 60.65 64.12 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.08 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -130.87 142.16 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 131' ' ' THR . 65.2 t30 -64.4 127.13 30.18 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 29.0 mt -98.43 -29.21 13.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 32.5 tp10 85.81 7.94 0.35 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.785 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 10.8 mp -91.93 107.48 19.24 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.736 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 51.7 m -90.27 105.37 17.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.09 99.78 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.56 100.94 13.6 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.486 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -94.58 98.42 10.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.367 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 pt? -122.62 127.93 50.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.457 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.79 86.14 1.7 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.568 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -79.96 141.08 36.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.12 -1.4 . . . . 0.0 107.943 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -68.96 -38.6 79.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -90.59 96.7 10.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.2 152.9 28.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -85.42 159.06 20.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.116 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -72.49 156.54 38.92 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.877 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.41 67.47 8.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.1 11.41 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.198 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -58.29 -25.94 62.41 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 120.623 0.249 . . . . 0.0 111.255 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.14 -17.68 74.11 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.805 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -95.34 -4.32 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 109.956 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.8 mt -82.11 131.9 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 2.5 m -91.6 122.77 34.47 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -174.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -71.18 -63.33 1.13 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.86 135.17 34.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 172.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.13 -54.91 41.65 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.979 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 46.58 71.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.176 0.512 . . . . 0.0 110.965 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.21 93.25 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 5.9 p -78.04 6.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -119.17 124.81 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.57 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.328 1.061 . . . . 0.0 113.745 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 m -124.28 139.18 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.37 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.89 117.77 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.008 0.432 . . . . 0.0 112.033 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -104.24 105.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.841 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.63 121.74 54.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 111.713 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -126.5 76.99 1.67 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.47 -170.28 2.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.444 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -56.4 -47.29 79.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -98.64 -56.65 2.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.903 0.774 . . . . 0.0 110.099 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.46 90.82 5.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 3.1 m -106.87 114.61 28.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.822 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 109' ' ' THR . 3.5 m-20 71.5 26.85 3.14 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.166 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -84.52 111.66 19.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.375 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.58 99.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.336 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 113' ' ' LEU . 3.6 mp -95.39 137.19 34.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.08 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.59 114.81 26.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -97.82 -19.56 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.422 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.33 -135.81 14.69 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.453 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.717 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 19.3 Cg_exo -67.23 142.15 59.66 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.02 2.48 . . . . 0.0 114.063 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.83 171.29 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.639 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 m -148.61 157.68 43.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.13 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 73.9 mtm -100.58 129.26 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 136' ' ' ARG . . . -97.63 -17.42 19.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.31 -118.85 4.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.48 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.4 tt -107.5 120.3 41.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.204 0.526 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.3 pt -140.68 -166.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 17.5 m120 -117.17 131.55 56.85 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.235 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 1.6 mm? -110.08 108.1 18.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' SER . 7.2 t 61.39 29.14 18.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 55.3 m 84.31 -10.49 0.88 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.571 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 m -81.64 126.31 76.13 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.05 117.4 4.51 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.828 1.685 . . . . 0.0 112.14 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.482 ' HG1' HD23 ' A' ' 126' ' ' LEU . 15.0 p -120.25 142.89 48.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.553 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.11 164.29 15.77 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.358 0.599 . . . . 0.0 111.538 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 62.61 34.27 15.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.527 ' HE1' ' HA ' ' A' ' 134' ' ' MET . 10.7 mmt -79.32 137.2 37.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.505 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 65.6 mt -96.25 133.69 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.584 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 37.5 ttt180 -120.43 125.23 47.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.762 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -142.9 139.08 30.63 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.92 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -80.44 96.52 6.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.145 0.974 . . . . 0.0 110.982 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -165.56 131.74 2.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.521 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.67 83.62 0.87 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -89.42 140.24 29.71 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.24 157.63 39.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.996 1.379 . . . . 0.0 114.315 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.77 150.0 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.292 175.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' H ' ' H1 ' ' B' ' 8' ' ' CA1 . . . 92.38 -27.35 10.69 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -93.15 7.37 44.5 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 12.6 p -79.58 125.7 29.94 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.181 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 127.93 -16.66 6.1 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.303 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 151.67 33.6 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.653 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.37 119.13 45.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.332 0.587 . . . . 0.0 112.039 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.64 110.04 19.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -152.85 -170.4 3.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.024 0.916 . . . . 0.0 113.129 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -166.1 178.6 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.989 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.0 t -55.44 107.98 0.38 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.471 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 60.11 30.24 70.01 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.541 ' HE2' ' OG ' ' A' ' 91' ' ' SER . 2.5 tpmt? -145.3 91.67 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.713 -0.743 . . . . 0.0 111.453 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -93.75 122.52 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -92.32 -46.79 7.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.054 0.454 . . . . 0.0 110.351 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.555 ' CA ' HD11 ' A' ' 173' ' ' LEU . . . 163.85 -154.73 25.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.125 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.36 146.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.53 0.681 . . . . 0.0 111.234 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -78.9 115.05 18.34 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.644 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.24 -28.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.65 -151.5 8.99 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.209 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -173.18 167.09 39.76 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.489 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 24.8 t-20 -136.76 94.43 2.98 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.4 -96.43 0.49 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.398 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -108.96 9.88 26.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.19 0.519 . . . . 0.0 110.879 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -121.29 135.67 55.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.98 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.19 139.29 14.41 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 60.9 m-85 -120.59 121.52 38.55 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.93 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.6 m -121.17 167.94 12.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.617 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.511 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.49 143.2 37.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.06 116.17 18.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.555 HD11 ' CA ' ' A' ' 158' ' ' GLY . 8.7 mp -93.58 86.3 5.15 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 91' ' ' SER . 28.6 mttm -76.3 146.67 38.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.446 ' HB3' ' HZ3' ' A' ' 175' ' ' LYS . 7.3 ttpm? -58.34 -31.94 68.04 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 111.695 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -50.9 -42.23 59.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.402 ' CG ' HD22 ' A' ' 62' ' ' LEU . 9.0 m-85 -64.01 -38.54 91.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -92.47 -22.18 19.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.84 -14.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.461 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.43 -9.39 20.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.194 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -111.1 99.67 8.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.617 0.723 . . . . 0.0 112.85 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.866 177.015 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.9 149.88 50.59 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.614 0.571 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.4 tt0 -118.22 77.11 1.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -78.65 155.37 29.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 51.0 tp -110.46 142.9 41.56 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 21.3 m-85 -57.16 136.08 56.4 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 94.1 mt-30 . . . . . 0 N--CA 1.44 -0.938 0 C-N-CA 119.665 -0.814 . . . . 0.0 . -176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.963 ' CX7' ' HZ2' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 120.297 -0.168 . . . . 0.0 113.004 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -43.78 -50.3 7.33 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.901 1.734 . . . . 0.0 112.731 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 152' ' ' ALA . 38.6 t30 -62.1 -50.99 69.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.547 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -56.86 -53.38 58.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.175 -1.375 . . . . 0.0 112.935 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.547 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.2 mp0 -71.33 -26.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.309 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.56 -45.71 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.402 ' HB3' HG11 ' A' ' 102' ' ' VAL . . . -56.89 -45.39 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.403 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.61 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 7.5 tt -59.76 -42.33 93.02 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 m -70.3 -36.49 74.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.256 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -70.26 -47.41 61.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.0 pp -64.81 -25.02 67.73 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 69.6 mtp180 -70.0 -50.07 45.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.31 -23.99 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -108.51 -4.55 17.15 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 43.4 mm -114.59 117.08 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.816 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -120.79 137.31 54.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.313 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 m -76.71 103.28 6.59 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.97 102.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.686 0.755 . . . . 0.0 111.575 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 63.4 m -71.13 100.01 1.97 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.791 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -107.4 175.7 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.954 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.509 ' H ' HG23 ' A' ' 20' ' ' THR . 3.4 m -55.15 -47.31 75.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 7.7 mmpt? -89.83 2.11 55.35 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.71 -175.97 27.73 Favored Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.853 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.6 ' O ' ' HB3' ' A' ' 105' ' ' SER . 30.2 mt-10 -101.48 112.6 25.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -106.93 162.59 13.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.951 0.881 . . . . 0.0 112.951 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 86.3 m -80.73 106.8 13.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.847 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.27 116.48 4.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.694 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -94.42 108.95 20.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 110.795 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.8 108.08 2.41 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -75.43 -55.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.891 0.377 . . . . 0.0 111.802 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -162.96 138.92 7.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.617 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 13.0 t70 57.32 -94.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.069 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 76' ' ' THR . 79.2 mtt85 -126.28 8.74 7.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.802 0.81 . . . . 0.0 110.163 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.9 t -92.71 113.18 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.866 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 p -124.06 142.8 50.87 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.11 137.09 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.023 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 tt -144.95 139.95 15.72 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.525 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.2 144.1 72.06 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.457 1.438 . . . . 0.0 112.439 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.78 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 89.7 m -63.9 -37.6 87.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -72.52 6.54 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.17 -19.1 30.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.668 0.747 . . . . 0.0 109.937 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 64.98 69.51 0.66 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.196 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.81 110.49 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.638 1.559 . . . . 0.0 109.48 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -141.84 1.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.546 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.01 -28.32 15.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.952 0.882 . . . . 0.0 109.227 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -136.88 132.4 34.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.039 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.81 153.15 36.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 mp -97.01 104.01 15.98 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.118 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 49' ' ' VAL . 7.2 p -82.02 96.03 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.34 10.53 7.3 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.47 -28.76 3.96 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.461 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -78.88 118.38 20.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.127 0.489 . . . . 0.0 110.741 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 6.9 mtpm? -72.55 107.79 5.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.9 mt -119.39 126.4 75.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.257 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -77.56 146.22 36.42 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 110.084 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.27 138.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -84.46 -45.56 12.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.78 144.48 15.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -136.67 112.67 9.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -112.95 129.35 56.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.339 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.43 110.79 16.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 36.9 tp -81.19 115.1 20.44 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.44 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.59 167.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.673 -1.603 . . . . 0.0 108.218 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 17.9 t70 -87.0 143.32 34.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.59 -17.05 6.25 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.367 2.045 . . . . 0.0 113.513 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.89 7.18 9.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.86 39.99 2.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.938 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 150.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.846 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -66.4 137.39 56.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 18.6 mt -105.38 -28.38 10.91 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.78 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 35.8 tp10 80.7 9.03 1.18 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.948 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.473 ' HG ' HD21 ' A' ' 173' ' ' LEU . 2.3 mm? -95.54 133.41 39.58 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.904 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.8 m -105.61 115.56 30.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.61 96.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -93.28 103.55 15.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.928 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 19.9 m -94.44 100.5 12.49 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.22 156.63 16.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.758 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -83.87 103.53 13.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -129.96 143.1 50.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.459 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -87.34 -59.02 2.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.77 90.64 4.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 55.6 pttt -68.07 163.66 21.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -79.23 145.91 33.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.343 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -62.45 130.82 46.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.717 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.94 80.93 0.47 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 122.173 -0.329 . . . . 0.0 111.437 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.36 19.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 O-C-N 121.448 -0.782 . . . . 0.0 110.403 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.48 -13.38 62.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.614 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.84 67.43 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.873 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.28 -10.15 50.52 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.86 131.84 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.9 m -105.43 133.68 49.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -81.97 -23.82 35.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -127.31 111.49 13.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.6 mt -52.74 -64.55 0.78 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.7 69.25 0.69 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.28 96.9 0.1 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.5 p -86.55 17.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.333 0.587 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -140.35 132.92 28.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.034 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.18 16.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.236 1.017 . . . . 0.0 113.38 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.3 m -128.23 142.1 51.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.389 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.76 110.97 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.142 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 7' ' ' ALA . 27.1 m -103.74 136.19 37.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.16 0.505 . . . . 0.0 110.999 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -122.54 133.87 67.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.909 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.586 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 64.5 t60 -138.64 45.03 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 m -108.78 -165.42 1.02 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.413 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -83.34 -18.52 38.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.619 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 11.9 p30 -67.49 -50.3 59.55 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -138.49 113.83 9.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.4 m -92.55 96.84 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.808 0.813 . . . . 0.0 112.22 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.586 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 8.0 t30 74.03 70.45 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.054 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 m -134.85 136.67 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.819 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.58 117.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.8 mp -111.91 113.16 25.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.49 120.58 24.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -97.06 -25.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.956 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.73 -129.12 9.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.838 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 25.1 Cg_exo -62.43 130.51 30.37 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.3 2.0 . . . . 0.0 113.231 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.45 131.66 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.0 p -122.98 144.98 48.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 72.8 mtm -81.31 114.28 19.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.51 -50.27 7.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.864 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.19 -119.95 5.86 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.785 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 123' ' ' LEU . 3.4 tm? -95.68 118.1 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.304 0.574 . . . . 0.0 112.53 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.8 pt -139.98 -174.46 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.1 m-20 -113.26 104.28 12.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.735 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.6 mm? -79.52 113.36 17.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.426 ' HB3' HD12 ' B' ' 5' ' ' LEU . 59.0 p 52.27 30.81 8.39 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.969 -0.457 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m 70.56 62.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -160.8 115.27 1.35 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.315 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.21 112.12 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.349 1.366 . . . . 0.0 111.6 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.498 ' HB ' HD22 ' A' ' 126' ' ' LEU . 17.7 m -125.79 128.86 48.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.854 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.517 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 57.7 t30 -106.86 162.79 13.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 19.6 ttm-85 70.88 34.82 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.286 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.3 mmm -87.37 139.44 30.55 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 111.68 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.4 mm -97.94 134.49 36.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.442 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -111.82 125.42 54.0 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -137.36 125.82 23.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.67 99.81 3.78 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 122.232 1.015 . . . . 0.0 110.773 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -166.7 128.19 1.71 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.47 91.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.1 p -90.72 162.42 14.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.336 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -132.17 150.33 52.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.971 0.891 . . . . 0.0 111.865 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.639 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.22 154.22 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.275 175.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -33.14 5.43 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.468 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 70.8 mt-30 -77.52 9.99 2.92 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.54 139.6 58.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.678 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.88 -14.96 34.31 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.951 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.68 145.1 40.11 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.532 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.42 122.19 50.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.645 0.736 . . . . 0.0 112.249 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.38 108.91 20.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.347 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 178.85 8.68 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.904 0.859 . . . . 0.0 112.802 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.408 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . . . -153.12 179.25 8.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.628 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 2.0 t -60.63 102.63 0.2 Allowed 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.794 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.95 88.01 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.608 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.08 119.36 16.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.641 0.721 . . . . 0.0 112.768 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -99.31 124.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -94.57 -35.03 12.42 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 161.05 -163.15 34.14 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.769 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.5 pt -129.85 152.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.842 0.829 . . . . 0.0 112.11 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -62.27 122.73 16.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.756 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.13 -30.98 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.183 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.21 -146.12 5.5 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.583 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -179.42 158.11 21.76 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.322 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.505 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 21.4 t30 -131.22 86.56 2.37 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.977 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.13 -99.74 0.81 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 114.995 -1.002 . . . . 0.0 114.973 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -94.25 -2.43 52.39 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 111.929 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -121.46 131.39 54.13 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.759 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.01 151.3 25.83 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -129.28 114.11 15.84 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.765 -1.174 . . . . 0.0 113.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.0 m -108.92 159.27 16.94 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.46 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.494 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -96.26 132.35 41.81 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.587 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.598 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 51.8 tt0 -70.96 107.86 4.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.12 0.486 . . . . 0.0 110.283 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 80.4 mt -85.59 93.83 8.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.556 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.75 125.56 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.726 0.774 . . . . 0.0 109.548 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -40.18 -39.86 1.0 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.4 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.48 -46.23 37.91 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -64.06 -17.0 62.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.38 -22.31 30.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 110.626 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.24 -29.46 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -65.67 -43.58 88.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.5 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -65.92 135.81 55.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.779 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.69 114.28 27.19 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -86.55 79.54 8.9 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.492 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.735 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.41 125.08 30.64 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 37.7 tp -86.02 146.75 26.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.505 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 16.2 m-85 -60.17 130.2 45.5 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 98.3 mt-30 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.647 -0.706 . . . . 0.0 . 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.668 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 120.357 -0.135 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.26 -48.78 4.0 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.969 2.446 . . . . 0.0 114.451 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.67 -40.49 76.39 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.58 0.705 . . . . 0.0 110.694 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -49.78 68.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.535 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 10.1 mm-40 -60.28 -33.82 72.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.388 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -68.81 -58.52 4.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 tp -70.46 -33.02 70.8 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -79.79 -34.55 39.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.42 -36.43 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.1 tp -54.94 -59.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.027 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.61 -27.04 61.92 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.71 -46.34 14.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.53 -6.06 9.24 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 65.2 mt -110.25 121.19 62.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.96 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.4 mtt -127.73 147.23 50.4 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.639 0.733 . . . . 0.0 109.817 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -64.92 110.98 2.63 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.009 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 39.7 mm -95.57 105.18 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -92.21 96.52 10.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.507 0.67 . . . . 0.0 109.301 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.402 HG21 HG22 ' A' ' 18' ' ' ILE . 1.3 p -102.81 -169.73 1.7 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.341 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -67.32 -32.04 72.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.703 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.961 ' HZ1' ' CX7' ' B' ' 8' ' ' CA1 . 49.4 tttm -83.03 -35.29 25.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.395 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.43 -151.57 22.64 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 119.479 -1.343 . . . . 0.0 115.34 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.42 120.28 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.306 -0.947 . . . . 0.0 110.531 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -126.44 159.58 32.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.184 0.992 . . . . 0.0 113.018 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.646 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 32.9 m -79.65 100.91 8.07 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.384 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -90.42 112.29 4.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.69 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -101.81 105.72 16.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.28 116.58 5.27 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.53 -60.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.223 0.512 . . . . 0.0 111.946 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -145.51 152.65 40.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.875 0.845 . . . . 0.0 112.678 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.499 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 41.6 m-20 45.14 -92.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.781 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 16.9 ptt180 -141.59 25.75 1.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.88 0.848 . . . . 0.0 109.661 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.53 118.61 53.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.548 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 m -117.48 146.07 43.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.869 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.89 122.91 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.062 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -134.76 141.11 37.39 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.243 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.6 144.3 97.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 121.583 1.522 . . . . 0.0 109.915 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 49.7 m -74.11 -32.44 63.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -71.53 -7.27 46.51 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.89 -29.44 66.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.952 0.882 . . . . 0.0 108.754 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 66.61 70.95 0.47 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.662 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.73 118.56 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.223 2.615 . . . . 0.0 108.64 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.52 -111.42 0.74 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.559 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.18 -35.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.558 0.694 . . . . 0.0 109.172 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -117.78 148.64 41.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.561 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 HG22 HD22 ' A' ' 75' ' ' LEU . 86.8 t -131.3 123.81 53.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.744 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.0 mt -74.41 88.32 2.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.198 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.24 98.98 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.5 23.04 12.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 -7.6 56.93 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.597 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -93.76 130.37 39.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.122 0.487 . . . . 0.0 111.665 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -74.35 88.62 2.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.925 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.94 136.07 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -100.67 154.75 18.34 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 117.956 -1.498 . . . . 0.0 113.889 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 59' ' ' LYS . 78.2 t -71.49 133.53 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.522 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' HD3' ' C ' ' A' ' 57' ' ' LYS . 11.0 tmtt? -100.95 -56.24 2.37 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -128.02 115.88 19.17 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.649 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.56 ' HB2' HG12 ' A' ' 56' ' ' VAL . 54.0 tttp -106.88 92.16 3.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -113.22 123.76 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.455 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -86.12 103.19 14.54 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 56.2 tp -69.19 114.75 7.74 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 123.376 1.56 . . . . 0.0 112.302 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.62 153.42 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' A' ' 66' ' ' GLU . 12.3 t70 -74.33 139.92 75.69 Favored Pre-proline 0 C--N 1.306 -1.291 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 67' ' ' ASN . 31.2 Cg_exo -44.72 -17.62 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.576 1.517 . . . . 0.0 112.086 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 64' ' ' ASP . 12.9 tp10 -68.42 -1.39 6.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.566 0.698 . . . . 0.0 109.161 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 65' ' ' PRO . 10.7 t30 72.21 30.21 2.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.052 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.3 mt -123.39 143.41 36.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.789 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.84 145.26 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.758 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 59.2 mt -126.26 -30.72 2.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.183 0.516 . . . . 0.0 109.833 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.758 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.4 mm-40 87.13 4.35 0.36 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.975 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 66.6 mt -87.92 98.12 11.32 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.014 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 m -76.46 103.45 6.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.033 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 62' ' ' LEU . 99.2 t -77.57 88.05 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.48 HD22 HG22 ' A' ' 47' ' ' VAL . 15.2 tp -93.76 115.01 27.41 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.109 -175.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -98.32 109.86 22.55 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.632 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.44 151.41 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.92 86.93 6.87 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.353 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 33' ' ' ARG . 29.2 mmm180 -103.81 146.96 27.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.009 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.96 -51.63 3.99 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -76.22 114.02 14.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.58 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 32' ' ' ASP . 11.7 ptpt -84.57 -179.48 7.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.729 0.776 . . . . 0.0 111.938 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.47 163.57 12.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.214 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -67.27 117.04 8.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -66.26 91.55 0.17 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.4 pt -90.18 20.0 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -62.85 -21.48 65.99 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.43 -18.4 71.28 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.542 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 96.7 m-85 -87.88 -1.98 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.103 0.478 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.4 mt -84.78 125.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.6 m -85.08 129.05 34.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.683 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -55.95 13.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.68 132.99 42.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.9 mt -55.62 -70.18 0.12 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 50.61 71.27 0.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.021 0.439 . . . . 0.0 110.046 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.08 88.27 0.07 OUTLIER Glycine 0 C--N 1.333 0.408 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.447 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 -0.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.355 0.597 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 12.5 t70 -128.91 114.69 16.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.687 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.03 165.12 20.92 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.961 0.886 . . . . 0.0 111.363 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.9 m -119.12 140.53 49.98 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.261 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.7 tp -109.83 124.81 51.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.479 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.43 111.36 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.478 HG13 ' H ' ' A' ' 105' ' ' SER . 10.5 t -103.52 137.85 30.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.34 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.445 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 86.5 t60 -136.41 42.05 2.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.478 ' H ' HG13 ' A' ' 103' ' ' VAL . 54.6 m -107.29 -176.59 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.209 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -44.41 -57.91 3.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -79.83 -47.94 14.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.047 0.839 . . . . 0.0 112.26 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -108.99 96.08 6.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.651 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 3.1 m -98.08 103.58 15.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.808 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 109' ' ' THR . 16.9 t30 73.36 72.2 0.13 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.978 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -140.09 125.09 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.193 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.1 tt -113.07 126.19 70.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 tt -143.0 127.87 18.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -81.01 108.02 14.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.23 -33.21 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.958 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.72 -118.96 5.84 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.513 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 26.6 Cg_endo -58.02 107.29 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 116.03 -175.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.8 t -96.47 118.93 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.59 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 24.5 m -137.66 141.23 41.16 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.501 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -81.92 130.19 35.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.313 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.31 -18.38 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.52 -130.18 9.53 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.403 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 123' ' ' LEU . 2.9 tm? -93.5 112.38 24.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 47.9 pt -135.83 -174.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 1.0 OUTLIER -108.33 106.44 16.58 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.857 -179.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.625 HD12 ' O ' ' B' ' 4' ' ' ALA . 56.3 tp -82.57 111.21 18.35 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.431 ' HG ' ' C ' ' A' ' 126' ' ' LEU . 92.1 p 56.42 37.31 28.72 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.076 0.465 . . . . 0.0 110.991 -177.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.4 m 77.73 11.14 2.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.892 0.877 . . . . 0.0 112.992 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -118.2 118.19 34.4 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.622 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.05 116.62 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.245 1.964 . . . . 0.0 113.825 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 p -125.09 145.4 49.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.839 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -112.9 163.26 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.909 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.605 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 80.2 mtt180 58.94 41.86 20.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.642 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -77.63 127.87 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.54 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.517 ' HB ' ' OG ' ' A' ' 170' ' ' SER . 39.4 mm -87.38 120.84 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 24.8 ttt180 -104.88 124.65 49.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.613 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.549 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.6 OUTLIER -117.19 115.86 26.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.879 -1.896 . . . . 0.0 105.879 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -71.55 90.42 1.01 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.016 0.912 . . . . 0.0 112.059 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -166.96 132.12 2.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.328 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.41 0.54 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.518 0.675 . . . . 0.0 111.582 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 131.79 54.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.491 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 7.2 mtpm? -122.29 179.3 4.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.7 150.75 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.773 177.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.08 -20.22 41.39 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.039 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.28 5.87 40.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.537 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 14.5 p -78.53 140.98 38.49 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.182 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 116.96 -19.29 12.11 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.16 150.44 29.13 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.098 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.96 124.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.44 0.638 . . . . 0.0 111.967 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.36 108.96 20.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -144.99 -178.72 6.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.927 0.87 . . . . 0.0 112.453 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.2 179.74 7.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.397 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 t -65.17 117.23 7.46 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.559 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.7 76.91 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.618 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 8.7 ptpp? -159.32 138.91 11.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.776 0.788 . . . . 0.0 112.602 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 63.6 mt -113.41 135.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.635 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.03 -39.61 6.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.798 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.508 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 175.08 -171.1 44.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.5 pt -125.54 142.83 41.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.871 0.843 . . . . 0.0 111.111 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.537 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.0 t-160 -61.7 112.75 2.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.234 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.87 -25.17 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.265 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.36 -145.94 5.46 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.402 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 175.43 164.11 29.43 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.3 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 31.1 t30 -136.88 99.98 4.18 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.477 0.656 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 60.56 -110.03 2.71 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 115.014 0.765 . . . . 0.0 115.014 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -92.93 18.96 8.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.447 0.642 . . . . 0.0 111.337 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.426 HE21 ' HB2' ' A' ' 167' ' ' GLN . 14.2 mt-30 -135.1 128.56 32.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -91.05 145.28 17.7 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 136' ' ' ARG . 44.9 m-85 -127.18 126.98 43.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.672 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.517 ' OG ' ' HB ' ' A' ' 135' ' ' ILE . 19.8 p -124.92 169.61 11.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.178 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.88 140.21 41.33 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.6 pt20 -70.3 118.5 13.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.508 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.0 mp -97.78 75.9 2.44 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.449 ' HB3' ' HZ2' ' A' ' 174' ' ' LYS . 9.1 mtpm? -83.74 142.1 30.96 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -50.98 -22.97 2.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -54.63 -22.54 13.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -97.82 -16.22 19.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.2 -6.2 15.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.3 -18.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.5 -58.6 7.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.522 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -92.04 127.28 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.616 175.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.034 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.8 mm? -135.31 138.4 43.41 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.243 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.2 tt0 -106.96 90.1 3.2 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.625 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -96.42 126.51 41.67 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.117 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -87.03 158.68 19.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.717 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.568 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.0 m-85 -62.58 147.45 49.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.491 ' NE2' ' HA ' ' A' ' 142' ' ' LYS . 97.1 mt-30 . . . . . 0 N--CA 1.434 -1.258 0 C-N-CA 118.402 -1.319 . . . . 0.0 . 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' CA1 . . . . . 0.961 ' CX7' ' HZ1' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.47 0.126 0 N-CA-C 113.907 0.695 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 11.1 t30 -68.77 -48.27 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.374 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 m -70.23 -29.02 65.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.714 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.56 -50.0 74.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.52 -47.31 84.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.475 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.36 58.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.533 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.79 -23.68 64.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -76.94 -51.23 11.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.591 0.71 . . . . 0.0 109.853 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.4 tp -57.13 -44.51 83.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.254 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 69.6 tp -53.86 -49.91 67.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.203 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -78.02 -28.38 49.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -86.54 -52.57 5.49 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.86 1.98 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 40.2 mm -106.25 133.02 51.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.435 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 50' ' ' ASN . 46.2 ttm -150.55 144.04 25.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.799 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.0 m -69.23 113.59 6.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.59 108.77 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 14.0 m -93.91 122.5 36.47 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.8 0.81 . . . . 0.0 109.994 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 -163.9 1.45 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.44 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.37 -44.4 62.11 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HZ2' ' HZ ' ' A' ' 25' ' ' PHE . 55.1 tttm -85.36 1.2 49.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.877 0.762 . . . . 0.0 111.863 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.67 -149.76 17.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.31 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.26 129.66 35.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.055 -0.573 . . . . 0.0 111.584 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' HZ ' ' HZ2' ' A' ' 22' ' ' LYS . 68.7 m-85 -131.85 157.26 44.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.109 0.957 . . . . 0.0 111.96 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 80.5 m -72.66 107.53 5.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.332 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.24 107.24 3.16 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.399 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.37 99.06 11.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.37 123.01 7.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.681 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.93 -56.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 117.179 0.489 . . . . 0.0 110.03 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.95 153.31 5.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.605 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.06 -89.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.999 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.1 ptp180 -132.02 10.25 4.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -110.69 131.82 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.931 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 p -133.13 156.68 47.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.51 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.45 139.82 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.469 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.8 tt -143.54 141.58 19.27 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.367 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.16 153.06 13.43 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 C-N-CA 121.313 1.342 . . . . 0.0 112.243 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 39.5 m -77.61 -37.45 50.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -66.91 -13.08 61.35 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.63 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.72 -21.18 64.41 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.024 0.916 . . . . 0.0 109.224 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 45.1 mt-30 61.12 69.07 1.12 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.311 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 12.3 Cg_exo -75.25 131.23 13.78 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.806 2.337 . . . . 0.0 107.97 175.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.84 -134.37 7.6 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.417 -1.373 . . . . 0.0 114.602 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.39 -26.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.685 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 53' ' ' LYS . 13.0 p-10 -144.67 133.69 22.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.96 158.67 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.892 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 45.6 mt -101.8 98.71 8.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 16' ' ' MET . 41.0 t -91.81 103.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.549 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 65.8 t30 66.47 24.78 10.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.699 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.57 -20.1 52.01 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.35 115.57 18.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.362 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 87.7 tttt -74.74 109.49 8.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.759 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.17 139.89 46.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.435 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.28 153.77 22.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.963 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.591 HG21 ' HB2' ' A' ' 59' ' ' LYS . 14.6 p -73.81 141.59 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -99.9 -42.85 6.62 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 37.9 t70 -159.13 118.35 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.304 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 56' ' ' VAL . 28.5 ttpp -111.47 106.41 15.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 86.0 t80 -115.87 110.41 18.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.764 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.11 105.59 6.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 60.0 tp -75.69 114.74 14.63 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-O 122.243 1.02 . . . . 0.0 111.89 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.25 159.9 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.434 -1.712 . . . . 0.0 107.852 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -74.84 149.04 85.36 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.28 -23.84 7.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.75 2.3 . . . . 0.0 113.666 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 68' ' ' ILE . 7.6 mm-40 -86.37 25.04 1.26 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.604 0.716 . . . . 0.0 109.805 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.289 0.3 OUTLIER 39.99 61.98 1.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.495 1.118 . . . . 0.0 113.202 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' GLU . 25.2 mm -138.62 155.59 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.492 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -57.5 131.33 49.84 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.783 -0.573 . . . . 0.0 111.761 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.556 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.7 tp -103.89 -22.94 13.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 161' ' ' VAL . 22.7 tp10 80.61 7.89 1.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.403 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.85 109.62 22.01 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.397 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 99.8 m -85.27 107.44 17.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 84.0 t -72.79 101.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.02 100.32 11.46 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.05 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 21.5 m -96.77 121.84 39.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.665 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mm? -120.34 158.54 26.9 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.63 82.15 6.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -79.64 117.37 20.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.492 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.82 -53.81 13.9 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.5 89.86 7.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.27 143.44 52.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.127 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -82.88 148.68 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.058 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.63 144.35 51.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.75 83.24 1.17 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -87.45 12.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.756 -0.59 . . . . 0.0 109.577 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.08 -19.8 65.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.791 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.91 73.86 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.559 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -84.49 -21.12 30.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.704 -0.248 . . . . 0.0 110.474 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.12 121.69 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 13.7 m -113.06 148.48 35.1 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.67 -33.42 12.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.7 105.63 15.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.715 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 17.4 mt -68.33 -57.16 6.35 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 5.6 pt-20 55.75 13.48 1.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 0.0 111.247 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 98' ' ' ASP . . . -115.87 67.3 0.29 Allowed Glycine 0 C--N 1.334 0.459 0 CA-C-O 121.603 0.557 . . . . 0.0 112.838 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -60.87 -3.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.071 0.462 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 96' ' ' GLY . 24.7 t70 -117.94 111.89 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.58 160.43 34.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.849 0.833 . . . . 0.0 112.865 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.1 m -125.63 137.0 53.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.337 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 160' ' ' HIS . 57.2 tp -102.33 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.016 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 t -104.05 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.62 129.91 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.674 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -138.86 35.07 2.17 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -108.54 -170.05 1.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -44.15 -51.93 7.7 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.18 -29.41 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.812 0.733 . . . . 0.0 112.355 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -140.02 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.887 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 m -96.83 119.35 35.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.463 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 96.1 m-20 69.39 70.4 0.25 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.039 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 m -141.71 107.99 5.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.068 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.0 mt -86.32 108.3 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.053 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.1 mt -116.64 107.53 14.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.342 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -73.59 125.43 27.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.49 -25.18 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 89.5 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.504 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 5.8 Cg_exo -75.52 122.36 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.284 1.989 . . . . 0.0 112.974 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.21 132.87 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.307 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -134.95 -169.64 2.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.759 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.3 ptm -129.47 149.7 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.428 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.16 -4.68 21.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.134 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.44 -108.07 2.73 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.14 128.48 54.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.073 -0.563 . . . . 0.0 111.099 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.6 pt -150.63 -178.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 120.679 0.276 . . . . 0.0 110.346 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 30.4 m-80 -96.19 136.42 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 40.6 tp -120.72 105.68 10.99 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t 60.23 42.76 14.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m 66.69 8.92 6.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.883 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.5 m -112.03 112.63 52.63 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.63 124.08 15.27 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.233 1.288 . . . . 0.0 111.204 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.0 m -130.33 141.32 50.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.84 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -99.42 151.87 20.61 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 57.64 62.82 2.0 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.945 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.421 ' CE ' ' HA ' ' A' ' 134' ' ' MET . 8.0 mmt -93.63 134.45 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.715 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 57.4 mt -94.97 141.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.905 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 18.3 ttp180 -125.43 125.39 43.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.578 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.9 OUTLIER -127.6 130.83 49.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.349 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 87.36 3.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.621 0.724 . . . . 0.0 109.202 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.06 114.7 1.5 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.094 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.8 116.51 3.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 112.236 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.67 160.02 37.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.956 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 142' ' ' LYS . 53.2 mtpt -136.97 177.24 8.01 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.349 1.071 . . . . 0.0 112.101 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 1.5 p -45.03 155.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.126 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.37 13.26 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.67 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -90.9 -6.31 54.32 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.138 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.625 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 26.6 p -73.3 133.87 44.02 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.889 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.84 -21.18 18.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.0 149.07 38.79 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.095 -0.552 . . . . 0.0 112.976 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 26' ' ' THR . 25.6 t -87.47 121.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 112.46 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.1 tp -93.66 107.72 19.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.8 p -149.19 172.29 15.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.081 0.943 . . . . 0.0 113.325 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 167.61 24.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.273 -1.785 . . . . 0.0 107.437 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.9 t -65.1 101.21 0.5 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.944 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.61 -12.95 39.13 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -134.46 121.53 21.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.6 mt -101.48 117.09 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -88.48 -33.64 17.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.124 0.487 . . . . 0.0 111.806 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 173' ' ' LEU . . . 152.18 -150.73 22.63 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.538 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.1 pt -129.54 145.95 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.046 0.927 . . . . 0.0 112.024 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.424 ' HB2' HD11 ' A' ' 101' ' ' LEU . 6.6 t60 -60.99 123.75 18.53 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.603 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.519 HG21 ' HG2' ' A' ' 71' ' ' GLU . 9.8 p -111.84 -29.11 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.351 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -177.13 -147.51 6.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.229 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.54 160.32 29.62 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.77 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 15.3 t-20 -137.23 105.02 5.58 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.58 -115.26 5.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.263 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -104.79 -0.28 27.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.19 0.519 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.18 125.14 48.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.21 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.66 149.59 23.59 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 136' ' ' ARG . 49.3 m-85 -125.71 129.52 49.7 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.88 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.5 m -121.6 165.16 16.11 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.987 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.19 132.42 38.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.404 HE21 HD11 ' A' ' 94' ' ' LEU . 35.6 tt0 -82.36 106.27 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.868 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.491 HD13 ' CA ' ' A' ' 158' ' ' GLY . 11.0 mp -85.28 85.73 7.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.98 129.1 37.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.837 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -43.1 -38.55 2.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.477 0.656 . . . . 0.0 111.489 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -49.75 -41.74 44.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.689 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 121.253 0.549 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.9 tt0 -115.66 81.44 1.59 Allowed 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -80.97 149.14 29.46 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 35.8 tp -103.81 152.98 21.25 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.561 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.8 m-85 -61.2 145.03 52.57 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.625 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.8 mt-30 . . . . . 0 N--CA 1.443 -0.806 0 C-N-CA 118.836 -1.145 . . . . 0.0 . -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 CA--C 1.537 0.652 0 N-CA-C 114.117 0.776 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -52.4 -47.87 66.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.842 0.83 . . . . 0.0 110.934 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -56.28 -52.74 63.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.881 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.26 -30.23 63.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.81 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.28 -50.41 70.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -64.56 -40.74 96.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.374 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.5 tt -54.54 -46.31 73.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -79.82 -32.7 40.71 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.933 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.28 -43.43 98.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.026 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 4.6 pp -67.14 -26.89 66.89 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 65.5 mtp180 -73.69 -27.82 61.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.72 0.295 . . . . 0.0 111.101 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -97.55 -50.94 4.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -114.59 13.67 17.52 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 57.6 mt -122.29 117.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.034 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.1 mtp -128.99 146.89 50.85 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.788 0.804 . . . . 0.0 110.128 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.24 99.08 2.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.32 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.24 98.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.664 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 73.0 p -74.67 98.08 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.97 179.37 4.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.43 -176.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.551 ' H ' HG22 ' A' ' 20' ' ' THR . 4.8 m -62.48 -25.49 68.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.167 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -93.7 -39.17 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.99 -154.02 14.24 Favored Glycine 0 C--O 1.234 0.126 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -93.67 117.25 29.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -117.12 151.28 37.17 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.025 0.917 . . . . 0.0 112.978 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 149' ' ' VAL . 21.3 m -79.06 100.21 7.25 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.06 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.09 101.15 2.17 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -96.41 111.38 23.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 131.7 11.07 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' A' ' 178' ' ' PHE . 43.2 mm -98.84 -56.59 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 117.518 0.659 . . . . 0.0 111.097 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -145.45 129.55 17.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.908 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 m-20 55.12 -90.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.824 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.4 ptp180 -128.32 7.41 5.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.4 0.619 . . . . 0.0 111.397 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.7 t -87.65 111.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.938 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.2 m -119.3 159.14 24.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.68 144.52 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.576 0.703 . . . . 0.0 111.098 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -152.68 140.55 13.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.631 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.19 148.31 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.052 1.168 . . . . 0.0 111.234 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.725 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 77.7 m -68.86 -40.33 79.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.633 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -68.42 4.02 1.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.68 -25.53 53.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.885 0.85 . . . . 0.0 108.88 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 57.99 70.97 1.13 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.854 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.89 131.12 10.9 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.087 2.525 . . . . 0.0 111.318 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.18 -161.29 32.45 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.554 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.12 -21.39 50.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.767 0.784 . . . . 0.0 109.383 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.5 p-10 -133.03 133.79 43.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.93 163.67 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.796 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -103.01 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.301 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.64 92.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 68.38 19.72 8.82 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.285 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.4 32.9 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.841 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 112.98 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 2.2 pptp? -76.51 134.18 39.55 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.43 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.8 tp -144.35 137.55 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.084 -1.417 . . . . 0.0 108.488 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 39.0 mtt180 -93.69 138.54 31.8 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.614 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.51 138.26 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.87 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -83.39 -49.55 9.22 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.841 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.06 137.56 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.001 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -124.7 85.55 2.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -90.94 123.1 34.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.321 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.48 127.41 32.09 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.678 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 83.5 mt -90.13 116.77 28.39 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.372 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.19 159.55 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.621 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 27.6 t70 -76.64 144.86 74.12 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 15.9 Cg_endo -55.88 -5.16 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.395 2.063 . . . . 0.0 113.123 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.68 17.8 19.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.033 0.921 . . . . 0.0 109.939 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t30 74.5 0.02 3.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.814 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.34 155.01 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -67.4 146.62 53.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 0.0 111.742 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.4 tp -108.75 -22.8 12.06 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.725 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 24.4 tp10 78.96 11.8 1.44 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.397 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.9 mm? -102.25 151.25 22.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.218 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.8 m -124.47 120.38 31.85 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.308 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.4 100.82 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.1 93.42 9.14 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.583 0.706 . . . . 0.0 109.996 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -87.15 109.82 19.71 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.134 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 69.7 mt -106.77 151.73 24.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.648 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.92 102.45 6.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' NH2' ' HG2' ' A' ' 81' ' ' GLU . 22.5 mmm180 -119.29 108.13 14.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -83.28 -29.58 28.27 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -101.25 91.38 4.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 174.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 52.3 pttt -97.86 178.96 4.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.48 171.85 8.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.787 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.46 138.23 31.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.67 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.44 92.09 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.67 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.6 pt -88.13 21.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.057 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.44 -30.39 64.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.57 -20.28 77.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.074 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 77.5 m-85 -93.19 -8.84 41.28 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.8 mm -76.97 134.04 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -81.41 112.88 19.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -77.03 -27.03 54.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -143.44 131.75 22.07 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.991 -1.913 . . . . 0.0 106.219 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.2 mt -74.82 -80.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.26 71.38 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.466 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.23 80.41 0.14 Allowed Glycine 0 C--N 1.331 0.262 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 9.3 p -70.3 9.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 20.7 t70 -138.75 124.53 19.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.44 155.54 47.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.19 0.995 . . . . 0.0 112.958 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 m -107.76 143.13 36.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.154 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -115.73 111.94 21.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.76 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG21 ' HB1' ' A' ' 7' ' ' ALA . 27.6 t -95.23 99.54 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.42 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.03 122.69 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.431 0.634 . . . . 0.0 111.197 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.623 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 66.0 t60 -135.42 57.09 1.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -121.63 -163.91 1.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 112.996 -1.911 . . . . 0.0 112.379 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.05 -44.52 88.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.528 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -70.82 -60.84 2.02 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.679 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -113.11 108.63 17.57 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.856 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 15.7 m -96.48 97.62 9.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.446 0.641 . . . . 0.0 109.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.623 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 28.6 t-20 74.44 71.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.584 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 m -143.51 121.47 12.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.698 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.43 115.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.141 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.15 157.52 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.93 140.09 40.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.07 -23.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.807 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.34 -125.92 7.13 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.881 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.714 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.5 Cg_endo -67.61 113.91 3.12 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.596 2.197 . . . . 0.0 114.187 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 157.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -145.45 158.75 43.78 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.104 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.21 140.14 48.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.897 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.99 -28.35 12.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.647 0.261 . . . . 0.0 111.671 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.99 -121.46 7.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.282 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.05 113.94 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.627 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.2 pt -132.46 176.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 38.4 m-80 -94.66 102.97 14.9 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.399 0.619 . . . . 0.0 110.804 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 57.0 tp -83.75 104.93 14.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.2 m 63.34 31.03 15.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.288 0.566 . . . . 0.0 109.657 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.4 m 81.41 0.58 1.62 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.545 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.9 m -108.51 117.48 54.3 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.5 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.26 119.93 6.55 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.336 2.024 . . . . 0.0 112.88 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -132.27 134.12 44.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.881 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.6 t30 -104.53 161.19 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.993 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.621 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 1.9 mpt_? 69.12 43.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.3 mmt -90.95 116.35 28.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 70.6 mt -85.44 130.65 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -110.75 136.04 50.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -148.48 113.55 5.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 6.7 p-10 -74.59 97.99 3.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.566 1.174 . . . . 0.0 110.526 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -149.02 139.26 22.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 111.873 -2.421 . . . . 0.0 107.69 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.85 90.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -106.17 158.56 16.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -139.24 159.64 41.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.198 0.999 . . . . 0.0 111.747 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.48 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 2.8 m -44.3 158.92 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.852 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.81 -17.75 57.23 Favored Glycine 0 N--CA 1.462 0.401 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.912 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -94.22 8.57 41.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.708 -0.246 . . . . 0.0 111.575 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.78 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 16.8 m -63.2 122.0 15.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.208 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 118.61 -20.87 10.02 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.71 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.91 130.24 23.04 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.12 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 26' ' ' THR . 58.3 t -84.94 115.55 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.2 tp -88.76 108.51 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.7 p -147.6 176.95 9.67 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.992 0.901 . . . . 0.0 112.785 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.97 173.09 14.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.529 -1.668 . . . . 0.0 107.765 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.8 m -64.49 108.75 1.74 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.191 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.27 -7.19 59.96 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.922 -0.656 . . . . 0.0 114.291 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 18.3 ptpt -155.89 137.32 14.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.02 126.79 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -88.06 -34.34 17.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.208 0.527 . . . . 0.0 111.49 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 160.37 -159.08 30.51 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.288 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 161' ' ' VAL . 46.0 pt -129.97 149.75 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.669 0.747 . . . . 0.0 111.671 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -61.77 120.27 10.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.862 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 159' ' ' ILE . 94.8 t -114.55 -26.83 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.377 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.09 -149.24 7.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.169 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.32 148.43 7.5 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.491 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 9.0 t-20 -118.27 105.69 12.02 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.08 -102.95 0.98 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -121.75 19.03 11.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.302 0.572 . . . . 0.0 110.601 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 0.5 OUTLIER -111.94 109.03 18.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -71.07 146.95 42.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.1 m-85 -127.53 119.45 26.06 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.2 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.4 m -110.6 156.0 21.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.627 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.504 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.05 131.85 37.01 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -71.31 105.17 3.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.645 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.419 HD21 ' HG ' ' A' ' 72' ' ' LEU . 73.0 mt -87.98 91.26 8.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.522 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -79.68 127.0 31.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.599 0.714 . . . . 0.0 109.54 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -42.25 -34.83 0.84 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.853 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.52 -38.92 64.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -67.42 -13.44 62.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.409 ' CE1' HG13 ' A' ' 30' ' ' ILE . 83.9 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.164 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 41.0 tt0 -106.08 81.59 1.65 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -85.32 127.86 34.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.183 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 28.5 tp -89.78 151.12 21.97 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -58.27 139.77 54.51 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.78 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.6 mt-30 . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 120.183 -0.607 . . . . 0.0 . 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 CA--C 1.53 0.275 0 N-CA-C 112.655 0.214 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.419 HD21 ' C ' ' A' ' 3' ' ' ASN . 0.2 OUTLIER -62.57 -40.05 95.62 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.866 0.841 . . . . 0.0 109.177 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -43.83 87.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.41 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -64.43 -42.65 95.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.196 0.522 . . . . 0.0 109.708 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.14 -47.19 86.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 109.758 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.82 92.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.13 -48.59 80.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -70.69 -38.83 73.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.256 0.55 . . . . 0.0 110.113 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.41 -42.88 96.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.425 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 8.4 tt -60.33 -51.46 69.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.611 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -67.55 -28.76 68.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 4.7 mmpt? -99.86 -26.27 14.07 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.156 0.889 . . . . 0.0 113.088 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -123.58 -12.43 7.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.5 mt -107.07 120.88 59.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.726 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 22.4 mmt -127.45 145.69 50.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.065 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -76.52 105.69 7.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 43.2 mm -95.3 111.82 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.338 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 13.5 m -91.44 114.43 26.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.896 0.855 . . . . 0.0 110.468 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 41' ' ' ALA . 9.0 p -118.05 -162.95 0.91 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.186 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 13.0 m -69.76 -38.08 76.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HE3' ' HZ ' ' A' ' 25' ' ' PHE . 26.0 ttpp -83.0 -19.79 36.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.328 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.38 -156.93 27.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.412 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -109.39 117.82 35.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.922 0.867 . . . . 0.0 109.952 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HZ ' ' HE3' ' A' ' 22' ' ' LYS . 41.3 m-85 -109.91 171.75 7.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.629 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.681 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 73.1 m -86.89 108.94 19.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -94.01 126.88 8.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -101.31 104.63 15.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.087 0.47 . . . . 0.0 111.236 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 111.07 3.23 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.9 mm -75.4 -58.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 122.561 -0.376 . . . . 0.0 112.007 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -166.41 164.11 17.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.557 0.694 . . . . 0.0 112.79 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.99 -101.37 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.389 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.6 ptt180 -129.19 20.85 5.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.421 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.87 124.69 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.232 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 75' ' ' LEU . 6.3 p -124.27 141.12 52.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.202 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.87 121.52 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.371 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.09 133.56 24.39 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.646 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.83 139.04 78.12 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 N-CA-C 109.013 -1.187 . . . . 0.0 109.013 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.573 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.9 m -63.84 -35.38 80.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.753 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -69.3 -3.52 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -71.8 -28.66 63.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 72.2 mm-40 62.51 71.38 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.771 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -75.32 142.7 27.22 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.075 2.517 . . . . 0.0 111.496 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.03 -157.02 30.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.001 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.52 -21.94 28.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.595 0.712 . . . . 0.0 110.354 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.36 117.59 19.98 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.58 145.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 69.8 mt -85.23 103.47 14.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.659 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.27 90.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 12.4 t30 59.03 58.36 3.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.241 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.59 -32.64 1.87 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.659 -1.155 . . . . 0.0 114.391 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.413 ' OE1' HG12 ' A' ' 54' ' ' ILE . 25.0 tm0? -83.52 142.42 30.91 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.759 -0.26 . . . . 0.0 110.542 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.08 127.4 38.61 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.458 ' CG2' ' HB2' ' A' ' 77' ' ' LEU . 21.3 mm -137.39 133.45 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.358 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -91.5 142.46 27.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 110.838 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.44 136.18 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.333 -176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -88.64 -42.74 11.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -171.96 132.23 0.68 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.337 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.42 119.39 36.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.45 126.48 50.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.466 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 49.9 mtpt -79.57 128.29 33.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 26.6 mt -95.58 127.25 41.46 Favored 'General case' 0 C--O 1.254 1.327 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 69' ' ' ASN . 32.6 m -123.47 156.16 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 66' ' ' GLU . 24.4 t70 -72.73 142.19 83.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.407 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.0 -10.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.54 1.493 . . . . 0.0 112.096 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 tp10 -76.92 -3.2 37.49 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 108.704 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.9 m120 75.44 16.71 2.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.002 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.29 147.71 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HA ' HG12 ' A' ' 63' ' ' VAL . 64.0 t30 -59.9 135.93 57.85 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -99.79 -22.81 15.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 28.3 tp10 76.28 14.96 2.35 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.119 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 78.6 mt -98.81 114.11 26.52 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.438 0.461 . . . . 0.0 112.013 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.5 m -93.5 111.48 23.15 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 62' ' ' LEU . 61.5 t -78.04 100.05 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.4 tp -83.28 94.32 7.89 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.959 0.885 . . . . 0.0 110.958 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.8 m -85.37 105.96 16.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -108.37 152.9 24.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.31 -177.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -84.56 94.62 8.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.839 0.828 . . . . 0.0 109.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -144.35 128.07 17.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.384 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.03 -21.89 29.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.92 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -79.93 87.06 5.38 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -72.86 157.05 38.2 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.583 -175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -93.9 147.33 23.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.38 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -55.92 135.88 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 85' ' ' ASP . 3.3 p-10 -81.95 89.56 6.39 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.454 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 28' ' ' LEU . 32.8 pt -86.74 15.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.504 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -61.8 -23.66 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.91 -19.23 80.03 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.574 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 97.8 m-85 -86.34 -22.38 26.72 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 59.4 mt -71.98 136.8 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -125.12 142.47 51.47 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.543 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.1 pm0 -80.91 -15.34 56.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.42 153.56 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -100.07 -68.09 0.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.493 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 41.7 73.87 0.12 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.83 88.85 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.2 -13.61 16.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.968 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -106.85 125.68 51.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.92 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.63 149.66 39.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.878 0.847 . . . . 0.0 112.179 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -112.62 142.01 45.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 148' ' ' GLY . 1.2 tm? -115.63 109.67 18.09 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.59 114.65 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.295 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.8 133.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.749 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -140.0 31.94 1.98 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -109.77 -160.67 0.73 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.385 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -52.09 -61.74 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.99 -34.85 71.78 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -137.84 122.47 18.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.725 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 8.4 m -119.34 128.77 54.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.95 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' THR . 88.5 m-20 65.95 28.51 10.57 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.501 0.667 . . . . 0.0 110.095 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 m -99.87 103.36 14.95 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.906 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -90.55 100.08 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.37 117.98 30.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.35 120.78 18.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.52 -36.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.885 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.67 -128.56 8.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.859 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.67 113.43 3.49 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.023 1.815 . . . . 0.0 112.542 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.1 p -107.82 147.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.468 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 t -155.88 167.03 31.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.4 ttm -93.05 141.83 27.97 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.804 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.24 -33.75 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.517 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.52 -101.99 2.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.324 -0.853 . . . . 0.0 114.307 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp -125.24 122.24 36.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.729 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 48.3 pt -143.02 -176.53 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 10.0 m120 -106.55 85.76 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 23.4 tp -70.54 111.15 5.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.616 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.41 ' N ' ' O ' ' B' ' 4' ' ' ALA . 53.6 p 64.07 25.25 13.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.421 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 m 85.65 -3.68 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.222 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 37.1 m -99.89 125.97 38.43 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.797 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 129' ' ' THR . 32.4 Cg_exo -61.62 120.23 7.76 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.334 2.022 . . . . 0.0 113.879 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 p -123.97 137.74 54.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.862 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -110.39 160.5 16.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 16.0 mmm180 64.76 29.31 12.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.097 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.454 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -73.05 121.73 20.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.017 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.76 144.19 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.048 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 13.8 ptt180 -129.38 143.15 50.73 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.904 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -129.36 131.43 46.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.82 103.49 1.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.198 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -178.42 133.75 0.14 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.496 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -69.18 110.35 4.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.372 0.606 . . . . 0.0 110.1 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.423 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 21.2 p -111.25 148.6 32.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.029 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -133.24 151.46 51.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.067 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.3 161.46 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.129 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.53 -13.42 67.4 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.532 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -102.08 8.22 40.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.863 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.774 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 7.6 m -64.75 141.63 58.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.127 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.681 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.61 -6.7 74.39 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.058 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . -52.44 131.28 38.75 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.18 110.78 17.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.71 105.06 15.22 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.2 p -144.45 178.07 8.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.397 1.094 . . . . 0.0 113.639 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.43 176.1 9.62 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.605 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 m -71.21 100.52 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.573 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.24 12.16 60.31 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.831 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 40.3 ttmt -155.33 134.58 12.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.306 0.574 . . . . 0.0 111.124 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.11 131.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.766 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.79 -43.01 7.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 169.17 -152.65 20.46 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.938 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.9 pt -135.22 150.18 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 122.077 0.942 . . . . 0.0 113.147 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.33 118.7 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.907 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 126' ' ' LEU . 43.8 t -113.47 -21.73 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.049 0.452 . . . . 0.0 110.857 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.28 -147.75 8.13 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.927 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 169' ' ' PHE . . . 171.51 161.12 21.57 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 55.2 t30 -128.23 82.17 2.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.495 0.664 . . . . 0.0 109.248 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.28 -107.22 2.1 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.869 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 95.6 mtt180 -90.59 7.55 38.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -124.75 110.77 14.75 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -77.8 142.55 26.78 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 136' ' ' ARG . 49.2 m-85 -118.83 127.16 53.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.852 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -125.3 163.48 22.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.157 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.455 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -99.35 141.11 32.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.275 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 8.3 tt0 -77.39 106.91 9.44 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.986 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.517 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.1 mp -94.52 85.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.225 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.91 135.13 37.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 7.4 ttpm? -54.38 -35.95 63.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.719 0.771 . . . . 0.0 109.813 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -53.06 -34.56 57.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.633 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -71.92 -25.9 62.09 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.257 -0.277 . . . . 0.0 111.08 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.517 0.675 . . . . 0.0 110.357 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 6.6 mp . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 120.991 0.424 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -96.48 74.77 2.84 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.51 146.75 38.24 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.9 tp -106.05 148.69 27.48 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 19.1 m-85 -57.74 135.64 56.8 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.774 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 81.7 mt-30 . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 . 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo . . . . . 0 N--CA 1.464 -0.219 0 N-CA-C 113.488 0.534 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.04 -35.64 66.79 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -65.19 -44.97 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.154 0.978 . . . . 0.0 108.584 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.86 -47.03 83.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.634 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.75 -46.3 79.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.276 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.03 93.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.21 -44.8 94.29 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 122.165 -0.334 . . . . 0.0 110.796 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -65.38 -40.12 93.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 109.893 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.5 tp -64.54 -44.81 89.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.169 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 5.4 tt -55.14 -46.64 75.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.251 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.13 -45.46 66.8 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.56 -2.21 20.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 115.635 1.716 . . . . 0.0 115.635 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -135.55 -12.24 2.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.265 -0.974 . . . . 0.0 113.294 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 49.2 mm -106.83 101.82 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.81 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -120.22 135.89 54.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.542 0.687 . . . . 0.0 110.261 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.13 102.25 2.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.09 100.0 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.325 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 48' ' ' LEU . 8.9 t -94.94 130.2 41.67 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.105 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.5 t -146.4 -157.55 0.82 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 m -51.54 -50.74 59.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.71 -16.25 39.63 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.73 -157.69 28.41 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 119.608 -1.282 . . . . 0.0 114.727 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -112.48 114.36 27.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.394 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.37 159.78 25.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.58 0.705 . . . . 0.0 111.674 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.2 m -72.64 106.01 4.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.613 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.62 106.68 3.34 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -87.53 106.55 18.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.336 0.589 . . . . 0.0 111.957 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 117.72 8.01 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 47.9 mm -89.08 -64.21 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 117.099 0.45 . . . . 0.0 112.077 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 58.36 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.237 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.9 ptp180 -129.78 15.22 5.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 110.678 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.93 122.66 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.788 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -122.37 156.03 34.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.804 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -114.82 135.16 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.478 0.656 . . . . 0.0 109.847 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.539 ' O ' ' HB ' ' A' ' 73' ' ' THR . 12.3 tt -144.94 142.06 18.13 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.614 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.47 149.66 23.02 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 120.888 1.059 . . . . 0.0 110.579 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 33.0 m -73.27 -36.74 66.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -66.94 -1.26 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -22.14 59.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.541 0.686 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.31 71.96 1.09 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.56 127.06 18.05 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.932 2.421 . . . . 0.0 112.374 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.58 -169.15 29.32 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.451 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 56' ' ' VAL . 2.6 p-10 -78.15 -16.31 58.05 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -143.18 137.61 29.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.69 156.12 37.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 19' ' ' THR . 7.5 mp -97.41 103.08 14.98 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.301 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.7 p -84.66 102.42 10.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.542 0.686 . . . . 0.0 110.154 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.6 t30 66.66 19.17 10.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.644 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.12 -22.11 11.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.583 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -92.1 115.66 28.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.318 0.559 . . . . 0.0 111.89 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.58 128.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -139.27 137.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.878 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -65.18 139.61 58.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.474 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 45' ' ' ASP . 14.4 p -87.06 136.75 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 76' ' ' THR . 57.1 tptt -78.36 -47.04 18.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.82 0.819 . . . . 0.0 108.833 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.06 133.46 1.46 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -106.99 92.76 4.22 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -86.22 106.21 17.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.754 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.77 121.08 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.906 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mt -89.88 113.34 24.93 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.704 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -94.02 165.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 133' ' ' ARG . 15.7 t70 -71.58 137.42 83.29 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.632 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HG2' ' NH2' ' A' ' 133' ' ' ARG . 7.0 Cg_endo -52.36 -15.68 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.857 1.705 . . . . 0.0 112.771 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.48 16.48 8.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.894 0.854 . . . . 0.0 109.059 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.0 t30 72.21 10.43 5.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.92 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 69' ' ' ASN . 15.9 mt -92.66 176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.539 ' H ' HG22 ' A' ' 68' ' ' ILE . 51.4 t30 -81.75 143.4 31.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 118.514 0.597 . . . . 0.0 111.22 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 26.5 tp -118.54 -27.49 5.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.58 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 26.5 tp10 70.55 10.62 7.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.666 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 10.9 tp -96.11 103.11 14.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.866 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 78.0 m -90.92 115.42 27.94 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.565 0.698 . . . . 0.0 111.616 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.73 94.17 3.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.3 tp -81.47 104.51 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.797 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 8.7 m -98.59 115.09 27.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.572 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.0 mp -117.47 150.01 39.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.718 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.73 91.49 7.97 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.481 ' HA ' ' HE ' ' A' ' 79' ' ' ARG . 2.2 tpm_? -112.51 110.33 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.58 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -59.31 -54.0 51.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.783 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -74.73 92.59 2.48 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -70.74 147.3 49.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.221 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -88.06 146.96 25.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.991 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -58.41 120.62 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.103 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 7.4 p-10 -77.37 94.24 4.18 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 121.709 0.766 . . . . 0.0 112.408 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.2 17.13 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.95 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 88' ' ' GLY . 5.0 ppt_? -59.03 -23.95 62.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.16 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 87' ' ' ARG . . . -84.08 -13.63 73.99 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.642 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.53 -3.36 46.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 40.1 mt -82.55 127.31 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.449 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 6.5 m -83.69 110.89 18.66 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.19 -49.95 31.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' SER . 23.8 t70 -97.78 115.66 28.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 173.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.1 mt -60.75 -72.23 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.88 67.41 0.93 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.618 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -146.49 75.38 0.28 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.344 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 p -97.38 0.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 10.9 t70 -149.88 125.72 10.48 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.115 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -153.6 176.7 11.77 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.473 1.13 . . . . 0.0 114.041 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -115.4 138.78 50.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.783 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -115.55 110.66 19.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.09 124.78 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.096 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 108' ' ' PHE . 1.7 t -114.6 139.82 38.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 122.035 0.921 . . . . 0.0 113.063 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -149.35 71.79 1.13 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.045 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.4 p -125.55 -174.01 2.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.637 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -59.85 -44.68 93.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.866 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.85 -41.05 15.33 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 103' ' ' VAL . 93.3 m-85 -115.96 98.15 6.49 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.4 m -105.59 122.78 46.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.581 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 66.73 73.36 0.36 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.8 m -142.25 102.85 4.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.731 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.93 108.92 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.11 120.98 32.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -72.54 118.1 15.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 137' ' ' TYR . 13.8 p -92.14 -26.29 4.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.707 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.57 -125.84 7.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.593 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.6 Cg_exo -62.87 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.345 2.03 . . . . 0.0 113.453 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 96' ' ' GLY . 2.8 p -136.61 141.89 39.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.589 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 m -153.08 139.37 18.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 27.3 ptt? -74.01 140.2 45.28 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.822 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.07 -66.24 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.48 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.32 -122.35 1.78 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.885 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt -103.06 117.79 35.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.448 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 36.0 pt -138.52 -176.38 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.6 m120 -105.18 83.95 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.982 0.42 . . . . 0.0 111.198 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 59.3 tp -65.93 108.03 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.212 0.529 . . . . 0.0 110.048 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 128' ' ' SER . 3.5 m 61.24 33.48 19.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 127' ' ' SER . 22.7 t 76.97 8.97 2.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.472 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -112.12 113.45 51.83 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.819 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.67 113.37 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.847 1.698 . . . . 0.0 111.649 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 126' ' ' LEU . 29.5 m -124.69 139.65 53.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.103 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -113.4 159.66 19.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' A' ' 64' ' ' ASP . 8.2 mtm180 56.37 61.45 2.7 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.319 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.0 mtp -109.6 132.67 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.156 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 50.2 mt -86.1 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ttp180 -132.27 147.01 52.39 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.16 0.505 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 115' ' ' VAL . 23.2 p90 -143.16 134.97 26.71 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.35 94.52 7.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.248 1.023 . . . . 0.0 110.555 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -155.86 133.63 11.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.942 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.11 105.56 0.42 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.394 0.616 . . . . 0.0 111.22 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 p -119.17 141.97 48.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -129.29 164.39 23.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.095 0.95 . . . . 0.0 112.03 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 1.0 OUTLIER -43.1 150.25 0.18 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.405 174.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.51 9.36 Favored Glycine 0 N--CA 1.463 0.44 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -68.55 -7.81 35.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.814 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.803 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 22.5 m -58.75 137.86 57.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 99.39 -17.87 57.19 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.734 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.26 126.86 37.78 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.242 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.15 117.49 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.07 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.25 110.45 17.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.0 p -147.03 -177.25 5.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.056 0.931 . . . . 0.0 112.704 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.76 30.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 t -62.93 108.28 1.17 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.831 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.1 75.51 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.923 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -141.55 121.01 13.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 35.2 mm -102.87 130.1 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.56 -52.92 2.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -176.89 -174.09 43.03 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.792 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 pt -118.97 139.07 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.414 0.626 . . . . 0.0 110.586 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -69.52 122.27 18.69 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.28 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.76 -9.58 11.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.8 -161.78 29.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.167 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.36 158.46 26.9 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.061 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 3.7 t-20 -129.75 89.62 2.85 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.909 0.385 . . . . 0.0 110.336 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 -107.88 2.33 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.408 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -96.04 1.67 52.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.238 0.542 . . . . 0.0 110.173 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -107.95 109.3 20.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.314 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -80.26 137.67 18.72 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.02 125.48 46.39 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.571 -0.852 . . . . 0.0 113.069 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.4 m -120.92 151.82 39.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.106 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.44 130.91 39.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.536 ' HB3' HD11 ' A' ' 135' ' ' ILE . 20.0 pt20 -87.79 110.99 20.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 118.468 -1.293 . . . . 0.0 112.722 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -88.76 94.78 10.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.88 139.79 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.952 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -45.6 -35.41 4.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -55.05 -26.45 37.66 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.42 -15.74 54.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 173' ' ' LEU . 25.3 m-85 . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.1 mm? . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.5 tt0 -114.59 71.85 0.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.88 133.71 39.2 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.397 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 15.9 tp -95.73 152.17 18.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.56 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 27.8 m-85 -56.98 137.7 55.24 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.803 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.5 mt-30 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 . 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--O 1.231 0.157 0 N-CA-C 114.085 0.763 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.613 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.7 t-20 -68.53 -45.14 73.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.709 0.766 . . . . 0.0 110.528 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.4 m -57.54 -43.59 84.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.143 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.02 -24.29 52.13 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.8 -43.54 58.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.35 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.175 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 8' ' ' LEU . 2.8 tm? -59.53 -39.44 83.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.279 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -69.53 -47.34 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.794 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.42 -38.5 84.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.7 tp -55.57 -49.14 73.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -68.49 -28.12 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.266 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -86.78 -63.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.11 -3.6 12.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -173.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 54.6 mt -99.99 131.45 47.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.872 -1.131 . . . . 0.0 113.008 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -151.62 146.42 25.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.923 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 m -68.88 117.86 11.09 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.488 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mt -98.64 98.69 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.901 0.858 . . . . 0.0 110.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 58.5 m -70.9 99.22 1.72 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.018 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -175.53 3.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.45 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 m -70.54 -28.8 65.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.613 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -88.17 -45.81 9.79 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.083 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.27 -168.07 26.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.492 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 34.3 mt-10 -108.22 103.03 12.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.798 0.808 . . . . 0.0 109.228 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 41' ' ' ALA . 40.6 m-85 -97.75 165.39 11.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.853 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 97.7 m -83.24 108.17 16.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.97 136.49 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.93 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -124.61 135.72 53.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.582 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -77.64 142.69 27.12 Favored Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.83 -54.2 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.978 0.889 . . . . 0.0 110.066 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -167.83 138.77 2.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 82' ' ' LYS . 31.2 m-20 57.18 -88.74 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.508 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -125.49 5.78 7.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.405 0.622 . . . . 0.0 111.175 -178.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 74' ' ' VAL . 49.0 t -88.18 120.67 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.034 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 36.8 t -131.48 141.25 49.74 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.009 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.59 151.13 34.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.56 167.8 12.6 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 113.043 -1.889 . . . . 0.0 106.303 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.78 175.47 2.3 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 121.289 1.326 . . . . 0.0 112.147 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.51 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 99.5 m -80.56 -36.81 32.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.544 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -72.3 4.99 3.14 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -69.21 -28.49 66.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.791 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 60.58 72.83 0.68 Allowed Pre-proline 0 CA--C 1.514 -0.43 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.27 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.28 123.52 6.66 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.013 2.475 . . . . 0.0 112.843 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.36 -172.01 46.04 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.19 -17.12 38.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.888 0.844 . . . . 0.0 109.71 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 18.9 t70 -134.85 109.77 8.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.55 154.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 95.3 mt -99.42 99.6 10.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.494 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 49' ' ' VAL . 19.6 m -83.06 93.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.415 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 t30 66.19 17.96 10.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.708 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.12 -21.81 8.15 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.523 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.87 118.02 23.14 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.741 -0.27 . . . . 0.0 110.278 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.707 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -81.98 119.34 23.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.706 0.765 . . . . 0.0 110.508 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.49 130.7 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.026 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.2 mtp-105 -85.83 126.48 34.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.264 0.554 . . . . 0.0 110.069 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.01 143.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.281 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -77.99 -52.79 8.25 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.763 0.792 . . . . 0.0 109.237 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -141.73 126.71 18.3 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.406 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -109.29 104.44 13.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -104.29 120.11 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.875 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.88 125.1 28.12 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 29.8 mt -90.7 111.85 23.37 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 122.0 0.905 . . . . 0.0 111.545 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.1 m -113.85 159.11 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 67' ' ' ASN . 14.7 t70 -67.72 138.42 93.23 Favored Pre-proline 0 C--N 1.311 -1.101 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.47 -21.99 32.64 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.532 1.488 . . . . 0.0 112.815 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.71 -0.04 55.55 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' ASP . 63.9 m-80 71.76 72.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.134 -1.848 . . . . 0.0 115.454 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 69' ' ' ASN . 34.6 mm -137.41 151.96 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.516 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 131' ' ' THR . 22.8 t30 -62.87 111.83 2.3 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.883 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.623 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 15.0 tp -87.36 -27.11 23.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HG2' HG11 ' A' ' 161' ' ' VAL . 13.7 tp10 71.62 31.14 2.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.898 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 94.1 mt -123.42 151.55 42.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 25.3 m -132.64 127.07 34.11 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.373 0.606 . . . . 0.0 110.516 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.416 HG23 ' HG ' ' A' ' 62' ' ' LEU . 85.7 t -87.63 107.38 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.974 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.31 92.24 8.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -74.36 90.51 2.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.043 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.25 91.48 5.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 33' ' ' ARG . 18.7 p-10 -78.82 61.57 3.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.376 0.608 . . . . 0.0 109.866 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -82.55 160.32 22.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.34 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -61.31 -51.66 67.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -78.64 110.72 14.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 61.2 mttp -77.08 152.2 35.13 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.782 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -80.33 141.4 35.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.109 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.12 138.14 58.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.682 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 87' ' ' ARG . 11.4 p-10 -73.96 88.12 1.85 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.128 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.8 pt -88.0 12.11 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 85' ' ' ASP . 45.2 ttt180 -53.7 -38.4 64.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.838 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.74 76.75 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.709 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -87.49 -12.7 45.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.62 129.98 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.608 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 13.5 m -120.5 122.39 40.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.649 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.5 mp0 -64.66 -48.41 74.87 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 91' ' ' SER . 30.0 t70 -95.48 120.06 35.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -76.5 -54.83 6.17 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 41.05 66.15 0.7 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.306 0.574 . . . . 0.0 109.928 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.14 80.93 0.1 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.863 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -70.53 -7.59 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.82 121.49 45.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.81 40.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.599 0.714 . . . . 0.0 112.176 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 96.0 m -116.03 135.22 54.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.256 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -92.06 116.85 29.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.392 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.06 103.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 22.1 t -100.38 124.11 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.446 0.641 . . . . 0.0 110.98 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -137.37 50.3 1.98 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.8 m -107.93 -172.54 2.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.333 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 13.4 p30 -62.05 -35.37 78.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -55.61 -50.5 69.97 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.824 -0.547 . . . . 0.0 112.215 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -158.79 132.97 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.317 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 23.2 m -84.39 114.55 21.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.603 0.716 . . . . 0.0 110.969 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 109' ' ' THR . 5.6 m-20 77.24 72.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 2.0 m -116.73 109.29 16.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.5 pt -107.99 99.56 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.051 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.8 mt -97.29 117.64 31.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.892 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.03 98.93 9.54 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.92 -16.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.098 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.34 -128.99 9.04 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.535 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 22.9 Cg_endo -65.11 119.11 6.07 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.193 1.929 . . . . 0.0 114.816 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 137' ' ' TYR . 34.3 m -111.87 148.63 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.512 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 m -150.39 144.4 25.43 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.0 ptp -82.01 142.96 31.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.193 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.53 -42.46 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.093 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.27 -128.92 8.45 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.067 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 48.1 tp -99.26 110.52 23.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.84 0.352 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.62 175.33 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.996 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.8 m-20 -87.54 126.13 34.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 46.5 tp -111.58 107.51 16.69 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.429 ' HB3' HD12 ' B' ' 5' ' ' LEU . 95.6 p 57.86 32.07 21.42 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.006 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.0 m 76.73 29.75 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.929 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -140.36 120.85 9.03 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.14 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.38 117.94 4.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.502 2.135 . . . . 0.0 114.123 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 69' ' ' ASN . 82.9 m -127.31 131.68 50.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.549 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 29.8 p-10 -102.67 169.38 8.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.61 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER 57.7 42.13 24.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.846 175.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.8 mmt -86.32 136.75 33.02 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.38 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 48.8 mm -101.07 137.63 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -127.84 148.32 50.46 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.502 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB3' HG12 ' A' ' 118' ' ' VAL . 25.0 p90 -143.03 151.74 41.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.263 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.89 113.51 22.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.832 0.825 . . . . 0.0 111.43 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -176.12 133.19 0.25 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.327 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -68.32 100.82 1.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.818 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.1 p -93.39 171.4 8.94 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.749 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -161.44 145.63 13.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.56 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.597 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.24 158.72 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.706 175.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.77 -24.33 15.64 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.003 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -85.76 4.49 36.6 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.769 0.428 . . . . 0.0 112.009 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.814 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 13.4 m -62.18 140.96 58.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 107.02 -20.69 32.99 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.77 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.76 130.45 26.92 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.532 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.36 124.18 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 110.73 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.7 tp -101.56 106.7 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.4 p -149.74 176.4 10.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.972 0.891 . . . . 0.0 112.922 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -137.28 172.73 12.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.591 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.3 t -61.31 108.76 0.97 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.066 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.56 -4.2 86.37 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -141.47 116.78 10.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.729 0.764 . . . . 0.0 111.836 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -93.99 126.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.73 -44.13 6.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.79 -165.01 34.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.7 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -129.63 144.5 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.437 0.637 . . . . 0.0 110.797 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -66.82 115.37 6.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.438 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.472 HG11 ' HG2' ' A' ' 71' ' ' GLU . 54.0 t -107.16 -27.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.169 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.19 -147.86 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.082 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.32 164.69 29.69 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.221 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 8.8 t30 -128.23 88.37 2.74 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.67 -109.62 2.78 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.636 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 166' ' ' ARG . 18.1 ttt180 -88.54 3.84 48.91 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 113.37 19.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.295 0.569 . . . . 0.0 109.977 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -78.41 143.21 26.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 44.6 m-85 -121.86 124.42 44.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.352 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -123.11 142.38 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.008 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.37 125.45 31.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.689 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.553 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 50.2 tt0 -72.03 119.86 16.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.123 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.519 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.6 mp -88.19 92.83 9.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.83 132.56 33.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.649 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 ttpm? -58.48 -17.32 20.12 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.24 -29.99 67.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -81.11 -28.15 35.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.66 0.267 . . . . 0.0 111.569 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.468 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.561 0.696 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 34.5 tt0 -126.24 77.47 1.69 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.83 152.51 26.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.6 tp -107.69 154.87 20.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -63.69 141.28 58.83 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.814 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.6 mt-30 . . . . . 0 C--N 1.295 -1.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 . 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 N--CA 1.464 -0.264 0 N-CA-C 113.134 0.398 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.36 -42.65 78.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.293 -0.163 . . . . 0.0 110.897 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -72.2 -27.59 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.44 -45.5 75.86 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.87 -45.71 89.5 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.315 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.38 83.57 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.8 tp -68.1 -38.92 82.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -67.66 -38.08 83.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.002 0.429 . . . . 0.0 110.028 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.415 HD11 HD13 ' A' ' 86' ' ' ILE . 60.8 tp -65.46 -40.45 93.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.528 0.68 . . . . 0.0 109.567 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 11' ' ' LEU . 3.1 tm? -50.59 -48.69 57.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.218 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -70.01 -29.61 66.72 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.39 -58.85 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.2 7.24 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 48.2 mm -105.15 106.7 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.969 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.3 mtp -121.6 147.73 45.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -76.29 111.23 11.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.088 -178.209 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.7 mm -92.84 106.15 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.601 0.715 . . . . 0.0 110.463 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 6.7 m -75.96 98.35 4.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.628 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -103.47 -178.08 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.521 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 16.4 m -59.47 -32.24 70.06 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -88.97 -1.63 58.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.03 0.832 . . . . 0.0 111.253 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.24 -163.7 23.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.844 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 105' ' ' SER . 25.3 mt-10 -96.85 128.37 43.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.407 0.622 . . . . 0.0 110.902 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -123.22 166.94 14.4 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.804 0.812 . . . . 0.0 111.325 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 2.7 m -68.64 100.43 1.13 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.875 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -81.2 109.54 3.01 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.637 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.46 94.47 9.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.902 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.44 122.41 8.62 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.5 -50.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 117.678 0.739 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -161.25 153.64 20.24 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.963 0.887 . . . . 0.0 113.117 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.628 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 42.8 m-20 51.65 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.615 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.1 ptt180 -140.15 16.36 2.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.702 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.9 115.42 39.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.154 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -120.18 148.7 43.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.21 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.69 130.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.498 0.666 . . . . 0.0 112.141 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.39 165.42 28.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.85 163.62 36.68 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 121.647 1.565 . . . . 0.0 112.61 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.737 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 44.8 m -81.11 -38.95 26.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.161 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -71.31 2.27 5.02 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -12.9 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.663 0.744 . . . . 0.0 109.156 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 68.8 mt-30 62.44 73.23 0.55 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.341 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.88 159.54 47.97 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 122.537 2.158 . . . . 0.0 111.873 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.14 178.96 17.0 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.047 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.532 ' HA ' HG12 ' A' ' 56' ' ' VAL . 24.0 m-20 -81.89 -19.7 40.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.889 0.844 . . . . 0.0 109.467 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -137.37 113.17 9.62 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.86 173.07 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.829 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 6.2 mp -112.3 138.16 49.4 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.765 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.33 83.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.492 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 2.4 t-20 62.23 27.0 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.12 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.39 -44.79 1.16 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.159 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -75.16 115.77 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -76.4 122.02 23.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -125.43 149.01 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.227 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 7.8 mpt_? -96.61 145.51 25.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.221 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 45' ' ' ASP . 8.5 p -86.99 138.88 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.998 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.18 -42.23 17.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -158.81 132.12 7.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -117.44 116.38 27.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.55 120.54 39.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.256 0.55 . . . . 0.0 111.095 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.12 121.71 27.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.791 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 76.9 mt -85.91 123.51 31.34 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.331 0.586 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 20.5 m -122.01 171.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.185 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 16.8 t70 -78.73 143.08 62.09 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -48.54 -26.13 8.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.829 2.353 . . . . 0.0 113.618 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.34 22.74 4.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 111.09 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 73.11 11.6 5.09 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.107 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 25.4 mm -88.16 163.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.427 ' N ' HG22 ' A' ' 68' ' ' ILE . 54.9 t30 -73.33 139.27 45.92 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.79 -36.68 6.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.737 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.8 tp10 84.07 22.0 0.14 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.34 -1.754 . . . . 0.0 114.498 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.562 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.8 mm? -111.4 146.04 37.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.21 0.529 . . . . 0.0 110.834 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 26.3 m -117.33 114.48 23.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.564 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.413 HG23 ' HG ' ' A' ' 62' ' ' LEU . 88.8 t -80.93 100.08 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.32 100.67 12.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.71 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.4 m -92.38 93.88 8.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.066 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 96.0 mt -85.62 159.16 19.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.371 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -78.76 92.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -128.61 123.21 32.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.084 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -80.8 -57.3 3.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.61 114.79 5.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 13.1 ptpt -76.1 145.78 39.8 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.68 145.98 42.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 4.9 tpm_? -56.93 122.81 13.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.031 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 90.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.106 0.479 . . . . 0.0 111.072 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.415 HD13 HD11 ' A' ' 10' ' ' LEU . 41.0 pt -96.27 32.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.033 0.444 . . . . 0.0 110.111 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.3 -30.72 71.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.237 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.59 -19.22 79.95 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.939 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -80.14 -16.39 55.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.613 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 52.7 m -94.69 122.41 37.27 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.063 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.594 ' O ' ' HE2' ' A' ' 174' ' ' LYS . 5.0 pt-20 -61.5 -29.65 70.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.031 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HA ' ' CE ' ' A' ' 174' ' ' LYS . 37.8 t70 -131.05 163.35 27.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 95' ' ' GLU . 43.6 mt -74.47 -81.1 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 94' ' ' LEU . 12.8 pt-20 33.32 74.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.253 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.474 ' HA3' ' CZ ' ' A' ' 157' ' ' PHE . . . -157.7 92.25 0.12 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.462 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 61.5 t -62.15 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.2 t70 -124.36 132.45 53.54 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.58 174.6 10.81 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.738 0.78 . . . . 0.0 112.752 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.9 m -131.06 146.26 52.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.593 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.5 tp -105.98 113.91 27.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.34 110.92 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 109.994 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -112.08 117.33 54.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.275 0.56 . . . . 0.0 111.365 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -130.9 83.09 2.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 71.1 p -129.57 -164.56 1.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.891 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.76 -13.95 57.1 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -90.52 -66.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.347 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 56.2 m-85 -108.48 120.97 43.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.704 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.4 p -100.0 110.66 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.891 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.56 32.38 16.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 39.9 m -81.91 102.11 10.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.697 0.761 . . . . 0.0 110.905 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 112' ' ' ILE . 9.5 tt -100.13 92.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -101.22 113.15 25.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.139 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.69 112.0 6.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.832 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.15 -33.94 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.05 -123.68 7.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.323 -0.942 . . . . 0.0 114.165 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 35.1 Cg_endo -64.58 124.52 13.38 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.533 2.156 . . . . 0.0 113.85 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -106.21 137.43 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.063 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 p -132.27 171.01 14.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 59.6 ttp -120.13 139.66 52.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.938 0.399 . . . . 0.0 112.05 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.42 -43.66 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.693 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.43 -111.75 4.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.094 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -103.54 116.68 32.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 0.0 110.72 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.433 HG21 HD23 ' B' ' 2' ' ' LEU . 46.8 pt -144.8 -176.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 m-20 -101.95 123.05 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.257 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.3 mm? -102.13 111.69 24.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' SER . 17.3 t 60.46 30.88 20.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.453 0.644 . . . . 0.0 109.933 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 45.4 m 83.37 2.34 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.377 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.4 m -112.01 116.47 49.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.063 0.227 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.49 123.35 11.14 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 122.413 2.075 . . . . 0.0 112.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 126' ' ' LEU . 70.6 m -131.94 138.42 48.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.903 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -101.93 169.59 8.68 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 13.5 mmt180 63.29 34.77 12.97 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.05 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 171' ' ' ALA . 31.7 mmt -82.17 128.43 34.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.734 0.778 . . . . 0.0 112.058 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 19.9 mm -95.21 144.07 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 33.0 ptt180 -131.6 139.46 49.17 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.506 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.1 130.97 24.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.361 0.6 . . . . 0.0 109.928 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.2 96.71 0.66 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.246 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -175.09 121.25 0.21 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.093 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.56 108.17 2.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.849 0.833 . . . . 0.0 112.286 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.67 148.48 43.87 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.151 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 35.0 mmtp -133.67 176.99 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.881 0.848 . . . . 0.0 112.81 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.9 OUTLIER -44.08 150.2 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.357 176.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.33 -22.69 31.19 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.352 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.84 3.7 47.35 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.776 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 1.8 m -58.93 134.88 57.33 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.954 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.65 8.35 59.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.523 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.91 135.93 20.97 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.239 -1.458 . . . . 0.0 109.571 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.4 t -86.32 117.45 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.666 0.733 . . . . 0.0 111.32 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.14 105.06 17.37 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.1 p -141.3 165.42 27.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.951 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.58 179.26 6.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -60.24 101.1 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.484 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.5 22.43 78.96 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.613 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 32.5 ttmt -147.92 108.72 4.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -94.36 123.1 46.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.474 ' CZ ' ' HA3' ' A' ' 96' ' ' GLY . 91.6 m-85 -91.57 -39.09 12.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.474 0.655 . . . . 0.0 110.755 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 157.4 -155.17 26.16 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.935 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.79 150.16 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.541 0.686 . . . . 0.0 110.903 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -69.15 122.22 18.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.016 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.07 -23.08 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.49 -156.54 12.0 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.855 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.64 157.9 25.61 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.481 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.1 t-20 -128.65 92.32 3.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.575 0.703 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.72 -104.99 1.49 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.741 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -95.85 2.27 53.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -127.25 129.55 47.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.308 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.1 146.52 22.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.483 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.9 m-85 -123.78 131.5 53.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.778 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.5 m -125.3 159.48 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.289 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -97.77 141.04 31.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.317 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 77.0 mt-30 -79.85 117.24 20.54 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.558 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 66.9 mt -96.74 71.75 2.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 92' ' ' GLU . 38.6 mtpt -79.75 135.3 36.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -56.38 -15.62 4.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.652 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.73 -16.91 64.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.15 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.36 -9.98 34.11 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.119 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 120.99 0.424 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.8 tt0 -110.99 78.94 1.15 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.64 137.75 34.39 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 39.2 tp -95.62 144.63 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.0 m-85 -59.87 137.86 57.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.776 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.9 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.226 -0.443 . . . . 0.0 . -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 CA--C 1.532 0.412 0 N-CA-C 115.255 1.213 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -66.35 -59.58 3.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 0.0 112.026 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 m -56.87 -42.22 79.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.89 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.41 -25.8 57.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.949 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -67.62 -46.44 72.51 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.69 99.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.26 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.2 tm? -61.62 -46.29 90.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -65.94 -44.96 83.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 86' ' ' ILE . 60.5 tp -62.83 -41.94 99.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.828 0.823 . . . . 0.0 110.811 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 31.0 tp -51.81 -51.48 56.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.01 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 15.1 mtp180 -63.02 -28.16 69.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -108.28 -49.26 3.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.43 -6.81 22.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 41.8 mt -102.18 108.44 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.415 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.1 mmt -119.17 148.32 43.22 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.953 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 m -76.83 117.17 18.17 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.147 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.78 95.79 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 28.1 m -84.07 108.57 17.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -129.73 -170.6 2.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.538 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -56.81 -49.1 76.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 tmtt? -71.02 -27.71 63.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.64 -156.99 28.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.677 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.02 117.1 32.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 43.6 m-85 -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.154 0.978 . . . . 0.0 112.295 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 75.4 m -88.68 95.77 10.39 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 113.399 -1.728 . . . . 0.0 107.93 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.23 116.94 4.36 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.184 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.88 101.02 13.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.357 0.599 . . . . 0.0 110.998 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -68.36 127.32 23.6 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 87' ' ' ARG . 36.2 mm -97.18 -47.4 12.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 118.07 0.935 . . . . 0.0 110.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 33' ' ' ARG . 40.3 p-80 -165.75 166.81 17.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 40.99 -84.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.759 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' HIS . 16.4 ptp180 -143.92 21.51 1.78 Allowed 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 122.273 -0.267 . . . . 0.0 111.388 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 HG13 ' A' ' 74' ' ' VAL . 7.2 p -119.03 134.18 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 60.4 m -119.59 159.21 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.639 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.88 131.84 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.551 0.691 . . . . 0.0 111.571 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.72 165.17 29.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.98 170.69 18.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.216 1.277 . . . . 0.0 111.438 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.424 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 35.5 m -82.18 -33.27 29.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.043 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -72.8 2.01 7.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.823 0.344 . . . . 0.0 110.731 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -72.1 -19.55 61.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 53.68 70.3 1.83 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.599 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.35 124.98 10.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.692 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 -164.25 14.0 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.375 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.34 -31.0 16.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 108.837 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.15 118.65 18.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.28 159.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.986 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 85.3 mt -90.46 107.65 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.644 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.95 100.84 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.012 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.92 32.76 12.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.615 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.72 -14.93 64.21 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.828 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -100.92 126.36 47.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.507 0.654 . . . . 0.0 111.479 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.64 112.35 5.35 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 35.8 mm -114.62 118.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.379 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.54 157.91 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.94 -45.04 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.781 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 20.0 t70 -142.56 94.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.834 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 17.6 ptpt -93.0 90.26 6.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -97.19 115.11 26.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.406 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.88 129.36 37.53 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.916 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 20.0 mt -88.51 101.28 13.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -108.2 144.21 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 171.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' C ' ' N ' ' A' ' 66' ' ' GLU . 15.2 t70 -80.18 150.59 71.54 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 64' ' ' ASP . 65.0 Cg_exo -45.23 -20.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.618 0.879 . . . . 0.0 110.258 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 6.4 tp10 -63.12 -14.69 51.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.686 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 20.6 t30 80.43 3.36 1.84 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.372 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.419 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 49.0 mm -97.07 155.16 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.584 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.77 126.35 29.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.0 tp -93.9 -15.58 24.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.2 tp10 70.24 14.25 7.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.728 -1.578 . . . . 0.0 113.152 175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 173' ' ' LEU . 8.5 mp -101.63 159.22 15.5 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -135.81 117.09 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG23 ' HG ' ' A' ' 62' ' ' LEU . 69.2 t -78.57 96.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.33 85.35 7.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.437 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 3.2 m -80.35 104.63 11.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.028 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 65.9 mt -95.55 159.75 14.84 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.786 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.65 86.35 7.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 33' ' ' ARG . 27.1 tpt180 -117.72 126.27 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.565 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -84.36 -48.76 9.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.26 116.04 15.56 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -82.32 150.17 27.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 122.018 0.913 . . . . 0.0 112.644 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.797 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -82.76 129.74 35.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.8 p-10 -75.61 97.8 3.86 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.429 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.414 HD13 HD11 ' A' ' 10' ' ' LEU . 33.5 pt -96.25 29.38 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.777 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 57.3 mtm180 -66.7 -27.0 67.29 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.032 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.7 -1.86 22.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.63 141.57 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 19.1 m -93.7 119.9 33.28 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.87 -47.14 60.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 91' ' ' SER . 19.2 t0 -114.28 144.1 43.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 173.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.0 mt -66.98 -71.19 0.21 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 59.23 70.88 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.715 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -143.31 92.41 0.17 Allowed Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 114.153 -1.385 . . . . 0.0 113.616 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.8 p -101.42 -8.35 9.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 6.1 t70 -144.46 135.67 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.756 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.61 155.13 38.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.528 0.68 . . . . 0.0 111.868 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 23.8 m -120.62 139.81 52.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 160' ' ' HIS . 1.0 OUTLIER -108.48 120.86 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.231 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.2 p -114.87 121.81 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.154 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.17 135.62 45.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.824 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -137.9 85.0 2.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 106' ' ' ASN . 37.2 t -135.89 -159.08 0.92 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.223 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.423 ' N ' ' OG ' ' A' ' 105' ' ' SER . 9.4 t30 -46.41 -64.45 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -101.01 -45.01 5.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 0.0 111.68 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.71 106.94 14.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.687 0.756 . . . . 0.0 112.929 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 p -116.43 138.74 51.12 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.868 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 51.8 28.13 4.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.821 0.448 . . . . 0.0 111.83 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 20.6 m -74.81 90.04 2.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.489 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.79 97.47 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 120.22 32.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.571 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.9 pt-20 -80.11 144.85 32.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.012 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.0 m -101.65 -20.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.59 -123.03 5.89 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.562 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 20.7 Cg_endo -61.8 114.25 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.294 1.996 . . . . 0.0 112.882 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -118.52 151.39 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.776 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.2 p -146.83 -177.54 5.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 21.2 ptt? -120.4 163.63 17.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.781 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.07 -2.55 8.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 -121.7 6.05 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.481 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.18 120.86 39.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.178 0.514 . . . . 0.0 109.69 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 26.4 pt -138.16 -171.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.922 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -102.22 135.18 44.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.269 0.557 . . . . 0.0 109.923 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 45.6 tp -119.23 103.79 9.82 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' SER . 2.8 m 63.75 32.56 13.54 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 110.32 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.8 m 82.76 1.6 1.18 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 126' ' ' LEU . 12.8 t -114.35 124.76 30.19 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.07 125.41 18.49 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.338 2.025 . . . . 0.0 113.215 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.03 138.78 54.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 2.9 p30 -111.76 152.13 28.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.656 0.741 . . . . 0.0 112.652 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 66.37 53.28 1.01 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.015 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.9 mmm -93.06 134.91 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.712 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 170' ' ' SER . 14.2 tt -108.85 142.5 21.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 167' ' ' GLN . 19.4 ptt85 -127.23 139.75 52.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.546 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.3 OUTLIER -122.72 135.15 54.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.431 0.634 . . . . 0.0 110.941 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.5 87.78 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.41 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -171.89 127.27 0.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.374 -1.739 . . . . 0.0 107.268 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.35 100.19 1.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.704 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 137.79 52.57 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 96.2 mttt -127.96 176.63 7.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.567 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.37 152.99 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 111.107 -2.77 . . . . 0.0 111.664 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.07 -15.13 57.06 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.455 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -115.02 9.84 16.09 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.663 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 21.1 p -78.41 135.88 37.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 117.959 -1.496 . . . . 0.0 110.026 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.605 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 126.63 -16.88 6.53 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.84 153.88 44.06 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.14 129.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.338 0.589 . . . . 0.0 112.366 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.88 111.42 23.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.2 p -147.62 179.01 8.0 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 112.744 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.34 -178.5 6.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.041 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.9 t -60.92 101.76 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.63 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.93 31.07 77.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.889 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -153.35 111.2 3.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.708 0.289 . . . . 0.0 111.007 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.5 mt -96.78 129.38 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.54 -49.16 5.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.156 0.503 . . . . 0.0 112.017 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.731 ' HA2' HD23 ' A' ' 173' ' ' LEU . . . 175.92 -166.55 37.82 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.191 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.83 142.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.739 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.8 t60 -63.23 113.76 3.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.606 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.38 -27.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.05 -147.74 6.18 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.882 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 179.37 164.72 32.37 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.494 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.3 t-20 -137.56 96.68 3.29 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.206 0.527 . . . . 0.0 109.861 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.85 -119.26 5.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.997 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -97.29 19.66 12.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.202 0.525 . . . . 0.0 110.815 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 8.8 tt0 -134.36 115.86 14.54 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.875 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.59 148.94 34.41 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.245 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 46.7 m-85 -124.67 121.53 34.93 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.848 0.832 . . . . 0.0 111.129 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.57 ' HB3' HG23 ' A' ' 135' ' ' ILE . 15.2 t -117.5 156.44 28.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.145 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.78 134.19 39.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.538 ' OE1' ' HE2' ' A' ' 174' ' ' LYS . 76.1 mt-30 -71.03 122.49 20.13 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.731 HD23 ' HA2' ' A' ' 158' ' ' GLY . 2.5 mm? -85.52 93.9 8.89 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.538 ' HE2' ' OE1' ' A' ' 172' ' ' GLN . 51.2 mttm -93.21 128.03 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.668 0.747 . . . . 0.0 111.462 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -50.21 -31.12 13.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.388 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -37.3 -56.64 0.95 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.33 -9.71 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.88 179.625 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.5 mm? . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.366 0.603 . . . . 0.0 111.663 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -113.35 81.06 1.44 Allowed 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -83.18 153.73 24.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 36.0 tp -109.35 151.92 25.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.1 m-85 -60.3 133.98 56.62 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.663 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.7 mt-30 . . . . . 0 N--CA 1.439 -0.996 0 C-N-CA 119.219 -0.993 . . . . 0.0 . -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 CA--C 1.533 0.444 0 N-CA-C 113.745 0.633 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -60.18 -50.53 73.31 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.948 0.88 . . . . 0.0 110.98 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -43.24 99.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.901 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -60.45 -55.58 31.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.175 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.7 -45.55 86.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.51 82.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -67.82 -40.08 83.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.699 0.285 . . . . 0.0 110.925 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -66.77 -42.37 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.64 -37.5 82.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.309 0.576 . . . . 0.0 109.916 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.622 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 3.4 tm? -51.41 -56.81 11.18 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.572 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.38 -27.84 66.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.367 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.53 -69.97 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.54 3.7 14.07 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 43.1 mm -97.86 96.39 5.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.5 mtm -126.91 144.12 51.08 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.715 0.769 . . . . 0.0 110.974 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 7.3 m -74.27 116.84 15.38 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 37' ' ' ILE . 22.0 mt -111.2 108.28 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.34 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 25.0 m -76.12 114.02 14.3 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.93 0.872 . . . . 0.0 109.86 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 p -95.8 -161.16 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.419 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -71.98 -31.71 66.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -76.09 -47.04 26.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.191 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.97 -153.6 24.58 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.621 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 47.7 mt-10 -75.35 116.46 16.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.952 -0.624 . . . . 0.0 112.381 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -124.4 151.93 43.86 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.706 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 47.2 m -75.7 108.36 8.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.76 116.98 5.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.464 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 103.64 16.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.081 0.467 . . . . 0.0 110.746 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.11 132.55 12.93 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.83 -59.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 118.262 1.031 . . . . 0.0 111.3 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -170.36 163.23 8.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.714 0.768 . . . . 0.0 112.75 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m-20 44.7 -90.02 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -127.36 6.91 6.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.099 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 p -133.18 149.75 52.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.326 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 72' ' ' LEU . 33.5 m -110.5 135.69 48.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.827 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 18' ' ' ILE . 27.6 mm -135.01 139.4 31.92 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.232 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.75 141.58 97.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.336 1.357 . . . . 0.0 111.1 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.736 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 99.4 m -60.84 -43.42 98.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.374 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.35 -11.03 28.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.78 -15.07 60.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.857 0.837 . . . . 0.0 109.235 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 60.25 70.72 0.97 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.94 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.2 115.75 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 N-CA-C 107.702 -1.691 . . . . 0.0 107.702 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.75 -124.38 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.23 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' VAL . 21.0 t70 -95.31 -32.07 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.939 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -144.5 144.42 31.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.724 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 m -128.1 155.25 39.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.828 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 16.1 tp -97.75 100.66 12.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.3 t -89.95 107.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.087 0.946 . . . . 0.0 111.308 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 p30 56.7 12.57 1.16 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.485 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.13 -6.65 13.05 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.507 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -103.64 117.35 34.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.02 114.1 6.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.068 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 tp -120.64 131.63 72.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -88.02 147.77 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 111.295 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 45' ' ' ASP . 8.0 p -73.09 136.5 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -87.03 -50.11 6.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -169.17 151.96 4.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.147 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -128.38 132.36 48.53 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -115.62 117.48 30.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.365 0.603 . . . . 0.0 112.285 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -66.19 106.7 1.72 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 65.9 tp -85.98 104.74 15.89 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 122.558 1.171 . . . . 0.0 109.782 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 31.6 m -113.67 164.53 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 113.572 -1.649 . . . . 0.0 106.665 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.5 134.92 78.98 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.538 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.71 -10.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 114.941 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.92 19.67 12.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.965 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.2 m120 71.03 29.08 3.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.916 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.451 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 37.5 mt -108.79 147.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.968 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t-20 -64.59 131.01 45.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.823 0.344 . . . . 0.0 111.548 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.677 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 6.7 tt -111.87 -27.02 8.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.736 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 34.8 tp10 78.8 8.78 1.97 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 36' ' ' VAL . 15.4 tp -99.41 133.12 44.18 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.239 0.542 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.4 m -106.93 112.62 25.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.41 101.2 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.7 tp -85.25 108.01 17.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.767 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -93.33 116.62 29.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.181 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.7 mt -116.75 124.33 49.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.778 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.87 103.9 11.02 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.915 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.28 136.19 41.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -62.24 -39.72 93.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.19 117.92 19.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 32' ' ' ASP . 72.1 mmtt -71.64 140.98 49.93 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.01 149.2 49.05 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 1.1 tpm_? -61.19 126.31 26.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.324 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.516 ' OD2' ' HD2' ' A' ' 87' ' ' ARG . 14.5 t70 -67.42 81.56 0.15 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -97.88 20.86 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HD2' ' OD2' ' A' ' 85' ' ' ASP . 6.7 ptm180 -63.46 -28.71 70.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.4 -6.38 86.06 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.104 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -91.17 -7.01 52.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.61 142.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 48.8 m -100.5 134.73 43.01 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER -76.17 -41.57 49.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 91' ' ' SER . 26.6 t70 -119.47 129.3 54.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 172' ' ' GLN . 26.6 mt -65.23 -73.16 0.13 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 57.29 68.71 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.43 87.82 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.126 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 11.6 p -81.19 -0.73 4.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.114 0.483 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 9.3 t70 -125.27 129.88 50.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.805 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.43 165.1 31.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.679 0.752 . . . . 0.0 112.438 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.2 m -134.81 141.65 46.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.435 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.558 HD11 ' OH ' ' A' ' 137' ' ' TYR . 78.9 mt -96.18 119.93 35.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.556 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.56 100.22 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.85 129.4 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.726 0.774 . . . . 0.0 112.206 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.19 49.38 1.65 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 m -106.49 -163.15 0.9 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.731 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -56.61 -48.17 78.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.121 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -88.16 -62.72 1.43 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.888 -0.507 . . . . 0.0 112.288 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.61 112.37 21.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -100.95 108.49 20.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.661 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 m120 58.97 72.33 0.54 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.736 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 m -140.56 130.85 25.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 112' ' ' ILE . 23.9 pt -105.37 99.46 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.7 mp -91.66 103.79 16.33 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.948 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -69.77 107.68 3.6 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.064 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.7 -121.05 5.32 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.34 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.7 Cg_endo -65.75 116.51 3.99 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.535 2.157 . . . . 0.0 114.719 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 137' ' ' TYR . 32.4 m -120.74 136.84 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.311 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -138.37 160.05 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -89.16 139.8 30.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.824 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.64 -56.78 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.001 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.11 -128.83 6.54 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 5.0 tt -99.66 113.47 25.94 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.5 pt -133.16 -159.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 20.3 m120 -125.99 125.9 43.43 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 2.7 mm? -100.48 113.36 26.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.497 ' OG ' HD12 ' B' ' 5' ' ' LEU . 4.0 m 57.23 29.31 16.5 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.317 0.58 . . . . 0.0 111.262 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 127' ' ' SER . 42.6 m 87.18 7.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 126' ' ' LEU . 6.0 t -111.03 139.68 22.02 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.601 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 21.3 Cg_exo -64.67 111.82 1.79 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 126' ' ' LEU . 26.3 m -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.864 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 133' ' ' ARG . 19.0 t-20 -119.3 163.25 17.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 37.7 ttm-85 68.41 35.45 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.937 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mmt -92.93 139.37 30.6 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.803 0.811 . . . . 0.0 113.004 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.6 mt -95.41 137.93 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.453 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -117.47 141.27 48.55 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.558 ' OH ' HD11 ' A' ' 101' ' ' LEU . 33.2 p90 -148.63 145.07 27.6 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.201 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.73 92.96 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.736 0.779 . . . . 0.0 112.112 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -161.43 137.18 7.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.59 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.78 87.01 5.29 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.486 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.1 p -89.91 151.04 21.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.081 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -130.27 151.57 50.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.045 0.926 . . . . 0.0 113.007 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.7 OUTLIER -45.35 152.3 0.3 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.225 175.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.58 -14.52 63.77 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.001 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 34.1 tt0 -99.33 7.2 45.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.317 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.776 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 6.9 m -60.56 136.11 57.96 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.37 -10.48 36.17 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 123.654 0.596 . . . . 0.0 111.952 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -51.1 121.01 10.26 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.086 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' ILE . 86.9 t -80.36 108.54 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.529 0.68 . . . . 0.0 111.212 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.5 tp -81.63 103.84 11.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.988 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -143.38 177.68 8.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.744 0.783 . . . . 0.0 111.998 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.13 -178.55 6.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.753 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.8 t -64.17 98.31 0.22 Allowed 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.802 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.42 29.05 54.28 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.162 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 33.4 ttmt -156.2 129.36 8.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.471 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.2 mt -112.77 129.14 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.23 -41.22 7.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 162.99 -156.09 27.7 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.82 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -127.89 151.16 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.923 0.868 . . . . 0.0 111.822 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.5 123.16 19.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -114.2 -28.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.55 -152.35 9.07 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.177 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.68 153.96 16.32 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.851 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 34.1 t30 -131.42 100.94 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.84 -121.88 6.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.404 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -102.21 22.92 12.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.675 0.75 . . . . 0.0 109.611 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 9.8 tt0 -127.61 115.53 18.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.365 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.42 148.75 28.25 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 47.5 m-85 -121.86 132.65 54.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.1 t -133.48 141.95 48.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.581 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -80.61 127.64 32.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.484 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 27.5 tt0 -74.6 109.2 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.895 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.494 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 55.2 mt -87.69 94.43 9.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.401 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.67 129.82 34.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.865 0.841 . . . . 0.0 111.379 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.35 -29.5 10.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.939 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -44.76 -43.16 8.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.659 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -79.81 -47.04 15.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 112.263 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.715 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.2 tt0 -101.64 83.96 2.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -88.75 141.06 28.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.6 tp -94.94 148.17 22.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 20.4 m-85 -61.32 139.59 58.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.776 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.8 mt-30 . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.971 -0.559 . . . . 0.0 . 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.46 -0.465 0 CA-C-O 121.016 0.34 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 22.8 t-20 -63.14 -53.25 56.38 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.389 1.09 . . . . 0.0 109.699 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 m -50.43 -53.71 27.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.073 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -57.49 -51.53 69.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.801 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.74 -50.58 72.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.171 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -44.95 95.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.7 tt -68.0 -35.06 77.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.571 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -70.05 -38.55 75.83 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.65 -40.76 93.19 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.196 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 29.7 mt -50.43 -57.66 7.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.431 1.11 . . . . 0.0 111.175 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -60.92 -28.0 68.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.719 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.59 -61.63 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.27 -7.26 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.6 mm -92.7 126.8 45.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.968 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtm -133.77 148.37 51.37 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -82.31 111.81 18.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.718 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.07 134.06 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 20.9 m -120.6 101.18 7.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.461 0.648 . . . . 0.0 109.941 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 p -105.74 -163.48 0.94 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.232 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -60.98 -18.57 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.0 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.683 ' HE2' ' OE1' ' A' ' 42' ' ' GLN . 6.3 mptp? -95.19 -59.05 1.98 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.06 0.457 . . . . 0.0 110.007 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . 172.2 -143.34 7.37 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.917 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -85.1 121.92 28.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.164 0.507 . . . . 0.0 111.327 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -125.88 161.57 27.14 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.395 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 37.8 m -89.26 112.03 22.99 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.485 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.73 109.11 3.38 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -87.62 98.47 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 111.672 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.13 10.35 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.68 -56.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.357 0.578 . . . . 0.0 109.858 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -154.82 144.07 21.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.987 0.899 . . . . 0.0 112.858 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 4.1 p30 46.78 -86.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.684 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 37.6 ptt180 -134.23 14.16 3.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.5 0.667 . . . . 0.0 110.595 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -94.67 113.05 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.1 m -118.87 154.07 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.842 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.33 133.1 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.14 143.58 25.27 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.662 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.7 153.04 52.11 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 120.849 1.033 . . . . 0.0 111.069 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.574 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 97.0 m -73.68 -39.55 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -65.11 -1.8 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.51 54.71 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.288 0.566 . . . . 0.0 110.802 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.683 ' OE1' ' HE2' ' A' ' 22' ' ' LYS . 42.5 mt-30 65.22 72.15 0.49 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.046 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.38 123.92 2.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.608 2.872 . . . . 0.0 109.949 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.25 -133.14 6.07 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.544 -0.836 . . . . 0.0 114.262 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.617 ' O ' HG12 ' A' ' 56' ' ' VAL . 28.0 t70 -83.84 -44.92 13.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 3.2 p30 -127.75 144.17 51.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.7 153.97 27.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.156 0.503 . . . . 0.0 111.146 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.84 103.71 16.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 49' ' ' VAL . 17.7 m -89.36 93.85 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.054 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 69.87 13.1 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.64 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.84 -29.83 5.7 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.94 120.91 19.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -84.73 114.98 22.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.851 0.834 . . . . 0.0 110.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.39 141.83 44.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.018 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 34.4 ttt180 -90.54 151.06 21.51 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.47 0.652 . . . . 0.0 112.058 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -92.38 145.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -89.09 -41.94 12.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.733 0.778 . . . . 0.0 109.018 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -160.07 129.79 5.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.206 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.54 112.41 22.17 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -104.89 107.07 17.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.731 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.84 126.29 28.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.079 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -90.42 103.87 16.51 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.91 141.08 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 172.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 11.8 t70 -72.95 135.89 80.14 Favored Pre-proline 0 C--N 1.31 -1.15 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.631 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 64' ' ' ASP . 72.8 Cg_exo -52.59 -8.16 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.835 1.69 . . . . 0.0 112.217 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 64' ' ' ASP . 28.6 tt0 -81.54 3.24 25.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 73.48 25.22 2.15 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.863 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.28 152.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' THR . 52.7 t30 -63.84 134.86 55.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.615 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 41.7 tp -102.99 -22.13 13.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.574 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.1 tp10 72.04 13.29 5.91 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.071 175.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.86 158.94 16.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.937 0.399 . . . . 0.0 110.27 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.6 m -135.88 120.8 18.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.208 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.05 102.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.7 tp -93.09 97.68 10.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.992 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 m -92.12 90.66 7.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 4.8 mp -74.21 152.5 39.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.513 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.37 75.49 10.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 79' ' ' ARG . 5.0 tpt180 -106.92 128.28 54.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.007 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.5 -12.74 51.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 38.2 mt-10 -90.56 117.86 29.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.612 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -93.5 111.29 22.93 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.258 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -81.98 165.85 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.482 0.658 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 84' ' ' ARG . 18.8 ttt180 -50.93 126.52 16.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.864 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -81.79 98.75 8.61 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.45 0.643 . . . . 0.0 109.859 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.5 pt -91.04 21.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 122.054 0.931 . . . . 0.0 109.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -55.28 -33.4 63.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.484 -1.689 . . . . 0.0 113.239 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.11 -7.74 88.16 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.864 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.81 2.05 51.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.44 131.85 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -93.28 105.12 17.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' A' ' 174' ' ' LYS . 0.1 OUTLIER -62.43 -54.77 35.32 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 176.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.41 135.2 45.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 95' ' ' GLU . 25.6 mt -61.03 -55.44 32.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 15.0 pt-20 36.61 71.8 0.13 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.591 . . . . 0.0 111.147 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.39 105.69 0.21 Allowed Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.651 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -91.97 9.98 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.083 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -111.62 118.33 35.38 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.09 151.54 37.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.044 0.926 . . . . 0.0 112.423 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.5 m -122.03 135.92 54.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.262 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.9 105.41 17.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.294 0.569 . . . . 0.0 110.222 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.674 ' HB ' HG23 ' A' ' 149' ' ' VAL . 35.3 t -80.38 102.16 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 108' ' ' PHE . 14.7 t -89.35 108.24 18.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.426 0.631 . . . . 0.0 111.71 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 29.6 t60 -129.9 39.35 3.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 97.2 p -108.9 -161.18 0.75 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.177 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -73.9 -17.25 61.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.704 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -78.01 -76.69 0.18 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 103' ' ' VAL . 79.8 m-85 -117.99 147.85 42.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.096 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.74 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 6.4 m -124.63 124.97 43.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.269 0.557 . . . . 0.0 110.794 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 109' ' ' THR . 12.3 t-20 80.82 -2.2 1.82 Allowed 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.658 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.0 m -92.67 119.38 32.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.26 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 112' ' ' ILE . 41.2 pt -95.25 126.62 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.0 110.53 20.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.54 122.13 18.44 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.58 -32.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.729 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.07 -105.12 2.04 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.879 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 88.5 Cg_endo -84.5 128.85 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.208 1.939 . . . . 0.0 114.145 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.81 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.6 p -132.14 163.77 27.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.726 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.15 153.92 20.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.46 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.51 0.13 11.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.871 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.93 -116.04 4.14 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.214 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 123' ' ' LEU . 7.3 tt -121.16 127.24 51.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.001 0.429 . . . . 0.0 111.239 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.7 pt -136.91 179.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 19.9 m120 -95.81 84.04 3.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.233 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 55.3 tp -65.49 105.86 1.28 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.0 m 62.52 32.67 16.45 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.373 0.606 . . . . 0.0 109.615 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 127' ' ' SER . 38.0 m 81.84 -10.46 1.14 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.378 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -91.49 120.98 68.08 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.518 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.34 114.59 2.04 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.493 1.462 . . . . 0.0 110.762 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 69' ' ' ASN . 23.3 m -134.34 134.88 42.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.016 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 26.8 p30 -113.42 -177.62 3.18 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.909 -0.717 . . . . 0.0 112.714 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 65.91 26.96 10.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.459 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 74.0 mt -92.34 135.5 27.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -117.26 130.99 56.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.627 0.727 . . . . 0.0 111.873 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.8 p90 -142.9 112.12 6.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.12 105.71 2.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.728 0.775 . . . . 0.0 109.246 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -167.59 135.4 2.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.75 102.7 0.97 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.825 0.821 . . . . 0.0 111.655 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 t -140.26 147.07 39.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.386 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 26.4 mtpp -141.51 -179.13 5.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.339 1.066 . . . . 0.0 111.962 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -37.6 150.2 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.986 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.69 -28.33 13.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.876 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -87.17 10.49 16.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.0 0.429 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.808 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 4.8 m -63.37 135.14 56.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.771 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 102.96 -21.37 40.41 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.488 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.24 133.72 24.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.942 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.674 HG23 ' HB ' ' A' ' 102' ' ' VAL . 17.7 m -92.16 112.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 0.0 111.719 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.66 109.66 18.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.63 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -146.12 172.68 13.06 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.176 0.988 . . . . 0.0 113.231 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -130.91 172.58 11.88 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.682 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -68.62 103.25 1.66 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.773 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.54 -0.48 77.5 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.581 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -139.18 109.35 6.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.5 mm -90.49 111.55 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.33 -48.65 12.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 170.0 -160.54 33.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.621 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 149' ' ' VAL . 23.4 pt -122.41 143.37 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.838 0.828 . . . . 0.0 112.583 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.24 118.72 10.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.152 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 17.1 m -113.24 -23.01 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.748 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.37 -152.2 8.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.522 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.81 153.81 12.01 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.766 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.584 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 16.0 t30 -126.36 105.68 8.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.175 0.512 . . . . 0.0 110.399 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.96 -106.66 1.93 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.322 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 166' ' ' ARG . 29.7 ttm180 -116.73 20.45 13.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -122.62 116.54 24.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.164 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.53 149.61 35.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.864 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 51.5 m-85 -130.51 115.38 16.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.45 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 69.5 m -109.45 172.64 6.73 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.676 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.473 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -115.0 132.25 56.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.9 pt20 -86.42 133.98 33.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.0 mt -85.92 88.92 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.297 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.539 ' HB3' ' OE2' ' A' ' 92' ' ' GLU . 9.6 mtpm? -79.1 111.26 15.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.087 0.946 . . . . 0.0 108.799 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -35.71 -36.23 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.497 ' HG2' ' CG ' ' A' ' 92' ' ' GLU . 17.0 mm100 -56.34 -27.95 57.51 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -68.46 -18.39 64.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.489 0.662 . . . . 0.0 109.245 177.871 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 4.5 mp . . . . . 0 CA--C 1.512 -0.509 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.4 tt0 -89.31 77.42 7.43 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.35 118.55 22.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.136 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 21.0 tp -83.6 152.11 25.0 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.9 m-85 -58.22 141.01 52.02 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.808 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.2 mt-30 . . . . . 0 C--N 1.307 -1.243 0 C-N-CA 120.708 -0.397 . . . . 0.0 . 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 N-CA-C 115.679 1.377 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 64.2 t30 -57.12 -48.77 77.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -68.39 -42.54 78.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.891 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -61.7 -43.98 97.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.264 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.17 -49.0 76.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.128 0.489 . . . . 0.0 110.387 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 -46.04 85.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.577 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.95 -42.72 99.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -68.07 -44.84 75.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.585 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.73 -45.79 91.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.738 0.78 . . . . 0.0 110.16 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 57.5 tp -55.99 -49.89 72.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.408 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.39 -28.57 56.77 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.64 -34.05 10.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -121.33 -9.81 9.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 50.8 mm -97.8 114.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.627 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.429 ' CE ' ' HA ' ' A' ' 16' ' ' MET . 2.1 mmt -122.24 146.18 47.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.323 0.582 . . . . 0.0 110.355 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.52 86.32 4.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 HG21 HD13 ' A' ' 37' ' ' ILE . 47.4 mm -75.61 94.33 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.0 109.765 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.3 m -86.62 96.12 10.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.741 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.19 179.65 4.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.932 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -55.92 -35.97 67.2 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -89.25 -31.7 17.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.9 -169.9 42.44 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 119.495 -1.336 . . . . 0.0 115.054 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -95.52 109.05 21.32 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 114.84 -0.68 . . . . 0.0 110.066 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 41' ' ' ALA . 86.7 m-85 -112.04 158.68 19.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.74 0.781 . . . . 0.0 112.245 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.0 m -83.05 106.66 15.05 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.559 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -89.64 119.99 5.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.938 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -93.99 100.68 12.77 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 0.0 110.186 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.38 106.99 1.9 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.0 -55.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -163.02 144.12 9.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.577 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 34.0 t70 54.02 -94.27 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.786 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.577 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -133.17 23.51 4.14 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.633 -0.667 . . . . 0.0 110.604 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.8 t -102.27 119.42 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.747 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -123.71 142.5 51.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.6 t -109.55 131.88 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 122.227 1.013 . . . . 0.0 112.111 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 18' ' ' ILE . 19.4 pt -141.75 165.53 27.55 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.44 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 25.0 Cg_exo -66.28 170.0 12.85 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 120.757 0.972 . . . . 0.0 111.098 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.565 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 62.6 m -76.44 -37.47 56.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.97 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -69.06 9.41 0.41 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 25' ' ' PHE . . . -75.64 -29.98 59.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.3 mm-40 61.37 72.9 0.63 Allowed Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.928 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.54 132.4 33.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.642 2.228 . . . . 0.0 111.263 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.53 -129.17 5.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.635 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.29 -30.73 12.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 109.188 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 55' ' ' ARG . 16.2 m-20 -132.38 155.62 48.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -129.7 134.38 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.54 104.84 13.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.423 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' GLY . 62.9 t -82.44 91.14 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.119 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 70.75 -9.57 0.81 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.104 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 152.55 -26.73 0.85 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -74.77 113.55 12.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.55 -0.825 . . . . 0.0 110.425 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.58 93.96 2.58 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.97 142.78 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.766 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.497 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 1.7 mmp_? -63.26 133.03 53.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.73 108.65 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -68.3 -40.51 81.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.122 0.963 . . . . 0.0 109.281 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -171.48 147.83 2.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.617 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.664 ' HD2' ' O ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -117.87 139.31 51.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.755 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.407 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 65.1 t80 -141.47 106.34 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.573 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -71.81 135.95 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 38.2 tp -104.18 109.17 20.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.379 1.085 . . . . 0.0 113.293 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.57 160.21 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 136.95 60.41 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -43.42 -26.13 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.473 2.115 . . . . 0.0 113.65 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.75 -9.37 57.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.75 0.786 . . . . 0.0 109.332 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.65 66.27 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.792 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 132' ' ' ASN . 63.0 mt -144.38 150.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 112.442 -2.163 . . . . 0.0 105.935 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -65.65 135.06 54.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.263 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 29.0 tp -108.62 -29.32 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.565 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 18.0 tp10 74.92 23.88 1.63 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.123 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.06 157.13 18.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 47.3 m -132.26 120.14 21.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.124 0.488 . . . . 0.0 109.796 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 65.9 t -86.4 88.52 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.8 tp -84.26 110.86 18.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.93 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -98.06 101.67 13.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.868 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.96 155.25 16.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.88 76.29 9.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -104.35 104.55 14.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.25 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.54 -38.03 74.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -82.62 82.25 8.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 20.4 ptmt -61.52 154.3 25.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.595 -1.184 . . . . 0.0 113.944 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.2 169.93 10.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.215 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -71.97 137.31 47.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.266 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -86.82 87.31 7.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.423 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -85.45 14.62 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -63.13 -16.13 59.01 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.792 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.79 -20.49 79.78 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.194 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -93.41 -0.37 56.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.7 mt -74.99 144.53 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 12.8 m -91.56 123.87 35.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.619 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.2 pm0 -78.96 -31.51 45.02 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' SER . 41.2 t0 -136.31 148.09 47.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 32.2 mt -71.41 -55.53 7.76 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 94' ' ' LEU . 1.9 pt-20 38.2 72.0 0.14 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.453 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.42 99.22 0.14 Allowed Glycine 0 N--CA 1.444 -0.784 0 O-C-N 124.0 0.813 . . . . 0.0 111.781 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.6 p -74.89 -21.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.87 0.366 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -92.3 119.36 31.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.596 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.96 154.31 48.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.105 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -120.71 137.47 54.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.176 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -107.98 127.02 53.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.38 113.98 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.62 123.44 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.916 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 39.7 t60 -150.49 71.96 1.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 60.7 p -143.16 -150.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.325 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.1 t-20 -55.02 -54.79 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.177 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 m120 -74.36 -68.53 0.52 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.412 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 36.0 m-85 -116.36 157.09 25.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -136.61 147.47 46.96 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.277 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.32 13.14 6.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.0 0.428 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 23.0 m -93.02 104.51 16.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.436 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.98 111.95 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.315 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.11 129.23 51.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.328 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.53 122.75 30.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 137' ' ' TYR . 9.1 p -89.26 -32.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.036 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.67 -130.69 10.31 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.642 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 76.3 Cg_endo -78.27 134.41 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.878 1.719 . . . . 0.0 112.891 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.33 165.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.159 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 p -132.79 -178.78 5.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.1 mtt -115.4 149.62 37.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.753 0.311 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 -31.08 5.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.41 -112.62 4.26 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.073 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 tt -123.31 112.08 17.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.8 pt -130.26 175.75 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.018 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 53.0 m-80 -86.9 87.32 7.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.51 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 49.8 tp -75.45 106.42 6.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.3 t 61.67 36.55 16.49 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.8 m 74.18 -0.07 3.46 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.516 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 m -104.23 113.69 64.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.912 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.74 111.78 0.87 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.989 1.792 . . . . 0.0 111.493 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 m -124.04 136.63 54.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.16 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.4 ' HB2' HG21 ' A' ' 68' ' ' ILE . 65.0 t30 -103.84 164.16 11.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 67.13 45.89 1.62 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.983 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mmt -91.66 127.35 37.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.281 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 170' ' ' SER . 28.9 mm -93.9 147.18 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -134.18 140.2 46.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 111.757 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.477 ' CD1' HG21 ' A' ' 115' ' ' VAL . 36.4 p90 -149.04 140.98 23.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.13 117.63 25.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.409 1.099 . . . . 0.0 110.15 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -174.08 137.96 0.57 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.242 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.38 96.2 0.08 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.322 0.582 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.9 p -107.96 144.37 35.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.333 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.3 158.25 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.516 1.15 . . . . 0.0 112.79 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.48 152.1 0.1 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.289 173.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.51 -14.51 50.84 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 107' ' ' ASN . 11.2 mm-40 -99.86 -0.27 40.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 119.792 -0.147 . . . . 0.0 110.872 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.644 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 10.5 p -78.3 135.26 37.48 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.309 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 119.78 -23.12 8.44 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.929 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.52 138.01 19.27 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.399 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.78 125.33 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.775 0.798 . . . . 0.0 112.911 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.17 109.07 21.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.384 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -149.29 -174.5 4.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.106 0.955 . . . . 0.0 113.326 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.35 172.85 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.212 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.1 t -60.52 108.8 0.88 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.572 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.18 63.44 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.344 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -162.66 113.75 1.52 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.83 119.9 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -83.98 -41.11 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 164.08 -156.45 28.33 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.605 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.4 pt -126.62 147.5 31.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.21 0.528 . . . . 0.0 111.05 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.1 133.13 48.46 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.43 -28.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.61 -155.91 11.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.08 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.71 154.27 25.0 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.029 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.577 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 10.3 t-20 -135.16 116.14 14.17 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.69 -112.59 4.71 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.06 -1.066 . . . . 0.0 111.06 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -118.08 19.45 13.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.481 . . . . 0.0 109.828 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.0 135.17 51.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.316 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.77 138.28 14.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 44.9 m-85 -116.72 132.92 56.56 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.439 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 18.5 m -124.86 165.35 18.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.546 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -106.91 143.03 35.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -81.95 110.75 17.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.436 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -88.55 93.02 9.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' SER . 86.4 mttt -87.3 135.22 33.4 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 122.643 1.211 . . . . 0.0 113.45 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 16.1 tptm -42.78 -43.08 3.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.537 -2.12 . . . . 0.0 112.78 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -41.51 -46.41 3.5 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.74 -23.02 55.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 . . . . . 0 C--N 1.321 -0.661 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.679 -178.583 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.9 mm? . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 121.326 0.584 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.0 tt0 -114.68 85.77 2.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -91.09 130.5 36.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 23.2 tp -88.55 154.71 20.12 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.574 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 24.3 m-85 -62.64 145.64 54.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.644 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 95.2 mt-30 . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 118.702 -1.199 . . . . 0.0 . 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--O 1.229 0.061 0 N-CA-C 114.609 0.965 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 66.6 t30 -79.83 -49.54 11.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.209 0.528 . . . . 0.0 111.932 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -68.38 -42.29 79.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.738 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.42 -29.54 63.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.097 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -65.58 -46.32 79.87 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.59 75.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.432 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.13 -43.63 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.603 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 m -69.85 -41.74 74.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.179 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.85 -42.07 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.716 0.77 . . . . 0.0 109.945 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.645 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -56.41 -53.5 56.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.882 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.7 -25.99 66.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -83.42 -55.58 4.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -118.06 -2.42 11.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 40.5 mm -101.94 114.24 40.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.31 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtm -128.03 155.05 44.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.506 0.669 . . . . 0.0 111.434 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -85.3 109.15 18.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.9 mt -103.08 110.69 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.678 0.751 . . . . 0.0 110.224 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 11.3 m -85.5 114.22 22.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.37 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -106.52 -176.3 3.04 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -75.83 -15.83 60.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.112 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -82.62 -42.34 18.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.052 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.94 38.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.98 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.99 116.14 28.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.75 166.33 13.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.969 0.89 . . . . 0.0 111.333 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 19.0 m -73.55 105.01 4.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.51 105.53 3.23 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -107.07 130.1 54.72 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.794 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.43 126.08 7.22 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.17 -56.76 5.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.125 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -158.43 151.09 22.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.259 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 8.1 t70 56.25 -94.36 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.52 20.25 1.86 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.877 0.846 . . . . 0.0 108.885 177.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.0 106.73 18.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 m -115.29 152.6 32.46 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.34 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.73 144.69 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -146.98 140.39 14.94 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.757 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.36 145.39 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.772 1.648 . . . . 0.0 111.981 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 67.0 m -75.29 -34.86 61.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.293 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -65.01 -11.97 45.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.38 -23.26 46.89 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.563 0.697 . . . . 0.0 109.888 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 48.27 72.1 1.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.81 130.57 28.16 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.41 -155.07 4.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.374 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -82.22 -35.98 27.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.188 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.29 121.53 22.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.2 m -117.28 150.94 19.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.369 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 34.4 mt -83.34 107.12 15.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.348 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -92.45 89.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.0 t30 58.49 36.27 25.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.107 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.95 -15.06 57.09 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.156 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 15.8 mm-40 -106.09 108.71 20.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.91 139.46 30.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.722 -179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.0 tp -135.85 135.54 50.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -84.91 128.0 34.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.38 142.58 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -77.14 -49.73 14.58 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -150.76 120.33 6.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.817 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -97.59 98.21 9.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -100.49 123.79 45.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.017 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 61' ' ' LYS . 3.4 mppt? -94.53 108.2 20.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 47.2 tp -86.12 118.22 25.44 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.07 172.75 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.98 140.94 86.26 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 117.723 0.238 . . . . 0.0 111.637 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.55 -29.02 9.77 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.267 1.311 . . . . 0.0 111.954 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.0 8.87 16.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.274 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 64.02 68.36 0.57 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.681 0.753 . . . . 0.0 110.469 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.0 mt -142.97 164.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.985 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -69.0 116.54 9.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 118.298 0.499 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.56 -32.93 10.53 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 30.3 tp10 77.38 15.11 1.76 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.995 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 80.4 mt -103.37 111.68 24.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.038 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -90.11 107.54 19.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.3 t -79.04 97.16 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.658 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 tp -78.21 94.57 4.79 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.102 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.2 m -83.95 98.63 9.9 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.691 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -103.4 144.13 31.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.064 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.35 96.82 7.98 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.18 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 77' ' ' LEU . 8.3 mmm180 -117.52 150.01 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -82.09 -44.82 16.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 110.08 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.79 76.11 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 59.6 pttt -67.76 172.31 5.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.491 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -93.65 160.89 14.57 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -71.83 143.61 49.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.479 -1.692 . . . . 0.0 112.299 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.47 91.77 2.81 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.371 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.0 pt -89.89 11.49 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -70.07 -27.06 64.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.305 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.26 -20.69 73.47 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 67.4 m-85 -92.54 -16.91 25.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.34 121.76 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.8 m -101.6 107.65 18.98 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.296 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 174' ' ' LYS . 12.5 pt-20 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -94.79 112.88 24.59 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.34 -71.36 0.09 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 49.97 67.98 0.82 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.08 92.52 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.264 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 60.7 t -83.79 -4.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.825 0.345 . . . . 0.0 111.515 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -114.21 110.4 19.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -130.62 165.69 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 112.739 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 m -119.97 141.62 49.51 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.723 -1.581 . . . . 0.0 109.69 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.8 tp -109.85 120.02 41.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 102' ' ' VAL . 31.3 m -116.31 108.38 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 120.214 -0.595 . . . . 0.0 110.05 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.91 136.98 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.755 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -142.28 75.73 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.57 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.9 p -124.24 -162.68 1.09 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -45.34 -67.63 0.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -94.15 -34.78 12.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.309 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.74 83.51 7.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 112.545 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.3 p -92.73 123.39 35.98 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.599 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER 38.61 62.9 0.95 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.099 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -99.02 103.13 15.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.642 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.8 mt -93.08 109.11 21.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.868 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.64 123.51 50.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.28 107.81 9.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.498 HG21 ' CD1' ' A' ' 137' ' ' TYR . 8.7 p -86.35 -24.76 6.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.307 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.21 -122.41 5.97 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.461 -0.876 . . . . 0.0 115.03 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.5 Cg_endo -66.24 117.59 4.82 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.407 2.072 . . . . 0.0 115.629 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.495 HG12 ' HB3' ' A' ' 137' ' ' TYR . 30.9 m -108.3 151.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.6 m -151.41 135.55 16.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.606 0.241 . . . . 0.0 110.928 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.1 ttm -66.71 122.44 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.695 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.43 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.14 -115.81 5.34 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.34 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.78 119.1 32.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.531 HG21 HD23 ' B' ' 2' ' ' LEU . 44.4 pt -133.22 -170.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.875 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 128' ' ' SER . 5.7 m-20 -110.38 109.42 19.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.8 mm? -87.57 112.1 21.91 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 128' ' ' SER . 26.7 t 65.21 10.33 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.568 0.699 . . . . 0.0 110.643 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 4.8 m 82.99 66.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.001 1.32 . . . . 0.0 112.823 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 126' ' ' LEU . 15.2 t -163.3 131.49 2.77 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.778 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.35 109.96 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 121.361 1.374 . . . . 0.0 113.84 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 126' ' ' LEU . 7.3 m -111.67 132.89 54.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.479 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -111.22 160.89 16.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.1 mtt180 65.36 43.37 3.51 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.078 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 85.1 mmm -92.24 136.6 33.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.3 tt -117.91 137.52 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -105.37 150.14 25.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 115' ' ' VAL . 1.5 p90 -144.68 152.8 40.97 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.368 0.604 . . . . 0.0 110.226 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.2 99.96 7.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.862 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 115' ' ' VAL . 47.2 t80 -178.2 119.93 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.755 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.68 120.63 16.58 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.6 t -143.01 151.85 41.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.752 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.9 174.21 10.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.701 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' ' CA ' ' B' ' 7' ' ' GLN . 17.8 p -38.91 155.47 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.318 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.3 -29.9 8.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -86.69 -4.87 59.23 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.636 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 26.3 p -78.1 144.57 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.508 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.42 -22.59 17.27 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.46 34.52 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.984 -0.608 . . . . 0.0 112.217 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.26 126.8 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.417 0.627 . . . . 0.0 112.297 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.73 106.6 18.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.2 p -149.24 -176.33 5.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.093 0.949 . . . . 0.0 112.306 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.68 174.69 13.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.816 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 8.8 t -62.02 115.75 4.34 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.794 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.05 90.67 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 19.2 ptmt -156.82 142.04 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.488 1.144 . . . . 0.0 112.772 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.43 138.85 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.614 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -106.53 -39.41 5.87 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.943 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.493 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 175.59 -167.77 39.83 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 173' ' ' LEU . 20.0 pt -129.48 141.8 45.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.699 0.762 . . . . 0.0 110.604 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 6.1 t60 -65.57 107.44 1.71 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.471 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 27.2 m -95.3 -21.03 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.759 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 175.8 -146.75 8.34 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.125 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.56 163.4 32.5 Favored Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.336 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 2.9 t30 -123.49 94.8 4.36 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.85 0.833 . . . . 0.0 109.765 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.65 -104.87 1.31 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.393 -1.276 . . . . 0.0 114.223 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 166' ' ' ARG . 1.0 OUTLIER -97.55 -8.25 29.51 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.56 -0.82 . . . . 0.0 111.972 -177.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -108.99 133.04 53.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.282 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -85.68 149.94 23.88 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.2 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 49.8 m-85 -133.11 122.68 24.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.702 0.763 . . . . 0.0 112.022 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 t -117.99 150.64 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.987 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.1 128.26 36.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -63.01 118.82 8.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.415 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.493 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 42.5 mt -87.66 85.19 7.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 92' ' ' GLU . 55.7 mtpt -89.56 133.89 34.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.752 0.787 . . . . 0.0 109.538 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -50.29 -19.64 0.86 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.639 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -9.09 58.79 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 . . . . . 0 C--N 1.312 -1.032 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.099 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.531 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.07 76.37 1.04 Allowed 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.44 140.58 33.33 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.0 tp -104.97 145.84 29.86 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.558 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 31.2 m-85 -57.61 142.09 45.94 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.636 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 81.9 mt-30 . . . . . 0 N--CA 1.436 -1.171 0 C-N-CA 119.344 -0.942 . . . . 0.0 . -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 CA--C 1.529 0.253 0 N-CA-C 113.375 0.49 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.78 -53.8 19.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.1 0.476 . . . . 0.0 110.585 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -63.49 -35.52 80.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.779 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -61.82 -51.65 67.4 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -57.87 -48.43 79.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.269 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -55.78 -49.14 73.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.328 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.13 -43.73 98.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -71.34 -39.61 71.22 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.91 -41.34 95.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 122.182 0.991 . . . . 0.0 108.6 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 HD21 ' OD1' ' A' ' 110' ' ' ASN . 53.4 tp -59.49 -56.32 23.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.879 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -69.71 -28.87 66.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -103.23 -29.19 11.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.48 -19.25 8.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.519 HG23 HG23 ' A' ' 26' ' ' THR . 47.9 mt -93.35 117.99 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.075 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -125.87 156.77 39.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.186 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 p -86.73 106.11 17.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.8 mp -93.38 110.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 89.3 m -72.07 114.34 10.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.881 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 58.6 p -109.27 -163.57 0.88 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.7 t -77.53 -29.2 52.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -90.38 -33.15 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.95 -167.2 39.95 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.423 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.89 115.36 21.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -121.5 159.22 26.76 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.944 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -72.71 113.2 9.48 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.573 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -114.76 129.91 8.92 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.247 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.36 104.49 16.83 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.44 90.97 0.94 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 90' ' ' ILE . 24.5 mm -59.18 -50.98 77.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 111.35 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 11.7 p80 -166.94 164.24 16.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.307 1.051 . . . . 0.0 113.328 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HA ' ' CB ' ' A' ' 82' ' ' LYS . 1.6 m-20 45.97 -92.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.997 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 31.5 ptt180 -142.55 19.87 2.03 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.037 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.36 119.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.543 0.687 . . . . 0.0 110.765 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 m -117.33 139.98 50.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.047 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -99.84 124.69 53.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.574 . . . . 0.0 109.847 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 pt -136.84 163.89 46.35 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.66 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.18 150.43 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.549 1.499 . . . . 0.0 111.615 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.569 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 94.9 m -81.19 -42.52 20.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.355 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -63.17 -17.12 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -67.29 -19.21 65.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 109.422 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.3 mt-30 68.01 72.87 0.36 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.28 133.05 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.454 2.769 . . . . 0.0 110.657 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.82 26.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.613 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -103.07 -5.89 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.205 1.002 . . . . 0.0 109.355 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 10.7 t70 -139.72 107.43 5.63 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.44 148.01 15.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.108 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.76 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 7.3 mp -96.9 103.7 15.65 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.736 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.87 106.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 64.22 23.99 13.26 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.955 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.38 -17.54 46.96 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.733 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -83.47 105.67 14.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.859 -0.201 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 15.0 ptpt -71.9 114.23 9.77 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 77' ' ' LEU . 4.6 tt -127.22 143.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.53 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 20.2 mmm180 -66.35 142.99 57.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.73 150.68 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.36 -49.76 5.31 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.53 114.54 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.351 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -107.21 132.11 53.43 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' CE2' HD23 ' A' ' 62' ' ' LEU . 24.0 t80 -130.13 118.29 21.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.42 104.44 10.03 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.456 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 96.1 mt -62.52 109.49 1.39 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.992 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.8 m -91.96 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 22.3 t70 -89.04 132.68 37.21 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.66 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.61 -18.49 2.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.0 2.467 . . . . 0.0 114.551 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 44.2 mt-10 -89.82 19.58 4.69 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 111.133 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 25.0 t-20 77.32 15.38 1.75 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.142 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 69' ' ' ASN . 25.8 mm -109.26 179.1 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.79 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 68' ' ' ILE . 52.8 t30 -92.14 146.16 23.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.192 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.777 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 27.4 tp -108.33 -22.39 12.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.569 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 19.4 tp10 68.89 13.0 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.476 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 76.1 mt -105.47 110.48 22.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.96 0.163 . . . . 0.0 110.951 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.0 m -91.98 116.51 28.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.044 0.449 . . . . 0.0 111.493 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.31 105.93 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.158 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -84.44 93.13 8.23 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 13.0 tp -93.59 155.79 17.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.772 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 54' ' ' ILE . 28.7 t70 -89.48 67.36 7.6 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 11.2 tpt180 -117.07 101.88 8.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -89.32 -6.0 57.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.831 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -87.03 107.14 18.29 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' CB ' ' HA ' ' A' ' 32' ' ' ASP . 20.5 ptmt -78.21 157.7 29.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -88.04 167.09 13.98 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 111.989 -2.369 . . . . 0.0 108.262 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -64.03 130.54 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.395 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' OD1' ' HD2' ' A' ' 87' ' ' ARG . 10.3 m-20 -68.56 95.16 0.62 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -96.38 25.96 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 9.7 mtp180 -63.17 -36.07 82.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.645 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.08 -11.75 85.28 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.433 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -90.15 -17.71 27.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.562 0.681 . . . . 0.0 109.287 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 30' ' ' ILE . 30.0 mt -69.02 130.8 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 21.1 m -107.61 129.0 55.04 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.3 -43.23 52.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 91' ' ' SER . 10.2 t70 -106.05 124.81 50.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.167 175.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.66 -71.49 0.37 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 49.47 72.16 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -162.03 82.92 0.12 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.754 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.56 3.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.12 0.486 . . . . 0.0 111.304 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.1 t70 -143.8 119.17 10.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.187 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.428 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -142.5 172.2 13.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.085 0.945 . . . . 0.0 112.337 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -120.64 144.6 48.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.115 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -111.0 124.51 52.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.775 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 7' ' ' ALA . 19.3 m -114.17 120.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.467 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 t -113.38 133.41 59.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.53 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -140.77 75.24 1.49 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.9 p -118.4 -166.98 1.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -68.82 -38.43 79.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.234 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.43 -60.84 1.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.637 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.615 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 46.4 m-85 -96.68 108.94 21.66 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.239 0.543 . . . . 0.0 110.063 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 15.2 m -113.36 117.7 32.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.423 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 109' ' ' THR . 92.5 m-20 70.4 34.54 2.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.49 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 2.6 m -87.26 122.4 30.98 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.3 tt -119.96 109.28 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.6 mt -115.03 128.54 56.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.85 106.0 17.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.5 m -78.95 -38.47 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 98.15 -123.17 7.76 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.899 -1.143 . . . . 0.0 114.499 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.7 Cg_exo -61.35 108.89 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.804 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 99' ' ' ALA . 90.4 t -106.27 139.54 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 4.4 m -153.09 151.71 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.81 151.07 26.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.243 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -114.5 -35.93 4.76 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.64 -97.52 1.63 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.729 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.97 125.26 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.095 0.474 . . . . 0.0 111.492 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.0 pt -141.58 179.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 36.9 m-80 -100.47 93.83 5.83 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.297 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 4' ' ' ALA . 31.4 tp -72.74 97.18 2.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.508 ' HG ' ' H ' ' B' ' 6' ' ' PHE . 5.1 m 62.59 35.22 14.5 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.749 0.785 . . . . 0.0 110.267 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 74.7 m 79.14 0.91 2.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.29 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.9 m -103.82 107.11 55.63 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.91 123.07 12.22 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 121.833 1.688 . . . . 0.0 112.99 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 144.91 49.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.401 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.9 t30 -117.43 168.02 10.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.582 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 3.2 mpt_? 65.58 31.46 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.5 mmm -82.21 130.33 35.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.936 0.874 . . . . 0.0 113.031 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 49.0 mt -98.7 142.66 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.143 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 119' ' ' THR . 6.6 ptm180 -122.76 157.17 32.94 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 167' ' ' GLN . 20.2 p90 -157.75 141.8 15.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.534 0.683 . . . . 0.0 109.997 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.09 98.32 5.73 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.755 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -171.49 134.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.08 114.17 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.311 0.577 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.8 p -121.3 162.05 20.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 143' ' ' THR . 58.6 tttm -157.28 150.47 23.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.22 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 142' ' ' LYS . 57.1 p -37.58 158.83 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.88 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.74 -25.61 8.32 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.4 -0.86 57.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.625 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 9.8 p -76.68 142.53 40.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.58 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.57 -20.36 20.64 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.08 144.71 41.84 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.744 -0.728 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.02 124.25 46.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.302 0.573 . . . . 0.0 112.11 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -90.84 111.61 23.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -146.94 177.27 9.26 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.901 0.858 . . . . 0.0 112.681 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.08 177.54 10.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.944 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.6 t -60.93 111.65 1.75 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.208 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.1 77.77 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.157 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -151.98 121.14 6.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.17 0.485 . . . . 0.0 112.182 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.95 128.68 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -93.82 -41.16 9.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.237 0.541 . . . . 0.0 111.248 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 159.1 -158.47 29.49 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.537 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.92 143.54 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.558 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 162' ' ' GLY . 83.8 t60 -72.8 102.75 3.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.495 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.2 m -91.19 -19.37 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.549 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 160' ' ' HIS . . . -176.88 -152.75 10.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.929 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 176.39 168.31 36.32 Favored Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.544 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 22.0 t-20 -127.92 84.05 2.21 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.622 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.09 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.806 -1.543 . . . . 0.0 115.654 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -102.73 4.54 38.16 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 63.0 mt-30 -126.73 126.59 43.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.426 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.56 143.6 22.69 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.412 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 24.7 m-85 -122.54 109.44 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.918 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.8 t -108.5 146.56 33.0 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.541 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.64 125.07 38.05 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.6 pt20 -69.17 116.17 9.3 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.881 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 90' ' ' ILE . 18.8 tp -83.24 91.91 7.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.918 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -83.67 142.95 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.552 0.691 . . . . 0.0 112.263 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -66.09 -16.43 63.94 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -48.42 -50.98 28.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.733 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -70.91 -29.48 65.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.444 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.218 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.473 ' N ' HD12 ' B' ' 2' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.503 -0.862 0 CA-C-O 120.613 0.244 . . . . 0.0 111.636 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.3 tt0 -94.77 79.17 3.71 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 173.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.581 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -72.42 135.77 45.88 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.587 HD13 ' N ' ' B' ' 6' ' ' PHE . 0.4 OUTLIER -91.18 134.45 34.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.587 ' N ' HD13 ' B' ' 5' ' ' LEU . 25.1 m-85 -50.04 137.02 17.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.625 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 72.1 mt-30 . . . . . 0 N--CA 1.439 -1.024 0 C-N-CA 117.098 -1.841 . . . . 0.0 . -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 112.703 0.232 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.87 -44.35 55.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.431 0.634 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -55.19 -57.32 12.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.758 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.5 -34.31 75.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.6 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.47 -53.83 30.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.258 0.551 . . . . 0.0 110.625 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.38 98.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.947 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.6 tt -62.79 -42.95 99.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.696 0.284 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -69.93 -43.21 72.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.21 -40.68 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.352 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 8.3 tt -60.64 -45.0 95.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.013 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 41.7 mtp180 -73.73 -29.8 62.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -94.87 -51.61 4.61 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.92 -17.31 14.23 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.0 mm -88.05 123.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.65 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.414 ' CE ' ' HA ' ' A' ' 16' ' ' MET . 3.7 mmt -123.53 130.23 52.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -71.96 103.98 3.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.196 178.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 56.6 mt -89.83 107.86 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 122.123 0.963 . . . . 0.0 111.607 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 m -80.41 110.66 16.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.334 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 21' ' ' SER . 6.2 t -134.11 -171.6 2.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.68 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.426 ' N ' ' OG1' ' A' ' 20' ' ' THR . 15.7 m -60.9 -28.47 68.93 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 40' ' ' HIS . 74.3 mmtt -92.78 -4.55 52.86 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.853 -0.53 . . . . 0.0 111.302 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 -151.75 19.1 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 29.1 mt-10 -112.34 129.33 56.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -118.12 167.27 11.64 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.134 0.968 . . . . 0.0 112.428 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 27.0 m -78.75 99.34 6.62 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.931 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 136.39 12.86 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.6 pt? -121.32 129.74 53.26 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 118.389 -1.325 . . . . 0.0 112.597 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.9 109.64 2.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 90' ' ' ILE . 45.8 mm -67.9 -43.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.276 0.56 . . . . 0.0 110.611 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -171.88 146.78 2.1 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.474 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 50.28 -86.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.2 ptt180 -133.85 9.58 3.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.62 -174.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.95 113.78 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.524 0.678 . . . . 0.0 112.06 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.0 m -117.96 144.21 45.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.343 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.21 143.78 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.291 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.8 tt -148.13 144.84 19.37 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.921 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.94 149.14 15.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.153 1.235 . . . . 0.0 110.879 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 28.4 m -70.79 -37.11 73.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 42.8 p-80 -64.34 -7.96 11.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 20' ' ' THR . . . -71.41 -21.74 61.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 55.71 72.5 1.02 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.76 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.86 135.24 25.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.866 2.377 . . . . 0.0 111.873 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.71 -160.05 36.09 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.087 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' VAL . 9.1 p-10 -76.03 -23.78 55.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.206 0.527 . . . . 0.0 110.148 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 1.4 p-10 -139.81 132.96 29.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.81 148.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.511 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.0 mt -96.86 104.36 16.36 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.812 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' OD1' ' A' ' 50' ' ' ASN . 7.6 p -93.9 109.21 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 122.182 0.992 . . . . 0.0 109.962 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 9.4 p-10 45.74 28.36 0.55 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.954 -1.476 . . . . 0.0 113.12 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.45 -20.49 12.3 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.449 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.12 132.41 33.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.3 tttp -85.59 118.41 25.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -138.62 119.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.045 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 36.4 ptt180 -72.57 151.79 42.19 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.82 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 45' ' ' ASP . 11.1 p -74.54 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.056 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -98.36 -40.56 8.25 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 27.4 t0 -155.43 134.68 12.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.482 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -136.34 115.32 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.414 . . . . 0.0 110.633 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -122.97 125.9 46.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 49.9 mtmt -84.48 112.45 20.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.642 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 39.9 mt -75.47 109.08 8.72 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 m -101.55 148.79 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.45 140.93 95.24 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.326 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -45.9 -24.78 2.32 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.526 2.151 . . . . 0.0 113.851 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 9.81 3.62 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.374 0.607 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 73.11 30.97 1.53 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 132' ' ' ASN . 34.7 mt -119.61 155.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -64.93 129.17 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.642 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 37.2 tp -104.07 -22.49 13.43 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.553 ' HG2' HG11 ' A' ' 161' ' ' VAL . 37.3 tp10 75.09 8.45 4.04 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.47 107.61 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.971 0.351 . . . . 0.0 111.09 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 93.1 m -89.62 112.53 23.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.516 . . . . 0.0 109.72 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 62' ' ' LEU . 87.1 t -82.53 106.22 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -101.28 100.9 11.48 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.175 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 17.6 m -91.49 110.33 21.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.426 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 31.0 mt -117.81 120.24 37.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.605 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.64 101.89 0.85 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 117.729 -1.588 . . . . 0.0 109.46 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HE ' ' HG2' ' A' ' 81' ' ' GLU . 6.6 tpt180 -102.41 129.69 48.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.65 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -76.49 -25.65 54.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.024 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' HE ' ' A' ' 79' ' ' ARG . 15.3 pt-20 -97.15 120.78 38.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -73.6 129.33 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -77.2 137.57 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -44.78 131.56 6.91 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.274 -0.266 . . . . 0.0 111.041 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.25 92.66 3.88 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.282 0.563 . . . . 0.0 112.12 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.4 pt -93.48 20.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -61.64 -39.13 90.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.079 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.35 -11.32 85.14 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.104 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 47.2 m-85 -87.82 -20.58 25.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 117.77 0.785 . . . . 0.0 109.652 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 30' ' ' ILE . 45.4 mt -74.06 146.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 p -120.2 139.61 52.39 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.495 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 176' ' ' GLN . 8.6 pt-20 -78.01 -42.63 31.98 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.27 120.53 42.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 172' ' ' GLN . 26.7 mt -58.87 -68.18 0.29 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 56.57 70.87 0.61 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.46 93.42 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.13 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -87.84 3.42 5.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.889 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 13.5 t70 -131.05 124.34 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.368 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.79 163.85 31.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.227 1.013 . . . . 0.0 113.115 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.1 m -116.19 143.32 45.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.638 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -116.22 122.11 44.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 -177.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.43 113.03 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.304 0.573 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -99.37 139.75 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.631 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.548 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.8 t60 -146.36 59.62 1.22 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.1 m -108.88 -179.5 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.118 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.8 p-10 -68.39 -38.91 81.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.436 1.016 . . . . 0.0 111.765 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.434 ' HA ' HD21 ' A' ' 107' ' ' ASN . 7.2 m120 -70.08 -60.12 2.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.087 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -108.06 92.9 4.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 m -91.83 110.64 21.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.514 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.548 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 41.2 t30 64.01 71.8 0.48 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.608 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.3 m -130.98 103.47 6.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.124 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.7 113.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.591 0.71 . . . . 0.0 110.414 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.1 mt -122.53 134.31 54.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.754 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.67 104.45 16.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.24 -41.09 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 96.54 -119.06 6.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.716 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.5 Cg_exo -60.42 100.41 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 115.684 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 137' ' ' TYR . 6.4 m -108.05 126.09 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -142.28 146.78 35.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -77.88 135.27 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.546 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.82 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.19 -116.11 3.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.283 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.93 106.99 14.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.888 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.464 HG21 HD23 ' B' ' 2' ' ' LEU . 44.1 pt -125.17 -172.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.154 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.8 m120 -113.14 95.39 5.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.35 0.595 . . . . 0.0 110.653 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.507 HD21 ' CG1' ' A' ' 161' ' ' VAL . 43.9 tp -81.62 106.85 13.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.4 m 64.77 25.74 12.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.2 m 86.1 -11.24 0.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.824 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.8 m -87.07 119.42 71.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.404 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.19 117.39 4.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.199 1.932 . . . . 0.0 112.36 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -117.46 132.87 56.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.178 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 63.2 t30 -98.76 141.04 32.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.707 0.765 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 64.09 47.08 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.713 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.412 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.78 130.42 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.666 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 61.4 mt -89.44 134.54 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.493 0.663 . . . . 0.0 111.61 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -109.17 130.64 55.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.565 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.65 ' HB3' HG12 ' A' ' 118' ' ' VAL . 2.4 p90 -139.19 127.83 23.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.61 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.66 110.61 5.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.991 0.9 . . . . 0.0 111.251 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -179.71 132.05 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.799 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -61.49 106.68 0.68 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.4 p -112.38 140.18 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.531 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -130.44 152.61 49.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.267 1.032 . . . . 0.0 112.001 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.491 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.18 153.68 0.06 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.759 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.66 -18.2 55.83 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.42 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -94.24 -4.57 48.66 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.529 -0.836 . . . . 0.0 112.155 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.658 ' SG ' ' CA ' ' B' ' 7' ' ' GLN 0.265 29.2 p -85.55 151.82 23.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 116.575 -2.05 . . . . 0.0 113.763 -174.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.712 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 106.59 -20.56 34.24 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -53.47 146.83 19.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.735 -0.732 . . . . 0.0 111.697 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.48 125.96 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.821 0.819 . . . . 0.0 113.162 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.43 HD13 HD23 ' A' ' 101' ' ' LEU . 37.8 tp -90.78 108.99 20.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.617 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.9 p -145.48 -179.72 6.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.031 0.919 . . . . 0.0 113.381 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.24 -172.71 4.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.642 -1.617 . . . . 0.0 108.568 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 153' ' ' THR . 9.8 t -66.93 101.75 0.88 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.012 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.9 83.99 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.302 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 79.3 mttt -140.43 140.08 35.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.415 0.626 . . . . 0.0 111.816 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.92 123.54 71.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -97.75 -31.89 12.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.934 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 167.53 -163.12 36.88 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.423 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.5 144.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.701 0.762 . . . . 0.0 111.413 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.453 ' HB2' HD21 ' A' ' 101' ' ' LEU . 6.1 t60 -62.72 114.11 3.41 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.454 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 71' ' ' GLU . 47.8 t -103.6 -33.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.563 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.42 -147.13 5.54 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.646 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.37 166.3 32.18 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.306 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.514 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 5.3 t30 -132.91 89.67 2.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 109.812 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.52 -102.25 0.42 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.097 -0.956 . . . . 0.0 114.491 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 23.4 mtp180 -94.29 4.81 53.37 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -131.98 114.75 14.98 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.27 39.44 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.838 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.0 m-85 -129.01 118.16 22.11 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.021 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.48 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 27.0 t -111.64 159.83 17.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.252 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.87 131.54 44.26 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.47 ' HG3' HD21 ' A' ' 94' ' ' LEU . 47.3 tt0 -68.88 104.49 2.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.086 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 19.0 tp -80.16 92.87 5.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -87.67 119.94 28.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.994 0.902 . . . . 0.0 112.614 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -53.47 -31.16 44.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.537 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 4.9 pt20 -60.71 -17.74 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.98 -14.66 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.089 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.269 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.682 0.277 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.7 tt0 -109.99 74.21 0.88 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 171.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.514 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -74.94 153.68 38.47 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 23.4 tp -113.42 152.4 30.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.622 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 23.2 m-85 -56.99 146.98 25.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.658 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.6 mt-30 . . . . . 0 N--CA 1.436 -1.174 0 C-N-CA 119.891 -0.723 . . . . 0.0 . 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 N--CA 1.462 -0.329 0 N-CA-C 113.363 0.486 . . . . 0.0 113.363 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.451 ' HA ' ' OG1' ' A' ' 153' ' ' THR . 17.7 m120 -66.27 -44.17 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.131 0.491 . . . . 0.0 112.136 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -46.35 83.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.214 0.53 . . . . 0.0 111.869 -178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -55.01 -55.08 34.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.316 0.579 . . . . 0.0 111.659 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -63.47 -47.33 82.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.94 90.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.488 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 6.4 tt -67.36 -39.44 85.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 p -69.75 -41.49 75.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.184 -0.323 . . . . 0.0 111.201 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.7 tt -69.8 -39.84 76.32 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.043 0.449 . . . . 0.0 110.963 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD22 ' HD2' ' A' ' 12' ' ' ARG . 7.0 tt -54.76 -55.76 26.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD22 ' A' ' 11' ' ' LEU . 12.4 mpt_? -61.2 -27.82 68.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.1 -52.98 4.56 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -106.44 -9.64 16.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -100.3 109.15 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.548 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt -121.96 155.54 35.3 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.845 0.831 . . . . 0.0 110.72 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -75.87 101.13 5.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.985 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.47 107.39 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.433 0.635 . . . . 0.0 110.544 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.6 m -76.82 99.91 5.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.089 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.8 p -95.33 -177.59 4.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.538 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m -75.28 -14.94 60.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.167 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -105.5 -8.11 18.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.415 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 -179.66 22.07 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 17' ' ' THR . 46.3 mm-40 -79.15 121.18 24.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -127.1 164.73 20.95 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.789 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.4 m -74.86 95.27 2.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.182 -1.826 . . . . 0.0 111.018 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.05 104.87 2.38 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 tp -88.73 104.89 17.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.0 112.162 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.58 126.64 12.87 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 90' ' ' ILE . 29.3 mm -89.34 -51.57 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 117.417 0.608 . . . . 0.0 110.399 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -171.95 149.17 2.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.614 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.06 -87.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -135.86 16.06 3.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.494 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.51 119.83 49.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.302 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -125.39 147.16 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.506 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.66 136.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.859 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' A' ' 73' ' ' THR . 15.5 mm -141.04 142.68 28.48 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.34 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.37 148.04 91.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.277 1.318 . . . . 0.0 111.657 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 52.2 m -68.23 -35.52 78.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.837 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' B' ' 6' ' ' PHE . 54.6 p-80 -74.02 -3.96 32.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -20.7 38.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.581 0.705 . . . . 0.0 109.366 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 59.14 71.64 0.92 Allowed Pre-proline 0 CA--C 1.517 -0.311 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.052 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.67 125.44 10.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.59 1.526 . . . . 0.0 108.963 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.15 178.88 50.94 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.372 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 56' ' ' VAL . 19.7 t70 -70.07 -31.2 68.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 4.9 p-10 -120.18 140.94 50.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.13 161.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.407 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -98.22 114.48 26.75 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.678 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -91.9 92.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.165 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 66.78 5.25 3.84 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.339 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -31.88 2.34 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.976 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' CD ' HH12 ' A' ' 79' ' ' ARG . 50.3 tt0 -81.72 137.3 35.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 110.449 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -78.45 128.97 34.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.44 154.44 13.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.611 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.5 mtm180 -106.33 153.39 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.944 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 75' ' ' LEU . 7.7 p -94.96 118.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.49 -33.11 68.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.17 107.83 4.13 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.863 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.47 95.88 6.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -109.31 123.35 49.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.589 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -76.4 124.27 27.28 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -89.51 103.86 16.46 Favored 'General case' 0 C--O 1.259 1.596 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 29.6 m -110.82 173.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.844 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -72.5 139.64 81.32 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.55 -27.58 41.63 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.936 1.758 . . . . 0.0 111.788 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -85.54 8.39 19.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.459 0.647 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.5 t30 64.06 68.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.457 1.123 . . . . 0.0 111.183 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.455 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.9 mt -139.93 170.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 112.313 -2.221 . . . . 0.0 105.32 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 68' ' ' ILE . 65.7 t30 -86.43 135.72 33.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.342 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.641 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 20.4 mt -108.0 -26.94 10.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.0 tp10 79.09 3.6 2.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.132 -1.394 . . . . 0.0 113.169 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 17.7 mt -89.88 126.05 35.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.406 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 39.8 m -103.96 118.8 37.52 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.063 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.2 102.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 56' ' ' VAL . 13.9 tp -95.42 94.95 8.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.85 -178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -84.17 94.95 8.49 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.958 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' VAL . 83.6 mt -99.29 122.57 42.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.213 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.26 84.7 5.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.406 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.429 HH12 ' CD ' ' A' ' 52' ' ' GLN . 27.9 tpt180 -95.56 133.01 40.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.661 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.22 -44.42 79.51 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 118.11 17.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -87.14 134.51 33.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.331 0.586 . . . . 0.0 111.945 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -68.92 137.47 53.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.438 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -72.91 131.4 42.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.946 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.86 86.07 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 18.5 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -63.56 -28.44 69.94 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.698 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.74 -18.65 74.94 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.531 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 92.5 m-85 -77.43 -22.78 50.96 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HD12 ' A' ' 30' ' ' ILE . 72.9 mt -72.58 123.66 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.6 t -123.37 136.35 54.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -65.92 -42.14 90.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.96 107.01 18.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.72 -76.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HB3' ' NZ ' ' A' ' 155' ' ' LYS . 39.2 tt0 51.43 70.82 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.82 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.02 86.84 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.573 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.61 2.14 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.453 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.9 t70 -139.35 124.4 18.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.557 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.36 168.57 19.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.644 0.735 . . . . 0.0 112.545 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 34.2 m -119.67 136.42 54.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.381 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 160' ' ' HIS . 3.1 tm? -99.48 114.11 26.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.12 120.49 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.161 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -113.99 119.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.425 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -129.32 72.8 1.48 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.2 p -121.36 -171.95 2.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.632 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.44 -35.76 71.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.27 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.58 -55.81 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.04 125.35 12.27 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.392 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 1.6 p -88.15 112.58 22.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' THR . 84.0 m-20 76.29 74.48 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 103' ' ' VAL . 23.8 m -142.22 136.37 29.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.195 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.47 137.24 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 109.651 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.78 108.72 13.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.624 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.7 pt-20 -75.65 108.2 8.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.08 -29.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.547 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.62 -115.81 4.61 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.945 -1.121 . . . . 0.0 115.735 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 15.4 Cg_exo -60.19 109.35 0.61 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.95 2.434 . . . . 0.0 115.448 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.88 134.94 35.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -134.64 -172.27 2.98 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.86 147.55 48.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.07 -14.19 11.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.49 -111.69 3.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.974 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.2 118.73 32.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.51 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' B' ' 2' ' ' LEU . 49.3 pt -135.32 -179.27 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 5.4 m-20 -96.29 123.7 40.02 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.967 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 53.7 tp -106.12 104.22 13.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 128' ' ' SER . 10.1 t 63.47 28.57 15.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 127' ' ' SER . 93.4 p 80.16 1.23 2.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.873 1.669 . . . . 0.0 112.011 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 m -95.3 114.45 63.85 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.291 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.23 114.06 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.11 1.873 . . . . 0.0 112.718 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -121.3 130.01 53.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.615 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -105.59 164.46 11.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 55.18 50.07 15.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.352 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 35.2 ttm -101.85 134.65 44.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.061 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 70.0 mt -86.78 152.07 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.296 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -129.58 151.03 50.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.45 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -156.32 142.95 18.6 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.584 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.44 99.36 6.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.505 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -171.02 127.9 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.062 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 110.94 3.25 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.529 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.437 HG22 HE22 ' A' ' 145' ' ' GLN . 29.1 p -109.62 156.54 20.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.855 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 143' ' ' THR . 51.0 tttm -143.36 152.41 41.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.016 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 6.3 p -40.59 161.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.481 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.65 -28.58 7.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.502 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.437 HE22 HG22 ' A' ' 141' ' ' THR . 24.7 mt-30 -83.09 -11.58 57.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.64 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 25.2 p -72.08 111.95 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.634 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 137.23 -14.71 3.74 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.615 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.75 151.72 52.21 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 124.32 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 112.039 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.0 tp -91.98 109.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.3 p -144.59 178.25 8.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.97 0.89 . . . . 0.0 112.13 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.7 174.65 10.46 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.766 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 3' ' ' ASN . 27.9 m -72.45 94.44 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.04 -24.61 9.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.584 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 94.0 mttt -134.65 146.52 49.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.73 0.776 . . . . 0.0 112.507 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 mm -110.1 130.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -101.69 -45.39 5.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.46 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.596 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.0 -170.17 43.0 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.651 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.506 HG23 HD11 ' A' ' 173' ' ' LEU . 30.5 pt -116.68 143.63 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.542 ' HB2' HD21 ' A' ' 101' ' ' LEU . 67.0 t60 -73.52 114.98 12.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.321 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.77 -21.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -176.63 -157.01 16.75 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.886 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.96 165.96 35.82 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.578 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 28.1 t-20 -136.62 85.99 2.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.778 0.799 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.31 -106.99 1.61 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.563 -1.198 . . . . 0.0 115.178 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.14 -17.11 57.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.93 127.31 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.48 142.4 17.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.464 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 66.6 m-85 -119.5 122.06 40.81 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.236 1.018 . . . . 0.0 111.994 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 32.3 t -119.83 149.71 41.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.38 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.39 136.29 35.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -67.46 123.99 21.95 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.596 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 29.6 mt -90.61 84.96 5.97 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -80.75 135.72 36.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.999 0.428 . . . . 0.0 110.37 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.09 -29.14 68.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.401 0.619 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -55.14 -32.12 61.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.536 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.3 -11.64 51.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 . . . . . 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.489 -179.871 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' A' ' 124' ' ' ILE . 2.7 mm? . . . . . 0 CA--C 1.514 -0.438 0 CA-C-O 121.457 0.646 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.2 tt0 -122.49 79.67 1.64 Allowed 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 171.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.59 145.63 30.53 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 33.2 tp -98.59 153.58 18.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.5 m-85 -59.15 142.35 51.82 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.64 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.3 mt-30 . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 118.203 -1.399 . . . . 0.0 . -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo . . . . . 0 CA--C 1.543 0.929 0 N-CA-C 115.186 1.187 . . . . 0.0 115.186 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.1 t-20 -57.01 -51.07 70.72 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.828 -0.545 . . . . 0.0 112.206 -177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -56.28 -45.29 80.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.698 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.12 -28.35 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 111.224 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.05 -44.66 83.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.82 90.76 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.485 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.33 -49.81 74.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.987 0.423 . . . . 0.0 110.193 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.24 -39.55 82.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.972 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.8 tp -62.09 -49.57 75.4 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.509 0.671 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.8 tt -54.6 -43.72 72.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.155 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -64.91 -29.69 70.65 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.6 6.15 13.38 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.953 0.797 . . . . 0.0 112.982 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.8 -38.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.1 mt -86.39 115.89 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.353 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.4 mtt -119.72 161.74 20.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.925 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -92.8 123.67 36.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.92 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -112.84 105.57 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.931 0.872 . . . . 0.0 111.448 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.683 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.1 m -78.0 123.04 26.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.619 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.1 p -126.26 -173.48 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 m -81.03 -9.47 59.83 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -91.46 -43.47 9.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.6 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.66 -169.05 42.18 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.268 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG2' HG23 ' A' ' 19' ' ' THR . 31.4 mt-10 -106.02 107.32 18.26 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -101.98 171.13 7.69 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.423 1.106 . . . . 0.0 113.516 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.7 m -79.9 113.77 18.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.534 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.02 112.49 4.48 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.781 -1.199 . . . . 0.0 110.877 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 tp -94.98 120.0 34.46 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -89.25 129.86 9.88 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.476 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -90.61 -56.85 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.72 0.76 . . . . 0.0 110.426 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -160.33 127.56 4.42 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 12.5 t0 56.89 -78.35 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.486 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 15.2 mmt-85 -120.46 -11.24 9.14 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.851 -0.531 . . . . 0.0 110.666 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 HG13 ' A' ' 74' ' ' VAL . 57.2 t -80.19 99.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.331 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 45.7 t -114.23 141.84 47.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.838 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 173' ' ' LEU . 24.1 m -111.84 137.64 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.712 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.7 tt -142.24 141.7 22.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.36 142.53 16.91 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.253 1.302 . . . . 0.0 111.351 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.539 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 83.7 m -70.82 -34.84 72.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.132 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -65.62 -7.22 13.91 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.389 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.95 60.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.48 0.657 . . . . 0.0 109.672 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.6 mm-40 50.1 72.83 1.12 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.893 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.03 156.06 60.94 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.96 2.44 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -153.46 26.14 Favored Glycine 0 N--CA 1.455 -0.062 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.835 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.24 -15.58 35.51 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 2.2 p30 -139.27 156.56 46.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.223 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.23 161.06 17.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 77.3 mt -104.38 108.51 19.96 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 17' ' ' THR . 80.2 t -84.6 85.07 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.352 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 73.82 -10.1 1.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.091 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.82 -33.33 0.57 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.91 111.08 1.16 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.802 -1.199 . . . . 0.0 111.557 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -75.12 96.48 3.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 tt -123.92 148.02 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.661 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 8.4 mpt_? -97.44 165.05 12.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.326 0.584 . . . . 0.0 111.526 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.4 t -90.45 120.65 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.725 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 78' ' ' ASP . 75.9 tttt -79.86 -38.67 32.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.385 0.612 . . . . 0.0 110.152 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -159.29 132.63 7.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.395 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.97 114.57 26.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.185 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -118.06 105.73 12.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.319 -178.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.09 110.11 18.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.543 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 71.2 mt -79.32 120.86 24.38 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.447 ' HA ' ' H ' ' A' ' 70' ' ' LEU . 33.5 m -116.01 154.87 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 12.6 t70 -87.1 143.45 34.85 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 119.034 0.834 . . . . 0.0 112.91 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -43.72 -17.13 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.52 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.633 ' HG2' ' OD1' ' A' ' 64' ' ' ASP . 52.7 mm-40 -71.34 0.9 7.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.316 0.579 . . . . 0.0 109.827 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 64.4 m-80 72.75 18.82 4.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -116.98 145.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.858 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -51.6 135.58 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.106 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.0 tp -104.56 -16.69 14.96 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.539 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 68.3 14.76 9.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.122 -1.399 . . . . 0.0 113.648 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 82.1 mt -105.91 105.29 15.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.061 0.457 . . . . 0.0 111.499 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -89.54 110.19 21.06 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.434 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 95.5 t -81.51 108.86 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 tp -101.49 100.34 10.77 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.815 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 14.1 m -74.41 102.76 4.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 33' ' ' ARG . 86.5 mt -104.71 127.81 52.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.619 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 57' ' ' LYS . 14.1 t70 -87.79 89.46 8.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -93.61 133.89 36.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.61 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.91 -28.75 58.21 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.34 118.36 36.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 19.0 pttp -59.89 129.21 40.71 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.211 -0.995 . . . . 0.0 108.842 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -78.97 161.53 26.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.593 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -49.08 122.84 6.33 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -175.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.22 93.76 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.841 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 156' ' ' ILE . 49.0 pt -96.81 19.11 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -56.16 -35.31 67.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.312 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.76 -16.28 79.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.062 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -87.61 -13.13 43.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.55 133.37 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 7.1 m -96.25 130.94 43.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -77.97 -55.1 5.57 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 91' ' ' SER . 29.0 t70 -100.94 131.68 46.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.4 mt -79.39 -67.64 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.827 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 47.04 71.68 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -167.26 78.32 0.11 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.2 p -71.83 12.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 27.8 t70 -150.31 121.55 7.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.833 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.76 12.6 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.866 0.841 . . . . 0.0 111.591 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 m -120.06 145.96 46.36 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.585 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.459 HD21 ' HA3' ' A' ' 148' ' ' GLY . 9.6 tt -120.56 121.94 39.5 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 112' ' ' ILE . 24.2 m -111.21 121.92 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.061 0.458 . . . . 0.0 111.04 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 4.0 t -100.5 134.48 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.08 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -135.7 70.97 1.42 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 m -127.18 175.43 8.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.764 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 25.8 p-10 -71.42 -20.05 62.16 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.359 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -84.97 -34.16 22.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.423 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.47 97.29 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.421 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 102.85 15.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 60.55 70.83 0.6 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.839 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 28.6 m -117.75 111.87 19.69 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.855 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 102' ' ' VAL . 2.0 mp -87.36 105.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 tt -116.56 127.24 54.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.658 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.71 128.51 34.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.17 -24.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.03 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 79.13 -124.12 6.43 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.852 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 27.9 Cg_endo -62.66 105.11 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.52 2.147 . . . . 0.0 114.495 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 90.6 t -97.2 118.32 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.694 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 p -138.07 167.58 21.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.971 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -104.53 126.04 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.61 -49.79 6.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.88 -115.89 4.13 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.476 -0.868 . . . . 0.0 115.114 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 123' ' ' LEU . 3.8 mp -95.96 107.8 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.061 -0.569 . . . . 0.0 112.096 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 42.2 pt -138.98 -177.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.274 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -102.1 136.53 41.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.008 0.432 . . . . 0.0 110.598 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 4.1 mm? -115.07 103.81 11.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' SER . 10.3 t 60.8 31.13 20.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.768 -0.582 . . . . 0.0 109.751 -177.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 127' ' ' SER . 67.0 m 79.96 2.94 2.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.444 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -99.59 115.68 65.45 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.777 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.05 115.37 2.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.947 1.765 . . . . 0.0 112.368 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.563 ' HB ' HD23 ' A' ' 126' ' ' LEU . 19.7 m -128.69 141.84 51.21 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.014 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 60.3 t30 -117.91 162.8 17.54 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 3.2 mpt_? 77.84 22.94 0.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.659 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.48 129.27 37.62 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.146 0.974 . . . . 0.0 113.303 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 79.6 mt -92.3 132.66 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.278 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -107.25 129.22 54.9 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.515 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 1.3 p90 -133.29 143.44 49.05 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.96 99.49 9.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.636 0.732 . . . . 0.0 112.009 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 141' ' ' THR . 88.8 t80 -170.11 126.16 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.023 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.12 110.97 1.76 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 36.8 p -112.52 151.68 29.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -143.16 151.52 40.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.334 1.064 . . . . 0.0 110.916 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.403 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.86 156.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.363 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.81 -20.74 45.41 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 121.726 0.625 . . . . 0.0 111.648 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -87.33 2.94 48.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.459 -0.871 . . . . 0.0 112.228 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.79 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 16.6 m -64.8 142.62 58.37 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.621 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 104.5 -23.54 31.24 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.866 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 101' ' ' LEU . . . -49.74 135.92 24.3 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.562 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 47.3 t -88.78 122.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 111.847 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -93.46 108.83 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -146.65 166.18 27.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.193 0.997 . . . . 0.0 113.418 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -128.74 173.25 10.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.485 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -67.53 106.26 2.1 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.885 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.99 6.47 89.44 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.24 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -137.96 112.98 9.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.416 ' CD1' HD12 ' A' ' 86' ' ' ILE . 65.7 mt -103.59 134.73 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.362 0.601 . . . . 0.0 110.596 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -99.53 -55.13 2.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.931 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.64 -156.97 21.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.55 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.1 pt -125.94 148.04 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.334 0.588 . . . . 0.0 112.089 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.01 116.55 6.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.195 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 171' ' ' ALA . 46.2 t -104.48 -28.88 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.625 0.726 . . . . 0.0 109.901 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' B' ' 7' ' ' GLN . . . 174.44 -145.84 8.26 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.589 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.62 174.11 44.56 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.4 t-20 -135.26 86.26 2.23 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.733 0.778 . . . . 0.0 109.769 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.05 -103.52 0.73 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.545 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -82.85 -11.49 58.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.68 -177.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.474 ' OE1' ' HB3' ' A' ' 166' ' ' ARG . 1.1 mp0 -112.8 145.99 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.851 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -105.13 150.8 17.11 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.7 m-85 -132.8 119.69 20.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.217 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.7 t -113.59 152.66 30.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.579 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 161' ' ' VAL . . . -90.98 135.19 33.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 9.0 tt0 -74.93 113.48 12.28 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.595 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.4 mp -82.9 83.04 7.92 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -81.06 121.14 25.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.122 0.963 . . . . 0.0 111.249 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -39.67 -39.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.253 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -45.56 -51.21 12.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -69.45 -19.99 63.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.704 -179.367 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.8 mm? . . . . . 0 CA--C 1.508 -0.637 0 CA-C-O 121.273 0.559 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -121.89 77.32 1.36 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -77.51 147.2 35.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.508 HD12 ' H ' ' B' ' 6' ' ' PHE . 55.1 tp -103.24 142.85 33.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.508 ' H ' HD12 ' B' ' 5' ' ' LEU . 24.6 m-85 -57.78 125.39 22.81 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.06 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.79 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 83.2 mt-30 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 116.525 -0.307 . . . . 0.0 . 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo . . . . . 0 CA--C 1.529 0.266 0 N-CA-C 113.913 0.697 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.3 -51.81 53.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.296 0.57 . . . . 0.0 110.834 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -67.63 -36.15 80.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.941 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.19 -50.53 73.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 110.578 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.19 -48.75 79.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.05 83.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.438 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.3 tt -64.28 -40.39 95.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.596 0.236 . . . . 0.0 110.666 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -63.95 -43.71 94.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.38 . . . . 0.0 110.678 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.3 tp -67.51 -43.17 81.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.682 0.754 . . . . 0.0 110.58 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.3 tp -49.77 -50.54 44.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.436 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 78.4 mtp180 -56.9 -40.05 75.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.74 -15.49 8.9 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.9 5.56 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.8 mm -119.12 109.48 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.4 mmt -124.78 150.84 45.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.654 0.74 . . . . 0.0 111.211 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -76.33 95.36 3.76 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.7 mp -87.86 104.5 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 m -95.88 113.57 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.199 1.0 . . . . 0.0 109.987 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 69.4 p -94.44 -162.84 0.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.863 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.6 m -80.15 -7.25 58.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.68 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -100.74 -56.21 2.39 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.255 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.46 -163.59 26.55 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -83.49 123.39 29.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.267 -0.466 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -126.41 159.28 33.72 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 121.189 0.519 . . . . 0.0 109.709 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 14.2 m -90.16 109.23 20.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.141 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -88.23 110.18 3.6 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.368 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.1 120.4 36.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -87.27 138.84 15.66 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.63 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 31' ' ' HIS . 4.1 mp -120.57 -39.8 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 118.447 1.124 . . . . 0.0 110.911 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 36.0 m-70 -135.43 128.61 31.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 18.8 t70 43.72 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 14.3 ptt180 -127.08 21.54 6.78 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.963 0.887 . . . . 0.0 109.253 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.38 112.46 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.064 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 63.2 m -116.76 156.7 26.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.65 139.52 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.176 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 pt -142.01 162.86 43.64 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.0 152.45 71.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 121.212 1.275 . . . . 0.0 111.52 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 61.0 m -70.69 -33.1 70.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -79.13 3.89 16.3 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.64 59.67 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 20' ' ' THR . 12.7 mm100 68.41 72.32 0.36 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.44 117.01 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.985 2.457 . . . . 0.0 110.086 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.35 -138.11 2.81 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.812 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' HG12 ' A' ' 56' ' ' VAL . 24.8 t70 -77.55 -24.67 49.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.515 ' HB3' HH11 ' A' ' 55' ' ' ARG . 4.9 p-10 -142.83 162.63 34.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.881 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -140.79 149.04 21.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 84.6 mt -82.99 99.99 10.17 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.731 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -86.16 96.1 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.156 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 63.91 18.91 11.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.39 -17.81 21.09 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.338 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -90.64 123.54 34.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.11 113.31 14.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.181 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.2 mt -116.75 122.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.5 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 46' ' ' ASP . 2.7 mpt_? -66.84 152.0 46.43 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.368 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -94.4 137.25 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 33' ' ' ARG . 67.7 mttm -92.56 -55.52 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' ' HB ' ' A' ' 76' ' ' THR . 29.1 m-20 -128.26 140.14 52.05 Favored 'General case' 0 N--CA 1.46 0.049 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.622 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -132.44 78.93 1.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.567 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 90.6 t80 -88.01 131.33 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.591 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 10.6 mptt -90.1 116.13 27.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.98 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 17.2 mt -82.93 119.08 23.96 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-O 121.608 0.718 . . . . 0.0 110.549 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 29.8 m -128.62 158.22 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.147 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.05 145.26 88.57 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.261 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.11 -19.12 3.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.809 1.673 . . . . 0.0 113.218 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.06 5.57 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 109.81 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.76 61.59 0.97 Allowed 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.808 0.813 . . . . 0.0 109.641 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' LEU . 35.9 mm -133.44 145.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.026 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -59.57 128.87 39.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -105.1 -24.36 12.79 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 174.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.629 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 75.22 10.31 3.67 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.452 -1.703 . . . . 0.0 113.607 175.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 10.5 mp -95.13 122.2 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.4 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 92.4 m -98.26 112.45 24.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.485 0.659 . . . . 0.0 109.883 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 98.9 t -76.2 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.7 tp -94.25 102.02 14.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.388 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 20.1 m -89.36 100.84 13.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 122.091 0.948 . . . . 0.0 109.178 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.8 mt -74.63 141.25 44.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 19.5 t70 -82.88 72.63 9.95 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.09 133.67 46.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.148 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -81.05 -32.13 34.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.97 98.44 2.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -88.46 150.18 23.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.139 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.404 ' HB2' ' H ' ' A' ' 84' ' ' ARG . 5.8 p90 -92.21 -163.9 1.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.528 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 12.5 tpp180 -83.86 117.58 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.598 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 31' ' ' HIS . 4.8 m-20 -66.57 99.46 0.59 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -91.56 27.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 122.037 -0.414 . . . . 0.0 111.544 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -65.1 -15.46 62.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.463 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.6 -16.42 75.66 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.764 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -91.7 -14.41 30.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.06 127.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 38.9 m -125.95 132.85 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.495 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.3 pm0 -81.93 -27.29 33.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.75 149.08 26.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.4 mt -103.4 -68.61 0.83 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 41.75 37.66 0.8 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.433 0.635 . . . . 0.0 112.31 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.57 73.62 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 118' ' ' VAL . 1.2 p -73.5 20.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.138 -1.531 . . . . 0.0 114.818 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -121.59 130.12 53.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.43 166.32 25.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.476 -0.89 . . . . 0.0 113.1 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 96.4 m -121.55 142.54 49.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.49 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.13 113.41 26.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.6 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.95 97.57 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -87.93 123.01 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.619 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.0 t60 -137.64 33.31 2.47 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 20.1 p -109.51 -162.44 0.81 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.024 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 105' ' ' SER . 29.0 t-20 -53.35 -56.58 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.15 -44.25 80.24 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.557 -0.714 . . . . 0.0 112.055 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.55 106.28 7.74 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.416 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 23.9 m -93.91 105.72 17.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.619 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 9.9 t30 79.18 72.42 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.275 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.3 m -141.15 107.86 5.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.37 100.37 11.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.801 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 139' ' ' TYR . 58.1 tp -127.55 128.24 45.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.327 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 8.6 pt-20 -79.19 142.53 36.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.83 -20.07 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.55 -124.78 7.96 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.958 -1.115 . . . . 0.0 114.846 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.25 128.62 12.26 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 114.833 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 97' ' ' VAL . 86.8 t -104.91 157.58 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.764 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 36.7 m -160.21 114.89 2.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -78.01 115.94 18.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 118.668 -1.213 . . . . 0.0 108.059 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.9 -11.88 46.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.612 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.08 -120.64 5.26 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.788 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 68' ' ' ILE . 48.5 tp -94.17 113.66 25.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' ' 2' ' ' LEU . 34.4 pt -138.42 177.83 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.1 m-20 -94.64 128.35 41.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.657 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 68.4 tp -115.36 105.05 12.41 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' SER . 12.5 t 62.24 30.57 17.61 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.7 m 82.1 -1.55 1.48 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.151 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 39.3 m -100.22 123.09 47.98 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.874 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.71 116.37 3.21 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.04 1.827 . . . . 0.0 111.739 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.6 m -126.82 134.25 50.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.279 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -108.93 163.2 13.51 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 177' ' ' TYR . 15.8 mmt180 66.37 24.0 10.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.022 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 tpt -72.24 128.86 36.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.143 0.973 . . . . 0.0 112.034 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 38.2 mm -92.43 126.61 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.899 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' THR . 33.8 ttt-85 -104.75 137.27 42.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.33 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.4 p90 -145.63 109.51 4.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -74.01 99.3 3.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.829 1.3 . . . . 0.0 110.914 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 113' ' ' LEU . 85.4 t80 -160.21 137.95 9.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 111.497 -2.592 . . . . 0.0 106.32 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 86.18 1.95 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -101.01 161.84 13.31 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -141.99 168.29 20.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.849 1.309 . . . . 0.0 113.093 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.576 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.03 152.61 0.17 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.763 175.523 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.5 -19.81 50.38 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -94.22 7.21 46.12 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.205 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.796 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 13.7 m -62.47 136.97 58.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.0 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 103.91 -16.98 50.01 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.829 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.5 142.28 43.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.505 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.13 114.9 29.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.439 0.638 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.7 tp -89.54 106.56 18.53 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.016 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.0 p -149.85 -177.17 5.74 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.039 0.923 . . . . 0.0 111.447 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.99 163.96 35.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.734 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 t -61.12 120.94 11.28 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.717 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.87 -19.39 45.85 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 24.9 ttmm -144.41 124.59 13.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.878 0.839 . . . . 0.0 111.537 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.33 135.34 38.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.455 ' HA ' HE22 ' A' ' 172' ' ' GLN . 93.1 m-85 -103.06 -71.21 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . -152.56 -169.13 17.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.387 -1.387 . . . . 0.0 114.719 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 161' ' ' VAL . 27.4 pt -119.36 140.67 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.457 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -61.09 120.33 10.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 159' ' ' ILE . 73.2 t -117.08 -28.35 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.491 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.09 -151.28 8.4 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.345 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.48 161.16 27.6 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.0 t-20 -135.29 107.91 7.43 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.34 -110.18 3.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.872 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -113.06 25.82 11.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.248 1.023 . . . . 0.0 109.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -126.07 135.99 52.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.447 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -94.38 148.39 18.98 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.282 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.2 m-85 -128.96 123.42 32.44 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.822 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.8 t -116.07 155.5 28.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.511 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.91 123.8 42.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 174' ' ' LYS . 55.8 tp60 -72.27 124.85 25.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.638 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.0 mp -88.87 84.17 6.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 172' ' ' GLN . 66.4 mttm -78.43 132.72 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.495 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 8.1 ttpm? -52.12 -30.81 28.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -53.61 -29.44 37.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.406 ' OH ' ' HG3' ' A' ' 133' ' ' ARG . 7.8 m-85 -72.18 -32.3 66.7 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.722 -0.611 . . . . 0.0 111.362 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.535 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 90.7 m-85 . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.212 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.448 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.9 mm? . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 121.185 0.517 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.6 tt0 -119.43 78.05 1.27 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 171.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.74 143.61 31.71 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.536 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 24.2 tp -99.89 153.34 19.23 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.536 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 25.4 m-85 -60.07 130.31 46.08 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.796 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.8 mt-30 . . . . . 0 C--N 1.315 -0.928 0 C-N-CA 120.623 -0.431 . . . . 0.0 . 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 CA--C 1.535 0.564 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 12.2 t30 -61.71 -55.64 28.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 m -74.37 -33.6 63.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.91 -24.81 58.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.75 -42.69 97.8 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.48 85.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.76 -50.28 72.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.955 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -71.23 -37.17 72.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.993 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.85 -44.72 95.37 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.5 pp -63.69 -29.95 71.11 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -76.23 -28.53 57.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.13 -45.7 6.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -120.25 6.64 10.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.737 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 46.1 mm -106.22 106.0 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.0 mtp -111.84 147.58 35.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.216 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 101.66 12.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.143 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.72 98.87 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 32.5 m -80.66 100.0 8.45 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -170.79 2.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.905 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -74.01 -29.75 62.11 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.586 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.82 -23.71 22.76 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.212 -0.305 . . . . 0.0 111.516 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.27 -164.99 37.54 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.644 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -97.86 107.82 20.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.634 0.731 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -108.97 164.14 12.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.904 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.3 m -89.34 118.18 28.83 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.64 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.23 99.1 2.49 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.652 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.92 104.89 14.38 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.51 120.83 5.65 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.446 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.0 mp -81.75 -58.91 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 117.576 0.688 . . . . 0.0 110.581 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -155.04 148.82 25.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 26.0 m-20 51.71 -91.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.776 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -137.22 22.5 3.0 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.29 119.58 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 110.41 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.0 m -114.31 159.17 20.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.2 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.14 140.97 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 73' ' ' THR . 14.0 tt -148.36 141.89 15.85 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.13 143.25 25.81 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 120.604 0.869 . . . . 0.0 110.167 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.576 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 71.5 m -67.74 -35.03 78.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -68.41 -7.57 32.82 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.42 68.24 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.636 0.732 . . . . 0.0 109.663 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 59.46 69.68 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.198 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -77.62 146.24 23.92 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.27 2.647 . . . . 0.0 110.549 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.41 -140.42 8.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.982 -1.104 . . . . 0.0 114.079 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.83 -24.38 38.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.732 -0.734 . . . . 0.0 110.324 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.62 139.83 34.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 27.6 m -124.55 153.47 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.246 0.546 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.3 mt -94.52 101.87 13.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.179 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.99 87.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.61 16.02 8.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.522 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.63 -25.07 6.64 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.034 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.08 108.47 17.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 76.5 mttt -73.8 142.38 46.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.715 0.769 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -136.53 142.17 39.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.85 140.12 33.08 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.854 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.45 155.56 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.408 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -113.72 -46.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.54 134.5 8.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.474 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -124.1 116.01 22.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 87.5 t80 -133.65 123.85 25.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.778 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 61' ' ' LYS . 2.4 mppt? -83.9 112.9 20.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . 6.7 tt -96.49 115.13 26.92 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.174 0.988 . . . . 0.0 109.876 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 27.7 m -111.35 178.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.165 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.6 t70 -70.93 136.56 85.09 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.92 -28.55 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.363 2.042 . . . . 0.0 113.948 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -90.12 20.21 4.48 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.6 0.714 . . . . 0.0 110.742 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.75 62.06 1.56 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.887 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 54.9 mt -133.13 158.29 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -77.94 144.58 36.7 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.14 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.707 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.4 tp -127.48 -35.65 2.14 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 55.4 mm-40 85.96 7.26 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.5 HD13 ' HG ' ' A' ' 70' ' ' LEU . 11.3 mp -78.97 93.66 5.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.164 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.576 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 45.7 m -84.01 106.25 15.52 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 70.0 t -71.16 96.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.5 tp -103.04 98.74 8.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 111.304 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -92.26 125.51 36.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.463 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.1 mt -114.02 153.43 29.39 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.938 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.62 68.5 8.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.266 -1.373 . . . . 0.0 108.475 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -78.82 117.58 20.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.877 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -76.31 -52.18 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.947 0.403 . . . . 0.0 109.982 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.92 82.98 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 19.5 pttp -73.27 139.16 45.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.641 0.734 . . . . 0.0 112.139 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -82.1 -178.32 6.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -69.64 147.87 50.07 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.565 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 6.6 t70 -88.69 95.98 10.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.848 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 90' ' ' ILE . 39.1 pt -91.49 15.66 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 13.9 ttp180 -62.7 -29.56 70.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.833 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.32 -16.47 80.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.679 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -92.46 -20.17 21.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 56.9 mt -68.74 124.35 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 19.0 m -103.52 120.54 41.06 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.33 -38.07 36.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 91' ' ' SER . 22.1 t70 -101.04 130.62 47.07 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 172.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 mt -90.57 -78.82 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 49.7 70.31 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.42 86.82 0.11 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.6 p -79.41 15.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.123 -0.539 . . . . 0.0 112.272 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 15.2 t70 -141.03 132.14 26.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.965 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.57 31.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.025 0.917 . . . . 0.0 111.031 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.05 135.85 51.37 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.329 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.93 117.97 34.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.256 0.55 . . . . 0.0 111.879 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.31 93.77 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 108' ' ' PHE . 4.9 t -83.04 122.06 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.457 0.646 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 72.5 t60 -145.71 41.65 1.22 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.7 p -108.35 -164.9 0.99 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.18 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.37 -48.92 79.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.79 -17.58 53.04 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' HB2' HG11 ' A' ' 103' ' ' VAL . 20.7 m-85 -150.94 101.39 2.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.507 -0.746 . . . . 0.0 110.742 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 p -85.65 110.02 18.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.519 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 t30 66.43 71.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.564 0.697 . . . . 0.0 111.655 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 m -139.81 109.31 6.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.08 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.0 tp -82.39 120.87 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 116.05 20.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.579 -176.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 7.6 pt-20 -74.15 128.3 35.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.35 -27.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.067 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.45 -131.23 10.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.912 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 39.5 Cg_exo -61.38 115.93 3.07 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.842 2.362 . . . . 0.0 114.19 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -92.46 116.51 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.295 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -123.53 172.08 9.02 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 67.2 mtt -115.75 154.33 29.8 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.0 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.82 -22.92 10.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.02 -111.05 3.23 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.064 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -109.66 111.98 23.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.848 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 46.2 pt -139.35 -177.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 84.5 m-20 -101.43 127.7 47.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.823 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 34.7 tp -107.75 106.58 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 128' ' ' SER . 60.6 p 60.84 30.27 19.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.297 0.57 . . . . 0.0 109.951 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' SER . 63.4 m 85.67 0.52 0.7 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.282 1.033 . . . . 0.0 112.431 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.9 m -110.1 115.27 55.03 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 75.6 Cg_exo -52.05 128.09 25.75 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.529 2.153 . . . . 0.0 114.365 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 p -125.46 145.35 50.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.098 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 65.9 t30 -115.68 160.82 19.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.322 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 5.2 mpt_? 65.83 32.72 8.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.074 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.4 mmm -77.91 127.28 32.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.565 0.698 . . . . 0.0 112.807 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 71.7 mt -85.41 145.39 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.843 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.85 134.0 44.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 111.675 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -152.94 148.41 27.08 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.54 120.03 36.11 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 122.65 1.214 . . . . 0.0 111.502 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -175.06 129.84 0.3 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.811 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.04 0.79 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.151 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.8 t -119.55 138.45 53.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.112 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.43 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 113.455 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.19 153.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.276 174.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.16 -20.11 31.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.429 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -90.68 -7.84 51.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.327 -0.437 . . . . 0.0 111.495 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.621 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 25.8 p -73.61 135.13 43.81 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.024 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 124.03 -24.14 6.39 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.053 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.48 148.82 25.27 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.142 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.95 121.61 50.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 112.38 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.8 tp -92.41 113.42 25.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.283 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -149.26 169.9 19.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.752 0.787 . . . . 0.0 112.823 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.6 169.95 16.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.132 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 1.6 t -62.69 106.11 0.75 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.87 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.12 70.43 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.402 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.87 106.92 9.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.4 mt -95.08 115.96 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.09 -65.37 1.02 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.894 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.501 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -177.39 -155.6 14.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.103 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.4 pt -119.52 142.76 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.374 0.607 . . . . 0.0 111.236 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.15 115.62 7.83 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.35 -25.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.42 -154.84 10.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.564 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.31 161.77 31.89 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.516 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 48.3 t30 -136.2 98.54 3.88 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.86 -119.78 6.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.657 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -103.03 17.38 24.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.821 0.81 . . . . 0.0 111.015 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -113.01 124.65 53.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.74 139.03 15.17 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.404 ' CZ ' ' HG ' ' B' ' 2' ' ' LEU . 73.4 m-85 -119.09 118.03 30.3 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.088 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 40.4 t -110.94 154.12 24.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.249 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -101.49 136.21 41.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.991 0.424 . . . . 0.0 110.078 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 133' ' ' ARG . 3.0 mm100 -76.92 117.03 18.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.501 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 92.6 mt -89.85 87.19 6.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 177' ' ' TYR . 92.5 mttt -80.52 126.5 31.31 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.325 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 63.0 tttm -43.07 -43.78 4.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.226 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LYS . 3.9 pt20 -57.71 -23.52 52.21 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.489 ' CD2' ' HB2' ' A' ' 174' ' ' LYS . 54.4 m-85 -75.63 -25.99 57.37 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.644 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.203 0.525 . . . . 0.0 110.921 -179.13 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.2 mm? . . . . . 0 CA--C 1.509 -0.62 0 CA-C-O 121.505 0.669 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.4 tt0 -119.74 84.85 2.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 172.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -89.58 146.39 24.6 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 45.9 tp -102.14 151.7 21.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.55 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 22.3 m-85 -57.78 140.87 50.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.621 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 93.8 mt-30 . . . . . 0 N--CA 1.441 -0.892 0 C-N-CA 118.353 -1.339 . . . . 0.0 . 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 CA--C 1.526 0.09 0 N-CA-C 114.073 0.759 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 52.6 t30 -70.78 -46.8 62.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.914 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -62.72 -33.65 75.55 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.812 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.15 -47.01 88.2 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.389 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -62.1 -44.38 96.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.233 0.54 . . . . 0.0 109.835 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.71 87.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.705 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 1.6 tt -64.68 -40.07 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.653 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -67.6 -48.1 67.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 -39.72 87.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.879 0.847 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 67.1 tp -54.9 -49.86 70.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.115 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 16.8 mtm180 -72.33 -29.6 63.97 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -91.12 -48.98 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -175.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -118.49 0.06 11.51 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 55.0 mt -106.44 122.99 60.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.6 mtp -133.98 165.6 24.66 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.991 0.901 . . . . 0.0 110.584 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.74 111.79 12.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.958 -1.474 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.1 mm -104.53 110.38 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 2.0 m -87.31 112.86 22.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.175 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -122.35 -171.93 2.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.32 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.475 ' H ' HG22 ' A' ' 20' ' ' THR . 14.9 m -55.28 -37.09 66.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 25' ' ' PHE . 23.9 ttpp -91.02 0.43 57.54 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.78 -160.16 21.69 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.466 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -89.91 122.85 33.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.136 0.493 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CZ ' ' HE3' ' A' ' 22' ' ' LYS . 66.9 m-85 -113.45 177.6 4.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.233 1.016 . . . . 0.0 112.003 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 49.4 m -91.94 107.18 19.02 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.742 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -93.3 112.1 4.23 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 tp -95.6 103.9 15.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.418 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.68 125.58 13.63 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.7 mm -89.99 -46.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 117.199 0.5 . . . . 0.0 111.106 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 57.0 p-80 -171.83 149.93 2.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.99 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.646 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 31.6 t70 46.49 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.646 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 10.2 ptp85 -125.44 18.86 8.15 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.811 -0.556 . . . . 0.0 111.074 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.51 122.92 58.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.625 0.726 . . . . 0.0 111.71 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.44 141.68 50.97 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.377 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.67 135.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.562 0.696 . . . . 0.0 109.785 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 73' ' ' THR . 8.1 tp -141.04 137.78 17.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.798 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.52 151.53 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.775 0.983 . . . . 0.0 111.196 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 92.0 m -78.35 -34.84 48.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.936 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -72.2 3.8 4.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.759 0.314 . . . . 0.0 111.111 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.33 -24.62 50.78 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.0 0.905 . . . . 0.0 109.336 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 56.9 70.18 1.48 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.817 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.95 152.12 24.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.875 2.383 . . . . 0.0 109.41 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.57 -134.78 7.04 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.91 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.83 -9.14 24.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.499 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 11.6 t70 -136.91 124.43 22.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.082 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.95 172.58 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.697 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.618 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.6 mp -117.03 121.92 42.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.76 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.24 98.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 t30 55.9 58.14 4.64 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.793 -176.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -38.07 1.9 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -72.41 118.7 15.63 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 48' ' ' LEU . 4.6 mtmp? -80.71 146.02 31.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.638 0.732 . . . . 0.0 112.166 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -144.58 146.32 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.076 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 24.8 mmm180 -79.89 145.35 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.67 0.271 . . . . 0.0 110.466 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.29 150.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.647 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -94.65 -58.25 2.24 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.36 117.53 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.277 -1.328 . . . . 0.0 110.454 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 59' ' ' LYS . 38.1 ttpt -107.56 115.67 30.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -121.66 117.46 26.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -77.28 109.36 11.1 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 57.4 tp -85.45 114.36 22.43 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-O 122.475 1.131 . . . . 0.0 110.877 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 34.6 m -123.52 168.36 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 113.092 -1.867 . . . . 0.0 108.786 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 13.3 t70 -63.99 144.16 98.16 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.945 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.75 -19.71 8.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.248 1.965 . . . . 0.0 113.682 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.94 15.75 19.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 109.112 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t30 60.65 64.12 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.08 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -130.87 142.16 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 131' ' ' THR . 65.2 t30 -64.4 127.13 30.18 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 29.0 mt -98.43 -29.21 13.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 32.5 tp10 85.81 7.94 0.35 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.785 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 10.8 mp -91.93 107.48 19.24 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.736 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 51.7 m -90.27 105.37 17.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.09 99.78 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.56 100.94 13.6 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.486 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -94.58 98.42 10.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.367 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 77' ' ' LEU . 2.0 pt? -122.62 127.93 50.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.457 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.79 86.14 1.7 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.568 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -79.96 141.08 36.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.12 -1.4 . . . . 0.0 107.943 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -68.96 -38.6 79.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -90.59 96.7 10.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.2 152.9 28.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -85.42 159.06 20.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.116 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' HIS . 23.7 mmm180 -72.49 156.54 38.92 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.877 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.41 67.47 8.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.8 pp -75.1 11.41 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.198 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -58.29 -25.94 62.41 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 120.623 0.249 . . . . 0.0 111.255 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.14 -17.68 74.11 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.805 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -95.34 -4.32 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 109.956 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.402 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.8 mt -82.11 131.9 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 2.5 m -91.6 122.77 34.47 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -174.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -71.18 -63.33 1.13 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.86 135.17 34.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 172.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.13 -54.91 41.65 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.979 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 46.58 71.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.176 0.512 . . . . 0.0 110.965 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.21 93.25 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 5.9 p -78.04 6.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -119.17 124.81 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.57 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.328 1.061 . . . . 0.0 113.745 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 m -124.28 139.18 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.37 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.89 117.77 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.008 0.432 . . . . 0.0 112.033 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -104.24 105.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.841 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.63 121.74 54.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 111.713 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -126.5 76.99 1.67 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.47 -170.28 2.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.444 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -56.4 -47.29 79.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -98.64 -56.65 2.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.903 0.774 . . . . 0.0 110.099 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.46 90.82 5.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 3.1 m -106.87 114.61 28.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.822 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' THR . 3.5 m-20 71.5 26.85 3.14 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.166 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -84.52 111.66 19.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.375 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.58 99.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.336 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 113' ' ' LEU . 3.6 mp -95.39 137.19 34.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.08 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.59 114.81 26.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -97.82 -19.56 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.422 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.33 -135.81 14.69 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.453 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 19.3 Cg_exo -67.23 142.15 59.66 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.02 2.48 . . . . 0.0 114.063 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.83 171.29 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.639 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 m -148.61 157.68 43.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.13 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 73.9 mtm -100.58 129.26 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -97.63 -17.42 19.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.31 -118.85 4.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.48 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.4 tt -107.5 120.3 41.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.204 0.526 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.42 HG21 HD23 ' B' ' 2' ' ' LEU . 40.3 pt -140.68 -166.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 17.5 m120 -117.17 131.55 56.85 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.235 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 1.6 mm? -110.08 108.1 18.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 128' ' ' SER . 7.2 t 61.39 29.14 18.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 127' ' ' SER . 55.3 m 84.31 -10.49 0.88 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.571 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 m -81.64 126.31 76.13 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.05 117.4 4.51 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.828 1.685 . . . . 0.0 112.14 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.0 p -120.25 142.89 48.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.553 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.11 164.29 15.77 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.358 0.599 . . . . 0.0 111.538 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 62.61 34.27 15.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG3' HG12 ' A' ' 124' ' ' ILE . 10.7 mmt -79.32 137.2 37.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.505 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 65.6 mt -96.25 133.69 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.584 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 37.5 ttt180 -120.43 125.23 47.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.762 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -142.9 139.08 30.63 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.92 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -80.44 96.52 6.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.145 0.974 . . . . 0.0 110.982 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -165.56 131.74 2.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.521 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.67 83.62 0.87 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -89.42 140.24 29.71 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.24 157.63 39.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.996 1.379 . . . . 0.0 114.315 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.77 150.0 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.292 175.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.38 -27.35 10.69 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -93.15 7.37 44.5 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.627 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 12.6 p -79.58 125.7 29.94 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.181 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.571 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 127.93 -16.66 6.1 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.303 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 151.67 33.6 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.653 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.37 119.13 45.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.332 0.587 . . . . 0.0 112.039 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.64 110.04 19.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -152.85 -170.4 3.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.024 0.916 . . . . 0.0 113.129 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -166.1 178.6 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.989 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 3.0 t -55.44 107.98 0.38 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.471 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 60.11 30.24 70.01 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.557 ' HE2' ' OG ' ' A' ' 91' ' ' SER . 2.5 tpmt? -145.3 91.67 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.713 -0.743 . . . . 0.0 111.453 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.0 mt -93.75 122.52 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -92.32 -46.79 7.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.054 0.454 . . . . 0.0 110.351 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 163.85 -154.73 25.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.125 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.36 146.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.53 0.681 . . . . 0.0 111.234 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -78.9 115.05 18.34 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.644 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.24 -28.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.65 -151.5 8.99 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.209 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -173.18 167.09 39.76 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.489 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 24.8 t-20 -136.76 94.43 2.98 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.4 -96.43 0.49 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.398 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -108.96 9.88 26.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.19 0.519 . . . . 0.0 110.879 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -121.29 135.67 55.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.98 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.19 139.29 14.41 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 60.9 m-85 -120.59 121.52 38.55 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.93 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.6 m -121.17 167.94 12.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.617 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.49 143.2 37.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.06 116.17 18.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.574 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 8.7 mp -93.58 86.3 5.15 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 91' ' ' SER . 28.6 mttm -76.3 146.67 38.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -58.34 -31.94 68.04 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 111.695 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -50.9 -42.23 59.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' A' ' 62' ' ' LEU . 9.0 m-85 -64.01 -38.54 91.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -174.619 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 124' ' ' ILE . 2.7 mm? . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.4 tt0 -118.22 77.11 1.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -78.65 155.37 29.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 51.0 tp -110.46 142.9 41.56 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.544 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 21.3 m-85 -57.16 136.08 56.4 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.627 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.1 mt-30 . . . . . 0 N--CA 1.44 -0.938 0 C-N-CA 119.665 -0.814 . . . . 0.0 . -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 CA-C-O 120.851 0.271 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.43 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 38.6 t30 -62.1 -50.99 69.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.553 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -56.86 -53.38 58.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.175 -1.375 . . . . 0.0 112.935 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.553 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.2 mp0 -71.33 -26.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.309 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.56 -45.71 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -56.89 -45.39 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.403 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 7.5 tt -59.76 -42.33 93.02 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 m -70.3 -36.49 74.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.256 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -70.26 -47.41 61.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.679 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.0 pp -64.81 -25.02 67.73 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 69.6 mtp180 -70.0 -50.07 45.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.31 -23.99 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -108.51 -4.55 17.15 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 43.4 mm -114.59 117.08 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.816 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -120.79 137.31 54.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.313 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 m -76.71 103.28 6.59 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.97 102.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.686 0.755 . . . . 0.0 111.575 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 63.4 m -71.13 100.01 1.97 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.791 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -107.4 175.7 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.954 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.524 ' H ' HG22 ' A' ' 20' ' ' THR . 3.4 m -55.15 -47.31 75.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.714 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 7.7 mmpt? -89.83 2.11 55.35 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.71 -175.97 27.73 Favored Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.853 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 105' ' ' SER . 30.2 mt-10 -101.48 112.6 25.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -106.93 162.59 13.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.951 0.881 . . . . 0.0 112.951 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.691 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 86.3 m -80.73 106.8 13.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.847 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.27 116.48 4.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.694 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -94.42 108.95 20.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 110.795 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.8 108.08 2.41 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 86' ' ' ILE . 39.6 mm -75.43 -55.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.891 0.377 . . . . 0.0 111.802 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -162.96 138.92 7.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.617 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 13.0 t70 57.32 -94.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.069 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 76' ' ' THR . 79.2 mtt85 -126.28 8.74 7.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.802 0.81 . . . . 0.0 110.163 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 74' ' ' VAL . 96.9 t -92.71 113.18 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.866 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 p -124.06 142.8 50.87 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.11 137.09 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.023 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 tt -144.95 139.95 15.72 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.525 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.2 144.1 72.06 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.457 1.438 . . . . 0.0 112.439 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.816 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 89.7 m -63.9 -37.6 87.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -72.52 6.54 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.17 -19.1 30.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.668 0.747 . . . . 0.0 109.937 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 64.98 69.51 0.66 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.196 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.81 110.49 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.638 1.559 . . . . 0.0 109.48 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -141.84 1.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.546 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.01 -28.32 15.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.952 0.882 . . . . 0.0 109.227 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -136.88 132.4 34.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.039 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.81 153.15 36.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 mp -97.01 104.01 15.98 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.118 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.2 p -82.02 96.03 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.34 10.53 7.3 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.47 -28.76 3.96 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.461 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 54' ' ' ILE . 58.5 tt0 -78.88 118.38 20.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.127 0.489 . . . . 0.0 110.741 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -72.55 107.79 5.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.405 HD12 HG11 ' A' ' 49' ' ' VAL . 8.9 mt -119.39 126.4 75.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.257 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -77.56 146.22 36.42 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 110.084 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.27 138.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -84.46 -45.56 12.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.78 144.48 15.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -136.67 112.67 9.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -112.95 129.35 56.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.339 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.43 110.79 16.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.647 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 36.9 tp -81.19 115.1 20.44 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.44 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.59 167.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.673 -1.603 . . . . 0.0 108.218 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 17.9 t70 -87.0 143.32 34.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.59 -17.05 6.25 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.367 2.045 . . . . 0.0 113.513 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.89 7.18 9.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.86 39.99 2.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.938 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 150.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.846 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -66.4 137.39 56.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 18.6 mt -105.38 -28.38 10.91 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.816 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 35.8 tp10 80.7 9.03 1.18 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.948 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HG ' HD21 ' A' ' 173' ' ' LEU . 2.3 mm? -95.54 133.41 39.58 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.904 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.8 m -105.61 115.56 30.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 34' ' ' VAL . 60.4 t -74.61 96.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -93.28 103.55 15.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.928 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 19.9 m -94.44 100.5 12.49 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.22 156.63 16.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.758 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -83.87 103.53 13.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -129.96 143.1 50.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.459 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -87.34 -59.02 2.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.77 90.64 4.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 55.6 pttt -68.07 163.66 21.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -79.23 145.91 33.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.343 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -62.45 130.82 46.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.717 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.94 80.93 0.47 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 122.173 -0.329 . . . . 0.0 111.437 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 86' ' ' ILE . 2.6 pp -87.36 19.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 O-C-N 121.448 -0.782 . . . . 0.0 110.403 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.48 -13.38 62.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.614 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.84 67.43 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.873 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.28 -10.15 50.52 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.86 131.84 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.9 m -105.43 133.68 49.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -81.97 -23.82 35.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -127.31 111.49 13.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.6 mt -52.74 -64.55 0.78 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.7 69.25 0.69 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.28 96.9 0.1 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.5 p -86.55 17.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.333 0.587 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -140.35 132.92 28.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.034 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.18 16.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.236 1.017 . . . . 0.0 113.38 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.3 m -128.23 142.1 51.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.389 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.76 110.97 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.142 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 7' ' ' ALA . 27.1 m -103.74 136.19 37.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.16 0.505 . . . . 0.0 110.999 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 105' ' ' SER . 27.4 t -122.54 133.87 67.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.909 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.603 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 64.5 t60 -138.64 45.03 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 m -108.78 -165.42 1.02 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.413 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -83.34 -18.52 38.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.619 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 11.9 p30 -67.49 -50.3 59.55 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -138.49 113.83 9.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.4 m -92.55 96.84 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.808 0.813 . . . . 0.0 112.22 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.603 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 8.0 t30 74.03 70.45 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.054 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 m -134.85 136.67 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.819 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.58 117.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.8 mp -111.91 113.16 25.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.49 120.58 24.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -97.06 -25.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.956 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.73 -129.12 9.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.838 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 25.1 Cg_exo -62.43 130.51 30.37 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.3 2.0 . . . . 0.0 113.231 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 137' ' ' TYR . 15.0 m -121.45 131.66 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.0 p -122.98 144.98 48.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 72.8 mtm -81.31 114.28 19.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.51 -50.27 7.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.864 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.19 -119.95 5.86 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.785 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.45 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -95.68 118.1 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.304 0.574 . . . . 0.0 112.53 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.8 pt -139.98 -174.46 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.1 m-20 -113.26 104.28 12.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.757 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.6 mm? -79.52 113.36 17.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.45 ' HB3' HD12 ' B' ' 5' ' ' LEU . 59.0 p 52.27 30.81 8.39 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.969 -0.457 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m 70.56 62.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -160.8 115.27 1.35 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.315 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.21 112.12 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.349 1.366 . . . . 0.0 111.6 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.625 ' HB ' HD23 ' A' ' 126' ' ' LEU . 17.7 m -125.79 128.86 48.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.854 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 57.7 t30 -106.86 162.79 13.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.639 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 19.6 ttm-85 70.88 34.82 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.286 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.3 mmm -87.37 139.44 30.55 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 111.68 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.4 mm -97.94 134.49 36.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.442 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -111.82 125.42 54.0 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.438 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -137.36 125.82 23.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.67 99.81 3.78 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 122.232 1.015 . . . . 0.0 110.773 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -166.7 128.19 1.71 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.47 91.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.1 p -90.72 162.42 14.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.336 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -132.17 150.33 52.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.971 0.891 . . . . 0.0 111.865 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.648 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.22 154.22 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.275 175.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -33.14 5.43 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.497 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 70.8 mt-30 -77.52 9.99 2.92 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.823 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 23.6 m -65.54 139.6 58.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.691 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.88 -14.96 34.31 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.951 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.68 145.1 40.11 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.532 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.42 122.19 50.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.645 0.736 . . . . 0.0 112.249 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.38 108.91 20.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.347 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 178.85 8.68 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.904 0.859 . . . . 0.0 112.802 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.417 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . . . -153.12 179.25 8.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.628 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 2.0 t -60.63 102.63 0.2 Allowed 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.794 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.95 88.01 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.608 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.08 119.36 16.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.641 0.721 . . . . 0.0 112.768 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -99.31 124.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -94.57 -35.03 12.42 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 161.05 -163.15 34.14 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.769 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.5 pt -129.85 152.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.842 0.829 . . . . 0.0 112.11 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -62.27 122.73 16.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.756 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.13 -30.98 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.183 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' B' ' 7' ' ' GLN . . . -174.21 -146.12 5.5 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.583 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -179.42 158.11 21.76 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.322 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 21.4 t30 -131.22 86.56 2.37 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.977 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.13 -99.74 0.81 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 114.995 -1.002 . . . . 0.0 114.973 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -94.25 -2.43 52.39 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 111.929 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -121.46 131.39 54.13 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.759 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.01 151.3 25.83 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -129.28 114.11 15.84 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.765 -1.174 . . . . 0.0 113.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.0 m -108.92 159.27 16.94 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.46 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -96.26 132.35 41.81 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.587 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 51.8 tt0 -70.96 107.86 4.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.12 0.486 . . . . 0.0 110.283 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.489 HD21 ' HG ' ' A' ' 72' ' ' LEU . 80.4 mt -85.59 93.83 8.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.556 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.75 125.56 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.726 0.774 . . . . 0.0 109.548 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -40.18 -39.86 1.0 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.4 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.48 -46.23 37.91 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -64.06 -17.0 62.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 110.626 179.472 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.414 ' N ' HD12 ' B' ' 2' ' ' LEU . 6.3 mp . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -86.55 79.54 8.9 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.492 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.757 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.41 125.08 30.64 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 37.7 tp -86.02 146.75 26.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.516 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 16.2 m-85 -60.17 130.2 45.5 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.823 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.3 mt-30 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.647 -0.706 . . . . 0.0 . 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 CA--C 1.535 0.532 0 N-CA-C 114.451 0.904 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.67 -40.49 76.39 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.58 0.705 . . . . 0.0 110.694 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -49.78 68.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.535 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.28 -33.82 72.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.388 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -68.81 -58.52 4.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 tp -70.46 -33.02 70.8 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -79.79 -34.55 39.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.42 -36.43 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.1 tp -54.94 -59.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.027 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.61 -27.04 61.92 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.608 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.71 -46.34 14.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.53 -6.06 9.24 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.2 mt -110.25 121.19 62.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.96 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.4 mtt -127.73 147.23 50.4 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.639 0.733 . . . . 0.0 109.817 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -64.92 110.98 2.63 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.009 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 39.7 mm -95.57 105.18 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -92.21 96.52 10.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.507 0.67 . . . . 0.0 109.301 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.458 HG23 HG22 ' A' ' 18' ' ' ILE . 1.3 p -102.81 -169.73 1.7 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.341 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -67.32 -32.04 72.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.703 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HZ2' ' HZ ' ' A' ' 25' ' ' PHE . 49.4 tttm -83.03 -35.29 25.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.395 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.43 -151.57 22.64 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 119.479 -1.343 . . . . 0.0 115.34 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.42 120.28 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.306 -0.947 . . . . 0.0 110.531 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.576 ' HZ ' ' HZ2' ' A' ' 22' ' ' LYS . 63.1 m-85 -126.44 159.58 32.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.184 0.992 . . . . 0.0 113.018 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 32.9 m -79.65 100.91 8.07 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.384 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -90.42 112.29 4.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.69 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -101.81 105.72 16.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.28 116.58 5.27 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 46.4 mm -83.53 -60.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.223 0.512 . . . . 0.0 111.946 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -145.51 152.65 40.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.875 0.845 . . . . 0.0 112.678 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 41.6 m-20 45.14 -92.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.781 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 16.9 ptt180 -141.59 25.75 1.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.88 0.848 . . . . 0.0 109.661 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.53 118.61 53.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.548 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 m -117.48 146.07 43.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.869 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.89 122.91 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.062 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 18' ' ' ILE . 57.0 mt -134.76 141.11 37.39 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.243 -177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HB3' ' CE1' ' A' ' 40' ' ' HIS . 45.9 Cg_exo -58.6 144.3 97.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 121.583 1.522 . . . . 0.0 109.915 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 49.7 m -74.11 -32.44 63.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 38' ' ' PRO . 43.0 p-80 -71.53 -7.27 46.51 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.89 -29.44 66.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.952 0.882 . . . . 0.0 108.754 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 66.61 70.95 0.47 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.662 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.73 118.56 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.223 2.615 . . . . 0.0 108.64 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.52 -111.42 0.74 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.559 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.18 -35.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.558 0.694 . . . . 0.0 109.172 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -117.78 148.64 41.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.561 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 75' ' ' LEU . 86.8 t -131.3 123.81 53.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.744 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.402 HD21 ' HE2' ' A' ' 53' ' ' LYS . 36.0 mt -74.41 88.32 2.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.198 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 54' ' ' ILE . 48.1 t -83.24 98.98 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.2 t30 64.5 23.04 12.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 -7.6 56.93 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.597 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -93.76 130.37 39.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.122 0.487 . . . . 0.0 111.665 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HE2' HD21 ' A' ' 48' ' ' LEU . 59.5 mmtt -74.35 88.62 2.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.925 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 49' ' ' VAL . 57.9 mt -102.94 136.07 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -100.67 154.75 18.34 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 117.956 -1.498 . . . . 0.0 113.889 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 59' ' ' LYS . 78.2 t -71.49 133.53 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.522 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 57' ' ' LYS . 11.0 tmtt? -100.95 -56.24 2.37 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -128.02 115.88 19.17 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.649 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HB2' HG11 ' A' ' 56' ' ' VAL . 54.0 tttp -106.88 92.16 3.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -113.22 123.76 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.455 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 5.7 mptt -86.12 103.19 14.54 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 56.2 tp -69.19 114.75 7.74 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 123.376 1.56 . . . . 0.0 112.302 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.9 m -114.62 153.42 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 174.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' A' ' 66' ' ' GLU . 12.3 t70 -74.33 139.92 75.69 Favored Pre-proline 0 C--N 1.306 -1.291 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 31.2 Cg_exo -44.72 -17.62 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.576 1.517 . . . . 0.0 112.086 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 64' ' ' ASP . 12.9 tp10 -68.42 -1.39 6.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.566 0.698 . . . . 0.0 109.161 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' PRO . 10.7 t30 72.21 30.21 2.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.052 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.3 mt -123.39 143.41 36.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.789 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.41 ' HA ' HG12 ' A' ' 63' ' ' VAL . 15.8 m120 -59.84 145.26 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.768 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 59.2 mt -126.26 -30.72 2.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.183 0.516 . . . . 0.0 109.833 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.4 mm-40 87.13 4.35 0.36 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.975 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 66.6 mt -87.92 98.12 11.32 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.014 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 m -76.46 103.45 6.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.033 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 62' ' ' LEU . 99.2 t -77.57 88.05 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 47' ' ' VAL . 15.2 tp -93.76 115.01 27.41 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.109 -175.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -98.32 109.86 22.55 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.632 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.44 151.41 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.92 86.93 6.87 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.353 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 33' ' ' ARG . 29.2 mmm180 -103.81 146.96 27.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.009 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.96 -51.63 3.99 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -76.22 114.02 14.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.58 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 32' ' ' ASP . 11.7 ptpt -84.57 -179.48 7.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.729 0.776 . . . . 0.0 111.938 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.47 163.57 12.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.214 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -67.27 117.04 8.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -66.26 91.55 0.17 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.4 pt -90.18 20.0 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -62.85 -21.48 65.99 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.43 -18.4 71.28 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.542 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 96.7 m-85 -87.88 -1.98 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.103 0.478 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 30' ' ' ILE . 64.4 mt -84.78 125.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.6 m -85.08 129.05 34.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.683 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -55.95 13.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.68 132.99 42.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.9 mt -55.62 -70.18 0.12 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 50.61 71.27 0.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.021 0.439 . . . . 0.0 110.046 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.08 88.27 0.07 OUTLIER Glycine 0 C--N 1.333 0.408 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.447 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.7 p -79.77 -0.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.355 0.597 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 12.5 t70 -128.91 114.69 16.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.687 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.03 165.12 20.92 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.961 0.886 . . . . 0.0 111.363 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 7.9 m -119.12 140.53 49.98 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.261 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.7 tp -109.83 124.81 51.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.479 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.43 111.36 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 105' ' ' SER . 10.5 t -103.52 137.85 30.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.34 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.449 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 86.5 t60 -136.41 42.05 2.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.535 ' H ' HG12 ' A' ' 103' ' ' VAL . 54.6 m -107.29 -176.59 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.209 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -44.41 -57.91 3.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -79.83 -47.94 14.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.047 0.839 . . . . 0.0 112.26 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -108.99 96.08 6.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.651 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 3.1 m -98.08 103.58 15.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.808 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 109' ' ' THR . 16.9 t30 73.36 72.2 0.13 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.978 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -140.09 125.09 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.193 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.1 tt -113.07 126.19 70.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 tt -143.0 127.87 18.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 14.0 pt-20 -81.01 108.02 14.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.23 -33.21 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.958 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.72 -118.96 5.84 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 26.6 Cg_endo -58.02 107.29 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 116.03 -175.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.8 t -96.47 118.93 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.59 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 24.5 m -137.66 141.23 41.16 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.501 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -81.92 130.19 35.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.313 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.31 -18.38 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.52 -130.18 9.53 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.403 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 123' ' ' LEU . 2.9 tm? -93.5 112.38 24.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 47.9 pt -135.83 -174.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 4.4 m-20 -108.33 106.44 16.58 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.857 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.636 HD12 ' O ' ' B' ' 4' ' ' ALA . 56.3 tp -82.57 111.21 18.35 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.1 p 56.42 37.31 28.72 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.076 0.465 . . . . 0.0 110.991 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.4 m 77.73 11.14 2.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.892 0.877 . . . . 0.0 112.992 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -118.2 118.19 34.4 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.622 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 51.2 Cg_exo -54.05 116.62 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.245 1.964 . . . . 0.0 113.825 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 p -125.09 145.4 49.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.839 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' HB3' HD23 ' A' ' 123' ' ' LEU . 25.2 p-10 -112.9 163.26 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.909 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 80.2 mtt180 58.94 41.86 20.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.642 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -77.63 127.87 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.54 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.528 ' HB ' ' OG ' ' A' ' 170' ' ' SER . 39.4 mm -87.38 120.84 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 24.8 ttt180 -104.88 124.65 49.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.613 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.552 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.6 OUTLIER -117.19 115.86 26.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.879 -1.896 . . . . 0.0 105.879 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -71.55 90.42 1.01 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.016 0.912 . . . . 0.0 112.059 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -166.96 132.12 2.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.328 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.41 0.54 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.518 0.675 . . . . 0.0 111.582 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 131.79 54.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 7.2 mtpm? -122.29 179.3 4.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.7 150.75 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.773 177.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.08 -20.22 41.39 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.039 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.28 5.87 40.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.648 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 14.5 p -78.53 140.98 38.49 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.182 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.652 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 116.96 -19.29 12.11 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.16 150.44 29.13 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.098 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.96 124.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.44 0.638 . . . . 0.0 111.967 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.36 108.96 20.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -144.99 -178.72 6.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.927 0.87 . . . . 0.0 112.453 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.2 179.74 7.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.397 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 t -65.17 117.23 7.46 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.559 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.7 76.91 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.618 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 8.7 ptpp? -159.32 138.91 11.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.776 0.788 . . . . 0.0 112.602 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 63.6 mt -113.41 135.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.635 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.03 -39.61 6.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.798 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 175.08 -171.1 44.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.5 pt -125.54 142.83 41.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.871 0.843 . . . . 0.0 111.111 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.0 t-160 -61.7 112.75 2.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.234 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.87 -25.17 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.265 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.36 -145.94 5.46 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.402 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 175.43 164.11 29.43 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.3 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 2.7 t-20 -136.88 99.98 4.18 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.477 0.656 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 60.56 -110.03 2.71 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 115.014 0.765 . . . . 0.0 115.014 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -92.93 18.96 8.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.447 0.642 . . . . 0.0 111.337 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -135.1 128.56 32.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -91.05 145.28 17.7 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 136' ' ' ARG . 44.9 m-85 -127.18 126.98 43.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.672 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.528 ' OG ' ' HB ' ' A' ' 135' ' ' ILE . 19.8 p -124.92 169.61 11.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.178 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.88 140.21 41.33 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.6 pt20 -70.3 118.5 13.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.0 mp -97.78 75.9 2.44 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -83.74 142.1 30.96 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -50.98 -22.97 2.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -54.63 -22.54 13.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -97.82 -16.22 19.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -173.582 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.8 mm? . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 120.828 0.347 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.2 tt0 -106.96 90.1 3.2 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -96.42 126.51 41.67 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.117 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -87.03 158.68 19.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.717 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.576 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.0 m-85 -62.58 147.45 49.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLN . . . . . 0.648 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.1 mt-30 . . . . . 0 N--CA 1.434 -1.258 0 C-N-CA 118.402 -1.319 . . . . 0.0 . 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 120.465 -0.075 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 123.123 2.549 . . . . 0.0 113.907 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 11.1 t30 -68.77 -48.27 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.374 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 m -70.23 -29.02 65.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.714 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.56 -50.0 74.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.52 -47.31 84.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.475 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.36 58.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.533 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.79 -23.68 64.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -76.94 -51.23 11.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.591 0.71 . . . . 0.0 109.853 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.4 tp -57.13 -44.51 83.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.254 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 69.6 tp -53.86 -49.91 67.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.203 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -78.02 -28.38 49.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -86.54 -52.57 5.49 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.86 1.98 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 40.2 mm -106.25 133.02 51.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.435 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 50' ' ' ASN . 46.2 ttm -150.55 144.04 25.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.799 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.0 m -69.23 113.59 6.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.59 108.77 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 14.0 m -93.91 122.5 36.47 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.8 0.81 . . . . 0.0 109.994 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 -163.9 1.45 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.44 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.37 -44.4 62.11 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HZ1' ' CX7' ' B' ' 8' ' ' CA1 . 55.1 tttm -85.36 1.2 49.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.877 0.762 . . . . 0.0 111.863 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.67 -149.76 17.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.31 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.26 129.66 35.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.055 -0.573 . . . . 0.0 111.584 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ3' ' A' ' 22' ' ' LYS . 68.7 m-85 -131.85 157.26 44.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.109 0.957 . . . . 0.0 111.96 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 80.5 m -72.66 107.53 5.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.332 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.24 107.24 3.16 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.399 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.37 99.06 11.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.37 123.01 7.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.681 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.93 -56.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 117.179 0.489 . . . . 0.0 110.03 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.95 153.31 5.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.605 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.06 -89.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.999 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.1 ptp180 -132.02 10.25 4.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -110.69 131.82 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.931 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 p -133.13 156.68 47.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.51 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.45 139.82 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.469 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.8 tt -143.54 141.58 19.27 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.367 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.16 153.06 13.43 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 C-N-CA 121.313 1.342 . . . . 0.0 112.243 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 39.5 m -77.61 -37.45 50.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -66.91 -13.08 61.35 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.63 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.72 -21.18 64.41 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.024 0.916 . . . . 0.0 109.224 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 45.1 mt-30 61.12 69.07 1.12 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.311 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 12.3 Cg_exo -75.25 131.23 13.78 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.806 2.337 . . . . 0.0 107.97 175.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.84 -134.37 7.6 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.417 -1.373 . . . . 0.0 114.602 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.39 -26.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.685 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 53' ' ' LYS . 13.0 p-10 -144.67 133.69 22.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.96 158.67 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.892 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 45.6 mt -101.8 98.71 8.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 16' ' ' MET . 41.0 t -91.81 103.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.549 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 65.8 t30 66.47 24.78 10.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.699 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.57 -20.1 52.01 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.35 115.57 18.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.362 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 87.7 tttt -74.74 109.49 8.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.759 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.17 139.89 46.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.435 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.28 153.77 22.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.963 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG21 ' HB2' ' A' ' 59' ' ' LYS . 14.6 p -73.81 141.59 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -99.9 -42.85 6.62 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 37.9 t70 -159.13 118.35 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.304 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 56' ' ' VAL . 28.5 ttpp -111.47 106.41 15.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 86.0 t80 -115.87 110.41 18.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.764 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.11 105.59 6.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 60.0 tp -75.69 114.74 14.63 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-O 122.243 1.02 . . . . 0.0 111.89 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.25 159.9 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.434 -1.712 . . . . 0.0 107.852 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -74.84 149.04 85.36 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.28 -23.84 7.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.75 2.3 . . . . 0.0 113.666 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 68' ' ' ILE . 7.6 mm-40 -86.37 25.04 1.26 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.604 0.716 . . . . 0.0 109.805 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.289 0.3 OUTLIER 39.99 61.98 1.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.495 1.118 . . . . 0.0 113.202 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' GLU . 25.2 mm -138.62 155.59 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.492 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -57.5 131.33 49.84 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.783 -0.573 . . . . 0.0 111.761 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.556 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.7 tp -103.89 -22.94 13.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 161' ' ' VAL . 22.7 tp10 80.61 7.89 1.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.403 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.85 109.62 22.01 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.397 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 99.8 m -85.27 107.44 17.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 84.0 t -72.79 101.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.02 100.32 11.46 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.05 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 21.5 m -96.77 121.84 39.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.665 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mm? -120.34 158.54 26.9 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.63 82.15 6.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -79.64 117.37 20.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.492 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.82 -53.81 13.9 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.5 89.86 7.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.27 143.44 52.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.127 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -82.88 148.68 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.058 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.63 144.35 51.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.75 83.24 1.17 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -87.45 12.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.756 -0.59 . . . . 0.0 109.577 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.08 -19.8 65.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.791 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.91 73.86 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.559 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -84.49 -21.12 30.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.704 -0.248 . . . . 0.0 110.474 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.12 121.69 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 13.7 m -113.06 148.48 35.1 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.67 -33.42 12.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.7 105.63 15.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.715 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 17.4 mt -68.33 -57.16 6.35 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 5.6 pt-20 55.75 13.48 1.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 0.0 111.247 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 98' ' ' ASP . . . -115.87 67.3 0.29 Allowed Glycine 0 C--N 1.334 0.459 0 CA-C-O 121.603 0.557 . . . . 0.0 112.838 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -60.87 -3.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.071 0.462 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 96' ' ' GLY . 24.7 t70 -117.94 111.89 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.58 160.43 34.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.849 0.833 . . . . 0.0 112.865 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.1 m -125.63 137.0 53.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.337 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 160' ' ' HIS . 57.2 tp -102.33 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.016 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 t -104.05 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.62 129.91 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.674 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -138.86 35.07 2.17 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -108.54 -170.05 1.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -44.15 -51.93 7.7 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.18 -29.41 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.812 0.733 . . . . 0.0 112.355 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -140.02 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.887 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 m -96.83 119.35 35.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.463 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 96.1 m-20 69.39 70.4 0.25 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.039 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 m -141.71 107.99 5.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.068 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.0 mt -86.32 108.3 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.053 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.1 mt -116.64 107.53 14.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.342 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -73.59 125.43 27.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.49 -25.18 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 89.5 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.504 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 5.8 Cg_exo -75.52 122.36 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.284 1.989 . . . . 0.0 112.974 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.21 132.87 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.307 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -134.95 -169.64 2.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.759 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.3 ptm -129.47 149.7 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.428 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.16 -4.68 21.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.134 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.44 -108.07 2.73 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.14 128.48 54.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.073 -0.563 . . . . 0.0 111.099 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.6 pt -150.63 -178.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 120.679 0.276 . . . . 0.0 110.346 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 30.4 m-80 -96.19 136.42 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 40.6 tp -120.72 105.68 10.99 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t 60.23 42.76 14.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m 66.69 8.92 6.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.883 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.5 m -112.03 112.63 52.63 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.63 124.08 15.27 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.233 1.288 . . . . 0.0 111.204 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.0 m -130.33 141.32 50.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.84 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -99.42 151.87 20.61 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 57.64 62.82 2.0 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.945 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.421 ' CE ' ' HA ' ' A' ' 134' ' ' MET . 8.0 mmt -93.63 134.45 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.715 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 57.4 mt -94.97 141.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.905 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 18.3 ttp180 -125.43 125.39 43.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.578 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.9 OUTLIER -127.6 130.83 49.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.349 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 87.36 3.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.621 0.724 . . . . 0.0 109.202 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.06 114.7 1.5 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.094 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.8 116.51 3.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 112.236 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.67 160.02 37.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.956 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 142' ' ' LYS . 53.2 mtpt -136.97 177.24 8.01 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.349 1.071 . . . . 0.0 112.101 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 1.5 p -45.03 155.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.126 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.576 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 90.52 -25.37 13.26 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.67 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -90.9 -6.31 54.32 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.138 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 133.87 44.02 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.889 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.84 -21.18 18.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.0 149.07 38.79 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.095 -0.552 . . . . 0.0 112.976 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 26' ' ' THR . 25.6 t -87.47 121.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 112.46 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.1 tp -93.66 107.72 19.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.8 p -149.19 172.29 15.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.081 0.943 . . . . 0.0 113.325 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 167.61 24.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.273 -1.785 . . . . 0.0 107.437 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.9 t -65.1 101.21 0.5 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.944 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.61 -12.95 39.13 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -134.46 121.53 21.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.6 mt -101.48 117.09 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -88.48 -33.64 17.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.124 0.487 . . . . 0.0 111.806 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 173' ' ' LEU . . . 152.18 -150.73 22.63 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.538 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.1 pt -129.54 145.95 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.046 0.927 . . . . 0.0 112.024 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.424 ' HB2' HD11 ' A' ' 101' ' ' LEU . 6.6 t60 -60.99 123.75 18.53 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.603 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.519 HG21 ' HG2' ' A' ' 71' ' ' GLU . 9.8 p -111.84 -29.11 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.351 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -177.13 -147.51 6.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.229 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.54 160.32 29.62 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.77 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 15.3 t-20 -137.23 105.02 5.58 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.58 -115.26 5.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.263 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -104.79 -0.28 27.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.19 0.519 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.18 125.14 48.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.21 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.66 149.59 23.59 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 136' ' ' ARG . 49.3 m-85 -125.71 129.52 49.7 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.88 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.5 m -121.6 165.16 16.11 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.987 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.19 132.42 38.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.404 HE21 HD11 ' A' ' 94' ' ' LEU . 35.6 tt0 -82.36 106.27 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.868 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.491 HD13 ' CA ' ' A' ' 158' ' ' GLY . 11.0 mp -85.28 85.73 7.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.98 129.1 37.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.837 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -43.1 -38.55 2.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.477 0.656 . . . . 0.0 111.489 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 180' ' ' GLU . 79.3 mt-30 -49.75 -41.74 44.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -105.32 -35.2 7.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.7 p -62.12 -28.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.665 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 176' ' ' GLN . 5.0 pt-20 -77.39 -24.35 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -84.02 140.56 31.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.091 0.948 . . . . 0.0 113.273 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.364 -178.172 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.149 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? -129.65 147.35 51.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.253 0.549 . . . . 0.0 110.476 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.9 tt0 -115.66 81.44 1.59 Allowed 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -80.97 149.14 29.46 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 35.8 tp -103.81 152.98 21.25 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.561 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.8 m-85 -61.2 145.03 52.57 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 94.8 mt-30 . . . . . 0 N--CA 1.443 -0.806 0 C-N-CA 118.836 -1.145 . . . . 0.0 . -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.734 ' CX7' ' HZ1' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 CA-C-O 120.964 0.202 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.69 -55.18 4.37 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.612 2.208 . . . . 0.0 114.117 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -52.4 -47.87 66.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.842 0.83 . . . . 0.0 110.934 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -56.28 -52.74 63.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.881 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.26 -30.23 63.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.81 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.28 -50.41 70.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -64.56 -40.74 96.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.374 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.5 tt -54.54 -46.31 73.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -79.82 -32.7 40.71 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.933 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.28 -43.43 98.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.026 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 4.6 pp -67.14 -26.89 66.89 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 65.5 mtp180 -73.69 -27.82 61.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.72 0.295 . . . . 0.0 111.101 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -97.55 -50.94 4.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -114.59 13.67 17.52 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 57.6 mt -122.29 117.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.034 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.1 mtp -128.99 146.89 50.85 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.788 0.804 . . . . 0.0 110.128 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.24 99.08 2.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.32 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.24 98.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.664 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 73.0 p -74.67 98.08 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.97 179.37 4.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.43 -176.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.551 ' H ' HG22 ' A' ' 20' ' ' THR . 4.8 m -62.48 -25.49 68.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.167 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -93.7 -39.17 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.99 -154.02 14.24 Favored Glycine 0 C--O 1.234 0.126 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -93.67 117.25 29.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -117.12 151.28 37.17 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.025 0.917 . . . . 0.0 112.978 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 149' ' ' VAL . 21.3 m -79.06 100.21 7.25 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.06 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.09 101.15 2.17 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -96.41 111.38 23.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 131.7 11.07 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' A' ' 178' ' ' PHE . 43.2 mm -98.84 -56.59 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 117.518 0.659 . . . . 0.0 111.097 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -145.45 129.55 17.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.908 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 m-20 55.12 -90.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.824 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.4 ptp180 -128.32 7.41 5.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.4 0.619 . . . . 0.0 111.397 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.7 t -87.65 111.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.938 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.2 m -119.3 159.14 24.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.68 144.52 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.576 0.703 . . . . 0.0 111.098 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -152.68 140.55 13.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.631 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.19 148.31 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.052 1.168 . . . . 0.0 111.234 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.725 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 77.7 m -68.86 -40.33 79.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.633 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -68.42 4.02 1.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.68 -25.53 53.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.885 0.85 . . . . 0.0 108.88 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 57.99 70.97 1.13 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.854 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.89 131.12 10.9 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.087 2.525 . . . . 0.0 111.318 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.18 -161.29 32.45 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.554 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.12 -21.39 50.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.767 0.784 . . . . 0.0 109.383 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.5 p-10 -133.03 133.79 43.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.93 163.67 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.796 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -103.01 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.301 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.64 92.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 68.38 19.72 8.82 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.285 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.4 32.9 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.841 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 112.98 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 2.2 pptp? -76.51 134.18 39.55 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.43 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.8 tp -144.35 137.55 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.084 -1.417 . . . . 0.0 108.488 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 39.0 mtt180 -93.69 138.54 31.8 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.614 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.51 138.26 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.87 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -83.39 -49.55 9.22 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.841 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.06 137.56 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.001 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -124.7 85.55 2.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -90.94 123.1 34.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.321 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.48 127.41 32.09 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.678 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 83.5 mt -90.13 116.77 28.39 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.372 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.19 159.55 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.621 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 27.6 t70 -76.64 144.86 74.12 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 15.9 Cg_endo -55.88 -5.16 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.395 2.063 . . . . 0.0 113.123 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.68 17.8 19.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.033 0.921 . . . . 0.0 109.939 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t30 74.5 0.02 3.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.814 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.34 155.01 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -67.4 146.62 53.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 0.0 111.742 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.4 tp -108.75 -22.8 12.06 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.725 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 24.4 tp10 78.96 11.8 1.44 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.397 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.9 mm? -102.25 151.25 22.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.218 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.8 m -124.47 120.38 31.85 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.308 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.4 100.82 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.1 93.42 9.14 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.583 0.706 . . . . 0.0 109.996 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -87.15 109.82 19.71 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.134 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 69.7 mt -106.77 151.73 24.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.648 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.92 102.45 6.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' NH2' ' HG2' ' A' ' 81' ' ' GLU . 22.5 mmm180 -119.29 108.13 14.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -83.28 -29.58 28.27 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -101.25 91.38 4.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 174.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 52.3 pttt -97.86 178.96 4.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.48 171.85 8.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.787 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.46 138.23 31.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.67 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.44 92.09 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.67 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.6 pt -88.13 21.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.057 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.44 -30.39 64.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.57 -20.28 77.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.074 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 77.5 m-85 -93.19 -8.84 41.28 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.8 mm -76.97 134.04 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -81.41 112.88 19.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -77.03 -27.03 54.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -143.44 131.75 22.07 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.991 -1.913 . . . . 0.0 106.219 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.2 mt -74.82 -80.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.26 71.38 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.466 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.23 80.41 0.14 Allowed Glycine 0 C--N 1.331 0.262 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 9.3 p -70.3 9.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 20.7 t70 -138.75 124.53 19.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.44 155.54 47.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.19 0.995 . . . . 0.0 112.958 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 m -107.76 143.13 36.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.154 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -115.73 111.94 21.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.76 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG21 ' HB1' ' A' ' 7' ' ' ALA . 27.6 t -95.23 99.54 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.42 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.03 122.69 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.431 0.634 . . . . 0.0 111.197 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.623 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 66.0 t60 -135.42 57.09 1.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -121.63 -163.91 1.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 112.996 -1.911 . . . . 0.0 112.379 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.05 -44.52 88.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.528 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -70.82 -60.84 2.02 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.679 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -113.11 108.63 17.57 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.856 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 15.7 m -96.48 97.62 9.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.446 0.641 . . . . 0.0 109.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.623 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 28.6 t-20 74.44 71.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.584 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 m -143.51 121.47 12.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.698 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.43 115.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.141 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.15 157.52 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.93 140.09 40.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.07 -23.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.807 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.34 -125.92 7.13 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.881 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.714 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.5 Cg_endo -67.61 113.91 3.12 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.596 2.197 . . . . 0.0 114.187 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 157.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -145.45 158.75 43.78 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.104 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.21 140.14 48.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.897 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.99 -28.35 12.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.647 0.261 . . . . 0.0 111.671 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.99 -121.46 7.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.282 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.05 113.94 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.627 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.2 pt -132.46 176.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 38.4 m-80 -94.66 102.97 14.9 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.399 0.619 . . . . 0.0 110.804 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 57.0 tp -83.75 104.93 14.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.2 m 63.34 31.03 15.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.288 0.566 . . . . 0.0 109.657 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.4 m 81.41 0.58 1.62 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.545 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.9 m -108.51 117.48 54.3 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.5 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.26 119.93 6.55 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.336 2.024 . . . . 0.0 112.88 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -132.27 134.12 44.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.881 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.6 t30 -104.53 161.19 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.993 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.621 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 1.9 mpt_? 69.12 43.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.3 mmt -90.95 116.35 28.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 70.6 mt -85.44 130.65 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -110.75 136.04 50.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -148.48 113.55 5.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 6.7 p-10 -74.59 97.99 3.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.566 1.174 . . . . 0.0 110.526 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -149.02 139.26 22.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 111.873 -2.421 . . . . 0.0 107.69 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.85 90.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -106.17 158.56 16.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -139.24 159.64 41.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.198 0.999 . . . . 0.0 111.747 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.48 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 2.8 m -44.3 158.92 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.852 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.611 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.81 -17.75 57.23 Favored Glycine 0 N--CA 1.462 0.401 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.912 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -94.22 8.57 41.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.708 -0.246 . . . . 0.0 111.575 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.577 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 16.8 m -63.2 122.0 15.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.208 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 118.61 -20.87 10.02 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.71 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.91 130.24 23.04 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.12 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 26' ' ' THR . 58.3 t -84.94 115.55 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.2 tp -88.76 108.51 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.7 p -147.6 176.95 9.67 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.992 0.901 . . . . 0.0 112.785 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.97 173.09 14.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.529 -1.668 . . . . 0.0 107.765 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.8 m -64.49 108.75 1.74 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.191 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.27 -7.19 59.96 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.922 -0.656 . . . . 0.0 114.291 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 18.3 ptpt -155.89 137.32 14.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.02 126.79 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -88.06 -34.34 17.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.208 0.527 . . . . 0.0 111.49 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 160.37 -159.08 30.51 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.288 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 161' ' ' VAL . 46.0 pt -129.97 149.75 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.669 0.747 . . . . 0.0 111.671 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -61.77 120.27 10.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.862 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 159' ' ' ILE . 94.8 t -114.55 -26.83 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.377 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.09 -149.24 7.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.169 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.32 148.43 7.5 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.491 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 9.0 t-20 -118.27 105.69 12.02 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.08 -102.95 0.98 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -121.75 19.03 11.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.302 0.572 . . . . 0.0 110.601 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 0.5 OUTLIER -111.94 109.03 18.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -71.07 146.95 42.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.1 m-85 -127.53 119.45 26.06 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.2 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.4 m -110.6 156.0 21.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.627 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.504 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.05 131.85 37.01 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -71.31 105.17 3.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.645 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.419 HD21 ' HG ' ' A' ' 72' ' ' LEU . 73.0 mt -87.98 91.26 8.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.522 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -79.68 127.0 31.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.599 0.714 . . . . 0.0 109.54 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 179' ' ' VAL . 82.0 tttt -42.25 -34.83 0.84 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.853 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.52 -38.92 64.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -67.42 -13.44 62.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.409 ' CE1' HG13 ' A' ' 30' ' ' ILE . 83.9 m-85 -97.77 -34.23 10.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 175' ' ' LYS . 4.0 t -69.22 -1.85 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.027 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.43 -27.4 66.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 109.253 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -107.83 133.06 52.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.982 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.199 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ACE . . . . . 0.404 ' O ' HD13 ' B' ' 2' ' ' LEU . . . . . . . . 0 C--O 1.225 -0.234 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? -141.33 144.69 34.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 41.0 tt0 -106.08 81.59 1.65 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -85.32 127.86 34.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.183 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 28.5 tp -89.78 151.12 21.97 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -58.27 139.77 54.51 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.48 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 97.6 mt-30 . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 120.183 -0.607 . . . . 0.0 . 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.611 ' CX7' ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.684 0 N-CA-C 112.599 -0.2 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.15 -37.21 96.49 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 122.076 1.85 . . . . 0.0 112.655 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.419 HD21 ' C ' ' A' ' 3' ' ' ASN . 0.2 OUTLIER -62.57 -40.05 95.62 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.866 0.841 . . . . 0.0 109.177 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -43.83 87.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.41 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -64.43 -42.65 95.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.196 0.522 . . . . 0.0 109.708 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.14 -47.19 86.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 109.758 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.82 92.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.13 -48.59 80.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -70.69 -38.83 73.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.256 0.55 . . . . 0.0 110.113 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.41 -42.88 96.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.425 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 8.4 tt -60.33 -51.46 69.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.611 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -67.55 -28.76 68.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 4.7 mmpt? -99.86 -26.27 14.07 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.156 0.889 . . . . 0.0 113.088 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -123.58 -12.43 7.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.5 mt -107.07 120.88 59.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.726 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 22.4 mmt -127.45 145.69 50.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.065 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -76.52 105.69 7.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 43.2 mm -95.3 111.82 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.338 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 13.5 m -91.44 114.43 26.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.896 0.855 . . . . 0.0 110.468 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 41' ' ' ALA . 9.0 p -118.05 -162.95 0.91 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.186 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 13.0 m -69.76 -38.08 76.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HE3' ' HZ ' ' A' ' 25' ' ' PHE . 26.0 ttpp -83.0 -19.79 36.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.328 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.38 -156.93 27.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.412 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -109.39 117.82 35.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.922 0.867 . . . . 0.0 109.952 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HZ ' ' HE3' ' A' ' 22' ' ' LYS . 41.3 m-85 -109.91 171.75 7.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.629 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.681 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 73.1 m -86.89 108.94 19.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -94.01 126.88 8.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -101.31 104.63 15.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.087 0.47 . . . . 0.0 111.236 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 111.07 3.23 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.9 mm -75.4 -58.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 122.561 -0.376 . . . . 0.0 112.007 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -166.41 164.11 17.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.557 0.694 . . . . 0.0 112.79 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.99 -101.37 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.389 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.6 ptt180 -129.19 20.85 5.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.421 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.87 124.69 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.232 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 75' ' ' LEU . 6.3 p -124.27 141.12 52.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.202 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.87 121.52 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.371 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.09 133.56 24.39 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.646 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.83 139.04 78.12 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 N-CA-C 109.013 -1.187 . . . . 0.0 109.013 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.573 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.9 m -63.84 -35.38 80.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.753 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -69.3 -3.52 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -71.8 -28.66 63.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 72.2 mm-40 62.51 71.38 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.771 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -75.32 142.7 27.22 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.075 2.517 . . . . 0.0 111.496 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.03 -157.02 30.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.001 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.52 -21.94 28.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.595 0.712 . . . . 0.0 110.354 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.36 117.59 19.98 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.58 145.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 69.8 mt -85.23 103.47 14.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.659 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.27 90.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 12.4 t30 59.03 58.36 3.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.241 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.59 -32.64 1.87 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.659 -1.155 . . . . 0.0 114.391 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.413 ' OE1' HG12 ' A' ' 54' ' ' ILE . 25.0 tm0? -83.52 142.42 30.91 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.759 -0.26 . . . . 0.0 110.542 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.08 127.4 38.61 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.458 ' CG2' ' HB2' ' A' ' 77' ' ' LEU . 21.3 mm -137.39 133.45 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.358 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -91.5 142.46 27.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 110.838 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.44 136.18 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.333 -176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -88.64 -42.74 11.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -171.96 132.23 0.68 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.337 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.42 119.39 36.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.45 126.48 50.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.466 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 49.9 mtpt -79.57 128.29 33.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 26.6 mt -95.58 127.25 41.46 Favored 'General case' 0 C--O 1.254 1.327 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 69' ' ' ASN . 32.6 m -123.47 156.16 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 66' ' ' GLU . 24.4 t70 -72.73 142.19 83.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.407 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.0 -10.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.54 1.493 . . . . 0.0 112.096 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 tp10 -76.92 -3.2 37.49 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 108.704 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.9 m120 75.44 16.71 2.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.002 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.29 147.71 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HA ' HG12 ' A' ' 63' ' ' VAL . 64.0 t30 -59.9 135.93 57.85 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -99.79 -22.81 15.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 28.3 tp10 76.28 14.96 2.35 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.119 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 78.6 mt -98.81 114.11 26.52 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.438 0.461 . . . . 0.0 112.013 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.5 m -93.5 111.48 23.15 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 62' ' ' LEU . 61.5 t -78.04 100.05 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.4 tp -83.28 94.32 7.89 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.959 0.885 . . . . 0.0 110.958 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.8 m -85.37 105.96 16.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -108.37 152.9 24.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.31 -177.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -84.56 94.62 8.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.839 0.828 . . . . 0.0 109.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -144.35 128.07 17.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.384 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.03 -21.89 29.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.92 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -79.93 87.06 5.38 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -72.86 157.05 38.2 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.583 -175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -93.9 147.33 23.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.38 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -55.92 135.88 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 85' ' ' ASP . 3.3 p-10 -81.95 89.56 6.39 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.454 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 28' ' ' LEU . 32.8 pt -86.74 15.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.504 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -61.8 -23.66 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.91 -19.23 80.03 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.574 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 97.8 m-85 -86.34 -22.38 26.72 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 59.4 mt -71.98 136.8 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -125.12 142.47 51.47 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.543 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.1 pm0 -80.91 -15.34 56.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.42 153.56 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -100.07 -68.09 0.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.493 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 41.7 73.87 0.12 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.83 88.85 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.2 -13.61 16.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.968 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -106.85 125.68 51.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.92 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.63 149.66 39.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.878 0.847 . . . . 0.0 112.179 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -112.62 142.01 45.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 148' ' ' GLY . 1.2 tm? -115.63 109.67 18.09 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.59 114.65 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.295 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.8 133.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.749 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -140.0 31.94 1.98 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -109.77 -160.67 0.73 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.385 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -52.09 -61.74 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.99 -34.85 71.78 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -137.84 122.47 18.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.725 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 8.4 m -119.34 128.77 54.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.95 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' THR . 88.5 m-20 65.95 28.51 10.57 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.501 0.667 . . . . 0.0 110.095 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 m -99.87 103.36 14.95 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.906 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -90.55 100.08 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.37 117.98 30.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.35 120.78 18.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.52 -36.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.885 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.67 -128.56 8.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.859 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.67 113.43 3.49 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.023 1.815 . . . . 0.0 112.542 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.1 p -107.82 147.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.468 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 t -155.88 167.03 31.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.4 ttm -93.05 141.83 27.97 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.804 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.24 -33.75 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.517 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.52 -101.99 2.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.324 -0.853 . . . . 0.0 114.307 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp -125.24 122.24 36.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.729 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 48.3 pt -143.02 -176.53 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 10.0 m120 -106.55 85.76 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 23.4 tp -70.54 111.15 5.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.616 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.41 ' N ' ' O ' ' B' ' 4' ' ' ALA . 53.6 p 64.07 25.25 13.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.421 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 m 85.65 -3.68 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.222 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 37.1 m -99.89 125.97 38.43 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.797 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 129' ' ' THR . 32.4 Cg_exo -61.62 120.23 7.76 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.334 2.022 . . . . 0.0 113.879 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 p -123.97 137.74 54.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.862 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -110.39 160.5 16.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 16.0 mmm180 64.76 29.31 12.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.097 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.454 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -73.05 121.73 20.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.017 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.76 144.19 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.048 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 13.8 ptt180 -129.38 143.15 50.73 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.904 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -129.36 131.43 46.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.82 103.49 1.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.198 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -178.42 133.75 0.14 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.496 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -69.18 110.35 4.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.372 0.606 . . . . 0.0 110.1 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.423 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 21.2 p -111.25 148.6 32.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.029 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -133.24 151.46 51.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.067 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.402 HG22 ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -43.3 161.46 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.129 176.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.538 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.53 -13.42 67.4 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.532 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -102.08 8.22 40.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.863 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.402 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 7.6 m -64.75 141.63 58.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.127 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.681 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.61 -6.7 74.39 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.058 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . -52.44 131.28 38.75 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.18 110.78 17.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.71 105.06 15.22 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.2 p -144.45 178.07 8.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.397 1.094 . . . . 0.0 113.639 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.43 176.1 9.62 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.605 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 m -71.21 100.52 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.573 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.24 12.16 60.31 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.831 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 40.3 ttmt -155.33 134.58 12.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.306 0.574 . . . . 0.0 111.124 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.11 131.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.766 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.79 -43.01 7.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 169.17 -152.65 20.46 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.938 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.9 pt -135.22 150.18 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 122.077 0.942 . . . . 0.0 113.147 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.33 118.7 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.907 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 126' ' ' LEU . 43.8 t -113.47 -21.73 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.049 0.452 . . . . 0.0 110.857 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.28 -147.75 8.13 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.927 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 169' ' ' PHE . . . 171.51 161.12 21.57 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 55.2 t30 -128.23 82.17 2.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.495 0.664 . . . . 0.0 109.248 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.28 -107.22 2.1 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.869 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 95.6 mtt180 -90.59 7.55 38.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -124.75 110.77 14.75 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -77.8 142.55 26.78 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 136' ' ' ARG . 49.2 m-85 -118.83 127.16 53.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.852 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -125.3 163.48 22.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.157 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.455 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -99.35 141.11 32.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.275 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 8.3 tt0 -77.39 106.91 9.44 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.986 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.517 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.1 mp -94.52 85.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.225 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.91 135.13 37.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 7.4 ttpm? -54.38 -35.95 63.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.719 0.771 . . . . 0.0 109.813 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -53.06 -34.56 57.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.633 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -71.92 -25.9 62.09 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.257 -0.277 . . . . 0.0 111.08 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.11 -4.45 59.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.517 0.675 . . . . 0.0 110.357 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.35 -30.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.38 -47.32 81.99 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.88 136.57 34.03 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 . . . . . 0 C--N 1.316 -0.858 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.024 -179.432 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 6.6 mp -114.64 120.48 40.29 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -96.48 74.77 2.84 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.51 146.75 38.24 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.9 tp -106.05 148.69 27.48 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 19.1 m-85 -57.74 135.64 56.8 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.423 ' OE1' ' HB ' ' A' ' 141' ' ' THR . 81.7 mt-30 . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 . 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.538 ' CX7' ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 112.974 -0.05 . . . . 0.0 112.974 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.5 -35.74 95.09 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.873 2.382 . . . . 0.0 113.488 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.04 -35.64 66.79 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -65.19 -44.97 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.154 0.978 . . . . 0.0 108.584 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.86 -47.03 83.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.634 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.75 -46.3 79.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.276 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.03 93.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.21 -44.8 94.29 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 122.165 -0.334 . . . . 0.0 110.796 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -65.38 -40.12 93.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 109.893 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.5 tp -64.54 -44.81 89.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.169 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 5.4 tt -55.14 -46.64 75.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.251 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.13 -45.46 66.8 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.56 -2.21 20.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 115.635 1.716 . . . . 0.0 115.635 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -135.55 -12.24 2.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.265 -0.974 . . . . 0.0 113.294 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 49.2 mm -106.83 101.82 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.81 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -120.22 135.89 54.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.542 0.687 . . . . 0.0 110.261 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.13 102.25 2.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.09 100.0 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.325 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 48' ' ' LEU . 8.9 t -94.94 130.2 41.67 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.105 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.5 t -146.4 -157.55 0.82 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 m -51.54 -50.74 59.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.71 -16.25 39.63 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.73 -157.69 28.41 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 119.608 -1.282 . . . . 0.0 114.727 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -112.48 114.36 27.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.394 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.37 159.78 25.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.58 0.705 . . . . 0.0 111.674 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.2 m -72.64 106.01 4.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.613 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.62 106.68 3.34 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -87.53 106.55 18.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.336 0.589 . . . . 0.0 111.957 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 117.72 8.01 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 47.9 mm -89.08 -64.21 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 117.099 0.45 . . . . 0.0 112.077 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 58.36 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.237 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.9 ptp180 -129.78 15.22 5.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 110.678 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.93 122.66 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.788 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -122.37 156.03 34.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.804 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -114.82 135.16 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.478 0.656 . . . . 0.0 109.847 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' O ' ' HB ' ' A' ' 73' ' ' THR . 12.3 tt -144.94 142.06 18.13 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.614 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.47 149.66 23.02 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 120.888 1.059 . . . . 0.0 110.579 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 33.0 m -73.27 -36.74 66.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -66.94 -1.26 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -22.14 59.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.541 0.686 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.31 71.96 1.09 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.56 127.06 18.05 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.932 2.421 . . . . 0.0 112.374 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.58 -169.15 29.32 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.451 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 56' ' ' VAL . 2.6 p-10 -78.15 -16.31 58.05 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -143.18 137.61 29.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.69 156.12 37.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 19' ' ' THR . 7.5 mp -97.41 103.08 14.98 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.301 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.7 p -84.66 102.42 10.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.542 0.686 . . . . 0.0 110.154 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.6 t30 66.66 19.17 10.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.644 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.12 -22.11 11.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.583 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -92.1 115.66 28.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.318 0.559 . . . . 0.0 111.89 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.58 128.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -139.27 137.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.878 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -65.18 139.61 58.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.474 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 45' ' ' ASP . 14.4 p -87.06 136.75 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 76' ' ' THR . 57.1 tptt -78.36 -47.04 18.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.82 0.819 . . . . 0.0 108.833 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.06 133.46 1.46 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -106.99 92.76 4.22 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -86.22 106.21 17.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.754 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.77 121.08 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.906 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mt -89.88 113.34 24.93 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.704 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -94.02 165.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 133' ' ' ARG . 15.7 t70 -71.58 137.42 83.29 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.632 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HG2' ' NH2' ' A' ' 133' ' ' ARG . 7.0 Cg_endo -52.36 -15.68 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.857 1.705 . . . . 0.0 112.771 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.48 16.48 8.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.894 0.854 . . . . 0.0 109.059 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.0 t30 72.21 10.43 5.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.92 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 69' ' ' ASN . 15.9 mt -92.66 176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.539 ' H ' HG22 ' A' ' 68' ' ' ILE . 51.4 t30 -81.75 143.4 31.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 118.514 0.597 . . . . 0.0 111.22 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 26.5 tp -118.54 -27.49 5.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.58 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 26.5 tp10 70.55 10.62 7.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.666 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 10.9 tp -96.11 103.11 14.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.866 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 78.0 m -90.92 115.42 27.94 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.565 0.698 . . . . 0.0 111.616 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.73 94.17 3.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.3 tp -81.47 104.51 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.797 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 8.7 m -98.59 115.09 27.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.572 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.0 mp -117.47 150.01 39.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.718 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.73 91.49 7.97 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.481 ' HA ' ' HE ' ' A' ' 79' ' ' ARG . 2.2 tpm_? -112.51 110.33 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.58 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -59.31 -54.0 51.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.783 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -74.73 92.59 2.48 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -70.74 147.3 49.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.221 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -88.06 146.96 25.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.991 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -58.41 120.62 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.103 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 7.4 p-10 -77.37 94.24 4.18 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 121.709 0.766 . . . . 0.0 112.408 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.2 17.13 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.95 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 88' ' ' GLY . 5.0 ppt_? -59.03 -23.95 62.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.16 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 87' ' ' ARG . . . -84.08 -13.63 73.99 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.642 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.53 -3.36 46.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 40.1 mt -82.55 127.31 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.449 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 6.5 m -83.69 110.89 18.66 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.19 -49.95 31.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' SER . 23.8 t70 -97.78 115.66 28.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 173.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.1 mt -60.75 -72.23 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.88 67.41 0.93 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.618 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -146.49 75.38 0.28 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.344 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 p -97.38 0.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 10.9 t70 -149.88 125.72 10.48 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.115 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -153.6 176.7 11.77 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.473 1.13 . . . . 0.0 114.041 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -115.4 138.78 50.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.783 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -115.55 110.66 19.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.09 124.78 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.096 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 108' ' ' PHE . 1.7 t -114.6 139.82 38.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 122.035 0.921 . . . . 0.0 113.063 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -149.35 71.79 1.13 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.045 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.4 p -125.55 -174.01 2.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.637 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -59.85 -44.68 93.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.866 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.85 -41.05 15.33 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 103' ' ' VAL . 93.3 m-85 -115.96 98.15 6.49 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.4 m -105.59 122.78 46.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.581 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 66.73 73.36 0.36 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.8 m -142.25 102.85 4.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.731 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.93 108.92 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.11 120.98 32.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -72.54 118.1 15.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 137' ' ' TYR . 13.8 p -92.14 -26.29 4.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.707 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.57 -125.84 7.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.593 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.6 Cg_exo -62.87 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.345 2.03 . . . . 0.0 113.453 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 96' ' ' GLY . 2.8 p -136.61 141.89 39.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.589 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 m -153.08 139.37 18.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 27.3 ptt? -74.01 140.2 45.28 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.822 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.07 -66.24 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.48 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.32 -122.35 1.78 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.885 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt -103.06 117.79 35.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.448 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 36.0 pt -138.52 -176.38 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.6 m120 -105.18 83.95 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.982 0.42 . . . . 0.0 111.198 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 59.3 tp -65.93 108.03 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.212 0.529 . . . . 0.0 110.048 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 128' ' ' SER . 3.5 m 61.24 33.48 19.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 127' ' ' SER . 22.7 t 76.97 8.97 2.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.472 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -112.12 113.45 51.83 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.819 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.67 113.37 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.847 1.698 . . . . 0.0 111.649 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 126' ' ' LEU . 29.5 m -124.69 139.65 53.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.103 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -113.4 159.66 19.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' A' ' 64' ' ' ASP . 8.2 mtm180 56.37 61.45 2.7 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.319 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.0 mtp -109.6 132.67 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.156 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 50.2 mt -86.1 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ttp180 -132.27 147.01 52.39 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.16 0.505 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 115' ' ' VAL . 23.2 p90 -143.16 134.97 26.71 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.35 94.52 7.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.248 1.023 . . . . 0.0 110.555 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -155.86 133.63 11.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.942 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.11 105.56 0.42 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.394 0.616 . . . . 0.0 111.22 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 p -119.17 141.97 48.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -129.29 164.39 23.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.095 0.95 . . . . 0.0 112.03 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 1.0 OUTLIER -43.1 150.25 0.18 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.405 174.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.51 9.36 Favored Glycine 0 N--CA 1.463 0.44 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -68.55 -7.81 35.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.814 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.573 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 22.5 m -58.75 137.86 57.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 99.39 -17.87 57.19 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.734 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.26 126.86 37.78 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.242 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.15 117.49 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.07 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.25 110.45 17.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.0 p -147.03 -177.25 5.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.056 0.931 . . . . 0.0 112.704 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.76 30.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 t -62.93 108.28 1.17 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.831 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.1 75.51 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.923 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -141.55 121.01 13.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 35.2 mm -102.87 130.1 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.56 -52.92 2.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -176.89 -174.09 43.03 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.792 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 pt -118.97 139.07 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.414 0.626 . . . . 0.0 110.586 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -69.52 122.27 18.69 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.28 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.76 -9.58 11.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.8 -161.78 29.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.167 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.36 158.46 26.9 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.061 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 3.7 t-20 -129.75 89.62 2.85 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.909 0.385 . . . . 0.0 110.336 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 -107.88 2.33 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.408 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -96.04 1.67 52.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.238 0.542 . . . . 0.0 110.173 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -107.95 109.3 20.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.314 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -80.26 137.67 18.72 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.02 125.48 46.39 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.571 -0.852 . . . . 0.0 113.069 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.4 m -120.92 151.82 39.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.106 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.44 130.91 39.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.536 ' HB3' HD11 ' A' ' 135' ' ' ILE . 20.0 pt20 -87.79 110.99 20.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 118.468 -1.293 . . . . 0.0 112.722 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -88.76 94.78 10.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.88 139.79 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.952 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -45.6 -35.41 4.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -55.05 -26.45 37.66 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.42 -15.74 54.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 180' ' ' GLU . 25.3 m-85 -107.93 -38.06 5.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 179' ' ' VAL . 55.4 t -77.63 6.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' A' ' 178' ' ' PHE . 10.1 tt0 -65.1 -35.77 82.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.168 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -88.73 89.7 8.1 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.745 -1.571 . . . . 0.0 114.825 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.251 176.098 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.074 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.1 mm? -121.28 154.75 35.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.5 tt0 -114.59 71.85 0.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.88 133.71 39.2 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.397 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 15.9 tp -95.73 152.17 18.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.56 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 27.8 m-85 -56.98 137.7 55.24 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.542 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 97.5 mt-30 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 . 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.573 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.069 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.7 -51.66 10.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.427 2.085 . . . . 0.0 114.085 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.613 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.7 t-20 -68.53 -45.14 73.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.709 0.766 . . . . 0.0 110.528 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.4 m -57.54 -43.59 84.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.143 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.02 -24.29 52.13 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.8 -43.54 58.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.35 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.175 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 8' ' ' LEU . 2.8 tm? -59.53 -39.44 83.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.279 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -69.53 -47.34 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.794 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.42 -38.5 84.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.7 tp -55.57 -49.14 73.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -68.49 -28.12 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.266 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -86.78 -63.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.11 -3.6 12.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -173.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 54.6 mt -99.99 131.45 47.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.872 -1.131 . . . . 0.0 113.008 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -151.62 146.42 25.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.923 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 m -68.88 117.86 11.09 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.488 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mt -98.64 98.69 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.901 0.858 . . . . 0.0 110.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 58.5 m -70.9 99.22 1.72 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.018 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -175.53 3.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.45 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 m -70.54 -28.8 65.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.613 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' HG2' ' H8 ' ' B' ' 8' ' ' CA1 . 23.4 ttmm -88.17 -45.81 9.79 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.083 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.27 -168.07 26.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.492 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 34.3 mt-10 -108.22 103.03 12.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.798 0.808 . . . . 0.0 109.228 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 41' ' ' ALA . 40.6 m-85 -97.75 165.39 11.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.853 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 97.7 m -83.24 108.17 16.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.97 136.49 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.93 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -124.61 135.72 53.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.582 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -77.64 142.69 27.12 Favored Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.83 -54.2 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.978 0.889 . . . . 0.0 110.066 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -167.83 138.77 2.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 82' ' ' LYS . 31.2 m-20 57.18 -88.74 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.508 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -125.49 5.78 7.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.405 0.622 . . . . 0.0 111.175 -178.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 74' ' ' VAL . 49.0 t -88.18 120.67 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.034 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 36.8 t -131.48 141.25 49.74 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.009 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.59 151.13 34.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.56 167.8 12.6 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 113.043 -1.889 . . . . 0.0 106.303 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.78 175.47 2.3 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 121.289 1.326 . . . . 0.0 112.147 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.51 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 99.5 m -80.56 -36.81 32.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.544 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -72.3 4.99 3.14 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -69.21 -28.49 66.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.791 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 60.58 72.83 0.68 Allowed Pre-proline 0 CA--C 1.514 -0.43 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.27 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.28 123.52 6.66 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.013 2.475 . . . . 0.0 112.843 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.36 -172.01 46.04 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.19 -17.12 38.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.888 0.844 . . . . 0.0 109.71 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 18.9 t70 -134.85 109.77 8.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.55 154.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 95.3 mt -99.42 99.6 10.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.494 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 49' ' ' VAL . 19.6 m -83.06 93.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.415 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 t30 66.19 17.96 10.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.708 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.12 -21.81 8.15 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.523 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.87 118.02 23.14 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.741 -0.27 . . . . 0.0 110.278 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.707 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -81.98 119.34 23.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.706 0.765 . . . . 0.0 110.508 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.49 130.7 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.026 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.2 mtp-105 -85.83 126.48 34.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.264 0.554 . . . . 0.0 110.069 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.01 143.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.281 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -77.99 -52.79 8.25 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.763 0.792 . . . . 0.0 109.237 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -141.73 126.71 18.3 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.406 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -109.29 104.44 13.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -104.29 120.11 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.875 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.88 125.1 28.12 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 29.8 mt -90.7 111.85 23.37 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 122.0 0.905 . . . . 0.0 111.545 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.1 m -113.85 159.11 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 67' ' ' ASN . 14.7 t70 -67.72 138.42 93.23 Favored Pre-proline 0 C--N 1.311 -1.101 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.47 -21.99 32.64 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.532 1.488 . . . . 0.0 112.815 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.71 -0.04 55.55 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' ASP . 63.9 m-80 71.76 72.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.134 -1.848 . . . . 0.0 115.454 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 69' ' ' ASN . 34.6 mm -137.41 151.96 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.516 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 131' ' ' THR . 22.8 t30 -62.87 111.83 2.3 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.883 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.623 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 15.0 tp -87.36 -27.11 23.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HG2' HG11 ' A' ' 161' ' ' VAL . 13.7 tp10 71.62 31.14 2.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.898 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 94.1 mt -123.42 151.55 42.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 25.3 m -132.64 127.07 34.11 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.373 0.606 . . . . 0.0 110.516 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.416 HG23 ' HG ' ' A' ' 62' ' ' LEU . 85.7 t -87.63 107.38 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.974 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.31 92.24 8.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -74.36 90.51 2.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.043 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.25 91.48 5.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 33' ' ' ARG . 18.7 p-10 -78.82 61.57 3.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.376 0.608 . . . . 0.0 109.866 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -82.55 160.32 22.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.34 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -61.31 -51.66 67.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -78.64 110.72 14.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 61.2 mttp -77.08 152.2 35.13 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.782 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -80.33 141.4 35.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.109 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.12 138.14 58.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.682 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 87' ' ' ARG . 11.4 p-10 -73.96 88.12 1.85 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.128 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.8 pt -88.0 12.11 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' NH2' ' HA ' ' A' ' 179' ' ' VAL . 45.2 ttt180 -53.7 -38.4 64.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.838 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.74 76.75 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.709 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -87.49 -12.7 45.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.62 129.98 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.608 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 13.5 m -120.5 122.39 40.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.649 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.5 mp0 -64.66 -48.41 74.87 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 91' ' ' SER . 30.0 t70 -95.48 120.06 35.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -76.5 -54.83 6.17 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 41.05 66.15 0.7 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.306 0.574 . . . . 0.0 109.928 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.14 80.93 0.1 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.863 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -70.53 -7.59 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.82 121.49 45.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.81 40.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.599 0.714 . . . . 0.0 112.176 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 96.0 m -116.03 135.22 54.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.256 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -92.06 116.85 29.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.392 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.06 103.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 22.1 t -100.38 124.11 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.446 0.641 . . . . 0.0 110.98 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -137.37 50.3 1.98 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.8 m -107.93 -172.54 2.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.333 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 13.4 p30 -62.05 -35.37 78.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -55.61 -50.5 69.97 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.824 -0.547 . . . . 0.0 112.215 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -158.79 132.97 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.317 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 23.2 m -84.39 114.55 21.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.603 0.716 . . . . 0.0 110.969 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 109' ' ' THR . 5.6 m-20 77.24 72.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 2.0 m -116.73 109.29 16.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.5 pt -107.99 99.56 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.051 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.8 mt -97.29 117.64 31.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.892 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.03 98.93 9.54 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.92 -16.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.098 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.34 -128.99 9.04 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.535 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 22.9 Cg_endo -65.11 119.11 6.07 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.193 1.929 . . . . 0.0 114.816 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 137' ' ' TYR . 34.3 m -111.87 148.63 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.512 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 m -150.39 144.4 25.43 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.0 ptp -82.01 142.96 31.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.193 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.53 -42.46 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.093 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.27 -128.92 8.45 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.067 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 48.1 tp -99.26 110.52 23.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.84 0.352 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.62 175.33 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.996 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.8 m-20 -87.54 126.13 34.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 46.5 tp -111.58 107.51 16.69 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.429 ' HB3' HD12 ' B' ' 5' ' ' LEU . 95.6 p 57.86 32.07 21.42 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.006 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.0 m 76.73 29.75 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.929 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -140.36 120.85 9.03 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.14 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.38 117.94 4.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.502 2.135 . . . . 0.0 114.123 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 69' ' ' ASN . 82.9 m -127.31 131.68 50.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.549 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 29.8 p-10 -102.67 169.38 8.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.61 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER 57.7 42.13 24.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.846 175.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.8 mmt -86.32 136.75 33.02 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.38 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 48.8 mm -101.07 137.63 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -127.84 148.32 50.46 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.502 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB3' HG12 ' A' ' 118' ' ' VAL . 25.0 p90 -143.03 151.74 41.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.263 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.89 113.51 22.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.832 0.825 . . . . 0.0 111.43 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -176.12 133.19 0.25 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.327 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -68.32 100.82 1.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.818 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.1 p -93.39 171.4 8.94 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.749 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -161.44 145.63 13.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.56 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.597 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.24 158.72 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.706 175.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' N ' ' OX8' ' B' ' 8' ' ' CA1 . . . 89.77 -24.33 15.64 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.003 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -85.76 4.49 36.6 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.769 0.428 . . . . 0.0 112.009 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 13.4 m -62.18 140.96 58.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 107.02 -20.69 32.99 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.77 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.76 130.45 26.92 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.532 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.36 124.18 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 110.73 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.7 tp -101.56 106.7 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.4 p -149.74 176.4 10.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.972 0.891 . . . . 0.0 112.922 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -137.28 172.73 12.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.591 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.3 t -61.31 108.76 0.97 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.066 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.56 -4.2 86.37 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -141.47 116.78 10.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.729 0.764 . . . . 0.0 111.836 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -93.99 126.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.73 -44.13 6.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.79 -165.01 34.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.7 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -129.63 144.5 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.437 0.637 . . . . 0.0 110.797 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -66.82 115.37 6.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.438 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.472 HG11 ' HG2' ' A' ' 71' ' ' GLU . 54.0 t -107.16 -27.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.169 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.19 -147.86 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.082 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.32 164.69 29.69 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.221 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 8.8 t30 -128.23 88.37 2.74 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.67 -109.62 2.78 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.636 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 166' ' ' ARG . 18.1 ttt180 -88.54 3.84 48.91 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 113.37 19.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.295 0.569 . . . . 0.0 109.977 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -78.41 143.21 26.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 44.6 m-85 -121.86 124.42 44.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.352 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -123.11 142.38 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.008 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.37 125.45 31.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.689 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.553 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 50.2 tt0 -72.03 119.86 16.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.123 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.519 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.6 mp -88.19 92.83 9.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.83 132.56 33.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.649 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 ttpm? -58.48 -17.32 20.12 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.24 -29.99 67.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -81.11 -28.15 35.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.66 0.267 . . . . 0.0 111.569 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -86.37 -32.55 20.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.464 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 12.5 p -65.63 -21.99 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 110.344 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -38.14 86.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.748 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.91 120.13 38.84 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.854 177.544 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.099 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -135.25 164.43 27.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.561 0.696 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 34.5 tt0 -126.24 77.47 1.69 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.83 152.51 26.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.6 tp -107.69 154.87 20.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -63.69 141.28 58.83 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.597 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.6 mt-30 . . . . . 0 C--N 1.295 -1.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 . 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.476 ' H8 ' ' HG2' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.35 -42.16 29.66 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.368 2.046 . . . . 0.0 113.134 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.36 -42.65 78.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.293 -0.163 . . . . 0.0 110.897 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -72.2 -27.59 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.44 -45.5 75.86 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.87 -45.71 89.5 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.315 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.38 83.57 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.8 tp -68.1 -38.92 82.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -67.66 -38.08 83.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.002 0.429 . . . . 0.0 110.028 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.415 HD11 HD13 ' A' ' 86' ' ' ILE . 60.8 tp -65.46 -40.45 93.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.528 0.68 . . . . 0.0 109.567 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 11' ' ' LEU . 3.1 tm? -50.59 -48.69 57.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.218 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -70.01 -29.61 66.72 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.39 -58.85 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.2 7.24 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 48.2 mm -105.15 106.7 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.969 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.3 mtp -121.6 147.73 45.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -76.29 111.23 11.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.088 -178.209 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.7 mm -92.84 106.15 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.601 0.715 . . . . 0.0 110.463 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 6.7 m -75.96 98.35 4.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.628 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -103.47 -178.08 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.521 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 16.4 m -59.47 -32.24 70.06 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.505 ' HZ3' ' CJ1' ' B' ' 8' ' ' CA1 . 5.8 mtmp? -88.97 -1.63 58.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.03 0.832 . . . . 0.0 111.253 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.24 -163.7 23.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.844 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 105' ' ' SER . 25.3 mt-10 -96.85 128.37 43.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.407 0.622 . . . . 0.0 110.902 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -123.22 166.94 14.4 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.804 0.812 . . . . 0.0 111.325 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 2.7 m -68.64 100.43 1.13 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.875 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -81.2 109.54 3.01 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.637 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.46 94.47 9.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.902 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.44 122.41 8.62 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.5 -50.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 117.678 0.739 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -161.25 153.64 20.24 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.963 0.887 . . . . 0.0 113.117 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.628 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 42.8 m-20 51.65 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.615 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.1 ptt180 -140.15 16.36 2.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.702 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.9 115.42 39.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.154 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -120.18 148.7 43.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.21 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.69 130.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.498 0.666 . . . . 0.0 112.141 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.39 165.42 28.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.85 163.62 36.68 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 121.647 1.565 . . . . 0.0 112.61 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.737 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 44.8 m -81.11 -38.95 26.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.161 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -71.31 2.27 5.02 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -12.9 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.663 0.744 . . . . 0.0 109.156 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 68.8 mt-30 62.44 73.23 0.55 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.341 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.88 159.54 47.97 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 122.537 2.158 . . . . 0.0 111.873 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.14 178.96 17.0 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.047 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.532 ' HA ' HG12 ' A' ' 56' ' ' VAL . 24.0 m-20 -81.89 -19.7 40.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.889 0.844 . . . . 0.0 109.467 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -137.37 113.17 9.62 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.86 173.07 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.829 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 6.2 mp -112.3 138.16 49.4 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.765 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.33 83.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.492 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 2.4 t-20 62.23 27.0 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.12 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.39 -44.79 1.16 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.159 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -75.16 115.77 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -76.4 122.02 23.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -125.43 149.01 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.227 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 7.8 mpt_? -96.61 145.51 25.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.221 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 45' ' ' ASP . 8.5 p -86.99 138.88 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.998 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.18 -42.23 17.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -158.81 132.12 7.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -117.44 116.38 27.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.55 120.54 39.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.256 0.55 . . . . 0.0 111.095 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.12 121.71 27.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.791 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 76.9 mt -85.91 123.51 31.34 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.331 0.586 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 20.5 m -122.01 171.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.185 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 16.8 t70 -78.73 143.08 62.09 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -48.54 -26.13 8.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.829 2.353 . . . . 0.0 113.618 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.34 22.74 4.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 111.09 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 73.11 11.6 5.09 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.107 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 25.4 mm -88.16 163.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.427 ' N ' HG22 ' A' ' 68' ' ' ILE . 54.9 t30 -73.33 139.27 45.92 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.79 -36.68 6.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.737 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.8 tp10 84.07 22.0 0.14 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.34 -1.754 . . . . 0.0 114.498 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.562 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.8 mm? -111.4 146.04 37.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.21 0.529 . . . . 0.0 110.834 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 26.3 m -117.33 114.48 23.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.564 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.413 HG23 ' HG ' ' A' ' 62' ' ' LEU . 88.8 t -80.93 100.08 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.32 100.67 12.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.71 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.4 m -92.38 93.88 8.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.066 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 96.0 mt -85.62 159.16 19.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.371 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -78.76 92.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -128.61 123.21 32.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.084 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -80.8 -57.3 3.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.61 114.79 5.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 13.1 ptpt -76.1 145.78 39.8 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.68 145.98 42.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 4.9 tpm_? -56.93 122.81 13.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.031 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 90.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.106 0.479 . . . . 0.0 111.072 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.415 HD13 HD11 ' A' ' 10' ' ' LEU . 41.0 pt -96.27 32.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.033 0.444 . . . . 0.0 110.111 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.593 HH22 ' HA ' ' A' ' 182' ' ' GLN . 13.0 mtp180 -65.3 -30.72 71.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.237 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.59 -19.22 79.95 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.939 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -80.14 -16.39 55.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.613 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 52.7 m -94.69 122.41 37.27 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.063 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.594 ' O ' ' HE2' ' A' ' 174' ' ' LYS . 5.0 pt-20 -61.5 -29.65 70.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.031 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HA ' ' CE ' ' A' ' 174' ' ' LYS . 37.8 t70 -131.05 163.35 27.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 95' ' ' GLU . 43.6 mt -74.47 -81.1 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 94' ' ' LEU . 12.8 pt-20 33.32 74.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.253 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.474 ' HA3' ' CZ ' ' A' ' 157' ' ' PHE . . . -157.7 92.25 0.12 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.462 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 61.5 t -62.15 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.2 t70 -124.36 132.45 53.54 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.58 174.6 10.81 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.738 0.78 . . . . 0.0 112.752 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.9 m -131.06 146.26 52.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.593 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.5 tp -105.98 113.91 27.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.34 110.92 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 109.994 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -112.08 117.33 54.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.275 0.56 . . . . 0.0 111.365 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -130.9 83.09 2.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 71.1 p -129.57 -164.56 1.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.891 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.76 -13.95 57.1 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -90.52 -66.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.347 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 56.2 m-85 -108.48 120.97 43.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.704 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.4 p -100.0 110.66 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.891 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.56 32.38 16.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 39.9 m -81.91 102.11 10.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.697 0.761 . . . . 0.0 110.905 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 112' ' ' ILE . 9.5 tt -100.13 92.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -101.22 113.15 25.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.139 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.69 112.0 6.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.832 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.15 -33.94 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.05 -123.68 7.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.323 -0.942 . . . . 0.0 114.165 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 35.1 Cg_endo -64.58 124.52 13.38 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.533 2.156 . . . . 0.0 113.85 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -106.21 137.43 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.063 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 p -132.27 171.01 14.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 59.6 ttp -120.13 139.66 52.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.938 0.399 . . . . 0.0 112.05 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.42 -43.66 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.693 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.43 -111.75 4.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.094 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -103.54 116.68 32.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 0.0 110.72 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.433 HG21 HD23 ' B' ' 2' ' ' LEU . 46.8 pt -144.8 -176.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 m-20 -101.95 123.05 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.257 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.3 mm? -102.13 111.69 24.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' SER . 17.3 t 60.46 30.88 20.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.453 0.644 . . . . 0.0 109.933 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 45.4 m 83.37 2.34 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.377 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.4 m -112.01 116.47 49.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.063 0.227 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.49 123.35 11.14 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 122.413 2.075 . . . . 0.0 112.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 126' ' ' LEU . 70.6 m -131.94 138.42 48.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.903 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -101.93 169.59 8.68 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 13.5 mmt180 63.29 34.77 12.97 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.05 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 171' ' ' ALA . 31.7 mmt -82.17 128.43 34.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.734 0.778 . . . . 0.0 112.058 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 19.9 mm -95.21 144.07 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 33.0 ptt180 -131.6 139.46 49.17 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.506 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.1 130.97 24.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.361 0.6 . . . . 0.0 109.928 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.2 96.71 0.66 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.246 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -175.09 121.25 0.21 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.093 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.56 108.17 2.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.849 0.833 . . . . 0.0 112.286 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.67 148.48 43.87 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.151 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 35.0 mmtp -133.67 176.99 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.881 0.848 . . . . 0.0 112.81 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.9 OUTLIER -44.08 150.2 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.357 176.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.33 -22.69 31.19 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.352 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.84 3.7 47.35 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 m -58.93 134.88 57.33 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.954 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.65 8.35 59.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.523 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.91 135.93 20.97 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.239 -1.458 . . . . 0.0 109.571 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.4 t -86.32 117.45 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.666 0.733 . . . . 0.0 111.32 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.14 105.06 17.37 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.1 p -141.3 165.42 27.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.951 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.58 179.26 6.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -60.24 101.1 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.484 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.5 22.43 78.96 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.613 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 32.5 ttmt -147.92 108.72 4.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -94.36 123.1 46.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.474 ' CZ ' ' HA3' ' A' ' 96' ' ' GLY . 91.6 m-85 -91.57 -39.09 12.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.474 0.655 . . . . 0.0 110.755 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 157.4 -155.17 26.16 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.935 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.79 150.16 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.541 0.686 . . . . 0.0 110.903 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -69.15 122.22 18.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.016 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.07 -23.08 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.49 -156.54 12.0 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.855 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.64 157.9 25.61 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.481 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.1 t-20 -128.65 92.32 3.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.575 0.703 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.72 -104.99 1.49 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.741 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -95.85 2.27 53.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -127.25 129.55 47.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.308 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.1 146.52 22.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.483 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.9 m-85 -123.78 131.5 53.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.778 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.5 m -125.3 159.48 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.289 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -97.77 141.04 31.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.317 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 77.0 mt-30 -79.85 117.24 20.54 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.558 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 66.9 mt -96.74 71.75 2.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 92' ' ' GLU . 38.6 mtpt -79.75 135.3 36.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -56.38 -15.62 4.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.652 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 179' ' ' VAL . 10.9 pt20 -67.73 -16.91 64.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.15 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.36 -9.98 34.11 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.06 11.35 23.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.119 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 176' ' ' GLN . 8.2 p -96.61 -6.39 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.487 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -86.87 -52.43 5.48 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -71.34 125.88 28.15 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.593 ' HA ' HH22 ' A' ' 87' ' ' ARG . 21.7 tt0 . . . . . 0 C--N 1.317 -0.826 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.125 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? -144.18 149.58 36.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.99 0.424 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.8 tt0 -110.99 78.94 1.15 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.64 137.75 34.39 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 39.2 tp -95.62 144.63 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.0 m-85 -59.87 137.86 57.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 97.9 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.226 -0.443 . . . . 0.0 . -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.505 ' CJ1' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.674 0 N-CA-C 112.376 -0.29 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -47.42 -41.93 28.65 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.009 2.472 . . . . 0.0 115.255 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -66.35 -59.58 3.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 0.0 112.026 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 m -56.87 -42.22 79.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.89 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.41 -25.8 57.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.949 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -67.62 -46.44 72.51 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.69 99.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.26 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.2 tm? -61.62 -46.29 90.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -65.94 -44.96 83.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 86' ' ' ILE . 60.5 tp -62.83 -41.94 99.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.828 0.823 . . . . 0.0 110.811 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 31.0 tp -51.81 -51.48 56.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.01 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 15.1 mtp180 -63.02 -28.16 69.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -108.28 -49.26 3.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.43 -6.81 22.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 41.8 mt -102.18 108.44 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.415 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.1 mmt -119.17 148.32 43.22 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.953 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 m -76.83 117.17 18.17 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.147 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.78 95.79 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 28.1 m -84.07 108.57 17.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -129.73 -170.6 2.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.538 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -56.81 -49.1 76.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.935 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 10.8 tmtt? -71.02 -27.71 63.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.64 -156.99 28.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.677 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.02 117.1 32.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 43.6 m-85 -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.154 0.978 . . . . 0.0 112.295 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 75.4 m -88.68 95.77 10.39 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 113.399 -1.728 . . . . 0.0 107.93 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.23 116.94 4.36 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.184 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.88 101.02 13.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.357 0.599 . . . . 0.0 110.998 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -68.36 127.32 23.6 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 87' ' ' ARG . 36.2 mm -97.18 -47.4 12.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 118.07 0.935 . . . . 0.0 110.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 33' ' ' ARG . 40.3 p-80 -165.75 166.81 17.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 40.99 -84.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.759 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' HIS . 16.4 ptp180 -143.92 21.51 1.78 Allowed 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 122.273 -0.267 . . . . 0.0 111.388 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 HG13 ' A' ' 74' ' ' VAL . 7.2 p -119.03 134.18 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 60.4 m -119.59 159.21 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.639 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.88 131.84 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.551 0.691 . . . . 0.0 111.571 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.72 165.17 29.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.98 170.69 18.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.216 1.277 . . . . 0.0 111.438 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.424 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 35.5 m -82.18 -33.27 29.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.043 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -72.8 2.01 7.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.823 0.344 . . . . 0.0 110.731 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -72.1 -19.55 61.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 53.68 70.3 1.83 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.599 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.35 124.98 10.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.692 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 -164.25 14.0 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.375 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.34 -31.0 16.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 108.837 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.15 118.65 18.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.28 159.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.986 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 85.3 mt -90.46 107.65 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.644 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.95 100.84 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.012 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.92 32.76 12.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.615 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.72 -14.93 64.21 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.828 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -100.92 126.36 47.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.507 0.654 . . . . 0.0 111.479 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.64 112.35 5.35 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 35.8 mm -114.62 118.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.379 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.54 157.91 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.94 -45.04 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.781 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 20.0 t70 -142.56 94.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.834 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 17.6 ptpt -93.0 90.26 6.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -97.19 115.11 26.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.406 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.88 129.36 37.53 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.916 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 20.0 mt -88.51 101.28 13.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -108.2 144.21 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 171.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' C ' ' N ' ' A' ' 66' ' ' GLU . 15.2 t70 -80.18 150.59 71.54 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 64' ' ' ASP . 65.0 Cg_exo -45.23 -20.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.618 0.879 . . . . 0.0 110.258 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 6.4 tp10 -63.12 -14.69 51.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.686 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 20.6 t30 80.43 3.36 1.84 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.372 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.419 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 49.0 mm -97.07 155.16 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.584 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.77 126.35 29.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.0 tp -93.9 -15.58 24.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.2 tp10 70.24 14.25 7.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.728 -1.578 . . . . 0.0 113.152 175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 173' ' ' LEU . 8.5 mp -101.63 159.22 15.5 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -135.81 117.09 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG23 ' HG ' ' A' ' 62' ' ' LEU . 69.2 t -78.57 96.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.33 85.35 7.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.437 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 3.2 m -80.35 104.63 11.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.028 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 65.9 mt -95.55 159.75 14.84 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.786 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.65 86.35 7.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 33' ' ' ARG . 27.1 tpt180 -117.72 126.27 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.565 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -84.36 -48.76 9.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.26 116.04 15.56 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -82.32 150.17 27.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 122.018 0.913 . . . . 0.0 112.644 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.797 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -82.76 129.74 35.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.8 p-10 -75.61 97.8 3.86 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.429 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.414 HD13 HD11 ' A' ' 10' ' ' LEU . 33.5 pt -96.25 29.38 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.777 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 57.3 mtm180 -66.7 -27.0 67.29 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.032 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.7 -1.86 22.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.63 141.57 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 19.1 m -93.7 119.9 33.28 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.87 -47.14 60.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 91' ' ' SER . 19.2 t0 -114.28 144.1 43.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 173.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.0 mt -66.98 -71.19 0.21 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 59.23 70.88 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.715 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -143.31 92.41 0.17 Allowed Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 114.153 -1.385 . . . . 0.0 113.616 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.8 p -101.42 -8.35 9.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 6.1 t70 -144.46 135.67 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.756 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.61 155.13 38.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.528 0.68 . . . . 0.0 111.868 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 23.8 m -120.62 139.81 52.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 160' ' ' HIS . 1.0 OUTLIER -108.48 120.86 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.231 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.2 p -114.87 121.81 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.154 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.17 135.62 45.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.824 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -137.9 85.0 2.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 106' ' ' ASN . 37.2 t -135.89 -159.08 0.92 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.223 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.423 ' N ' ' OG ' ' A' ' 105' ' ' SER . 9.4 t30 -46.41 -64.45 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -101.01 -45.01 5.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 0.0 111.68 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.71 106.94 14.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.687 0.756 . . . . 0.0 112.929 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 p -116.43 138.74 51.12 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.868 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 51.8 28.13 4.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.821 0.448 . . . . 0.0 111.83 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 20.6 m -74.81 90.04 2.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.489 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.79 97.47 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 120.22 32.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.571 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.9 pt-20 -80.11 144.85 32.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.012 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.0 m -101.65 -20.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.59 -123.03 5.89 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.562 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 20.7 Cg_endo -61.8 114.25 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.294 1.996 . . . . 0.0 112.882 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -118.52 151.39 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.776 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.2 p -146.83 -177.54 5.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 21.2 ptt? -120.4 163.63 17.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.781 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.07 -2.55 8.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 -121.7 6.05 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.481 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.18 120.86 39.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.178 0.514 . . . . 0.0 109.69 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 26.4 pt -138.16 -171.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.922 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -102.22 135.18 44.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.269 0.557 . . . . 0.0 109.923 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 45.6 tp -119.23 103.79 9.82 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' SER . 2.8 m 63.75 32.56 13.54 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 110.32 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.8 m 82.76 1.6 1.18 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 126' ' ' LEU . 12.8 t -114.35 124.76 30.19 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.07 125.41 18.49 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.338 2.025 . . . . 0.0 113.215 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.03 138.78 54.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 2.9 p30 -111.76 152.13 28.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.656 0.741 . . . . 0.0 112.652 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 66.37 53.28 1.01 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.015 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.9 mmm -93.06 134.91 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.712 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 170' ' ' SER . 14.2 tt -108.85 142.5 21.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 167' ' ' GLN . 19.4 ptt85 -127.23 139.75 52.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.546 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.3 OUTLIER -122.72 135.15 54.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.431 0.634 . . . . 0.0 110.941 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.5 87.78 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.41 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -171.89 127.27 0.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.374 -1.739 . . . . 0.0 107.268 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.35 100.19 1.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.704 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 137.79 52.57 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 96.2 mttt -127.96 176.63 7.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.567 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.37 152.99 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 111.107 -2.77 . . . . 0.0 111.664 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.495 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 88.07 -15.13 57.06 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.455 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -115.02 9.84 16.09 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 21.1 p -78.41 135.88 37.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 117.959 -1.496 . . . . 0.0 110.026 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.605 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 126.63 -16.88 6.53 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.84 153.88 44.06 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.14 129.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.338 0.589 . . . . 0.0 112.366 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.88 111.42 23.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.2 p -147.62 179.01 8.0 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 112.744 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.34 -178.5 6.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.041 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.9 t -60.92 101.76 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.63 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.93 31.07 77.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.889 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -153.35 111.2 3.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.708 0.289 . . . . 0.0 111.007 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.5 mt -96.78 129.38 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.54 -49.16 5.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.156 0.503 . . . . 0.0 112.017 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.731 ' HA2' HD23 ' A' ' 173' ' ' LEU . . . 175.92 -166.55 37.82 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.191 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.83 142.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.739 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.8 t60 -63.23 113.76 3.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.606 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.38 -27.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.05 -147.74 6.18 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.882 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 179.37 164.72 32.37 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.494 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.3 t-20 -137.56 96.68 3.29 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.206 0.527 . . . . 0.0 109.861 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.85 -119.26 5.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.997 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -97.29 19.66 12.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.202 0.525 . . . . 0.0 110.815 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 8.8 tt0 -134.36 115.86 14.54 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.875 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.59 148.94 34.41 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.245 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 46.7 m-85 -124.67 121.53 34.93 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.848 0.832 . . . . 0.0 111.129 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.57 ' HB3' HG23 ' A' ' 135' ' ' ILE . 15.2 t -117.5 156.44 28.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.145 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.78 134.19 39.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.538 ' OE1' ' HE2' ' A' ' 174' ' ' LYS . 76.1 mt-30 -71.03 122.49 20.13 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.731 HD23 ' HA2' ' A' ' 158' ' ' GLY . 2.5 mm? -85.52 93.9 8.89 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.538 ' HE2' ' OE1' ' A' ' 172' ' ' GLN . 51.2 mttm -93.21 128.03 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.668 0.747 . . . . 0.0 111.462 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -50.21 -31.12 13.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.388 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 180' ' ' GLU . 1.6 mp0 -37.3 -56.64 0.95 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.33 -9.71 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.76 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 13.1 tp10 -63.53 -50.76 68.28 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.813 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.05 131.67 46.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.343 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.089 -179.299 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.19 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.5 mm? -118.24 139.47 51.26 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.663 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -113.35 81.06 1.44 Allowed 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -83.18 153.73 24.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 36.0 tp -109.35 151.92 25.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.1 m-85 -60.3 133.98 56.62 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.7 mt-30 . . . . . 0 N--CA 1.439 -0.996 0 C-N-CA 119.219 -0.993 . . . . 0.0 . -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.935 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.696 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.548 0 CA-C-O 120.424 -0.098 . . . . 0.0 113.285 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -38.38 -51.05 2.2 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.197 1.932 . . . . 0.0 113.745 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -60.18 -50.53 73.31 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.948 0.88 . . . . 0.0 110.98 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -43.24 99.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.901 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.696 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 22.9 mm-40 -60.45 -55.58 31.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.175 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.7 -45.55 86.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.51 82.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -67.82 -40.08 83.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.699 0.285 . . . . 0.0 110.925 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -66.77 -42.37 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.64 -37.5 82.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.309 0.576 . . . . 0.0 109.916 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.622 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 3.4 tm? -51.41 -56.81 11.18 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.572 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.38 -27.84 66.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.367 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.53 -69.97 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.54 3.7 14.07 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 43.1 mm -97.86 96.39 5.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.5 mtm -126.91 144.12 51.08 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.715 0.769 . . . . 0.0 110.974 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 7.3 m -74.27 116.84 15.38 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 37' ' ' ILE . 22.0 mt -111.2 108.28 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.34 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 25.0 m -76.12 114.02 14.3 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.93 0.872 . . . . 0.0 109.86 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 p -95.8 -161.16 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.419 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -71.98 -31.71 66.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -76.09 -47.04 26.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.191 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.97 -153.6 24.58 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.621 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 47.7 mt-10 -75.35 116.46 16.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.952 -0.624 . . . . 0.0 112.381 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -124.4 151.93 43.86 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.706 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 47.2 m -75.7 108.36 8.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.76 116.98 5.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.464 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 103.64 16.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.081 0.467 . . . . 0.0 110.746 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.11 132.55 12.93 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.83 -59.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 118.262 1.031 . . . . 0.0 111.3 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -170.36 163.23 8.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.714 0.768 . . . . 0.0 112.75 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m-20 44.7 -90.02 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -127.36 6.91 6.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.099 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 p -133.18 149.75 52.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.326 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 72' ' ' LEU . 33.5 m -110.5 135.69 48.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.827 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 18' ' ' ILE . 27.6 mm -135.01 139.4 31.92 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.232 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.75 141.58 97.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.336 1.357 . . . . 0.0 111.1 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.736 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 99.4 m -60.84 -43.42 98.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.374 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.35 -11.03 28.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.78 -15.07 60.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.857 0.837 . . . . 0.0 109.235 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 60.25 70.72 0.97 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.94 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.2 115.75 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 N-CA-C 107.702 -1.691 . . . . 0.0 107.702 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.75 -124.38 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.23 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' VAL . 21.0 t70 -95.31 -32.07 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.939 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -144.5 144.42 31.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.724 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 m -128.1 155.25 39.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.828 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 16.1 tp -97.75 100.66 12.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.3 t -89.95 107.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.087 0.946 . . . . 0.0 111.308 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 p30 56.7 12.57 1.16 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.485 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.13 -6.65 13.05 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.507 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -103.64 117.35 34.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.02 114.1 6.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.068 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 tp -120.64 131.63 72.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -88.02 147.77 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 111.295 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 45' ' ' ASP . 8.0 p -73.09 136.5 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -87.03 -50.11 6.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -169.17 151.96 4.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.147 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -128.38 132.36 48.53 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -115.62 117.48 30.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.365 0.603 . . . . 0.0 112.285 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -66.19 106.7 1.72 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 65.9 tp -85.98 104.74 15.89 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 122.558 1.171 . . . . 0.0 109.782 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 31.6 m -113.67 164.53 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 113.572 -1.649 . . . . 0.0 106.665 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.5 134.92 78.98 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.538 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.71 -10.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 114.941 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.92 19.67 12.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.965 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.2 m120 71.03 29.08 3.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.916 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.451 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 37.5 mt -108.79 147.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.968 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t-20 -64.59 131.01 45.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.823 0.344 . . . . 0.0 111.548 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.677 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 6.7 tt -111.87 -27.02 8.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.736 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 34.8 tp10 78.8 8.78 1.97 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 36' ' ' VAL . 15.4 tp -99.41 133.12 44.18 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.239 0.542 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.4 m -106.93 112.62 25.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.41 101.2 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.7 tp -85.25 108.01 17.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.767 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -93.33 116.62 29.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.181 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.7 mt -116.75 124.33 49.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.778 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.87 103.9 11.02 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.915 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.28 136.19 41.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -62.24 -39.72 93.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.19 117.92 19.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 32' ' ' ASP . 72.1 mmtt -71.64 140.98 49.93 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.01 149.2 49.05 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 1.1 tpm_? -61.19 126.31 26.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.324 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.516 ' OD2' ' HD2' ' A' ' 87' ' ' ARG . 14.5 t70 -67.42 81.56 0.15 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -97.88 20.86 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HD2' ' OD2' ' A' ' 85' ' ' ASP . 6.7 ptm180 -63.46 -28.71 70.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.4 -6.38 86.06 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.104 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -91.17 -7.01 52.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.61 142.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 48.8 m -100.5 134.73 43.01 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER -76.17 -41.57 49.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 91' ' ' SER . 26.6 t70 -119.47 129.3 54.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 172' ' ' GLN . 26.6 mt -65.23 -73.16 0.13 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 57.29 68.71 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.43 87.82 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.126 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 11.6 p -81.19 -0.73 4.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.114 0.483 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 9.3 t70 -125.27 129.88 50.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.805 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.43 165.1 31.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.679 0.752 . . . . 0.0 112.438 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.2 m -134.81 141.65 46.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.435 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.558 HD11 ' OH ' ' A' ' 137' ' ' TYR . 78.9 mt -96.18 119.93 35.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.556 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.56 100.22 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.85 129.4 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.726 0.774 . . . . 0.0 112.206 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.19 49.38 1.65 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 m -106.49 -163.15 0.9 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.731 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -56.61 -48.17 78.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.121 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -88.16 -62.72 1.43 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.888 -0.507 . . . . 0.0 112.288 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.61 112.37 21.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -100.95 108.49 20.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.661 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 m120 58.97 72.33 0.54 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.736 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 m -140.56 130.85 25.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 112' ' ' ILE . 23.9 pt -105.37 99.46 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.7 mp -91.66 103.79 16.33 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.948 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -69.77 107.68 3.6 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.064 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.7 -121.05 5.32 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.34 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.7 Cg_endo -65.75 116.51 3.99 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.535 2.157 . . . . 0.0 114.719 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 137' ' ' TYR . 32.4 m -120.74 136.84 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.311 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -138.37 160.05 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -89.16 139.8 30.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.824 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.64 -56.78 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.001 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.11 -128.83 6.54 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 5.0 tt -99.66 113.47 25.94 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.5 pt -133.16 -159.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 20.3 m120 -125.99 125.9 43.43 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 2.7 mm? -100.48 113.36 26.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.497 ' OG ' HD12 ' B' ' 5' ' ' LEU . 4.0 m 57.23 29.31 16.5 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.317 0.58 . . . . 0.0 111.262 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 127' ' ' SER . 42.6 m 87.18 7.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 126' ' ' LEU . 6.0 t -111.03 139.68 22.02 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.601 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 21.3 Cg_exo -64.67 111.82 1.79 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 126' ' ' LEU . 26.3 m -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.864 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 133' ' ' ARG . 19.0 t-20 -119.3 163.25 17.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 37.7 ttm-85 68.41 35.45 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.937 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mmt -92.93 139.37 30.6 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.803 0.811 . . . . 0.0 113.004 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.6 mt -95.41 137.93 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.453 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -117.47 141.27 48.55 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.558 ' OH ' HD11 ' A' ' 101' ' ' LEU . 33.2 p90 -148.63 145.07 27.6 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.201 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.73 92.96 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.736 0.779 . . . . 0.0 112.112 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -161.43 137.18 7.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.59 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.78 87.01 5.29 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.486 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.1 p -89.91 151.04 21.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.081 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -130.27 151.57 50.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.045 0.926 . . . . 0.0 113.007 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.7 OUTLIER -45.35 152.3 0.3 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.225 175.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.461 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 91.58 -14.52 63.77 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.001 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 34.1 tt0 -99.33 7.2 45.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.317 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.531 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 6.9 m -60.56 136.11 57.96 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.37 -10.48 36.17 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 123.654 0.596 . . . . 0.0 111.952 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -51.1 121.01 10.26 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.086 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' ILE . 86.9 t -80.36 108.54 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.529 0.68 . . . . 0.0 111.212 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.5 tp -81.63 103.84 11.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.988 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -143.38 177.68 8.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.744 0.783 . . . . 0.0 111.998 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.13 -178.55 6.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.753 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.8 t -64.17 98.31 0.22 Allowed 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.802 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.42 29.05 54.28 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.162 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 33.4 ttmt -156.2 129.36 8.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.471 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.2 mt -112.77 129.14 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.23 -41.22 7.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 162.99 -156.09 27.7 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.82 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -127.89 151.16 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.923 0.868 . . . . 0.0 111.822 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.5 123.16 19.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -114.2 -28.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.55 -152.35 9.07 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.177 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.68 153.96 16.32 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.851 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 34.1 t30 -131.42 100.94 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.84 -121.88 6.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.404 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -102.21 22.92 12.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.675 0.75 . . . . 0.0 109.611 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 9.8 tt0 -127.61 115.53 18.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.365 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.42 148.75 28.25 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 47.5 m-85 -121.86 132.65 54.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.1 t -133.48 141.95 48.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.581 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -80.61 127.64 32.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.484 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 27.5 tt0 -74.6 109.2 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.895 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.494 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 55.2 mt -87.69 94.43 9.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.401 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.67 129.82 34.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.865 0.841 . . . . 0.0 111.379 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.35 -29.5 10.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.939 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -44.76 -43.16 8.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.659 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -79.81 -47.04 15.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 112.263 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.03 -16.63 61.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.23 -29.33 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 O-C-N 121.386 -0.821 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.76 -36.68 11.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.833 0.349 . . . . 0.0 111.15 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.61 119.7 17.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.091 -178.107 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ACE . . . . . 0.507 ' O ' HD13 ' B' ' 2' ' ' LEU . . . . . . . . 0 C--O 1.225 -0.227 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.507 HD13 ' O ' ' B' ' 1' ' ' ACE . 2.3 mm? -140.45 132.25 27.47 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.309 0.381 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.2 tt0 -101.64 83.96 2.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -88.75 141.06 28.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.6 tp -94.94 148.17 22.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 20.4 m-85 -61.32 139.59 58.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.8 mt-30 . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.971 -0.559 . . . . 0.0 . 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.531 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.627 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.49 -30.38 52.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.504 1.469 . . . . 0.0 111.57 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 22.8 t-20 -63.14 -53.25 56.38 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.389 1.09 . . . . 0.0 109.699 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 m -50.43 -53.71 27.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.073 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -57.49 -51.53 69.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.801 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.74 -50.58 72.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.171 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -44.95 95.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.7 tt -68.0 -35.06 77.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.571 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -70.05 -38.55 75.83 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.65 -40.76 93.19 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.196 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 29.7 mt -50.43 -57.66 7.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.431 1.11 . . . . 0.0 111.175 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -60.92 -28.0 68.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.719 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.59 -61.63 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.27 -7.26 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.6 mm -92.7 126.8 45.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.968 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtm -133.77 148.37 51.37 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -82.31 111.81 18.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.718 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.07 134.06 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 20.9 m -120.6 101.18 7.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.461 0.648 . . . . 0.0 109.941 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 p -105.74 -163.48 0.94 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.232 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -60.98 -18.57 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.0 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.683 ' HE2' ' OE1' ' A' ' 42' ' ' GLN . 6.3 mptp? -95.19 -59.05 1.98 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.06 0.457 . . . . 0.0 110.007 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . 172.2 -143.34 7.37 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.917 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -85.1 121.92 28.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.164 0.507 . . . . 0.0 111.327 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -125.88 161.57 27.14 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.395 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 37.8 m -89.26 112.03 22.99 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.485 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.73 109.11 3.38 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -87.62 98.47 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 111.672 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.13 10.35 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.68 -56.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.357 0.578 . . . . 0.0 109.858 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -154.82 144.07 21.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.987 0.899 . . . . 0.0 112.858 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 4.1 p30 46.78 -86.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.684 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 37.6 ptt180 -134.23 14.16 3.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.5 0.667 . . . . 0.0 110.595 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -94.67 113.05 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.1 m -118.87 154.07 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.842 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.33 133.1 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.14 143.58 25.27 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.662 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.7 153.04 52.11 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 120.849 1.033 . . . . 0.0 111.069 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.574 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 97.0 m -73.68 -39.55 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -65.11 -1.8 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.51 54.71 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.288 0.566 . . . . 0.0 110.802 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.683 ' OE1' ' HE2' ' A' ' 22' ' ' LYS . 42.5 mt-30 65.22 72.15 0.49 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.046 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.38 123.92 2.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.608 2.872 . . . . 0.0 109.949 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.25 -133.14 6.07 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.544 -0.836 . . . . 0.0 114.262 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.617 ' O ' HG12 ' A' ' 56' ' ' VAL . 28.0 t70 -83.84 -44.92 13.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 3.2 p30 -127.75 144.17 51.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.7 153.97 27.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.156 0.503 . . . . 0.0 111.146 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.84 103.71 16.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 49' ' ' VAL . 17.7 m -89.36 93.85 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.054 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 69.87 13.1 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.64 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.84 -29.83 5.7 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.94 120.91 19.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -84.73 114.98 22.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.851 0.834 . . . . 0.0 110.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.39 141.83 44.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.018 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 34.4 ttt180 -90.54 151.06 21.51 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.47 0.652 . . . . 0.0 112.058 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -92.38 145.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -89.09 -41.94 12.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.733 0.778 . . . . 0.0 109.018 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -160.07 129.79 5.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.206 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.54 112.41 22.17 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -104.89 107.07 17.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.731 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.84 126.29 28.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.079 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -90.42 103.87 16.51 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.91 141.08 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 172.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 11.8 t70 -72.95 135.89 80.14 Favored Pre-proline 0 C--N 1.31 -1.15 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.631 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 64' ' ' ASP . 72.8 Cg_exo -52.59 -8.16 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.835 1.69 . . . . 0.0 112.217 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 64' ' ' ASP . 28.6 tt0 -81.54 3.24 25.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 73.48 25.22 2.15 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.863 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.28 152.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' THR . 52.7 t30 -63.84 134.86 55.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.615 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 41.7 tp -102.99 -22.13 13.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.574 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.1 tp10 72.04 13.29 5.91 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.071 175.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.86 158.94 16.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.937 0.399 . . . . 0.0 110.27 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.6 m -135.88 120.8 18.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.208 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.05 102.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.7 tp -93.09 97.68 10.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.992 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 m -92.12 90.66 7.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 4.8 mp -74.21 152.5 39.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.513 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.37 75.49 10.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 79' ' ' ARG . 5.0 tpt180 -106.92 128.28 54.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.007 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.5 -12.74 51.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 38.2 mt-10 -90.56 117.86 29.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.612 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -93.5 111.29 22.93 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.258 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -81.98 165.85 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.482 0.658 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 84' ' ' ARG . 18.8 ttt180 -50.93 126.52 16.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.864 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -81.79 98.75 8.61 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.45 0.643 . . . . 0.0 109.859 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.5 pt -91.04 21.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 122.054 0.931 . . . . 0.0 109.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -55.28 -33.4 63.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.484 -1.689 . . . . 0.0 113.239 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.11 -7.74 88.16 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.864 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.81 2.05 51.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.44 131.85 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -93.28 105.12 17.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' A' ' 174' ' ' LYS . 0.1 OUTLIER -62.43 -54.77 35.32 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 176.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.41 135.2 45.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 95' ' ' GLU . 25.6 mt -61.03 -55.44 32.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 15.0 pt-20 36.61 71.8 0.13 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.591 . . . . 0.0 111.147 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.39 105.69 0.21 Allowed Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.651 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -91.97 9.98 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.083 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -111.62 118.33 35.38 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.09 151.54 37.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.044 0.926 . . . . 0.0 112.423 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.5 m -122.03 135.92 54.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.262 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.9 105.41 17.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.294 0.569 . . . . 0.0 110.222 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.674 ' HB ' HG23 ' A' ' 149' ' ' VAL . 35.3 t -80.38 102.16 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 108' ' ' PHE . 14.7 t -89.35 108.24 18.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.426 0.631 . . . . 0.0 111.71 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 29.6 t60 -129.9 39.35 3.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 97.2 p -108.9 -161.18 0.75 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.177 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -73.9 -17.25 61.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.704 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -78.01 -76.69 0.18 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 103' ' ' VAL . 79.8 m-85 -117.99 147.85 42.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.096 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.74 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 6.4 m -124.63 124.97 43.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.269 0.557 . . . . 0.0 110.794 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 109' ' ' THR . 12.3 t-20 80.82 -2.2 1.82 Allowed 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.658 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.0 m -92.67 119.38 32.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.26 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 112' ' ' ILE . 41.2 pt -95.25 126.62 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.0 110.53 20.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.54 122.13 18.44 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.58 -32.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.729 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.07 -105.12 2.04 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.879 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 88.5 Cg_endo -84.5 128.85 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.208 1.939 . . . . 0.0 114.145 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.81 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.6 p -132.14 163.77 27.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.726 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.15 153.92 20.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.46 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.51 0.13 11.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.871 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.93 -116.04 4.14 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.214 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 123' ' ' LEU . 7.3 tt -121.16 127.24 51.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.001 0.429 . . . . 0.0 111.239 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.7 pt -136.91 179.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 19.9 m120 -95.81 84.04 3.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.233 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 55.3 tp -65.49 105.86 1.28 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.0 m 62.52 32.67 16.45 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.373 0.606 . . . . 0.0 109.615 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 127' ' ' SER . 38.0 m 81.84 -10.46 1.14 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.378 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -91.49 120.98 68.08 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.518 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.34 114.59 2.04 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.493 1.462 . . . . 0.0 110.762 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 69' ' ' ASN . 23.3 m -134.34 134.88 42.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.016 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 26.8 p30 -113.42 -177.62 3.18 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.909 -0.717 . . . . 0.0 112.714 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 65.91 26.96 10.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.459 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 74.0 mt -92.34 135.5 27.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -117.26 130.99 56.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.627 0.727 . . . . 0.0 111.873 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.8 p90 -142.9 112.12 6.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.12 105.71 2.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.728 0.775 . . . . 0.0 109.246 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -167.59 135.4 2.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.75 102.7 0.97 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.825 0.821 . . . . 0.0 111.655 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 t -140.26 147.07 39.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.386 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 26.4 mtpp -141.51 -179.13 5.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.339 1.066 . . . . 0.0 111.962 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -37.6 150.2 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.986 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.406 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 96.69 -28.33 13.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.876 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -87.17 10.49 16.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.0 0.429 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.656 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 4.8 m -63.37 135.14 56.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.771 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 102.96 -21.37 40.41 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.488 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.24 133.72 24.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.942 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.674 HG23 ' HB ' ' A' ' 102' ' ' VAL . 17.7 m -92.16 112.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 0.0 111.719 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.66 109.66 18.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.63 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -146.12 172.68 13.06 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.176 0.988 . . . . 0.0 113.231 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -130.91 172.58 11.88 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.682 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -68.62 103.25 1.66 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.773 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.54 -0.48 77.5 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.581 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -139.18 109.35 6.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.5 mm -90.49 111.55 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.33 -48.65 12.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 170.0 -160.54 33.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.621 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 149' ' ' VAL . 23.4 pt -122.41 143.37 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.838 0.828 . . . . 0.0 112.583 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.24 118.72 10.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.152 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 17.1 m -113.24 -23.01 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.748 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.37 -152.2 8.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.522 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.81 153.81 12.01 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.766 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.584 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 16.0 t30 -126.36 105.68 8.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.175 0.512 . . . . 0.0 110.399 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.96 -106.66 1.93 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.322 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 166' ' ' ARG . 29.7 ttm180 -116.73 20.45 13.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -122.62 116.54 24.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.164 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.53 149.61 35.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.864 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 51.5 m-85 -130.51 115.38 16.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.45 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 69.5 m -109.45 172.64 6.73 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.676 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.473 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -115.0 132.25 56.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.9 pt20 -86.42 133.98 33.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.0 mt -85.92 88.92 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.297 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.539 ' HB3' ' OE2' ' A' ' 92' ' ' GLU . 9.6 mtpm? -79.1 111.26 15.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.087 0.946 . . . . 0.0 108.799 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -35.71 -36.23 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.497 ' HG2' ' CG ' ' A' ' 92' ' ' GLU . 17.0 mm100 -56.34 -27.95 57.51 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -68.46 -18.39 64.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.42 -12.1 26.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.489 0.662 . . . . 0.0 109.245 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -89.96 -44.93 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.195 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -27.66 56.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.561 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -80.38 108.16 13.77 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.583 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.435 177.425 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.038 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 4.5 mp -108.79 106.96 17.2 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.069 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.4 tt0 -89.31 77.42 7.43 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.35 118.55 22.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.136 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 21.0 tp -83.6 152.11 25.0 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.9 m-85 -58.22 141.01 52.02 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 98.2 mt-30 . . . . . 0 C--N 1.307 -1.243 0 C-N-CA 120.708 -0.397 . . . . 0.0 . 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.656 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.832 -0.107 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.91 -58.53 1.53 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.827 2.351 . . . . 0.0 115.679 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 64.2 t30 -57.12 -48.77 77.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -68.39 -42.54 78.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.891 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -61.7 -43.98 97.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.264 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.17 -49.0 76.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.128 0.489 . . . . 0.0 110.387 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 -46.04 85.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.577 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.95 -42.72 99.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -68.07 -44.84 75.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.585 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.73 -45.79 91.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.738 0.78 . . . . 0.0 110.16 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 57.5 tp -55.99 -49.89 72.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.408 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.39 -28.57 56.77 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.64 -34.05 10.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -121.33 -9.81 9.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 50.8 mm -97.8 114.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.627 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.429 ' CE ' ' HA ' ' A' ' 16' ' ' MET . 2.1 mmt -122.24 146.18 47.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.323 0.582 . . . . 0.0 110.355 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.52 86.32 4.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 HG21 HD13 ' A' ' 37' ' ' ILE . 47.4 mm -75.61 94.33 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.0 109.765 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.3 m -86.62 96.12 10.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.741 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.19 179.65 4.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.932 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -55.92 -35.97 67.2 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.732 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 13.8 tmtt? -89.25 -31.7 17.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.9 -169.9 42.44 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 119.495 -1.336 . . . . 0.0 115.054 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -95.52 109.05 21.32 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 114.84 -0.68 . . . . 0.0 110.066 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 41' ' ' ALA . 86.7 m-85 -112.04 158.68 19.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.74 0.781 . . . . 0.0 112.245 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.0 m -83.05 106.66 15.05 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.559 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -89.64 119.99 5.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.938 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -93.99 100.68 12.77 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 0.0 110.186 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.38 106.99 1.9 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.0 -55.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -163.02 144.12 9.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.577 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 34.0 t70 54.02 -94.27 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.786 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -133.17 23.51 4.14 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.633 -0.667 . . . . 0.0 110.604 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.8 t -102.27 119.42 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.747 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -123.71 142.5 51.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.6 t -109.55 131.88 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 122.227 1.013 . . . . 0.0 112.111 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 18' ' ' ILE . 19.4 pt -141.75 165.53 27.55 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.44 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 25.0 Cg_exo -66.28 170.0 12.85 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 120.757 0.972 . . . . 0.0 111.098 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.565 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 62.6 m -76.44 -37.47 56.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.97 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -69.06 9.41 0.41 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 25' ' ' PHE . . . -75.64 -29.98 59.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.3 mm-40 61.37 72.9 0.63 Allowed Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.928 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.54 132.4 33.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.642 2.228 . . . . 0.0 111.263 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.53 -129.17 5.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.635 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.29 -30.73 12.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 109.188 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 55' ' ' ARG . 16.2 m-20 -132.38 155.62 48.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -129.7 134.38 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.54 104.84 13.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.423 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' GLY . 62.9 t -82.44 91.14 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.119 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 70.75 -9.57 0.81 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.104 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 152.55 -26.73 0.85 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -74.77 113.55 12.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.55 -0.825 . . . . 0.0 110.425 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.58 93.96 2.58 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.97 142.78 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.766 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.497 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 1.7 mmp_? -63.26 133.03 53.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.73 108.65 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -68.3 -40.51 81.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.122 0.963 . . . . 0.0 109.281 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -171.48 147.83 2.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.617 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.664 ' HD2' ' O ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -117.87 139.31 51.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.755 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.407 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 65.1 t80 -141.47 106.34 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.573 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -71.81 135.95 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 38.2 tp -104.18 109.17 20.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.379 1.085 . . . . 0.0 113.293 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.57 160.21 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 136.95 60.41 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -43.42 -26.13 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.473 2.115 . . . . 0.0 113.65 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.75 -9.37 57.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.75 0.786 . . . . 0.0 109.332 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.65 66.27 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.792 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 132' ' ' ASN . 63.0 mt -144.38 150.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 112.442 -2.163 . . . . 0.0 105.935 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -65.65 135.06 54.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.263 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 29.0 tp -108.62 -29.32 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.565 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 18.0 tp10 74.92 23.88 1.63 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.123 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.06 157.13 18.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 47.3 m -132.26 120.14 21.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.124 0.488 . . . . 0.0 109.796 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 65.9 t -86.4 88.52 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.8 tp -84.26 110.86 18.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.93 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -98.06 101.67 13.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.868 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.96 155.25 16.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.88 76.29 9.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -104.35 104.55 14.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.25 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.54 -38.03 74.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -82.62 82.25 8.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 20.4 ptmt -61.52 154.3 25.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.595 -1.184 . . . . 0.0 113.944 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.2 169.93 10.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.215 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -71.97 137.31 47.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.266 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -86.82 87.31 7.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.423 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -85.45 14.62 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -63.13 -16.13 59.01 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.792 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.79 -20.49 79.78 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.194 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -93.41 -0.37 56.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.7 mt -74.99 144.53 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 12.8 m -91.56 123.87 35.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.619 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.2 pm0 -78.96 -31.51 45.02 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' SER . 41.2 t0 -136.31 148.09 47.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 32.2 mt -71.41 -55.53 7.76 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 94' ' ' LEU . 1.9 pt-20 38.2 72.0 0.14 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.453 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.42 99.22 0.14 Allowed Glycine 0 N--CA 1.444 -0.784 0 O-C-N 124.0 0.813 . . . . 0.0 111.781 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.6 p -74.89 -21.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.87 0.366 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -92.3 119.36 31.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.596 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.96 154.31 48.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.105 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -120.71 137.47 54.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.176 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -107.98 127.02 53.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.38 113.98 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.62 123.44 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.916 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 39.7 t60 -150.49 71.96 1.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 60.7 p -143.16 -150.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.325 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.1 t-20 -55.02 -54.79 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.177 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 m120 -74.36 -68.53 0.52 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.412 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 36.0 m-85 -116.36 157.09 25.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -136.61 147.47 46.96 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.277 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.32 13.14 6.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.0 0.428 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 23.0 m -93.02 104.51 16.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.436 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.98 111.95 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.315 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.11 129.23 51.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.328 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.53 122.75 30.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 137' ' ' TYR . 9.1 p -89.26 -32.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.036 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.67 -130.69 10.31 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.642 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 76.3 Cg_endo -78.27 134.41 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.878 1.719 . . . . 0.0 112.891 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.33 165.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.159 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 p -132.79 -178.78 5.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.1 mtt -115.4 149.62 37.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.753 0.311 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 -31.08 5.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.41 -112.62 4.26 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.073 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 tt -123.31 112.08 17.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.8 pt -130.26 175.75 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.018 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 53.0 m-80 -86.9 87.32 7.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.51 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 49.8 tp -75.45 106.42 6.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.3 t 61.67 36.55 16.49 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.8 m 74.18 -0.07 3.46 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.516 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 m -104.23 113.69 64.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.912 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.74 111.78 0.87 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.989 1.792 . . . . 0.0 111.493 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 m -124.04 136.63 54.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.16 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.4 ' HB2' HG21 ' A' ' 68' ' ' ILE . 65.0 t30 -103.84 164.16 11.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 67.13 45.89 1.62 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.983 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mmt -91.66 127.35 37.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.281 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 170' ' ' SER . 28.9 mm -93.9 147.18 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -134.18 140.2 46.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 111.757 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.477 ' CD1' HG21 ' A' ' 115' ' ' VAL . 36.4 p90 -149.04 140.98 23.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.13 117.63 25.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.409 1.099 . . . . 0.0 110.15 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -174.08 137.96 0.57 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.242 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.38 96.2 0.08 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.322 0.582 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.9 p -107.96 144.37 35.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.333 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.3 158.25 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.516 1.15 . . . . 0.0 112.79 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.589 ' CG2' ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -42.48 152.1 0.1 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.289 173.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.636 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 85.51 -14.51 50.84 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.269 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 107' ' ' ASN . 11.2 mm-40 -99.86 -0.27 40.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 119.792 -0.147 . . . . 0.0 110.872 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 10.5 p -78.3 135.26 37.48 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.309 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 119.78 -23.12 8.44 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.929 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.52 138.01 19.27 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.399 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.78 125.33 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.775 0.798 . . . . 0.0 112.911 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.17 109.07 21.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.384 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -149.29 -174.5 4.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.106 0.955 . . . . 0.0 113.326 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.35 172.85 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.212 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.1 t -60.52 108.8 0.88 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.572 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.18 63.44 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.344 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -162.66 113.75 1.52 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.83 119.9 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -83.98 -41.11 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 164.08 -156.45 28.33 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.605 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.4 pt -126.62 147.5 31.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.21 0.528 . . . . 0.0 111.05 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.1 133.13 48.46 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.43 -28.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.61 -155.91 11.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.08 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.71 154.27 25.0 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.029 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.577 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 10.3 t-20 -135.16 116.14 14.17 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.69 -112.59 4.71 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.06 -1.066 . . . . 0.0 111.06 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -118.08 19.45 13.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.481 . . . . 0.0 109.828 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.0 135.17 51.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.316 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.77 138.28 14.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 44.9 m-85 -116.72 132.92 56.56 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.439 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 18.5 m -124.86 165.35 18.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.546 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -106.91 143.03 35.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -81.95 110.75 17.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.436 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -88.55 93.02 9.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' SER . 86.4 mttt -87.3 135.22 33.4 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 122.643 1.211 . . . . 0.0 113.45 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 179' ' ' VAL . 16.1 tptm -42.78 -43.08 3.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.537 -2.12 . . . . 0.0 112.78 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -41.51 -46.41 3.5 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.74 -23.02 55.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.679 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 175' ' ' LYS . 92.1 t -74.27 -24.21 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.5 -19.8 61.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.819 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -79.91 119.68 23.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.608 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.491 -179.557 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.202 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.9 mm? -131.19 150.55 52.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.326 0.584 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.0 tt0 -114.68 85.77 2.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -91.09 130.5 36.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 23.2 tp -88.55 154.71 20.12 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.574 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 24.3 m-85 -62.64 145.64 54.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 95.2 mt-30 . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 118.702 -1.199 . . . . 0.0 . 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.732 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.655 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.495 2.611 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 12.2 Cg_endo -52.68 -32.02 53.04 Favored 'Trans proline' 0 C--N 1.334 -0.188 0 C-N-CA 122.574 2.183 . . . . 0.0 114.609 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 66.6 t30 -79.83 -49.54 11.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.209 0.528 . . . . 0.0 111.932 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -68.38 -42.29 79.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.738 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 13.5 pt-20 -72.42 -29.54 63.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.097 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -65.58 -46.32 79.87 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.59 75.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.432 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.13 -43.63 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.603 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 m -69.85 -41.74 74.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.179 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.85 -42.07 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.716 0.77 . . . . 0.0 109.945 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.645 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -56.41 -53.5 56.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.882 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.7 -25.99 66.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -83.42 -55.58 4.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -118.06 -2.42 11.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 40.5 mm -101.94 114.24 40.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.31 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtm -128.03 155.05 44.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.506 0.669 . . . . 0.0 111.434 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -85.3 109.15 18.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.9 mt -103.08 110.69 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.678 0.751 . . . . 0.0 110.224 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 11.3 m -85.5 114.22 22.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.37 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -106.52 -176.3 3.04 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -75.83 -15.83 60.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.112 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -82.62 -42.34 18.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.052 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.94 38.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.98 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.99 116.14 28.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.75 166.33 13.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.969 0.89 . . . . 0.0 111.333 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 19.0 m -73.55 105.01 4.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.51 105.53 3.23 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -107.07 130.1 54.72 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.794 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.43 126.08 7.22 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.17 -56.76 5.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.125 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -158.43 151.09 22.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.259 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 8.1 t70 56.25 -94.36 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.52 20.25 1.86 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.877 0.846 . . . . 0.0 108.885 177.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.0 106.73 18.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 m -115.29 152.6 32.46 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.34 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.73 144.69 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -146.98 140.39 14.94 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.757 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.36 145.39 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.772 1.648 . . . . 0.0 111.981 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 67.0 m -75.29 -34.86 61.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.293 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -65.01 -11.97 45.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.38 -23.26 46.89 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.563 0.697 . . . . 0.0 109.888 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 48.27 72.1 1.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.81 130.57 28.16 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.41 -155.07 4.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.374 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -82.22 -35.98 27.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.188 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.29 121.53 22.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.2 m -117.28 150.94 19.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.369 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 34.4 mt -83.34 107.12 15.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.348 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -92.45 89.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.0 t30 58.49 36.27 25.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.107 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.95 -15.06 57.09 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.156 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 15.8 mm-40 -106.09 108.71 20.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.91 139.46 30.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.722 -179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.0 tp -135.85 135.54 50.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -84.91 128.0 34.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.38 142.58 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -77.14 -49.73 14.58 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -150.76 120.33 6.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.817 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -97.59 98.21 9.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -100.49 123.79 45.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.017 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 61' ' ' LYS . 3.4 mppt? -94.53 108.2 20.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 47.2 tp -86.12 118.22 25.44 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.07 172.75 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.98 140.94 86.26 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 117.723 0.238 . . . . 0.0 111.637 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.55 -29.02 9.77 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.267 1.311 . . . . 0.0 111.954 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.0 8.87 16.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.274 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 64.02 68.36 0.57 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.681 0.753 . . . . 0.0 110.469 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.0 mt -142.97 164.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.985 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -69.0 116.54 9.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 118.298 0.499 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.56 -32.93 10.53 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 30.3 tp10 77.38 15.11 1.76 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.995 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 80.4 mt -103.37 111.68 24.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.038 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -90.11 107.54 19.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.455 HG11 ' HE3' ' A' ' 181' ' ' LYS . 36.3 t -79.04 97.16 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.658 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 tp -78.21 94.57 4.79 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.102 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.2 m -83.95 98.63 9.9 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.691 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -103.4 144.13 31.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.064 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.35 96.82 7.98 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.18 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 77' ' ' LEU . 8.3 mmm180 -117.52 150.01 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -82.09 -44.82 16.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 110.08 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.79 76.11 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 59.6 pttt -67.76 172.31 5.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.491 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -93.65 160.89 14.57 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -71.83 143.61 49.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.479 -1.692 . . . . 0.0 112.299 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.47 91.77 2.81 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.371 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.0 pt -89.89 11.49 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -70.07 -27.06 64.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.305 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.26 -20.69 73.47 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 67.4 m-85 -92.54 -16.91 25.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.34 121.76 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.8 m -101.6 107.65 18.98 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.296 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 174' ' ' LYS . 12.5 pt-20 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -94.79 112.88 24.59 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.34 -71.36 0.09 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 49.97 67.98 0.82 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.08 92.52 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.264 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 60.7 t -83.79 -4.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.825 0.345 . . . . 0.0 111.515 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -114.21 110.4 19.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -130.62 165.69 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 112.739 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 m -119.97 141.62 49.51 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.723 -1.581 . . . . 0.0 109.69 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.8 tp -109.85 120.02 41.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 102' ' ' VAL . 31.3 m -116.31 108.38 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 120.214 -0.595 . . . . 0.0 110.05 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.91 136.98 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.755 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -142.28 75.73 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.57 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.9 p -124.24 -162.68 1.09 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -45.34 -67.63 0.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -94.15 -34.78 12.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.309 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.74 83.51 7.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 112.545 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.3 p -92.73 123.39 35.98 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.599 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER 38.61 62.9 0.95 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -99.02 103.13 15.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.642 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.8 mt -93.08 109.11 21.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.868 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.64 123.51 50.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.28 107.81 9.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.498 HG21 ' CD1' ' A' ' 137' ' ' TYR . 8.7 p -86.35 -24.76 6.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.307 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.21 -122.41 5.97 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.461 -0.876 . . . . 0.0 115.03 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.5 Cg_endo -66.24 117.59 4.82 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.407 2.072 . . . . 0.0 115.629 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.495 HG12 ' HB3' ' A' ' 137' ' ' TYR . 30.9 m -108.3 151.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.6 m -151.41 135.55 16.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.606 0.241 . . . . 0.0 110.928 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.1 ttm -66.71 122.44 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.695 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.43 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.14 -115.81 5.34 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.34 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.78 119.1 32.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.531 HG21 HD23 ' B' ' 2' ' ' LEU . 44.4 pt -133.22 -170.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.875 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 128' ' ' SER . 5.7 m-20 -110.38 109.42 19.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.8 mm? -87.57 112.1 21.91 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 128' ' ' SER . 26.7 t 65.21 10.33 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.568 0.699 . . . . 0.0 110.643 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 4.8 m 82.99 66.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.001 1.32 . . . . 0.0 112.823 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 126' ' ' LEU . 15.2 t -163.3 131.49 2.77 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.778 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.35 109.96 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 121.361 1.374 . . . . 0.0 113.84 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 126' ' ' LEU . 7.3 m -111.67 132.89 54.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.479 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -111.22 160.89 16.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.1 mtt180 65.36 43.37 3.51 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.078 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 85.1 mmm -92.24 136.6 33.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.3 tt -117.91 137.52 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -105.37 150.14 25.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 115' ' ' VAL . 1.5 p90 -144.68 152.8 40.97 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.368 0.604 . . . . 0.0 110.226 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.2 99.96 7.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.862 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 115' ' ' VAL . 47.2 t80 -178.2 119.93 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.755 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.68 120.63 16.58 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.6 t -143.01 151.85 41.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.752 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.9 174.21 10.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.701 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' ' CA ' ' B' ' 7' ' ' GLN . 17.8 p -38.91 155.47 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.318 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.443 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 94.3 -29.9 8.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -86.69 -4.87 59.23 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 26.3 p -78.1 144.57 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.508 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.42 -22.59 17.27 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.46 34.52 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.984 -0.608 . . . . 0.0 112.217 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.26 126.8 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.417 0.627 . . . . 0.0 112.297 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.73 106.6 18.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.2 p -149.24 -176.33 5.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.093 0.949 . . . . 0.0 112.306 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.68 174.69 13.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.816 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 8.8 t -62.02 115.75 4.34 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.794 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.05 90.67 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 19.2 ptmt -156.82 142.04 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.488 1.144 . . . . 0.0 112.772 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.43 138.85 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.614 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -106.53 -39.41 5.87 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.943 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.493 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 175.59 -167.77 39.83 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 173' ' ' LEU . 20.0 pt -129.48 141.8 45.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.699 0.762 . . . . 0.0 110.604 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 6.1 t60 -65.57 107.44 1.71 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.471 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 27.2 m -95.3 -21.03 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.759 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 175.8 -146.75 8.34 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.125 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.56 163.4 32.5 Favored Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.336 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 2.9 t30 -123.49 94.8 4.36 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.85 0.833 . . . . 0.0 109.765 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.65 -104.87 1.31 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.393 -1.276 . . . . 0.0 114.223 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 166' ' ' ARG . 1.0 OUTLIER -97.55 -8.25 29.51 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.56 -0.82 . . . . 0.0 111.972 -177.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -108.99 133.04 53.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.282 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -85.68 149.94 23.88 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.2 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 49.8 m-85 -133.11 122.68 24.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.702 0.763 . . . . 0.0 112.022 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 t -117.99 150.64 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.987 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.1 128.26 36.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -63.01 118.82 8.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.415 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.493 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 42.5 mt -87.66 85.19 7.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 92' ' ' GLU . 55.7 mtpt -89.56 133.89 34.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.752 0.787 . . . . 0.0 109.538 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -50.29 -19.64 0.86 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.639 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -9.09 58.79 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -108.99 13.25 24.8 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 p -88.48 -42.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.31 -11.63 37.44 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.966 0.803 . . . . 0.0 112.064 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HE3' HG11 ' A' ' 74' ' ' VAL . 26.6 tptp -73.45 137.44 44.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 112.569 -2.105 . . . . 0.0 108.094 176.16 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.174 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.531 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? -137.03 149.45 47.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.07 76.37 1.04 Allowed 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.44 140.58 33.33 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.0 tp -104.97 145.84 29.86 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.558 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 31.2 m-85 -57.61 142.09 45.94 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 81.9 mt-30 . . . . . 0 N--CA 1.436 -1.171 0 C-N-CA 119.344 -0.942 . . . . 0.0 . -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.443 HX51 ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.643 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.88 -25.2 74.34 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.4 2.066 . . . . 0.0 113.375 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.78 -53.8 19.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.1 0.476 . . . . 0.0 110.585 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -63.49 -35.52 80.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.779 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -61.82 -51.65 67.4 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -57.87 -48.43 79.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.269 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -55.78 -49.14 73.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.328 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.13 -43.73 98.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -71.34 -39.61 71.22 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.91 -41.34 95.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 122.182 0.991 . . . . 0.0 108.6 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 HD21 ' OD1' ' A' ' 110' ' ' ASN . 53.4 tp -59.49 -56.32 23.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.879 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -69.71 -28.87 66.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -103.23 -29.19 11.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.48 -19.25 8.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.519 HG23 HG23 ' A' ' 26' ' ' THR . 47.9 mt -93.35 117.99 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.075 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -125.87 156.77 39.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.186 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 p -86.73 106.11 17.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.8 mp -93.38 110.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 89.3 m -72.07 114.34 10.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.881 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 58.6 p -109.27 -163.57 0.88 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.7 t -77.53 -29.2 52.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -90.38 -33.15 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.95 -167.2 39.95 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.423 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.89 115.36 21.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -121.5 159.22 26.76 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.944 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -72.71 113.2 9.48 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.573 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -114.76 129.91 8.92 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.247 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.36 104.49 16.83 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.44 90.97 0.94 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 90' ' ' ILE . 24.5 mm -59.18 -50.98 77.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 111.35 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 11.7 p80 -166.94 164.24 16.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.307 1.051 . . . . 0.0 113.328 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HA ' ' CB ' ' A' ' 82' ' ' LYS . 1.6 m-20 45.97 -92.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.997 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 31.5 ptt180 -142.55 19.87 2.03 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.037 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.36 119.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.543 0.687 . . . . 0.0 110.765 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 m -117.33 139.98 50.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.047 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -99.84 124.69 53.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.574 . . . . 0.0 109.847 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 pt -136.84 163.89 46.35 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.66 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.18 150.43 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.549 1.499 . . . . 0.0 111.615 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.569 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 94.9 m -81.19 -42.52 20.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.355 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -63.17 -17.12 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -67.29 -19.21 65.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 109.422 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.3 mt-30 68.01 72.87 0.36 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.28 133.05 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.454 2.769 . . . . 0.0 110.657 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.82 26.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.613 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -103.07 -5.89 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.205 1.002 . . . . 0.0 109.355 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 10.7 t70 -139.72 107.43 5.63 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.44 148.01 15.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.108 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.76 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 7.3 mp -96.9 103.7 15.65 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.736 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.87 106.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 64.22 23.99 13.26 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.955 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.38 -17.54 46.96 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.733 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -83.47 105.67 14.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.859 -0.201 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 15.0 ptpt -71.9 114.23 9.77 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 77' ' ' LEU . 4.6 tt -127.22 143.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.53 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 20.2 mmm180 -66.35 142.99 57.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.73 150.68 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.36 -49.76 5.31 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.53 114.54 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.351 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -107.21 132.11 53.43 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' CE2' HD23 ' A' ' 62' ' ' LEU . 24.0 t80 -130.13 118.29 21.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.42 104.44 10.03 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.456 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 96.1 mt -62.52 109.49 1.39 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.992 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.8 m -91.96 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 22.3 t70 -89.04 132.68 37.21 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.66 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.61 -18.49 2.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.0 2.467 . . . . 0.0 114.551 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 44.2 mt-10 -89.82 19.58 4.69 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 111.133 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 25.0 t-20 77.32 15.38 1.75 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.142 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 69' ' ' ASN . 25.8 mm -109.26 179.1 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.79 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 68' ' ' ILE . 52.8 t30 -92.14 146.16 23.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.192 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.777 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 27.4 tp -108.33 -22.39 12.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.569 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 19.4 tp10 68.89 13.0 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.476 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 76.1 mt -105.47 110.48 22.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.96 0.163 . . . . 0.0 110.951 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.0 m -91.98 116.51 28.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.044 0.449 . . . . 0.0 111.493 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.31 105.93 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.158 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -84.44 93.13 8.23 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 13.0 tp -93.59 155.79 17.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.772 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 54' ' ' ILE . 28.7 t70 -89.48 67.36 7.6 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 11.2 tpt180 -117.07 101.88 8.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -89.32 -6.0 57.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.831 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -87.03 107.14 18.29 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' CB ' ' HA ' ' A' ' 32' ' ' ASP . 20.5 ptmt -78.21 157.7 29.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -88.04 167.09 13.98 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 111.989 -2.369 . . . . 0.0 108.262 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -64.03 130.54 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.395 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' OD1' ' HD2' ' A' ' 87' ' ' ARG . 10.3 m-20 -68.56 95.16 0.62 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -96.38 25.96 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 9.7 mtp180 -63.17 -36.07 82.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.645 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.08 -11.75 85.28 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.433 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -90.15 -17.71 27.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.562 0.681 . . . . 0.0 109.287 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 30' ' ' ILE . 30.0 mt -69.02 130.8 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 21.1 m -107.61 129.0 55.04 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.3 -43.23 52.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 91' ' ' SER . 10.2 t70 -106.05 124.81 50.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.167 175.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.66 -71.49 0.37 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 49.47 72.16 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -162.03 82.92 0.12 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.754 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.56 3.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.12 0.486 . . . . 0.0 111.304 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.1 t70 -143.8 119.17 10.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.187 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.428 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -142.5 172.2 13.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.085 0.945 . . . . 0.0 112.337 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -120.64 144.6 48.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.115 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -111.0 124.51 52.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.775 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 7' ' ' ALA . 19.3 m -114.17 120.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.467 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 t -113.38 133.41 59.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.53 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -140.77 75.24 1.49 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.9 p -118.4 -166.98 1.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -68.82 -38.43 79.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.234 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.43 -60.84 1.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.637 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.615 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 46.4 m-85 -96.68 108.94 21.66 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.239 0.543 . . . . 0.0 110.063 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 15.2 m -113.36 117.7 32.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.423 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 109' ' ' THR . 92.5 m-20 70.4 34.54 2.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.49 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 2.6 m -87.26 122.4 30.98 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.3 tt -119.96 109.28 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.6 mt -115.03 128.54 56.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.85 106.0 17.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.5 m -78.95 -38.47 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 98.15 -123.17 7.76 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.899 -1.143 . . . . 0.0 114.499 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.7 Cg_exo -61.35 108.89 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.804 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 99' ' ' ALA . 90.4 t -106.27 139.54 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 4.4 m -153.09 151.71 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.81 151.07 26.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.243 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -114.5 -35.93 4.76 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.64 -97.52 1.63 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.729 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.97 125.26 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.095 0.474 . . . . 0.0 111.492 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.0 pt -141.58 179.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 36.9 m-80 -100.47 93.83 5.83 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.297 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 4' ' ' ALA . 31.4 tp -72.74 97.18 2.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.508 ' HG ' ' H ' ' B' ' 6' ' ' PHE . 5.1 m 62.59 35.22 14.5 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.749 0.785 . . . . 0.0 110.267 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 74.7 m 79.14 0.91 2.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.29 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.9 m -103.82 107.11 55.63 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.91 123.07 12.22 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 121.833 1.688 . . . . 0.0 112.99 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 144.91 49.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.401 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.9 t30 -117.43 168.02 10.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.582 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 3.2 mpt_? 65.58 31.46 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.5 mmm -82.21 130.33 35.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.936 0.874 . . . . 0.0 113.031 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 49.0 mt -98.7 142.66 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.143 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 119' ' ' THR . 6.6 ptm180 -122.76 157.17 32.94 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 167' ' ' GLN . 20.2 p90 -157.75 141.8 15.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.534 0.683 . . . . 0.0 109.997 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.09 98.32 5.73 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.755 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -171.49 134.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.08 114.17 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.311 0.577 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.8 p -121.3 162.05 20.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 143' ' ' THR . 58.6 tttm -157.28 150.47 23.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.22 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 142' ' ' LYS . 57.1 p -37.58 158.83 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.88 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.555 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 87.74 -25.61 8.32 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.4 -0.86 57.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.546 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 9.8 p -76.68 142.53 40.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.58 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.57 -20.36 20.64 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.08 144.71 41.84 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.744 -0.728 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.02 124.25 46.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.302 0.573 . . . . 0.0 112.11 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -90.84 111.61 23.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -146.94 177.27 9.26 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.901 0.858 . . . . 0.0 112.681 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.08 177.54 10.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.944 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.6 t -60.93 111.65 1.75 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.208 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.1 77.77 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.157 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -151.98 121.14 6.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.17 0.485 . . . . 0.0 112.182 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.95 128.68 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -93.82 -41.16 9.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.237 0.541 . . . . 0.0 111.248 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 159.1 -158.47 29.49 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.537 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.92 143.54 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.558 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 162' ' ' GLY . 83.8 t60 -72.8 102.75 3.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.495 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.2 m -91.19 -19.37 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.549 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 160' ' ' HIS . . . -176.88 -152.75 10.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.929 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 176.39 168.31 36.32 Favored Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.544 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 22.0 t-20 -127.92 84.05 2.21 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.622 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.09 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.806 -1.543 . . . . 0.0 115.654 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -102.73 4.54 38.16 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 63.0 mt-30 -126.73 126.59 43.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.426 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.56 143.6 22.69 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.412 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 24.7 m-85 -122.54 109.44 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.918 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.8 t -108.5 146.56 33.0 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.541 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.64 125.07 38.05 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.6 pt20 -69.17 116.17 9.3 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.881 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 90' ' ' ILE . 18.8 tp -83.24 91.91 7.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.918 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -83.67 142.95 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.552 0.691 . . . . 0.0 112.263 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -66.09 -16.43 63.94 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -48.42 -50.98 28.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.733 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -70.91 -29.48 65.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.444 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.0 0.63 57.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -17.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.15 -25.96 18.47 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.173 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -117.39 120.92 39.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.289 -179.698 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.164 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.473 ' N ' HD12 ' B' ' 2' ' ' LEU . 4.8 mp -118.52 116.5 26.79 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.636 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.3 tt0 -94.77 79.17 3.71 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 173.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.581 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -72.42 135.77 45.88 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.587 HD13 ' N ' ' B' ' 6' ' ' PHE . 0.4 OUTLIER -91.18 134.45 34.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.587 ' N ' HD13 ' B' ' 5' ' ' LEU . 25.1 m-85 -50.04 137.02 17.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 72.1 mt-30 . . . . . 0 N--CA 1.439 -1.024 0 C-N-CA 117.098 -1.841 . . . . 0.0 . -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.555 HX51 ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 112.887 -0.085 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.91 -40.51 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.232 1.955 . . . . 0.0 112.703 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.87 -44.35 55.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.431 0.634 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -55.19 -57.32 12.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.758 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.5 -34.31 75.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.6 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.47 -53.83 30.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.258 0.551 . . . . 0.0 110.625 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.38 98.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.947 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.6 tt -62.79 -42.95 99.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.696 0.284 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -69.93 -43.21 72.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.21 -40.68 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.352 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 8.3 tt -60.64 -45.0 95.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.013 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 41.7 mtp180 -73.73 -29.8 62.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -94.87 -51.61 4.61 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.92 -17.31 14.23 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.0 mm -88.05 123.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.65 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.414 ' CE ' ' HA ' ' A' ' 16' ' ' MET . 3.7 mmt -123.53 130.23 52.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -71.96 103.98 3.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.196 178.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 56.6 mt -89.83 107.86 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 122.123 0.963 . . . . 0.0 111.607 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 m -80.41 110.66 16.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.334 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 21' ' ' SER . 6.2 t -134.11 -171.6 2.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.68 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.426 ' N ' ' OG1' ' A' ' 20' ' ' THR . 15.7 m -60.9 -28.47 68.93 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 40' ' ' HIS . 74.3 mmtt -92.78 -4.55 52.86 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.853 -0.53 . . . . 0.0 111.302 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 -151.75 19.1 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 29.1 mt-10 -112.34 129.33 56.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -118.12 167.27 11.64 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.134 0.968 . . . . 0.0 112.428 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 27.0 m -78.75 99.34 6.62 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.931 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 136.39 12.86 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.6 pt? -121.32 129.74 53.26 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 118.389 -1.325 . . . . 0.0 112.597 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.9 109.64 2.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 90' ' ' ILE . 45.8 mm -67.9 -43.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.276 0.56 . . . . 0.0 110.611 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -171.88 146.78 2.1 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.474 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 50.28 -86.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.2 ptt180 -133.85 9.58 3.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.62 -174.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.95 113.78 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.524 0.678 . . . . 0.0 112.06 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.0 m -117.96 144.21 45.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.343 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.21 143.78 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.291 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.8 tt -148.13 144.84 19.37 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.921 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.94 149.14 15.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.153 1.235 . . . . 0.0 110.879 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 28.4 m -70.79 -37.11 73.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 42.8 p-80 -64.34 -7.96 11.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 20' ' ' THR . . . -71.41 -21.74 61.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 55.71 72.5 1.02 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.76 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.86 135.24 25.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.866 2.377 . . . . 0.0 111.873 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.71 -160.05 36.09 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.087 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' VAL . 9.1 p-10 -76.03 -23.78 55.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.206 0.527 . . . . 0.0 110.148 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 1.4 p-10 -139.81 132.96 29.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.81 148.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.511 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.0 mt -96.86 104.36 16.36 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.812 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' OD1' ' A' ' 50' ' ' ASN . 7.6 p -93.9 109.21 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 122.182 0.992 . . . . 0.0 109.962 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 9.4 p-10 45.74 28.36 0.55 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.954 -1.476 . . . . 0.0 113.12 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.45 -20.49 12.3 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.449 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.12 132.41 33.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.3 tttp -85.59 118.41 25.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -138.62 119.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.045 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 36.4 ptt180 -72.57 151.79 42.19 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.82 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 45' ' ' ASP . 11.1 p -74.54 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.056 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -98.36 -40.56 8.25 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 27.4 t0 -155.43 134.68 12.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.482 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -136.34 115.32 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.414 . . . . 0.0 110.633 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -122.97 125.9 46.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 49.9 mtmt -84.48 112.45 20.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.642 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 39.9 mt -75.47 109.08 8.72 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 m -101.55 148.79 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.45 140.93 95.24 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.326 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -45.9 -24.78 2.32 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.526 2.151 . . . . 0.0 113.851 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 9.81 3.62 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.374 0.607 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 73.11 30.97 1.53 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 132' ' ' ASN . 34.7 mt -119.61 155.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -64.93 129.17 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.642 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 37.2 tp -104.07 -22.49 13.43 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' HG2' HG11 ' A' ' 161' ' ' VAL . 37.3 tp10 75.09 8.45 4.04 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.47 107.61 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.971 0.351 . . . . 0.0 111.09 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 93.1 m -89.62 112.53 23.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.516 . . . . 0.0 109.72 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 62' ' ' LEU . 87.1 t -82.53 106.22 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -101.28 100.9 11.48 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.175 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 17.6 m -91.49 110.33 21.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.426 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 31.0 mt -117.81 120.24 37.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.605 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.64 101.89 0.85 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 117.729 -1.588 . . . . 0.0 109.46 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HE ' ' HG2' ' A' ' 81' ' ' GLU . 6.6 tpt180 -102.41 129.69 48.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.65 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -76.49 -25.65 54.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.024 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' HE ' ' A' ' 79' ' ' ARG . 15.3 pt-20 -97.15 120.78 38.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -73.6 129.33 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -77.2 137.57 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -44.78 131.56 6.91 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.274 -0.266 . . . . 0.0 111.041 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.25 92.66 3.88 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.282 0.563 . . . . 0.0 112.12 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.4 pt -93.48 20.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -61.64 -39.13 90.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.079 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.35 -11.32 85.14 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.104 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 47.2 m-85 -87.82 -20.58 25.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 117.77 0.785 . . . . 0.0 109.652 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 30' ' ' ILE . 45.4 mt -74.06 146.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 p -120.2 139.61 52.39 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.495 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 176' ' ' GLN . 8.6 pt-20 -78.01 -42.63 31.98 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.27 120.53 42.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 172' ' ' GLN . 26.7 mt -58.87 -68.18 0.29 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 56.57 70.87 0.61 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.46 93.42 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.13 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -87.84 3.42 5.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.889 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 13.5 t70 -131.05 124.34 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.368 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.79 163.85 31.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.227 1.013 . . . . 0.0 113.115 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.1 m -116.19 143.32 45.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.638 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -116.22 122.11 44.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 -177.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.43 113.03 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.304 0.573 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -99.37 139.75 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.631 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.548 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.8 t60 -146.36 59.62 1.22 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.1 m -108.88 -179.5 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.118 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.8 p-10 -68.39 -38.91 81.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.436 1.016 . . . . 0.0 111.765 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' HA ' HD21 ' A' ' 107' ' ' ASN . 7.2 m120 -70.08 -60.12 2.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.087 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -108.06 92.9 4.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 m -91.83 110.64 21.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.514 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.548 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 41.2 t30 64.01 71.8 0.48 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.608 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.3 m -130.98 103.47 6.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.124 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.7 113.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.591 0.71 . . . . 0.0 110.414 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.1 mt -122.53 134.31 54.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.754 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.67 104.45 16.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.24 -41.09 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 96.54 -119.06 6.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.716 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.5 Cg_exo -60.42 100.41 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 115.684 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 137' ' ' TYR . 6.4 m -108.05 126.09 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -142.28 146.78 35.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -77.88 135.27 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.546 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.82 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.19 -116.11 3.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.283 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.93 106.99 14.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.888 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.464 HG21 HD23 ' B' ' 2' ' ' LEU . 44.1 pt -125.17 -172.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.154 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.8 m120 -113.14 95.39 5.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.35 0.595 . . . . 0.0 110.653 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.507 HD21 ' CG1' ' A' ' 161' ' ' VAL . 43.9 tp -81.62 106.85 13.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.4 m 64.77 25.74 12.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.2 m 86.1 -11.24 0.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.824 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.8 m -87.07 119.42 71.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.404 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.19 117.39 4.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.199 1.932 . . . . 0.0 112.36 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -117.46 132.87 56.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.178 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 63.2 t30 -98.76 141.04 32.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.707 0.765 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 64.09 47.08 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.713 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.412 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.78 130.42 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.666 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 61.4 mt -89.44 134.54 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.493 0.663 . . . . 0.0 111.61 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -109.17 130.64 55.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.565 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.65 ' HB3' HG12 ' A' ' 118' ' ' VAL . 2.4 p90 -139.19 127.83 23.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.61 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.66 110.61 5.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.991 0.9 . . . . 0.0 111.251 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -179.71 132.05 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.799 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -61.49 106.68 0.68 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.4 p -112.38 140.18 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.531 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -130.44 152.61 49.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.267 1.032 . . . . 0.0 112.001 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.504 HG22 ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -42.18 153.68 0.06 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.759 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.66 -18.2 55.83 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -94.24 -4.57 48.66 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.529 -0.836 . . . . 0.0 112.155 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . 0.265 29.2 p -85.55 151.82 23.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 116.575 -2.05 . . . . 0.0 113.763 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.712 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 106.59 -20.56 34.24 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -53.47 146.83 19.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.735 -0.732 . . . . 0.0 111.697 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.48 125.96 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.821 0.819 . . . . 0.0 113.162 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.43 HD13 HD23 ' A' ' 101' ' ' LEU . 37.8 tp -90.78 108.99 20.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.617 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.9 p -145.48 -179.72 6.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.031 0.919 . . . . 0.0 113.381 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.24 -172.71 4.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.642 -1.617 . . . . 0.0 108.568 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 153' ' ' THR . 9.8 t -66.93 101.75 0.88 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.012 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.9 83.99 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.302 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 79.3 mttt -140.43 140.08 35.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.415 0.626 . . . . 0.0 111.816 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.92 123.54 71.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -97.75 -31.89 12.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.934 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 167.53 -163.12 36.88 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.423 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.5 144.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.701 0.762 . . . . 0.0 111.413 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.453 ' HB2' HD21 ' A' ' 101' ' ' LEU . 6.1 t60 -62.72 114.11 3.41 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.454 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 71' ' ' GLU . 47.8 t -103.6 -33.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.563 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.42 -147.13 5.54 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.646 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.37 166.3 32.18 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.306 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.514 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 5.3 t30 -132.91 89.67 2.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 109.812 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.52 -102.25 0.42 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.097 -0.956 . . . . 0.0 114.491 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 23.4 mtp180 -94.29 4.81 53.37 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -131.98 114.75 14.98 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.27 39.44 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.838 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.0 m-85 -129.01 118.16 22.11 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.021 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.48 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 27.0 t -111.64 159.83 17.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.252 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.87 131.54 44.26 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.47 ' HG3' HD21 ' A' ' 94' ' ' LEU . 47.3 tt0 -68.88 104.49 2.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.086 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 19.0 tp -80.16 92.87 5.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -87.67 119.94 28.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.994 0.902 . . . . 0.0 112.614 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -53.47 -31.16 44.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.537 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.495 ' HA ' HG12 ' A' ' 179' ' ' VAL . 4.9 pt20 -60.71 -17.74 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.98 -14.66 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.089 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -105.06 -30.91 9.45 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 176' ' ' GLN . 12.7 p -83.22 -2.95 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.57 -25.51 57.14 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.487 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -122.57 170.2 10.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.413 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.15 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? -133.77 139.89 46.6 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.443 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.7 tt0 -109.99 74.21 0.88 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 171.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.514 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -74.94 153.68 38.47 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 23.4 tp -113.42 152.4 30.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.622 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 23.2 m-85 -56.99 146.98 25.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.6 mt-30 . . . . . 0 N--CA 1.436 -1.174 0 C-N-CA 119.891 -0.723 . . . . 0.0 . 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.504 ' H2 ' HG22 ' A' ' 143' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 112.392 -0.283 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.74 -60.6 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.876 1.717 . . . . 0.0 113.363 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.451 ' HA ' ' OG1' ' A' ' 153' ' ' THR . 17.7 m120 -66.27 -44.17 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.131 0.491 . . . . 0.0 112.136 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -46.35 83.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.214 0.53 . . . . 0.0 111.869 -178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -55.01 -55.08 34.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.316 0.579 . . . . 0.0 111.659 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -63.47 -47.33 82.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.94 90.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.488 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 6.4 tt -67.36 -39.44 85.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 p -69.75 -41.49 75.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.184 -0.323 . . . . 0.0 111.201 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.7 tt -69.8 -39.84 76.32 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.043 0.449 . . . . 0.0 110.963 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD22 ' HD2' ' A' ' 12' ' ' ARG . 7.0 tt -54.76 -55.76 26.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD22 ' A' ' 11' ' ' LEU . 12.4 mpt_? -61.2 -27.82 68.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.1 -52.98 4.56 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -106.44 -9.64 16.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -100.3 109.15 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.548 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt -121.96 155.54 35.3 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.845 0.831 . . . . 0.0 110.72 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -75.87 101.13 5.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.985 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.47 107.39 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.433 0.635 . . . . 0.0 110.544 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.6 m -76.82 99.91 5.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.089 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.8 p -95.33 -177.59 4.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.538 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m -75.28 -14.94 60.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.167 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.747 ' HZ2' ' CX7' ' B' ' 8' ' ' CA1 . 0.8 OUTLIER -105.5 -8.11 18.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.415 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 -179.66 22.07 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 17' ' ' THR . 46.3 mm-40 -79.15 121.18 24.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -127.1 164.73 20.95 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.789 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.4 m -74.86 95.27 2.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.182 -1.826 . . . . 0.0 111.018 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.05 104.87 2.38 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 tp -88.73 104.89 17.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.0 112.162 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.58 126.64 12.87 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 90' ' ' ILE . 29.3 mm -89.34 -51.57 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 117.417 0.608 . . . . 0.0 110.399 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -171.95 149.17 2.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.614 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.06 -87.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -135.86 16.06 3.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.494 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.51 119.83 49.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.302 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -125.39 147.16 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.506 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.66 136.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.859 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' A' ' 73' ' ' THR . 15.5 mm -141.04 142.68 28.48 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.34 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.37 148.04 91.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.277 1.318 . . . . 0.0 111.657 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 52.2 m -68.23 -35.52 78.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.837 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' B' ' 6' ' ' PHE . 54.6 p-80 -74.02 -3.96 32.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -20.7 38.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.581 0.705 . . . . 0.0 109.366 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 59.14 71.64 0.92 Allowed Pre-proline 0 CA--C 1.517 -0.311 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.052 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.67 125.44 10.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.59 1.526 . . . . 0.0 108.963 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.15 178.88 50.94 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.372 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 56' ' ' VAL . 19.7 t70 -70.07 -31.2 68.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 4.9 p-10 -120.18 140.94 50.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.13 161.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.407 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -98.22 114.48 26.75 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.678 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -91.9 92.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.165 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 66.78 5.25 3.84 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.339 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -31.88 2.34 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.976 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' CD ' HH12 ' A' ' 79' ' ' ARG . 50.3 tt0 -81.72 137.3 35.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 110.449 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -78.45 128.97 34.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.44 154.44 13.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.611 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.5 mtm180 -106.33 153.39 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.944 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 75' ' ' LEU . 7.7 p -94.96 118.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.49 -33.11 68.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.17 107.83 4.13 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.863 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.47 95.88 6.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -109.31 123.35 49.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.589 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -76.4 124.27 27.28 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -89.51 103.86 16.46 Favored 'General case' 0 C--O 1.259 1.596 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 29.6 m -110.82 173.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.844 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -72.5 139.64 81.32 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.55 -27.58 41.63 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.936 1.758 . . . . 0.0 111.788 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -85.54 8.39 19.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.459 0.647 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.5 t30 64.06 68.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.457 1.123 . . . . 0.0 111.183 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.455 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.9 mt -139.93 170.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 112.313 -2.221 . . . . 0.0 105.32 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 68' ' ' ILE . 65.7 t30 -86.43 135.72 33.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.342 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.641 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 20.4 mt -108.0 -26.94 10.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.0 tp10 79.09 3.6 2.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.132 -1.394 . . . . 0.0 113.169 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 17.7 mt -89.88 126.05 35.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.406 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 39.8 m -103.96 118.8 37.52 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.063 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.2 102.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 56' ' ' VAL . 13.9 tp -95.42 94.95 8.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.85 -178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -84.17 94.95 8.49 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.958 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' VAL . 83.6 mt -99.29 122.57 42.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.213 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.26 84.7 5.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.406 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.429 HH12 ' CD ' ' A' ' 52' ' ' GLN . 27.9 tpt180 -95.56 133.01 40.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.661 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.22 -44.42 79.51 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 118.11 17.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -87.14 134.51 33.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.331 0.586 . . . . 0.0 111.945 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -68.92 137.47 53.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.438 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -72.91 131.4 42.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.946 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.86 86.07 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 18.5 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -63.56 -28.44 69.94 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.698 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.74 -18.65 74.94 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.531 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 92.5 m-85 -77.43 -22.78 50.96 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HD12 ' A' ' 30' ' ' ILE . 72.9 mt -72.58 123.66 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.6 t -123.37 136.35 54.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -65.92 -42.14 90.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.96 107.01 18.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.72 -76.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HB3' ' NZ ' ' A' ' 155' ' ' LYS . 39.2 tt0 51.43 70.82 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.82 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.02 86.84 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.573 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.61 2.14 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.453 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.9 t70 -139.35 124.4 18.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.557 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.36 168.57 19.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.644 0.735 . . . . 0.0 112.545 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 34.2 m -119.67 136.42 54.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.381 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 160' ' ' HIS . 3.1 tm? -99.48 114.11 26.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.12 120.49 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.161 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -113.99 119.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.425 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -129.32 72.8 1.48 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.2 p -121.36 -171.95 2.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.632 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.44 -35.76 71.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.27 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.58 -55.81 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.04 125.35 12.27 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.392 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 1.6 p -88.15 112.58 22.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' THR . 84.0 m-20 76.29 74.48 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 103' ' ' VAL . 23.8 m -142.22 136.37 29.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.195 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.47 137.24 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 109.651 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.78 108.72 13.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.624 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.7 pt-20 -75.65 108.2 8.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.08 -29.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.547 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.62 -115.81 4.61 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.945 -1.121 . . . . 0.0 115.735 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 15.4 Cg_exo -60.19 109.35 0.61 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.95 2.434 . . . . 0.0 115.448 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.88 134.94 35.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -134.64 -172.27 2.98 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.86 147.55 48.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.07 -14.19 11.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.49 -111.69 3.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.974 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.2 118.73 32.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.51 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' B' ' 2' ' ' LEU . 49.3 pt -135.32 -179.27 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 5.4 m-20 -96.29 123.7 40.02 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.967 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 53.7 tp -106.12 104.22 13.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 128' ' ' SER . 10.1 t 63.47 28.57 15.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 127' ' ' SER . 93.4 p 80.16 1.23 2.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.873 1.669 . . . . 0.0 112.011 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 m -95.3 114.45 63.85 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.291 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.23 114.06 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.11 1.873 . . . . 0.0 112.718 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -121.3 130.01 53.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.615 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -105.59 164.46 11.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 55.18 50.07 15.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.352 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 35.2 ttm -101.85 134.65 44.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.061 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 70.0 mt -86.78 152.07 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.296 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -129.58 151.03 50.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.45 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -156.32 142.95 18.6 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.584 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.44 99.36 6.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.505 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -171.02 127.9 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.062 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 110.94 3.25 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.529 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.437 HG22 HE22 ' A' ' 145' ' ' GLN . 29.1 p -109.62 156.54 20.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.855 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 143' ' ' THR . 51.0 tttm -143.36 152.41 41.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.016 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 6.3 p -40.59 161.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.481 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 90.65 -28.58 7.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.502 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.437 HE22 HG22 ' A' ' 141' ' ' THR . 24.7 mt-30 -83.09 -11.58 57.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.458 ' HB3' ' H ' ' B' ' 7' ' ' GLN . 25.2 p -72.08 111.95 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.634 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 137.23 -14.71 3.74 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.615 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.75 151.72 52.21 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 124.32 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 112.039 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.0 tp -91.98 109.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.3 p -144.59 178.25 8.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.97 0.89 . . . . 0.0 112.13 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.7 174.65 10.46 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.766 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 3' ' ' ASN . 27.9 m -72.45 94.44 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.04 -24.61 9.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.584 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 94.0 mttt -134.65 146.52 49.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.73 0.776 . . . . 0.0 112.507 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 mm -110.1 130.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -101.69 -45.39 5.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.46 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.596 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.0 -170.17 43.0 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.651 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.506 HG23 HD11 ' A' ' 173' ' ' LEU . 30.5 pt -116.68 143.63 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.542 ' HB2' HD21 ' A' ' 101' ' ' LEU . 67.0 t60 -73.52 114.98 12.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.321 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.77 -21.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -176.63 -157.01 16.75 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.886 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.96 165.96 35.82 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.578 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 28.1 t-20 -136.62 85.99 2.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.778 0.799 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.31 -106.99 1.61 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.563 -1.198 . . . . 0.0 115.178 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.14 -17.11 57.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.93 127.31 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.48 142.4 17.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.464 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 66.6 m-85 -119.5 122.06 40.81 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.236 1.018 . . . . 0.0 111.994 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 32.3 t -119.83 149.71 41.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.38 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.39 136.29 35.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -67.46 123.99 21.95 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.596 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 29.6 mt -90.61 84.96 5.97 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -80.75 135.72 36.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.999 0.428 . . . . 0.0 110.37 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.09 -29.14 68.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.401 0.619 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -55.14 -32.12 61.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.536 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.3 -11.64 51.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -111.1 -18.76 12.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.489 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.01 -8.46 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.45 ' OE2' ' HB2' ' A' ' 181' ' ' LYS . 0.7 OUTLIER -72.85 -17.68 61.52 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.43 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.528 ' NZ ' ' HB2' ' A' ' 181' ' ' LYS . 4.4 ttmp? -94.87 89.32 5.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.713 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.381 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' A' ' 124' ' ' ILE . 2.7 mm? -139.27 151.55 46.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.457 0.646 . . . . 0.0 110.768 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.2 tt0 -122.49 79.67 1.64 Allowed 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 171.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.59 145.63 30.53 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 33.2 tp -98.59 153.58 18.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.5 m-85 -59.15 142.35 51.82 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.506 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 94.3 mt-30 . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 118.203 -1.399 . . . . 0.0 . -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.747 ' CX7' ' HZ2' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.693 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.69 -60.79 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.564 2.176 . . . . 0.0 115.186 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.1 t-20 -57.01 -51.07 70.72 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.828 -0.545 . . . . 0.0 112.206 -177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -56.28 -45.29 80.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.698 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.12 -28.35 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 111.224 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.05 -44.66 83.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.82 90.76 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.485 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.33 -49.81 74.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.987 0.423 . . . . 0.0 110.193 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.24 -39.55 82.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.972 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.8 tp -62.09 -49.57 75.4 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.509 0.671 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.8 tt -54.6 -43.72 72.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.155 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -64.91 -29.69 70.65 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.6 6.15 13.38 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.953 0.797 . . . . 0.0 112.982 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.8 -38.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.1 mt -86.39 115.89 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.353 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.4 mtt -119.72 161.74 20.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.925 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -92.8 123.67 36.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.92 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -112.84 105.57 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.931 0.872 . . . . 0.0 111.448 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.683 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.1 m -78.0 123.04 26.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.619 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.1 p -126.26 -173.48 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 m -81.03 -9.47 59.83 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -91.46 -43.47 9.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.6 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.66 -169.05 42.18 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.268 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG2' HG23 ' A' ' 19' ' ' THR . 31.4 mt-10 -106.02 107.32 18.26 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -101.98 171.13 7.69 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.423 1.106 . . . . 0.0 113.516 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.7 m -79.9 113.77 18.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.534 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.02 112.49 4.48 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.781 -1.199 . . . . 0.0 110.877 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 tp -94.98 120.0 34.46 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -89.25 129.86 9.88 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.476 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -90.61 -56.85 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.72 0.76 . . . . 0.0 110.426 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -160.33 127.56 4.42 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 12.5 t0 56.89 -78.35 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.486 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 15.2 mmt-85 -120.46 -11.24 9.14 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.851 -0.531 . . . . 0.0 110.666 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 HG13 ' A' ' 74' ' ' VAL . 57.2 t -80.19 99.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.331 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 45.7 t -114.23 141.84 47.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.838 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 173' ' ' LEU . 24.1 m -111.84 137.64 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.712 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.7 tt -142.24 141.7 22.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.36 142.53 16.91 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.253 1.302 . . . . 0.0 111.351 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.539 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 83.7 m -70.82 -34.84 72.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.132 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -65.62 -7.22 13.91 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.389 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.95 60.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.48 0.657 . . . . 0.0 109.672 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.6 mm-40 50.1 72.83 1.12 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.893 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.03 156.06 60.94 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.96 2.44 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -153.46 26.14 Favored Glycine 0 N--CA 1.455 -0.062 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.835 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.24 -15.58 35.51 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 2.2 p30 -139.27 156.56 46.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.223 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.23 161.06 17.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 77.3 mt -104.38 108.51 19.96 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 17' ' ' THR . 80.2 t -84.6 85.07 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.352 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 73.82 -10.1 1.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.091 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.82 -33.33 0.57 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.91 111.08 1.16 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.802 -1.199 . . . . 0.0 111.557 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -75.12 96.48 3.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 tt -123.92 148.02 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.661 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 8.4 mpt_? -97.44 165.05 12.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.326 0.584 . . . . 0.0 111.526 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.4 t -90.45 120.65 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.725 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 78' ' ' ASP . 75.9 tttt -79.86 -38.67 32.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.385 0.612 . . . . 0.0 110.152 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -159.29 132.63 7.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.395 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.97 114.57 26.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.185 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -118.06 105.73 12.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.319 -178.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.09 110.11 18.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.543 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 71.2 mt -79.32 120.86 24.38 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.447 ' HA ' ' H ' ' A' ' 70' ' ' LEU . 33.5 m -116.01 154.87 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 12.6 t70 -87.1 143.45 34.85 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 119.034 0.834 . . . . 0.0 112.91 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -43.72 -17.13 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.52 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.633 ' HG2' ' OD1' ' A' ' 64' ' ' ASP . 52.7 mm-40 -71.34 0.9 7.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.316 0.579 . . . . 0.0 109.827 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 64.4 m-80 72.75 18.82 4.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -116.98 145.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.858 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -51.6 135.58 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.106 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.0 tp -104.56 -16.69 14.96 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 68.3 14.76 9.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.122 -1.399 . . . . 0.0 113.648 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 82.1 mt -105.91 105.29 15.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.061 0.457 . . . . 0.0 111.499 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -89.54 110.19 21.06 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.434 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 95.5 t -81.51 108.86 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 tp -101.49 100.34 10.77 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.815 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 14.1 m -74.41 102.76 4.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 33' ' ' ARG . 86.5 mt -104.71 127.81 52.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.619 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 57' ' ' LYS . 14.1 t70 -87.79 89.46 8.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -93.61 133.89 36.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.61 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.91 -28.75 58.21 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.34 118.36 36.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 19.0 pttp -59.89 129.21 40.71 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.211 -0.995 . . . . 0.0 108.842 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -78.97 161.53 26.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.593 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -49.08 122.84 6.33 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -175.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.22 93.76 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.841 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 156' ' ' ILE . 49.0 pt -96.81 19.11 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -56.16 -35.31 67.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.312 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.76 -16.28 79.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.062 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -87.61 -13.13 43.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.55 133.37 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 7.1 m -96.25 130.94 43.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -77.97 -55.1 5.57 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 91' ' ' SER . 29.0 t70 -100.94 131.68 46.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.4 mt -79.39 -67.64 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.827 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 47.04 71.68 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -167.26 78.32 0.11 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.2 p -71.83 12.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 27.8 t70 -150.31 121.55 7.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.833 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.76 12.6 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.866 0.841 . . . . 0.0 111.591 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 m -120.06 145.96 46.36 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.585 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.459 HD21 ' HA3' ' A' ' 148' ' ' GLY . 9.6 tt -120.56 121.94 39.5 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 112' ' ' ILE . 24.2 m -111.21 121.92 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.061 0.458 . . . . 0.0 111.04 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 4.0 t -100.5 134.48 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.08 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -135.7 70.97 1.42 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 m -127.18 175.43 8.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.764 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 25.8 p-10 -71.42 -20.05 62.16 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.359 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -84.97 -34.16 22.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.423 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.47 97.29 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.421 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 102.85 15.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 60.55 70.83 0.6 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.839 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 28.6 m -117.75 111.87 19.69 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.855 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 102' ' ' VAL . 2.0 mp -87.36 105.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 tt -116.56 127.24 54.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.658 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.71 128.51 34.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.17 -24.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.03 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 79.13 -124.12 6.43 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.852 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 27.9 Cg_endo -62.66 105.11 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.52 2.147 . . . . 0.0 114.495 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 90.6 t -97.2 118.32 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.694 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 p -138.07 167.58 21.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.971 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -104.53 126.04 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.61 -49.79 6.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.88 -115.89 4.13 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.476 -0.868 . . . . 0.0 115.114 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 123' ' ' LEU . 3.8 mp -95.96 107.8 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.061 -0.569 . . . . 0.0 112.096 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 42.2 pt -138.98 -177.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.274 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -102.1 136.53 41.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.008 0.432 . . . . 0.0 110.598 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 4.1 mm? -115.07 103.81 11.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' SER . 10.3 t 60.8 31.13 20.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.768 -0.582 . . . . 0.0 109.751 -177.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 127' ' ' SER . 67.0 m 79.96 2.94 2.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.444 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -99.59 115.68 65.45 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.777 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.05 115.37 2.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.947 1.765 . . . . 0.0 112.368 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.563 ' HB ' HD23 ' A' ' 126' ' ' LEU . 19.7 m -128.69 141.84 51.21 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.014 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 60.3 t30 -117.91 162.8 17.54 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 3.2 mpt_? 77.84 22.94 0.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.659 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.48 129.27 37.62 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.146 0.974 . . . . 0.0 113.303 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 79.6 mt -92.3 132.66 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.278 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -107.25 129.22 54.9 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.515 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 1.3 p90 -133.29 143.44 49.05 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.96 99.49 9.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.636 0.732 . . . . 0.0 112.009 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 141' ' ' THR . 88.8 t80 -170.11 126.16 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.023 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.12 110.97 1.76 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 36.8 p -112.52 151.68 29.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -143.16 151.52 40.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.334 1.064 . . . . 0.0 110.916 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.403 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.86 156.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.363 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.81 -20.74 45.41 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 121.726 0.625 . . . . 0.0 111.648 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -87.33 2.94 48.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.459 -0.871 . . . . 0.0 112.228 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.551 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 16.6 m -64.8 142.62 58.37 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.621 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 104.5 -23.54 31.24 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.866 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 101' ' ' LEU . . . -49.74 135.92 24.3 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.562 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 47.3 t -88.78 122.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 111.847 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -93.46 108.83 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -146.65 166.18 27.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.193 0.997 . . . . 0.0 113.418 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -128.74 173.25 10.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.485 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -67.53 106.26 2.1 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.885 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.99 6.47 89.44 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.24 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -137.96 112.98 9.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.416 ' CD1' HD12 ' A' ' 86' ' ' ILE . 65.7 mt -103.59 134.73 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.362 0.601 . . . . 0.0 110.596 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -99.53 -55.13 2.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.931 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.64 -156.97 21.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.55 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.1 pt -125.94 148.04 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.334 0.588 . . . . 0.0 112.089 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.01 116.55 6.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.195 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 171' ' ' ALA . 46.2 t -104.48 -28.88 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.625 0.726 . . . . 0.0 109.901 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' B' ' 7' ' ' GLN . . . 174.44 -145.84 8.26 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.589 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.62 174.11 44.56 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.4 t-20 -135.26 86.26 2.23 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.733 0.778 . . . . 0.0 109.769 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.05 -103.52 0.73 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.545 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -82.85 -11.49 58.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.68 -177.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.474 ' OE1' ' HB3' ' A' ' 166' ' ' ARG . 1.1 mp0 -112.8 145.99 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.851 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -105.13 150.8 17.11 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.7 m-85 -132.8 119.69 20.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.217 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.7 t -113.59 152.66 30.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.579 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 161' ' ' VAL . . . -90.98 135.19 33.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 9.0 tt0 -74.93 113.48 12.28 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.595 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.4 mp -82.9 83.04 7.92 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -81.06 121.14 25.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.122 0.963 . . . . 0.0 111.249 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -39.67 -39.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.253 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -45.56 -51.21 12.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -69.45 -19.99 63.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -97.59 -29.62 13.33 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.704 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.41 -20.89 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.165 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.24 -23.95 18.35 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.47 114.36 20.15 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.377 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.089 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.8 mm? -136.63 155.19 50.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.273 0.559 . . . . 0.0 109.792 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -121.89 77.32 1.36 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -77.51 147.2 35.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.508 HD12 ' H ' ' B' ' 6' ' ' PHE . 55.1 tp -103.24 142.85 33.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.508 ' H ' HD12 ' B' ' 5' ' ' LEU . 24.6 m-85 -57.78 125.39 22.81 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.06 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.463 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 83.2 mt-30 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 116.525 -0.307 . . . . 0.0 . 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.551 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 112.594 -0.203 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.49 -35.62 81.39 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 121.907 1.738 . . . . 0.0 113.913 -178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.3 -51.81 53.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.296 0.57 . . . . 0.0 110.834 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -67.63 -36.15 80.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.941 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 7.2 tp10 -58.19 -50.53 73.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 110.578 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.19 -48.75 79.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.05 83.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.438 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.3 tt -64.28 -40.39 95.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.596 0.236 . . . . 0.0 110.666 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -63.95 -43.71 94.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.38 . . . . 0.0 110.678 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.3 tp -67.51 -43.17 81.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.682 0.754 . . . . 0.0 110.58 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.3 tp -49.77 -50.54 44.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.436 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 78.4 mtp180 -56.9 -40.05 75.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.74 -15.49 8.9 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.9 5.56 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.8 mm -119.12 109.48 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.4 mmt -124.78 150.84 45.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.654 0.74 . . . . 0.0 111.211 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -76.33 95.36 3.76 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.7 mp -87.86 104.5 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 m -95.88 113.57 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.199 1.0 . . . . 0.0 109.987 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 69.4 p -94.44 -162.84 0.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.863 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.6 m -80.15 -7.25 58.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.68 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -100.74 -56.21 2.39 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.255 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.46 -163.59 26.55 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -83.49 123.39 29.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.267 -0.466 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -126.41 159.28 33.72 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 121.189 0.519 . . . . 0.0 109.709 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 14.2 m -90.16 109.23 20.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.141 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -88.23 110.18 3.6 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.368 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.1 120.4 36.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -87.27 138.84 15.66 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.63 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 31' ' ' HIS . 4.1 mp -120.57 -39.8 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 118.447 1.124 . . . . 0.0 110.911 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 36.0 m-70 -135.43 128.61 31.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 18.8 t70 43.72 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 14.3 ptt180 -127.08 21.54 6.78 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.963 0.887 . . . . 0.0 109.253 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.38 112.46 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.064 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 63.2 m -116.76 156.7 26.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.65 139.52 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.176 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 pt -142.01 162.86 43.64 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.0 152.45 71.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 121.212 1.275 . . . . 0.0 111.52 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 61.0 m -70.69 -33.1 70.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -79.13 3.89 16.3 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.64 59.67 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 20' ' ' THR . 12.7 mm100 68.41 72.32 0.36 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.44 117.01 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.985 2.457 . . . . 0.0 110.086 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.35 -138.11 2.81 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.812 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' HG12 ' A' ' 56' ' ' VAL . 24.8 t70 -77.55 -24.67 49.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.515 ' HB3' HH11 ' A' ' 55' ' ' ARG . 4.9 p-10 -142.83 162.63 34.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.881 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -140.79 149.04 21.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 84.6 mt -82.99 99.99 10.17 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.731 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -86.16 96.1 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.156 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 63.91 18.91 11.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.39 -17.81 21.09 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.338 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -90.64 123.54 34.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.11 113.31 14.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.181 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.2 mt -116.75 122.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.5 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 46' ' ' ASP . 2.7 mpt_? -66.84 152.0 46.43 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.368 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -94.4 137.25 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 33' ' ' ARG . 67.7 mttm -92.56 -55.52 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' ' HB ' ' A' ' 76' ' ' THR . 29.1 m-20 -128.26 140.14 52.05 Favored 'General case' 0 N--CA 1.46 0.049 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.622 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -132.44 78.93 1.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.567 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 90.6 t80 -88.01 131.33 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.591 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 10.6 mptt -90.1 116.13 27.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.98 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 17.2 mt -82.93 119.08 23.96 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-O 121.608 0.718 . . . . 0.0 110.549 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 29.8 m -128.62 158.22 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.147 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.05 145.26 88.57 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.261 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.11 -19.12 3.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.809 1.673 . . . . 0.0 113.218 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.06 5.57 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 109.81 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.76 61.59 0.97 Allowed 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.808 0.813 . . . . 0.0 109.641 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' LEU . 35.9 mm -133.44 145.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.026 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -59.57 128.87 39.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -105.1 -24.36 12.79 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 174.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.629 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 75.22 10.31 3.67 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.452 -1.703 . . . . 0.0 113.607 175.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 10.5 mp -95.13 122.2 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.4 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 92.4 m -98.26 112.45 24.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.485 0.659 . . . . 0.0 109.883 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 98.9 t -76.2 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.7 tp -94.25 102.02 14.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.388 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 20.1 m -89.36 100.84 13.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 122.091 0.948 . . . . 0.0 109.178 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.8 mt -74.63 141.25 44.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 19.5 t70 -82.88 72.63 9.95 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.09 133.67 46.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.148 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -81.05 -32.13 34.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.97 98.44 2.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -88.46 150.18 23.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.139 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' HB2' ' H ' ' A' ' 84' ' ' ARG . 5.8 p90 -92.21 -163.9 1.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.528 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 12.5 tpp180 -83.86 117.58 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.598 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 31' ' ' HIS . 4.8 m-20 -66.57 99.46 0.59 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -91.56 27.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 122.037 -0.414 . . . . 0.0 111.544 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -65.1 -15.46 62.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.463 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.6 -16.42 75.66 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.764 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -91.7 -14.41 30.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.06 127.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 38.9 m -125.95 132.85 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.3 pm0 -81.93 -27.29 33.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.75 149.08 26.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.4 mt -103.4 -68.61 0.83 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 41.75 37.66 0.8 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.433 0.635 . . . . 0.0 112.31 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.57 73.62 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 118' ' ' VAL . 1.2 p -73.5 20.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.138 -1.531 . . . . 0.0 114.818 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -121.59 130.12 53.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.43 166.32 25.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.476 -0.89 . . . . 0.0 113.1 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 96.4 m -121.55 142.54 49.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.49 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.13 113.41 26.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.6 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.95 97.57 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -87.93 123.01 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.619 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.0 t60 -137.64 33.31 2.47 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 20.1 p -109.51 -162.44 0.81 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.024 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 105' ' ' SER . 29.0 t-20 -53.35 -56.58 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.15 -44.25 80.24 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.557 -0.714 . . . . 0.0 112.055 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.55 106.28 7.74 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.416 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 23.9 m -93.91 105.72 17.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.619 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 9.9 t30 79.18 72.42 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.275 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.3 m -141.15 107.86 5.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.37 100.37 11.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.801 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 139' ' ' TYR . 58.1 tp -127.55 128.24 45.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.327 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 8.6 pt-20 -79.19 142.53 36.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.83 -20.07 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.55 -124.78 7.96 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.958 -1.115 . . . . 0.0 114.846 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.25 128.62 12.26 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 114.833 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 97' ' ' VAL . 86.8 t -104.91 157.58 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.764 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 36.7 m -160.21 114.89 2.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -78.01 115.94 18.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 118.668 -1.213 . . . . 0.0 108.059 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.9 -11.88 46.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.612 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.08 -120.64 5.26 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.788 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 68' ' ' ILE . 48.5 tp -94.17 113.66 25.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' ' 2' ' ' LEU . 34.4 pt -138.42 177.83 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.1 m-20 -94.64 128.35 41.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.657 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 68.4 tp -115.36 105.05 12.41 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' SER . 12.5 t 62.24 30.57 17.61 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.7 m 82.1 -1.55 1.48 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.151 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 39.3 m -100.22 123.09 47.98 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.874 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.71 116.37 3.21 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.04 1.827 . . . . 0.0 111.739 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.6 m -126.82 134.25 50.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.279 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -108.93 163.2 13.51 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 177' ' ' TYR . 15.8 mmt180 66.37 24.0 10.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.022 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 tpt -72.24 128.86 36.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.143 0.973 . . . . 0.0 112.034 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 38.2 mm -92.43 126.61 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.899 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' THR . 33.8 ttt-85 -104.75 137.27 42.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.33 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.4 p90 -145.63 109.51 4.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -74.01 99.3 3.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.829 1.3 . . . . 0.0 110.914 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 113' ' ' LEU . 85.4 t80 -160.21 137.95 9.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 111.497 -2.592 . . . . 0.0 106.32 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 86.18 1.95 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -101.01 161.84 13.31 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -141.99 168.29 20.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.849 1.309 . . . . 0.0 113.093 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.576 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.03 152.61 0.17 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.763 175.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.494 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 93.5 -19.81 50.38 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.51 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -94.22 7.21 46.12 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.205 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.698 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 13.7 m -62.47 136.97 58.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.0 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 103.91 -16.98 50.01 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.829 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.5 142.28 43.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.505 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.13 114.9 29.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.439 0.638 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.7 tp -89.54 106.56 18.53 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.016 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.0 p -149.85 -177.17 5.74 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.039 0.923 . . . . 0.0 111.447 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.99 163.96 35.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.734 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 t -61.12 120.94 11.28 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.717 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.87 -19.39 45.85 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 24.9 ttmm -144.41 124.59 13.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.878 0.839 . . . . 0.0 111.537 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.33 135.34 38.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.455 ' HA ' HE22 ' A' ' 172' ' ' GLN . 93.1 m-85 -103.06 -71.21 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . -152.56 -169.13 17.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.387 -1.387 . . . . 0.0 114.719 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 161' ' ' VAL . 27.4 pt -119.36 140.67 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.457 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -61.09 120.33 10.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 159' ' ' ILE . 73.2 t -117.08 -28.35 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.491 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.09 -151.28 8.4 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.345 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.48 161.16 27.6 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.0 t-20 -135.29 107.91 7.43 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.34 -110.18 3.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.872 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -113.06 25.82 11.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.248 1.023 . . . . 0.0 109.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -126.07 135.99 52.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.447 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -94.38 148.39 18.98 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.282 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.2 m-85 -128.96 123.42 32.44 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.822 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.8 t -116.07 155.5 28.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.511 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.91 123.8 42.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 174' ' ' LYS . 55.8 tp60 -72.27 124.85 25.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.638 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.0 mp -88.87 84.17 6.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 172' ' ' GLN . 66.4 mttm -78.43 132.72 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 179' ' ' VAL . 8.1 ttpm? -52.12 -30.81 28.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -53.61 -29.44 37.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.406 ' OH ' ' HG3' ' A' ' 133' ' ' ARG . 7.8 m-85 -72.18 -32.3 66.7 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.722 -0.611 . . . . 0.0 111.362 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.535 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 90.7 m-85 -87.81 -13.72 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.212 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 175' ' ' LYS . 57.4 t -67.15 -11.64 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.5 -24.61 62.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.133 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -111.28 170.54 8.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.519 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.548 178.507 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.054 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.448 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.9 mm? -138.93 149.21 44.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.185 0.517 . . . . 0.0 110.712 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.6 tt0 -119.43 78.05 1.27 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 171.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.74 143.61 31.71 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.536 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 24.2 tp -99.89 153.34 19.23 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.536 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 25.4 m-85 -60.07 130.31 46.08 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.576 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 98.8 mt-30 . . . . . 0 C--N 1.315 -0.928 0 C-N-CA 120.623 -0.431 . . . . 0.0 . 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.698 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.9 -40.51 85.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.795 2.33 . . . . 0.0 115.29 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 12.2 t30 -61.71 -55.64 28.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 m -74.37 -33.6 63.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.91 -24.81 58.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.75 -42.69 97.8 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.48 85.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.76 -50.28 72.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.955 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -71.23 -37.17 72.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.993 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.85 -44.72 95.37 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.5 pp -63.69 -29.95 71.11 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -76.23 -28.53 57.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.13 -45.7 6.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -120.25 6.64 10.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.737 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 46.1 mm -106.22 106.0 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.0 mtp -111.84 147.58 35.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.216 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 101.66 12.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.143 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.72 98.87 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 32.5 m -80.66 100.0 8.45 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -170.79 2.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.905 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -74.01 -29.75 62.11 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.586 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.82 -23.71 22.76 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.212 -0.305 . . . . 0.0 111.516 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.27 -164.99 37.54 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.644 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -97.86 107.82 20.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.634 0.731 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -108.97 164.14 12.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.904 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.3 m -89.34 118.18 28.83 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.64 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.23 99.1 2.49 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.652 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.92 104.89 14.38 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.51 120.83 5.65 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.446 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.0 mp -81.75 -58.91 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 117.576 0.688 . . . . 0.0 110.581 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -155.04 148.82 25.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 26.0 m-20 51.71 -91.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.776 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -137.22 22.5 3.0 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.29 119.58 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 110.41 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.0 m -114.31 159.17 20.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.2 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.14 140.97 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 73' ' ' THR . 14.0 tt -148.36 141.89 15.85 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.13 143.25 25.81 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 120.604 0.869 . . . . 0.0 110.167 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.576 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 71.5 m -67.74 -35.03 78.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -68.41 -7.57 32.82 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.42 68.24 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.636 0.732 . . . . 0.0 109.663 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 59.46 69.68 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.198 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -77.62 146.24 23.92 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.27 2.647 . . . . 0.0 110.549 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.41 -140.42 8.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.982 -1.104 . . . . 0.0 114.079 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.83 -24.38 38.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.732 -0.734 . . . . 0.0 110.324 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.62 139.83 34.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 27.6 m -124.55 153.47 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.246 0.546 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.3 mt -94.52 101.87 13.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.179 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.99 87.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.61 16.02 8.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.522 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.63 -25.07 6.64 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.034 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.08 108.47 17.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 76.5 mttt -73.8 142.38 46.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.715 0.769 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -136.53 142.17 39.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.85 140.12 33.08 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.854 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.45 155.56 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.408 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -113.72 -46.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.54 134.5 8.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.474 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -124.1 116.01 22.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 87.5 t80 -133.65 123.85 25.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.778 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 61' ' ' LYS . 2.4 mppt? -83.9 112.9 20.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . 6.7 tt -96.49 115.13 26.92 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.174 0.988 . . . . 0.0 109.876 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 27.7 m -111.35 178.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.165 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.6 t70 -70.93 136.56 85.09 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.92 -28.55 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.363 2.042 . . . . 0.0 113.948 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -90.12 20.21 4.48 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.6 0.714 . . . . 0.0 110.742 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.75 62.06 1.56 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.887 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 54.9 mt -133.13 158.29 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -77.94 144.58 36.7 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.14 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.707 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.4 tp -127.48 -35.65 2.14 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 55.4 mm-40 85.96 7.26 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.5 HD13 ' HG ' ' A' ' 70' ' ' LEU . 11.3 mp -78.97 93.66 5.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.164 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.576 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 45.7 m -84.01 106.25 15.52 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 70.0 t -71.16 96.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.5 tp -103.04 98.74 8.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 111.304 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.453 ' OG1' ' HE2' ' A' ' 181' ' ' LYS . 3.8 m -92.26 125.51 36.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.463 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.1 mt -114.02 153.43 29.39 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.938 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.62 68.5 8.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.266 -1.373 . . . . 0.0 108.475 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -78.82 117.58 20.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.877 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -76.31 -52.18 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.947 0.403 . . . . 0.0 109.982 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.92 82.98 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 19.5 pttp -73.27 139.16 45.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.641 0.734 . . . . 0.0 112.139 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -82.1 -178.32 6.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -69.64 147.87 50.07 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.565 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 6.6 t70 -88.69 95.98 10.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.848 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 90' ' ' ILE . 39.1 pt -91.49 15.66 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 13.9 ttp180 -62.7 -29.56 70.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.833 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.32 -16.47 80.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.679 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -92.46 -20.17 21.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 56.9 mt -68.74 124.35 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 19.0 m -103.52 120.54 41.06 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.33 -38.07 36.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 91' ' ' SER . 22.1 t70 -101.04 130.62 47.07 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 172.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 mt -90.57 -78.82 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 49.7 70.31 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.42 86.82 0.11 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.6 p -79.41 15.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.123 -0.539 . . . . 0.0 112.272 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 15.2 t70 -141.03 132.14 26.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.965 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.57 31.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.025 0.917 . . . . 0.0 111.031 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.05 135.85 51.37 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.329 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.93 117.97 34.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.256 0.55 . . . . 0.0 111.879 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.31 93.77 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 108' ' ' PHE . 4.9 t -83.04 122.06 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.457 0.646 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 72.5 t60 -145.71 41.65 1.22 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.7 p -108.35 -164.9 0.99 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.18 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.37 -48.92 79.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.79 -17.58 53.04 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' HB2' HG11 ' A' ' 103' ' ' VAL . 20.7 m-85 -150.94 101.39 2.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.507 -0.746 . . . . 0.0 110.742 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 p -85.65 110.02 18.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.519 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 t30 66.43 71.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.564 0.697 . . . . 0.0 111.655 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 m -139.81 109.31 6.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.08 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.0 tp -82.39 120.87 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 116.05 20.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.579 -176.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 7.6 pt-20 -74.15 128.3 35.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.35 -27.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.067 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.45 -131.23 10.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.912 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 39.5 Cg_exo -61.38 115.93 3.07 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.842 2.362 . . . . 0.0 114.19 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -92.46 116.51 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.295 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -123.53 172.08 9.02 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 67.2 mtt -115.75 154.33 29.8 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.0 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.82 -22.92 10.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.02 -111.05 3.23 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.064 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -109.66 111.98 23.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.848 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 46.2 pt -139.35 -177.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 84.5 m-20 -101.43 127.7 47.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.823 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 34.7 tp -107.75 106.58 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 128' ' ' SER . 60.6 p 60.84 30.27 19.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.297 0.57 . . . . 0.0 109.951 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' SER . 63.4 m 85.67 0.52 0.7 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.282 1.033 . . . . 0.0 112.431 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.9 m -110.1 115.27 55.03 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 75.6 Cg_exo -52.05 128.09 25.75 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.529 2.153 . . . . 0.0 114.365 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 p -125.46 145.35 50.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.098 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 65.9 t30 -115.68 160.82 19.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.322 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 5.2 mpt_? 65.83 32.72 8.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.074 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.4 mmm -77.91 127.28 32.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.565 0.698 . . . . 0.0 112.807 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 71.7 mt -85.41 145.39 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.843 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.85 134.0 44.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 111.675 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -152.94 148.41 27.08 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.54 120.03 36.11 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 122.65 1.214 . . . . 0.0 111.502 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -175.06 129.84 0.3 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.811 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.04 0.79 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.151 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.8 t -119.55 138.45 53.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.112 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.43 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 113.455 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.531 ' CG2' ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -41.19 153.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.276 174.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.561 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 88.16 -20.11 31.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.429 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -90.68 -7.84 51.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.327 -0.437 . . . . 0.0 111.495 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 25.8 p -73.61 135.13 43.81 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.024 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 124.03 -24.14 6.39 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.053 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.48 148.82 25.27 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.142 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.95 121.61 50.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 112.38 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.8 tp -92.41 113.42 25.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.283 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -149.26 169.9 19.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.752 0.787 . . . . 0.0 112.823 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.6 169.95 16.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.132 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 1.6 t -62.69 106.11 0.75 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.87 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.12 70.43 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.402 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.87 106.92 9.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.4 mt -95.08 115.96 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.09 -65.37 1.02 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.894 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.501 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -177.39 -155.6 14.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.103 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.4 pt -119.52 142.76 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.374 0.607 . . . . 0.0 111.236 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.15 115.62 7.83 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.35 -25.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.42 -154.84 10.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.564 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.31 161.77 31.89 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.516 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 48.3 t30 -136.2 98.54 3.88 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.86 -119.78 6.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.657 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -103.03 17.38 24.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.821 0.81 . . . . 0.0 111.015 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -113.01 124.65 53.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.74 139.03 15.17 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.404 ' CZ ' ' HG ' ' B' ' 2' ' ' LEU . 73.4 m-85 -119.09 118.03 30.3 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.088 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 40.4 t -110.94 154.12 24.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.249 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -101.49 136.21 41.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.991 0.424 . . . . 0.0 110.078 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 133' ' ' ARG . 3.0 mm100 -76.92 117.03 18.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 92.6 mt -89.85 87.19 6.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 177' ' ' TYR . 92.5 mttt -80.52 126.5 31.31 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.325 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 63.0 tttm -43.07 -43.78 4.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.226 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LYS . 3.9 pt20 -57.71 -23.52 52.21 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.489 ' CD2' ' HB2' ' A' ' 174' ' ' LYS . 54.4 m-85 -75.63 -25.99 57.37 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.644 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -84.43 3.66 35.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.203 0.525 . . . . 0.0 110.921 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 179' ' ' VAL . 15.9 t -93.08 -3.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -78.75 -51.35 9.91 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.453 ' HE2' ' OG1' ' A' ' 76' ' ' THR . 63.1 tttp -71.37 136.59 47.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.168 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.603 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.22 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.2 mm? -135.11 149.39 50.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.4 tt0 -119.74 84.85 2.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 172.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -89.58 146.39 24.6 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 45.9 tp -102.14 151.7 21.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.55 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 22.3 m-85 -57.78 140.87 50.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 93.8 mt-30 . . . . . 0 N--CA 1.441 -0.892 0 C-N-CA 118.353 -1.339 . . . . 0.0 . 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.561 HX51 ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.646 ' O ' ' HG3' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.499 2.85 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -59.61 -33.92 96.7 Favored 'Trans proline' 0 CA--C 1.526 0.09 0 C-N-CA 122.559 2.173 . . . . 0.0 114.073 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 52.6 t30 -70.78 -46.8 62.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.914 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -62.72 -33.65 75.55 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.812 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 44.9 mt-10 -61.15 -47.01 88.2 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.389 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -62.1 -44.38 96.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.233 0.54 . . . . 0.0 109.835 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.71 87.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.705 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 1.6 tt -64.68 -40.07 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.653 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -67.6 -48.1 67.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 -39.72 87.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.879 0.847 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 67.1 tp -54.9 -49.86 70.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.115 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 16.8 mtm180 -72.33 -29.6 63.97 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -91.12 -48.98 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -175.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -118.49 0.06 11.51 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 55.0 mt -106.44 122.99 60.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.6 mtp -133.98 165.6 24.66 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.991 0.901 . . . . 0.0 110.584 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.74 111.79 12.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.958 -1.474 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.1 mm -104.53 110.38 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 2.0 m -87.31 112.86 22.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.175 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -122.35 -171.93 2.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.32 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.475 ' H ' HG22 ' A' ' 20' ' ' THR . 14.9 m -55.28 -37.09 66.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.622 ' HZ3' ' H4 ' ' B' ' 8' ' ' CA1 . 23.9 ttpp -91.02 0.43 57.54 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.78 -160.16 21.69 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.466 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -89.91 122.85 33.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.136 0.493 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CZ ' ' HE3' ' A' ' 22' ' ' LYS . 66.9 m-85 -113.45 177.6 4.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.233 1.016 . . . . 0.0 112.003 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 49.4 m -91.94 107.18 19.02 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.742 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -93.3 112.1 4.23 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 tp -95.6 103.9 15.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.418 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.68 125.58 13.63 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.7 mm -89.99 -46.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 117.199 0.5 . . . . 0.0 111.106 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 57.0 p-80 -171.83 149.93 2.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.99 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.646 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 31.6 t70 46.49 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.646 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 10.2 ptp85 -125.44 18.86 8.15 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.811 -0.556 . . . . 0.0 111.074 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.51 122.92 58.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.625 0.726 . . . . 0.0 111.71 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.44 141.68 50.97 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.377 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.67 135.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.562 0.696 . . . . 0.0 109.785 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 73' ' ' THR . 8.1 tp -141.04 137.78 17.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.798 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.52 151.53 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.775 0.983 . . . . 0.0 111.196 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 92.0 m -78.35 -34.84 48.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.936 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -72.2 3.8 4.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.759 0.314 . . . . 0.0 111.111 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.33 -24.62 50.78 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.0 0.905 . . . . 0.0 109.336 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 56.9 70.18 1.48 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.817 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.95 152.12 24.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.875 2.383 . . . . 0.0 109.41 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.57 -134.78 7.04 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.91 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.83 -9.14 24.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.499 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 11.6 t70 -136.91 124.43 22.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.082 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.95 172.58 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.697 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.618 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.6 mp -117.03 121.92 42.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.76 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.24 98.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 t30 55.9 58.14 4.64 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.793 -176.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -38.07 1.9 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -72.41 118.7 15.63 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 48' ' ' LEU . 4.6 mtmp? -80.71 146.02 31.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.638 0.732 . . . . 0.0 112.166 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -144.58 146.32 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.076 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 24.8 mmm180 -79.89 145.35 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.67 0.271 . . . . 0.0 110.466 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.29 150.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.647 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -94.65 -58.25 2.24 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.36 117.53 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.277 -1.328 . . . . 0.0 110.454 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 59' ' ' LYS . 38.1 ttpt -107.56 115.67 30.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -121.66 117.46 26.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -77.28 109.36 11.1 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 57.4 tp -85.45 114.36 22.43 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-O 122.475 1.131 . . . . 0.0 110.877 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 34.6 m -123.52 168.36 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 113.092 -1.867 . . . . 0.0 108.786 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 13.3 t70 -63.99 144.16 98.16 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.945 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.75 -19.71 8.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.248 1.965 . . . . 0.0 113.682 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.94 15.75 19.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 109.112 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t30 60.65 64.12 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.08 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -130.87 142.16 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 131' ' ' THR . 65.2 t30 -64.4 127.13 30.18 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 29.0 mt -98.43 -29.21 13.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 32.5 tp10 85.81 7.94 0.35 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.785 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 10.8 mp -91.93 107.48 19.24 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.736 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 51.7 m -90.27 105.37 17.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.09 99.78 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.56 100.94 13.6 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.486 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -94.58 98.42 10.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.367 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 77' ' ' LEU . 2.0 pt? -122.62 127.93 50.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.457 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.79 86.14 1.7 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.568 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -79.96 141.08 36.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.12 -1.4 . . . . 0.0 107.943 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -68.96 -38.6 79.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -90.59 96.7 10.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.2 152.9 28.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -85.42 159.06 20.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.116 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' HIS . 23.7 mmm180 -72.49 156.54 38.92 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.877 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.41 67.47 8.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.8 pp -75.1 11.41 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.198 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -58.29 -25.94 62.41 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 120.623 0.249 . . . . 0.0 111.255 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.14 -17.68 74.11 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.805 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -95.34 -4.32 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 109.956 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.402 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.8 mt -82.11 131.9 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 2.5 m -91.6 122.77 34.47 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -174.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -71.18 -63.33 1.13 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.86 135.17 34.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 172.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.13 -54.91 41.65 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.979 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 46.58 71.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.176 0.512 . . . . 0.0 110.965 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.21 93.25 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 5.9 p -78.04 6.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -119.17 124.81 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.57 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.328 1.061 . . . . 0.0 113.745 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 m -124.28 139.18 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.37 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.89 117.77 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.008 0.432 . . . . 0.0 112.033 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -104.24 105.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.841 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.63 121.74 54.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 111.713 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -126.5 76.99 1.67 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.47 -170.28 2.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.444 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -56.4 -47.29 79.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -98.64 -56.65 2.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.903 0.774 . . . . 0.0 110.099 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.46 90.82 5.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 3.1 m -106.87 114.61 28.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.822 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' THR . 3.5 m-20 71.5 26.85 3.14 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.166 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -84.52 111.66 19.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.375 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.58 99.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.336 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 113' ' ' LEU . 3.6 mp -95.39 137.19 34.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.08 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.59 114.81 26.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -97.82 -19.56 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.422 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.33 -135.81 14.69 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.453 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 19.3 Cg_exo -67.23 142.15 59.66 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.02 2.48 . . . . 0.0 114.063 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.83 171.29 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.639 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 m -148.61 157.68 43.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.13 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 73.9 mtm -100.58 129.26 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -97.63 -17.42 19.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.31 -118.85 4.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.48 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.4 tt -107.5 120.3 41.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.204 0.526 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.42 HG21 HD23 ' B' ' 2' ' ' LEU . 40.3 pt -140.68 -166.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 17.5 m120 -117.17 131.55 56.85 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.235 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 1.6 mm? -110.08 108.1 18.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 128' ' ' SER . 7.2 t 61.39 29.14 18.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 127' ' ' SER . 55.3 m 84.31 -10.49 0.88 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.571 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 m -81.64 126.31 76.13 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.05 117.4 4.51 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.828 1.685 . . . . 0.0 112.14 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.0 p -120.25 142.89 48.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.553 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.11 164.29 15.77 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.358 0.599 . . . . 0.0 111.538 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 62.61 34.27 15.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG3' HG12 ' A' ' 124' ' ' ILE . 10.7 mmt -79.32 137.2 37.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.505 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 65.6 mt -96.25 133.69 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.584 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 37.5 ttt180 -120.43 125.23 47.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.762 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -142.9 139.08 30.63 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.92 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -80.44 96.52 6.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.145 0.974 . . . . 0.0 110.982 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -165.56 131.74 2.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.521 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.67 83.62 0.87 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -89.42 140.24 29.71 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.24 157.63 39.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.996 1.379 . . . . 0.0 114.315 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.77 150.0 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.292 175.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 92.38 -27.35 10.69 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -93.15 7.37 44.5 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 12.6 p -79.58 125.7 29.94 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.181 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.571 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 127.93 -16.66 6.1 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.303 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 151.67 33.6 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.653 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.37 119.13 45.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.332 0.587 . . . . 0.0 112.039 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.64 110.04 19.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -152.85 -170.4 3.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.024 0.916 . . . . 0.0 113.129 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -166.1 178.6 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.989 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 3.0 t -55.44 107.98 0.38 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.471 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 60.11 30.24 70.01 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.557 ' HE2' ' OG ' ' A' ' 91' ' ' SER . 2.5 tpmt? -145.3 91.67 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.713 -0.743 . . . . 0.0 111.453 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.0 mt -93.75 122.52 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -92.32 -46.79 7.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.054 0.454 . . . . 0.0 110.351 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 163.85 -154.73 25.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.125 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.36 146.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.53 0.681 . . . . 0.0 111.234 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -78.9 115.05 18.34 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.644 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.24 -28.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.65 -151.5 8.99 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.209 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -173.18 167.09 39.76 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.489 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 24.8 t-20 -136.76 94.43 2.98 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.4 -96.43 0.49 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.398 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -108.96 9.88 26.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.19 0.519 . . . . 0.0 110.879 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -121.29 135.67 55.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.98 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.19 139.29 14.41 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 60.9 m-85 -120.59 121.52 38.55 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.93 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.6 m -121.17 167.94 12.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.617 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.49 143.2 37.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.06 116.17 18.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.574 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 8.7 mp -93.58 86.3 5.15 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 91' ' ' SER . 28.6 mttm -76.3 146.67 38.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -58.34 -31.94 68.04 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 111.695 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -50.9 -42.23 59.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' A' ' 62' ' ' LEU . 9.0 m-85 -64.01 -38.54 91.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -92.47 -22.18 19.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -174.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.84 -14.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.461 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.43 -9.39 20.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.194 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -111.1 99.67 8.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.617 0.723 . . . . 0.0 112.85 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.866 177.015 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 124' ' ' ILE . 2.7 mm? -128.9 149.88 50.59 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.614 0.571 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.4 tt0 -118.22 77.11 1.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -78.65 155.37 29.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 51.0 tp -110.46 142.9 41.56 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.544 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 21.3 m-85 -57.16 136.08 56.4 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 94.1 mt-30 . . . . . 0 N--CA 1.44 -0.938 0 C-N-CA 119.665 -0.814 . . . . 0.0 . -176.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.622 ' H4 ' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 120.297 -0.168 . . . . 0.0 113.004 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -43.78 -50.3 7.33 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.901 1.734 . . . . 0.0 112.731 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.43 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 38.6 t30 -62.1 -50.99 69.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.553 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -56.86 -53.38 58.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.175 -1.375 . . . . 0.0 112.935 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.553 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.2 mp0 -71.33 -26.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.309 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.56 -45.71 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -56.89 -45.39 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.403 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 7.5 tt -59.76 -42.33 93.02 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 m -70.3 -36.49 74.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.256 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -70.26 -47.41 61.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.679 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.0 pp -64.81 -25.02 67.73 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 69.6 mtp180 -70.0 -50.07 45.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.31 -23.99 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -108.51 -4.55 17.15 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 43.4 mm -114.59 117.08 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.816 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -120.79 137.31 54.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.313 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 m -76.71 103.28 6.59 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.97 102.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.686 0.755 . . . . 0.0 111.575 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 63.4 m -71.13 100.01 1.97 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.791 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -107.4 175.7 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.954 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.524 ' H ' HG22 ' A' ' 20' ' ' THR . 3.4 m -55.15 -47.31 75.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.714 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 7.7 mmpt? -89.83 2.11 55.35 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.71 -175.97 27.73 Favored Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.853 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 105' ' ' SER . 30.2 mt-10 -101.48 112.6 25.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -106.93 162.59 13.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.951 0.881 . . . . 0.0 112.951 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.691 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 86.3 m -80.73 106.8 13.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.847 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.27 116.48 4.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.694 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -94.42 108.95 20.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 110.795 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.8 108.08 2.41 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 86' ' ' ILE . 39.6 mm -75.43 -55.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.891 0.377 . . . . 0.0 111.802 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -162.96 138.92 7.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.617 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 13.0 t70 57.32 -94.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.069 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 76' ' ' THR . 79.2 mtt85 -126.28 8.74 7.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.802 0.81 . . . . 0.0 110.163 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 74' ' ' VAL . 96.9 t -92.71 113.18 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.866 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 p -124.06 142.8 50.87 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.11 137.09 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.023 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 tt -144.95 139.95 15.72 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.525 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.2 144.1 72.06 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.457 1.438 . . . . 0.0 112.439 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.816 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 89.7 m -63.9 -37.6 87.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -72.52 6.54 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.17 -19.1 30.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.668 0.747 . . . . 0.0 109.937 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 64.98 69.51 0.66 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.196 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.81 110.49 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.638 1.559 . . . . 0.0 109.48 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -141.84 1.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.546 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.01 -28.32 15.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.952 0.882 . . . . 0.0 109.227 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -136.88 132.4 34.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.039 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.81 153.15 36.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 mp -97.01 104.01 15.98 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.118 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.2 p -82.02 96.03 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.34 10.53 7.3 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.47 -28.76 3.96 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.461 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 54' ' ' ILE . 58.5 tt0 -78.88 118.38 20.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.127 0.489 . . . . 0.0 110.741 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -72.55 107.79 5.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.405 HD12 HG11 ' A' ' 49' ' ' VAL . 8.9 mt -119.39 126.4 75.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.257 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -77.56 146.22 36.42 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 110.084 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.27 138.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -84.46 -45.56 12.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.78 144.48 15.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -136.67 112.67 9.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -112.95 129.35 56.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.339 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.43 110.79 16.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.647 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 36.9 tp -81.19 115.1 20.44 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.44 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.59 167.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.673 -1.603 . . . . 0.0 108.218 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 17.9 t70 -87.0 143.32 34.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.59 -17.05 6.25 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.367 2.045 . . . . 0.0 113.513 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.89 7.18 9.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.86 39.99 2.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.938 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 150.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.846 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -66.4 137.39 56.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 18.6 mt -105.38 -28.38 10.91 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.816 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 35.8 tp10 80.7 9.03 1.18 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.948 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HG ' HD21 ' A' ' 173' ' ' LEU . 2.3 mm? -95.54 133.41 39.58 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.904 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.8 m -105.61 115.56 30.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 34' ' ' VAL . 60.4 t -74.61 96.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -93.28 103.55 15.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.928 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 19.9 m -94.44 100.5 12.49 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.22 156.63 16.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.758 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -83.87 103.53 13.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -129.96 143.1 50.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.459 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -87.34 -59.02 2.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.77 90.64 4.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 55.6 pttt -68.07 163.66 21.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -79.23 145.91 33.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.343 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -62.45 130.82 46.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.717 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.94 80.93 0.47 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 122.173 -0.329 . . . . 0.0 111.437 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 86' ' ' ILE . 2.6 pp -87.36 19.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 O-C-N 121.448 -0.782 . . . . 0.0 110.403 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.48 -13.38 62.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.614 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.84 67.43 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.873 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.28 -10.15 50.52 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.86 131.84 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.9 m -105.43 133.68 49.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -81.97 -23.82 35.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -127.31 111.49 13.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.6 mt -52.74 -64.55 0.78 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.7 69.25 0.69 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.28 96.9 0.1 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.5 p -86.55 17.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.333 0.587 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -140.35 132.92 28.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.034 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.18 16.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.236 1.017 . . . . 0.0 113.38 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.3 m -128.23 142.1 51.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.389 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.76 110.97 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.142 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 7' ' ' ALA . 27.1 m -103.74 136.19 37.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.16 0.505 . . . . 0.0 110.999 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 105' ' ' SER . 27.4 t -122.54 133.87 67.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.909 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.603 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 64.5 t60 -138.64 45.03 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 m -108.78 -165.42 1.02 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.413 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -83.34 -18.52 38.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.619 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 11.9 p30 -67.49 -50.3 59.55 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -138.49 113.83 9.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.4 m -92.55 96.84 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.808 0.813 . . . . 0.0 112.22 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.603 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 8.0 t30 74.03 70.45 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.054 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 m -134.85 136.67 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.819 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.58 117.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.8 mp -111.91 113.16 25.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.49 120.58 24.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -97.06 -25.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.956 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.73 -129.12 9.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.838 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 25.1 Cg_exo -62.43 130.51 30.37 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.3 2.0 . . . . 0.0 113.231 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 137' ' ' TYR . 15.0 m -121.45 131.66 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.0 p -122.98 144.98 48.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 72.8 mtm -81.31 114.28 19.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.51 -50.27 7.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.864 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.19 -119.95 5.86 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.785 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.45 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -95.68 118.1 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.304 0.574 . . . . 0.0 112.53 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.8 pt -139.98 -174.46 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.1 m-20 -113.26 104.28 12.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.757 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.6 mm? -79.52 113.36 17.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.45 ' HB3' HD12 ' B' ' 5' ' ' LEU . 59.0 p 52.27 30.81 8.39 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.969 -0.457 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m 70.56 62.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -160.8 115.27 1.35 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.315 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.21 112.12 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.349 1.366 . . . . 0.0 111.6 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.625 ' HB ' HD23 ' A' ' 126' ' ' LEU . 17.7 m -125.79 128.86 48.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.854 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 57.7 t30 -106.86 162.79 13.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.639 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 19.6 ttm-85 70.88 34.82 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.286 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.3 mmm -87.37 139.44 30.55 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 111.68 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.4 mm -97.94 134.49 36.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.442 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -111.82 125.42 54.0 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.438 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -137.36 125.82 23.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.67 99.81 3.78 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 122.232 1.015 . . . . 0.0 110.773 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -166.7 128.19 1.71 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.47 91.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.1 p -90.72 162.42 14.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.336 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -132.17 150.33 52.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.971 0.891 . . . . 0.0 111.865 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.648 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.22 154.22 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.275 175.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -33.14 5.43 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.497 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 70.8 mt-30 -77.52 9.99 2.92 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.54 139.6 58.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.691 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.88 -14.96 34.31 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.951 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.68 145.1 40.11 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.532 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.42 122.19 50.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.645 0.736 . . . . 0.0 112.249 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.38 108.91 20.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.347 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 178.85 8.68 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.904 0.859 . . . . 0.0 112.802 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.417 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . . . -153.12 179.25 8.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.628 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 2.0 t -60.63 102.63 0.2 Allowed 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.794 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.95 88.01 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.608 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.08 119.36 16.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.641 0.721 . . . . 0.0 112.768 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -99.31 124.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -94.57 -35.03 12.42 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 161.05 -163.15 34.14 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.769 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.5 pt -129.85 152.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.842 0.829 . . . . 0.0 112.11 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -62.27 122.73 16.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.756 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.13 -30.98 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.183 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' B' ' 7' ' ' GLN . . . -174.21 -146.12 5.5 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.583 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -179.42 158.11 21.76 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.322 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 21.4 t30 -131.22 86.56 2.37 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.977 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.13 -99.74 0.81 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 114.995 -1.002 . . . . 0.0 114.973 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -94.25 -2.43 52.39 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 111.929 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -121.46 131.39 54.13 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.759 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.01 151.3 25.83 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -129.28 114.11 15.84 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.765 -1.174 . . . . 0.0 113.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.0 m -108.92 159.27 16.94 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.46 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -96.26 132.35 41.81 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.587 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 51.8 tt0 -70.96 107.86 4.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.12 0.486 . . . . 0.0 110.283 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.489 HD21 ' HG ' ' A' ' 72' ' ' LEU . 80.4 mt -85.59 93.83 8.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.556 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.75 125.56 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.726 0.774 . . . . 0.0 109.548 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -40.18 -39.86 1.0 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.4 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.48 -46.23 37.91 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 180' ' ' GLU . 27.8 m-85 -64.06 -17.0 62.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.38 -22.31 30.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 110.626 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.24 -29.46 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 177' ' ' TYR . 19.2 tp10 -65.67 -43.58 88.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.5 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -65.92 135.81 55.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.779 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.414 ' N ' HD12 ' B' ' 2' ' ' LEU . 6.3 mp -111.69 114.28 27.19 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -86.55 79.54 8.9 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.492 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.757 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.41 125.08 30.64 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 37.7 tp -86.02 146.75 26.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.516 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 16.2 m-85 -60.17 130.2 45.5 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.648 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 98.3 mt-30 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.647 -0.706 . . . . 0.0 . 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.671 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 120.357 -0.135 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.26 -48.78 4.0 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.969 2.446 . . . . 0.0 114.451 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.67 -40.49 76.39 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.58 0.705 . . . . 0.0 110.694 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -49.78 68.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.535 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 10.1 mm-40 -60.28 -33.82 72.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.388 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -68.81 -58.52 4.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 tp -70.46 -33.02 70.8 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -79.79 -34.55 39.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.42 -36.43 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.1 tp -54.94 -59.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.027 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.61 -27.04 61.92 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.608 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.71 -46.34 14.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.53 -6.06 9.24 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.2 mt -110.25 121.19 62.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.96 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.4 mtt -127.73 147.23 50.4 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.639 0.733 . . . . 0.0 109.817 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -64.92 110.98 2.63 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.009 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 39.7 mm -95.57 105.18 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -92.21 96.52 10.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.507 0.67 . . . . 0.0 109.301 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.458 HG23 HG22 ' A' ' 18' ' ' ILE . 1.3 p -102.81 -169.73 1.7 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.341 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -67.32 -32.04 72.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.703 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 49.4 tttm -83.03 -35.29 25.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.395 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.43 -151.57 22.64 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 119.479 -1.343 . . . . 0.0 115.34 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.42 120.28 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.306 -0.947 . . . . 0.0 110.531 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.576 ' HZ ' ' HZ2' ' A' ' 22' ' ' LYS . 63.1 m-85 -126.44 159.58 32.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.184 0.992 . . . . 0.0 113.018 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 32.9 m -79.65 100.91 8.07 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.384 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -90.42 112.29 4.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.69 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -101.81 105.72 16.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.28 116.58 5.27 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 46.4 mm -83.53 -60.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.223 0.512 . . . . 0.0 111.946 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -145.51 152.65 40.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.875 0.845 . . . . 0.0 112.678 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 41.6 m-20 45.14 -92.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.781 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 16.9 ptt180 -141.59 25.75 1.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.88 0.848 . . . . 0.0 109.661 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.53 118.61 53.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.548 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 m -117.48 146.07 43.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.869 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.89 122.91 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.062 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 18' ' ' ILE . 57.0 mt -134.76 141.11 37.39 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.243 -177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HB3' ' CE1' ' A' ' 40' ' ' HIS . 45.9 Cg_exo -58.6 144.3 97.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 121.583 1.522 . . . . 0.0 109.915 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 49.7 m -74.11 -32.44 63.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 38' ' ' PRO . 43.0 p-80 -71.53 -7.27 46.51 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.89 -29.44 66.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.952 0.882 . . . . 0.0 108.754 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 66.61 70.95 0.47 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.662 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.73 118.56 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.223 2.615 . . . . 0.0 108.64 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.52 -111.42 0.74 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.559 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.18 -35.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.558 0.694 . . . . 0.0 109.172 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -117.78 148.64 41.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.561 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 75' ' ' LEU . 86.8 t -131.3 123.81 53.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.744 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.402 HD21 ' HE2' ' A' ' 53' ' ' LYS . 36.0 mt -74.41 88.32 2.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.198 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 54' ' ' ILE . 48.1 t -83.24 98.98 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.2 t30 64.5 23.04 12.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 -7.6 56.93 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.597 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -93.76 130.37 39.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.122 0.487 . . . . 0.0 111.665 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HE2' HD21 ' A' ' 48' ' ' LEU . 59.5 mmtt -74.35 88.62 2.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.925 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 49' ' ' VAL . 57.9 mt -102.94 136.07 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -100.67 154.75 18.34 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 117.956 -1.498 . . . . 0.0 113.889 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 59' ' ' LYS . 78.2 t -71.49 133.53 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.522 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 57' ' ' LYS . 11.0 tmtt? -100.95 -56.24 2.37 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -128.02 115.88 19.17 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.649 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HB2' HG11 ' A' ' 56' ' ' VAL . 54.0 tttp -106.88 92.16 3.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -113.22 123.76 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.455 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 5.7 mptt -86.12 103.19 14.54 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 56.2 tp -69.19 114.75 7.74 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 123.376 1.56 . . . . 0.0 112.302 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.9 m -114.62 153.42 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 174.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' A' ' 66' ' ' GLU . 12.3 t70 -74.33 139.92 75.69 Favored Pre-proline 0 C--N 1.306 -1.291 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 31.2 Cg_exo -44.72 -17.62 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.576 1.517 . . . . 0.0 112.086 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 64' ' ' ASP . 12.9 tp10 -68.42 -1.39 6.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.566 0.698 . . . . 0.0 109.161 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' PRO . 10.7 t30 72.21 30.21 2.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.052 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.3 mt -123.39 143.41 36.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.789 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.41 ' HA ' HG12 ' A' ' 63' ' ' VAL . 15.8 m120 -59.84 145.26 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.768 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 59.2 mt -126.26 -30.72 2.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.183 0.516 . . . . 0.0 109.833 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.4 mm-40 87.13 4.35 0.36 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.975 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 66.6 mt -87.92 98.12 11.32 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.014 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 m -76.46 103.45 6.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.033 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 62' ' ' LEU . 99.2 t -77.57 88.05 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 47' ' ' VAL . 15.2 tp -93.76 115.01 27.41 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.109 -175.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -98.32 109.86 22.55 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.632 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.44 151.41 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.92 86.93 6.87 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.353 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 33' ' ' ARG . 29.2 mmm180 -103.81 146.96 27.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.009 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.96 -51.63 3.99 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -76.22 114.02 14.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.58 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 32' ' ' ASP . 11.7 ptpt -84.57 -179.48 7.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.729 0.776 . . . . 0.0 111.938 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.47 163.57 12.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.214 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -67.27 117.04 8.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -66.26 91.55 0.17 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.4 pt -90.18 20.0 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -62.85 -21.48 65.99 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.43 -18.4 71.28 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.542 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 96.7 m-85 -87.88 -1.98 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.103 0.478 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 30' ' ' ILE . 64.4 mt -84.78 125.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.6 m -85.08 129.05 34.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.683 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -55.95 13.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.68 132.99 42.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.9 mt -55.62 -70.18 0.12 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 50.61 71.27 0.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.021 0.439 . . . . 0.0 110.046 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.08 88.27 0.07 OUTLIER Glycine 0 C--N 1.333 0.408 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.447 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.7 p -79.77 -0.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.355 0.597 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 12.5 t70 -128.91 114.69 16.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.687 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.03 165.12 20.92 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.961 0.886 . . . . 0.0 111.363 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 7.9 m -119.12 140.53 49.98 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.261 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.7 tp -109.83 124.81 51.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.479 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.43 111.36 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 105' ' ' SER . 10.5 t -103.52 137.85 30.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.34 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.449 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 86.5 t60 -136.41 42.05 2.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.535 ' H ' HG12 ' A' ' 103' ' ' VAL . 54.6 m -107.29 -176.59 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.209 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -44.41 -57.91 3.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -79.83 -47.94 14.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.047 0.839 . . . . 0.0 112.26 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -108.99 96.08 6.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.651 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 3.1 m -98.08 103.58 15.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.808 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 109' ' ' THR . 16.9 t30 73.36 72.2 0.13 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.978 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -140.09 125.09 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.193 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.1 tt -113.07 126.19 70.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 tt -143.0 127.87 18.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 14.0 pt-20 -81.01 108.02 14.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.23 -33.21 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.958 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.72 -118.96 5.84 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 26.6 Cg_endo -58.02 107.29 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 116.03 -175.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.8 t -96.47 118.93 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.59 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 24.5 m -137.66 141.23 41.16 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.501 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -81.92 130.19 35.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.313 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.31 -18.38 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.52 -130.18 9.53 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.403 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 123' ' ' LEU . 2.9 tm? -93.5 112.38 24.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 47.9 pt -135.83 -174.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 4.4 m-20 -108.33 106.44 16.58 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.857 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.636 HD12 ' O ' ' B' ' 4' ' ' ALA . 56.3 tp -82.57 111.21 18.35 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.1 p 56.42 37.31 28.72 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.076 0.465 . . . . 0.0 110.991 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.4 m 77.73 11.14 2.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.892 0.877 . . . . 0.0 112.992 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -118.2 118.19 34.4 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.622 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 51.2 Cg_exo -54.05 116.62 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.245 1.964 . . . . 0.0 113.825 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 p -125.09 145.4 49.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.839 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' HB3' HD23 ' A' ' 123' ' ' LEU . 25.2 p-10 -112.9 163.26 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.909 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 80.2 mtt180 58.94 41.86 20.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.642 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -77.63 127.87 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.54 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.528 ' HB ' ' OG ' ' A' ' 170' ' ' SER . 39.4 mm -87.38 120.84 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 24.8 ttt180 -104.88 124.65 49.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.613 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.552 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.6 OUTLIER -117.19 115.86 26.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.879 -1.896 . . . . 0.0 105.879 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -71.55 90.42 1.01 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.016 0.912 . . . . 0.0 112.059 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -166.96 132.12 2.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.328 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.41 0.54 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.518 0.675 . . . . 0.0 111.582 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 131.79 54.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 7.2 mtpm? -122.29 179.3 4.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.7 150.75 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.773 177.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.467 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 91.08 -20.22 41.39 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.039 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.28 5.87 40.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.572 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 14.5 p -78.53 140.98 38.49 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.182 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.652 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 116.96 -19.29 12.11 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.16 150.44 29.13 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.098 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.96 124.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.44 0.638 . . . . 0.0 111.967 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.36 108.96 20.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -144.99 -178.72 6.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.927 0.87 . . . . 0.0 112.453 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.2 179.74 7.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.397 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 t -65.17 117.23 7.46 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.559 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.7 76.91 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.618 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 8.7 ptpp? -159.32 138.91 11.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.776 0.788 . . . . 0.0 112.602 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 63.6 mt -113.41 135.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.635 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.03 -39.61 6.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.798 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 175.08 -171.1 44.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.5 pt -125.54 142.83 41.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.871 0.843 . . . . 0.0 111.111 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.0 t-160 -61.7 112.75 2.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.234 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.87 -25.17 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.265 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.36 -145.94 5.46 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.402 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 175.43 164.11 29.43 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.3 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 2.7 t-20 -136.88 99.98 4.18 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.477 0.656 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 60.56 -110.03 2.71 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 115.014 0.765 . . . . 0.0 115.014 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -92.93 18.96 8.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.447 0.642 . . . . 0.0 111.337 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -135.1 128.56 32.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -91.05 145.28 17.7 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 136' ' ' ARG . 44.9 m-85 -127.18 126.98 43.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.672 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.528 ' OG ' ' HB ' ' A' ' 135' ' ' ILE . 19.8 p -124.92 169.61 11.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.178 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.88 140.21 41.33 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.6 pt20 -70.3 118.5 13.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.0 mp -97.78 75.9 2.44 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -83.74 142.1 30.96 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -50.98 -22.97 2.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -54.63 -22.54 13.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -97.82 -16.22 19.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.2 -6.2 15.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.3 -18.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.5 -58.6 7.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.522 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -92.04 127.28 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.616 175.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.034 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.8 mm? -135.31 138.4 43.41 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.243 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.2 tt0 -106.96 90.1 3.2 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -96.42 126.51 41.67 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.117 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -87.03 158.68 19.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.717 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.576 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.0 m-85 -62.58 147.45 49.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 142' ' ' LYS . 97.1 mt-30 . . . . . 0 N--CA 1.434 -1.258 0 C-N-CA 118.402 -1.319 . . . . 0.0 . 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' CA1 . . . . . 0.585 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.47 0.126 0 N-CA-C 113.907 0.695 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 11.1 t30 -68.77 -48.27 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.374 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 m -70.23 -29.02 65.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.714 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.56 -50.0 74.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.52 -47.31 84.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.475 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.36 58.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.533 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.79 -23.68 64.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -76.94 -51.23 11.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.591 0.71 . . . . 0.0 109.853 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.4 tp -57.13 -44.51 83.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.254 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 69.6 tp -53.86 -49.91 67.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.203 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -78.02 -28.38 49.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -86.54 -52.57 5.49 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.86 1.98 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 40.2 mm -106.25 133.02 51.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.435 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 50' ' ' ASN . 46.2 ttm -150.55 144.04 25.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.799 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.0 m -69.23 113.59 6.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.59 108.77 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 14.0 m -93.91 122.5 36.47 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.8 0.81 . . . . 0.0 109.994 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 -163.9 1.45 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.44 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.37 -44.4 62.11 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HZ2' ' HZ ' ' A' ' 25' ' ' PHE . 55.1 tttm -85.36 1.2 49.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.877 0.762 . . . . 0.0 111.863 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.67 -149.76 17.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.31 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.26 129.66 35.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.055 -0.573 . . . . 0.0 111.584 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' HZ ' ' HZ2' ' A' ' 22' ' ' LYS . 68.7 m-85 -131.85 157.26 44.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.109 0.957 . . . . 0.0 111.96 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 80.5 m -72.66 107.53 5.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.332 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.24 107.24 3.16 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.399 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.37 99.06 11.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.37 123.01 7.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.681 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.93 -56.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 117.179 0.489 . . . . 0.0 110.03 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.95 153.31 5.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.605 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.06 -89.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.999 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.1 ptp180 -132.02 10.25 4.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -110.69 131.82 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.931 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 p -133.13 156.68 47.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.51 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.45 139.82 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.469 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.8 tt -143.54 141.58 19.27 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.367 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.16 153.06 13.43 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 C-N-CA 121.313 1.342 . . . . 0.0 112.243 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 39.5 m -77.61 -37.45 50.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -66.91 -13.08 61.35 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.63 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.72 -21.18 64.41 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.024 0.916 . . . . 0.0 109.224 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 45.1 mt-30 61.12 69.07 1.12 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.311 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 12.3 Cg_exo -75.25 131.23 13.78 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.806 2.337 . . . . 0.0 107.97 175.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.84 -134.37 7.6 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.417 -1.373 . . . . 0.0 114.602 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.39 -26.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.685 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 53' ' ' LYS . 13.0 p-10 -144.67 133.69 22.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.96 158.67 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.892 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 45.6 mt -101.8 98.71 8.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 16' ' ' MET . 41.0 t -91.81 103.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.549 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 65.8 t30 66.47 24.78 10.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.699 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.57 -20.1 52.01 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.35 115.57 18.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.362 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 87.7 tttt -74.74 109.49 8.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.759 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.17 139.89 46.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.435 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.28 153.77 22.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.963 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.591 HG21 ' HB2' ' A' ' 59' ' ' LYS . 14.6 p -73.81 141.59 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -99.9 -42.85 6.62 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 37.9 t70 -159.13 118.35 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.304 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 56' ' ' VAL . 28.5 ttpp -111.47 106.41 15.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 86.0 t80 -115.87 110.41 18.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.764 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.11 105.59 6.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 60.0 tp -75.69 114.74 14.63 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-O 122.243 1.02 . . . . 0.0 111.89 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.25 159.9 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.434 -1.712 . . . . 0.0 107.852 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -74.84 149.04 85.36 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.28 -23.84 7.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.75 2.3 . . . . 0.0 113.666 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 68' ' ' ILE . 7.6 mm-40 -86.37 25.04 1.26 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.604 0.716 . . . . 0.0 109.805 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.289 0.3 OUTLIER 39.99 61.98 1.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.495 1.118 . . . . 0.0 113.202 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' GLU . 25.2 mm -138.62 155.59 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.492 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -57.5 131.33 49.84 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.783 -0.573 . . . . 0.0 111.761 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.556 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.7 tp -103.89 -22.94 13.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 161' ' ' VAL . 22.7 tp10 80.61 7.89 1.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.403 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.85 109.62 22.01 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.397 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 99.8 m -85.27 107.44 17.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 84.0 t -72.79 101.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.02 100.32 11.46 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.05 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 21.5 m -96.77 121.84 39.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.665 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mm? -120.34 158.54 26.9 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.63 82.15 6.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -79.64 117.37 20.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.492 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.82 -53.81 13.9 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.5 89.86 7.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.27 143.44 52.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.127 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -82.88 148.68 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.058 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.63 144.35 51.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.75 83.24 1.17 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -87.45 12.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.756 -0.59 . . . . 0.0 109.577 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.08 -19.8 65.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.791 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.91 73.86 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.559 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -84.49 -21.12 30.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.704 -0.248 . . . . 0.0 110.474 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.12 121.69 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 13.7 m -113.06 148.48 35.1 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.67 -33.42 12.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.7 105.63 15.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.715 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 17.4 mt -68.33 -57.16 6.35 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 5.6 pt-20 55.75 13.48 1.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 0.0 111.247 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 98' ' ' ASP . . . -115.87 67.3 0.29 Allowed Glycine 0 C--N 1.334 0.459 0 CA-C-O 121.603 0.557 . . . . 0.0 112.838 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -60.87 -3.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.071 0.462 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 96' ' ' GLY . 24.7 t70 -117.94 111.89 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.58 160.43 34.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.849 0.833 . . . . 0.0 112.865 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.1 m -125.63 137.0 53.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.337 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 160' ' ' HIS . 57.2 tp -102.33 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.016 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 t -104.05 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.62 129.91 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.674 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -138.86 35.07 2.17 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -108.54 -170.05 1.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -44.15 -51.93 7.7 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.18 -29.41 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.812 0.733 . . . . 0.0 112.355 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -140.02 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.887 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 m -96.83 119.35 35.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.463 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 96.1 m-20 69.39 70.4 0.25 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.039 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 m -141.71 107.99 5.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.068 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.0 mt -86.32 108.3 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.053 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.1 mt -116.64 107.53 14.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.342 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -73.59 125.43 27.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.49 -25.18 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 89.5 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.504 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 5.8 Cg_exo -75.52 122.36 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.284 1.989 . . . . 0.0 112.974 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.21 132.87 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.307 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -134.95 -169.64 2.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.759 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.3 ptm -129.47 149.7 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.428 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.16 -4.68 21.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.134 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.44 -108.07 2.73 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.14 128.48 54.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.073 -0.563 . . . . 0.0 111.099 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.6 pt -150.63 -178.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 120.679 0.276 . . . . 0.0 110.346 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 30.4 m-80 -96.19 136.42 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 40.6 tp -120.72 105.68 10.99 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t 60.23 42.76 14.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m 66.69 8.92 6.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.883 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.5 m -112.03 112.63 52.63 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.63 124.08 15.27 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.233 1.288 . . . . 0.0 111.204 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.0 m -130.33 141.32 50.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.84 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -99.42 151.87 20.61 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 57.64 62.82 2.0 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.945 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.421 ' HA ' ' CE ' ' A' ' 134' ' ' MET . 8.0 mmt -93.63 134.45 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.715 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 57.4 mt -94.97 141.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.905 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 18.3 ttp180 -125.43 125.39 43.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.578 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.9 OUTLIER -127.6 130.83 49.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.349 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 87.36 3.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.621 0.724 . . . . 0.0 109.202 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.06 114.7 1.5 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.094 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.8 116.51 3.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 112.236 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.67 160.02 37.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.956 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 142' ' ' LYS . 53.2 mtpt -136.97 177.24 8.01 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.349 1.071 . . . . 0.0 112.101 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 1.5 p -45.03 155.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.126 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.37 13.26 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.67 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -90.9 -6.31 54.32 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.138 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.625 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 26.6 p -73.3 133.87 44.02 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.889 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.84 -21.18 18.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.0 149.07 38.79 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.095 -0.552 . . . . 0.0 112.976 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 26' ' ' THR . 25.6 t -87.47 121.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 112.46 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.1 tp -93.66 107.72 19.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.8 p -149.19 172.29 15.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.081 0.943 . . . . 0.0 113.325 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 167.61 24.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.273 -1.785 . . . . 0.0 107.437 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.9 t -65.1 101.21 0.5 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.944 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.61 -12.95 39.13 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -134.46 121.53 21.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.6 mt -101.48 117.09 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -88.48 -33.64 17.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.124 0.487 . . . . 0.0 111.806 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 173' ' ' LEU . . . 152.18 -150.73 22.63 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.538 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.1 pt -129.54 145.95 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.046 0.927 . . . . 0.0 112.024 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.424 ' HB2' HD11 ' A' ' 101' ' ' LEU . 6.6 t60 -60.99 123.75 18.53 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.603 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.519 HG21 ' HG2' ' A' ' 71' ' ' GLU . 9.8 p -111.84 -29.11 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.351 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -177.13 -147.51 6.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.229 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.54 160.32 29.62 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.77 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 15.3 t-20 -137.23 105.02 5.58 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.58 -115.26 5.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.263 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -104.79 -0.28 27.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.19 0.519 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.18 125.14 48.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.21 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.66 149.59 23.59 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 136' ' ' ARG . 49.3 m-85 -125.71 129.52 49.7 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.88 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.5 m -121.6 165.16 16.11 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.987 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.19 132.42 38.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.404 HE21 HD11 ' A' ' 94' ' ' LEU . 35.6 tt0 -82.36 106.27 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.868 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.491 HD13 ' CA ' ' A' ' 158' ' ' GLY . 11.0 mp -85.28 85.73 7.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.98 129.1 37.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.837 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -43.1 -38.55 2.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.477 0.656 . . . . 0.0 111.489 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -49.75 -41.74 44.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.689 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 121.253 0.549 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.9 tt0 -115.66 81.44 1.59 Allowed 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -80.97 149.14 29.46 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 35.8 tp -103.81 152.98 21.25 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.561 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.8 m-85 -61.2 145.03 52.57 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.625 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.8 mt-30 . . . . . 0 N--CA 1.443 -0.806 0 C-N-CA 118.836 -1.145 . . . . 0.0 . -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 CA--C 1.537 0.652 0 N-CA-C 114.117 0.776 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -52.4 -47.87 66.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.842 0.83 . . . . 0.0 110.934 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -56.28 -52.74 63.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.881 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.26 -30.23 63.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.81 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.28 -50.41 70.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -64.56 -40.74 96.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.374 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.5 tt -54.54 -46.31 73.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -79.82 -32.7 40.71 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.933 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.28 -43.43 98.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.026 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 4.6 pp -67.14 -26.89 66.89 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 65.5 mtp180 -73.69 -27.82 61.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.72 0.295 . . . . 0.0 111.101 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -97.55 -50.94 4.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -114.59 13.67 17.52 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 57.6 mt -122.29 117.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.034 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.1 mtp -128.99 146.89 50.85 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.788 0.804 . . . . 0.0 110.128 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.24 99.08 2.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.32 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.24 98.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.664 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 73.0 p -74.67 98.08 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.97 179.37 4.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.43 -176.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.551 ' H ' HG22 ' A' ' 20' ' ' THR . 4.8 m -62.48 -25.49 68.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.167 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -93.7 -39.17 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.99 -154.02 14.24 Favored Glycine 0 C--O 1.234 0.126 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -93.67 117.25 29.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -117.12 151.28 37.17 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.025 0.917 . . . . 0.0 112.978 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 149' ' ' VAL . 21.3 m -79.06 100.21 7.25 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.06 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.09 101.15 2.17 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -96.41 111.38 23.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 131.7 11.07 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' A' ' 178' ' ' PHE . 43.2 mm -98.84 -56.59 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 117.518 0.659 . . . . 0.0 111.097 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -145.45 129.55 17.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.908 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 m-20 55.12 -90.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.824 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.4 ptp180 -128.32 7.41 5.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.4 0.619 . . . . 0.0 111.397 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.7 t -87.65 111.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.938 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.2 m -119.3 159.14 24.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.68 144.52 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.576 0.703 . . . . 0.0 111.098 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -152.68 140.55 13.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.631 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.19 148.31 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.052 1.168 . . . . 0.0 111.234 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.725 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 77.7 m -68.86 -40.33 79.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.633 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -68.42 4.02 1.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.68 -25.53 53.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.885 0.85 . . . . 0.0 108.88 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 57.99 70.97 1.13 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.854 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.89 131.12 10.9 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.087 2.525 . . . . 0.0 111.318 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.18 -161.29 32.45 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.554 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.12 -21.39 50.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.767 0.784 . . . . 0.0 109.383 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.5 p-10 -133.03 133.79 43.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.93 163.67 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.796 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -103.01 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.301 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.64 92.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 68.38 19.72 8.82 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.285 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.4 32.9 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.841 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 112.98 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 2.2 pptp? -76.51 134.18 39.55 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.43 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.8 tp -144.35 137.55 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.084 -1.417 . . . . 0.0 108.488 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 39.0 mtt180 -93.69 138.54 31.8 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.614 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.51 138.26 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.87 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -83.39 -49.55 9.22 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.841 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.06 137.56 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.001 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -124.7 85.55 2.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -90.94 123.1 34.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.321 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.48 127.41 32.09 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.678 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 83.5 mt -90.13 116.77 28.39 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.372 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.19 159.55 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.621 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 27.6 t70 -76.64 144.86 74.12 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 15.9 Cg_endo -55.88 -5.16 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.395 2.063 . . . . 0.0 113.123 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.68 17.8 19.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.033 0.921 . . . . 0.0 109.939 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t30 74.5 0.02 3.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.814 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.34 155.01 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -67.4 146.62 53.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 0.0 111.742 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.4 tp -108.75 -22.8 12.06 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.725 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 24.4 tp10 78.96 11.8 1.44 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.397 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.9 mm? -102.25 151.25 22.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.218 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.8 m -124.47 120.38 31.85 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.308 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.4 100.82 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.1 93.42 9.14 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.583 0.706 . . . . 0.0 109.996 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -87.15 109.82 19.71 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.134 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 69.7 mt -106.77 151.73 24.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.648 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.92 102.45 6.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' NH2' ' HG2' ' A' ' 81' ' ' GLU . 22.5 mmm180 -119.29 108.13 14.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -83.28 -29.58 28.27 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -101.25 91.38 4.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 174.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 52.3 pttt -97.86 178.96 4.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.48 171.85 8.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.787 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.46 138.23 31.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.67 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.44 92.09 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.67 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.6 pt -88.13 21.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.057 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.44 -30.39 64.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.57 -20.28 77.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.074 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 77.5 m-85 -93.19 -8.84 41.28 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.8 mm -76.97 134.04 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -81.41 112.88 19.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -77.03 -27.03 54.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -143.44 131.75 22.07 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.991 -1.913 . . . . 0.0 106.219 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.2 mt -74.82 -80.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.26 71.38 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.466 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.23 80.41 0.14 Allowed Glycine 0 C--N 1.331 0.262 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 9.3 p -70.3 9.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 20.7 t70 -138.75 124.53 19.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.44 155.54 47.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.19 0.995 . . . . 0.0 112.958 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 m -107.76 143.13 36.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.154 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -115.73 111.94 21.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.76 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG21 ' HB1' ' A' ' 7' ' ' ALA . 27.6 t -95.23 99.54 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.42 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.03 122.69 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.431 0.634 . . . . 0.0 111.197 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.623 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 66.0 t60 -135.42 57.09 1.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -121.63 -163.91 1.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 112.996 -1.911 . . . . 0.0 112.379 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.05 -44.52 88.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.528 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -70.82 -60.84 2.02 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.679 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -113.11 108.63 17.57 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.856 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 15.7 m -96.48 97.62 9.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.446 0.641 . . . . 0.0 109.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.623 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 16.6 t30 74.44 71.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.584 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 m -143.51 121.47 12.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.698 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.43 115.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.141 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.15 157.52 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.93 140.09 40.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.07 -23.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.807 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.34 -125.92 7.13 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.881 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.714 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.5 Cg_endo -67.61 113.91 3.12 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.596 2.197 . . . . 0.0 114.187 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 157.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -145.45 158.75 43.78 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.104 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.21 140.14 48.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.897 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.99 -28.35 12.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.647 0.261 . . . . 0.0 111.671 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.99 -121.46 7.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.282 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.05 113.94 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.627 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.2 pt -132.46 176.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 38.4 m-80 -94.66 102.97 14.9 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.399 0.619 . . . . 0.0 110.804 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 57.0 tp -83.75 104.93 14.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.2 m 63.34 31.03 15.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.288 0.566 . . . . 0.0 109.657 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.4 m 81.41 0.58 1.62 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.545 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.9 m -108.51 117.48 54.3 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.5 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.26 119.93 6.55 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.336 2.024 . . . . 0.0 112.88 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -132.27 134.12 44.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.881 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.6 t30 -104.53 161.19 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.993 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.621 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 1.9 mpt_? 69.12 43.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.3 mmt -90.95 116.35 28.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 70.6 mt -85.44 130.65 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -110.75 136.04 50.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -148.48 113.55 5.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 6.7 p-10 -74.59 97.99 3.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.566 1.174 . . . . 0.0 110.526 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -149.02 139.26 22.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 111.873 -2.421 . . . . 0.0 107.69 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.85 90.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -106.17 158.56 16.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -139.24 159.64 41.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.198 0.999 . . . . 0.0 111.747 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.48 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 2.8 m -44.3 158.92 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.852 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.81 -17.75 57.23 Favored Glycine 0 N--CA 1.462 0.401 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.912 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -94.22 8.57 41.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.708 -0.246 . . . . 0.0 111.575 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.78 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 16.8 m -63.2 122.0 15.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.208 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 118.61 -20.87 10.02 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.71 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.91 130.24 23.04 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.12 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 26' ' ' THR . 58.3 t -84.94 115.55 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.2 tp -88.76 108.51 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.7 p -147.6 176.95 9.67 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.992 0.901 . . . . 0.0 112.785 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.97 173.09 14.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.529 -1.668 . . . . 0.0 107.765 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.8 m -64.49 108.75 1.74 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.191 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.27 -7.19 59.96 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.922 -0.656 . . . . 0.0 114.291 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 18.3 ptpt -155.89 137.32 14.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.02 126.79 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -88.06 -34.34 17.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.208 0.527 . . . . 0.0 111.49 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 160.37 -159.08 30.51 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.288 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 161' ' ' VAL . 46.0 pt -129.97 149.75 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.669 0.747 . . . . 0.0 111.671 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -61.77 120.27 10.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.862 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 159' ' ' ILE . 94.8 t -114.55 -26.83 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.377 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.09 -149.24 7.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.169 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.32 148.43 7.5 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.491 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 9.0 t-20 -118.27 105.69 12.02 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.08 -102.95 0.98 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -121.75 19.03 11.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.302 0.572 . . . . 0.0 110.601 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 0.5 OUTLIER -111.94 109.03 18.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -71.07 146.95 42.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.1 m-85 -127.53 119.45 26.06 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.2 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.4 m -110.6 156.0 21.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.627 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.504 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.05 131.85 37.01 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -71.31 105.17 3.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.645 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.419 HD21 ' HG ' ' A' ' 72' ' ' LEU . 73.0 mt -87.98 91.26 8.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.522 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -79.68 127.0 31.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.599 0.714 . . . . 0.0 109.54 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -42.25 -34.83 0.84 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.853 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.52 -38.92 64.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -67.42 -13.44 62.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.409 ' CE1' HG13 ' A' ' 30' ' ' ILE . 83.9 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.164 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 41.0 tt0 -106.08 81.59 1.65 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -85.32 127.86 34.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.183 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 28.5 tp -89.78 151.12 21.97 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -58.27 139.77 54.51 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.78 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.6 mt-30 . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 120.183 -0.607 . . . . 0.0 . 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 CA--C 1.53 0.275 0 N-CA-C 112.655 0.214 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -62.57 -40.05 95.62 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.866 0.841 . . . . 0.0 109.177 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -43.83 87.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.41 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -64.43 -42.65 95.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.196 0.522 . . . . 0.0 109.708 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.14 -47.19 86.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 109.758 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.82 92.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.13 -48.59 80.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -70.69 -38.83 73.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.256 0.55 . . . . 0.0 110.113 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.41 -42.88 96.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.425 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 8.4 tt -60.33 -51.46 69.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.611 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -67.55 -28.76 68.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 4.7 mmpt? -99.86 -26.27 14.07 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.156 0.889 . . . . 0.0 113.088 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -123.58 -12.43 7.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.5 mt -107.07 120.88 59.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.726 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 22.4 mmt -127.45 145.69 50.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.065 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -76.52 105.69 7.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 43.2 mm -95.3 111.82 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.338 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 13.5 m -91.44 114.43 26.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.896 0.855 . . . . 0.0 110.468 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 41' ' ' ALA . 9.0 p -118.05 -162.95 0.91 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.186 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 13.0 m -69.76 -38.08 76.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HE3' ' HZ ' ' A' ' 25' ' ' PHE . 26.0 ttpp -83.0 -19.79 36.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.328 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.38 -156.93 27.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.412 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -109.39 117.82 35.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.922 0.867 . . . . 0.0 109.952 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HZ ' ' HE3' ' A' ' 22' ' ' LYS . 41.3 m-85 -109.91 171.75 7.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.629 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.681 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 73.1 m -86.89 108.94 19.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -94.01 126.88 8.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -101.31 104.63 15.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.087 0.47 . . . . 0.0 111.236 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 111.07 3.23 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.9 mm -75.4 -58.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 122.561 -0.376 . . . . 0.0 112.007 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -166.41 164.11 17.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.557 0.694 . . . . 0.0 112.79 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.99 -101.37 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.389 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.6 ptt180 -129.19 20.85 5.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.421 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.87 124.69 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.232 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 75' ' ' LEU . 6.3 p -124.27 141.12 52.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.202 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.87 121.52 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.371 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.09 133.56 24.39 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.646 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.83 139.04 78.12 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 N-CA-C 109.013 -1.187 . . . . 0.0 109.013 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.573 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.9 m -63.84 -35.38 80.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.753 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -69.3 -3.52 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -71.8 -28.66 63.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 72.2 mm-40 62.51 71.38 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.771 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -75.32 142.7 27.22 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.075 2.517 . . . . 0.0 111.496 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.03 -157.02 30.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.001 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.52 -21.94 28.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.595 0.712 . . . . 0.0 110.354 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.36 117.59 19.98 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.58 145.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 69.8 mt -85.23 103.47 14.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.659 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.27 90.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 12.4 t30 59.03 58.36 3.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.241 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.59 -32.64 1.87 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.659 -1.155 . . . . 0.0 114.391 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.413 ' OE1' HG12 ' A' ' 54' ' ' ILE . 25.0 tm0? -83.52 142.42 30.91 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.759 -0.26 . . . . 0.0 110.542 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.08 127.4 38.61 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.458 ' CG2' ' HB2' ' A' ' 77' ' ' LEU . 21.3 mm -137.39 133.45 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.358 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -91.5 142.46 27.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 110.838 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.44 136.18 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.333 -176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -88.64 -42.74 11.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -171.96 132.23 0.68 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.337 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.42 119.39 36.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.45 126.48 50.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.466 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 49.9 mtpt -79.57 128.29 33.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 26.6 mt -95.58 127.25 41.46 Favored 'General case' 0 C--O 1.254 1.327 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 69' ' ' ASN . 32.6 m -123.47 156.16 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 66' ' ' GLU . 24.4 t70 -72.73 142.19 83.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.407 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.0 -10.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.54 1.493 . . . . 0.0 112.096 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 tp10 -76.92 -3.2 37.49 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 108.704 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.9 m120 75.44 16.71 2.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.002 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.29 147.71 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HA ' HG12 ' A' ' 63' ' ' VAL . 64.0 t30 -59.9 135.93 57.85 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -99.79 -22.81 15.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 28.3 tp10 76.28 14.96 2.35 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.119 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 78.6 mt -98.81 114.11 26.52 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.438 0.461 . . . . 0.0 112.013 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.5 m -93.5 111.48 23.15 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 62' ' ' LEU . 61.5 t -78.04 100.05 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.4 tp -83.28 94.32 7.89 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.959 0.885 . . . . 0.0 110.958 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.8 m -85.37 105.96 16.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -108.37 152.9 24.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.31 -177.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -84.56 94.62 8.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.839 0.828 . . . . 0.0 109.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -144.35 128.07 17.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.384 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.03 -21.89 29.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.92 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -79.93 87.06 5.38 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -72.86 157.05 38.2 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.583 -175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -93.9 147.33 23.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.38 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -55.92 135.88 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 85' ' ' ASP . 3.3 p-10 -81.95 89.56 6.39 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.454 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 28' ' ' LEU . 32.8 pt -86.74 15.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.504 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -61.8 -23.66 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.91 -19.23 80.03 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.574 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 97.8 m-85 -86.34 -22.38 26.72 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 59.4 mt -71.98 136.8 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -125.12 142.47 51.47 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.1 pm0 -80.91 -15.34 56.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.42 153.56 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -100.07 -68.09 0.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.493 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 41.7 73.87 0.12 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.83 88.85 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.2 -13.61 16.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.968 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -106.85 125.68 51.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.92 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.63 149.66 39.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.878 0.847 . . . . 0.0 112.179 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -112.62 142.01 45.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 148' ' ' GLY . 1.2 tm? -115.63 109.67 18.09 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.59 114.65 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.295 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.8 133.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.749 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -140.0 31.94 1.98 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -109.77 -160.67 0.73 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.385 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -52.09 -61.74 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.99 -34.85 71.78 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -137.84 122.47 18.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.725 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 8.4 m -119.34 128.77 54.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.95 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' THR . 88.5 m-20 65.95 28.51 10.57 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.501 0.667 . . . . 0.0 110.095 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 m -99.87 103.36 14.95 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.906 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -90.55 100.08 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.37 117.98 30.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.35 120.78 18.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.52 -36.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.885 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.67 -128.56 8.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.859 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.67 113.43 3.49 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.023 1.815 . . . . 0.0 112.542 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.1 p -107.82 147.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.468 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 t -155.88 167.03 31.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.4 ttm -93.05 141.83 27.97 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.804 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.24 -33.75 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.517 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.52 -101.99 2.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.324 -0.853 . . . . 0.0 114.307 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp -125.24 122.24 36.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.729 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 48.3 pt -143.02 -176.53 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 10.0 m120 -106.55 85.76 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 23.4 tp -70.54 111.15 5.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.616 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.41 ' N ' ' O ' ' B' ' 4' ' ' ALA . 53.6 p 64.07 25.25 13.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.421 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 m 85.65 -3.68 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.222 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 37.1 m -99.89 125.97 38.43 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.797 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 129' ' ' THR . 32.4 Cg_exo -61.62 120.23 7.76 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.334 2.022 . . . . 0.0 113.879 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 p -123.97 137.74 54.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.862 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -110.39 160.5 16.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 16.0 mmm180 64.76 29.31 12.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.097 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.454 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -73.05 121.73 20.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.017 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.76 144.19 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.048 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 13.8 ptt180 -129.38 143.15 50.73 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.904 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -129.36 131.43 46.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.82 103.49 1.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.198 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -178.42 133.75 0.14 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.496 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -69.18 110.35 4.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.372 0.606 . . . . 0.0 110.1 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.423 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 21.2 p -111.25 148.6 32.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.029 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -133.24 151.46 51.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.067 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.3 161.46 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.129 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.53 -13.42 67.4 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.532 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -102.08 8.22 40.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.863 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.774 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 7.6 m -64.75 141.63 58.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.127 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.681 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.61 -6.7 74.39 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.058 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . -52.44 131.28 38.75 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.18 110.78 17.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.71 105.06 15.22 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.2 p -144.45 178.07 8.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.397 1.094 . . . . 0.0 113.639 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.43 176.1 9.62 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.605 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 m -71.21 100.52 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.573 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.24 12.16 60.31 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.831 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 40.3 ttmt -155.33 134.58 12.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.306 0.574 . . . . 0.0 111.124 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.11 131.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.766 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.79 -43.01 7.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 169.17 -152.65 20.46 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.938 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.9 pt -135.22 150.18 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 122.077 0.942 . . . . 0.0 113.147 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.33 118.7 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.907 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 126' ' ' LEU . 43.8 t -113.47 -21.73 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.049 0.452 . . . . 0.0 110.857 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.28 -147.75 8.13 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.927 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 169' ' ' PHE . . . 171.51 161.12 21.57 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 55.2 t30 -128.23 82.17 2.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.495 0.664 . . . . 0.0 109.248 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.28 -107.22 2.1 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.869 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 95.6 mtt180 -90.59 7.55 38.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -124.75 110.77 14.75 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -77.8 142.55 26.78 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 136' ' ' ARG . 49.2 m-85 -118.83 127.16 53.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.852 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -125.3 163.48 22.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.157 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.455 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -99.35 141.11 32.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.275 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 8.3 tt0 -77.39 106.91 9.44 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.986 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.517 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.1 mp -94.52 85.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.225 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.91 135.13 37.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 7.4 ttpm? -54.38 -35.95 63.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.719 0.771 . . . . 0.0 109.813 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -53.06 -34.56 57.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.633 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -71.92 -25.9 62.09 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.257 -0.277 . . . . 0.0 111.08 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.517 0.675 . . . . 0.0 110.357 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 6.6 mp . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 120.991 0.424 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -96.48 74.77 2.84 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.51 146.75 38.24 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.9 tp -106.05 148.69 27.48 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 19.1 m-85 -57.74 135.64 56.8 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.774 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 81.7 mt-30 . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 . 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo . . . . . 0 N--CA 1.464 -0.219 0 N-CA-C 113.488 0.534 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.04 -35.64 66.79 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -65.19 -44.97 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.154 0.978 . . . . 0.0 108.584 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.86 -47.03 83.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.634 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.75 -46.3 79.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.276 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.03 93.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.21 -44.8 94.29 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 122.165 -0.334 . . . . 0.0 110.796 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -65.38 -40.12 93.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 109.893 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.5 tp -64.54 -44.81 89.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.169 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 5.4 tt -55.14 -46.64 75.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.251 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.13 -45.46 66.8 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.56 -2.21 20.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 115.635 1.716 . . . . 0.0 115.635 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -135.55 -12.24 2.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.265 -0.974 . . . . 0.0 113.294 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 49.2 mm -106.83 101.82 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.81 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -120.22 135.89 54.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.542 0.687 . . . . 0.0 110.261 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.13 102.25 2.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.09 100.0 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.325 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 48' ' ' LEU . 8.9 t -94.94 130.2 41.67 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.105 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.5 t -146.4 -157.55 0.82 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 m -51.54 -50.74 59.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.71 -16.25 39.63 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.73 -157.69 28.41 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 119.608 -1.282 . . . . 0.0 114.727 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -112.48 114.36 27.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.394 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.37 159.78 25.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.58 0.705 . . . . 0.0 111.674 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.2 m -72.64 106.01 4.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.613 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.62 106.68 3.34 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -87.53 106.55 18.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.336 0.589 . . . . 0.0 111.957 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 117.72 8.01 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 47.9 mm -89.08 -64.21 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 117.099 0.45 . . . . 0.0 112.077 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 58.36 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.237 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.9 ptp180 -129.78 15.22 5.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 110.678 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.93 122.66 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.788 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -122.37 156.03 34.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.804 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -114.82 135.16 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.478 0.656 . . . . 0.0 109.847 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.539 ' O ' ' HB ' ' A' ' 73' ' ' THR . 12.3 tt -144.94 142.06 18.13 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.614 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.47 149.66 23.02 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 120.888 1.059 . . . . 0.0 110.579 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 33.0 m -73.27 -36.74 66.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -66.94 -1.26 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -22.14 59.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.541 0.686 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.31 71.96 1.09 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.56 127.06 18.05 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.932 2.421 . . . . 0.0 112.374 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.58 -169.15 29.32 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.451 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 56' ' ' VAL . 2.6 p-10 -78.15 -16.31 58.05 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -143.18 137.61 29.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.69 156.12 37.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 19' ' ' THR . 7.5 mp -97.41 103.08 14.98 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.301 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.7 p -84.66 102.42 10.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.542 0.686 . . . . 0.0 110.154 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.6 t30 66.66 19.17 10.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.644 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.12 -22.11 11.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.583 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -92.1 115.66 28.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.318 0.559 . . . . 0.0 111.89 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.58 128.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -139.27 137.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.878 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -65.18 139.61 58.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.474 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 45' ' ' ASP . 14.4 p -87.06 136.75 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 76' ' ' THR . 57.1 tptt -78.36 -47.04 18.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.82 0.819 . . . . 0.0 108.833 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.06 133.46 1.46 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -106.99 92.76 4.22 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -86.22 106.21 17.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.754 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.77 121.08 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.906 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mt -89.88 113.34 24.93 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.704 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -94.02 165.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 133' ' ' ARG . 15.7 t70 -71.58 137.42 83.29 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.632 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HG2' ' NH2' ' A' ' 133' ' ' ARG . 7.0 Cg_endo -52.36 -15.68 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.857 1.705 . . . . 0.0 112.771 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.48 16.48 8.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.894 0.854 . . . . 0.0 109.059 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.0 t30 72.21 10.43 5.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.92 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 69' ' ' ASN . 15.9 mt -92.66 176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.539 ' H ' HG22 ' A' ' 68' ' ' ILE . 51.4 t30 -81.75 143.4 31.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 118.514 0.597 . . . . 0.0 111.22 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 26.5 tp -118.54 -27.49 5.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.58 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 26.5 tp10 70.55 10.62 7.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.666 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 10.9 tp -96.11 103.11 14.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.866 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 78.0 m -90.92 115.42 27.94 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.565 0.698 . . . . 0.0 111.616 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.73 94.17 3.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.3 tp -81.47 104.51 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.797 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 8.7 m -98.59 115.09 27.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.572 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 77' ' ' LEU . 2.0 mp -117.47 150.01 39.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.718 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.73 91.49 7.97 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.481 ' HE ' ' HA ' ' A' ' 79' ' ' ARG . 2.2 tpm_? -112.51 110.33 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.58 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.31 -54.0 51.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.783 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -74.73 92.59 2.48 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -70.74 147.3 49.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.221 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -88.06 146.96 25.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.991 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -58.41 120.62 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.103 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 7.4 p-10 -77.37 94.24 4.18 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 121.709 0.766 . . . . 0.0 112.408 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.2 17.13 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.95 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 88' ' ' GLY . 5.0 ppt_? -59.03 -23.95 62.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.16 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 87' ' ' ARG . . . -84.08 -13.63 73.99 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.642 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.53 -3.36 46.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 40.1 mt -82.55 127.31 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.449 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 6.5 m -83.69 110.89 18.66 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.19 -49.95 31.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' SER . 23.8 t70 -97.78 115.66 28.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 173.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.1 mt -60.75 -72.23 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.88 67.41 0.93 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.618 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -146.49 75.38 0.28 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.344 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 p -97.38 0.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 10.9 t70 -149.88 125.72 10.48 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.115 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -153.6 176.7 11.77 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.473 1.13 . . . . 0.0 114.041 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -115.4 138.78 50.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.783 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -115.55 110.66 19.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.09 124.78 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.096 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 108' ' ' PHE . 1.7 t -114.6 139.82 38.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 122.035 0.921 . . . . 0.0 113.063 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -149.35 71.79 1.13 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.045 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.4 p -125.55 -174.01 2.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.637 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -59.85 -44.68 93.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.866 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.85 -41.05 15.33 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 103' ' ' VAL . 93.3 m-85 -115.96 98.15 6.49 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.4 m -105.59 122.78 46.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.581 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 66.73 73.36 0.36 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.8 m -142.25 102.85 4.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.731 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.93 108.92 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.11 120.98 32.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -72.54 118.1 15.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 137' ' ' TYR . 13.8 p -92.14 -26.29 4.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.707 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.57 -125.84 7.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.593 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.6 Cg_exo -62.87 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.345 2.03 . . . . 0.0 113.453 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 96' ' ' GLY . 2.8 p -136.61 141.89 39.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.589 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 m -153.08 139.37 18.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 27.3 ptt? -74.01 140.2 45.28 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.822 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.07 -66.24 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.48 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.32 -122.35 1.78 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.885 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt -103.06 117.79 35.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.448 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 36.0 pt -138.52 -176.38 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.6 m120 -105.18 83.95 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.982 0.42 . . . . 0.0 111.198 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 59.3 tp -65.93 108.03 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.212 0.529 . . . . 0.0 110.048 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 128' ' ' SER . 3.5 m 61.24 33.48 19.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 127' ' ' SER . 22.7 t 76.97 8.97 2.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.472 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -112.12 113.45 51.83 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.819 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.67 113.37 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.847 1.698 . . . . 0.0 111.649 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 126' ' ' LEU . 29.5 m -124.69 139.65 53.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.103 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -113.4 159.66 19.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' A' ' 64' ' ' ASP . 8.2 mtm180 56.37 61.45 2.7 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.319 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.0 mtp -109.6 132.67 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.156 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 50.2 mt -86.1 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ttp180 -132.27 147.01 52.39 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.16 0.505 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 115' ' ' VAL . 23.2 p90 -143.16 134.97 26.71 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.35 94.52 7.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.248 1.023 . . . . 0.0 110.555 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -155.86 133.63 11.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.942 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.11 105.56 0.42 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.394 0.616 . . . . 0.0 111.22 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 p -119.17 141.97 48.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -129.29 164.39 23.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.095 0.95 . . . . 0.0 112.03 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 1.0 OUTLIER -43.1 150.25 0.18 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.405 174.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.51 9.36 Favored Glycine 0 N--CA 1.463 0.44 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -68.55 -7.81 35.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.814 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.803 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 22.5 m -58.75 137.86 57.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 99.39 -17.87 57.19 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.734 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.26 126.86 37.78 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.242 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.15 117.49 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.07 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.25 110.45 17.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.0 p -147.03 -177.25 5.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.056 0.931 . . . . 0.0 112.704 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.76 30.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 t -62.93 108.28 1.17 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.831 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.1 75.51 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.923 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -141.55 121.01 13.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 35.2 mm -102.87 130.1 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.56 -52.92 2.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -176.89 -174.09 43.03 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.792 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 pt -118.97 139.07 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.414 0.626 . . . . 0.0 110.586 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -69.52 122.27 18.69 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.28 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.76 -9.58 11.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.8 -161.78 29.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.167 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.36 158.46 26.9 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.061 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 3.7 t-20 -129.75 89.62 2.85 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.909 0.385 . . . . 0.0 110.336 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 -107.88 2.33 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.408 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -96.04 1.67 52.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.238 0.542 . . . . 0.0 110.173 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -107.95 109.3 20.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.314 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -80.26 137.67 18.72 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.02 125.48 46.39 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.571 -0.852 . . . . 0.0 113.069 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.4 m -120.92 151.82 39.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.106 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.44 130.91 39.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.536 ' HB3' HD11 ' A' ' 135' ' ' ILE . 20.0 pt20 -87.79 110.99 20.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 118.468 -1.293 . . . . 0.0 112.722 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -88.76 94.78 10.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.88 139.79 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.952 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -45.6 -35.41 4.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.05 -26.45 37.66 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.42 -15.74 54.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 173' ' ' LEU . 25.3 m-85 . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.1 mm? . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.5 tt0 -114.59 71.85 0.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.88 133.71 39.2 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.397 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 15.9 tp -95.73 152.17 18.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.56 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 27.8 m-85 -56.98 137.7 55.24 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.803 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.5 mt-30 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 . 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--O 1.231 0.157 0 N-CA-C 114.085 0.763 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.613 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.7 t-20 -68.53 -45.14 73.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.709 0.766 . . . . 0.0 110.528 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.4 m -57.54 -43.59 84.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.143 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.02 -24.29 52.13 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.8 -43.54 58.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.35 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.175 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 8' ' ' LEU . 2.8 tm? -59.53 -39.44 83.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.279 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -69.53 -47.34 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.794 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.42 -38.5 84.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.7 tp -55.57 -49.14 73.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -68.49 -28.12 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.266 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -86.78 -63.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.11 -3.6 12.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -173.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 54.6 mt -99.99 131.45 47.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.872 -1.131 . . . . 0.0 113.008 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -151.62 146.42 25.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.923 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 m -68.88 117.86 11.09 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.488 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mt -98.64 98.69 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.901 0.858 . . . . 0.0 110.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 58.5 m -70.9 99.22 1.72 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.018 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -175.53 3.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.45 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 m -70.54 -28.8 65.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.613 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -88.17 -45.81 9.79 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.083 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.27 -168.07 26.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.492 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 34.3 mt-10 -108.22 103.03 12.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.798 0.808 . . . . 0.0 109.228 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 41' ' ' ALA . 40.6 m-85 -97.75 165.39 11.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.853 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 97.7 m -83.24 108.17 16.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.97 136.49 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.93 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -124.61 135.72 53.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.582 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -77.64 142.69 27.12 Favored Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.83 -54.2 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.978 0.889 . . . . 0.0 110.066 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -167.83 138.77 2.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 82' ' ' LYS . 31.2 m-20 57.18 -88.74 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.508 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -125.49 5.78 7.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.405 0.622 . . . . 0.0 111.175 -178.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 74' ' ' VAL . 49.0 t -88.18 120.67 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.034 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 36.8 t -131.48 141.25 49.74 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.009 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.59 151.13 34.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.56 167.8 12.6 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 113.043 -1.889 . . . . 0.0 106.303 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.78 175.47 2.3 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 121.289 1.326 . . . . 0.0 112.147 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.51 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 99.5 m -80.56 -36.81 32.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.544 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -72.3 4.99 3.14 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -69.21 -28.49 66.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.791 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 60.58 72.83 0.68 Allowed Pre-proline 0 CA--C 1.514 -0.43 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.27 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.28 123.52 6.66 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.013 2.475 . . . . 0.0 112.843 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.36 -172.01 46.04 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.19 -17.12 38.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.888 0.844 . . . . 0.0 109.71 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 18.9 t70 -134.85 109.77 8.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.55 154.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 95.3 mt -99.42 99.6 10.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.494 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 19.6 m -83.06 93.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.415 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 t30 66.19 17.96 10.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.708 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.12 -21.81 8.15 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.523 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.87 118.02 23.14 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.741 -0.27 . . . . 0.0 110.278 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.707 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -81.98 119.34 23.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.706 0.765 . . . . 0.0 110.508 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.49 130.7 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.026 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.2 mtp-105 -85.83 126.48 34.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.264 0.554 . . . . 0.0 110.069 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.01 143.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.281 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -77.99 -52.79 8.25 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.763 0.792 . . . . 0.0 109.237 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -141.73 126.71 18.3 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.406 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -109.29 104.44 13.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -104.29 120.11 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.875 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.88 125.1 28.12 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 29.8 mt -90.7 111.85 23.37 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 122.0 0.905 . . . . 0.0 111.545 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.1 m -113.85 159.11 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 67' ' ' ASN . 14.7 t70 -67.72 138.42 93.23 Favored Pre-proline 0 C--N 1.311 -1.101 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.47 -21.99 32.64 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.532 1.488 . . . . 0.0 112.815 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.71 -0.04 55.55 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' ASP . 63.9 m-80 71.76 72.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.134 -1.848 . . . . 0.0 115.454 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 69' ' ' ASN . 34.6 mm -137.41 151.96 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.516 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 131' ' ' THR . 22.8 t30 -62.87 111.83 2.3 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.883 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.623 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 15.0 tp -87.36 -27.11 23.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HG2' HG11 ' A' ' 161' ' ' VAL . 13.7 tp10 71.62 31.14 2.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.898 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 94.1 mt -123.42 151.55 42.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 25.3 m -132.64 127.07 34.11 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.373 0.606 . . . . 0.0 110.516 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.416 HG23 ' HG ' ' A' ' 62' ' ' LEU . 85.7 t -87.63 107.38 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.974 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.31 92.24 8.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -74.36 90.51 2.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.043 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.25 91.48 5.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 33' ' ' ARG . 18.7 p-10 -78.82 61.57 3.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.376 0.608 . . . . 0.0 109.866 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -82.55 160.32 22.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.34 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -61.31 -51.66 67.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -78.64 110.72 14.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 61.2 mttp -77.08 152.2 35.13 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.782 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -80.33 141.4 35.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.109 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.12 138.14 58.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.682 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 87' ' ' ARG . 11.4 p-10 -73.96 88.12 1.85 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.128 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.8 pt -88.0 12.11 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 85' ' ' ASP . 45.2 ttt180 -53.7 -38.4 64.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.838 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.74 76.75 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.709 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -87.49 -12.7 45.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.62 129.98 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.608 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 13.5 m -120.5 122.39 40.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.649 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.5 mp0 -64.66 -48.41 74.87 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 91' ' ' SER . 30.0 t70 -95.48 120.06 35.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -76.5 -54.83 6.17 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 41.05 66.15 0.7 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.306 0.574 . . . . 0.0 109.928 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.14 80.93 0.1 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.863 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -70.53 -7.59 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.82 121.49 45.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.81 40.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.599 0.714 . . . . 0.0 112.176 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 96.0 m -116.03 135.22 54.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.256 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -92.06 116.85 29.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.392 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.06 103.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 22.1 t -100.38 124.11 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.446 0.641 . . . . 0.0 110.98 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -137.37 50.3 1.98 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.8 m -107.93 -172.54 2.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.333 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 13.4 p30 -62.05 -35.37 78.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -55.61 -50.5 69.97 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.824 -0.547 . . . . 0.0 112.215 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -158.79 132.97 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.317 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 23.2 m -84.39 114.55 21.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.603 0.716 . . . . 0.0 110.969 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 109' ' ' THR . 5.6 m-20 77.24 72.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 2.0 m -116.73 109.29 16.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.5 pt -107.99 99.56 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.051 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.8 mt -97.29 117.64 31.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.892 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.03 98.93 9.54 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.92 -16.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.098 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.34 -128.99 9.04 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.535 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 22.9 Cg_endo -65.11 119.11 6.07 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.193 1.929 . . . . 0.0 114.816 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 137' ' ' TYR . 34.3 m -111.87 148.63 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.512 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 m -150.39 144.4 25.43 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.0 ptp -82.01 142.96 31.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.193 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.53 -42.46 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.093 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.27 -128.92 8.45 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.067 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 48.1 tp -99.26 110.52 23.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.84 0.352 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.62 175.33 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.996 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.8 m-20 -87.54 126.13 34.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 46.5 tp -111.58 107.51 16.69 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.429 ' HB3' HD12 ' B' ' 5' ' ' LEU . 95.6 p 57.86 32.07 21.42 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.006 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.0 m 76.73 29.75 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.929 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -140.36 120.85 9.03 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.14 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.38 117.94 4.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.502 2.135 . . . . 0.0 114.123 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 69' ' ' ASN . 82.9 m -127.31 131.68 50.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.549 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 29.8 p-10 -102.67 169.38 8.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.61 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER 57.7 42.13 24.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.846 175.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.8 mmt -86.32 136.75 33.02 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.38 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 48.8 mm -101.07 137.63 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -127.84 148.32 50.46 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.502 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB3' HG12 ' A' ' 118' ' ' VAL . 25.0 p90 -143.03 151.74 41.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.263 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.89 113.51 22.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.832 0.825 . . . . 0.0 111.43 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -176.12 133.19 0.25 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.327 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -68.32 100.82 1.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.818 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.1 p -93.39 171.4 8.94 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.749 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -161.44 145.63 13.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.56 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.597 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.24 158.72 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.706 175.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.77 -24.33 15.64 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.003 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -85.76 4.49 36.6 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.769 0.428 . . . . 0.0 112.009 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.814 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 13.4 m -62.18 140.96 58.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 107.02 -20.69 32.99 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.77 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.76 130.45 26.92 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.532 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.36 124.18 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 110.73 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.7 tp -101.56 106.7 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.4 p -149.74 176.4 10.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.972 0.891 . . . . 0.0 112.922 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -137.28 172.73 12.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.591 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.3 t -61.31 108.76 0.97 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.066 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.56 -4.2 86.37 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -141.47 116.78 10.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.729 0.764 . . . . 0.0 111.836 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -93.99 126.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.73 -44.13 6.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.79 -165.01 34.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.7 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -129.63 144.5 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.437 0.637 . . . . 0.0 110.797 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -66.82 115.37 6.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.438 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.472 HG11 ' HG2' ' A' ' 71' ' ' GLU . 54.0 t -107.16 -27.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.169 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.19 -147.86 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.082 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.32 164.69 29.69 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.221 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 8.8 t30 -128.23 88.37 2.74 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.67 -109.62 2.78 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.636 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.664 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 18.1 ttt180 -88.54 3.84 48.91 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 113.37 19.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.295 0.569 . . . . 0.0 109.977 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -78.41 143.21 26.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 44.6 m-85 -121.86 124.42 44.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.352 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -123.11 142.38 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.008 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.37 125.45 31.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.689 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.553 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 50.2 tt0 -72.03 119.86 16.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.123 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.519 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.6 mp -88.19 92.83 9.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.83 132.56 33.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.649 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 ttpm? -58.48 -17.32 20.12 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.24 -29.99 67.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -81.11 -28.15 35.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.66 0.267 . . . . 0.0 111.569 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.468 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.561 0.696 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 34.5 tt0 -126.24 77.47 1.69 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.83 152.51 26.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.6 tp -107.69 154.87 20.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -63.69 141.28 58.83 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.814 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.6 mt-30 . . . . . 0 C--N 1.295 -1.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 . 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 N--CA 1.464 -0.264 0 N-CA-C 113.134 0.398 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.36 -42.65 78.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.293 -0.163 . . . . 0.0 110.897 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -72.2 -27.59 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.44 -45.5 75.86 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.87 -45.71 89.5 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.315 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.38 83.57 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.8 tp -68.1 -38.92 82.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -67.66 -38.08 83.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.002 0.429 . . . . 0.0 110.028 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.415 HD11 HD13 ' A' ' 86' ' ' ILE . 60.8 tp -65.46 -40.45 93.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.528 0.68 . . . . 0.0 109.567 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 11' ' ' LEU . 3.1 tm? -50.59 -48.69 57.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.218 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -70.01 -29.61 66.72 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.39 -58.85 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.2 7.24 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 48.2 mm -105.15 106.7 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.969 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.3 mtp -121.6 147.73 45.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -76.29 111.23 11.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.088 -178.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.7 mm -92.84 106.15 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.601 0.715 . . . . 0.0 110.463 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 6.7 m -75.96 98.35 4.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.628 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -103.47 -178.08 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.521 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 16.4 m -59.47 -32.24 70.06 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -88.97 -1.63 58.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.03 0.832 . . . . 0.0 111.253 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.24 -163.7 23.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.844 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 105' ' ' SER . 25.3 mt-10 -96.85 128.37 43.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.407 0.622 . . . . 0.0 110.902 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -123.22 166.94 14.4 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.804 0.812 . . . . 0.0 111.325 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 2.7 m -68.64 100.43 1.13 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.875 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -81.2 109.54 3.01 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.637 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.46 94.47 9.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.902 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.44 122.41 8.62 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.5 -50.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 117.678 0.739 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -161.25 153.64 20.24 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.963 0.887 . . . . 0.0 113.117 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.628 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 42.8 m-20 51.65 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.615 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.1 ptt180 -140.15 16.36 2.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.702 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.9 115.42 39.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.154 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -120.18 148.7 43.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.21 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.69 130.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.498 0.666 . . . . 0.0 112.141 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.39 165.42 28.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.85 163.62 36.68 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 121.647 1.565 . . . . 0.0 112.61 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.737 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 44.8 m -81.11 -38.95 26.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.161 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -71.31 2.27 5.02 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -12.9 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.663 0.744 . . . . 0.0 109.156 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 68.8 mt-30 62.44 73.23 0.55 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.341 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.88 159.54 47.97 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 122.537 2.158 . . . . 0.0 111.873 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.14 178.96 17.0 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.047 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.532 ' HA ' HG12 ' A' ' 56' ' ' VAL . 24.0 m-20 -81.89 -19.7 40.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.889 0.844 . . . . 0.0 109.467 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -137.37 113.17 9.62 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.86 173.07 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.829 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 6.2 mp -112.3 138.16 49.4 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.765 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.33 83.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.492 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 2.4 t-20 62.23 27.0 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.12 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.39 -44.79 1.16 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.159 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.16 115.77 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -76.4 122.02 23.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -125.43 149.01 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.227 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.616 ' HD2' ' N ' ' A' ' 55' ' ' ARG . 7.8 mpt_? -96.61 145.51 25.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.221 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 45' ' ' ASP . 8.5 p -86.99 138.88 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.998 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.18 -42.23 17.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -158.81 132.12 7.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -117.44 116.38 27.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.55 120.54 39.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.256 0.55 . . . . 0.0 111.095 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.12 121.71 27.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.791 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 76.9 mt -85.91 123.51 31.34 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.331 0.586 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 20.5 m -122.01 171.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.185 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 16.8 t70 -78.73 143.08 62.09 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -48.54 -26.13 8.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.829 2.353 . . . . 0.0 113.618 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.34 22.74 4.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 111.09 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.11 11.6 5.09 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.107 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 25.4 mm -88.16 163.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.427 ' N ' HG22 ' A' ' 68' ' ' ILE . 54.9 t30 -73.33 139.27 45.92 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.79 -36.68 6.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.737 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.8 tp10 84.07 22.0 0.14 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.34 -1.754 . . . . 0.0 114.498 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.562 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.8 mm? -111.4 146.04 37.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.21 0.529 . . . . 0.0 110.834 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 26.3 m -117.33 114.48 23.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.564 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.413 HG23 ' HG ' ' A' ' 62' ' ' LEU . 88.8 t -80.93 100.08 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.32 100.67 12.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.71 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.4 m -92.38 93.88 8.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.066 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 96.0 mt -85.62 159.16 19.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.371 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -78.76 92.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -128.61 123.21 32.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.084 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -80.8 -57.3 3.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.61 114.79 5.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 13.1 ptpt -76.1 145.78 39.8 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.68 145.98 42.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 4.9 tpm_? -56.93 122.81 13.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.031 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 90.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.106 0.479 . . . . 0.0 111.072 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.415 HD13 HD11 ' A' ' 10' ' ' LEU . 41.0 pt -96.27 32.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.033 0.444 . . . . 0.0 110.111 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.3 -30.72 71.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.237 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.59 -19.22 79.95 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.939 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -80.14 -16.39 55.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.613 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 52.7 m -94.69 122.41 37.27 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.063 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.594 ' O ' ' HE2' ' A' ' 174' ' ' LYS . 5.0 pt-20 -61.5 -29.65 70.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.031 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HA ' ' CE ' ' A' ' 174' ' ' LYS . 37.8 t70 -131.05 163.35 27.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 95' ' ' GLU . 43.6 mt -74.47 -81.1 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 94' ' ' LEU . 12.8 pt-20 33.32 74.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.253 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.474 ' HA3' ' CZ ' ' A' ' 157' ' ' PHE . . . -157.7 92.25 0.12 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.462 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 61.5 t -62.15 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.2 t70 -124.36 132.45 53.54 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.58 174.6 10.81 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.738 0.78 . . . . 0.0 112.752 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.9 m -131.06 146.26 52.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.593 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.5 tp -105.98 113.91 27.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.34 110.92 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 109.994 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -112.08 117.33 54.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.275 0.56 . . . . 0.0 111.365 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -130.9 83.09 2.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 71.1 p -129.57 -164.56 1.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.891 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.76 -13.95 57.1 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -90.52 -66.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.347 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 56.2 m-85 -108.48 120.97 43.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.704 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.4 p -100.0 110.66 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.891 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.56 32.38 16.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 39.9 m -81.91 102.11 10.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.697 0.761 . . . . 0.0 110.905 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 112' ' ' ILE . 9.5 tt -100.13 92.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -101.22 113.15 25.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.139 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.69 112.0 6.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.832 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.15 -33.94 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.05 -123.68 7.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.323 -0.942 . . . . 0.0 114.165 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 35.1 Cg_endo -64.58 124.52 13.38 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.533 2.156 . . . . 0.0 113.85 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -106.21 137.43 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.063 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 p -132.27 171.01 14.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 59.6 ttp -120.13 139.66 52.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.938 0.399 . . . . 0.0 112.05 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.42 -43.66 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.693 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.43 -111.75 4.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.094 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -103.54 116.68 32.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 0.0 110.72 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.433 HG21 HD23 ' B' ' 2' ' ' LEU . 46.8 pt -144.8 -176.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 m-20 -101.95 123.05 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.257 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.3 mm? -102.13 111.69 24.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' SER . 17.3 t 60.46 30.88 20.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.453 0.644 . . . . 0.0 109.933 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 45.4 m 83.37 2.34 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.377 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.4 m -112.01 116.47 49.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.063 0.227 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.49 123.35 11.14 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 122.413 2.075 . . . . 0.0 112.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 126' ' ' LEU . 70.6 m -131.94 138.42 48.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.903 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -101.93 169.59 8.68 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 13.5 mmt180 63.29 34.77 12.97 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.05 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 171' ' ' ALA . 31.7 mmt -82.17 128.43 34.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.734 0.778 . . . . 0.0 112.058 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 19.9 mm -95.21 144.07 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 33.0 ptt180 -131.6 139.46 49.17 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.506 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.1 130.97 24.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.361 0.6 . . . . 0.0 109.928 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.2 96.71 0.66 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.246 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -175.09 121.25 0.21 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.093 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.56 108.17 2.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.849 0.833 . . . . 0.0 112.286 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.67 148.48 43.87 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.151 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 35.0 mmtp -133.67 176.99 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.881 0.848 . . . . 0.0 112.81 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.9 OUTLIER -44.08 150.2 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.357 176.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.33 -22.69 31.19 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.352 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.84 3.7 47.35 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.776 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 1.8 m -58.93 134.88 57.33 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.954 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.65 8.35 59.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.523 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.91 135.93 20.97 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.239 -1.458 . . . . 0.0 109.571 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.4 t -86.32 117.45 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.666 0.733 . . . . 0.0 111.32 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.14 105.06 17.37 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.1 p -141.3 165.42 27.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.951 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.58 179.26 6.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -60.24 101.1 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.484 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.5 22.43 78.96 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.613 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 32.5 ttmt -147.92 108.72 4.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -94.36 123.1 46.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.474 ' CZ ' ' HA3' ' A' ' 96' ' ' GLY . 91.6 m-85 -91.57 -39.09 12.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.474 0.655 . . . . 0.0 110.755 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 157.4 -155.17 26.16 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.935 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.79 150.16 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.541 0.686 . . . . 0.0 110.903 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -69.15 122.22 18.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.016 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.07 -23.08 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.49 -156.54 12.0 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.855 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.64 157.9 25.61 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.481 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.1 t-20 -128.65 92.32 3.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.575 0.703 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.72 -104.99 1.49 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.741 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -95.85 2.27 53.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -127.25 129.55 47.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.308 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.1 146.52 22.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.483 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.9 m-85 -123.78 131.5 53.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.778 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.5 m -125.3 159.48 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.289 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -97.77 141.04 31.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.317 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 77.0 mt-30 -79.85 117.24 20.54 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.558 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 66.9 mt -96.74 71.75 2.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 92' ' ' GLU . 38.6 mtpt -79.75 135.3 36.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -56.38 -15.62 4.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.652 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -67.73 -16.91 64.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.15 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.36 -9.98 34.11 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.119 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 120.99 0.424 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.8 tt0 -110.99 78.94 1.15 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.64 137.75 34.39 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 39.2 tp -95.62 144.63 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.0 m-85 -59.87 137.86 57.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.776 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.9 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.226 -0.443 . . . . 0.0 . -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 CA--C 1.532 0.412 0 N-CA-C 115.255 1.213 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -66.35 -59.58 3.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 0.0 112.026 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 m -56.87 -42.22 79.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.89 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.41 -25.8 57.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.949 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -67.62 -46.44 72.51 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.69 99.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.26 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.2 tm? -61.62 -46.29 90.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -65.94 -44.96 83.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 86' ' ' ILE . 60.5 tp -62.83 -41.94 99.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.828 0.823 . . . . 0.0 110.811 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 31.0 tp -51.81 -51.48 56.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.01 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 15.1 mtp180 -63.02 -28.16 69.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -108.28 -49.26 3.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.43 -6.81 22.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 41.8 mt -102.18 108.44 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.415 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.1 mmt -119.17 148.32 43.22 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.953 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 m -76.83 117.17 18.17 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.147 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.78 95.79 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 28.1 m -84.07 108.57 17.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -129.73 -170.6 2.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.538 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -56.81 -49.1 76.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 tmtt? -71.02 -27.71 63.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.64 -156.99 28.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.677 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.02 117.1 32.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 43.6 m-85 -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.154 0.978 . . . . 0.0 112.295 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 75.4 m -88.68 95.77 10.39 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 113.399 -1.728 . . . . 0.0 107.93 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.23 116.94 4.36 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.184 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.88 101.02 13.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.357 0.599 . . . . 0.0 110.998 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -68.36 127.32 23.6 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 87' ' ' ARG . 36.2 mm -97.18 -47.4 12.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 118.07 0.935 . . . . 0.0 110.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 33' ' ' ARG . 6.7 p80 -165.75 166.81 17.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 40.99 -84.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.759 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' HIS . 16.4 ptp180 -143.92 21.51 1.78 Allowed 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 122.273 -0.267 . . . . 0.0 111.388 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 HG13 ' A' ' 74' ' ' VAL . 7.2 p -119.03 134.18 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 60.4 m -119.59 159.21 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.639 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.88 131.84 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.551 0.691 . . . . 0.0 111.571 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.72 165.17 29.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.98 170.69 18.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.216 1.277 . . . . 0.0 111.438 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.424 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 35.5 m -82.18 -33.27 29.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.043 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -72.8 2.01 7.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.823 0.344 . . . . 0.0 110.731 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -72.1 -19.55 61.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 53.68 70.3 1.83 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.599 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.35 124.98 10.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.692 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 -164.25 14.0 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.375 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.34 -31.0 16.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 108.837 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.15 118.65 18.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.28 159.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.986 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 85.3 mt -90.46 107.65 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.644 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.95 100.84 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.012 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.92 32.76 12.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.615 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.72 -14.93 64.21 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.828 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -100.92 126.36 47.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.507 0.654 . . . . 0.0 111.479 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.64 112.35 5.35 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 35.8 mm -114.62 118.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.379 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.54 157.91 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.94 -45.04 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.781 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 20.0 t70 -142.56 94.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.834 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 17.6 ptpt -93.0 90.26 6.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -97.19 115.11 26.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.406 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.88 129.36 37.53 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.916 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 20.0 mt -88.51 101.28 13.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -108.2 144.21 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 171.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' C ' ' N ' ' A' ' 66' ' ' GLU . 15.2 t70 -80.18 150.59 71.54 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 64' ' ' ASP . 65.0 Cg_exo -45.23 -20.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.618 0.879 . . . . 0.0 110.258 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 6.4 tp10 -63.12 -14.69 51.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.686 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 20.6 t30 80.43 3.36 1.84 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.372 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.07 155.16 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.584 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.77 126.35 29.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.0 tp -93.9 -15.58 24.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.2 tp10 70.24 14.25 7.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.728 -1.578 . . . . 0.0 113.152 175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 173' ' ' LEU . 8.5 mp -101.63 159.22 15.5 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -135.81 117.09 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG23 ' HG ' ' A' ' 62' ' ' LEU . 69.2 t -78.57 96.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.33 85.35 7.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.437 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 3.2 m -80.35 104.63 11.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.028 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 65.9 mt -95.55 159.75 14.84 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.786 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.65 86.35 7.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 33' ' ' ARG . 27.1 tpt180 -117.72 126.27 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.565 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -84.36 -48.76 9.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.26 116.04 15.56 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -82.32 150.17 27.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 122.018 0.913 . . . . 0.0 112.644 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.797 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -82.76 129.74 35.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.8 p-10 -75.61 97.8 3.86 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.429 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.414 HD13 HD11 ' A' ' 10' ' ' LEU . 33.5 pt -96.25 29.38 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.777 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 57.3 mtm180 -66.7 -27.0 67.29 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.032 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.7 -1.86 22.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.63 141.57 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 19.1 m -93.7 119.9 33.28 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.87 -47.14 60.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 91' ' ' SER . 19.2 t0 -114.28 144.1 43.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 173.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.0 mt -66.98 -71.19 0.21 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 59.23 70.88 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.715 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -143.31 92.41 0.17 Allowed Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 114.153 -1.385 . . . . 0.0 113.616 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.8 p -101.42 -8.35 9.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 6.1 t70 -144.46 135.67 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.756 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.61 155.13 38.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.528 0.68 . . . . 0.0 111.868 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 23.8 m -120.62 139.81 52.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 160' ' ' HIS . 1.0 OUTLIER -108.48 120.86 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.231 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.2 p -114.87 121.81 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.154 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.17 135.62 45.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.824 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -137.9 85.0 2.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 106' ' ' ASN . 37.2 t -135.89 -159.08 0.92 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.223 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.423 ' N ' ' OG ' ' A' ' 105' ' ' SER . 9.4 t30 -46.41 -64.45 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.01 -45.01 5.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 0.0 111.68 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.71 106.94 14.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.687 0.756 . . . . 0.0 112.929 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 p -116.43 138.74 51.12 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.868 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 51.8 28.13 4.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.821 0.448 . . . . 0.0 111.83 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 20.6 m -74.81 90.04 2.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.489 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.79 97.47 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 120.22 32.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.571 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.9 pt-20 -80.11 144.85 32.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.012 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.0 m -101.65 -20.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.59 -123.03 5.89 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.562 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 20.7 Cg_endo -61.8 114.25 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.294 1.996 . . . . 0.0 112.882 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -118.52 151.39 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.776 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.2 p -146.83 -177.54 5.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 21.2 ptt? -120.4 163.63 17.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.781 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.07 -2.55 8.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 -121.7 6.05 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.481 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.18 120.86 39.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.178 0.514 . . . . 0.0 109.69 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 26.4 pt -138.16 -171.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.922 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -102.22 135.18 44.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.269 0.557 . . . . 0.0 109.923 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 45.6 tp -119.23 103.79 9.82 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' SER . 2.8 m 63.75 32.56 13.54 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 110.32 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.8 m 82.76 1.6 1.18 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 126' ' ' LEU . 12.8 t -114.35 124.76 30.19 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.07 125.41 18.49 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.338 2.025 . . . . 0.0 113.215 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.03 138.78 54.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 133' ' ' ARG . 7.2 p-10 -111.76 152.13 28.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.656 0.741 . . . . 0.0 112.652 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HG3' HD22 ' A' ' 132' ' ' ASN . 59.9 mtt-85 66.37 53.28 1.01 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.015 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.9 mmm -93.06 134.91 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.712 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 170' ' ' SER . 14.2 tt -108.85 142.5 21.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 167' ' ' GLN . 19.4 ptt85 -127.23 139.75 52.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.546 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.3 OUTLIER -122.72 135.15 54.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.431 0.634 . . . . 0.0 110.941 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.5 87.78 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.41 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -171.89 127.27 0.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.374 -1.739 . . . . 0.0 107.268 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.35 100.19 1.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.704 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 137.79 52.57 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 96.2 mttt -127.96 176.63 7.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.567 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.37 152.99 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 111.107 -2.77 . . . . 0.0 111.664 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.07 -15.13 57.06 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.455 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -115.02 9.84 16.09 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.663 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 21.1 p -78.41 135.88 37.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 117.959 -1.496 . . . . 0.0 110.026 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.605 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 126.63 -16.88 6.53 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.84 153.88 44.06 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.14 129.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.338 0.589 . . . . 0.0 112.366 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.88 111.42 23.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.2 p -147.62 179.01 8.0 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 112.744 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.34 -178.5 6.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.041 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.9 t -60.92 101.76 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.63 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.93 31.07 77.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.889 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -153.35 111.2 3.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.708 0.289 . . . . 0.0 111.007 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.5 mt -96.78 129.38 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.54 -49.16 5.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.156 0.503 . . . . 0.0 112.017 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.731 ' HA2' HD23 ' A' ' 173' ' ' LEU . . . 175.92 -166.55 37.82 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.191 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.83 142.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.739 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.8 t60 -63.23 113.76 3.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.606 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.38 -27.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.05 -147.74 6.18 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.882 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 179.37 164.72 32.37 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.494 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.3 t-20 -137.56 96.68 3.29 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.206 0.527 . . . . 0.0 109.861 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.85 -119.26 5.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.997 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -97.29 19.66 12.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.202 0.525 . . . . 0.0 110.815 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 8.8 tt0 -134.36 115.86 14.54 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.875 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.59 148.94 34.41 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.245 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 46.7 m-85 -124.67 121.53 34.93 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.848 0.832 . . . . 0.0 111.129 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.57 ' HB3' HG23 ' A' ' 135' ' ' ILE . 15.2 t -117.5 156.44 28.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.145 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.78 134.19 39.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.538 ' OE1' ' HE2' ' A' ' 174' ' ' LYS . 76.1 mt-30 -71.03 122.49 20.13 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.731 HD23 ' HA2' ' A' ' 158' ' ' GLY . 2.5 mm? -85.52 93.9 8.89 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.538 ' HE2' ' OE1' ' A' ' 172' ' ' GLN . 51.2 mttm -93.21 128.03 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.668 0.747 . . . . 0.0 111.462 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -50.21 -31.12 13.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.388 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -37.3 -56.64 0.95 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.33 -9.71 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.88 179.625 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.5 mm? . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.366 0.603 . . . . 0.0 111.663 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -113.35 81.06 1.44 Allowed 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -83.18 153.73 24.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 36.0 tp -109.35 151.92 25.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.1 m-85 -60.3 133.98 56.62 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.663 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.7 mt-30 . . . . . 0 N--CA 1.439 -0.996 0 C-N-CA 119.219 -0.993 . . . . 0.0 . -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 CA--C 1.533 0.444 0 N-CA-C 113.745 0.633 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -60.18 -50.53 73.31 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.948 0.88 . . . . 0.0 110.98 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -43.24 99.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.901 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -60.45 -55.58 31.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.175 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.7 -45.55 86.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.51 82.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 8' ' ' LEU . 3.0 tm? -67.82 -40.08 83.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.699 0.285 . . . . 0.0 110.925 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -66.77 -42.37 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.64 -37.5 82.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.309 0.576 . . . . 0.0 109.916 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.622 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 3.4 tm? -51.41 -56.81 11.18 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.572 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.38 -27.84 66.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.367 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.53 -69.97 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.54 3.7 14.07 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 43.1 mm -97.86 96.39 5.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.5 mtm -126.91 144.12 51.08 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.715 0.769 . . . . 0.0 110.974 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 7.3 m -74.27 116.84 15.38 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 37' ' ' ILE . 22.0 mt -111.2 108.28 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.34 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 25.0 m -76.12 114.02 14.3 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.93 0.872 . . . . 0.0 109.86 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 p -95.8 -161.16 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.419 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -71.98 -31.71 66.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -76.09 -47.04 26.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.191 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.97 -153.6 24.58 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.621 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 47.7 mt-10 -75.35 116.46 16.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.952 -0.624 . . . . 0.0 112.381 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -124.4 151.93 43.86 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.706 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 47.2 m -75.7 108.36 8.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.76 116.98 5.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.464 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 103.64 16.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.081 0.467 . . . . 0.0 110.746 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.11 132.55 12.93 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.83 -59.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 118.262 1.031 . . . . 0.0 111.3 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -170.36 163.23 8.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.714 0.768 . . . . 0.0 112.75 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m-20 44.7 -90.02 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -127.36 6.91 6.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.099 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 p -133.18 149.75 52.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.326 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 72' ' ' LEU . 33.5 m -110.5 135.69 48.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.827 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 18' ' ' ILE . 27.6 mm -135.01 139.4 31.92 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.232 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.75 141.58 97.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.336 1.357 . . . . 0.0 111.1 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.736 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 99.4 m -60.84 -43.42 98.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.374 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.35 -11.03 28.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.78 -15.07 60.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.857 0.837 . . . . 0.0 109.235 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 60.25 70.72 0.97 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.94 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.2 115.75 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 N-CA-C 107.702 -1.691 . . . . 0.0 107.702 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.75 -124.38 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.23 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' VAL . 21.0 t70 -95.31 -32.07 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.939 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -144.5 144.42 31.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.724 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 m -128.1 155.25 39.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.828 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 16.1 tp -97.75 100.66 12.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.3 t -89.95 107.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.087 0.946 . . . . 0.0 111.308 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 p30 56.7 12.57 1.16 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.485 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.13 -6.65 13.05 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.507 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -103.64 117.35 34.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.02 114.1 6.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.068 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 tp -120.64 131.63 72.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -88.02 147.77 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 111.295 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 45' ' ' ASP . 8.0 p -73.09 136.5 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -87.03 -50.11 6.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -169.17 151.96 4.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.147 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -128.38 132.36 48.53 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -115.62 117.48 30.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.365 0.603 . . . . 0.0 112.285 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -66.19 106.7 1.72 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 65.9 tp -85.98 104.74 15.89 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 122.558 1.171 . . . . 0.0 109.782 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 31.6 m -113.67 164.53 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 113.572 -1.649 . . . . 0.0 106.665 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.5 134.92 78.98 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.538 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.71 -10.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 114.941 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.92 19.67 12.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.965 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.2 m120 71.03 29.08 3.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.916 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.451 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 37.5 mt -108.79 147.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.968 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t-20 -64.59 131.01 45.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.823 0.344 . . . . 0.0 111.548 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.677 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 6.7 tt -111.87 -27.02 8.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.736 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 34.8 tp10 78.8 8.78 1.97 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 36' ' ' VAL . 15.4 tp -99.41 133.12 44.18 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.239 0.542 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.4 m -106.93 112.62 25.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.41 101.2 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.7 tp -85.25 108.01 17.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.767 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -93.33 116.62 29.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.181 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.7 mt -116.75 124.33 49.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.778 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.87 103.9 11.02 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.915 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.28 136.19 41.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -62.24 -39.72 93.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.19 117.92 19.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 32' ' ' ASP . 72.1 mmtt -71.64 140.98 49.93 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.01 149.2 49.05 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 1.1 tpm_? -61.19 126.31 26.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.324 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.516 ' OD2' ' HD2' ' A' ' 87' ' ' ARG . 14.5 t70 -67.42 81.56 0.15 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -97.88 20.86 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HD2' ' OD2' ' A' ' 85' ' ' ASP . 6.7 ptm180 -63.46 -28.71 70.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.4 -6.38 86.06 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.104 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -91.17 -7.01 52.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.61 142.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 48.8 m -100.5 134.73 43.01 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER -76.17 -41.57 49.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 91' ' ' SER . 26.6 t70 -119.47 129.3 54.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 172' ' ' GLN . 26.6 mt -65.23 -73.16 0.13 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 57.29 68.71 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.43 87.82 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.126 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 11.6 p -81.19 -0.73 4.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.114 0.483 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 9.3 t70 -125.27 129.88 50.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.805 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.43 165.1 31.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.679 0.752 . . . . 0.0 112.438 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.2 m -134.81 141.65 46.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.435 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.558 HD11 ' OH ' ' A' ' 137' ' ' TYR . 78.9 mt -96.18 119.93 35.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.556 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.56 100.22 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.85 129.4 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.726 0.774 . . . . 0.0 112.206 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.19 49.38 1.65 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 m -106.49 -163.15 0.9 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.731 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -56.61 -48.17 78.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.121 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -88.16 -62.72 1.43 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.888 -0.507 . . . . 0.0 112.288 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.61 112.37 21.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -100.95 108.49 20.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.661 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 m120 58.97 72.33 0.54 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.736 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 m -140.56 130.85 25.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 112' ' ' ILE . 23.9 pt -105.37 99.46 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.7 mp -91.66 103.79 16.33 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.948 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -69.77 107.68 3.6 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.064 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.7 -121.05 5.32 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.34 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.7 Cg_endo -65.75 116.51 3.99 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.535 2.157 . . . . 0.0 114.719 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 137' ' ' TYR . 32.4 m -120.74 136.84 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.311 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -138.37 160.05 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -89.16 139.8 30.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.824 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.64 -56.78 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.001 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.11 -128.83 6.54 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 5.0 tt -99.66 113.47 25.94 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.5 pt -133.16 -159.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 20.3 m120 -125.99 125.9 43.43 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 2.7 mm? -100.48 113.36 26.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.497 ' OG ' HD12 ' B' ' 5' ' ' LEU . 4.0 m 57.23 29.31 16.5 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.317 0.58 . . . . 0.0 111.262 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 127' ' ' SER . 42.6 m 87.18 7.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 126' ' ' LEU . 6.0 t -111.03 139.68 22.02 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.601 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 21.3 Cg_exo -64.67 111.82 1.79 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 126' ' ' LEU . 26.3 m -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.864 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 133' ' ' ARG . 19.0 t-20 -119.3 163.25 17.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 37.7 ttm-85 68.41 35.45 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.937 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mmt -92.93 139.37 30.6 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.803 0.811 . . . . 0.0 113.004 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.6 mt -95.41 137.93 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.453 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -117.47 141.27 48.55 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.558 ' OH ' HD11 ' A' ' 101' ' ' LEU . 33.2 p90 -148.63 145.07 27.6 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.201 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.73 92.96 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.736 0.779 . . . . 0.0 112.112 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -161.43 137.18 7.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.59 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.78 87.01 5.29 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.486 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.1 p -89.91 151.04 21.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.081 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -130.27 151.57 50.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.045 0.926 . . . . 0.0 113.007 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.7 OUTLIER -45.35 152.3 0.3 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.225 175.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.58 -14.52 63.77 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.001 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 22.2 tt0 -99.33 7.2 45.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.317 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.776 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 6.9 m -60.56 136.11 57.96 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.37 -10.48 36.17 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 123.654 0.596 . . . . 0.0 111.952 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -51.1 121.01 10.26 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.086 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' ILE . 86.9 t -80.36 108.54 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.529 0.68 . . . . 0.0 111.212 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.5 tp -81.63 103.84 11.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.988 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -143.38 177.68 8.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.744 0.783 . . . . 0.0 111.998 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.13 -178.55 6.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.753 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.8 t -64.17 98.31 0.22 Allowed 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.802 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.42 29.05 54.28 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.162 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 33.4 ttmt -156.2 129.36 8.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.471 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.2 mt -112.77 129.14 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.23 -41.22 7.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 162.99 -156.09 27.7 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.82 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -127.89 151.16 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.923 0.868 . . . . 0.0 111.822 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.5 123.16 19.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -114.2 -28.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.55 -152.35 9.07 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.177 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.68 153.96 16.32 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.851 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 34.1 t30 -131.42 100.94 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.84 -121.88 6.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.404 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -102.21 22.92 12.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.675 0.75 . . . . 0.0 109.611 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 9.8 tt0 -127.61 115.53 18.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.365 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.42 148.75 28.25 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 47.5 m-85 -121.86 132.65 54.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.1 t -133.48 141.95 48.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.581 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -80.61 127.64 32.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.484 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 27.5 tt0 -74.6 109.2 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.895 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.494 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 55.2 mt -87.69 94.43 9.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.401 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.67 129.82 34.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.865 0.841 . . . . 0.0 111.379 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.35 -29.5 10.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.939 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -44.76 -43.16 8.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.659 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -79.81 -47.04 15.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 112.263 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.715 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.2 tt0 -101.64 83.96 2.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -88.75 141.06 28.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.6 tp -94.94 148.17 22.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 20.4 m-85 -61.32 139.59 58.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.776 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.8 mt-30 . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.971 -0.559 . . . . 0.0 . 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.46 -0.465 0 CA-C-O 121.016 0.34 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 22.8 t-20 -63.14 -53.25 56.38 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.389 1.09 . . . . 0.0 109.699 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 m -50.43 -53.71 27.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.073 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -57.49 -51.53 69.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.801 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.74 -50.58 72.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.171 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -44.95 95.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.7 tt -68.0 -35.06 77.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.571 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -70.05 -38.55 75.83 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.65 -40.76 93.19 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.196 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 29.7 mt -50.43 -57.66 7.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.431 1.11 . . . . 0.0 111.175 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -60.92 -28.0 68.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.719 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.59 -61.63 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.27 -7.26 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.6 mm -92.7 126.8 45.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.968 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtm -133.77 148.37 51.37 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -82.31 111.81 18.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.718 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.07 134.06 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 20.9 m -120.6 101.18 7.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.461 0.648 . . . . 0.0 109.941 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 p -105.74 -163.48 0.94 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.232 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -60.98 -18.57 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.0 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.683 ' HE2' ' OE1' ' A' ' 42' ' ' GLN . 6.3 mptp? -95.19 -59.05 1.98 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.06 0.457 . . . . 0.0 110.007 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . 172.2 -143.34 7.37 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.917 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -85.1 121.92 28.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.164 0.507 . . . . 0.0 111.327 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -125.88 161.57 27.14 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.395 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 37.8 m -89.26 112.03 22.99 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.485 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.73 109.11 3.38 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -87.62 98.47 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 111.672 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.13 10.35 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.68 -56.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.357 0.578 . . . . 0.0 109.858 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -154.82 144.07 21.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.987 0.899 . . . . 0.0 112.858 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 4.1 p30 46.78 -86.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.684 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 37.6 ptt180 -134.23 14.16 3.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.5 0.667 . . . . 0.0 110.595 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -94.67 113.05 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.1 m -118.87 154.07 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.842 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.33 133.1 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.14 143.58 25.27 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.662 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.7 153.04 52.11 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 120.849 1.033 . . . . 0.0 111.069 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.574 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 97.0 m -73.68 -39.55 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -65.11 -1.8 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.51 54.71 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.288 0.566 . . . . 0.0 110.802 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.683 ' OE1' ' HE2' ' A' ' 22' ' ' LYS . 42.5 mt-30 65.22 72.15 0.49 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.046 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.38 123.92 2.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.608 2.872 . . . . 0.0 109.949 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.25 -133.14 6.07 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.544 -0.836 . . . . 0.0 114.262 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.617 ' O ' HG12 ' A' ' 56' ' ' VAL . 28.0 t70 -83.84 -44.92 13.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 3.2 p30 -127.75 144.17 51.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.7 153.97 27.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.156 0.503 . . . . 0.0 111.146 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.84 103.71 16.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.7 m -89.36 93.85 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.054 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 69.87 13.1 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.64 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.84 -29.83 5.7 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.94 120.91 19.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -84.73 114.98 22.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.851 0.834 . . . . 0.0 110.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.39 141.83 44.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.018 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 34.4 ttt180 -90.54 151.06 21.51 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.47 0.652 . . . . 0.0 112.058 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -92.38 145.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -89.09 -41.94 12.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.733 0.778 . . . . 0.0 109.018 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -160.07 129.79 5.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.206 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.54 112.41 22.17 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -104.89 107.07 17.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.731 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.84 126.29 28.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.079 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -90.42 103.87 16.51 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.91 141.08 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 172.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 11.8 t70 -72.95 135.89 80.14 Favored Pre-proline 0 C--N 1.31 -1.15 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.631 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 64' ' ' ASP . 72.8 Cg_exo -52.59 -8.16 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.835 1.69 . . . . 0.0 112.217 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 64' ' ' ASP . 28.6 tt0 -81.54 3.24 25.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 73.48 25.22 2.15 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.863 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.28 152.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' THR . 52.7 t30 -63.84 134.86 55.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.615 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 41.7 tp -102.99 -22.13 13.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.574 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.1 tp10 72.04 13.29 5.91 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.071 175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.86 158.94 16.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.937 0.399 . . . . 0.0 110.27 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.6 m -135.88 120.8 18.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.208 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.05 102.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.7 tp -93.09 97.68 10.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.992 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 m -92.12 90.66 7.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 4.8 mp -74.21 152.5 39.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.513 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.37 75.49 10.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 79' ' ' ARG . 5.0 tpt180 -106.92 128.28 54.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.007 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.5 -12.74 51.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 38.2 mt-10 -90.56 117.86 29.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.612 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -93.5 111.29 22.93 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.258 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -81.98 165.85 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.482 0.658 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 84' ' ' ARG . 18.8 ttt180 -50.93 126.52 16.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.864 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -81.79 98.75 8.61 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.45 0.643 . . . . 0.0 109.859 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.5 pt -91.04 21.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 122.054 0.931 . . . . 0.0 109.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -55.28 -33.4 63.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.484 -1.689 . . . . 0.0 113.239 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.11 -7.74 88.16 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.864 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.81 2.05 51.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.44 131.85 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -93.28 105.12 17.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' A' ' 174' ' ' LYS . 0.1 OUTLIER -62.43 -54.77 35.32 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 176.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.41 135.2 45.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 95' ' ' GLU . 25.6 mt -61.03 -55.44 32.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 15.0 pt-20 36.61 71.8 0.13 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.591 . . . . 0.0 111.147 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.39 105.69 0.21 Allowed Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.651 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -91.97 9.98 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.083 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -111.62 118.33 35.38 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.09 151.54 37.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.044 0.926 . . . . 0.0 112.423 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.5 m -122.03 135.92 54.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.262 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.9 105.41 17.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.294 0.569 . . . . 0.0 110.222 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.674 ' HB ' HG23 ' A' ' 149' ' ' VAL . 35.3 t -80.38 102.16 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 108' ' ' PHE . 14.7 t -89.35 108.24 18.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.426 0.631 . . . . 0.0 111.71 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 29.6 t60 -129.9 39.35 3.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 97.2 p -108.9 -161.18 0.75 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.177 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -73.9 -17.25 61.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.704 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -78.01 -76.69 0.18 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 103' ' ' VAL . 79.8 m-85 -117.99 147.85 42.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.096 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.74 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 6.4 m -124.63 124.97 43.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.269 0.557 . . . . 0.0 110.794 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 109' ' ' THR . 12.3 t-20 80.82 -2.2 1.82 Allowed 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.658 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.0 m -92.67 119.38 32.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.26 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 112' ' ' ILE . 41.2 pt -95.25 126.62 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.0 110.53 20.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.54 122.13 18.44 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.58 -32.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.729 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.07 -105.12 2.04 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.879 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 88.5 Cg_endo -84.5 128.85 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.208 1.939 . . . . 0.0 114.145 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.81 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.6 p -132.14 163.77 27.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.726 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.15 153.92 20.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.46 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.51 0.13 11.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.871 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.93 -116.04 4.14 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.214 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 123' ' ' LEU . 7.3 tt -121.16 127.24 51.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.001 0.429 . . . . 0.0 111.239 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.7 pt -136.91 179.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 19.9 m120 -95.81 84.04 3.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.233 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 55.3 tp -65.49 105.86 1.28 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.0 m 62.52 32.67 16.45 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.373 0.606 . . . . 0.0 109.615 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 127' ' ' SER . 38.0 m 81.84 -10.46 1.14 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.378 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -91.49 120.98 68.08 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.518 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.34 114.59 2.04 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.493 1.462 . . . . 0.0 110.762 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 69' ' ' ASN . 23.3 m -134.34 134.88 42.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.016 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 26.8 p30 -113.42 -177.62 3.18 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.909 -0.717 . . . . 0.0 112.714 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 65.91 26.96 10.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.459 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 74.0 mt -92.34 135.5 27.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -117.26 130.99 56.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.627 0.727 . . . . 0.0 111.873 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.8 p90 -142.9 112.12 6.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.12 105.71 2.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.728 0.775 . . . . 0.0 109.246 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -167.59 135.4 2.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.75 102.7 0.97 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.825 0.821 . . . . 0.0 111.655 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 t -140.26 147.07 39.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.386 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 26.4 mtpp -141.51 -179.13 5.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.339 1.066 . . . . 0.0 111.962 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -37.6 150.2 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.986 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.69 -28.33 13.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.876 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -87.17 10.49 16.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.0 0.429 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.808 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 4.8 m -63.37 135.14 56.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.771 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 102.96 -21.37 40.41 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.488 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.24 133.72 24.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.942 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.674 HG23 ' HB ' ' A' ' 102' ' ' VAL . 17.7 m -92.16 112.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 0.0 111.719 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.66 109.66 18.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.63 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -146.12 172.68 13.06 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.176 0.988 . . . . 0.0 113.231 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -130.91 172.58 11.88 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.682 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -68.62 103.25 1.66 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.773 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.54 -0.48 77.5 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.581 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -139.18 109.35 6.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.5 mm -90.49 111.55 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.33 -48.65 12.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 170.0 -160.54 33.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.621 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 149' ' ' VAL . 23.4 pt -122.41 143.37 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.838 0.828 . . . . 0.0 112.583 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.24 118.72 10.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.152 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 17.1 m -113.24 -23.01 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.748 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.37 -152.2 8.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.522 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.81 153.81 12.01 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.766 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.584 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 16.0 t30 -126.36 105.68 8.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.175 0.512 . . . . 0.0 110.399 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.96 -106.66 1.93 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.322 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 29.7 ttm180 -116.73 20.45 13.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -122.62 116.54 24.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.164 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.53 149.61 35.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.864 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 51.5 m-85 -130.51 115.38 16.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.45 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 69.5 m -109.45 172.64 6.73 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.676 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.473 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -115.0 132.25 56.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.9 pt20 -86.42 133.98 33.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.0 mt -85.92 88.92 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.297 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.539 ' HB3' ' OE2' ' A' ' 92' ' ' GLU . 9.6 mtpm? -79.1 111.26 15.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.087 0.946 . . . . 0.0 108.799 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -35.71 -36.23 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.497 ' HG2' ' CG ' ' A' ' 92' ' ' GLU . 17.0 mm100 -56.34 -27.95 57.51 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -68.46 -18.39 64.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.489 0.662 . . . . 0.0 109.245 177.871 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 4.5 mp . . . . . 0 CA--C 1.512 -0.509 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.4 tt0 -89.31 77.42 7.43 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.35 118.55 22.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.136 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 21.0 tp -83.6 152.11 25.0 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.9 m-85 -58.22 141.01 52.02 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.808 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.2 mt-30 . . . . . 0 C--N 1.307 -1.243 0 C-N-CA 120.708 -0.397 . . . . 0.0 . 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 N-CA-C 115.679 1.377 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 64.2 t30 -57.12 -48.77 77.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -68.39 -42.54 78.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.891 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -61.7 -43.98 97.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.264 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.17 -49.0 76.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.128 0.489 . . . . 0.0 110.387 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 -46.04 85.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.577 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.95 -42.72 99.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -68.07 -44.84 75.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.585 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.73 -45.79 91.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.738 0.78 . . . . 0.0 110.16 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 57.5 tp -55.99 -49.89 72.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.408 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.39 -28.57 56.77 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.64 -34.05 10.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -121.33 -9.81 9.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 50.8 mm -97.8 114.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.627 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 16' ' ' MET . 2.1 mmt -122.24 146.18 47.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.323 0.582 . . . . 0.0 110.355 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.52 86.32 4.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 HG21 HD13 ' A' ' 37' ' ' ILE . 47.4 mm -75.61 94.33 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.0 109.765 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.3 m -86.62 96.12 10.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.741 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.19 179.65 4.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.932 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -55.92 -35.97 67.2 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -89.25 -31.7 17.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.9 -169.9 42.44 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 119.495 -1.336 . . . . 0.0 115.054 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -95.52 109.05 21.32 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 114.84 -0.68 . . . . 0.0 110.066 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 41' ' ' ALA . 86.7 m-85 -112.04 158.68 19.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.74 0.781 . . . . 0.0 112.245 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.0 m -83.05 106.66 15.05 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.559 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -89.64 119.99 5.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.938 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -93.99 100.68 12.77 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 0.0 110.186 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.38 106.99 1.9 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.0 -55.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -163.02 144.12 9.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.577 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 34.0 t70 54.02 -94.27 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.786 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.577 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -133.17 23.51 4.14 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.633 -0.667 . . . . 0.0 110.604 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.8 t -102.27 119.42 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.747 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -123.71 142.5 51.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.6 t -109.55 131.88 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 122.227 1.013 . . . . 0.0 112.111 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 18' ' ' ILE . 19.4 pt -141.75 165.53 27.55 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.44 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 25.0 Cg_exo -66.28 170.0 12.85 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 120.757 0.972 . . . . 0.0 111.098 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.565 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 62.6 m -76.44 -37.47 56.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.97 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -69.06 9.41 0.41 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 25' ' ' PHE . . . -75.64 -29.98 59.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.3 mm-40 61.37 72.9 0.63 Allowed Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.928 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.54 132.4 33.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.642 2.228 . . . . 0.0 111.263 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.53 -129.17 5.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.635 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.29 -30.73 12.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 109.188 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 55' ' ' ARG . 16.2 m-20 -132.38 155.62 48.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -129.7 134.38 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.54 104.84 13.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.423 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' GLY . 62.9 t -82.44 91.14 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.119 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 70.75 -9.57 0.81 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.104 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 152.55 -26.73 0.85 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -74.77 113.55 12.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.55 -0.825 . . . . 0.0 110.425 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.58 93.96 2.58 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.97 142.78 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.766 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.497 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 1.7 mmp_? -63.26 133.03 53.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.73 108.65 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -68.3 -40.51 81.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.122 0.963 . . . . 0.0 109.281 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -171.48 147.83 2.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.617 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.664 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -117.87 139.31 51.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.755 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.407 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 65.1 t80 -141.47 106.34 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.573 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -71.81 135.95 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 38.2 tp -104.18 109.17 20.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.379 1.085 . . . . 0.0 113.293 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.57 160.21 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 136.95 60.41 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -43.42 -26.13 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.473 2.115 . . . . 0.0 113.65 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.75 -9.37 57.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.75 0.786 . . . . 0.0 109.332 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.65 66.27 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.792 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 132' ' ' ASN . 63.0 mt -144.38 150.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 112.442 -2.163 . . . . 0.0 105.935 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -65.65 135.06 54.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.263 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 29.0 tp -108.62 -29.32 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.565 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 18.0 tp10 74.92 23.88 1.63 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.123 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.06 157.13 18.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 47.3 m -132.26 120.14 21.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.124 0.488 . . . . 0.0 109.796 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 65.9 t -86.4 88.52 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.8 tp -84.26 110.86 18.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.93 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -98.06 101.67 13.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.868 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.96 155.25 16.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.88 76.29 9.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -104.35 104.55 14.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.25 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.54 -38.03 74.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -82.62 82.25 8.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 20.4 ptmt -61.52 154.3 25.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.595 -1.184 . . . . 0.0 113.944 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.2 169.93 10.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.215 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -71.97 137.31 47.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.266 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -86.82 87.31 7.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.423 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -85.45 14.62 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -63.13 -16.13 59.01 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.792 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.79 -20.49 79.78 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.194 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -93.41 -0.37 56.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.7 mt -74.99 144.53 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 12.8 m -91.56 123.87 35.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.2 pm0 -78.96 -31.51 45.02 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' SER . 41.2 t0 -136.31 148.09 47.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 32.2 mt -71.41 -55.53 7.76 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 94' ' ' LEU . 1.9 pt-20 38.2 72.0 0.14 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.453 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.42 99.22 0.14 Allowed Glycine 0 N--CA 1.444 -0.784 0 O-C-N 124.0 0.813 . . . . 0.0 111.781 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.6 p -74.89 -21.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.87 0.366 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -92.3 119.36 31.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.596 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.96 154.31 48.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.105 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -120.71 137.47 54.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.176 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -107.98 127.02 53.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.38 113.98 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.62 123.44 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.916 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 39.7 t60 -150.49 71.96 1.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 60.7 p -143.16 -150.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.325 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.1 t-20 -55.02 -54.79 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.177 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 145' ' ' GLN . 66.3 m-80 -74.36 -68.53 0.52 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.412 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 36.0 m-85 -116.36 157.09 25.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -136.61 147.47 46.96 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.277 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.32 13.14 6.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.0 0.428 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 23.0 m -93.02 104.51 16.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.436 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.98 111.95 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.315 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.11 129.23 51.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.328 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.53 122.75 30.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 137' ' ' TYR . 9.1 p -89.26 -32.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.036 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.67 -130.69 10.31 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.642 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 76.3 Cg_endo -78.27 134.41 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.878 1.719 . . . . 0.0 112.891 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.33 165.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.159 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 p -132.79 -178.78 5.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.1 mtt -115.4 149.62 37.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.753 0.311 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 -31.08 5.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.41 -112.62 4.26 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.073 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 tt -123.31 112.08 17.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.8 pt -130.26 175.75 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.018 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 53.0 m-80 -86.9 87.32 7.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.51 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 49.8 tp -75.45 106.42 6.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.3 t 61.67 36.55 16.49 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.8 m 74.18 -0.07 3.46 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.516 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 m -104.23 113.69 64.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.912 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.74 111.78 0.87 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.989 1.792 . . . . 0.0 111.493 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 m -124.04 136.63 54.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.16 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.4 ' HB2' HG21 ' A' ' 68' ' ' ILE . 65.0 t30 -103.84 164.16 11.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 67.13 45.89 1.62 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.983 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mmt -91.66 127.35 37.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.281 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 170' ' ' SER . 28.9 mm -93.9 147.18 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -134.18 140.2 46.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 111.757 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.477 ' CD1' HG21 ' A' ' 115' ' ' VAL . 36.4 p90 -149.04 140.98 23.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.13 117.63 25.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.409 1.099 . . . . 0.0 110.15 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -174.08 137.96 0.57 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.242 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.38 96.2 0.08 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.322 0.582 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.9 p -107.96 144.37 35.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.333 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.3 158.25 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.516 1.15 . . . . 0.0 112.79 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.48 152.1 0.1 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.289 173.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.51 -14.51 50.84 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 107' ' ' ASN . 11.2 mm-40 -99.86 -0.27 40.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 119.792 -0.147 . . . . 0.0 110.872 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.644 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 10.5 p -78.3 135.26 37.48 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.309 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 119.78 -23.12 8.44 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.929 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.52 138.01 19.27 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.399 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.78 125.33 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.775 0.798 . . . . 0.0 112.911 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.17 109.07 21.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.384 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -149.29 -174.5 4.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.106 0.955 . . . . 0.0 113.326 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.35 172.85 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.212 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.1 t -60.52 108.8 0.88 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.572 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.18 63.44 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.344 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -162.66 113.75 1.52 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.83 119.9 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -83.98 -41.11 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 164.08 -156.45 28.33 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.605 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.4 pt -126.62 147.5 31.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.21 0.528 . . . . 0.0 111.05 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.1 133.13 48.46 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.43 -28.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.61 -155.91 11.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.08 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.71 154.27 25.0 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.029 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.577 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 10.3 t-20 -135.16 116.14 14.17 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.69 -112.59 4.71 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.06 -1.066 . . . . 0.0 111.06 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -118.08 19.45 13.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.481 . . . . 0.0 109.828 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 167' ' ' GLN . 1.9 mp0 -111.0 135.17 51.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.316 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.77 138.28 14.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 44.9 m-85 -116.72 132.92 56.56 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.439 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 18.5 m -124.86 165.35 18.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.546 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -106.91 143.03 35.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -81.95 110.75 17.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.436 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -88.55 93.02 9.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' SER . 86.4 mttt -87.3 135.22 33.4 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 122.643 1.211 . . . . 0.0 113.45 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 16.1 tptm -42.78 -43.08 3.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.537 -2.12 . . . . 0.0 112.78 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -41.51 -46.41 3.5 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.74 -23.02 55.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 . . . . . 0 C--N 1.321 -0.661 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.679 -178.583 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.9 mm? . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 121.326 0.584 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.0 tt0 -114.68 85.77 2.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -91.09 130.5 36.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 23.2 tp -88.55 154.71 20.12 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.574 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 24.3 m-85 -62.64 145.64 54.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.644 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 95.2 mt-30 . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 118.702 -1.199 . . . . 0.0 . 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--O 1.229 0.061 0 N-CA-C 114.609 0.965 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 66.6 t30 -79.83 -49.54 11.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.209 0.528 . . . . 0.0 111.932 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -68.38 -42.29 79.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.738 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.42 -29.54 63.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.097 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -65.58 -46.32 79.87 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.59 75.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.432 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.13 -43.63 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.603 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 m -69.85 -41.74 74.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.179 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.85 -42.07 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.716 0.77 . . . . 0.0 109.945 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.645 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -56.41 -53.5 56.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.882 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.7 -25.99 66.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -83.42 -55.58 4.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -118.06 -2.42 11.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 40.5 mm -101.94 114.24 40.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.31 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtm -128.03 155.05 44.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.506 0.669 . . . . 0.0 111.434 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -85.3 109.15 18.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.9 mt -103.08 110.69 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.678 0.751 . . . . 0.0 110.224 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 11.3 m -85.5 114.22 22.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.37 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -106.52 -176.3 3.04 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -75.83 -15.83 60.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.112 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -82.62 -42.34 18.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.052 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.94 38.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.98 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.99 116.14 28.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.75 166.33 13.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.969 0.89 . . . . 0.0 111.333 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 19.0 m -73.55 105.01 4.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.51 105.53 3.23 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -107.07 130.1 54.72 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.794 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.43 126.08 7.22 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.17 -56.76 5.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.125 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -158.43 151.09 22.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.259 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 8.1 t70 56.25 -94.36 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.52 20.25 1.86 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.877 0.846 . . . . 0.0 108.885 177.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.0 106.73 18.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 m -115.29 152.6 32.46 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.34 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.73 144.69 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -146.98 140.39 14.94 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.757 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.36 145.39 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.772 1.648 . . . . 0.0 111.981 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 67.0 m -75.29 -34.86 61.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.293 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -65.01 -11.97 45.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.38 -23.26 46.89 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.563 0.697 . . . . 0.0 109.888 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 48.27 72.1 1.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.81 130.57 28.16 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.41 -155.07 4.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.374 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -82.22 -35.98 27.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.188 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.29 121.53 22.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.2 m -117.28 150.94 19.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.369 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 34.4 mt -83.34 107.12 15.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.348 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -92.45 89.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 58.49 36.27 25.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.107 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.95 -15.06 57.09 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.156 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 15.8 mm-40 -106.09 108.71 20.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.91 139.46 30.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.722 -179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.0 tp -135.85 135.54 50.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -84.91 128.0 34.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.38 142.58 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -77.14 -49.73 14.58 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -150.76 120.33 6.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.817 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -97.59 98.21 9.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -100.49 123.79 45.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.017 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 3.4 mppt? -94.53 108.2 20.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 47.2 tp -86.12 118.22 25.44 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.07 172.75 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.98 140.94 86.26 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 117.723 0.238 . . . . 0.0 111.637 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.55 -29.02 9.77 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.267 1.311 . . . . 0.0 111.954 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.0 8.87 16.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.274 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 64.02 68.36 0.57 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.681 0.753 . . . . 0.0 110.469 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.0 mt -142.97 164.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.985 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -69.0 116.54 9.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 118.298 0.499 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.56 -32.93 10.53 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 30.3 tp10 77.38 15.11 1.76 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.995 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 80.4 mt -103.37 111.68 24.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.038 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -90.11 107.54 19.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.3 t -79.04 97.16 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.658 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 tp -78.21 94.57 4.79 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.102 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.2 m -83.95 98.63 9.9 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.691 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -103.4 144.13 31.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.064 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.35 96.82 7.98 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.18 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 77' ' ' LEU . 8.3 mmm180 -117.52 150.01 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -82.09 -44.82 16.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 110.08 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.79 76.11 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 59.6 pttt -67.76 172.31 5.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.491 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -93.65 160.89 14.57 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -71.83 143.61 49.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.479 -1.692 . . . . 0.0 112.299 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.47 91.77 2.81 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.371 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.0 pt -89.89 11.49 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -70.07 -27.06 64.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.305 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.26 -20.69 73.47 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 67.4 m-85 -92.54 -16.91 25.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.34 121.76 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.8 m -101.6 107.65 18.98 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.296 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 174' ' ' LYS . 12.5 pt-20 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -94.79 112.88 24.59 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.412 HD11 ' NE2' ' A' ' 172' ' ' GLN . 44.9 mt -56.34 -71.36 0.09 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 49.97 67.98 0.82 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.08 92.52 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.264 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 60.7 t -83.79 -4.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.825 0.345 . . . . 0.0 111.515 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -114.21 110.4 19.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -130.62 165.69 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 112.739 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 m -119.97 141.62 49.51 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.723 -1.581 . . . . 0.0 109.69 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.8 tp -109.85 120.02 41.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 102' ' ' VAL . 31.3 m -116.31 108.38 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 120.214 -0.595 . . . . 0.0 110.05 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.91 136.98 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.755 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -142.28 75.73 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.57 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.9 p -124.24 -162.68 1.09 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -45.34 -67.63 0.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -94.15 -34.78 12.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.309 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.74 83.51 7.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 112.545 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.3 p -92.73 123.39 35.98 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.599 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER 38.61 62.9 0.95 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -99.02 103.13 15.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.642 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.8 mt -93.08 109.11 21.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.868 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.64 123.51 50.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.28 107.81 9.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.498 HG21 ' CD1' ' A' ' 137' ' ' TYR . 8.7 p -86.35 -24.76 6.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.307 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.21 -122.41 5.97 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.461 -0.876 . . . . 0.0 115.03 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.5 Cg_endo -66.24 117.59 4.82 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.407 2.072 . . . . 0.0 115.629 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.495 HG12 ' HB3' ' A' ' 137' ' ' TYR . 30.9 m -108.3 151.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.6 m -151.41 135.55 16.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.606 0.241 . . . . 0.0 110.928 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.1 ttm -66.71 122.44 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.695 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.43 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.14 -115.81 5.34 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.34 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.78 119.1 32.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.531 HG21 HD23 ' B' ' 2' ' ' LEU . 44.4 pt -133.22 -170.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.875 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 128' ' ' SER . 5.7 m-20 -110.38 109.42 19.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.8 mm? -87.57 112.1 21.91 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 128' ' ' SER . 26.7 t 65.21 10.33 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.568 0.699 . . . . 0.0 110.643 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 4.8 m 82.99 66.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.001 1.32 . . . . 0.0 112.823 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 126' ' ' LEU . 15.2 t -163.3 131.49 2.77 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.778 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.35 109.96 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 121.361 1.374 . . . . 0.0 113.84 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 126' ' ' LEU . 7.3 m -111.67 132.89 54.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.479 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -111.22 160.89 16.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.1 mtt180 65.36 43.37 3.51 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.078 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 85.1 mmm -92.24 136.6 33.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.3 tt -117.91 137.52 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -105.37 150.14 25.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 115' ' ' VAL . 1.5 p90 -144.68 152.8 40.97 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.368 0.604 . . . . 0.0 110.226 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.2 99.96 7.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.862 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 115' ' ' VAL . 47.2 t80 -178.2 119.93 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.755 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.68 120.63 16.58 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.6 t -143.01 151.85 41.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.752 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.9 174.21 10.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.701 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' ' CA ' ' B' ' 7' ' ' GLN . 17.8 p -38.91 155.47 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.318 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.3 -29.9 8.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -86.69 -4.87 59.23 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.636 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 26.3 p -78.1 144.57 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.508 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.42 -22.59 17.27 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.46 34.52 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.984 -0.608 . . . . 0.0 112.217 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.26 126.8 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.417 0.627 . . . . 0.0 112.297 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.73 106.6 18.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.2 p -149.24 -176.33 5.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.093 0.949 . . . . 0.0 112.306 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.68 174.69 13.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.816 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 8.8 t -62.02 115.75 4.34 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.794 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.05 90.67 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 19.2 ptmt -156.82 142.04 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.488 1.144 . . . . 0.0 112.772 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.43 138.85 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.614 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -106.53 -39.41 5.87 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.943 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.493 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 175.59 -167.77 39.83 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 173' ' ' LEU . 20.0 pt -129.48 141.8 45.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.699 0.762 . . . . 0.0 110.604 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 6.1 t60 -65.57 107.44 1.71 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.471 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 27.2 m -95.3 -21.03 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.759 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 175.8 -146.75 8.34 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.125 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.56 163.4 32.5 Favored Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.336 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 2.9 t30 -123.49 94.8 4.36 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.85 0.833 . . . . 0.0 109.765 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.65 -104.87 1.31 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.393 -1.276 . . . . 0.0 114.223 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 166' ' ' ARG . 1.0 OUTLIER -97.55 -8.25 29.51 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.56 -0.82 . . . . 0.0 111.972 -177.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -108.99 133.04 53.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.282 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -85.68 149.94 23.88 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.2 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 49.8 m-85 -133.11 122.68 24.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.702 0.763 . . . . 0.0 112.022 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 t -117.99 150.64 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.987 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.1 128.26 36.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.412 ' NE2' HD11 ' A' ' 94' ' ' LEU . 54.5 mt-30 -63.01 118.82 8.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.415 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.493 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 42.5 mt -87.66 85.19 7.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 92' ' ' GLU . 55.7 mtpt -89.56 133.89 34.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.752 0.787 . . . . 0.0 109.538 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -50.29 -19.64 0.86 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.639 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -9.09 58.79 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 . . . . . 0 C--N 1.312 -1.032 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.099 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.531 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.07 76.37 1.04 Allowed 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.44 140.58 33.33 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.0 tp -104.97 145.84 29.86 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.558 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 31.2 m-85 -57.61 142.09 45.94 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.636 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 81.9 mt-30 . . . . . 0 N--CA 1.436 -1.171 0 C-N-CA 119.344 -0.942 . . . . 0.0 . -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 CA--C 1.529 0.253 0 N-CA-C 113.375 0.49 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.78 -53.8 19.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.1 0.476 . . . . 0.0 110.585 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -63.49 -35.52 80.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.779 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -61.82 -51.65 67.4 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -57.87 -48.43 79.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.269 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -55.78 -49.14 73.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.328 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.13 -43.73 98.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -71.34 -39.61 71.22 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.91 -41.34 95.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 122.182 0.991 . . . . 0.0 108.6 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.596 HD21 ' ND2' ' A' ' 110' ' ' ASN . 53.4 tp -59.49 -56.32 23.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.879 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -69.71 -28.87 66.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -103.23 -29.19 11.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.48 -19.25 8.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.519 HG23 HG23 ' A' ' 26' ' ' THR . 47.9 mt -93.35 117.99 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.075 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -125.87 156.77 39.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.186 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 104' ' ' HIS . 1.9 p -86.73 106.11 17.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.515 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.8 mp -93.38 110.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 89.3 m -72.07 114.34 10.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.881 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 58.6 p -109.27 -163.57 0.88 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.7 t -77.53 -29.2 52.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -90.38 -33.15 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.95 -167.2 39.95 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.423 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.89 115.36 21.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -121.5 159.22 26.76 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.944 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -72.71 113.2 9.48 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.573 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -114.76 129.91 8.92 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.247 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.36 104.49 16.83 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.44 90.97 0.94 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 90' ' ' ILE . 24.5 mm -59.18 -50.98 77.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 111.35 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 11.7 p80 -166.94 164.24 16.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.307 1.051 . . . . 0.0 113.328 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HA ' ' CB ' ' A' ' 82' ' ' LYS . 1.6 m-20 45.97 -92.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.997 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 31.5 ptt180 -142.55 19.87 2.03 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.037 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.36 119.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.543 0.687 . . . . 0.0 110.765 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 m -117.33 139.98 50.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.047 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -99.84 124.69 53.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.574 . . . . 0.0 109.847 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 pt -136.84 163.89 46.35 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.66 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.18 150.43 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.549 1.499 . . . . 0.0 111.615 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.569 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 94.9 m -81.19 -42.52 20.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.355 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -63.17 -17.12 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -67.29 -19.21 65.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 109.422 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.3 mt-30 68.01 72.87 0.36 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.28 133.05 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.454 2.769 . . . . 0.0 110.657 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.82 26.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.613 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -103.07 -5.89 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.205 1.002 . . . . 0.0 109.355 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 10.7 t70 -139.72 107.43 5.63 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.44 148.01 15.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.108 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.76 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 7.3 mp -96.9 103.7 15.65 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.736 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.87 106.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 64.22 23.99 13.26 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.955 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.38 -17.54 46.96 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.733 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -83.47 105.67 14.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.859 -0.201 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 15.0 ptpt -71.9 114.23 9.77 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 77' ' ' LEU . 4.6 tt -127.22 143.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.53 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 20.2 mmm180 -66.35 142.99 57.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.73 150.68 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.36 -49.76 5.31 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.53 114.54 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.351 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -107.21 132.11 53.43 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' CE2' HD23 ' A' ' 62' ' ' LEU . 24.0 t80 -130.13 118.29 21.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.42 104.44 10.03 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.456 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 96.1 mt -62.52 109.49 1.39 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.992 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.8 m -91.96 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 22.3 t70 -89.04 132.68 37.21 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.66 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.61 -18.49 2.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.0 2.467 . . . . 0.0 114.551 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 44.2 mt-10 -89.82 19.58 4.69 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 111.133 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 25.0 t-20 77.32 15.38 1.75 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.142 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 69' ' ' ASN . 25.8 mm -109.26 179.1 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.79 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 68' ' ' ILE . 52.8 t30 -92.14 146.16 23.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.192 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.777 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 27.4 tp -108.33 -22.39 12.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.569 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 19.4 tp10 68.89 13.0 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.476 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 76.1 mt -105.47 110.48 22.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.96 0.163 . . . . 0.0 110.951 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.0 m -91.98 116.51 28.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.044 0.449 . . . . 0.0 111.493 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.31 105.93 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.158 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -84.44 93.13 8.23 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 13.0 tp -93.59 155.79 17.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.772 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 54' ' ' ILE . 28.7 t70 -89.48 67.36 7.6 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 11.2 tpt180 -117.07 101.88 8.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -89.32 -6.0 57.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.831 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -87.03 107.14 18.29 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' CB ' ' HA ' ' A' ' 32' ' ' ASP . 20.5 ptmt -78.21 157.7 29.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -88.04 167.09 13.98 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 111.989 -2.369 . . . . 0.0 108.262 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -64.03 130.54 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.395 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' OD1' ' HD2' ' A' ' 87' ' ' ARG . 10.3 m-20 -68.56 95.16 0.62 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -96.38 25.96 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 9.7 mtp180 -63.17 -36.07 82.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.645 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.08 -11.75 85.28 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.433 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -90.15 -17.71 27.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.562 0.681 . . . . 0.0 109.287 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 30' ' ' ILE . 30.0 mt -69.02 130.8 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 21.1 m -107.61 129.0 55.04 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.3 -43.23 52.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 91' ' ' SER . 10.2 t70 -106.05 124.81 50.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.167 175.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.66 -71.49 0.37 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 49.47 72.16 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -162.03 82.92 0.12 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.754 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.56 3.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.12 0.486 . . . . 0.0 111.304 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.1 t70 -143.8 119.17 10.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.187 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.428 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -142.5 172.2 13.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.085 0.945 . . . . 0.0 112.337 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -120.64 144.6 48.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.115 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -111.0 124.51 52.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.775 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 7' ' ' ALA . 19.3 m -114.17 120.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.467 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 t -113.38 133.41 59.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.53 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 17' ' ' THR . 74.1 t60 -140.77 75.24 1.49 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.9 p -118.4 -166.98 1.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -68.82 -38.43 79.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.234 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.43 -60.84 1.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.637 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.615 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 46.4 m-85 -96.68 108.94 21.66 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.239 0.543 . . . . 0.0 110.063 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 15.2 m -113.36 117.7 32.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.423 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.596 ' ND2' HD21 ' A' ' 11' ' ' LEU . 14.4 m120 70.4 34.54 2.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.49 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 2.6 m -87.26 122.4 30.98 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.3 tt -119.96 109.28 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.6 mt -115.03 128.54 56.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.85 106.0 17.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.5 m -78.95 -38.47 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 98.15 -123.17 7.76 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.899 -1.143 . . . . 0.0 114.499 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.7 Cg_exo -61.35 108.89 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.804 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 99' ' ' ALA . 90.4 t -106.27 139.54 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 4.4 m -153.09 151.71 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.81 151.07 26.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.243 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -114.5 -35.93 4.76 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.64 -97.52 1.63 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.729 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.97 125.26 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.095 0.474 . . . . 0.0 111.492 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.0 pt -141.58 179.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 36.9 m-80 -100.47 93.83 5.83 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.297 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 4' ' ' ALA . 31.4 tp -72.74 97.18 2.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.508 ' HG ' ' H ' ' B' ' 6' ' ' PHE . 5.1 m 62.59 35.22 14.5 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.749 0.785 . . . . 0.0 110.267 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 74.7 m 79.14 0.91 2.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.29 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.9 m -103.82 107.11 55.63 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.91 123.07 12.22 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 121.833 1.688 . . . . 0.0 112.99 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 144.91 49.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.401 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.9 t30 -117.43 168.02 10.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.582 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 3.2 mpt_? 65.58 31.46 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.5 mmm -82.21 130.33 35.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.936 0.874 . . . . 0.0 113.031 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 49.0 mt -98.7 142.66 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.143 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 119' ' ' THR . 6.6 ptm180 -122.76 157.17 32.94 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 167' ' ' GLN . 20.2 p90 -157.75 141.8 15.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.534 0.683 . . . . 0.0 109.997 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.09 98.32 5.73 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.755 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -171.49 134.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.08 114.17 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.311 0.577 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.8 p -121.3 162.05 20.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 143' ' ' THR . 58.6 tttm -157.28 150.47 23.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.22 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 142' ' ' LYS . 57.1 p -37.58 158.83 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.88 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.74 -25.61 8.32 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.4 -0.86 57.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.625 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 9.8 p -76.68 142.53 40.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.58 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.57 -20.36 20.64 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.08 144.71 41.84 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.744 -0.728 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.02 124.25 46.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.302 0.573 . . . . 0.0 112.11 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -90.84 111.61 23.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -146.94 177.27 9.26 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.901 0.858 . . . . 0.0 112.681 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.08 177.54 10.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.944 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.6 t -60.93 111.65 1.75 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.208 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.1 77.77 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.157 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -151.98 121.14 6.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.17 0.485 . . . . 0.0 112.182 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.95 128.68 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -93.82 -41.16 9.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.237 0.541 . . . . 0.0 111.248 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 159.1 -158.47 29.49 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.537 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.92 143.54 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.558 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 162' ' ' GLY . 83.8 t60 -72.8 102.75 3.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.495 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.2 m -91.19 -19.37 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.549 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 160' ' ' HIS . . . -176.88 -152.75 10.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.929 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 176.39 168.31 36.32 Favored Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.544 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 22.0 t-20 -127.92 84.05 2.21 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.622 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.09 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.806 -1.543 . . . . 0.0 115.654 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -102.73 4.54 38.16 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 63.0 mt-30 -126.73 126.59 43.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.426 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.56 143.6 22.69 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.412 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 24.7 m-85 -122.54 109.44 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.918 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.8 t -108.5 146.56 33.0 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.541 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.64 125.07 38.05 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.6 pt20 -69.17 116.17 9.3 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.881 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 90' ' ' ILE . 18.8 tp -83.24 91.91 7.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.918 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -83.67 142.95 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.552 0.691 . . . . 0.0 112.263 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -66.09 -16.43 63.94 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -48.42 -50.98 28.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.733 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -70.91 -29.48 65.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.444 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.218 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.473 ' N ' HD12 ' B' ' 2' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.503 -0.862 0 CA-C-O 120.613 0.244 . . . . 0.0 111.636 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.3 tt0 -94.77 79.17 3.71 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 173.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.581 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -72.42 135.77 45.88 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.587 HD13 ' N ' ' B' ' 6' ' ' PHE . 0.4 OUTLIER -91.18 134.45 34.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.587 ' N ' HD13 ' B' ' 5' ' ' LEU . 25.1 m-85 -50.04 137.02 17.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.625 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 72.1 mt-30 . . . . . 0 N--CA 1.439 -1.024 0 C-N-CA 117.098 -1.841 . . . . 0.0 . -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 112.703 0.232 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.87 -44.35 55.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.431 0.634 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -55.19 -57.32 12.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.758 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.5 -34.31 75.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.6 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.47 -53.83 30.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.258 0.551 . . . . 0.0 110.625 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.38 98.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.947 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.6 tt -62.79 -42.95 99.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.696 0.284 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -69.93 -43.21 72.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.21 -40.68 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.352 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 8.3 tt -60.64 -45.0 95.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.013 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 41.7 mtp180 -73.73 -29.8 62.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -94.87 -51.61 4.61 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.92 -17.31 14.23 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.0 mm -88.05 123.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.65 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.414 ' HA ' ' CE ' ' A' ' 16' ' ' MET . 3.7 mmt -123.53 130.23 52.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -71.96 103.98 3.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.196 178.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 56.6 mt -89.83 107.86 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 122.123 0.963 . . . . 0.0 111.607 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 m -80.41 110.66 16.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.334 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 21' ' ' SER . 6.2 t -134.11 -171.6 2.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.68 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.426 ' N ' ' OG1' ' A' ' 20' ' ' THR . 15.7 m -60.9 -28.47 68.93 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 40' ' ' HIS . 74.3 mmtt -92.78 -4.55 52.86 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.853 -0.53 . . . . 0.0 111.302 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 -151.75 19.1 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 29.1 mt-10 -112.34 129.33 56.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -118.12 167.27 11.64 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.134 0.968 . . . . 0.0 112.428 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 27.0 m -78.75 99.34 6.62 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.931 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 136.39 12.86 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.6 pt? -121.32 129.74 53.26 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 118.389 -1.325 . . . . 0.0 112.597 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.9 109.64 2.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 90' ' ' ILE . 45.8 mm -67.9 -43.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.276 0.56 . . . . 0.0 110.611 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -171.88 146.78 2.1 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.474 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 50.28 -86.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.2 ptt180 -133.85 9.58 3.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.62 -174.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.95 113.78 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.524 0.678 . . . . 0.0 112.06 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.0 m -117.96 144.21 45.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.343 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.21 143.78 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.291 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.8 tt -148.13 144.84 19.37 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.921 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.94 149.14 15.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.153 1.235 . . . . 0.0 110.879 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 28.4 m -70.79 -37.11 73.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 42.8 p-80 -64.34 -7.96 11.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 20' ' ' THR . . . -71.41 -21.74 61.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 55.71 72.5 1.02 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.76 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.86 135.24 25.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.866 2.377 . . . . 0.0 111.873 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.71 -160.05 36.09 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.087 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' VAL . 9.1 p-10 -76.03 -23.78 55.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.206 0.527 . . . . 0.0 110.148 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 1.4 p-10 -139.81 132.96 29.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.81 148.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.511 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.0 mt -96.86 104.36 16.36 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.812 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' OD1' ' A' ' 50' ' ' ASN . 7.6 p -93.9 109.21 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 122.182 0.992 . . . . 0.0 109.962 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 9.4 p-10 45.74 28.36 0.55 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.954 -1.476 . . . . 0.0 113.12 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.45 -20.49 12.3 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.449 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.12 132.41 33.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.3 tttp -85.59 118.41 25.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -138.62 119.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.045 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 36.4 ptt180 -72.57 151.79 42.19 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.82 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 45' ' ' ASP . 11.1 p -74.54 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.056 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -98.36 -40.56 8.25 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 27.4 t0 -155.43 134.68 12.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.482 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -136.34 115.32 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.414 . . . . 0.0 110.633 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -122.97 125.9 46.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 49.9 mtmt -84.48 112.45 20.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.642 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 39.9 mt -75.47 109.08 8.72 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 m -101.55 148.79 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.45 140.93 95.24 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.326 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -45.9 -24.78 2.32 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.526 2.151 . . . . 0.0 113.851 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 9.81 3.62 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.374 0.607 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 73.11 30.97 1.53 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 132' ' ' ASN . 34.7 mt -119.61 155.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -64.93 129.17 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.642 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 37.2 tp -104.07 -22.49 13.43 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.553 ' HG2' HG11 ' A' ' 161' ' ' VAL . 37.3 tp10 75.09 8.45 4.04 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.47 107.61 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.971 0.351 . . . . 0.0 111.09 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 93.1 m -89.62 112.53 23.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.516 . . . . 0.0 109.72 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 62' ' ' LEU . 87.1 t -82.53 106.22 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -101.28 100.9 11.48 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.175 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 17.6 m -91.49 110.33 21.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.426 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 31.0 mt -117.81 120.24 37.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.605 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.64 101.89 0.85 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 117.729 -1.588 . . . . 0.0 109.46 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HE ' ' HG2' ' A' ' 81' ' ' GLU . 6.6 tpt180 -102.41 129.69 48.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.65 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -76.49 -25.65 54.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.024 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' HE ' ' A' ' 79' ' ' ARG . 15.3 pt-20 -97.15 120.78 38.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -73.6 129.33 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -77.2 137.57 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -44.78 131.56 6.91 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.274 -0.266 . . . . 0.0 111.041 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.25 92.66 3.88 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.282 0.563 . . . . 0.0 112.12 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.4 pt -93.48 20.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -61.64 -39.13 90.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.079 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.35 -11.32 85.14 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.104 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 47.2 m-85 -87.82 -20.58 25.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 117.77 0.785 . . . . 0.0 109.652 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 30' ' ' ILE . 45.4 mt -74.06 146.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 p -120.2 139.61 52.39 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.495 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 176' ' ' GLN . 8.6 pt-20 -78.01 -42.63 31.98 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.27 120.53 42.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 172' ' ' GLN . 26.7 mt -58.87 -68.18 0.29 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 56.57 70.87 0.61 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.46 93.42 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.13 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -87.84 3.42 5.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.889 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 13.5 t70 -131.05 124.34 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.368 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.79 163.85 31.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.227 1.013 . . . . 0.0 113.115 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.1 m -116.19 143.32 45.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.638 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -116.22 122.11 44.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 -177.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.43 113.03 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.304 0.573 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -99.37 139.75 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.631 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.548 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.8 t60 -146.36 59.62 1.22 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.1 m -108.88 -179.5 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.118 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.8 p-10 -68.39 -38.91 81.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.436 1.016 . . . . 0.0 111.765 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.54 HD22 ' HA2' ' A' ' 144' ' ' GLY . 79.3 m-20 -70.08 -60.12 2.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.087 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -108.06 92.9 4.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 m -91.83 110.64 21.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.514 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.548 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 41.2 t30 64.01 71.8 0.48 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.608 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.3 m -130.98 103.47 6.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.124 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.7 113.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.591 0.71 . . . . 0.0 110.414 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.1 mt -122.53 134.31 54.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.754 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.67 104.45 16.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.24 -41.09 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 96.54 -119.06 6.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.716 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.5 Cg_exo -60.42 100.41 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 115.684 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 137' ' ' TYR . 6.4 m -108.05 126.09 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -142.28 146.78 35.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -77.88 135.27 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.546 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.82 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.19 -116.11 3.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.283 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.93 106.99 14.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.888 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.464 HG21 HD23 ' B' ' 2' ' ' LEU . 44.1 pt -125.17 -172.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.154 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.8 m120 -113.14 95.39 5.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.35 0.595 . . . . 0.0 110.653 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.507 HD21 ' CG1' ' A' ' 161' ' ' VAL . 43.9 tp -81.62 106.85 13.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.4 m 64.77 25.74 12.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.2 m 86.1 -11.24 0.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.824 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.8 m -87.07 119.42 71.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.404 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.19 117.39 4.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.199 1.932 . . . . 0.0 112.36 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -117.46 132.87 56.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.178 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 63.2 t30 -98.76 141.04 32.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.707 0.765 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 64.09 47.08 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.713 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.412 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.78 130.42 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.666 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 61.4 mt -89.44 134.54 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.493 0.663 . . . . 0.0 111.61 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -109.17 130.64 55.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.565 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.65 ' HB3' HG12 ' A' ' 118' ' ' VAL . 2.4 p90 -139.19 127.83 23.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.61 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.66 110.61 5.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.991 0.9 . . . . 0.0 111.251 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -179.71 132.05 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.799 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -61.49 106.68 0.68 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.4 p -112.38 140.18 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.531 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -130.44 152.61 49.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.267 1.032 . . . . 0.0 112.001 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.491 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.18 153.68 0.06 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.759 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.54 ' HA2' HD22 ' A' ' 107' ' ' ASN . . . 92.66 -18.2 55.83 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -94.24 -4.57 48.66 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.529 -0.836 . . . . 0.0 112.155 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.658 ' SG ' ' CA ' ' B' ' 7' ' ' GLN 0.265 29.2 p -85.55 151.82 23.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 116.575 -2.05 . . . . 0.0 113.763 -174.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.712 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 106.59 -20.56 34.24 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -53.47 146.83 19.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.735 -0.732 . . . . 0.0 111.697 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.48 125.96 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.821 0.819 . . . . 0.0 113.162 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.43 HD13 HD23 ' A' ' 101' ' ' LEU . 37.8 tp -90.78 108.99 20.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.617 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.9 p -145.48 -179.72 6.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.031 0.919 . . . . 0.0 113.381 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.24 -172.71 4.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.642 -1.617 . . . . 0.0 108.568 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 153' ' ' THR . 9.8 t -66.93 101.75 0.88 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.012 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.9 83.99 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.302 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 79.3 mttt -140.43 140.08 35.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.415 0.626 . . . . 0.0 111.816 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.92 123.54 71.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -97.75 -31.89 12.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.934 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 167.53 -163.12 36.88 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.423 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.5 144.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.701 0.762 . . . . 0.0 111.413 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.453 ' HB2' HD21 ' A' ' 101' ' ' LEU . 6.1 t60 -62.72 114.11 3.41 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.454 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 71' ' ' GLU . 47.8 t -103.6 -33.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.563 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.42 -147.13 5.54 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.646 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.37 166.3 32.18 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.306 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.514 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 5.3 t30 -132.91 89.67 2.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 109.812 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.52 -102.25 0.42 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.097 -0.956 . . . . 0.0 114.491 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 23.4 mtp180 -94.29 4.81 53.37 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -131.98 114.75 14.98 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.27 39.44 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.838 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.0 m-85 -129.01 118.16 22.11 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.021 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.48 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 27.0 t -111.64 159.83 17.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.252 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.87 131.54 44.26 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.47 ' HG3' HD21 ' A' ' 94' ' ' LEU . 47.3 tt0 -68.88 104.49 2.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.086 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 19.0 tp -80.16 92.87 5.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -87.67 119.94 28.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.994 0.902 . . . . 0.0 112.614 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -53.47 -31.16 44.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.537 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 4.9 pt20 -60.71 -17.74 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.98 -14.66 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.089 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.269 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.682 0.277 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.7 tt0 -109.99 74.21 0.88 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 171.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.514 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -74.94 153.68 38.47 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 23.4 tp -113.42 152.4 30.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.622 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 23.2 m-85 -56.99 146.98 25.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.658 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 96.6 mt-30 . . . . . 0 N--CA 1.436 -1.174 0 C-N-CA 119.891 -0.723 . . . . 0.0 . 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 N--CA 1.462 -0.329 0 N-CA-C 113.363 0.486 . . . . 0.0 113.363 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.451 ' HA ' ' OG1' ' A' ' 153' ' ' THR . 17.7 m120 -66.27 -44.17 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.131 0.491 . . . . 0.0 112.136 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -46.35 83.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.214 0.53 . . . . 0.0 111.869 -178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -55.01 -55.08 34.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.316 0.579 . . . . 0.0 111.659 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -63.47 -47.33 82.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.94 90.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.488 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 6.4 tt -67.36 -39.44 85.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 p -69.75 -41.49 75.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.184 -0.323 . . . . 0.0 111.201 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.7 tt -69.8 -39.84 76.32 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.043 0.449 . . . . 0.0 110.963 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD22 ' HD2' ' A' ' 12' ' ' ARG . 7.0 tt -54.76 -55.76 26.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD22 ' A' ' 11' ' ' LEU . 12.4 mpt_? -61.2 -27.82 68.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.1 -52.98 4.56 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -106.44 -9.64 16.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -100.3 109.15 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.548 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt -121.96 155.54 35.3 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.845 0.831 . . . . 0.0 110.72 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -75.87 101.13 5.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.985 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.47 107.39 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.433 0.635 . . . . 0.0 110.544 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.6 m -76.82 99.91 5.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.089 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.8 p -95.33 -177.59 4.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.538 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m -75.28 -14.94 60.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.167 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -105.5 -8.11 18.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.415 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 -179.66 22.07 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 17' ' ' THR . 46.3 mm-40 -79.15 121.18 24.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -127.1 164.73 20.95 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.789 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.4 m -74.86 95.27 2.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.182 -1.826 . . . . 0.0 111.018 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.05 104.87 2.38 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 tp -88.73 104.89 17.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.0 112.162 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.58 126.64 12.87 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 90' ' ' ILE . 29.3 mm -89.34 -51.57 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 117.417 0.608 . . . . 0.0 110.399 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -171.95 149.17 2.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.614 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.06 -87.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -135.86 16.06 3.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.494 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.51 119.83 49.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.302 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -125.39 147.16 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.506 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.66 136.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.859 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' A' ' 73' ' ' THR . 15.5 mm -141.04 142.68 28.48 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.34 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.37 148.04 91.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.277 1.318 . . . . 0.0 111.657 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 52.2 m -68.23 -35.52 78.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.837 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' B' ' 6' ' ' PHE . 54.6 p-80 -74.02 -3.96 32.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -20.7 38.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.581 0.705 . . . . 0.0 109.366 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 59.14 71.64 0.92 Allowed Pre-proline 0 CA--C 1.517 -0.311 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.052 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.67 125.44 10.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.59 1.526 . . . . 0.0 108.963 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.15 178.88 50.94 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.372 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 56' ' ' VAL . 19.7 t70 -70.07 -31.2 68.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 4.9 p-10 -120.18 140.94 50.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.13 161.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.407 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -98.22 114.48 26.75 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.678 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -91.9 92.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.165 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 66.78 5.25 3.84 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.339 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -31.88 2.34 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.976 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' CD ' HH12 ' A' ' 79' ' ' ARG . 50.3 tt0 -81.72 137.3 35.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 110.449 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -78.45 128.97 34.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.44 154.44 13.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.611 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.5 mtm180 -106.33 153.39 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.944 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 75' ' ' LEU . 7.7 p -94.96 118.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.49 -33.11 68.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.17 107.83 4.13 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.863 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.47 95.88 6.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -109.31 123.35 49.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.589 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -76.4 124.27 27.28 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -89.51 103.86 16.46 Favored 'General case' 0 C--O 1.259 1.596 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 29.6 m -110.82 173.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.844 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -72.5 139.64 81.32 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.55 -27.58 41.63 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.936 1.758 . . . . 0.0 111.788 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -85.54 8.39 19.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.459 0.647 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.5 t30 64.06 68.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.457 1.123 . . . . 0.0 111.183 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.455 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.9 mt -139.93 170.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 112.313 -2.221 . . . . 0.0 105.32 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 68' ' ' ILE . 65.7 t30 -86.43 135.72 33.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.342 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.641 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 20.4 mt -108.0 -26.94 10.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.0 tp10 79.09 3.6 2.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.132 -1.394 . . . . 0.0 113.169 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 17.7 mt -89.88 126.05 35.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.406 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 39.8 m -103.96 118.8 37.52 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.063 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.2 102.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 56' ' ' VAL . 13.9 tp -95.42 94.95 8.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.85 -178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -84.17 94.95 8.49 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.958 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' VAL . 83.6 mt -99.29 122.57 42.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.213 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.26 84.7 5.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.406 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.429 HH12 ' CD ' ' A' ' 52' ' ' GLN . 27.9 tpt180 -95.56 133.01 40.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.661 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.22 -44.42 79.51 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 118.11 17.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -87.14 134.51 33.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.331 0.586 . . . . 0.0 111.945 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -68.92 137.47 53.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.438 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -72.91 131.4 42.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.946 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.86 86.07 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 18.5 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -63.56 -28.44 69.94 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.698 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.74 -18.65 74.94 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.531 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 92.5 m-85 -77.43 -22.78 50.96 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HD12 ' A' ' 30' ' ' ILE . 72.9 mt -72.58 123.66 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.6 t -123.37 136.35 54.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -65.92 -42.14 90.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.96 107.01 18.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.72 -76.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HB3' ' NZ ' ' A' ' 155' ' ' LYS . 39.2 tt0 51.43 70.82 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.82 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.02 86.84 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.573 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.61 2.14 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.453 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.9 t70 -139.35 124.4 18.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.557 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.36 168.57 19.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.644 0.735 . . . . 0.0 112.545 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 34.2 m -119.67 136.42 54.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.381 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 160' ' ' HIS . 3.1 tm? -99.48 114.11 26.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.12 120.49 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.161 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -113.99 119.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.425 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -129.32 72.8 1.48 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.2 p -121.36 -171.95 2.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.632 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.44 -35.76 71.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.27 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.58 -55.81 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.04 125.35 12.27 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.392 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 1.6 p -88.15 112.58 22.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' THR . 84.0 m-20 76.29 74.48 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 103' ' ' VAL . 23.8 m -142.22 136.37 29.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.195 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.47 137.24 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 109.651 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.78 108.72 13.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.624 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.7 pt-20 -75.65 108.2 8.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.08 -29.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.547 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.62 -115.81 4.61 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.945 -1.121 . . . . 0.0 115.735 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 15.4 Cg_exo -60.19 109.35 0.61 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.95 2.434 . . . . 0.0 115.448 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.88 134.94 35.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -134.64 -172.27 2.98 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.86 147.55 48.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.07 -14.19 11.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.49 -111.69 3.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.974 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.2 118.73 32.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.51 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' B' ' 2' ' ' LEU . 49.3 pt -135.32 -179.27 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 5.4 m-20 -96.29 123.7 40.02 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.967 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 53.7 tp -106.12 104.22 13.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 128' ' ' SER . 10.1 t 63.47 28.57 15.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 127' ' ' SER . 93.4 p 80.16 1.23 2.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.873 1.669 . . . . 0.0 112.011 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 m -95.3 114.45 63.85 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.291 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.23 114.06 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.11 1.873 . . . . 0.0 112.718 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -121.3 130.01 53.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.615 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -105.59 164.46 11.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 55.18 50.07 15.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.352 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 35.2 ttm -101.85 134.65 44.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.061 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 70.0 mt -86.78 152.07 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.296 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -129.58 151.03 50.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.45 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -156.32 142.95 18.6 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.584 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.44 99.36 6.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.505 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -171.02 127.9 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.062 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 110.94 3.25 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.529 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.437 HG22 HE22 ' A' ' 145' ' ' GLN . 29.1 p -109.62 156.54 20.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.855 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 143' ' ' THR . 51.0 tttm -143.36 152.41 41.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.016 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 6.3 p -40.59 161.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.481 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.65 -28.58 7.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.502 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.437 HE22 HG22 ' A' ' 141' ' ' THR . 24.7 mt-30 -83.09 -11.58 57.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.64 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 25.2 p -72.08 111.95 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.634 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 137.23 -14.71 3.74 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.615 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.75 151.72 52.21 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 124.32 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 112.039 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.0 tp -91.98 109.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.3 p -144.59 178.25 8.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.97 0.89 . . . . 0.0 112.13 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.7 174.65 10.46 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.766 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 3' ' ' ASN . 27.9 m -72.45 94.44 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.04 -24.61 9.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.584 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 94.0 mttt -134.65 146.52 49.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.73 0.776 . . . . 0.0 112.507 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 mm -110.1 130.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -101.69 -45.39 5.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.46 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.596 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.0 -170.17 43.0 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.651 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.506 HG23 HD11 ' A' ' 173' ' ' LEU . 30.5 pt -116.68 143.63 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.542 ' HB2' HD21 ' A' ' 101' ' ' LEU . 67.0 t60 -73.52 114.98 12.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.321 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.77 -21.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -176.63 -157.01 16.75 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.886 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.96 165.96 35.82 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.578 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 28.1 t-20 -136.62 85.99 2.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.778 0.799 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.31 -106.99 1.61 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.563 -1.198 . . . . 0.0 115.178 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.14 -17.11 57.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.93 127.31 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.48 142.4 17.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.464 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 66.6 m-85 -119.5 122.06 40.81 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.236 1.018 . . . . 0.0 111.994 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 32.3 t -119.83 149.71 41.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.38 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.39 136.29 35.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -67.46 123.99 21.95 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.596 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 29.6 mt -90.61 84.96 5.97 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -80.75 135.72 36.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.999 0.428 . . . . 0.0 110.37 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.09 -29.14 68.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.401 0.619 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -55.14 -32.12 61.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.536 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.3 -11.64 51.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 . . . . . 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.489 -179.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' A' ' 124' ' ' ILE . 2.7 mm? . . . . . 0 CA--C 1.514 -0.438 0 CA-C-O 121.457 0.646 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.2 tt0 -122.49 79.67 1.64 Allowed 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 171.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.59 145.63 30.53 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 33.2 tp -98.59 153.58 18.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.5 m-85 -59.15 142.35 51.82 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.64 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.3 mt-30 . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 118.203 -1.399 . . . . 0.0 . -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo . . . . . 0 CA--C 1.543 0.929 0 N-CA-C 115.186 1.187 . . . . 0.0 115.186 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.1 t-20 -57.01 -51.07 70.72 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.828 -0.545 . . . . 0.0 112.206 -177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -56.28 -45.29 80.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.698 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.12 -28.35 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 111.224 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.05 -44.66 83.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.82 90.76 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.485 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.33 -49.81 74.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.987 0.423 . . . . 0.0 110.193 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.24 -39.55 82.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.972 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.8 tp -62.09 -49.57 75.4 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.509 0.671 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.8 tt -54.6 -43.72 72.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.155 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -64.91 -29.69 70.65 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.6 6.15 13.38 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.953 0.797 . . . . 0.0 112.982 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.8 -38.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.1 mt -86.39 115.89 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.353 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.4 mtt -119.72 161.74 20.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.925 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -92.8 123.67 36.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.92 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -112.84 105.57 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.931 0.872 . . . . 0.0 111.448 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.683 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.1 m -78.0 123.04 26.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.619 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.1 p -126.26 -173.48 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 m -81.03 -9.47 59.83 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -91.46 -43.47 9.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.6 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.66 -169.05 42.18 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.268 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG2' HG23 ' A' ' 19' ' ' THR . 31.4 mt-10 -106.02 107.32 18.26 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -101.98 171.13 7.69 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.423 1.106 . . . . 0.0 113.516 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.7 m -79.9 113.77 18.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.534 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.02 112.49 4.48 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.781 -1.199 . . . . 0.0 110.877 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 tp -94.98 120.0 34.46 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -89.25 129.86 9.88 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.476 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -90.61 -56.85 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.72 0.76 . . . . 0.0 110.426 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -160.33 127.56 4.42 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 12.5 t0 56.89 -78.35 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.486 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 15.2 mmt-85 -120.46 -11.24 9.14 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.851 -0.531 . . . . 0.0 110.666 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 HG13 ' A' ' 74' ' ' VAL . 57.2 t -80.19 99.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.331 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 45.7 t -114.23 141.84 47.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.838 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 173' ' ' LEU . 24.1 m -111.84 137.64 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.712 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.7 tt -142.24 141.7 22.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.36 142.53 16.91 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.253 1.302 . . . . 0.0 111.351 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.539 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 83.7 m -70.82 -34.84 72.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.132 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -65.62 -7.22 13.91 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.389 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.95 60.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.48 0.657 . . . . 0.0 109.672 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.6 mm-40 50.1 72.83 1.12 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.893 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.03 156.06 60.94 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.96 2.44 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -153.46 26.14 Favored Glycine 0 N--CA 1.455 -0.062 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.835 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.24 -15.58 35.51 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 2.2 p30 -139.27 156.56 46.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.223 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.23 161.06 17.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 77.3 mt -104.38 108.51 19.96 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 17' ' ' THR . 80.2 t -84.6 85.07 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.352 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 73.82 -10.1 1.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.091 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.82 -33.33 0.57 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.91 111.08 1.16 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.802 -1.199 . . . . 0.0 111.557 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -75.12 96.48 3.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 tt -123.92 148.02 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.661 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 8.4 mpt_? -97.44 165.05 12.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.326 0.584 . . . . 0.0 111.526 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.4 t -90.45 120.65 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.725 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 78' ' ' ASP . 75.9 tttt -79.86 -38.67 32.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.385 0.612 . . . . 0.0 110.152 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -159.29 132.63 7.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.395 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.97 114.57 26.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.185 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -118.06 105.73 12.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.319 -178.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.09 110.11 18.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.543 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 71.2 mt -79.32 120.86 24.38 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.447 ' HA ' ' H ' ' A' ' 70' ' ' LEU . 33.5 m -116.01 154.87 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 12.6 t70 -87.1 143.45 34.85 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 119.034 0.834 . . . . 0.0 112.91 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -43.72 -17.13 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.52 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.633 ' HG2' ' OD1' ' A' ' 64' ' ' ASP . 52.7 mm-40 -71.34 0.9 7.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.316 0.579 . . . . 0.0 109.827 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 64.4 m-80 72.75 18.82 4.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -116.98 145.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.858 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -51.6 135.58 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.106 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.0 tp -104.56 -16.69 14.96 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.539 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 68.3 14.76 9.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.122 -1.399 . . . . 0.0 113.648 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 82.1 mt -105.91 105.29 15.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.061 0.457 . . . . 0.0 111.499 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -89.54 110.19 21.06 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.434 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 95.5 t -81.51 108.86 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 tp -101.49 100.34 10.77 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.815 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 14.1 m -74.41 102.76 4.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 33' ' ' ARG . 86.5 mt -104.71 127.81 52.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.619 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 57' ' ' LYS . 14.1 t70 -87.79 89.46 8.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -93.61 133.89 36.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.61 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.91 -28.75 58.21 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.34 118.36 36.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 19.0 pttp -59.89 129.21 40.71 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.211 -0.995 . . . . 0.0 108.842 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -78.97 161.53 26.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.593 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -49.08 122.84 6.33 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -175.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.22 93.76 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.841 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 156' ' ' ILE . 49.0 pt -96.81 19.11 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -56.16 -35.31 67.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.312 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.76 -16.28 79.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.062 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -87.61 -13.13 43.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.55 133.37 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 7.1 m -96.25 130.94 43.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -77.97 -55.1 5.57 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 91' ' ' SER . 29.0 t70 -100.94 131.68 46.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.4 mt -79.39 -67.64 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.827 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 47.04 71.68 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -167.26 78.32 0.11 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.2 p -71.83 12.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 27.8 t70 -150.31 121.55 7.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.833 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.76 12.6 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.866 0.841 . . . . 0.0 111.591 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 m -120.06 145.96 46.36 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.585 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 9.6 tt -120.56 121.94 39.5 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 112' ' ' ILE . 24.2 m -111.21 121.92 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.061 0.458 . . . . 0.0 111.04 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 4.0 t -100.5 134.48 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.08 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -135.7 70.97 1.42 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 m -127.18 175.43 8.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.764 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 25.8 p-10 -71.42 -20.05 62.16 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.359 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -84.97 -34.16 22.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.423 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.47 97.29 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.421 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 102.85 15.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 60.55 70.83 0.6 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.839 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 28.6 m -117.75 111.87 19.69 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.855 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 102' ' ' VAL . 2.0 mp -87.36 105.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 tt -116.56 127.24 54.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.658 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.71 128.51 34.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.17 -24.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.03 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 79.13 -124.12 6.43 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.852 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 27.9 Cg_endo -62.66 105.11 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.52 2.147 . . . . 0.0 114.495 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 90.6 t -97.2 118.32 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.694 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 p -138.07 167.58 21.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.971 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -104.53 126.04 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.61 -49.79 6.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.88 -115.89 4.13 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.476 -0.868 . . . . 0.0 115.114 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 123' ' ' LEU . 3.8 mp -95.96 107.8 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.061 -0.569 . . . . 0.0 112.096 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 42.2 pt -138.98 -177.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.274 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -102.1 136.53 41.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.008 0.432 . . . . 0.0 110.598 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 4.1 mm? -115.07 103.81 11.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' SER . 10.3 t 60.8 31.13 20.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.768 -0.582 . . . . 0.0 109.751 -177.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 127' ' ' SER . 67.0 m 79.96 2.94 2.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.444 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -99.59 115.68 65.45 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.777 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.05 115.37 2.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.947 1.765 . . . . 0.0 112.368 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.563 ' HB ' HD23 ' A' ' 126' ' ' LEU . 19.7 m -128.69 141.84 51.21 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.014 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 60.3 t30 -117.91 162.8 17.54 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 3.2 mpt_? 77.84 22.94 0.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.659 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.48 129.27 37.62 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.146 0.974 . . . . 0.0 113.303 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 79.6 mt -92.3 132.66 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.278 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -107.25 129.22 54.9 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.515 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 1.3 p90 -133.29 143.44 49.05 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.96 99.49 9.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.636 0.732 . . . . 0.0 112.009 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 141' ' ' THR . 88.8 t80 -170.11 126.16 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.023 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.12 110.97 1.76 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 36.8 p -112.52 151.68 29.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -143.16 151.52 40.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.334 1.064 . . . . 0.0 110.916 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.403 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.86 156.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.363 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.81 -20.74 45.41 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 121.726 0.625 . . . . 0.0 111.648 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -87.33 2.94 48.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.459 -0.871 . . . . 0.0 112.228 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.79 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 16.6 m -64.8 142.62 58.37 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.621 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 104.5 -23.54 31.24 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.866 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 101' ' ' LEU . . . -49.74 135.92 24.3 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.562 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 47.3 t -88.78 122.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 111.847 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -93.46 108.83 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -146.65 166.18 27.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.193 0.997 . . . . 0.0 113.418 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -128.74 173.25 10.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.485 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -67.53 106.26 2.1 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.885 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.99 6.47 89.44 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.24 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -137.96 112.98 9.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.416 ' CD1' HD12 ' A' ' 86' ' ' ILE . 65.7 mt -103.59 134.73 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.362 0.601 . . . . 0.0 110.596 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -99.53 -55.13 2.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.931 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.64 -156.97 21.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.55 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.1 pt -125.94 148.04 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.334 0.588 . . . . 0.0 112.089 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.01 116.55 6.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.195 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 171' ' ' ALA . 46.2 t -104.48 -28.88 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.625 0.726 . . . . 0.0 109.901 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' B' ' 7' ' ' GLN . . . 174.44 -145.84 8.26 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.589 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.62 174.11 44.56 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.4 t-20 -135.26 86.26 2.23 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.733 0.778 . . . . 0.0 109.769 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.05 -103.52 0.73 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.545 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -82.85 -11.49 58.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.68 -177.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.474 ' OE1' ' HB3' ' A' ' 166' ' ' ARG . 1.1 mp0 -112.8 145.99 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.851 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -105.13 150.8 17.11 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.7 m-85 -132.8 119.69 20.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.217 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.7 t -113.59 152.66 30.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.579 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 161' ' ' VAL . . . -90.98 135.19 33.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 9.0 tt0 -74.93 113.48 12.28 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.595 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.4 mp -82.9 83.04 7.92 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -81.06 121.14 25.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.122 0.963 . . . . 0.0 111.249 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -39.67 -39.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.253 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -45.56 -51.21 12.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -69.45 -19.99 63.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.704 -179.367 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.8 mm? . . . . . 0 CA--C 1.508 -0.637 0 CA-C-O 121.273 0.559 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -121.89 77.32 1.36 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -77.51 147.2 35.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.508 HD12 ' H ' ' B' ' 6' ' ' PHE . 55.1 tp -103.24 142.85 33.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.508 ' H ' HD12 ' B' ' 5' ' ' LEU . 24.6 m-85 -57.78 125.39 22.81 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.06 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.79 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 83.2 mt-30 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 116.525 -0.307 . . . . 0.0 . 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo . . . . . 0 CA--C 1.529 0.266 0 N-CA-C 113.913 0.697 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.3 -51.81 53.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.296 0.57 . . . . 0.0 110.834 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -67.63 -36.15 80.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.941 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.19 -50.53 73.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 110.578 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.19 -48.75 79.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.05 83.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.438 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.3 tt -64.28 -40.39 95.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.596 0.236 . . . . 0.0 110.666 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -63.95 -43.71 94.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.38 . . . . 0.0 110.678 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.3 tp -67.51 -43.17 81.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.682 0.754 . . . . 0.0 110.58 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.3 tp -49.77 -50.54 44.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.436 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 78.4 mtp180 -56.9 -40.05 75.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.74 -15.49 8.9 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.9 5.56 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.8 mm -119.12 109.48 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.4 mmt -124.78 150.84 45.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.654 0.74 . . . . 0.0 111.211 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -76.33 95.36 3.76 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.7 mp -87.86 104.5 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 m -95.88 113.57 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.199 1.0 . . . . 0.0 109.987 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 69.4 p -94.44 -162.84 0.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.863 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.6 m -80.15 -7.25 58.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.68 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -100.74 -56.21 2.39 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.255 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.46 -163.59 26.55 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -83.49 123.39 29.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.267 -0.466 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -126.41 159.28 33.72 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 121.189 0.519 . . . . 0.0 109.709 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 14.2 m -90.16 109.23 20.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.141 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -88.23 110.18 3.6 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.368 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.1 120.4 36.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -87.27 138.84 15.66 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.63 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 31' ' ' HIS . 4.1 mp -120.57 -39.8 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 118.447 1.124 . . . . 0.0 110.911 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 36.0 m-70 -135.43 128.61 31.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 18.8 t70 43.72 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 14.3 ptt180 -127.08 21.54 6.78 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.963 0.887 . . . . 0.0 109.253 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.38 112.46 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.064 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 63.2 m -116.76 156.7 26.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.65 139.52 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.176 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 pt -142.01 162.86 43.64 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.0 152.45 71.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 121.212 1.275 . . . . 0.0 111.52 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 61.0 m -70.69 -33.1 70.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -79.13 3.89 16.3 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.64 59.67 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 20' ' ' THR . 12.7 mm100 68.41 72.32 0.36 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.44 117.01 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.985 2.457 . . . . 0.0 110.086 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.35 -138.11 2.81 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.812 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' HG12 ' A' ' 56' ' ' VAL . 24.8 t70 -77.55 -24.67 49.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.515 ' HB3' HH11 ' A' ' 55' ' ' ARG . 4.9 p-10 -142.83 162.63 34.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.881 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -140.79 149.04 21.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 84.6 mt -82.99 99.99 10.17 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.731 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -86.16 96.1 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.156 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 63.91 18.91 11.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.39 -17.81 21.09 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.338 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -90.64 123.54 34.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.11 113.31 14.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.181 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.2 mt -116.75 122.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.5 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 46' ' ' ASP . 2.7 mpt_? -66.84 152.0 46.43 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.368 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -94.4 137.25 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 33' ' ' ARG . 67.7 mttm -92.56 -55.52 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' ' HB ' ' A' ' 76' ' ' THR . 29.1 m-20 -128.26 140.14 52.05 Favored 'General case' 0 N--CA 1.46 0.049 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.622 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -132.44 78.93 1.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.567 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 90.6 t80 -88.01 131.33 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.591 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 10.6 mptt -90.1 116.13 27.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.98 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 17.2 mt -82.93 119.08 23.96 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-O 121.608 0.718 . . . . 0.0 110.549 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 29.8 m -128.62 158.22 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.147 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.05 145.26 88.57 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.261 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.11 -19.12 3.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.809 1.673 . . . . 0.0 113.218 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.06 5.57 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 109.81 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.76 61.59 0.97 Allowed 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.808 0.813 . . . . 0.0 109.641 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' LEU . 35.9 mm -133.44 145.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.026 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -59.57 128.87 39.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -105.1 -24.36 12.79 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 174.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.629 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 75.22 10.31 3.67 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.452 -1.703 . . . . 0.0 113.607 175.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 10.5 mp -95.13 122.2 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.4 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 92.4 m -98.26 112.45 24.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.485 0.659 . . . . 0.0 109.883 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 98.9 t -76.2 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.7 tp -94.25 102.02 14.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.388 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 20.1 m -89.36 100.84 13.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 122.091 0.948 . . . . 0.0 109.178 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.8 mt -74.63 141.25 44.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 19.5 t70 -82.88 72.63 9.95 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.09 133.67 46.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.148 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -81.05 -32.13 34.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.97 98.44 2.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -88.46 150.18 23.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.139 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.404 ' HB2' ' H ' ' A' ' 84' ' ' ARG . 5.8 p90 -92.21 -163.9 1.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.528 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 12.5 tpp180 -83.86 117.58 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.598 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 31' ' ' HIS . 4.8 m-20 -66.57 99.46 0.59 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -91.56 27.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 122.037 -0.414 . . . . 0.0 111.544 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -65.1 -15.46 62.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.463 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.6 -16.42 75.66 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.764 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -91.7 -14.41 30.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.06 127.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 38.9 m -125.95 132.85 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.495 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.3 pm0 -81.93 -27.29 33.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.75 149.08 26.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.4 mt -103.4 -68.61 0.83 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 41.75 37.66 0.8 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.433 0.635 . . . . 0.0 112.31 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.57 73.62 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 118' ' ' VAL . 1.2 p -73.5 20.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.138 -1.531 . . . . 0.0 114.818 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -121.59 130.12 53.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.43 166.32 25.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.476 -0.89 . . . . 0.0 113.1 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 96.4 m -121.55 142.54 49.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.49 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.13 113.41 26.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.6 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.95 97.57 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -87.93 123.01 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.619 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.0 t60 -137.64 33.31 2.47 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 20.1 p -109.51 -162.44 0.81 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.024 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 105' ' ' SER . 29.0 t-20 -53.35 -56.58 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.15 -44.25 80.24 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.557 -0.714 . . . . 0.0 112.055 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.55 106.28 7.74 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.416 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 23.9 m -93.91 105.72 17.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.619 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 9.9 t30 79.18 72.42 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.275 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.3 m -141.15 107.86 5.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.37 100.37 11.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.801 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 139' ' ' TYR . 58.1 tp -127.55 128.24 45.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.327 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 8.6 pt-20 -79.19 142.53 36.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.83 -20.07 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.55 -124.78 7.96 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.958 -1.115 . . . . 0.0 114.846 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.25 128.62 12.26 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 114.833 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 97' ' ' VAL . 86.8 t -104.91 157.58 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.764 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 36.7 m -160.21 114.89 2.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -78.01 115.94 18.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 118.668 -1.213 . . . . 0.0 108.059 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.9 -11.88 46.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.612 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.08 -120.64 5.26 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.788 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 68' ' ' ILE . 48.5 tp -94.17 113.66 25.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' ' 2' ' ' LEU . 34.4 pt -138.42 177.83 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.1 m-20 -94.64 128.35 41.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.657 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 68.4 tp -115.36 105.05 12.41 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' SER . 12.5 t 62.24 30.57 17.61 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.7 m 82.1 -1.55 1.48 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.151 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 39.3 m -100.22 123.09 47.98 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.874 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.71 116.37 3.21 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.04 1.827 . . . . 0.0 111.739 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.6 m -126.82 134.25 50.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.279 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -108.93 163.2 13.51 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 177' ' ' TYR . 15.8 mmt180 66.37 24.0 10.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.022 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 tpt -72.24 128.86 36.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.143 0.973 . . . . 0.0 112.034 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 38.2 mm -92.43 126.61 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.899 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' THR . 33.8 ttt-85 -104.75 137.27 42.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.33 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.4 p90 -145.63 109.51 4.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -74.01 99.3 3.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.829 1.3 . . . . 0.0 110.914 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 113' ' ' LEU . 85.4 t80 -160.21 137.95 9.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 111.497 -2.592 . . . . 0.0 106.32 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 86.18 1.95 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -101.01 161.84 13.31 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -141.99 168.29 20.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.849 1.309 . . . . 0.0 113.093 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.576 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.03 152.61 0.17 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.763 175.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.5 -19.81 50.38 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -94.22 7.21 46.12 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.205 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.796 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 13.7 m -62.47 136.97 58.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.0 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 103.91 -16.98 50.01 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.829 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.5 142.28 43.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.505 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.13 114.9 29.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.439 0.638 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.7 tp -89.54 106.56 18.53 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.016 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.0 p -149.85 -177.17 5.74 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.039 0.923 . . . . 0.0 111.447 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.99 163.96 35.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.734 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 t -61.12 120.94 11.28 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.717 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.87 -19.39 45.85 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 24.9 ttmm -144.41 124.59 13.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.878 0.839 . . . . 0.0 111.537 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.33 135.34 38.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.455 ' HA ' HE22 ' A' ' 172' ' ' GLN . 93.1 m-85 -103.06 -71.21 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . -152.56 -169.13 17.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.387 -1.387 . . . . 0.0 114.719 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 161' ' ' VAL . 27.4 pt -119.36 140.67 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.457 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -61.09 120.33 10.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 159' ' ' ILE . 73.2 t -117.08 -28.35 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.491 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.09 -151.28 8.4 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.345 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.48 161.16 27.6 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.0 t-20 -135.29 107.91 7.43 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.34 -110.18 3.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.872 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -113.06 25.82 11.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.248 1.023 . . . . 0.0 109.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -126.07 135.99 52.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.447 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -94.38 148.39 18.98 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.282 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.2 m-85 -128.96 123.42 32.44 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.822 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.8 t -116.07 155.5 28.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.511 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.91 123.8 42.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 174' ' ' LYS . 55.8 tp60 -72.27 124.85 25.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.638 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.0 mp -88.87 84.17 6.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 172' ' ' GLN . 66.4 mttm -78.43 132.72 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.495 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 8.1 ttpm? -52.12 -30.81 28.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -53.61 -29.44 37.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.406 ' OH ' ' HG3' ' A' ' 133' ' ' ARG . 7.8 m-85 -72.18 -32.3 66.7 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.722 -0.611 . . . . 0.0 111.362 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.535 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 90.7 m-85 . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.212 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.448 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.9 mm? . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 121.185 0.517 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.6 tt0 -119.43 78.05 1.27 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 171.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.74 143.61 31.71 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.536 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 24.2 tp -99.89 153.34 19.23 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.536 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 25.4 m-85 -60.07 130.31 46.08 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.796 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.8 mt-30 . . . . . 0 C--N 1.315 -0.928 0 C-N-CA 120.623 -0.431 . . . . 0.0 . 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 CA--C 1.535 0.564 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 12.2 t30 -61.71 -55.64 28.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 m -74.37 -33.6 63.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.91 -24.81 58.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.75 -42.69 97.8 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.48 85.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.76 -50.28 72.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.955 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -71.23 -37.17 72.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.993 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.85 -44.72 95.37 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.5 pp -63.69 -29.95 71.11 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -76.23 -28.53 57.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.13 -45.7 6.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -120.25 6.64 10.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.737 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 46.1 mm -106.22 106.0 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.0 mtp -111.84 147.58 35.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.216 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 101.66 12.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.143 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.72 98.87 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 32.5 m -80.66 100.0 8.45 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -170.79 2.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.905 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -74.01 -29.75 62.11 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.586 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.82 -23.71 22.76 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.212 -0.305 . . . . 0.0 111.516 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.27 -164.99 37.54 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.644 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -97.86 107.82 20.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.634 0.731 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -108.97 164.14 12.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.904 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.3 m -89.34 118.18 28.83 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.64 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.23 99.1 2.49 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.652 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.92 104.89 14.38 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.51 120.83 5.65 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.446 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.0 mp -81.75 -58.91 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 117.576 0.688 . . . . 0.0 110.581 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -155.04 148.82 25.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 26.0 m-20 51.71 -91.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.776 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -137.22 22.5 3.0 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.29 119.58 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 110.41 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.0 m -114.31 159.17 20.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.2 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.14 140.97 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 73' ' ' THR . 14.0 tt -148.36 141.89 15.85 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.13 143.25 25.81 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 120.604 0.869 . . . . 0.0 110.167 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.576 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 71.5 m -67.74 -35.03 78.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -68.41 -7.57 32.82 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.42 68.24 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.636 0.732 . . . . 0.0 109.663 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 59.46 69.68 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.198 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -77.62 146.24 23.92 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.27 2.647 . . . . 0.0 110.549 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.41 -140.42 8.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.982 -1.104 . . . . 0.0 114.079 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.83 -24.38 38.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.732 -0.734 . . . . 0.0 110.324 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.62 139.83 34.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 27.6 m -124.55 153.47 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.246 0.546 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.3 mt -94.52 101.87 13.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.179 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.99 87.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.61 16.02 8.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.522 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.63 -25.07 6.64 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.034 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.08 108.47 17.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 76.5 mttt -73.8 142.38 46.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.715 0.769 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -136.53 142.17 39.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.85 140.12 33.08 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.854 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.45 155.56 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.408 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -113.72 -46.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.54 134.5 8.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.474 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -124.1 116.01 22.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 87.5 t80 -133.65 123.85 25.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.778 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 61' ' ' LYS . 2.4 mppt? -83.9 112.9 20.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . 6.7 tt -96.49 115.13 26.92 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.174 0.988 . . . . 0.0 109.876 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 27.7 m -111.35 178.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.165 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.6 t70 -70.93 136.56 85.09 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.92 -28.55 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.363 2.042 . . . . 0.0 113.948 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -90.12 20.21 4.48 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.6 0.714 . . . . 0.0 110.742 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.75 62.06 1.56 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.887 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 54.9 mt -133.13 158.29 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -77.94 144.58 36.7 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.14 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.707 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.4 tp -127.48 -35.65 2.14 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 55.4 mm-40 85.96 7.26 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.5 HD13 ' HG ' ' A' ' 70' ' ' LEU . 11.3 mp -78.97 93.66 5.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.164 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.576 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 45.7 m -84.01 106.25 15.52 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 70.0 t -71.16 96.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.5 tp -103.04 98.74 8.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 111.304 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -92.26 125.51 36.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.463 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.1 mt -114.02 153.43 29.39 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.938 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.62 68.5 8.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.266 -1.373 . . . . 0.0 108.475 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -78.82 117.58 20.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.877 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -76.31 -52.18 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.947 0.403 . . . . 0.0 109.982 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.92 82.98 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 19.5 pttp -73.27 139.16 45.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.641 0.734 . . . . 0.0 112.139 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -82.1 -178.32 6.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -69.64 147.87 50.07 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.565 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 6.6 t70 -88.69 95.98 10.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.848 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 90' ' ' ILE . 39.1 pt -91.49 15.66 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 13.9 ttp180 -62.7 -29.56 70.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.833 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.32 -16.47 80.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.679 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -92.46 -20.17 21.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 56.9 mt -68.74 124.35 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 19.0 m -103.52 120.54 41.06 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.33 -38.07 36.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 91' ' ' SER . 22.1 t70 -101.04 130.62 47.07 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 172.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 mt -90.57 -78.82 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 49.7 70.31 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.42 86.82 0.11 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.6 p -79.41 15.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.123 -0.539 . . . . 0.0 112.272 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 15.2 t70 -141.03 132.14 26.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.965 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.57 31.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.025 0.917 . . . . 0.0 111.031 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.05 135.85 51.37 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.329 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.93 117.97 34.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.256 0.55 . . . . 0.0 111.879 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.31 93.77 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 108' ' ' PHE . 4.9 t -83.04 122.06 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.457 0.646 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 72.5 t60 -145.71 41.65 1.22 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.7 p -108.35 -164.9 0.99 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.18 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.37 -48.92 79.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.79 -17.58 53.04 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' HB2' HG11 ' A' ' 103' ' ' VAL . 20.7 m-85 -150.94 101.39 2.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.507 -0.746 . . . . 0.0 110.742 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 p -85.65 110.02 18.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.519 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 t30 66.43 71.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.564 0.697 . . . . 0.0 111.655 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 m -139.81 109.31 6.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.08 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.0 tp -82.39 120.87 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 116.05 20.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.579 -176.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 7.6 pt-20 -74.15 128.3 35.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.35 -27.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.067 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.45 -131.23 10.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.912 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 39.5 Cg_exo -61.38 115.93 3.07 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.842 2.362 . . . . 0.0 114.19 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -92.46 116.51 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.295 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -123.53 172.08 9.02 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 67.2 mtt -115.75 154.33 29.8 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.0 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.82 -22.92 10.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.02 -111.05 3.23 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.064 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -109.66 111.98 23.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.848 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 46.2 pt -139.35 -177.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 84.5 m-20 -101.43 127.7 47.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.823 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 34.7 tp -107.75 106.58 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 128' ' ' SER . 60.6 p 60.84 30.27 19.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.297 0.57 . . . . 0.0 109.951 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' SER . 63.4 m 85.67 0.52 0.7 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.282 1.033 . . . . 0.0 112.431 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.9 m -110.1 115.27 55.03 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 75.6 Cg_exo -52.05 128.09 25.75 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.529 2.153 . . . . 0.0 114.365 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 p -125.46 145.35 50.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.098 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 65.9 t30 -115.68 160.82 19.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.322 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 5.2 mpt_? 65.83 32.72 8.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.074 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.4 mmm -77.91 127.28 32.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.565 0.698 . . . . 0.0 112.807 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 71.7 mt -85.41 145.39 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.843 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.85 134.0 44.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 111.675 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -152.94 148.41 27.08 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.54 120.03 36.11 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 122.65 1.214 . . . . 0.0 111.502 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -175.06 129.84 0.3 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.811 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.04 0.79 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.151 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.8 t -119.55 138.45 53.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.112 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.43 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 113.455 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.19 153.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.276 174.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.16 -20.11 31.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.429 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -90.68 -7.84 51.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.327 -0.437 . . . . 0.0 111.495 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.621 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 25.8 p -73.61 135.13 43.81 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.024 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 124.03 -24.14 6.39 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.053 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.48 148.82 25.27 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.142 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.95 121.61 50.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 112.38 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.8 tp -92.41 113.42 25.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.283 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -149.26 169.9 19.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.752 0.787 . . . . 0.0 112.823 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.6 169.95 16.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.132 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 1.6 t -62.69 106.11 0.75 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.87 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.12 70.43 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.402 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.87 106.92 9.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.4 mt -95.08 115.96 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.09 -65.37 1.02 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.894 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.501 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -177.39 -155.6 14.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.103 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.4 pt -119.52 142.76 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.374 0.607 . . . . 0.0 111.236 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.15 115.62 7.83 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.35 -25.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.42 -154.84 10.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.564 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.31 161.77 31.89 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.516 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 48.3 t30 -136.2 98.54 3.88 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.86 -119.78 6.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.657 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -103.03 17.38 24.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.821 0.81 . . . . 0.0 111.015 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -113.01 124.65 53.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.74 139.03 15.17 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.404 ' CZ ' ' HG ' ' B' ' 2' ' ' LEU . 73.4 m-85 -119.09 118.03 30.3 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.088 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 40.4 t -110.94 154.12 24.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.249 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -101.49 136.21 41.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.991 0.424 . . . . 0.0 110.078 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 133' ' ' ARG . 3.0 mm100 -76.92 117.03 18.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.501 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 92.6 mt -89.85 87.19 6.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 177' ' ' TYR . 92.5 mttt -80.52 126.5 31.31 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.325 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 63.0 tttm -43.07 -43.78 4.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.226 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LYS . 3.9 pt20 -57.71 -23.52 52.21 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.489 ' CD2' ' HB2' ' A' ' 174' ' ' LYS . 54.4 m-85 -75.63 -25.99 57.37 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.644 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.203 0.525 . . . . 0.0 110.921 -179.13 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.2 mm? . . . . . 0 CA--C 1.509 -0.62 0 CA-C-O 121.505 0.669 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.4 tt0 -119.74 84.85 2.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 172.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -89.58 146.39 24.6 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 45.9 tp -102.14 151.7 21.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.55 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 22.3 m-85 -57.78 140.87 50.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.621 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 93.8 mt-30 . . . . . 0 N--CA 1.441 -0.892 0 C-N-CA 118.353 -1.339 . . . . 0.0 . 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 CA--C 1.526 0.09 0 N-CA-C 114.073 0.759 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 52.6 t30 -70.78 -46.8 62.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.914 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -62.72 -33.65 75.55 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.812 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.15 -47.01 88.2 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.389 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -62.1 -44.38 96.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.233 0.54 . . . . 0.0 109.835 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.71 87.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.705 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 1.6 tt -64.68 -40.07 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.653 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -67.6 -48.1 67.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 -39.72 87.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.879 0.847 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 67.1 tp -54.9 -49.86 70.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.115 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 16.8 mtm180 -72.33 -29.6 63.97 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -91.12 -48.98 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -175.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -118.49 0.06 11.51 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 55.0 mt -106.44 122.99 60.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.6 mtp -133.98 165.6 24.66 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.991 0.901 . . . . 0.0 110.584 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.74 111.79 12.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.958 -1.474 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.1 mm -104.53 110.38 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 2.0 m -87.31 112.86 22.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.175 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -122.35 -171.93 2.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.32 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.475 ' H ' HG22 ' A' ' 20' ' ' THR . 14.9 m -55.28 -37.09 66.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 25' ' ' PHE . 23.9 ttpp -91.02 0.43 57.54 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.78 -160.16 21.69 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.466 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -89.91 122.85 33.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.136 0.493 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CZ ' ' HE3' ' A' ' 22' ' ' LYS . 66.9 m-85 -113.45 177.6 4.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.233 1.016 . . . . 0.0 112.003 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 49.4 m -91.94 107.18 19.02 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.742 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -93.3 112.1 4.23 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 tp -95.6 103.9 15.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.418 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.68 125.58 13.63 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.7 mm -89.99 -46.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 117.199 0.5 . . . . 0.0 111.106 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 19.3 p80 -171.83 149.93 2.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.99 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.646 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 31.6 t70 46.49 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.646 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 10.2 ptp85 -125.44 18.86 8.15 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.811 -0.556 . . . . 0.0 111.074 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.51 122.92 58.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.625 0.726 . . . . 0.0 111.71 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.44 141.68 50.97 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.377 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.67 135.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.562 0.696 . . . . 0.0 109.785 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 73' ' ' THR . 8.1 tp -141.04 137.78 17.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.798 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.52 151.53 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.775 0.983 . . . . 0.0 111.196 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 92.0 m -78.35 -34.84 48.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.936 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -72.2 3.8 4.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.759 0.314 . . . . 0.0 111.111 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.33 -24.62 50.78 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.0 0.905 . . . . 0.0 109.336 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 56.9 70.18 1.48 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.817 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.95 152.12 24.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.875 2.383 . . . . 0.0 109.41 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.57 -134.78 7.04 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.91 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.83 -9.14 24.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.499 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 11.6 t70 -136.91 124.43 22.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.082 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.95 172.58 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.697 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.618 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.6 mp -117.03 121.92 42.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.76 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.24 98.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 55.9 58.14 4.64 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.793 -176.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -38.07 1.9 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 118.7 15.63 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 48' ' ' LEU . 4.6 mtmp? -80.71 146.02 31.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.638 0.732 . . . . 0.0 112.166 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -144.58 146.32 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.076 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 24.8 mmm180 -79.89 145.35 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.67 0.271 . . . . 0.0 110.466 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.29 150.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HE3' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -94.65 -58.25 2.24 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.36 117.53 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.277 -1.328 . . . . 0.0 110.454 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 59' ' ' LYS . 38.1 ttpt -107.56 115.67 30.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -121.66 117.46 26.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -77.28 109.36 11.1 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 57.4 tp -85.45 114.36 22.43 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-O 122.475 1.131 . . . . 0.0 110.877 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 34.6 m -123.52 168.36 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 113.092 -1.867 . . . . 0.0 108.786 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 13.3 t70 -63.99 144.16 98.16 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.945 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.75 -19.71 8.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.248 1.965 . . . . 0.0 113.682 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.94 15.75 19.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 109.112 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t30 60.65 64.12 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.08 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -130.87 142.16 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 131' ' ' THR . 65.2 t30 -64.4 127.13 30.18 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 29.0 mt -98.43 -29.21 13.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 32.5 tp10 85.81 7.94 0.35 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.785 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 10.8 mp -91.93 107.48 19.24 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.736 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 51.7 m -90.27 105.37 17.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.09 99.78 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.56 100.94 13.6 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.486 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -94.58 98.42 10.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.367 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.0 pt? -122.62 127.93 50.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.457 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.79 86.14 1.7 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.568 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -79.96 141.08 36.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.12 -1.4 . . . . 0.0 107.943 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -68.96 -38.6 79.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -90.59 96.7 10.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.2 152.9 28.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -85.42 159.06 20.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.116 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' HIS . 23.7 mmm180 -72.49 156.54 38.92 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.877 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.41 67.47 8.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.8 pp -75.1 11.41 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.198 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -58.29 -25.94 62.41 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 120.623 0.249 . . . . 0.0 111.255 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.14 -17.68 74.11 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.805 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -95.34 -4.32 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 109.956 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.402 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.8 mt -82.11 131.9 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 2.5 m -91.6 122.77 34.47 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -174.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -71.18 -63.33 1.13 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.86 135.17 34.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 172.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.13 -54.91 41.65 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.979 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 46.58 71.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.176 0.512 . . . . 0.0 110.965 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.21 93.25 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 5.9 p -78.04 6.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -119.17 124.81 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.57 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.328 1.061 . . . . 0.0 113.745 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 m -124.28 139.18 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.37 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.89 117.77 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.008 0.432 . . . . 0.0 112.033 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -104.24 105.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.841 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.63 121.74 54.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 111.713 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -126.5 76.99 1.67 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.47 -170.28 2.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.444 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -56.4 -47.29 79.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -98.64 -56.65 2.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.903 0.774 . . . . 0.0 110.099 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.46 90.82 5.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 3.1 m -106.87 114.61 28.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.822 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' THR . 3.5 m-20 71.5 26.85 3.14 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.166 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -84.52 111.66 19.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.375 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.58 99.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.336 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 113' ' ' LEU . 3.6 mp -95.39 137.19 34.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.08 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.59 114.81 26.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -97.82 -19.56 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.422 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.33 -135.81 14.69 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.453 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 19.3 Cg_exo -67.23 142.15 59.66 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.02 2.48 . . . . 0.0 114.063 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.83 171.29 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.639 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 m -148.61 157.68 43.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.13 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 73.9 mtm -100.58 129.26 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -97.63 -17.42 19.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.31 -118.85 4.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.48 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.4 tt -107.5 120.3 41.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.204 0.526 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.42 HG21 HD23 ' B' ' 2' ' ' LEU . 40.3 pt -140.68 -166.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 17.5 m120 -117.17 131.55 56.85 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.235 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 1.6 mm? -110.08 108.1 18.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 128' ' ' SER . 7.2 t 61.39 29.14 18.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 127' ' ' SER . 55.3 m 84.31 -10.49 0.88 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.571 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 m -81.64 126.31 76.13 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.05 117.4 4.51 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.828 1.685 . . . . 0.0 112.14 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.0 p -120.25 142.89 48.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.553 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.11 164.29 15.77 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.358 0.599 . . . . 0.0 111.538 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 62.61 34.27 15.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG3' HG12 ' A' ' 124' ' ' ILE . 10.7 mmt -79.32 137.2 37.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.505 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 65.6 mt -96.25 133.69 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.584 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 37.5 ttt180 -120.43 125.23 47.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.762 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -142.9 139.08 30.63 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.92 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -80.44 96.52 6.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.145 0.974 . . . . 0.0 110.982 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -165.56 131.74 2.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.521 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.67 83.62 0.87 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -89.42 140.24 29.71 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.24 157.63 39.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.996 1.379 . . . . 0.0 114.315 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.77 150.0 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.292 175.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.38 -27.35 10.69 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -93.15 7.37 44.5 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.627 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 12.6 p -79.58 125.7 29.94 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.181 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.571 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 127.93 -16.66 6.1 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.303 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 151.67 33.6 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.653 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.37 119.13 45.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.332 0.587 . . . . 0.0 112.039 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.64 110.04 19.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -152.85 -170.4 3.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.024 0.916 . . . . 0.0 113.129 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -166.1 178.6 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.989 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 3.0 t -55.44 107.98 0.38 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.471 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 60.11 30.24 70.01 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.557 ' HE2' ' OG ' ' A' ' 91' ' ' SER . 2.5 tpmt? -145.3 91.67 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.713 -0.743 . . . . 0.0 111.453 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.0 mt -93.75 122.52 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -92.32 -46.79 7.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.054 0.454 . . . . 0.0 110.351 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 163.85 -154.73 25.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.125 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.36 146.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.53 0.681 . . . . 0.0 111.234 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -78.9 115.05 18.34 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.644 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.24 -28.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.65 -151.5 8.99 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.209 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -173.18 167.09 39.76 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.489 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 24.8 t-20 -136.76 94.43 2.98 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.4 -96.43 0.49 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.398 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -108.96 9.88 26.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.19 0.519 . . . . 0.0 110.879 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -121.29 135.67 55.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.98 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.19 139.29 14.41 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 60.9 m-85 -120.59 121.52 38.55 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.93 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.6 m -121.17 167.94 12.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.617 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.49 143.2 37.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.06 116.17 18.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.574 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 8.7 mp -93.58 86.3 5.15 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 91' ' ' SER . 28.6 mttm -76.3 146.67 38.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -58.34 -31.94 68.04 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 111.695 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -50.9 -42.23 59.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' A' ' 62' ' ' LEU . 9.0 m-85 -64.01 -38.54 91.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -174.619 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 124' ' ' ILE . 2.7 mm? . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.4 tt0 -118.22 77.11 1.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -78.65 155.37 29.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 51.0 tp -110.46 142.9 41.56 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.544 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 21.3 m-85 -57.16 136.08 56.4 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.627 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 94.1 mt-30 . . . . . 0 N--CA 1.44 -0.938 0 C-N-CA 119.665 -0.814 . . . . 0.0 . -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 CA-C-O 120.851 0.271 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.43 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 38.6 t30 -62.1 -50.99 69.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.553 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -56.86 -53.38 58.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.175 -1.375 . . . . 0.0 112.935 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.553 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.2 mp0 -71.33 -26.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.309 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.56 -45.71 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -56.89 -45.39 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.403 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 7.5 tt -59.76 -42.33 93.02 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 m -70.3 -36.49 74.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.256 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -70.26 -47.41 61.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.679 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.0 pp -64.81 -25.02 67.73 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 69.6 mtp180 -70.0 -50.07 45.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.31 -23.99 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -108.51 -4.55 17.15 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 43.4 mm -114.59 117.08 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.816 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -120.79 137.31 54.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.313 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 m -76.71 103.28 6.59 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.97 102.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.686 0.755 . . . . 0.0 111.575 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 63.4 m -71.13 100.01 1.97 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.791 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -107.4 175.7 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.954 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.524 ' H ' HG22 ' A' ' 20' ' ' THR . 3.4 m -55.15 -47.31 75.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.714 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 7.7 mmpt? -89.83 2.11 55.35 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.71 -175.97 27.73 Favored Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.853 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 105' ' ' SER . 30.2 mt-10 -101.48 112.6 25.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -106.93 162.59 13.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.951 0.881 . . . . 0.0 112.951 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.691 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 86.3 m -80.73 106.8 13.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.847 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.27 116.48 4.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.694 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -94.42 108.95 20.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 110.795 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.8 108.08 2.41 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 86' ' ' ILE . 39.6 mm -75.43 -55.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.891 0.377 . . . . 0.0 111.802 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -162.96 138.92 7.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.617 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 13.0 t70 57.32 -94.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.069 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 76' ' ' THR . 79.2 mtt85 -126.28 8.74 7.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.802 0.81 . . . . 0.0 110.163 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 74' ' ' VAL . 96.9 t -92.71 113.18 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.866 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 p -124.06 142.8 50.87 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.11 137.09 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.023 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 tt -144.95 139.95 15.72 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.525 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.2 144.1 72.06 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.457 1.438 . . . . 0.0 112.439 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.816 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 89.7 m -63.9 -37.6 87.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -72.52 6.54 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.17 -19.1 30.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.668 0.747 . . . . 0.0 109.937 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 64.98 69.51 0.66 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.196 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.81 110.49 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.638 1.559 . . . . 0.0 109.48 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -141.84 1.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.546 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.01 -28.32 15.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.952 0.882 . . . . 0.0 109.227 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -136.88 132.4 34.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.039 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.81 153.15 36.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 mp -97.01 104.01 15.98 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.118 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.2 p -82.02 96.03 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.34 10.53 7.3 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.47 -28.76 3.96 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.461 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 54' ' ' ILE . 58.5 tt0 -78.88 118.38 20.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.127 0.489 . . . . 0.0 110.741 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -72.55 107.79 5.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.405 HD12 HG11 ' A' ' 49' ' ' VAL . 8.9 mt -119.39 126.4 75.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.257 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -77.56 146.22 36.42 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 110.084 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.27 138.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -84.46 -45.56 12.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.78 144.48 15.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -136.67 112.67 9.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -112.95 129.35 56.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.339 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.43 110.79 16.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.647 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 36.9 tp -81.19 115.1 20.44 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.44 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.59 167.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.673 -1.603 . . . . 0.0 108.218 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 17.9 t70 -87.0 143.32 34.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.59 -17.05 6.25 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.367 2.045 . . . . 0.0 113.513 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.89 7.18 9.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.86 39.99 2.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.938 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 150.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.846 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -66.4 137.39 56.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 18.6 mt -105.38 -28.38 10.91 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.816 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 35.8 tp10 80.7 9.03 1.18 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.948 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HG ' HD21 ' A' ' 173' ' ' LEU . 2.3 mm? -95.54 133.41 39.58 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.904 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.8 m -105.61 115.56 30.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 34' ' ' VAL . 60.4 t -74.61 96.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -93.28 103.55 15.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.928 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 19.9 m -94.44 100.5 12.49 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.22 156.63 16.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.758 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -83.87 103.53 13.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -129.96 143.1 50.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.459 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -87.34 -59.02 2.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.77 90.64 4.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 55.6 pttt -68.07 163.66 21.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -79.23 145.91 33.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.343 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -62.45 130.82 46.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.717 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.94 80.93 0.47 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 122.173 -0.329 . . . . 0.0 111.437 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 86' ' ' ILE . 2.6 pp -87.36 19.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 O-C-N 121.448 -0.782 . . . . 0.0 110.403 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.48 -13.38 62.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.614 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.84 67.43 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.873 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.28 -10.15 50.52 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.86 131.84 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.9 m -105.43 133.68 49.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -81.97 -23.82 35.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -127.31 111.49 13.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.6 mt -52.74 -64.55 0.78 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.7 69.25 0.69 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.28 96.9 0.1 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.5 p -86.55 17.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.333 0.587 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -140.35 132.92 28.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.034 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.18 16.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.236 1.017 . . . . 0.0 113.38 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.3 m -128.23 142.1 51.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.389 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.76 110.97 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.142 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 7' ' ' ALA . 27.1 m -103.74 136.19 37.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.16 0.505 . . . . 0.0 110.999 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 105' ' ' SER . 27.4 t -122.54 133.87 67.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.909 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.603 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 64.5 t60 -138.64 45.03 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 m -108.78 -165.42 1.02 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.413 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -83.34 -18.52 38.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.619 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 11.9 p30 -67.49 -50.3 59.55 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -138.49 113.83 9.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.4 m -92.55 96.84 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.808 0.813 . . . . 0.0 112.22 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.603 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 8.0 t30 74.03 70.45 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.054 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 m -134.85 136.67 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.819 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.58 117.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.8 mp -111.91 113.16 25.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.49 120.58 24.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -97.06 -25.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.956 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.73 -129.12 9.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.838 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 25.1 Cg_exo -62.43 130.51 30.37 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.3 2.0 . . . . 0.0 113.231 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 137' ' ' TYR . 15.0 m -121.45 131.66 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.0 p -122.98 144.98 48.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 72.8 mtm -81.31 114.28 19.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.51 -50.27 7.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.864 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.19 -119.95 5.86 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.785 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.45 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -95.68 118.1 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.304 0.574 . . . . 0.0 112.53 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.8 pt -139.98 -174.46 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.1 m-20 -113.26 104.28 12.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.757 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.6 mm? -79.52 113.36 17.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.45 ' HB3' HD12 ' B' ' 5' ' ' LEU . 59.0 p 52.27 30.81 8.39 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.969 -0.457 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m 70.56 62.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -160.8 115.27 1.35 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.315 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.21 112.12 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.349 1.366 . . . . 0.0 111.6 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.625 ' HB ' HD23 ' A' ' 126' ' ' LEU . 17.7 m -125.79 128.86 48.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.854 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 57.7 t30 -106.86 162.79 13.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.639 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 19.6 ttm-85 70.88 34.82 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.286 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.3 mmm -87.37 139.44 30.55 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 111.68 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.4 mm -97.94 134.49 36.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.442 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -111.82 125.42 54.0 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.438 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -137.36 125.82 23.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.67 99.81 3.78 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 122.232 1.015 . . . . 0.0 110.773 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -166.7 128.19 1.71 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.47 91.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.1 p -90.72 162.42 14.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.336 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -132.17 150.33 52.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.971 0.891 . . . . 0.0 111.865 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.648 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.22 154.22 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.275 175.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -33.14 5.43 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.497 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 70.8 mt-30 -77.52 9.99 2.92 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.823 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 23.6 m -65.54 139.6 58.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.691 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.88 -14.96 34.31 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.951 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.68 145.1 40.11 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.532 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.42 122.19 50.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.645 0.736 . . . . 0.0 112.249 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.38 108.91 20.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.347 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 178.85 8.68 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.904 0.859 . . . . 0.0 112.802 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.417 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . . . -153.12 179.25 8.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.628 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 2.0 t -60.63 102.63 0.2 Allowed 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.794 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.95 88.01 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.608 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.08 119.36 16.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.641 0.721 . . . . 0.0 112.768 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -99.31 124.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -94.57 -35.03 12.42 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 161.05 -163.15 34.14 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.769 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.5 pt -129.85 152.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.842 0.829 . . . . 0.0 112.11 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -62.27 122.73 16.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.756 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.13 -30.98 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.183 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' B' ' 7' ' ' GLN . . . -174.21 -146.12 5.5 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.583 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -179.42 158.11 21.76 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.322 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 21.4 t30 -131.22 86.56 2.37 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.977 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.13 -99.74 0.81 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 114.995 -1.002 . . . . 0.0 114.973 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -94.25 -2.43 52.39 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 111.929 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -121.46 131.39 54.13 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.759 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.01 151.3 25.83 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -129.28 114.11 15.84 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.765 -1.174 . . . . 0.0 113.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.0 m -108.92 159.27 16.94 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.46 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -96.26 132.35 41.81 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.587 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 51.8 tt0 -70.96 107.86 4.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.12 0.486 . . . . 0.0 110.283 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.489 HD21 ' HG ' ' A' ' 72' ' ' LEU . 80.4 mt -85.59 93.83 8.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.556 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.75 125.56 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.726 0.774 . . . . 0.0 109.548 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -40.18 -39.86 1.0 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.4 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.48 -46.23 37.91 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -64.06 -17.0 62.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 110.626 179.472 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.414 ' N ' HD12 ' B' ' 2' ' ' LEU . 6.3 mp . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -86.55 79.54 8.9 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.492 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.757 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.41 125.08 30.64 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 37.7 tp -86.02 146.75 26.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.516 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 16.2 m-85 -60.17 130.2 45.5 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.823 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 98.3 mt-30 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.647 -0.706 . . . . 0.0 . 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 CA--C 1.535 0.532 0 N-CA-C 114.451 0.904 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.67 -40.49 76.39 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.58 0.705 . . . . 0.0 110.694 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -49.78 68.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.535 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.28 -33.82 72.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.388 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -68.81 -58.52 4.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 tp -70.46 -33.02 70.8 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -79.79 -34.55 39.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.42 -36.43 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.1 tp -54.94 -59.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.027 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.61 -27.04 61.92 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.71 -46.34 14.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.53 -6.06 9.24 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.2 mt -110.25 121.19 62.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.96 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.4 mtt -127.73 147.23 50.4 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.639 0.733 . . . . 0.0 109.817 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -64.92 110.98 2.63 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.009 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 39.7 mm -95.57 105.18 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -92.21 96.52 10.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.507 0.67 . . . . 0.0 109.301 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.458 HG23 HG22 ' A' ' 18' ' ' ILE . 1.3 p -102.81 -169.73 1.7 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.341 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -67.32 -32.04 72.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.703 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HZ2' ' HZ ' ' A' ' 25' ' ' PHE . 49.4 tttm -83.03 -35.29 25.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.395 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.43 -151.57 22.64 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 119.479 -1.343 . . . . 0.0 115.34 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.42 120.28 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.306 -0.947 . . . . 0.0 110.531 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.576 ' HZ ' ' HZ2' ' A' ' 22' ' ' LYS . 63.1 m-85 -126.44 159.58 32.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.184 0.992 . . . . 0.0 113.018 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 32.9 m -79.65 100.91 8.07 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.384 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -90.42 112.29 4.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.69 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -101.81 105.72 16.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.28 116.58 5.27 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 46.4 mm -83.53 -60.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.223 0.512 . . . . 0.0 111.946 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -145.51 152.65 40.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.875 0.845 . . . . 0.0 112.678 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 41.6 m-20 45.14 -92.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.781 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 16.9 ptt180 -141.59 25.75 1.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.88 0.848 . . . . 0.0 109.661 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.53 118.61 53.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.548 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 m -117.48 146.07 43.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.869 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.89 122.91 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.062 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 18' ' ' ILE . 57.0 mt -134.76 141.11 37.39 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.243 -177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HB3' ' CE1' ' A' ' 40' ' ' HIS . 45.9 Cg_exo -58.6 144.3 97.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 121.583 1.522 . . . . 0.0 109.915 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 49.7 m -74.11 -32.44 63.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 38' ' ' PRO . 43.0 p-80 -71.53 -7.27 46.51 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.89 -29.44 66.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.952 0.882 . . . . 0.0 108.754 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 66.61 70.95 0.47 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.662 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.73 118.56 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.223 2.615 . . . . 0.0 108.64 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.52 -111.42 0.74 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.559 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.18 -35.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.558 0.694 . . . . 0.0 109.172 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -117.78 148.64 41.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.561 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 75' ' ' LEU . 86.8 t -131.3 123.81 53.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.744 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.402 HD21 ' HE2' ' A' ' 53' ' ' LYS . 36.0 mt -74.41 88.32 2.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.198 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 54' ' ' ILE . 48.1 t -83.24 98.98 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.5 23.04 12.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 -7.6 56.93 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.597 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -93.76 130.37 39.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.122 0.487 . . . . 0.0 111.665 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HE2' HD21 ' A' ' 48' ' ' LEU . 59.5 mmtt -74.35 88.62 2.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.925 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 49' ' ' VAL . 57.9 mt -102.94 136.07 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -100.67 154.75 18.34 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 117.956 -1.498 . . . . 0.0 113.889 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 59' ' ' LYS . 78.2 t -71.49 133.53 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.522 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 57' ' ' LYS . 11.0 tmtt? -100.95 -56.24 2.37 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -128.02 115.88 19.17 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.649 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HB2' HG11 ' A' ' 56' ' ' VAL . 54.0 tttp -106.88 92.16 3.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -113.22 123.76 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.455 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 5.7 mptt -86.12 103.19 14.54 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 56.2 tp -69.19 114.75 7.74 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 123.376 1.56 . . . . 0.0 112.302 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.9 m -114.62 153.42 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 174.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' A' ' 66' ' ' GLU . 12.3 t70 -74.33 139.92 75.69 Favored Pre-proline 0 C--N 1.306 -1.291 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 31.2 Cg_exo -44.72 -17.62 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.576 1.517 . . . . 0.0 112.086 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 64' ' ' ASP . 12.9 tp10 -68.42 -1.39 6.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.566 0.698 . . . . 0.0 109.161 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' PRO . 10.7 t30 72.21 30.21 2.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.052 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.3 mt -123.39 143.41 36.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.789 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.41 ' HA ' HG12 ' A' ' 63' ' ' VAL . 15.8 m120 -59.84 145.26 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.768 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 59.2 mt -126.26 -30.72 2.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.183 0.516 . . . . 0.0 109.833 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.4 mm-40 87.13 4.35 0.36 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.975 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 66.6 mt -87.92 98.12 11.32 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.014 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 m -76.46 103.45 6.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.033 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 62' ' ' LEU . 99.2 t -77.57 88.05 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 47' ' ' VAL . 15.2 tp -93.76 115.01 27.41 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.109 -175.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -98.32 109.86 22.55 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.632 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.44 151.41 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.92 86.93 6.87 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.353 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 33' ' ' ARG . 29.2 mmm180 -103.81 146.96 27.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.009 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.96 -51.63 3.99 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -76.22 114.02 14.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.58 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 32' ' ' ASP . 11.7 ptpt -84.57 -179.48 7.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.729 0.776 . . . . 0.0 111.938 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.47 163.57 12.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.214 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -67.27 117.04 8.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -66.26 91.55 0.17 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.4 pt -90.18 20.0 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -62.85 -21.48 65.99 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.43 -18.4 71.28 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.542 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 96.7 m-85 -87.88 -1.98 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.103 0.478 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 30' ' ' ILE . 64.4 mt -84.78 125.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.6 m -85.08 129.05 34.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.683 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -55.95 13.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.68 132.99 42.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.9 mt -55.62 -70.18 0.12 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 50.61 71.27 0.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.021 0.439 . . . . 0.0 110.046 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.08 88.27 0.07 OUTLIER Glycine 0 C--N 1.333 0.408 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.447 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.7 p -79.77 -0.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.355 0.597 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 12.5 t70 -128.91 114.69 16.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.687 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.03 165.12 20.92 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.961 0.886 . . . . 0.0 111.363 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 7.9 m -119.12 140.53 49.98 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.261 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.7 tp -109.83 124.81 51.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.479 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.43 111.36 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 105' ' ' SER . 10.5 t -103.52 137.85 30.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.34 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.449 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 86.5 t60 -136.41 42.05 2.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.535 ' H ' HG12 ' A' ' 103' ' ' VAL . 54.6 m -107.29 -176.59 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.209 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -44.41 -57.91 3.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -79.83 -47.94 14.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.047 0.839 . . . . 0.0 112.26 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -108.99 96.08 6.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.651 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 3.1 m -98.08 103.58 15.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.808 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 109' ' ' THR . 16.9 t30 73.36 72.2 0.13 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.978 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -140.09 125.09 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.193 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.1 tt -113.07 126.19 70.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 tt -143.0 127.87 18.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 14.0 pt-20 -81.01 108.02 14.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.23 -33.21 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.958 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.72 -118.96 5.84 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 26.6 Cg_endo -58.02 107.29 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 116.03 -175.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.8 t -96.47 118.93 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.59 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 24.5 m -137.66 141.23 41.16 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.501 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -81.92 130.19 35.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.313 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.31 -18.38 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.52 -130.18 9.53 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.403 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 123' ' ' LEU . 2.9 tm? -93.5 112.38 24.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 47.9 pt -135.83 -174.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 1.0 OUTLIER -108.33 106.44 16.58 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.857 -179.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.636 HD12 ' O ' ' B' ' 4' ' ' ALA . 56.3 tp -82.57 111.21 18.35 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.1 p 56.42 37.31 28.72 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.076 0.465 . . . . 0.0 110.991 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.4 m 77.73 11.14 2.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.892 0.877 . . . . 0.0 112.992 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -118.2 118.19 34.4 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.622 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 51.2 Cg_exo -54.05 116.62 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.245 1.964 . . . . 0.0 113.825 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 p -125.09 145.4 49.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.839 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' HB3' HD23 ' A' ' 123' ' ' LEU . 25.2 p-10 -112.9 163.26 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.909 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 80.2 mtt180 58.94 41.86 20.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.642 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -77.63 127.87 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.54 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.528 ' HB ' ' OG ' ' A' ' 170' ' ' SER . 39.4 mm -87.38 120.84 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 24.8 ttt180 -104.88 124.65 49.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.613 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.552 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.6 OUTLIER -117.19 115.86 26.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.879 -1.896 . . . . 0.0 105.879 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -71.55 90.42 1.01 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.016 0.912 . . . . 0.0 112.059 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -166.96 132.12 2.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.328 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.41 0.54 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.518 0.675 . . . . 0.0 111.582 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 131.79 54.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 7.2 mtpm? -122.29 179.3 4.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.7 150.75 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.773 177.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.08 -20.22 41.39 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.039 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.28 5.87 40.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.648 ' SG ' ' CA ' ' B' ' 7' ' ' GLN . 14.5 p -78.53 140.98 38.49 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.182 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.652 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 116.96 -19.29 12.11 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.16 150.44 29.13 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.098 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.96 124.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.44 0.638 . . . . 0.0 111.967 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.36 108.96 20.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -144.99 -178.72 6.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.927 0.87 . . . . 0.0 112.453 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.2 179.74 7.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.397 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 t -65.17 117.23 7.46 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.559 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.7 76.91 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.618 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 8.7 ptpp? -159.32 138.91 11.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.776 0.788 . . . . 0.0 112.602 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 63.6 mt -113.41 135.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.635 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.03 -39.61 6.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.798 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 175.08 -171.1 44.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.5 pt -125.54 142.83 41.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.871 0.843 . . . . 0.0 111.111 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.0 t-160 -61.7 112.75 2.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.234 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.87 -25.17 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.265 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.36 -145.94 5.46 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.402 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 175.43 164.11 29.43 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.3 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 31.1 t30 -136.88 99.98 4.18 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.477 0.656 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 60.56 -110.03 2.71 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 115.014 0.765 . . . . 0.0 115.014 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -92.93 18.96 8.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.447 0.642 . . . . 0.0 111.337 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.411 HE21 ' HB2' ' A' ' 167' ' ' GLN . 14.2 mt-30 -135.1 128.56 32.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -91.05 145.28 17.7 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 136' ' ' ARG . 44.9 m-85 -127.18 126.98 43.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.672 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.528 ' OG ' ' HB ' ' A' ' 135' ' ' ILE . 19.8 p -124.92 169.61 11.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.178 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.88 140.21 41.33 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.6 pt20 -70.3 118.5 13.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.0 mp -97.78 75.9 2.44 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -83.74 142.1 30.96 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -50.98 -22.97 2.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -54.63 -22.54 13.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -97.82 -16.22 19.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -173.582 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.8 mm? . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 120.828 0.347 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.2 tt0 -106.96 90.1 3.2 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -96.42 126.51 41.67 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.117 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -87.03 158.68 19.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.717 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.576 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.0 m-85 -62.58 147.45 49.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . 0.648 ' CA ' ' SG ' ' A' ' 146' ' ' CYS . 97.1 mt-30 . . . . . 0 N--CA 1.434 -1.258 0 C-N-CA 118.402 -1.319 . . . . 0.0 . 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 120.465 -0.075 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 123.123 2.549 . . . . 0.0 113.907 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 11.1 t30 -68.77 -48.27 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.374 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 m -70.23 -29.02 65.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.714 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.56 -50.0 74.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.52 -47.31 84.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.475 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.36 58.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.533 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.79 -23.68 64.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -76.94 -51.23 11.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.591 0.71 . . . . 0.0 109.853 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.4 tp -57.13 -44.51 83.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.254 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 69.6 tp -53.86 -49.91 67.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.203 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -78.02 -28.38 49.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -86.54 -52.57 5.49 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.86 1.98 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 40.2 mm -106.25 133.02 51.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.435 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 50' ' ' ASN . 46.2 ttm -150.55 144.04 25.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.799 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.0 m -69.23 113.59 6.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.59 108.77 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 14.0 m -93.91 122.5 36.47 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.8 0.81 . . . . 0.0 109.994 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 -163.9 1.45 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.44 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.37 -44.4 62.11 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HZ1' ' CX7' ' B' ' 8' ' ' CA1 . 55.1 tttm -85.36 1.2 49.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.877 0.762 . . . . 0.0 111.863 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.67 -149.76 17.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.31 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.26 129.66 35.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.055 -0.573 . . . . 0.0 111.584 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ3' ' A' ' 22' ' ' LYS . 68.7 m-85 -131.85 157.26 44.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.109 0.957 . . . . 0.0 111.96 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 80.5 m -72.66 107.53 5.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.332 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.24 107.24 3.16 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.399 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.37 99.06 11.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.37 123.01 7.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.681 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.93 -56.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 117.179 0.489 . . . . 0.0 110.03 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.95 153.31 5.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.605 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.06 -89.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.999 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.1 ptp180 -132.02 10.25 4.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -110.69 131.82 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.931 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 p -133.13 156.68 47.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.51 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.45 139.82 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.469 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.8 tt -143.54 141.58 19.27 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.367 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.16 153.06 13.43 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 C-N-CA 121.313 1.342 . . . . 0.0 112.243 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 39.5 m -77.61 -37.45 50.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -66.91 -13.08 61.35 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.63 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.72 -21.18 64.41 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.024 0.916 . . . . 0.0 109.224 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 45.1 mt-30 61.12 69.07 1.12 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.311 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 12.3 Cg_exo -75.25 131.23 13.78 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.806 2.337 . . . . 0.0 107.97 175.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.84 -134.37 7.6 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.417 -1.373 . . . . 0.0 114.602 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.39 -26.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.685 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 53' ' ' LYS . 13.0 p-10 -144.67 133.69 22.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.96 158.67 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.892 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 45.6 mt -101.8 98.71 8.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 16' ' ' MET . 41.0 t -91.81 103.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.549 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 65.8 t30 66.47 24.78 10.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.699 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.57 -20.1 52.01 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.35 115.57 18.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.362 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 87.7 tttt -74.74 109.49 8.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.759 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.17 139.89 46.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.435 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.28 153.77 22.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.963 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG21 ' HB2' ' A' ' 59' ' ' LYS . 14.6 p -73.81 141.59 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -99.9 -42.85 6.62 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 37.9 t70 -159.13 118.35 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.304 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 56' ' ' VAL . 28.5 ttpp -111.47 106.41 15.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 86.0 t80 -115.87 110.41 18.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.764 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.11 105.59 6.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 60.0 tp -75.69 114.74 14.63 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-O 122.243 1.02 . . . . 0.0 111.89 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.25 159.9 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.434 -1.712 . . . . 0.0 107.852 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -74.84 149.04 85.36 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.28 -23.84 7.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.75 2.3 . . . . 0.0 113.666 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 68' ' ' ILE . 7.6 mm-40 -86.37 25.04 1.26 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.604 0.716 . . . . 0.0 109.805 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.289 0.3 OUTLIER 39.99 61.98 1.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.495 1.118 . . . . 0.0 113.202 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' GLU . 25.2 mm -138.62 155.59 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.492 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -57.5 131.33 49.84 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.783 -0.573 . . . . 0.0 111.761 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.556 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.7 tp -103.89 -22.94 13.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 161' ' ' VAL . 22.7 tp10 80.61 7.89 1.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.403 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.85 109.62 22.01 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.397 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 99.8 m -85.27 107.44 17.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 84.0 t -72.79 101.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.02 100.32 11.46 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.05 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 21.5 m -96.77 121.84 39.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.665 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 2.0 mm? -120.34 158.54 26.9 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.63 82.15 6.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -79.64 117.37 20.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.492 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.82 -53.81 13.9 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.5 89.86 7.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.27 143.44 52.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.127 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -82.88 148.68 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.058 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.63 144.35 51.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.75 83.24 1.17 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -87.45 12.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.756 -0.59 . . . . 0.0 109.577 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.08 -19.8 65.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.791 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.91 73.86 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.559 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -84.49 -21.12 30.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.704 -0.248 . . . . 0.0 110.474 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.12 121.69 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 13.7 m -113.06 148.48 35.1 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.67 -33.42 12.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.7 105.63 15.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.715 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 17.4 mt -68.33 -57.16 6.35 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 5.6 pt-20 55.75 13.48 1.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 0.0 111.247 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 98' ' ' ASP . . . -115.87 67.3 0.29 Allowed Glycine 0 C--N 1.334 0.459 0 CA-C-O 121.603 0.557 . . . . 0.0 112.838 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -60.87 -3.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.071 0.462 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 96' ' ' GLY . 24.7 t70 -117.94 111.89 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.58 160.43 34.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.849 0.833 . . . . 0.0 112.865 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.1 m -125.63 137.0 53.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.337 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 160' ' ' HIS . 57.2 tp -102.33 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.016 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 t -104.05 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.62 129.91 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.674 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -138.86 35.07 2.17 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -108.54 -170.05 1.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -44.15 -51.93 7.7 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.18 -29.41 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.812 0.733 . . . . 0.0 112.355 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -140.02 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.887 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 m -96.83 119.35 35.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.463 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 96.1 m-20 69.39 70.4 0.25 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.039 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 m -141.71 107.99 5.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.068 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.0 mt -86.32 108.3 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.053 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.1 mt -116.64 107.53 14.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.342 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -73.59 125.43 27.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.49 -25.18 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 89.5 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.504 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 5.8 Cg_exo -75.52 122.36 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.284 1.989 . . . . 0.0 112.974 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.21 132.87 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.307 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -134.95 -169.64 2.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.759 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.3 ptm -129.47 149.7 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.428 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.16 -4.68 21.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.134 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.44 -108.07 2.73 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.14 128.48 54.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.073 -0.563 . . . . 0.0 111.099 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.6 pt -150.63 -178.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 120.679 0.276 . . . . 0.0 110.346 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 30.4 m-80 -96.19 136.42 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 40.6 tp -120.72 105.68 10.99 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t 60.23 42.76 14.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m 66.69 8.92 6.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.883 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.5 m -112.03 112.63 52.63 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.63 124.08 15.27 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.233 1.288 . . . . 0.0 111.204 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.0 m -130.33 141.32 50.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.84 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -99.42 151.87 20.61 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 57.64 62.82 2.0 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.945 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.421 ' HA ' ' CE ' ' A' ' 134' ' ' MET . 8.0 mmt -93.63 134.45 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.715 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 57.4 mt -94.97 141.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.905 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 18.3 ttp180 -125.43 125.39 43.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.578 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.9 OUTLIER -127.6 130.83 49.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.349 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 87.36 3.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.621 0.724 . . . . 0.0 109.202 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.06 114.7 1.5 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.094 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.8 116.51 3.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 112.236 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.67 160.02 37.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.956 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 142' ' ' LYS . 53.2 mtpt -136.97 177.24 8.01 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.349 1.071 . . . . 0.0 112.101 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 1.5 p -45.03 155.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.126 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.576 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 90.52 -25.37 13.26 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.67 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -90.9 -6.31 54.32 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.138 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 133.87 44.02 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.889 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.84 -21.18 18.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.0 149.07 38.79 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.095 -0.552 . . . . 0.0 112.976 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 26' ' ' THR . 25.6 t -87.47 121.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 112.46 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.1 tp -93.66 107.72 19.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.8 p -149.19 172.29 15.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.081 0.943 . . . . 0.0 113.325 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 167.61 24.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.273 -1.785 . . . . 0.0 107.437 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.9 t -65.1 101.21 0.5 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.944 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.61 -12.95 39.13 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -134.46 121.53 21.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.6 mt -101.48 117.09 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -88.48 -33.64 17.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.124 0.487 . . . . 0.0 111.806 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 173' ' ' LEU . . . 152.18 -150.73 22.63 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.538 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.1 pt -129.54 145.95 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.046 0.927 . . . . 0.0 112.024 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.424 ' HB2' HD11 ' A' ' 101' ' ' LEU . 6.6 t60 -60.99 123.75 18.53 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.603 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.519 HG21 ' HG2' ' A' ' 71' ' ' GLU . 9.8 p -111.84 -29.11 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.351 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -177.13 -147.51 6.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.229 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.54 160.32 29.62 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.77 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 15.3 t-20 -137.23 105.02 5.58 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.58 -115.26 5.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.263 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -104.79 -0.28 27.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.19 0.519 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.18 125.14 48.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.21 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.66 149.59 23.59 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 136' ' ' ARG . 49.3 m-85 -125.71 129.52 49.7 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.88 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.5 m -121.6 165.16 16.11 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.987 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.19 132.42 38.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.404 HE21 HD11 ' A' ' 94' ' ' LEU . 35.6 tt0 -82.36 106.27 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.868 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.491 HD13 ' CA ' ' A' ' 158' ' ' GLY . 11.0 mp -85.28 85.73 7.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.98 129.1 37.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.837 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -43.1 -38.55 2.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.477 0.656 . . . . 0.0 111.489 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 180' ' ' GLU . 79.3 mt-30 -49.75 -41.74 44.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -105.32 -35.2 7.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.7 p -62.12 -28.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.665 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 176' ' ' GLN . 5.0 pt-20 -77.39 -24.35 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -84.02 140.56 31.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.091 0.948 . . . . 0.0 113.273 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.364 -178.172 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.149 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.3 mm? -129.65 147.35 51.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.253 0.549 . . . . 0.0 110.476 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.9 tt0 -115.66 81.44 1.59 Allowed 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -80.97 149.14 29.46 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 35.8 tp -103.81 152.98 21.25 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.561 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.8 m-85 -61.2 145.03 52.57 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 94.8 mt-30 . . . . . 0 N--CA 1.443 -0.806 0 C-N-CA 118.836 -1.145 . . . . 0.0 . -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.734 ' CX7' ' HZ1' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 CA-C-O 120.964 0.202 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.69 -55.18 4.37 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.612 2.208 . . . . 0.0 114.117 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -52.4 -47.87 66.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.842 0.83 . . . . 0.0 110.934 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -56.28 -52.74 63.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.881 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.26 -30.23 63.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.81 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.28 -50.41 70.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -64.56 -40.74 96.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.374 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.5 tt -54.54 -46.31 73.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -79.82 -32.7 40.71 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.933 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.28 -43.43 98.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.026 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 4.6 pp -67.14 -26.89 66.89 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 65.5 mtp180 -73.69 -27.82 61.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.72 0.295 . . . . 0.0 111.101 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -97.55 -50.94 4.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -114.59 13.67 17.52 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 57.6 mt -122.29 117.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.034 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.1 mtp -128.99 146.89 50.85 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.788 0.804 . . . . 0.0 110.128 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.24 99.08 2.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.32 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.24 98.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.664 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 73.0 p -74.67 98.08 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -97.97 179.37 4.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.43 -176.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.551 ' H ' HG22 ' A' ' 20' ' ' THR . 4.8 m -62.48 -25.49 68.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.167 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -93.7 -39.17 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.99 -154.02 14.24 Favored Glycine 0 C--O 1.234 0.126 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -93.67 117.25 29.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -117.12 151.28 37.17 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.025 0.917 . . . . 0.0 112.978 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 149' ' ' VAL . 21.3 m -79.06 100.21 7.25 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.06 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.09 101.15 2.17 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -96.41 111.38 23.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 131.7 11.07 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' A' ' 178' ' ' PHE . 43.2 mm -98.84 -56.59 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 117.518 0.659 . . . . 0.0 111.097 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -145.45 129.55 17.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.908 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 m-20 55.12 -90.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.824 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.4 ptp180 -128.32 7.41 5.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.4 0.619 . . . . 0.0 111.397 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.7 t -87.65 111.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.938 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.2 m -119.3 159.14 24.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.68 144.52 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.576 0.703 . . . . 0.0 111.098 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -152.68 140.55 13.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.631 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.19 148.31 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.052 1.168 . . . . 0.0 111.234 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.725 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 77.7 m -68.86 -40.33 79.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.633 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -68.42 4.02 1.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.68 -25.53 53.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.885 0.85 . . . . 0.0 108.88 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 57.99 70.97 1.13 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.854 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.89 131.12 10.9 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.087 2.525 . . . . 0.0 111.318 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.18 -161.29 32.45 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.554 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.12 -21.39 50.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.767 0.784 . . . . 0.0 109.383 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.5 p-10 -133.03 133.79 43.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.93 163.67 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.796 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -103.01 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.301 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.64 92.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 68.38 19.72 8.82 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.285 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.4 32.9 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.841 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 112.98 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 2.2 pptp? -76.51 134.18 39.55 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.43 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.8 tp -144.35 137.55 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.084 -1.417 . . . . 0.0 108.488 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 39.0 mtt180 -93.69 138.54 31.8 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.614 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.51 138.26 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.87 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -83.39 -49.55 9.22 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.841 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.06 137.56 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.001 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -124.7 85.55 2.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -90.94 123.1 34.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.321 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.48 127.41 32.09 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.678 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 83.5 mt -90.13 116.77 28.39 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.372 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.19 159.55 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.621 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 27.6 t70 -76.64 144.86 74.12 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 15.9 Cg_endo -55.88 -5.16 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.395 2.063 . . . . 0.0 113.123 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.68 17.8 19.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.033 0.921 . . . . 0.0 109.939 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t30 74.5 0.02 3.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.814 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.34 155.01 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -67.4 146.62 53.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 0.0 111.742 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 31.4 tp -108.75 -22.8 12.06 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.725 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 24.4 tp10 78.96 11.8 1.44 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.397 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.9 mm? -102.25 151.25 22.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.218 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.8 m -124.47 120.38 31.85 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.308 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.4 100.82 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.1 93.42 9.14 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.583 0.706 . . . . 0.0 109.996 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -87.15 109.82 19.71 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.134 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 69.7 mt -106.77 151.73 24.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.648 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.92 102.45 6.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' NH2' ' HG2' ' A' ' 81' ' ' GLU . 22.5 mmm180 -119.29 108.13 14.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -83.28 -29.58 28.27 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -101.25 91.38 4.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 174.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 52.3 pttt -97.86 178.96 4.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.48 171.85 8.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.787 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.46 138.23 31.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.67 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.44 92.09 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.67 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.6 pt -88.13 21.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.057 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.44 -30.39 64.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.57 -20.28 77.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.074 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 77.5 m-85 -93.19 -8.84 41.28 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.8 mm -76.97 134.04 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -81.41 112.88 19.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -77.03 -27.03 54.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -143.44 131.75 22.07 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.991 -1.913 . . . . 0.0 106.219 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.2 mt -74.82 -80.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.26 71.38 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.466 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.23 80.41 0.14 Allowed Glycine 0 C--N 1.331 0.262 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 9.3 p -70.3 9.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 20.7 t70 -138.75 124.53 19.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.44 155.54 47.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.19 0.995 . . . . 0.0 112.958 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 m -107.76 143.13 36.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.154 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -115.73 111.94 21.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.76 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG21 ' HB1' ' A' ' 7' ' ' ALA . 27.6 t -95.23 99.54 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.42 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.03 122.69 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.431 0.634 . . . . 0.0 111.197 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.623 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 66.0 t60 -135.42 57.09 1.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -121.63 -163.91 1.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 112.996 -1.911 . . . . 0.0 112.379 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.05 -44.52 88.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.528 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -70.82 -60.84 2.02 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.679 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -113.11 108.63 17.57 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.856 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 15.7 m -96.48 97.62 9.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.446 0.641 . . . . 0.0 109.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.623 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 16.6 t30 74.44 71.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.584 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 m -143.51 121.47 12.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.698 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.43 115.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.141 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.15 157.52 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.93 140.09 40.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.07 -23.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.807 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.34 -125.92 7.13 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.881 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.714 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.5 Cg_endo -67.61 113.91 3.12 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.596 2.197 . . . . 0.0 114.187 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 157.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -145.45 158.75 43.78 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.104 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.21 140.14 48.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.897 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.99 -28.35 12.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.647 0.261 . . . . 0.0 111.671 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.99 -121.46 7.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.282 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.05 113.94 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.627 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 44.2 pt -132.46 176.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 38.4 m-80 -94.66 102.97 14.9 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.399 0.619 . . . . 0.0 110.804 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 57.0 tp -83.75 104.93 14.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.2 m 63.34 31.03 15.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.288 0.566 . . . . 0.0 109.657 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.4 m 81.41 0.58 1.62 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.545 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.9 m -108.51 117.48 54.3 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.5 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.26 119.93 6.55 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.336 2.024 . . . . 0.0 112.88 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -132.27 134.12 44.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.881 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.6 t30 -104.53 161.19 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.993 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.621 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 1.9 mpt_? 69.12 43.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.3 mmt -90.95 116.35 28.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 70.6 mt -85.44 130.65 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -110.75 136.04 50.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -148.48 113.55 5.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 6.7 p-10 -74.59 97.99 3.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.566 1.174 . . . . 0.0 110.526 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -149.02 139.26 22.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 111.873 -2.421 . . . . 0.0 107.69 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.85 90.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -106.17 158.56 16.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -139.24 159.64 41.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.198 0.999 . . . . 0.0 111.747 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.48 ' CG2' ' H2 ' ' B' ' 8' ' ' CA1 . 2.8 m -44.3 158.92 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.852 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.611 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.81 -17.75 57.23 Favored Glycine 0 N--CA 1.462 0.401 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.912 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -94.22 8.57 41.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.708 -0.246 . . . . 0.0 111.575 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.577 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 16.8 m -63.2 122.0 15.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.208 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 118.61 -20.87 10.02 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.71 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.91 130.24 23.04 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.12 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 26' ' ' THR . 58.3 t -84.94 115.55 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.2 tp -88.76 108.51 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.7 p -147.6 176.95 9.67 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.992 0.901 . . . . 0.0 112.785 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.97 173.09 14.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.529 -1.668 . . . . 0.0 107.765 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.8 m -64.49 108.75 1.74 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.191 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.27 -7.19 59.96 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.922 -0.656 . . . . 0.0 114.291 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 18.3 ptpt -155.89 137.32 14.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.02 126.79 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -88.06 -34.34 17.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.208 0.527 . . . . 0.0 111.49 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 160.37 -159.08 30.51 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.288 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 161' ' ' VAL . 46.0 pt -129.97 149.75 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.669 0.747 . . . . 0.0 111.671 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -61.77 120.27 10.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.862 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 159' ' ' ILE . 94.8 t -114.55 -26.83 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.377 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.09 -149.24 7.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.169 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.32 148.43 7.5 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.491 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 9.0 t-20 -118.27 105.69 12.02 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.08 -102.95 0.98 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -121.75 19.03 11.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.302 0.572 . . . . 0.0 110.601 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 0.5 OUTLIER -111.94 109.03 18.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -71.07 146.95 42.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.1 m-85 -127.53 119.45 26.06 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.2 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.4 m -110.6 156.0 21.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.627 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.504 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.05 131.85 37.01 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -71.31 105.17 3.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.645 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.419 HD21 ' HG ' ' A' ' 72' ' ' LEU . 73.0 mt -87.98 91.26 8.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.522 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -79.68 127.0 31.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.599 0.714 . . . . 0.0 109.54 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 179' ' ' VAL . 82.0 tttt -42.25 -34.83 0.84 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.853 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.52 -38.92 64.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -67.42 -13.44 62.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.409 ' CE1' HG13 ' A' ' 30' ' ' ILE . 83.9 m-85 -97.77 -34.23 10.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 175' ' ' LYS . 4.0 t -69.22 -1.85 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.027 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.43 -27.4 66.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 109.253 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -107.83 133.06 52.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.982 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.199 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . 0.404 ' O ' HD13 ' B' ' 2' ' ' LEU . . . . . . . . 0 C--O 1.225 -0.234 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.5 mm? -141.33 144.69 34.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 41.0 tt0 -106.08 81.59 1.65 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -85.32 127.86 34.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.183 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 28.5 tp -89.78 151.12 21.97 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -58.27 139.77 54.51 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.48 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 97.6 mt-30 . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 120.183 -0.607 . . . . 0.0 . 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.611 ' CX7' ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.684 0 N-CA-C 112.599 -0.2 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.15 -37.21 96.49 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 122.076 1.85 . . . . 0.0 112.655 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -62.57 -40.05 95.62 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.866 0.841 . . . . 0.0 109.177 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -43.83 87.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.41 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -64.43 -42.65 95.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.196 0.522 . . . . 0.0 109.708 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.14 -47.19 86.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 109.758 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.82 92.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.13 -48.59 80.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -70.69 -38.83 73.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.256 0.55 . . . . 0.0 110.113 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.41 -42.88 96.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.425 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 8.4 tt -60.33 -51.46 69.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.611 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -67.55 -28.76 68.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 4.7 mmpt? -99.86 -26.27 14.07 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.156 0.889 . . . . 0.0 113.088 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -123.58 -12.43 7.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.5 mt -107.07 120.88 59.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.726 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 22.4 mmt -127.45 145.69 50.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.065 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -76.52 105.69 7.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 43.2 mm -95.3 111.82 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.338 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 13.5 m -91.44 114.43 26.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.896 0.855 . . . . 0.0 110.468 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 41' ' ' ALA . 9.0 p -118.05 -162.95 0.91 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.186 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 13.0 m -69.76 -38.08 76.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HE3' ' HZ ' ' A' ' 25' ' ' PHE . 26.0 ttpp -83.0 -19.79 36.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.328 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.38 -156.93 27.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.412 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -109.39 117.82 35.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.922 0.867 . . . . 0.0 109.952 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HZ ' ' HE3' ' A' ' 22' ' ' LYS . 41.3 m-85 -109.91 171.75 7.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.629 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.681 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 73.1 m -86.89 108.94 19.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -94.01 126.88 8.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -101.31 104.63 15.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.087 0.47 . . . . 0.0 111.236 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 111.07 3.23 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.9 mm -75.4 -58.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 122.561 -0.376 . . . . 0.0 112.007 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -166.41 164.11 17.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.557 0.694 . . . . 0.0 112.79 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.99 -101.37 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.389 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.6 ptt180 -129.19 20.85 5.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.421 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.87 124.69 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.232 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 75' ' ' LEU . 6.3 p -124.27 141.12 52.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.202 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.87 121.52 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.371 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.09 133.56 24.39 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.646 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.83 139.04 78.12 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 N-CA-C 109.013 -1.187 . . . . 0.0 109.013 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.573 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.9 m -63.84 -35.38 80.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.753 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -69.3 -3.52 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -71.8 -28.66 63.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 72.2 mm-40 62.51 71.38 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.771 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -75.32 142.7 27.22 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.075 2.517 . . . . 0.0 111.496 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.03 -157.02 30.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.001 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.52 -21.94 28.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.595 0.712 . . . . 0.0 110.354 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.36 117.59 19.98 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.58 145.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 69.8 mt -85.23 103.47 14.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.659 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.27 90.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 12.4 t30 59.03 58.36 3.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.241 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.59 -32.64 1.87 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.659 -1.155 . . . . 0.0 114.391 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.413 ' OE1' HG12 ' A' ' 54' ' ' ILE . 25.0 tm0? -83.52 142.42 30.91 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.759 -0.26 . . . . 0.0 110.542 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.08 127.4 38.61 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.458 ' CG2' ' HB2' ' A' ' 77' ' ' LEU . 21.3 mm -137.39 133.45 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.358 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -91.5 142.46 27.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 110.838 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.44 136.18 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.333 -176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -88.64 -42.74 11.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -171.96 132.23 0.68 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.337 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.42 119.39 36.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.45 126.48 50.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.466 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 49.9 mtpt -79.57 128.29 33.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 26.6 mt -95.58 127.25 41.46 Favored 'General case' 0 C--O 1.254 1.327 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 69' ' ' ASN . 32.6 m -123.47 156.16 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 66' ' ' GLU . 24.4 t70 -72.73 142.19 83.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.407 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.0 -10.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.54 1.493 . . . . 0.0 112.096 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 tp10 -76.92 -3.2 37.49 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 108.704 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.9 m120 75.44 16.71 2.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.002 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.29 147.71 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HA ' HG12 ' A' ' 63' ' ' VAL . 64.0 t30 -59.9 135.93 57.85 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -99.79 -22.81 15.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 28.3 tp10 76.28 14.96 2.35 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.119 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 78.6 mt -98.81 114.11 26.52 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.438 0.461 . . . . 0.0 112.013 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.5 m -93.5 111.48 23.15 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 62' ' ' LEU . 61.5 t -78.04 100.05 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.4 tp -83.28 94.32 7.89 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.959 0.885 . . . . 0.0 110.958 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.8 m -85.37 105.96 16.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -108.37 152.9 24.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.31 -177.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -84.56 94.62 8.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.839 0.828 . . . . 0.0 109.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -144.35 128.07 17.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.384 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.03 -21.89 29.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.92 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -79.93 87.06 5.38 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -72.86 157.05 38.2 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.583 -175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -93.9 147.33 23.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.38 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -55.92 135.88 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 85' ' ' ASP . 3.3 p-10 -81.95 89.56 6.39 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.454 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 28' ' ' LEU . 32.8 pt -86.74 15.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.504 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -61.8 -23.66 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.91 -19.23 80.03 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.574 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 97.8 m-85 -86.34 -22.38 26.72 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 59.4 mt -71.98 136.8 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -125.12 142.47 51.47 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.1 pm0 -80.91 -15.34 56.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.42 153.56 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -100.07 -68.09 0.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.493 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 41.7 73.87 0.12 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.83 88.85 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.2 -13.61 16.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.968 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -106.85 125.68 51.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.92 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.63 149.66 39.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.878 0.847 . . . . 0.0 112.179 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -112.62 142.01 45.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 148' ' ' GLY . 1.2 tm? -115.63 109.67 18.09 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.59 114.65 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.295 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.8 133.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.749 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.7 t60 -140.0 31.94 1.98 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -109.77 -160.67 0.73 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.385 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -52.09 -61.74 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.99 -34.85 71.78 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -137.84 122.47 18.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.725 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 8.4 m -119.34 128.77 54.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.95 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' THR . 88.5 m-20 65.95 28.51 10.57 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.501 0.667 . . . . 0.0 110.095 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 m -99.87 103.36 14.95 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.906 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -90.55 100.08 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.37 117.98 30.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.35 120.78 18.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.52 -36.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.885 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.67 -128.56 8.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.859 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.67 113.43 3.49 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.023 1.815 . . . . 0.0 112.542 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.1 p -107.82 147.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.468 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 t -155.88 167.03 31.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.4 ttm -93.05 141.83 27.97 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.804 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.24 -33.75 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.517 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.52 -101.99 2.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.324 -0.853 . . . . 0.0 114.307 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp -125.24 122.24 36.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.729 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 48.3 pt -143.02 -176.53 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 10.0 m120 -106.55 85.76 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 23.4 tp -70.54 111.15 5.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.616 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.41 ' N ' ' O ' ' B' ' 4' ' ' ALA . 53.6 p 64.07 25.25 13.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.421 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 m 85.65 -3.68 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.222 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 37.1 m -99.89 125.97 38.43 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.797 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 129' ' ' THR . 32.4 Cg_exo -61.62 120.23 7.76 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.334 2.022 . . . . 0.0 113.879 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 p -123.97 137.74 54.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.862 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -110.39 160.5 16.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 16.0 mmm180 64.76 29.31 12.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.097 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.454 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -73.05 121.73 20.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.017 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.76 144.19 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.048 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 13.8 ptt180 -129.38 143.15 50.73 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.904 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -129.36 131.43 46.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.82 103.49 1.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.198 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -178.42 133.75 0.14 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.496 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -69.18 110.35 4.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.372 0.606 . . . . 0.0 110.1 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.423 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 21.2 p -111.25 148.6 32.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.029 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -133.24 151.46 51.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.067 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.402 HG22 ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -43.3 161.46 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.129 176.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.538 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.53 -13.42 67.4 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.532 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -102.08 8.22 40.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.863 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.402 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 7.6 m -64.75 141.63 58.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.127 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.681 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.61 -6.7 74.39 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.058 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . -52.44 131.28 38.75 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.18 110.78 17.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.71 105.06 15.22 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.2 p -144.45 178.07 8.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.397 1.094 . . . . 0.0 113.639 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.43 176.1 9.62 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.605 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 m -71.21 100.52 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.573 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.24 12.16 60.31 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.831 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 40.3 ttmt -155.33 134.58 12.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.306 0.574 . . . . 0.0 111.124 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.11 131.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.766 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.79 -43.01 7.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 169.17 -152.65 20.46 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.938 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.9 pt -135.22 150.18 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 122.077 0.942 . . . . 0.0 113.147 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.33 118.7 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.907 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 126' ' ' LEU . 43.8 t -113.47 -21.73 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.049 0.452 . . . . 0.0 110.857 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.28 -147.75 8.13 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.927 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 169' ' ' PHE . . . 171.51 161.12 21.57 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 55.2 t30 -128.23 82.17 2.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.495 0.664 . . . . 0.0 109.248 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.28 -107.22 2.1 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.869 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 95.6 mtt180 -90.59 7.55 38.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -124.75 110.77 14.75 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -77.8 142.55 26.78 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 136' ' ' ARG . 49.2 m-85 -118.83 127.16 53.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.852 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -125.3 163.48 22.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.157 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.455 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -99.35 141.11 32.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.275 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 8.3 tt0 -77.39 106.91 9.44 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.986 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.517 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.1 mp -94.52 85.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.225 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.91 135.13 37.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 7.4 ttpm? -54.38 -35.95 63.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.719 0.771 . . . . 0.0 109.813 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -53.06 -34.56 57.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.633 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -71.92 -25.9 62.09 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.257 -0.277 . . . . 0.0 111.08 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.11 -4.45 59.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.517 0.675 . . . . 0.0 110.357 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.35 -30.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.38 -47.32 81.99 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.88 136.57 34.03 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 . . . . . 0 C--N 1.316 -0.858 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.024 -179.432 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 6.6 mp -114.64 120.48 40.29 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -96.48 74.77 2.84 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.51 146.75 38.24 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.9 tp -106.05 148.69 27.48 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 19.1 m-85 -57.74 135.64 56.8 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.423 ' OE1' ' HB ' ' A' ' 141' ' ' THR . 81.7 mt-30 . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 . 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.538 ' CX7' ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 112.974 -0.05 . . . . 0.0 112.974 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.5 -35.74 95.09 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.873 2.382 . . . . 0.0 113.488 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.04 -35.64 66.79 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -65.19 -44.97 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.154 0.978 . . . . 0.0 108.584 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.86 -47.03 83.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.634 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.75 -46.3 79.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.276 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.03 93.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.21 -44.8 94.29 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 122.165 -0.334 . . . . 0.0 110.796 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -65.38 -40.12 93.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 109.893 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.5 tp -64.54 -44.81 89.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.169 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 5.4 tt -55.14 -46.64 75.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.251 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.13 -45.46 66.8 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.56 -2.21 20.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 115.635 1.716 . . . . 0.0 115.635 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -135.55 -12.24 2.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.265 -0.974 . . . . 0.0 113.294 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 49.2 mm -106.83 101.82 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.81 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -120.22 135.89 54.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.542 0.687 . . . . 0.0 110.261 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.13 102.25 2.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.09 100.0 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.325 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 48' ' ' LEU . 8.9 t -94.94 130.2 41.67 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.105 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.5 t -146.4 -157.55 0.82 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 m -51.54 -50.74 59.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.71 -16.25 39.63 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.73 -157.69 28.41 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 119.608 -1.282 . . . . 0.0 114.727 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -112.48 114.36 27.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.394 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.37 159.78 25.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.58 0.705 . . . . 0.0 111.674 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.2 m -72.64 106.01 4.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.613 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.62 106.68 3.34 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -87.53 106.55 18.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.336 0.589 . . . . 0.0 111.957 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 117.72 8.01 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 47.9 mm -89.08 -64.21 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 117.099 0.45 . . . . 0.0 112.077 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 58.36 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.237 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.9 ptp180 -129.78 15.22 5.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 110.678 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.93 122.66 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.788 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -122.37 156.03 34.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.804 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -114.82 135.16 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.478 0.656 . . . . 0.0 109.847 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' O ' ' HB ' ' A' ' 73' ' ' THR . 12.3 tt -144.94 142.06 18.13 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.614 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.47 149.66 23.02 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 120.888 1.059 . . . . 0.0 110.579 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 33.0 m -73.27 -36.74 66.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -66.94 -1.26 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -22.14 59.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.541 0.686 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.31 71.96 1.09 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.56 127.06 18.05 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.932 2.421 . . . . 0.0 112.374 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.58 -169.15 29.32 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.451 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 56' ' ' VAL . 2.6 p-10 -78.15 -16.31 58.05 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -143.18 137.61 29.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.69 156.12 37.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 19' ' ' THR . 7.5 mp -97.41 103.08 14.98 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.301 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.7 p -84.66 102.42 10.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.542 0.686 . . . . 0.0 110.154 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.6 t30 66.66 19.17 10.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.644 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.12 -22.11 11.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.583 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -92.1 115.66 28.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.318 0.559 . . . . 0.0 111.89 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.58 128.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -139.27 137.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.878 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -65.18 139.61 58.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.474 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 45' ' ' ASP . 14.4 p -87.06 136.75 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 76' ' ' THR . 57.1 tptt -78.36 -47.04 18.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.82 0.819 . . . . 0.0 108.833 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.06 133.46 1.46 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -106.99 92.76 4.22 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -86.22 106.21 17.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.754 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.77 121.08 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.906 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mt -89.88 113.34 24.93 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.704 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -94.02 165.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 133' ' ' ARG . 15.7 t70 -71.58 137.42 83.29 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.632 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HG2' ' NH2' ' A' ' 133' ' ' ARG . 7.0 Cg_endo -52.36 -15.68 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.857 1.705 . . . . 0.0 112.771 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.48 16.48 8.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.894 0.854 . . . . 0.0 109.059 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.0 t30 72.21 10.43 5.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.92 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 69' ' ' ASN . 15.9 mt -92.66 176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.539 ' H ' HG22 ' A' ' 68' ' ' ILE . 51.4 t30 -81.75 143.4 31.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 118.514 0.597 . . . . 0.0 111.22 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 26.5 tp -118.54 -27.49 5.92 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.58 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 26.5 tp10 70.55 10.62 7.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.666 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 10.9 tp -96.11 103.11 14.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.866 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 78.0 m -90.92 115.42 27.94 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.565 0.698 . . . . 0.0 111.616 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.73 94.17 3.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.3 tp -81.47 104.51 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.797 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 8.7 m -98.59 115.09 27.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.572 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 77' ' ' LEU . 2.0 mp -117.47 150.01 39.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.718 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.73 91.49 7.97 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.481 ' HE ' ' HA ' ' A' ' 79' ' ' ARG . 2.2 tpm_? -112.51 110.33 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.58 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.31 -54.0 51.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.783 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -74.73 92.59 2.48 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -70.74 147.3 49.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.221 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -88.06 146.96 25.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.991 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -58.41 120.62 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.103 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 7.4 p-10 -77.37 94.24 4.18 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 121.709 0.766 . . . . 0.0 112.408 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.2 17.13 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.95 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 88' ' ' GLY . 5.0 ppt_? -59.03 -23.95 62.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.16 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 87' ' ' ARG . . . -84.08 -13.63 73.99 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.642 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.53 -3.36 46.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 40.1 mt -82.55 127.31 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.449 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 6.5 m -83.69 110.89 18.66 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.19 -49.95 31.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' SER . 23.8 t70 -97.78 115.66 28.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 173.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.1 mt -60.75 -72.23 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.88 67.41 0.93 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.618 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -146.49 75.38 0.28 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.344 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 p -97.38 0.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 10.9 t70 -149.88 125.72 10.48 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.115 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -153.6 176.7 11.77 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.473 1.13 . . . . 0.0 114.041 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -115.4 138.78 50.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.783 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -115.55 110.66 19.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.09 124.78 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.096 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 108' ' ' PHE . 1.7 t -114.6 139.82 38.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 122.035 0.921 . . . . 0.0 113.063 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -149.35 71.79 1.13 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.045 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.4 p -125.55 -174.01 2.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.637 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -59.85 -44.68 93.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.866 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.85 -41.05 15.33 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 103' ' ' VAL . 93.3 m-85 -115.96 98.15 6.49 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.4 m -105.59 122.78 46.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.581 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 66.73 73.36 0.36 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.8 m -142.25 102.85 4.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.731 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.93 108.92 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.11 120.98 32.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -72.54 118.1 15.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 137' ' ' TYR . 13.8 p -92.14 -26.29 4.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.707 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.57 -125.84 7.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.593 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.6 Cg_exo -62.87 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.345 2.03 . . . . 0.0 113.453 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 96' ' ' GLY . 2.8 p -136.61 141.89 39.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.589 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 m -153.08 139.37 18.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 27.3 ptt? -74.01 140.2 45.28 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.822 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.07 -66.24 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.48 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.32 -122.35 1.78 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.885 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt -103.06 117.79 35.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.448 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 36.0 pt -138.52 -176.38 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.6 m120 -105.18 83.95 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.982 0.42 . . . . 0.0 111.198 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 59.3 tp -65.93 108.03 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.212 0.529 . . . . 0.0 110.048 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 128' ' ' SER . 3.5 m 61.24 33.48 19.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 127' ' ' SER . 22.7 t 76.97 8.97 2.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.472 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -112.12 113.45 51.83 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.819 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.67 113.37 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.847 1.698 . . . . 0.0 111.649 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 126' ' ' LEU . 29.5 m -124.69 139.65 53.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.103 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -113.4 159.66 19.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' A' ' 64' ' ' ASP . 8.2 mtm180 56.37 61.45 2.7 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.319 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.0 mtp -109.6 132.67 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.156 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 50.2 mt -86.1 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ttp180 -132.27 147.01 52.39 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.16 0.505 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 115' ' ' VAL . 23.2 p90 -143.16 134.97 26.71 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.35 94.52 7.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.248 1.023 . . . . 0.0 110.555 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -155.86 133.63 11.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.942 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.11 105.56 0.42 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.394 0.616 . . . . 0.0 111.22 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 p -119.17 141.97 48.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -129.29 164.39 23.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.095 0.95 . . . . 0.0 112.03 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 1.0 OUTLIER -43.1 150.25 0.18 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.405 174.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.51 9.36 Favored Glycine 0 N--CA 1.463 0.44 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -68.55 -7.81 35.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.814 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.573 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 22.5 m -58.75 137.86 57.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 99.39 -17.87 57.19 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.734 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.26 126.86 37.78 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.242 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.15 117.49 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.07 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.25 110.45 17.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.0 p -147.03 -177.25 5.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.056 0.931 . . . . 0.0 112.704 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.76 30.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 t -62.93 108.28 1.17 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.831 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.1 75.51 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.923 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -141.55 121.01 13.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 35.2 mm -102.87 130.1 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.56 -52.92 2.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -176.89 -174.09 43.03 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.792 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 pt -118.97 139.07 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.414 0.626 . . . . 0.0 110.586 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -69.52 122.27 18.69 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.28 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.76 -9.58 11.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.8 -161.78 29.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.167 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.36 158.46 26.9 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.061 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 3.7 t-20 -129.75 89.62 2.85 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.909 0.385 . . . . 0.0 110.336 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 -107.88 2.33 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.408 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -96.04 1.67 52.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.238 0.542 . . . . 0.0 110.173 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -107.95 109.3 20.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.314 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -80.26 137.67 18.72 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.02 125.48 46.39 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.571 -0.852 . . . . 0.0 113.069 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.4 m -120.92 151.82 39.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.106 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.44 130.91 39.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.536 ' HB3' HD11 ' A' ' 135' ' ' ILE . 20.0 pt20 -87.79 110.99 20.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 118.468 -1.293 . . . . 0.0 112.722 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -88.76 94.78 10.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.88 139.79 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.952 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -45.6 -35.41 4.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.05 -26.45 37.66 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.42 -15.74 54.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 180' ' ' GLU . 25.3 m-85 -107.93 -38.06 5.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 179' ' ' VAL . 55.4 t -77.63 6.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' A' ' 178' ' ' PHE . 10.1 tt0 -65.1 -35.77 82.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.168 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -88.73 89.7 8.1 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.745 -1.571 . . . . 0.0 114.825 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.251 176.098 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.074 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.1 mm? -121.28 154.75 35.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.5 tt0 -114.59 71.85 0.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -76.88 133.71 39.2 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.397 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 15.9 tp -95.73 152.17 18.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.56 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 27.8 m-85 -56.98 137.7 55.24 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.542 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 97.5 mt-30 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 . 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.573 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.069 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.7 -51.66 10.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.427 2.085 . . . . 0.0 114.085 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.613 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.7 t-20 -68.53 -45.14 73.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.709 0.766 . . . . 0.0 110.528 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.4 m -57.54 -43.59 84.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.143 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.02 -24.29 52.13 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.8 -43.54 58.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.35 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.175 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 8' ' ' LEU . 2.8 tm? -59.53 -39.44 83.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.279 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -69.53 -47.34 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.794 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.42 -38.5 84.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.7 tp -55.57 -49.14 73.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -68.49 -28.12 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.266 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -86.78 -63.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.11 -3.6 12.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -173.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 54.6 mt -99.99 131.45 47.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.872 -1.131 . . . . 0.0 113.008 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -151.62 146.42 25.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.923 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 m -68.88 117.86 11.09 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.488 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mt -98.64 98.69 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.901 0.858 . . . . 0.0 110.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 58.5 m -70.9 99.22 1.72 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.018 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -175.53 3.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.45 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 m -70.54 -28.8 65.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.613 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' HG2' ' H8 ' ' B' ' 8' ' ' CA1 . 23.4 ttmm -88.17 -45.81 9.79 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.083 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.27 -168.07 26.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.492 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 34.3 mt-10 -108.22 103.03 12.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.798 0.808 . . . . 0.0 109.228 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 41' ' ' ALA . 40.6 m-85 -97.75 165.39 11.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.853 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 97.7 m -83.24 108.17 16.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.97 136.49 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.93 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -124.61 135.72 53.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.582 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -77.64 142.69 27.12 Favored Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.83 -54.2 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.978 0.889 . . . . 0.0 110.066 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -167.83 138.77 2.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 82' ' ' LYS . 31.2 m-20 57.18 -88.74 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.508 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -125.49 5.78 7.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.405 0.622 . . . . 0.0 111.175 -178.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 74' ' ' VAL . 49.0 t -88.18 120.67 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.034 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 36.8 t -131.48 141.25 49.74 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.009 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.59 151.13 34.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.56 167.8 12.6 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 113.043 -1.889 . . . . 0.0 106.303 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.78 175.47 2.3 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 121.289 1.326 . . . . 0.0 112.147 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.51 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 99.5 m -80.56 -36.81 32.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.544 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -72.3 4.99 3.14 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -69.21 -28.49 66.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.791 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 60.58 72.83 0.68 Allowed Pre-proline 0 CA--C 1.514 -0.43 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.27 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.28 123.52 6.66 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.013 2.475 . . . . 0.0 112.843 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.36 -172.01 46.04 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.19 -17.12 38.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.888 0.844 . . . . 0.0 109.71 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 18.9 t70 -134.85 109.77 8.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.55 154.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 95.3 mt -99.42 99.6 10.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.494 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 19.6 m -83.06 93.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.415 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 t30 66.19 17.96 10.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.708 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.12 -21.81 8.15 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.523 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.87 118.02 23.14 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.741 -0.27 . . . . 0.0 110.278 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.707 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -81.98 119.34 23.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.706 0.765 . . . . 0.0 110.508 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.49 130.7 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.026 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.2 mtp-105 -85.83 126.48 34.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.264 0.554 . . . . 0.0 110.069 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.01 143.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.281 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -77.99 -52.79 8.25 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.763 0.792 . . . . 0.0 109.237 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -141.73 126.71 18.3 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.406 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -109.29 104.44 13.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -104.29 120.11 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.875 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.88 125.1 28.12 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 29.8 mt -90.7 111.85 23.37 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 122.0 0.905 . . . . 0.0 111.545 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.1 m -113.85 159.11 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 67' ' ' ASN . 14.7 t70 -67.72 138.42 93.23 Favored Pre-proline 0 C--N 1.311 -1.101 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.47 -21.99 32.64 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.532 1.488 . . . . 0.0 112.815 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.71 -0.04 55.55 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' ASP . 63.9 m-80 71.76 72.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.134 -1.848 . . . . 0.0 115.454 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 69' ' ' ASN . 34.6 mm -137.41 151.96 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.516 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 131' ' ' THR . 22.8 t30 -62.87 111.83 2.3 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.883 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.623 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 15.0 tp -87.36 -27.11 23.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HG2' HG11 ' A' ' 161' ' ' VAL . 13.7 tp10 71.62 31.14 2.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.898 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 94.1 mt -123.42 151.55 42.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 25.3 m -132.64 127.07 34.11 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.373 0.606 . . . . 0.0 110.516 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.416 HG23 ' HG ' ' A' ' 62' ' ' LEU . 85.7 t -87.63 107.38 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.974 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.31 92.24 8.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -74.36 90.51 2.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.043 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.25 91.48 5.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 33' ' ' ARG . 18.7 p-10 -78.82 61.57 3.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.376 0.608 . . . . 0.0 109.866 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -82.55 160.32 22.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.34 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -61.31 -51.66 67.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -78.64 110.72 14.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 61.2 mttp -77.08 152.2 35.13 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.782 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -80.33 141.4 35.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.109 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.12 138.14 58.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.682 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 87' ' ' ARG . 11.4 p-10 -73.96 88.12 1.85 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.128 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.8 pt -88.0 12.11 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' NH2' ' HA ' ' A' ' 179' ' ' VAL . 45.2 ttt180 -53.7 -38.4 64.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.838 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.74 76.75 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.709 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -87.49 -12.7 45.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.62 129.98 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.608 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 13.5 m -120.5 122.39 40.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.649 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.5 mp0 -64.66 -48.41 74.87 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 91' ' ' SER . 30.0 t70 -95.48 120.06 35.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -76.5 -54.83 6.17 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 41.05 66.15 0.7 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.306 0.574 . . . . 0.0 109.928 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.14 80.93 0.1 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.863 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -70.53 -7.59 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.82 121.49 45.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.81 40.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.599 0.714 . . . . 0.0 112.176 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 96.0 m -116.03 135.22 54.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.256 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -92.06 116.85 29.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.392 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.06 103.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 22.1 t -100.38 124.11 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.446 0.641 . . . . 0.0 110.98 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -137.37 50.3 1.98 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.8 m -107.93 -172.54 2.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.333 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 13.4 p30 -62.05 -35.37 78.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -55.61 -50.5 69.97 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.824 -0.547 . . . . 0.0 112.215 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -158.79 132.97 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.317 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 23.2 m -84.39 114.55 21.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.603 0.716 . . . . 0.0 110.969 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 109' ' ' THR . 5.6 m-20 77.24 72.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 2.0 m -116.73 109.29 16.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.5 pt -107.99 99.56 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.051 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.8 mt -97.29 117.64 31.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.892 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.03 98.93 9.54 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.92 -16.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.098 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.34 -128.99 9.04 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.535 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 22.9 Cg_endo -65.11 119.11 6.07 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.193 1.929 . . . . 0.0 114.816 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 137' ' ' TYR . 34.3 m -111.87 148.63 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.512 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 m -150.39 144.4 25.43 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.0 ptp -82.01 142.96 31.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.193 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.53 -42.46 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.093 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.27 -128.92 8.45 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.067 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 48.1 tp -99.26 110.52 23.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.84 0.352 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.62 175.33 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.996 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.8 m-20 -87.54 126.13 34.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 46.5 tp -111.58 107.51 16.69 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.429 ' HB3' HD12 ' B' ' 5' ' ' LEU . 95.6 p 57.86 32.07 21.42 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.006 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.0 m 76.73 29.75 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.929 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -140.36 120.85 9.03 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.14 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.38 117.94 4.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.502 2.135 . . . . 0.0 114.123 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 69' ' ' ASN . 82.9 m -127.31 131.68 50.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.549 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 29.8 p-10 -102.67 169.38 8.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.61 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER 57.7 42.13 24.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.846 175.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.8 mmt -86.32 136.75 33.02 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.38 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 48.8 mm -101.07 137.63 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -127.84 148.32 50.46 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.502 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB3' HG12 ' A' ' 118' ' ' VAL . 25.0 p90 -143.03 151.74 41.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.263 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.89 113.51 22.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.832 0.825 . . . . 0.0 111.43 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -176.12 133.19 0.25 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.327 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -68.32 100.82 1.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.818 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.1 p -93.39 171.4 8.94 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.749 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -161.44 145.63 13.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.56 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.597 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -42.24 158.72 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.706 175.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' N ' ' OX8' ' B' ' 8' ' ' CA1 . . . 89.77 -24.33 15.64 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.003 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -85.76 4.49 36.6 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.769 0.428 . . . . 0.0 112.009 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 13.4 m -62.18 140.96 58.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 107.02 -20.69 32.99 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.77 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.76 130.45 26.92 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.532 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.36 124.18 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 110.73 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.7 tp -101.56 106.7 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.4 p -149.74 176.4 10.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.972 0.891 . . . . 0.0 112.922 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -137.28 172.73 12.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.591 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.3 t -61.31 108.76 0.97 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.066 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.56 -4.2 86.37 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -141.47 116.78 10.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.729 0.764 . . . . 0.0 111.836 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -93.99 126.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.73 -44.13 6.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.79 -165.01 34.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.7 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -129.63 144.5 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.437 0.637 . . . . 0.0 110.797 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -66.82 115.37 6.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.438 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.472 HG11 ' HG2' ' A' ' 71' ' ' GLU . 54.0 t -107.16 -27.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.169 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.19 -147.86 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.082 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.32 164.69 29.69 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.221 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 8.8 t30 -128.23 88.37 2.74 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.67 -109.62 2.78 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.636 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.664 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 18.1 ttt180 -88.54 3.84 48.91 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 113.37 19.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.295 0.569 . . . . 0.0 109.977 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -78.41 143.21 26.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 44.6 m-85 -121.86 124.42 44.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.352 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -123.11 142.38 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.008 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.37 125.45 31.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.454 0.645 . . . . 0.0 109.689 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.553 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 50.2 tt0 -72.03 119.86 16.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.123 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.519 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.6 mp -88.19 92.83 9.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.83 132.56 33.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.649 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 ttpm? -58.48 -17.32 20.12 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.24 -29.99 67.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -81.11 -28.15 35.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.66 0.267 . . . . 0.0 111.569 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -86.37 -32.55 20.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.464 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 12.5 p -65.63 -21.99 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 110.344 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -38.14 86.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.748 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.91 120.13 38.84 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.854 177.544 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.099 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -135.25 164.43 27.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.561 0.696 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 34.5 tt0 -126.24 77.47 1.69 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.83 152.51 26.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.6 tp -107.69 154.87 20.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.6 m-85 -63.69 141.28 58.83 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.597 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.6 mt-30 . . . . . 0 C--N 1.295 -1.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 . 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.476 ' H8 ' ' HG2' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.35 -42.16 29.66 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.368 2.046 . . . . 0.0 113.134 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.36 -42.65 78.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.293 -0.163 . . . . 0.0 110.897 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -72.2 -27.59 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.44 -45.5 75.86 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.87 -45.71 89.5 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.315 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.38 83.57 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.8 tp -68.1 -38.92 82.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -67.66 -38.08 83.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.002 0.429 . . . . 0.0 110.028 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.415 HD11 HD13 ' A' ' 86' ' ' ILE . 60.8 tp -65.46 -40.45 93.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.528 0.68 . . . . 0.0 109.567 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 11' ' ' LEU . 3.1 tm? -50.59 -48.69 57.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.218 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -70.01 -29.61 66.72 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.39 -58.85 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.2 7.24 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 48.2 mm -105.15 106.7 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.969 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.3 mtp -121.6 147.73 45.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -76.29 111.23 11.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.088 -178.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.7 mm -92.84 106.15 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.601 0.715 . . . . 0.0 110.463 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 6.7 m -75.96 98.35 4.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.628 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -103.47 -178.08 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.521 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 16.4 m -59.47 -32.24 70.06 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.505 ' HZ3' ' CJ1' ' B' ' 8' ' ' CA1 . 5.8 mtmp? -88.97 -1.63 58.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.03 0.832 . . . . 0.0 111.253 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.24 -163.7 23.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.844 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 105' ' ' SER . 25.3 mt-10 -96.85 128.37 43.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.407 0.622 . . . . 0.0 110.902 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -123.22 166.94 14.4 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.804 0.812 . . . . 0.0 111.325 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 2.7 m -68.64 100.43 1.13 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.875 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -81.2 109.54 3.01 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.637 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.46 94.47 9.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.902 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.44 122.41 8.62 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.5 -50.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 117.678 0.739 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -161.25 153.64 20.24 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.963 0.887 . . . . 0.0 113.117 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.628 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 42.8 m-20 51.65 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.615 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.1 ptt180 -140.15 16.36 2.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.702 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.9 115.42 39.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.154 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -120.18 148.7 43.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.21 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.69 130.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.498 0.666 . . . . 0.0 112.141 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.39 165.42 28.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.85 163.62 36.68 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 121.647 1.565 . . . . 0.0 112.61 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.737 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 44.8 m -81.11 -38.95 26.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.161 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -71.31 2.27 5.02 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -12.9 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.663 0.744 . . . . 0.0 109.156 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 68.8 mt-30 62.44 73.23 0.55 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.341 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.88 159.54 47.97 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 122.537 2.158 . . . . 0.0 111.873 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.14 178.96 17.0 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.047 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.532 ' HA ' HG12 ' A' ' 56' ' ' VAL . 24.0 m-20 -81.89 -19.7 40.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.889 0.844 . . . . 0.0 109.467 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -137.37 113.17 9.62 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.86 173.07 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.829 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 6.2 mp -112.3 138.16 49.4 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.765 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.33 83.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.492 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 2.4 t-20 62.23 27.0 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.12 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.39 -44.79 1.16 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.159 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.16 115.77 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -76.4 122.02 23.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -125.43 149.01 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.227 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.616 ' HD2' ' N ' ' A' ' 55' ' ' ARG . 7.8 mpt_? -96.61 145.51 25.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.221 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 45' ' ' ASP . 8.5 p -86.99 138.88 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.998 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.18 -42.23 17.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -158.81 132.12 7.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -117.44 116.38 27.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.55 120.54 39.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.256 0.55 . . . . 0.0 111.095 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.12 121.71 27.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.791 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 76.9 mt -85.91 123.51 31.34 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.331 0.586 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 20.5 m -122.01 171.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.185 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 16.8 t70 -78.73 143.08 62.09 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -48.54 -26.13 8.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.829 2.353 . . . . 0.0 113.618 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.34 22.74 4.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 111.09 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.11 11.6 5.09 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.107 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 25.4 mm -88.16 163.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.427 ' N ' HG22 ' A' ' 68' ' ' ILE . 54.9 t30 -73.33 139.27 45.92 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.79 -36.68 6.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.737 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.8 tp10 84.07 22.0 0.14 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.34 -1.754 . . . . 0.0 114.498 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.562 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.8 mm? -111.4 146.04 37.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.21 0.529 . . . . 0.0 110.834 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 26.3 m -117.33 114.48 23.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.564 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.413 HG23 ' HG ' ' A' ' 62' ' ' LEU . 88.8 t -80.93 100.08 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.32 100.67 12.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.71 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.4 m -92.38 93.88 8.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.066 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 96.0 mt -85.62 159.16 19.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.371 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -78.76 92.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -128.61 123.21 32.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.084 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -80.8 -57.3 3.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.61 114.79 5.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 13.1 ptpt -76.1 145.78 39.8 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.68 145.98 42.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 4.9 tpm_? -56.93 122.81 13.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.031 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 90.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.106 0.479 . . . . 0.0 111.072 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.415 HD13 HD11 ' A' ' 10' ' ' LEU . 41.0 pt -96.27 32.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.033 0.444 . . . . 0.0 110.111 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.593 HH22 ' HA ' ' A' ' 182' ' ' GLN . 13.0 mtp180 -65.3 -30.72 71.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.237 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.59 -19.22 79.95 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.939 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -80.14 -16.39 55.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.613 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 52.7 m -94.69 122.41 37.27 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.063 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.594 ' O ' ' HE2' ' A' ' 174' ' ' LYS . 5.0 pt-20 -61.5 -29.65 70.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.031 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HA ' ' CE ' ' A' ' 174' ' ' LYS . 37.8 t70 -131.05 163.35 27.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 95' ' ' GLU . 43.6 mt -74.47 -81.1 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 94' ' ' LEU . 12.8 pt-20 33.32 74.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.253 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.474 ' HA3' ' CZ ' ' A' ' 157' ' ' PHE . . . -157.7 92.25 0.12 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.462 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 61.5 t -62.15 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.2 t70 -124.36 132.45 53.54 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.58 174.6 10.81 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.738 0.78 . . . . 0.0 112.752 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.9 m -131.06 146.26 52.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.593 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.5 tp -105.98 113.91 27.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.34 110.92 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 109.994 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -112.08 117.33 54.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.275 0.56 . . . . 0.0 111.365 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -130.9 83.09 2.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 71.1 p -129.57 -164.56 1.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.891 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.76 -13.95 57.1 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -90.52 -66.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.347 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 56.2 m-85 -108.48 120.97 43.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.704 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.4 p -100.0 110.66 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.891 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.56 32.38 16.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 39.9 m -81.91 102.11 10.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.697 0.761 . . . . 0.0 110.905 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 112' ' ' ILE . 9.5 tt -100.13 92.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -101.22 113.15 25.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.139 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.69 112.0 6.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.832 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.15 -33.94 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.05 -123.68 7.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.323 -0.942 . . . . 0.0 114.165 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 35.1 Cg_endo -64.58 124.52 13.38 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.533 2.156 . . . . 0.0 113.85 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -106.21 137.43 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.063 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 p -132.27 171.01 14.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 59.6 ttp -120.13 139.66 52.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.938 0.399 . . . . 0.0 112.05 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.42 -43.66 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.693 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.43 -111.75 4.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.094 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -103.54 116.68 32.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 0.0 110.72 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.433 HG21 HD23 ' B' ' 2' ' ' LEU . 46.8 pt -144.8 -176.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 m-20 -101.95 123.05 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.257 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.3 mm? -102.13 111.69 24.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' SER . 17.3 t 60.46 30.88 20.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.453 0.644 . . . . 0.0 109.933 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 45.4 m 83.37 2.34 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.377 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.4 m -112.01 116.47 49.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.063 0.227 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.49 123.35 11.14 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 122.413 2.075 . . . . 0.0 112.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 126' ' ' LEU . 70.6 m -131.94 138.42 48.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.903 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -101.93 169.59 8.68 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 13.5 mmt180 63.29 34.77 12.97 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.05 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 171' ' ' ALA . 31.7 mmt -82.17 128.43 34.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.734 0.778 . . . . 0.0 112.058 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 19.9 mm -95.21 144.07 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 33.0 ptt180 -131.6 139.46 49.17 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.506 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.1 130.97 24.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.361 0.6 . . . . 0.0 109.928 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.2 96.71 0.66 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.246 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -175.09 121.25 0.21 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.093 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.56 108.17 2.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.849 0.833 . . . . 0.0 112.286 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.67 148.48 43.87 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.151 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 35.0 mmtp -133.67 176.99 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.881 0.848 . . . . 0.0 112.81 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.9 OUTLIER -44.08 150.2 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.357 176.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 92.33 -22.69 31.19 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.352 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.84 3.7 47.35 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 m -58.93 134.88 57.33 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.954 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.65 8.35 59.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.523 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.91 135.93 20.97 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.239 -1.458 . . . . 0.0 109.571 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.4 t -86.32 117.45 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.666 0.733 . . . . 0.0 111.32 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.14 105.06 17.37 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.1 p -141.3 165.42 27.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.951 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.58 179.26 6.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -60.24 101.1 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.484 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.5 22.43 78.96 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.613 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 32.5 ttmt -147.92 108.72 4.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.5 mt -94.36 123.1 46.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.474 ' CZ ' ' HA3' ' A' ' 96' ' ' GLY . 91.6 m-85 -91.57 -39.09 12.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.474 0.655 . . . . 0.0 110.755 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 157.4 -155.17 26.16 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.935 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.79 150.16 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.541 0.686 . . . . 0.0 110.903 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -69.15 122.22 18.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.016 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.07 -23.08 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.49 -156.54 12.0 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.855 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.64 157.9 25.61 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.481 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.1 t-20 -128.65 92.32 3.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.575 0.703 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.72 -104.99 1.49 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.741 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -95.85 2.27 53.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -127.25 129.55 47.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.308 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.1 146.52 22.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.483 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.9 m-85 -123.78 131.5 53.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.778 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.5 m -125.3 159.48 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.289 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -97.77 141.04 31.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.317 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 77.0 mt-30 -79.85 117.24 20.54 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.558 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 66.9 mt -96.74 71.75 2.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 92' ' ' GLU . 38.6 mtpt -79.75 135.3 36.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -56.38 -15.62 4.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.652 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 179' ' ' VAL . 3.9 pt20 -67.73 -16.91 64.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.15 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.36 -9.98 34.11 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.06 11.35 23.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.119 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 176' ' ' GLN . 8.2 p -96.61 -6.39 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.487 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -86.87 -52.43 5.48 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -71.34 125.88 28.15 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.593 ' HA ' HH22 ' A' ' 87' ' ' ARG . 21.7 tt0 . . . . . 0 C--N 1.317 -0.826 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.125 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? -144.18 149.58 36.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.99 0.424 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.8 tt0 -110.99 78.94 1.15 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.64 137.75 34.39 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 39.2 tp -95.62 144.63 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.584 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 25.0 m-85 -59.87 137.86 57.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 97.9 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.226 -0.443 . . . . 0.0 . -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.505 ' CJ1' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.674 0 N-CA-C 112.376 -0.29 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -47.42 -41.93 28.65 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.009 2.472 . . . . 0.0 115.255 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -66.35 -59.58 3.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 0.0 112.026 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 m -56.87 -42.22 79.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.89 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.41 -25.8 57.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.949 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -67.62 -46.44 72.51 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.69 99.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.26 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.2 tm? -61.62 -46.29 90.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -65.94 -44.96 83.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 86' ' ' ILE . 60.5 tp -62.83 -41.94 99.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.828 0.823 . . . . 0.0 110.811 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 31.0 tp -51.81 -51.48 56.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.01 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 15.1 mtp180 -63.02 -28.16 69.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -108.28 -49.26 3.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.43 -6.81 22.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 41.8 mt -102.18 108.44 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.415 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.1 mmt -119.17 148.32 43.22 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.953 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 m -76.83 117.17 18.17 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.147 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.78 95.79 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 28.1 m -84.07 108.57 17.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -129.73 -170.6 2.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.538 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -56.81 -49.1 76.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.935 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 10.8 tmtt? -71.02 -27.71 63.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.64 -156.99 28.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.677 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.02 117.1 32.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 43.6 m-85 -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.154 0.978 . . . . 0.0 112.295 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 75.4 m -88.68 95.77 10.39 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 113.399 -1.728 . . . . 0.0 107.93 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.23 116.94 4.36 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.184 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.88 101.02 13.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.357 0.599 . . . . 0.0 110.998 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -68.36 127.32 23.6 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 87' ' ' ARG . 36.2 mm -97.18 -47.4 12.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 118.07 0.935 . . . . 0.0 110.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 33' ' ' ARG . 6.7 p80 -165.75 166.81 17.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 40.99 -84.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.759 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' HIS . 16.4 ptp180 -143.92 21.51 1.78 Allowed 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 122.273 -0.267 . . . . 0.0 111.388 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 HG13 ' A' ' 74' ' ' VAL . 7.2 p -119.03 134.18 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 60.4 m -119.59 159.21 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.639 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.88 131.84 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.551 0.691 . . . . 0.0 111.571 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.72 165.17 29.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.98 170.69 18.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.216 1.277 . . . . 0.0 111.438 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.424 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 35.5 m -82.18 -33.27 29.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.043 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -72.8 2.01 7.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.823 0.344 . . . . 0.0 110.731 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -72.1 -19.55 61.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 53.68 70.3 1.83 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.599 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.35 124.98 10.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.692 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 -164.25 14.0 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.375 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.34 -31.0 16.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 108.837 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.15 118.65 18.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.28 159.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.986 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 85.3 mt -90.46 107.65 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.644 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.95 100.84 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.012 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.92 32.76 12.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.615 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.72 -14.93 64.21 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.828 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -100.92 126.36 47.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.507 0.654 . . . . 0.0 111.479 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.64 112.35 5.35 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 35.8 mm -114.62 118.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.379 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.54 157.91 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.94 -45.04 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.781 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 20.0 t70 -142.56 94.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.834 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 17.6 ptpt -93.0 90.26 6.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -97.19 115.11 26.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.406 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.88 129.36 37.53 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.916 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 20.0 mt -88.51 101.28 13.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -108.2 144.21 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 171.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' C ' ' N ' ' A' ' 66' ' ' GLU . 15.2 t70 -80.18 150.59 71.54 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 64' ' ' ASP . 65.0 Cg_exo -45.23 -20.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.618 0.879 . . . . 0.0 110.258 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 6.4 tp10 -63.12 -14.69 51.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.686 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 20.6 t30 80.43 3.36 1.84 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.372 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.07 155.16 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.584 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.77 126.35 29.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.0 tp -93.9 -15.58 24.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.2 tp10 70.24 14.25 7.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.728 -1.578 . . . . 0.0 113.152 175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 173' ' ' LEU . 8.5 mp -101.63 159.22 15.5 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -135.81 117.09 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG23 ' HG ' ' A' ' 62' ' ' LEU . 69.2 t -78.57 96.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.33 85.35 7.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.437 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 3.2 m -80.35 104.63 11.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.028 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 65.9 mt -95.55 159.75 14.84 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.786 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.65 86.35 7.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 33' ' ' ARG . 27.1 tpt180 -117.72 126.27 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.565 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -84.36 -48.76 9.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.26 116.04 15.56 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -82.32 150.17 27.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 122.018 0.913 . . . . 0.0 112.644 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.797 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -82.76 129.74 35.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.8 p-10 -75.61 97.8 3.86 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.429 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.414 HD13 HD11 ' A' ' 10' ' ' LEU . 33.5 pt -96.25 29.38 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.777 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 57.3 mtm180 -66.7 -27.0 67.29 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.032 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.7 -1.86 22.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.63 141.57 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 19.1 m -93.7 119.9 33.28 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.87 -47.14 60.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 91' ' ' SER . 19.2 t0 -114.28 144.1 43.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 173.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.0 mt -66.98 -71.19 0.21 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 59.23 70.88 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.715 ' O ' HG13 ' A' ' 118' ' ' VAL . . . -143.31 92.41 0.17 Allowed Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 114.153 -1.385 . . . . 0.0 113.616 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.8 p -101.42 -8.35 9.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 6.1 t70 -144.46 135.67 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.756 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.61 155.13 38.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.528 0.68 . . . . 0.0 111.868 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 23.8 m -120.62 139.81 52.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 160' ' ' HIS . 1.0 OUTLIER -108.48 120.86 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.231 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.2 p -114.87 121.81 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.154 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.17 135.62 45.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.824 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -137.9 85.0 2.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 106' ' ' ASN . 37.2 t -135.89 -159.08 0.92 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.223 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.423 ' N ' ' OG ' ' A' ' 105' ' ' SER . 9.4 t30 -46.41 -64.45 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.01 -45.01 5.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 0.0 111.68 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.71 106.94 14.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.687 0.756 . . . . 0.0 112.929 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 p -116.43 138.74 51.12 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.868 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 51.8 28.13 4.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.821 0.448 . . . . 0.0 111.83 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 20.6 m -74.81 90.04 2.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.489 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.79 97.47 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 120.22 32.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.571 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.9 pt-20 -80.11 144.85 32.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.012 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.0 m -101.65 -20.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 81.59 -123.03 5.89 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.562 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 20.7 Cg_endo -61.8 114.25 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.294 1.996 . . . . 0.0 112.882 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -118.52 151.39 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.776 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.2 p -146.83 -177.54 5.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 135' ' ' ILE . 21.2 ptt? -120.4 163.63 17.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.781 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.07 -2.55 8.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 -121.7 6.05 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.481 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.18 120.86 39.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.178 0.514 . . . . 0.0 109.69 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 26.4 pt -138.16 -171.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.922 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -102.22 135.18 44.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.269 0.557 . . . . 0.0 109.923 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 45.6 tp -119.23 103.79 9.82 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' SER . 2.8 m 63.75 32.56 13.54 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 110.32 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.8 m 82.76 1.6 1.18 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 126' ' ' LEU . 12.8 t -114.35 124.76 30.19 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.07 125.41 18.49 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.338 2.025 . . . . 0.0 113.215 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.03 138.78 54.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 133' ' ' ARG . 7.2 p-10 -111.76 152.13 28.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.656 0.741 . . . . 0.0 112.652 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HG3' HD22 ' A' ' 132' ' ' ASN . 59.9 mtt-85 66.37 53.28 1.01 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.015 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.9 mmm -93.06 134.91 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.712 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 170' ' ' SER . 14.2 tt -108.85 142.5 21.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 167' ' ' GLN . 19.4 ptt85 -127.23 139.75 52.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.546 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.3 OUTLIER -122.72 135.15 54.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.431 0.634 . . . . 0.0 110.941 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.5 87.78 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.41 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -171.89 127.27 0.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.374 -1.739 . . . . 0.0 107.268 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.35 100.19 1.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.704 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 137.79 52.57 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 96.2 mttt -127.96 176.63 7.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.567 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -41.37 152.99 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 111.107 -2.77 . . . . 0.0 111.664 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.495 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 88.07 -15.13 57.06 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.455 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -115.02 9.84 16.09 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 21.1 p -78.41 135.88 37.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 117.959 -1.496 . . . . 0.0 110.026 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.605 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 126.63 -16.88 6.53 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.84 153.88 44.06 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.14 129.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.338 0.589 . . . . 0.0 112.366 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.88 111.42 23.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.2 p -147.62 179.01 8.0 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 112.744 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.34 -178.5 6.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.041 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.9 t -60.92 101.76 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.63 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.93 31.07 77.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.889 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -153.35 111.2 3.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.708 0.289 . . . . 0.0 111.007 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.5 mt -96.78 129.38 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.54 -49.16 5.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.156 0.503 . . . . 0.0 112.017 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.731 ' HA2' HD23 ' A' ' 173' ' ' LEU . . . 175.92 -166.55 37.82 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.191 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.83 142.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.739 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.8 t60 -63.23 113.76 3.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.606 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.38 -27.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.05 -147.74 6.18 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.882 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 179.37 164.72 32.37 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.494 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 18.3 t-20 -137.56 96.68 3.29 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.206 0.527 . . . . 0.0 109.861 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.85 -119.26 5.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.997 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -97.29 19.66 12.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.202 0.525 . . . . 0.0 110.815 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 8.8 tt0 -134.36 115.86 14.54 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.875 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.59 148.94 34.41 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.245 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 46.7 m-85 -124.67 121.53 34.93 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.848 0.832 . . . . 0.0 111.129 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.57 ' HB3' HG23 ' A' ' 135' ' ' ILE . 15.2 t -117.5 156.44 28.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.145 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.78 134.19 39.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.538 ' OE1' ' HE2' ' A' ' 174' ' ' LYS . 76.1 mt-30 -71.03 122.49 20.13 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.731 HD23 ' HA2' ' A' ' 158' ' ' GLY . 2.5 mm? -85.52 93.9 8.89 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.538 ' HE2' ' OE1' ' A' ' 172' ' ' GLN . 51.2 mttm -93.21 128.03 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.668 0.747 . . . . 0.0 111.462 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -50.21 -31.12 13.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.388 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 180' ' ' GLU . 1.6 mp0 -37.3 -56.64 0.95 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.33 -9.71 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.76 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 13.1 tp10 -63.53 -50.76 68.28 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.813 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.05 131.67 46.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.343 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.089 -179.299 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.19 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.5 mm? -118.24 139.47 51.26 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.663 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -113.35 81.06 1.44 Allowed 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -83.18 153.73 24.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 36.0 tp -109.35 151.92 25.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.1 m-85 -60.3 133.98 56.62 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.7 mt-30 . . . . . 0 N--CA 1.439 -0.996 0 C-N-CA 119.219 -0.993 . . . . 0.0 . -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.935 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.696 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.548 0 CA-C-O 120.424 -0.098 . . . . 0.0 113.285 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -38.38 -51.05 2.2 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.197 1.932 . . . . 0.0 113.745 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -60.18 -50.53 73.31 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.948 0.88 . . . . 0.0 110.98 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -43.24 99.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.901 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.696 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 22.9 mm-40 -60.45 -55.58 31.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.175 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.7 -45.55 86.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.51 82.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 8' ' ' LEU . 3.0 tm? -67.82 -40.08 83.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.699 0.285 . . . . 0.0 110.925 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -66.77 -42.37 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.64 -37.5 82.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.309 0.576 . . . . 0.0 109.916 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.622 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 3.4 tm? -51.41 -56.81 11.18 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.572 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.38 -27.84 66.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.367 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.53 -69.97 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.54 3.7 14.07 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 43.1 mm -97.86 96.39 5.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.5 mtm -126.91 144.12 51.08 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.715 0.769 . . . . 0.0 110.974 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 7.3 m -74.27 116.84 15.38 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 37' ' ' ILE . 22.0 mt -111.2 108.28 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.34 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 25.0 m -76.12 114.02 14.3 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.93 0.872 . . . . 0.0 109.86 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 p -95.8 -161.16 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.419 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -71.98 -31.71 66.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -76.09 -47.04 26.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.191 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.97 -153.6 24.58 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.621 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 47.7 mt-10 -75.35 116.46 16.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.952 -0.624 . . . . 0.0 112.381 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -124.4 151.93 43.86 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.706 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 47.2 m -75.7 108.36 8.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.76 116.98 5.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.464 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 103.64 16.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.081 0.467 . . . . 0.0 110.746 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.11 132.55 12.93 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.83 -59.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 118.262 1.031 . . . . 0.0 111.3 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -170.36 163.23 8.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.714 0.768 . . . . 0.0 112.75 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m-20 44.7 -90.02 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -127.36 6.91 6.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.099 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 p -133.18 149.75 52.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.326 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 72' ' ' LEU . 33.5 m -110.5 135.69 48.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.827 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 18' ' ' ILE . 27.6 mm -135.01 139.4 31.92 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.232 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.75 141.58 97.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.336 1.357 . . . . 0.0 111.1 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.736 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 99.4 m -60.84 -43.42 98.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.374 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.35 -11.03 28.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.78 -15.07 60.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.857 0.837 . . . . 0.0 109.235 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 60.25 70.72 0.97 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.94 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.2 115.75 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 N-CA-C 107.702 -1.691 . . . . 0.0 107.702 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.75 -124.38 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.23 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' VAL . 21.0 t70 -95.31 -32.07 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.939 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -144.5 144.42 31.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.724 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 m -128.1 155.25 39.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.828 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 16.1 tp -97.75 100.66 12.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.3 t -89.95 107.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.087 0.946 . . . . 0.0 111.308 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 p30 56.7 12.57 1.16 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.485 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.13 -6.65 13.05 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.507 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -103.64 117.35 34.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.02 114.1 6.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.068 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 tp -120.64 131.63 72.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -88.02 147.77 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 111.295 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 45' ' ' ASP . 8.0 p -73.09 136.5 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -87.03 -50.11 6.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -169.17 151.96 4.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.147 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -128.38 132.36 48.53 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -115.62 117.48 30.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.365 0.603 . . . . 0.0 112.285 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -66.19 106.7 1.72 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 65.9 tp -85.98 104.74 15.89 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 122.558 1.171 . . . . 0.0 109.782 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 31.6 m -113.67 164.53 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 113.572 -1.649 . . . . 0.0 106.665 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.5 134.92 78.98 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.538 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.71 -10.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 114.941 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.92 19.67 12.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.965 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.2 m120 71.03 29.08 3.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.916 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.451 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 37.5 mt -108.79 147.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.968 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t-20 -64.59 131.01 45.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.823 0.344 . . . . 0.0 111.548 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.677 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 6.7 tt -111.87 -27.02 8.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.736 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 34.8 tp10 78.8 8.78 1.97 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 36' ' ' VAL . 15.4 tp -99.41 133.12 44.18 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.239 0.542 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.4 m -106.93 112.62 25.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.41 101.2 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.7 tp -85.25 108.01 17.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.767 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -93.33 116.62 29.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.181 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.7 mt -116.75 124.33 49.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.778 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.87 103.9 11.02 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.915 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.28 136.19 41.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -62.24 -39.72 93.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.19 117.92 19.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 32' ' ' ASP . 72.1 mmtt -71.64 140.98 49.93 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.01 149.2 49.05 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 84' ' ' ARG . 1.1 tpm_? -61.19 126.31 26.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.324 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.516 ' OD2' ' HD2' ' A' ' 87' ' ' ARG . 14.5 t70 -67.42 81.56 0.15 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -97.88 20.86 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HD2' ' OD2' ' A' ' 85' ' ' ASP . 6.7 ptm180 -63.46 -28.71 70.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.4 -6.38 86.06 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.104 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -91.17 -7.01 52.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.61 142.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 48.8 m -100.5 134.73 43.01 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER -76.17 -41.57 49.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 91' ' ' SER . 26.6 t70 -119.47 129.3 54.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 172' ' ' GLN . 26.6 mt -65.23 -73.16 0.13 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 57.29 68.71 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.43 87.82 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.126 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 11.6 p -81.19 -0.73 4.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.114 0.483 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 9.3 t70 -125.27 129.88 50.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.805 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.43 165.1 31.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.679 0.752 . . . . 0.0 112.438 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.2 m -134.81 141.65 46.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.435 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.558 HD11 ' OH ' ' A' ' 137' ' ' TYR . 78.9 mt -96.18 119.93 35.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.556 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.56 100.22 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.85 129.4 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.726 0.774 . . . . 0.0 112.206 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.19 49.38 1.65 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 m -106.49 -163.15 0.9 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.731 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -56.61 -48.17 78.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.121 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -88.16 -62.72 1.43 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.888 -0.507 . . . . 0.0 112.288 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.61 112.37 21.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -100.95 108.49 20.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.661 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 m120 58.97 72.33 0.54 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.736 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 m -140.56 130.85 25.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 112' ' ' ILE . 23.9 pt -105.37 99.46 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.7 mp -91.66 103.79 16.33 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.948 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -69.77 107.68 3.6 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.064 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 82.7 -121.05 5.32 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.34 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.7 Cg_endo -65.75 116.51 3.99 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.535 2.157 . . . . 0.0 114.719 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 137' ' ' TYR . 32.4 m -120.74 136.84 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.311 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -138.37 160.05 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -89.16 139.8 30.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.824 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.64 -56.78 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.001 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.11 -128.83 6.54 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 5.0 tt -99.66 113.47 25.94 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.5 pt -133.16 -159.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 20.3 m120 -125.99 125.9 43.43 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 2.7 mm? -100.48 113.36 26.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.497 ' OG ' HD12 ' B' ' 5' ' ' LEU . 4.0 m 57.23 29.31 16.5 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.317 0.58 . . . . 0.0 111.262 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 127' ' ' SER . 42.6 m 87.18 7.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 126' ' ' LEU . 6.0 t -111.03 139.68 22.02 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.601 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 21.3 Cg_exo -64.67 111.82 1.79 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 126' ' ' LEU . 26.3 m -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.864 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 133' ' ' ARG . 19.0 t-20 -119.3 163.25 17.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 37.7 ttm-85 68.41 35.45 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.937 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mmt -92.93 139.37 30.6 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.803 0.811 . . . . 0.0 113.004 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.6 mt -95.41 137.93 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.453 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 35.4 ptt180 -117.47 141.27 48.55 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.558 ' OH ' HD11 ' A' ' 101' ' ' LEU . 33.2 p90 -148.63 145.07 27.6 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.201 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.73 92.96 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.736 0.779 . . . . 0.0 112.112 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -161.43 137.18 7.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.59 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.78 87.01 5.29 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.486 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.1 p -89.91 151.04 21.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.081 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -130.27 151.57 50.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.045 0.926 . . . . 0.0 113.007 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.7 OUTLIER -45.35 152.3 0.3 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.225 175.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.461 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 91.58 -14.52 63.77 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.001 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 22.2 tt0 -99.33 7.2 45.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.317 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.531 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 6.9 m -60.56 136.11 57.96 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.37 -10.48 36.17 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 123.654 0.596 . . . . 0.0 111.952 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -51.1 121.01 10.26 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.086 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' ILE . 86.9 t -80.36 108.54 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.529 0.68 . . . . 0.0 111.212 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.5 tp -81.63 103.84 11.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.988 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -143.38 177.68 8.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.744 0.783 . . . . 0.0 111.998 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.13 -178.55 6.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.753 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.8 t -64.17 98.31 0.22 Allowed 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.802 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.42 29.05 54.28 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.162 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 33.4 ttmt -156.2 129.36 8.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.471 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.2 mt -112.77 129.14 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.23 -41.22 7.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.494 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 162.99 -156.09 27.7 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.82 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -127.89 151.16 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.923 0.868 . . . . 0.0 111.822 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.5 123.16 19.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -114.2 -28.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.55 -152.35 9.07 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.177 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.68 153.96 16.32 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.851 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 34.1 t30 -131.42 100.94 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.84 -121.88 6.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.404 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -102.21 22.92 12.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.675 0.75 . . . . 0.0 109.611 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 136' ' ' ARG . 9.8 tt0 -127.61 115.53 18.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.365 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.42 148.75 28.25 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 136' ' ' ARG . 47.5 m-85 -121.86 132.65 54.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.1 t -133.48 141.95 48.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.581 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -80.61 127.64 32.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.484 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 27.5 tt0 -74.6 109.2 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.895 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.494 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 55.2 mt -87.69 94.43 9.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.401 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.67 129.82 34.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.865 0.841 . . . . 0.0 111.379 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.35 -29.5 10.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.939 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -44.76 -43.16 8.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.659 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -79.81 -47.04 15.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 112.263 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.03 -16.63 61.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.23 -29.33 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 O-C-N 121.386 -0.821 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.76 -36.68 11.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.833 0.349 . . . . 0.0 111.15 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.61 119.7 17.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.091 -178.107 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . 0.507 ' O ' HD13 ' B' ' 2' ' ' LEU . . . . . . . . 0 C--O 1.225 -0.227 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.507 HD13 ' O ' ' B' ' 1' ' ' ACE . 2.3 mm? -140.45 132.25 27.47 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.309 0.381 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.2 tt0 -101.64 83.96 2.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -88.75 141.06 28.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 27.6 tp -94.94 148.17 22.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 20.4 m-85 -61.32 139.59 58.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.8 mt-30 . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.971 -0.559 . . . . 0.0 . 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.531 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.627 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.49 -30.38 52.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.504 1.469 . . . . 0.0 111.57 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 22.8 t-20 -63.14 -53.25 56.38 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.389 1.09 . . . . 0.0 109.699 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 m -50.43 -53.71 27.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.073 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -57.49 -51.53 69.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.801 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.74 -50.58 72.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.171 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -44.95 95.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.7 tt -68.0 -35.06 77.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.571 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -70.05 -38.55 75.83 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.65 -40.76 93.19 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.196 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 29.7 mt -50.43 -57.66 7.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.431 1.11 . . . . 0.0 111.175 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -60.92 -28.0 68.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.719 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.59 -61.63 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.27 -7.26 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.6 mm -92.7 126.8 45.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.968 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtm -133.77 148.37 51.37 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -82.31 111.81 18.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.718 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.07 134.06 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 20.9 m -120.6 101.18 7.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.461 0.648 . . . . 0.0 109.941 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 p -105.74 -163.48 0.94 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.232 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -60.98 -18.57 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.0 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.683 ' HE2' ' OE1' ' A' ' 42' ' ' GLN . 6.3 mptp? -95.19 -59.05 1.98 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.06 0.457 . . . . 0.0 110.007 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . 172.2 -143.34 7.37 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.917 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -85.1 121.92 28.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.164 0.507 . . . . 0.0 111.327 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -125.88 161.57 27.14 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.395 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 37.8 m -89.26 112.03 22.99 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.485 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.73 109.11 3.38 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -87.62 98.47 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 111.672 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.13 10.35 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.68 -56.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.357 0.578 . . . . 0.0 109.858 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -154.82 144.07 21.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.987 0.899 . . . . 0.0 112.858 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 4.1 p30 46.78 -86.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.684 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 37.6 ptt180 -134.23 14.16 3.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.5 0.667 . . . . 0.0 110.595 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -94.67 113.05 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.1 m -118.87 154.07 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.842 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.33 133.1 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.14 143.58 25.27 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.662 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.7 153.04 52.11 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 120.849 1.033 . . . . 0.0 111.069 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.574 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 97.0 m -73.68 -39.55 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -65.11 -1.8 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.51 54.71 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.288 0.566 . . . . 0.0 110.802 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.683 ' OE1' ' HE2' ' A' ' 22' ' ' LYS . 42.5 mt-30 65.22 72.15 0.49 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.046 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.38 123.92 2.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.608 2.872 . . . . 0.0 109.949 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.25 -133.14 6.07 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.544 -0.836 . . . . 0.0 114.262 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.617 ' O ' HG12 ' A' ' 56' ' ' VAL . 28.0 t70 -83.84 -44.92 13.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 3.2 p30 -127.75 144.17 51.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.7 153.97 27.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.156 0.503 . . . . 0.0 111.146 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.84 103.71 16.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.7 m -89.36 93.85 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.054 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 69.87 13.1 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.64 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.84 -29.83 5.7 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.94 120.91 19.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -84.73 114.98 22.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.851 0.834 . . . . 0.0 110.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.39 141.83 44.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.018 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 34.4 ttt180 -90.54 151.06 21.51 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.47 0.652 . . . . 0.0 112.058 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -92.38 145.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -89.09 -41.94 12.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.733 0.778 . . . . 0.0 109.018 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -160.07 129.79 5.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.206 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.54 112.41 22.17 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -104.89 107.07 17.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.731 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.84 126.29 28.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.079 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -90.42 103.87 16.51 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.91 141.08 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 172.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 11.8 t70 -72.95 135.89 80.14 Favored Pre-proline 0 C--N 1.31 -1.15 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.631 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 64' ' ' ASP . 72.8 Cg_exo -52.59 -8.16 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.835 1.69 . . . . 0.0 112.217 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 64' ' ' ASP . 28.6 tt0 -81.54 3.24 25.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 73.48 25.22 2.15 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.863 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.28 152.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' THR . 52.7 t30 -63.84 134.86 55.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.615 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 41.7 tp -102.99 -22.13 13.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.574 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 17.1 tp10 72.04 13.29 5.91 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.071 175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.86 158.94 16.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.937 0.399 . . . . 0.0 110.27 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.6 m -135.88 120.8 18.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.208 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.05 102.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.7 tp -93.09 97.68 10.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.992 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 m -92.12 90.66 7.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 4.8 mp -74.21 152.5 39.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.513 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.37 75.49 10.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 79' ' ' ARG . 5.0 tpt180 -106.92 128.28 54.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.007 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.5 -12.74 51.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 38.2 mt-10 -90.56 117.86 29.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.612 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -93.5 111.29 22.93 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.258 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -81.98 165.85 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.482 0.658 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 84' ' ' ARG . 18.8 ttt180 -50.93 126.52 16.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.864 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -81.79 98.75 8.61 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.45 0.643 . . . . 0.0 109.859 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.5 pt -91.04 21.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 122.054 0.931 . . . . 0.0 109.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -55.28 -33.4 63.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.484 -1.689 . . . . 0.0 113.239 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.11 -7.74 88.16 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.864 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.81 2.05 51.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.44 131.85 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -93.28 105.12 17.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' A' ' 174' ' ' LYS . 0.1 OUTLIER -62.43 -54.77 35.32 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 176.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.41 135.2 45.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 95' ' ' GLU . 25.6 mt -61.03 -55.44 32.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 15.0 pt-20 36.61 71.8 0.13 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.591 . . . . 0.0 111.147 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.39 105.69 0.21 Allowed Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.651 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -91.97 9.98 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.083 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -111.62 118.33 35.38 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.09 151.54 37.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.044 0.926 . . . . 0.0 112.423 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.5 m -122.03 135.92 54.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.262 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.9 105.41 17.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.294 0.569 . . . . 0.0 110.222 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.674 ' HB ' HG23 ' A' ' 149' ' ' VAL . 35.3 t -80.38 102.16 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 108' ' ' PHE . 14.7 t -89.35 108.24 18.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.426 0.631 . . . . 0.0 111.71 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 29.6 t60 -129.9 39.35 3.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 97.2 p -108.9 -161.18 0.75 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.177 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -73.9 -17.25 61.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.704 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -78.01 -76.69 0.18 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 103' ' ' VAL . 79.8 m-85 -117.99 147.85 42.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.096 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.74 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 6.4 m -124.63 124.97 43.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.269 0.557 . . . . 0.0 110.794 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 109' ' ' THR . 12.3 t-20 80.82 -2.2 1.82 Allowed 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.658 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.0 m -92.67 119.38 32.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.26 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 112' ' ' ILE . 41.2 pt -95.25 126.62 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.0 110.53 20.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.54 122.13 18.44 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.58 -32.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.729 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.07 -105.12 2.04 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.879 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 88.5 Cg_endo -84.5 128.85 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.208 1.939 . . . . 0.0 114.145 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.81 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.6 p -132.14 163.77 27.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.726 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.15 153.92 20.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.46 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.51 0.13 11.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.871 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.93 -116.04 4.14 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.214 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 123' ' ' LEU . 7.3 tt -121.16 127.24 51.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.001 0.429 . . . . 0.0 111.239 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 39.7 pt -136.91 179.38 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 19.9 m120 -95.81 84.04 3.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.233 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 55.3 tp -65.49 105.86 1.28 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.0 m 62.52 32.67 16.45 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.373 0.606 . . . . 0.0 109.615 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 127' ' ' SER . 38.0 m 81.84 -10.46 1.14 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.378 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -91.49 120.98 68.08 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.518 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.34 114.59 2.04 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.493 1.462 . . . . 0.0 110.762 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 69' ' ' ASN . 23.3 m -134.34 134.88 42.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.016 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 26.8 p30 -113.42 -177.62 3.18 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.909 -0.717 . . . . 0.0 112.714 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 65.91 26.96 10.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.459 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 74.0 mt -92.34 135.5 27.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -117.26 130.99 56.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.627 0.727 . . . . 0.0 111.873 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.8 p90 -142.9 112.12 6.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.12 105.71 2.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.728 0.775 . . . . 0.0 109.246 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -167.59 135.4 2.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.75 102.7 0.97 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.825 0.821 . . . . 0.0 111.655 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 t -140.26 147.07 39.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.386 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 26.4 mtpp -141.51 -179.13 5.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.339 1.066 . . . . 0.0 111.962 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -37.6 150.2 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.986 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.406 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 96.69 -28.33 13.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.876 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -87.17 10.49 16.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.0 0.429 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.656 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 4.8 m -63.37 135.14 56.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.771 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 102.96 -21.37 40.41 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.488 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.24 133.72 24.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.942 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.674 HG23 ' HB ' ' A' ' 102' ' ' VAL . 17.7 m -92.16 112.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 0.0 111.719 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.66 109.66 18.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.63 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.4 p -146.12 172.68 13.06 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.176 0.988 . . . . 0.0 113.231 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -130.91 172.58 11.88 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.682 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.3 t -68.62 103.25 1.66 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.773 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.54 -0.48 77.5 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.581 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -139.18 109.35 6.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.5 mm -90.49 111.55 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.33 -48.65 12.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 170.0 -160.54 33.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.621 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 149' ' ' VAL . 23.4 pt -122.41 143.37 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.838 0.828 . . . . 0.0 112.583 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.24 118.72 10.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.152 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 17.1 m -113.24 -23.01 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.748 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.37 -152.2 8.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.522 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.81 153.81 12.01 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.766 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.584 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 16.0 t30 -126.36 105.68 8.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.175 0.512 . . . . 0.0 110.399 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.96 -106.66 1.93 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.322 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 166' ' ' ARG . 29.7 ttm180 -116.73 20.45 13.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -122.62 116.54 24.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.164 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -77.53 149.61 35.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.864 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 51.5 m-85 -130.51 115.38 16.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.45 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 69.5 m -109.45 172.64 6.73 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.676 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.473 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -115.0 132.25 56.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.9 pt20 -86.42 133.98 33.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.0 mt -85.92 88.92 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.297 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.539 ' HB3' ' OE2' ' A' ' 92' ' ' GLU . 9.6 mtpm? -79.1 111.26 15.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.087 0.946 . . . . 0.0 108.799 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -35.71 -36.23 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.497 ' HG2' ' CG ' ' A' ' 92' ' ' GLU . 17.0 mm100 -56.34 -27.95 57.51 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -68.46 -18.39 64.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.42 -12.1 26.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.489 0.662 . . . . 0.0 109.245 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -89.96 -44.93 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.195 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -27.66 56.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.561 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -80.38 108.16 13.77 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.583 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.435 177.425 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.038 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 4.5 mp -108.79 106.96 17.2 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.069 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 42.4 tt0 -89.31 77.42 7.43 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.35 118.55 22.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.136 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 21.0 tp -83.6 152.11 25.0 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.9 m-85 -58.22 141.01 52.02 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 98.2 mt-30 . . . . . 0 C--N 1.307 -1.243 0 C-N-CA 120.708 -0.397 . . . . 0.0 . 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.656 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.832 -0.107 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.91 -58.53 1.53 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.827 2.351 . . . . 0.0 115.679 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 64.2 t30 -57.12 -48.77 77.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -68.39 -42.54 78.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.891 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -61.7 -43.98 97.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.264 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.17 -49.0 76.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.128 0.489 . . . . 0.0 110.387 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 -46.04 85.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.577 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.95 -42.72 99.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -68.07 -44.84 75.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.585 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.73 -45.79 91.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.738 0.78 . . . . 0.0 110.16 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 57.5 tp -55.99 -49.89 72.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.408 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.39 -28.57 56.77 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.64 -34.05 10.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -121.33 -9.81 9.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 50.8 mm -97.8 114.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.627 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 16' ' ' MET . 2.1 mmt -122.24 146.18 47.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.323 0.582 . . . . 0.0 110.355 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.52 86.32 4.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 HG21 HD13 ' A' ' 37' ' ' ILE . 47.4 mm -75.61 94.33 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.0 109.765 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.3 m -86.62 96.12 10.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.741 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.19 179.65 4.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.932 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -55.92 -35.97 67.2 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.732 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 13.8 tmtt? -89.25 -31.7 17.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.9 -169.9 42.44 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 119.495 -1.336 . . . . 0.0 115.054 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -95.52 109.05 21.32 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 114.84 -0.68 . . . . 0.0 110.066 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 41' ' ' ALA . 86.7 m-85 -112.04 158.68 19.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.74 0.781 . . . . 0.0 112.245 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.0 m -83.05 106.66 15.05 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.559 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -89.64 119.99 5.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.938 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -93.99 100.68 12.77 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 0.0 110.186 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.38 106.99 1.9 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.0 -55.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -163.02 144.12 9.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.577 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 34.0 t70 54.02 -94.27 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.786 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -133.17 23.51 4.14 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.633 -0.667 . . . . 0.0 110.604 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.8 t -102.27 119.42 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.747 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -123.71 142.5 51.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.6 t -109.55 131.88 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 122.227 1.013 . . . . 0.0 112.111 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 18' ' ' ILE . 19.4 pt -141.75 165.53 27.55 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.44 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 25.0 Cg_exo -66.28 170.0 12.85 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 120.757 0.972 . . . . 0.0 111.098 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.565 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 62.6 m -76.44 -37.47 56.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.97 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -69.06 9.41 0.41 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 25' ' ' PHE . . . -75.64 -29.98 59.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.3 mm-40 61.37 72.9 0.63 Allowed Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.928 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.54 132.4 33.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.642 2.228 . . . . 0.0 111.263 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.53 -129.17 5.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.635 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.29 -30.73 12.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 109.188 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 55' ' ' ARG . 16.2 m-20 -132.38 155.62 48.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -129.7 134.38 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.54 104.84 13.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.423 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' GLY . 62.9 t -82.44 91.14 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.119 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 70.75 -9.57 0.81 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.104 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 152.55 -26.73 0.85 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -74.77 113.55 12.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.55 -0.825 . . . . 0.0 110.425 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.58 93.96 2.58 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.97 142.78 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.766 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.497 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 1.7 mmp_? -63.26 133.03 53.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.73 108.65 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -68.3 -40.51 81.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.122 0.963 . . . . 0.0 109.281 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -171.48 147.83 2.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.617 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.664 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -117.87 139.31 51.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.755 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.407 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 65.1 t80 -141.47 106.34 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.573 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -71.81 135.95 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 38.2 tp -104.18 109.17 20.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.379 1.085 . . . . 0.0 113.293 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.1 m -110.57 160.21 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 136.95 60.41 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -43.42 -26.13 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.473 2.115 . . . . 0.0 113.65 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.75 -9.37 57.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.75 0.786 . . . . 0.0 109.332 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.65 66.27 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.792 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 132' ' ' ASN . 63.0 mt -144.38 150.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 112.442 -2.163 . . . . 0.0 105.935 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -65.65 135.06 54.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.263 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 29.0 tp -108.62 -29.32 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.565 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 18.0 tp10 74.92 23.88 1.63 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.123 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.06 157.13 18.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 47.3 m -132.26 120.14 21.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.124 0.488 . . . . 0.0 109.796 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 65.9 t -86.4 88.52 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.8 tp -84.26 110.86 18.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.93 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -98.06 101.67 13.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.868 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.96 155.25 16.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.88 76.29 9.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -104.35 104.55 14.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.25 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.54 -38.03 74.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -82.62 82.25 8.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 20.4 ptmt -61.52 154.3 25.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.595 -1.184 . . . . 0.0 113.944 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.2 169.93 10.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.215 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -71.97 137.31 47.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.266 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -86.82 87.31 7.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.423 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -85.45 14.62 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -63.13 -16.13 59.01 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.792 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.79 -20.49 79.78 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.194 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -93.41 -0.37 56.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.7 mt -74.99 144.53 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 12.8 m -91.56 123.87 35.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.2 pm0 -78.96 -31.51 45.02 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' SER . 41.2 t0 -136.31 148.09 47.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 32.2 mt -71.41 -55.53 7.76 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 94' ' ' LEU . 1.9 pt-20 38.2 72.0 0.14 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.453 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.42 99.22 0.14 Allowed Glycine 0 N--CA 1.444 -0.784 0 O-C-N 124.0 0.813 . . . . 0.0 111.781 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 14.6 p -74.89 -21.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.87 0.366 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -92.3 119.36 31.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.596 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.96 154.31 48.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.105 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -120.71 137.47 54.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.176 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -107.98 127.02 53.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.38 113.98 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.62 123.44 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.916 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 39.7 t60 -150.49 71.96 1.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 60.7 p -143.16 -150.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.325 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.1 t-20 -55.02 -54.79 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.177 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 145' ' ' GLN . 66.3 m-80 -74.36 -68.53 0.52 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.412 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 36.0 m-85 -116.36 157.09 25.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -136.61 147.47 46.96 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.277 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.32 13.14 6.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.0 0.428 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 23.0 m -93.02 104.51 16.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.436 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.98 111.95 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.315 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.11 129.23 51.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.328 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.53 122.75 30.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 137' ' ' TYR . 9.1 p -89.26 -32.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.036 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.67 -130.69 10.31 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.642 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 76.3 Cg_endo -78.27 134.41 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.878 1.719 . . . . 0.0 112.891 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.33 165.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.159 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 p -132.79 -178.78 5.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.1 mtt -115.4 149.62 37.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.753 0.311 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 -31.08 5.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.41 -112.62 4.26 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.073 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 tt -123.31 112.08 17.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.8 pt -130.26 175.75 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.018 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 53.0 m-80 -86.9 87.32 7.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.51 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 49.8 tp -75.45 106.42 6.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.3 t 61.67 36.55 16.49 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.8 m 74.18 -0.07 3.46 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.516 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 m -104.23 113.69 64.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.912 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.74 111.78 0.87 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.989 1.792 . . . . 0.0 111.493 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 m -124.04 136.63 54.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.16 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.4 ' HB2' HG21 ' A' ' 68' ' ' ILE . 65.0 t30 -103.84 164.16 11.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 67.13 45.89 1.62 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.983 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mmt -91.66 127.35 37.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.281 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 170' ' ' SER . 28.9 mm -93.9 147.18 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -134.18 140.2 46.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 111.757 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.477 ' CD1' HG21 ' A' ' 115' ' ' VAL . 36.4 p90 -149.04 140.98 23.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.13 117.63 25.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.409 1.099 . . . . 0.0 110.15 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -174.08 137.96 0.57 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.242 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.38 96.2 0.08 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.322 0.582 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.9 p -107.96 144.37 35.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.333 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.3 158.25 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.516 1.15 . . . . 0.0 112.79 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.589 ' CG2' ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -42.48 152.1 0.1 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.289 173.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.636 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 85.51 -14.51 50.84 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.269 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 107' ' ' ASN . 11.2 mm-40 -99.86 -0.27 40.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 119.792 -0.147 . . . . 0.0 110.872 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 10.5 p -78.3 135.26 37.48 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.309 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 119.78 -23.12 8.44 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.929 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -49.52 138.01 19.27 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.399 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.78 125.33 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.775 0.798 . . . . 0.0 112.911 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.17 109.07 21.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.384 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -149.29 -174.5 4.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.106 0.955 . . . . 0.0 113.326 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.35 172.85 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.212 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 5.1 t -60.52 108.8 0.88 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.572 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.18 63.44 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.344 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -162.66 113.75 1.52 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -104.83 119.9 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -83.98 -41.11 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 164.08 -156.45 28.33 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.605 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.4 pt -126.62 147.5 31.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.21 0.528 . . . . 0.0 111.05 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.1 133.13 48.46 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.43 -28.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.61 -155.91 11.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.08 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.71 154.27 25.0 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.029 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.577 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 10.3 t-20 -135.16 116.14 14.17 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.69 -112.59 4.71 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.06 -1.066 . . . . 0.0 111.06 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -118.08 19.45 13.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.481 . . . . 0.0 109.828 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 167' ' ' GLN . 1.9 mp0 -111.0 135.17 51.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.316 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.77 138.28 14.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 44.9 m-85 -116.72 132.92 56.56 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.439 ' HB2' ' HB ' ' A' ' 135' ' ' ILE . 18.5 m -124.86 165.35 18.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.546 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -106.91 143.03 35.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -81.95 110.75 17.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.436 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -88.55 93.02 9.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' SER . 86.4 mttt -87.3 135.22 33.4 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 122.643 1.211 . . . . 0.0 113.45 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 179' ' ' VAL . 16.1 tptm -42.78 -43.08 3.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.537 -2.12 . . . . 0.0 112.78 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -41.51 -46.41 3.5 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.74 -23.02 55.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.679 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 175' ' ' LYS . 92.1 t -74.27 -24.21 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.5 -19.8 61.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.819 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -79.91 119.68 23.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.608 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.491 -179.557 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.202 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.9 mm? -131.19 150.55 52.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.326 0.584 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.0 tt0 -114.68 85.77 2.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -91.09 130.5 36.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 23.2 tp -88.55 154.71 20.12 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.574 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 24.3 m-85 -62.64 145.64 54.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 95.2 mt-30 . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 118.702 -1.199 . . . . 0.0 . 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.732 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.655 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.495 2.611 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 12.2 Cg_endo -52.68 -32.02 53.04 Favored 'Trans proline' 0 C--N 1.334 -0.188 0 C-N-CA 122.574 2.183 . . . . 0.0 114.609 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 66.6 t30 -79.83 -49.54 11.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.209 0.528 . . . . 0.0 111.932 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -68.38 -42.29 79.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.738 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 13.5 pt-20 -72.42 -29.54 63.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.097 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -65.58 -46.32 79.87 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.59 75.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.432 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.13 -43.63 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.603 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 m -69.85 -41.74 74.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.179 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.85 -42.07 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.716 0.77 . . . . 0.0 109.945 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.645 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -56.41 -53.5 56.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.882 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.7 -25.99 66.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -83.42 -55.58 4.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -118.06 -2.42 11.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 40.5 mm -101.94 114.24 40.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.31 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtm -128.03 155.05 44.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.506 0.669 . . . . 0.0 111.434 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -85.3 109.15 18.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.9 mt -103.08 110.69 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.678 0.751 . . . . 0.0 110.224 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 11.3 m -85.5 114.22 22.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.37 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -106.52 -176.3 3.04 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -75.83 -15.83 60.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.112 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -82.62 -42.34 18.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.052 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.94 38.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.98 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.99 116.14 28.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.75 166.33 13.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.969 0.89 . . . . 0.0 111.333 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 19.0 m -73.55 105.01 4.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.51 105.53 3.23 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -107.07 130.1 54.72 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.794 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.43 126.08 7.22 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.17 -56.76 5.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.125 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -158.43 151.09 22.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.259 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 8.1 t70 56.25 -94.36 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.52 20.25 1.86 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.877 0.846 . . . . 0.0 108.885 177.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.0 106.73 18.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 m -115.29 152.6 32.46 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.34 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.73 144.69 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -146.98 140.39 14.94 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.757 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.36 145.39 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.772 1.648 . . . . 0.0 111.981 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' CD ' ' A' ' 71' ' ' GLU . 67.0 m -75.29 -34.86 61.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.293 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -65.01 -11.97 45.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.38 -23.26 46.89 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.563 0.697 . . . . 0.0 109.888 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 48.27 72.1 1.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.81 130.57 28.16 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.41 -155.07 4.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.374 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -82.22 -35.98 27.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.188 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.29 121.53 22.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.2 m -117.28 150.94 19.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.369 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 34.4 mt -83.34 107.12 15.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.348 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -92.45 89.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 58.49 36.27 25.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.107 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.95 -15.06 57.09 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.156 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 15.8 mm-40 -106.09 108.71 20.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.91 139.46 30.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.722 -179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.0 tp -135.85 135.54 50.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -84.91 128.0 34.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.38 142.58 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -77.14 -49.73 14.58 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -150.76 120.33 6.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.817 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -97.59 98.21 9.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -100.49 123.79 45.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.017 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 3.4 mppt? -94.53 108.2 20.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 47.2 tp -86.12 118.22 25.44 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.07 172.75 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.98 140.94 86.26 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 117.723 0.238 . . . . 0.0 111.637 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.55 -29.02 9.77 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.267 1.311 . . . . 0.0 111.954 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.0 8.87 16.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.274 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 64.02 68.36 0.57 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.681 0.753 . . . . 0.0 110.469 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.0 mt -142.97 164.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.985 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -69.0 116.54 9.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 118.298 0.499 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.56 -32.93 10.53 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 30.3 tp10 77.38 15.11 1.76 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.995 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 80.4 mt -103.37 111.68 24.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.038 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -90.11 107.54 19.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.455 HG11 ' HE3' ' A' ' 181' ' ' LYS . 36.3 t -79.04 97.16 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.658 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 tp -78.21 94.57 4.79 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.102 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.2 m -83.95 98.63 9.9 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.691 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -103.4 144.13 31.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.064 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.35 96.82 7.98 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.18 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 77' ' ' LEU . 8.3 mmm180 -117.52 150.01 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -82.09 -44.82 16.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 110.08 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.79 76.11 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 59.6 pttt -67.76 172.31 5.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.491 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -93.65 160.89 14.57 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -71.83 143.61 49.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.479 -1.692 . . . . 0.0 112.299 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.47 91.77 2.81 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.371 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.0 pt -89.89 11.49 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -70.07 -27.06 64.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.305 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.26 -20.69 73.47 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 67.4 m-85 -92.54 -16.91 25.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.34 121.76 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.8 m -101.6 107.65 18.98 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.296 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 174' ' ' LYS . 12.5 pt-20 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -94.79 112.88 24.59 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.412 HD11 ' NE2' ' A' ' 172' ' ' GLN . 44.9 mt -56.34 -71.36 0.09 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 49.97 67.98 0.82 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.08 92.52 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.264 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 60.7 t -83.79 -4.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.825 0.345 . . . . 0.0 111.515 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -114.21 110.4 19.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 115' ' ' VAL . . . -130.62 165.69 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 112.739 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 m -119.97 141.62 49.51 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.723 -1.581 . . . . 0.0 109.69 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.8 tp -109.85 120.02 41.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 102' ' ' VAL . 31.3 m -116.31 108.38 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 120.214 -0.595 . . . . 0.0 110.05 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.91 136.98 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.755 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -142.28 75.73 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.57 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.9 p -124.24 -162.68 1.09 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -45.34 -67.63 0.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -94.15 -34.78 12.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.309 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.74 83.51 7.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 112.545 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.3 p -92.73 123.39 35.98 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.599 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER 38.61 62.9 0.95 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -99.02 103.13 15.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.642 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.8 mt -93.08 109.11 21.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.868 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.64 123.51 50.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.28 107.81 9.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.498 HG21 ' CD1' ' A' ' 137' ' ' TYR . 8.7 p -86.35 -24.76 6.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.307 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.21 -122.41 5.97 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.461 -0.876 . . . . 0.0 115.03 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.5 Cg_endo -66.24 117.59 4.82 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.407 2.072 . . . . 0.0 115.629 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.495 HG12 ' HB3' ' A' ' 137' ' ' TYR . 30.9 m -108.3 151.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.6 m -151.41 135.55 16.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.606 0.241 . . . . 0.0 110.928 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.1 ttm -66.71 122.44 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.695 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.43 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.14 -115.81 5.34 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.34 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.78 119.1 32.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.531 HG21 HD23 ' B' ' 2' ' ' LEU . 44.4 pt -133.22 -170.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.875 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 128' ' ' SER . 5.7 m-20 -110.38 109.42 19.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.8 mm? -87.57 112.1 21.91 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 128' ' ' SER . 26.7 t 65.21 10.33 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.568 0.699 . . . . 0.0 110.643 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 4.8 m 82.99 66.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.001 1.32 . . . . 0.0 112.823 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 126' ' ' LEU . 15.2 t -163.3 131.49 2.77 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.778 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.35 109.96 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 121.361 1.374 . . . . 0.0 113.84 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 126' ' ' LEU . 7.3 m -111.67 132.89 54.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.479 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -111.22 160.89 16.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.1 mtt180 65.36 43.37 3.51 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.078 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 85.1 mmm -92.24 136.6 33.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.3 tt -117.91 137.52 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -105.37 150.14 25.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 115' ' ' VAL . 1.5 p90 -144.68 152.8 40.97 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.368 0.604 . . . . 0.0 110.226 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.2 99.96 7.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.862 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 115' ' ' VAL . 47.2 t80 -178.2 119.93 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.755 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.68 120.63 16.58 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.6 t -143.01 151.85 41.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.752 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.9 174.21 10.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.701 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' ' CA ' ' B' ' 7' ' ' GLN . 17.8 p -38.91 155.47 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.318 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.443 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 94.3 -29.9 8.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -86.69 -4.87 59.23 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 26.3 p -78.1 144.57 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.508 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.42 -22.59 17.27 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.46 34.52 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.984 -0.608 . . . . 0.0 112.217 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.26 126.8 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.417 0.627 . . . . 0.0 112.297 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.73 106.6 18.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.2 p -149.24 -176.33 5.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.093 0.949 . . . . 0.0 112.306 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.68 174.69 13.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.816 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 8.8 t -62.02 115.75 4.34 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.794 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.05 90.67 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 19.2 ptmt -156.82 142.04 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.488 1.144 . . . . 0.0 112.772 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.43 138.85 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.614 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -106.53 -39.41 5.87 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.943 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.493 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 175.59 -167.77 39.83 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 173' ' ' LEU . 20.0 pt -129.48 141.8 45.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.699 0.762 . . . . 0.0 110.604 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 6.1 t60 -65.57 107.44 1.71 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.471 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 6' ' ' PHE . 27.2 m -95.3 -21.03 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.759 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 175.8 -146.75 8.34 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.125 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.56 163.4 32.5 Favored Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.336 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 2.9 t30 -123.49 94.8 4.36 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.85 0.833 . . . . 0.0 109.765 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.65 -104.87 1.31 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.393 -1.276 . . . . 0.0 114.223 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 166' ' ' ARG . 1.0 OUTLIER -97.55 -8.25 29.51 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.56 -0.82 . . . . 0.0 111.972 -177.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -108.99 133.04 53.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.282 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -85.68 149.94 23.88 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.2 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 164' ' ' ASN . 49.8 m-85 -133.11 122.68 24.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.702 0.763 . . . . 0.0 112.022 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 t -117.99 150.64 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.987 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.1 128.26 36.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.412 ' NE2' HD11 ' A' ' 94' ' ' LEU . 54.5 mt-30 -63.01 118.82 8.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.415 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.493 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 42.5 mt -87.66 85.19 7.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 92' ' ' GLU . 55.7 mtpt -89.56 133.89 34.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.752 0.787 . . . . 0.0 109.538 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -50.29 -19.64 0.86 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.639 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -9.09 58.79 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -108.99 13.25 24.8 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 p -88.48 -42.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.31 -11.63 37.44 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.966 0.803 . . . . 0.0 112.064 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HE3' HG11 ' A' ' 74' ' ' VAL . 26.6 tptp -73.45 137.44 44.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 112.569 -2.105 . . . . 0.0 108.094 176.16 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.174 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.531 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? -137.03 149.45 47.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.07 76.37 1.04 Allowed 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.44 140.58 33.33 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 46.0 tp -104.97 145.84 29.86 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.558 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 31.2 m-85 -57.61 142.09 45.94 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 81.9 mt-30 . . . . . 0 N--CA 1.436 -1.171 0 C-N-CA 119.344 -0.942 . . . . 0.0 . -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.443 HX51 ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.643 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.88 -25.2 74.34 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.4 2.066 . . . . 0.0 113.375 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.78 -53.8 19.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.1 0.476 . . . . 0.0 110.585 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -63.49 -35.52 80.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.779 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -61.82 -51.65 67.4 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -57.87 -48.43 79.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.269 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -55.78 -49.14 73.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.328 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.13 -43.73 98.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -71.34 -39.61 71.22 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.91 -41.34 95.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 122.182 0.991 . . . . 0.0 108.6 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.596 HD21 ' ND2' ' A' ' 110' ' ' ASN . 53.4 tp -59.49 -56.32 23.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.846 -1.525 . . . . 0.0 111.879 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -69.71 -28.87 66.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -103.23 -29.19 11.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.48 -19.25 8.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.519 HG23 HG23 ' A' ' 26' ' ' THR . 47.9 mt -93.35 117.99 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.075 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -125.87 156.77 39.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.186 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 104' ' ' HIS . 1.9 p -86.73 106.11 17.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.515 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.8 mp -93.38 110.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.76 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 89.3 m -72.07 114.34 10.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.881 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 58.6 p -109.27 -163.57 0.88 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.7 t -77.53 -29.2 52.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -90.38 -33.15 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.95 -167.2 39.95 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.423 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.89 115.36 21.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -121.5 159.22 26.76 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.944 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -72.71 113.2 9.48 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.573 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -114.76 129.91 8.92 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.247 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.36 104.49 16.83 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.44 90.97 0.94 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 90' ' ' ILE . 24.5 mm -59.18 -50.98 77.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 111.35 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 11.7 p80 -166.94 164.24 16.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.307 1.051 . . . . 0.0 113.328 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HA ' ' CB ' ' A' ' 82' ' ' LYS . 1.6 m-20 45.97 -92.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.997 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 31.5 ptt180 -142.55 19.87 2.03 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.037 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.36 119.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.543 0.687 . . . . 0.0 110.765 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 m -117.33 139.98 50.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.047 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -99.84 124.69 53.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.574 . . . . 0.0 109.847 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 pt -136.84 163.89 46.35 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.66 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.18 150.43 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.549 1.499 . . . . 0.0 111.615 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.569 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 94.9 m -81.19 -42.52 20.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.355 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -63.17 -17.12 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -67.29 -19.21 65.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 109.422 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.3 mt-30 68.01 72.87 0.36 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.28 133.05 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.454 2.769 . . . . 0.0 110.657 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.82 26.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.613 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -103.07 -5.89 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.205 1.002 . . . . 0.0 109.355 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 10.7 t70 -139.72 107.43 5.63 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.44 148.01 15.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.108 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.76 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 7.3 mp -96.9 103.7 15.65 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.736 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.87 106.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 64.22 23.99 13.26 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.955 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.38 -17.54 46.96 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.733 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -83.47 105.67 14.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.859 -0.201 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 15.0 ptpt -71.9 114.23 9.77 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 77' ' ' LEU . 4.6 tt -127.22 143.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.53 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 20.2 mmm180 -66.35 142.99 57.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.73 150.68 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.36 -49.76 5.31 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.53 114.54 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.351 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -107.21 132.11 53.43 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' CE2' HD23 ' A' ' 62' ' ' LEU . 24.0 t80 -130.13 118.29 21.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.42 104.44 10.03 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.456 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 96.1 mt -62.52 109.49 1.39 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.992 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.8 m -91.96 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 133' ' ' ARG . 22.3 t70 -89.04 132.68 37.21 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.66 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.61 -18.49 2.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.0 2.467 . . . . 0.0 114.551 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 67' ' ' ASN . 44.2 mt-10 -89.82 19.58 4.69 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 111.133 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 25.0 t-20 77.32 15.38 1.75 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.142 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 69' ' ' ASN . 25.8 mm -109.26 179.1 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.79 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 68' ' ' ILE . 52.8 t30 -92.14 146.16 23.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.192 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.777 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 27.4 tp -108.33 -22.39 12.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.569 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 19.4 tp10 68.89 13.0 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.476 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 76.1 mt -105.47 110.48 22.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.96 0.163 . . . . 0.0 110.951 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.0 m -91.98 116.51 28.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.044 0.449 . . . . 0.0 111.493 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.31 105.93 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.158 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -84.44 93.13 8.23 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 13.0 tp -93.59 155.79 17.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.772 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 54' ' ' ILE . 28.7 t70 -89.48 67.36 7.6 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 11.2 tpt180 -117.07 101.88 8.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -89.32 -6.0 57.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.831 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -87.03 107.14 18.29 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' CB ' ' HA ' ' A' ' 32' ' ' ASP . 20.5 ptmt -78.21 157.7 29.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -88.04 167.09 13.98 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 111.989 -2.369 . . . . 0.0 108.262 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -64.03 130.54 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.395 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' OD1' ' HD2' ' A' ' 87' ' ' ARG . 10.3 m-20 -68.56 95.16 0.62 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -96.38 25.96 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 9.7 mtp180 -63.17 -36.07 82.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.645 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.08 -11.75 85.28 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.433 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -90.15 -17.71 27.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.562 0.681 . . . . 0.0 109.287 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 30' ' ' ILE . 30.0 mt -69.02 130.8 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 21.1 m -107.61 129.0 55.04 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.3 -43.23 52.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 91' ' ' SER . 10.2 t70 -106.05 124.81 50.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.167 175.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.66 -71.49 0.37 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 49.47 72.16 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -162.03 82.92 0.12 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.754 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.56 3.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.12 0.486 . . . . 0.0 111.304 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.1 t70 -143.8 119.17 10.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.187 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.428 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -142.5 172.2 13.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.085 0.945 . . . . 0.0 112.337 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -120.64 144.6 48.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.115 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -111.0 124.51 52.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.775 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 7' ' ' ALA . 19.3 m -114.17 120.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.467 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 t -113.38 133.41 59.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.53 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 17' ' ' THR . 74.1 t60 -140.77 75.24 1.49 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.9 p -118.4 -166.98 1.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -68.82 -38.43 79.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.234 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.43 -60.84 1.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.637 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.615 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 46.4 m-85 -96.68 108.94 21.66 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.239 0.543 . . . . 0.0 110.063 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 15.2 m -113.36 117.7 32.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.423 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.596 ' ND2' HD21 ' A' ' 11' ' ' LEU . 14.4 m120 70.4 34.54 2.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.49 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 2.6 m -87.26 122.4 30.98 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.3 tt -119.96 109.28 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.6 mt -115.03 128.54 56.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.85 106.0 17.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.5 m -78.95 -38.47 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 98.15 -123.17 7.76 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.899 -1.143 . . . . 0.0 114.499 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 26.7 Cg_exo -61.35 108.89 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.804 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 99' ' ' ALA . 90.4 t -106.27 139.54 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 4.4 m -153.09 151.71 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.81 151.07 26.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.243 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -114.5 -35.93 4.76 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.64 -97.52 1.63 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.729 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.97 125.26 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.095 0.474 . . . . 0.0 111.492 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 45.0 pt -141.58 179.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 36.9 m-80 -100.47 93.83 5.83 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.297 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 4' ' ' ALA . 31.4 tp -72.74 97.18 2.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.508 ' HG ' ' H ' ' B' ' 6' ' ' PHE . 5.1 m 62.59 35.22 14.5 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.749 0.785 . . . . 0.0 110.267 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 74.7 m 79.14 0.91 2.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.29 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.9 m -103.82 107.11 55.63 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.91 123.07 12.22 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 121.833 1.688 . . . . 0.0 112.99 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 144.91 49.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.401 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 62.9 t30 -117.43 168.02 10.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.582 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 3.2 mpt_? 65.58 31.46 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.5 mmm -82.21 130.33 35.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.936 0.874 . . . . 0.0 113.031 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 49.0 mt -98.7 142.66 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.143 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 119' ' ' THR . 6.6 ptm180 -122.76 157.17 32.94 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 167' ' ' GLN . 20.2 p90 -157.75 141.8 15.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.534 0.683 . . . . 0.0 109.997 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.09 98.32 5.73 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.755 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -171.49 134.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.08 114.17 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.311 0.577 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.8 p -121.3 162.05 20.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 143' ' ' THR . 58.6 tttm -157.28 150.47 23.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.22 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 142' ' ' LYS . 57.1 p -37.58 158.83 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.88 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.555 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 87.74 -25.61 8.32 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.4 -0.86 57.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.546 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 9.8 p -76.68 142.53 40.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.58 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 112.57 -20.36 20.64 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.08 144.71 41.84 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.744 -0.728 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.02 124.25 46.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.302 0.573 . . . . 0.0 112.11 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -90.84 111.61 23.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -146.94 177.27 9.26 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.901 0.858 . . . . 0.0 112.681 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.08 177.54 10.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.644 -1.616 . . . . 0.0 107.944 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.6 t -60.93 111.65 1.75 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.208 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.1 77.77 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.157 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -151.98 121.14 6.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.17 0.485 . . . . 0.0 112.182 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.95 128.68 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -93.82 -41.16 9.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.237 0.541 . . . . 0.0 111.248 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 159.1 -158.47 29.49 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.537 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.92 143.54 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.558 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 162' ' ' GLY . 83.8 t60 -72.8 102.75 3.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.495 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.2 m -91.19 -19.37 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.549 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 160' ' ' HIS . . . -176.88 -152.75 10.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.929 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 176.39 168.31 36.32 Favored Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.544 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 22.0 t-20 -127.92 84.05 2.21 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.622 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.09 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.806 -1.543 . . . . 0.0 115.654 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -102.73 4.54 38.16 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 63.0 mt-30 -126.73 126.59 43.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.426 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.56 143.6 22.69 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.412 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 24.7 m-85 -122.54 109.44 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.918 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.8 t -108.5 146.56 33.0 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.541 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.64 125.07 38.05 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.6 pt20 -69.17 116.17 9.3 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.881 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 90' ' ' ILE . 18.8 tp -83.24 91.91 7.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.918 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -83.67 142.95 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.552 0.691 . . . . 0.0 112.263 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -66.09 -16.43 63.94 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -48.42 -50.98 28.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.733 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -70.91 -29.48 65.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.444 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.0 0.63 57.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -17.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.15 -25.96 18.47 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.173 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -117.39 120.92 39.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.289 -179.698 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.164 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.473 ' N ' HD12 ' B' ' 2' ' ' LEU . 4.8 mp -118.52 116.5 26.79 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.636 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.3 tt0 -94.77 79.17 3.71 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 173.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.581 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -72.42 135.77 45.88 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.587 HD13 ' N ' ' B' ' 6' ' ' PHE . 0.4 OUTLIER -91.18 134.45 34.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.587 ' N ' HD13 ' B' ' 5' ' ' LEU . 25.1 m-85 -50.04 137.02 17.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 72.1 mt-30 . . . . . 0 N--CA 1.439 -1.024 0 C-N-CA 117.098 -1.841 . . . . 0.0 . -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.555 HX51 ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 112.887 -0.085 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.91 -40.51 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.232 1.955 . . . . 0.0 112.703 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.87 -44.35 55.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.431 0.634 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -55.19 -57.32 12.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.758 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.5 -34.31 75.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.6 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.47 -53.83 30.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.258 0.551 . . . . 0.0 110.625 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.38 98.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.947 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 6.6 tt -62.79 -42.95 99.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.696 0.284 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -69.93 -43.21 72.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.21 -40.68 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.352 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 8.3 tt -60.64 -45.0 95.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.013 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 41.7 mtp180 -73.73 -29.8 62.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -94.87 -51.61 4.61 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.92 -17.31 14.23 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.0 mm -88.05 123.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.65 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.414 ' HA ' ' CE ' ' A' ' 16' ' ' MET . 3.7 mmt -123.53 130.23 52.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -71.96 103.98 3.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.196 178.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 56.6 mt -89.83 107.86 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 122.123 0.963 . . . . 0.0 111.607 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 m -80.41 110.66 16.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.334 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 21' ' ' SER . 6.2 t -134.11 -171.6 2.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.68 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.426 ' N ' ' OG1' ' A' ' 20' ' ' THR . 15.7 m -60.9 -28.47 68.93 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 40' ' ' HIS . 74.3 mmtt -92.78 -4.55 52.86 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.853 -0.53 . . . . 0.0 111.302 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 -151.75 19.1 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 29.1 mt-10 -112.34 129.33 56.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -118.12 167.27 11.64 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.134 0.968 . . . . 0.0 112.428 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 27.0 m -78.75 99.34 6.62 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.931 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 136.39 12.86 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.6 pt? -121.32 129.74 53.26 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 118.389 -1.325 . . . . 0.0 112.597 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.9 109.64 2.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 90' ' ' ILE . 45.8 mm -67.9 -43.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.276 0.56 . . . . 0.0 110.611 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -171.88 146.78 2.1 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.474 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 50.28 -86.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 19.2 ptt180 -133.85 9.58 3.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.62 -174.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.95 113.78 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.524 0.678 . . . . 0.0 112.06 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.0 m -117.96 144.21 45.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.343 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.21 143.78 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.291 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.8 tt -148.13 144.84 19.37 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.921 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.94 149.14 15.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.153 1.235 . . . . 0.0 110.879 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 28.4 m -70.79 -37.11 73.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 42.8 p-80 -64.34 -7.96 11.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 20' ' ' THR . . . -71.41 -21.74 61.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 55.71 72.5 1.02 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.76 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.86 135.24 25.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.866 2.377 . . . . 0.0 111.873 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.71 -160.05 36.09 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.087 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' VAL . 9.1 p-10 -76.03 -23.78 55.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.206 0.527 . . . . 0.0 110.148 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 1.4 p-10 -139.81 132.96 29.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.81 148.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.511 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.0 mt -96.86 104.36 16.36 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.812 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' OD1' ' A' ' 50' ' ' ASN . 7.6 p -93.9 109.21 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 122.182 0.992 . . . . 0.0 109.962 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 9.4 p-10 45.74 28.36 0.55 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.954 -1.476 . . . . 0.0 113.12 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.45 -20.49 12.3 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.449 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.12 132.41 33.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.3 tttp -85.59 118.41 25.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -138.62 119.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.045 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 36.4 ptt180 -72.57 151.79 42.19 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.82 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 45' ' ' ASP . 11.1 p -74.54 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.056 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -98.36 -40.56 8.25 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 27.4 t0 -155.43 134.68 12.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.482 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -136.34 115.32 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.414 . . . . 0.0 110.633 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -122.97 125.9 46.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 49.9 mtmt -84.48 112.45 20.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.642 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 39.9 mt -75.47 109.08 8.72 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 m -101.55 148.79 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.45 140.93 95.24 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.326 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -45.9 -24.78 2.32 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.526 2.151 . . . . 0.0 113.851 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 9.81 3.62 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.374 0.607 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 73.11 30.97 1.53 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 132' ' ' ASN . 34.7 mt -119.61 155.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -64.93 129.17 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.642 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 37.2 tp -104.07 -22.49 13.43 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' HG2' HG11 ' A' ' 161' ' ' VAL . 37.3 tp10 75.09 8.45 4.04 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.47 107.61 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.971 0.351 . . . . 0.0 111.09 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 93.1 m -89.62 112.53 23.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.516 . . . . 0.0 109.72 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 62' ' ' LEU . 87.1 t -82.53 106.22 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -101.28 100.9 11.48 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.175 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 58' ' ' ASP . 17.6 m -91.49 110.33 21.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.426 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 31.0 mt -117.81 120.24 37.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.605 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.64 101.89 0.85 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 117.729 -1.588 . . . . 0.0 109.46 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HE ' ' HG2' ' A' ' 81' ' ' GLU . 6.6 tpt180 -102.41 129.69 48.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.65 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -76.49 -25.65 54.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.024 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' HE ' ' A' ' 79' ' ' ARG . 15.3 pt-20 -97.15 120.78 38.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -73.6 129.33 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -77.2 137.57 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -44.78 131.56 6.91 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.274 -0.266 . . . . 0.0 111.041 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.25 92.66 3.88 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.282 0.563 . . . . 0.0 112.12 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.4 pt -93.48 20.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -61.64 -39.13 90.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.079 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.35 -11.32 85.14 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.104 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 47.2 m-85 -87.82 -20.58 25.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 117.77 0.785 . . . . 0.0 109.652 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 30' ' ' ILE . 45.4 mt -74.06 146.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 p -120.2 139.61 52.39 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.495 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 176' ' ' GLN . 8.6 pt-20 -78.01 -42.63 31.98 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.27 120.53 42.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 172' ' ' GLN . 26.7 mt -58.87 -68.18 0.29 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 56.57 70.87 0.61 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.46 93.42 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.13 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.9 p -87.84 3.42 5.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.889 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 13.5 t70 -131.05 124.34 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.368 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.79 163.85 31.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.227 1.013 . . . . 0.0 113.115 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.1 m -116.19 143.32 45.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.638 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -116.22 122.11 44.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 -177.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.43 113.03 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.304 0.573 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -99.37 139.75 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.631 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.548 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.8 t60 -146.36 59.62 1.22 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.1 m -108.88 -179.5 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.118 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.8 p-10 -68.39 -38.91 81.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.436 1.016 . . . . 0.0 111.765 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.54 HD22 ' HA2' ' A' ' 144' ' ' GLY . 79.3 m-20 -70.08 -60.12 2.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.087 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -108.06 92.9 4.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 m -91.83 110.64 21.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.514 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.548 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 41.2 t30 64.01 71.8 0.48 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.608 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.3 m -130.98 103.47 6.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.124 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.7 113.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.591 0.71 . . . . 0.0 110.414 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.1 mt -122.53 134.31 54.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.754 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.67 104.45 16.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.24 -41.09 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 96.54 -119.06 6.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.716 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.5 Cg_exo -60.42 100.41 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 115.684 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 137' ' ' TYR . 6.4 m -108.05 126.09 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -142.28 146.78 35.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -77.88 135.27 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.546 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.82 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.19 -116.11 3.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.283 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.93 106.99 14.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.888 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.464 HG21 HD23 ' B' ' 2' ' ' LEU . 44.1 pt -125.17 -172.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.154 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 14.8 m120 -113.14 95.39 5.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.35 0.595 . . . . 0.0 110.653 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.507 HD21 ' CG1' ' A' ' 161' ' ' VAL . 43.9 tp -81.62 106.85 13.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 128' ' ' SER . 4.4 m 64.77 25.74 12.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 127' ' ' SER . 49.2 m 86.1 -11.24 0.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.824 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.8 m -87.07 119.42 71.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.404 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.19 117.39 4.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.199 1.932 . . . . 0.0 112.36 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -117.46 132.87 56.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.178 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 63.2 t30 -98.76 141.04 32.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.707 0.765 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 64.09 47.08 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.713 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.412 ' SD ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.78 130.42 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.666 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 61.4 mt -89.44 134.54 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.493 0.663 . . . . 0.0 111.61 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -109.17 130.64 55.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.565 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.65 ' HB3' HG12 ' A' ' 118' ' ' VAL . 2.4 p90 -139.19 127.83 23.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.61 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.66 110.61 5.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.991 0.9 . . . . 0.0 111.251 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -179.71 132.05 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.799 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -61.49 106.68 0.68 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.4 p -112.38 140.18 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.531 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -130.44 152.61 49.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.267 1.032 . . . . 0.0 112.001 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.504 HG22 ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -42.18 153.68 0.06 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.759 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.54 ' HA2' HD22 ' A' ' 107' ' ' ASN . . . 92.66 -18.2 55.83 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -94.24 -4.57 48.66 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.529 -0.836 . . . . 0.0 112.155 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . 0.265 29.2 p -85.55 151.82 23.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 116.575 -2.05 . . . . 0.0 113.763 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.712 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 106.59 -20.56 34.24 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -53.47 146.83 19.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.735 -0.732 . . . . 0.0 111.697 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.48 125.96 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.821 0.819 . . . . 0.0 113.162 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.43 HD13 HD23 ' A' ' 101' ' ' LEU . 37.8 tp -90.78 108.99 20.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.617 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 6.9 p -145.48 -179.72 6.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.031 0.919 . . . . 0.0 113.381 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.24 -172.71 4.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.642 -1.617 . . . . 0.0 108.568 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 153' ' ' THR . 9.8 t -66.93 101.75 0.88 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.012 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.9 83.99 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.302 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 79.3 mttt -140.43 140.08 35.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.415 0.626 . . . . 0.0 111.816 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.92 123.54 71.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -97.75 -31.89 12.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.934 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 167.53 -163.12 36.88 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.423 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.5 144.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.701 0.762 . . . . 0.0 111.413 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.453 ' HB2' HD21 ' A' ' 101' ' ' LEU . 6.1 t60 -62.72 114.11 3.41 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.454 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 71' ' ' GLU . 47.8 t -103.6 -33.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.563 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -171.42 -147.13 5.54 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.646 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.37 166.3 32.18 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.306 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.514 ' HB2' ' CB ' ' B' ' 4' ' ' ALA . 5.3 t30 -132.91 89.67 2.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 109.812 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.52 -102.25 0.42 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.097 -0.956 . . . . 0.0 114.491 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 23.4 mtp180 -94.29 4.81 53.37 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -131.98 114.75 14.98 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.27 39.44 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.838 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 54.0 m-85 -129.01 118.16 22.11 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.021 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.48 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 27.0 t -111.64 159.83 17.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.252 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.87 131.54 44.26 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.47 ' HG3' HD21 ' A' ' 94' ' ' LEU . 47.3 tt0 -68.88 104.49 2.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.086 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 19.0 tp -80.16 92.87 5.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -87.67 119.94 28.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.994 0.902 . . . . 0.0 112.614 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -53.47 -31.16 44.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.537 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.495 ' HA ' HG12 ' A' ' 179' ' ' VAL . 4.9 pt20 -60.71 -17.74 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.98 -14.66 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.089 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -105.06 -30.91 9.45 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 176' ' ' GLN . 12.7 p -83.22 -2.95 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.57 -25.51 57.14 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.487 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -122.57 170.2 10.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.413 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.15 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 124' ' ' ILE . 2.5 mm? -133.77 139.89 46.6 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.443 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 40.7 tt0 -109.99 74.21 0.88 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 171.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.514 ' CB ' ' HB2' ' A' ' 164' ' ' ASN . . . -74.94 153.68 38.47 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 23.4 tp -113.42 152.4 30.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.622 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 23.2 m-85 -56.99 146.98 25.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 96.6 mt-30 . . . . . 0 N--CA 1.436 -1.174 0 C-N-CA 119.891 -0.723 . . . . 0.0 . 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.504 ' H2 ' HG22 ' A' ' 143' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 112.392 -0.283 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.74 -60.6 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.876 1.717 . . . . 0.0 113.363 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.451 ' HA ' ' OG1' ' A' ' 153' ' ' THR . 17.7 m120 -66.27 -44.17 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.131 0.491 . . . . 0.0 112.136 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -46.35 83.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.214 0.53 . . . . 0.0 111.869 -178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -55.01 -55.08 34.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.316 0.579 . . . . 0.0 111.659 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -63.47 -47.33 82.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.94 90.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.488 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 6.4 tt -67.36 -39.44 85.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 p -69.75 -41.49 75.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.184 -0.323 . . . . 0.0 111.201 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.7 tt -69.8 -39.84 76.32 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.043 0.449 . . . . 0.0 110.963 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD22 ' HD2' ' A' ' 12' ' ' ARG . 7.0 tt -54.76 -55.76 26.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD22 ' A' ' 11' ' ' LEU . 12.4 mpt_? -61.2 -27.82 68.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.1 -52.98 4.56 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -106.44 -9.64 16.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -100.3 109.15 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.548 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt -121.96 155.54 35.3 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.845 0.831 . . . . 0.0 110.72 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -75.87 101.13 5.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.985 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.47 107.39 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.433 0.635 . . . . 0.0 110.544 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.6 m -76.82 99.91 5.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.089 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.8 p -95.33 -177.59 4.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.538 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m -75.28 -14.94 60.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.167 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.747 ' HZ2' ' CX7' ' B' ' 8' ' ' CA1 . 0.8 OUTLIER -105.5 -8.11 18.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.415 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 -179.66 22.07 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 17' ' ' THR . 46.3 mm-40 -79.15 121.18 24.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -127.1 164.73 20.95 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.789 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.4 m -74.86 95.27 2.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.182 -1.826 . . . . 0.0 111.018 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.05 104.87 2.38 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 tp -88.73 104.89 17.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.0 112.162 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.58 126.64 12.87 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 90' ' ' ILE . 29.3 mm -89.34 -51.57 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 117.417 0.608 . . . . 0.0 110.399 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -171.95 149.17 2.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.614 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.06 -87.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -135.86 16.06 3.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.494 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.51 119.83 49.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.302 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -125.39 147.16 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.506 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.66 136.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.859 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' A' ' 73' ' ' THR . 15.5 mm -141.04 142.68 28.48 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.34 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.37 148.04 91.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.277 1.318 . . . . 0.0 111.657 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 52.2 m -68.23 -35.52 78.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.837 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' B' ' 6' ' ' PHE . 54.6 p-80 -74.02 -3.96 32.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -20.7 38.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.581 0.705 . . . . 0.0 109.366 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 59.14 71.64 0.92 Allowed Pre-proline 0 CA--C 1.517 -0.311 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.052 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.67 125.44 10.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.59 1.526 . . . . 0.0 108.963 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.15 178.88 50.94 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.372 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 56' ' ' VAL . 19.7 t70 -70.07 -31.2 68.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 4.9 p-10 -120.18 140.94 50.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.13 161.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.407 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -98.22 114.48 26.75 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.678 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -91.9 92.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.165 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 66.78 5.25 3.84 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.339 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -31.88 2.34 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.976 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' CD ' HH12 ' A' ' 79' ' ' ARG . 50.3 tt0 -81.72 137.3 35.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 110.449 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -78.45 128.97 34.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.44 154.44 13.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.611 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.5 mtm180 -106.33 153.39 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.944 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 75' ' ' LEU . 7.7 p -94.96 118.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.49 -33.11 68.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.17 107.83 4.13 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.863 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.47 95.88 6.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -109.31 123.35 49.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.589 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -76.4 124.27 27.28 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -89.51 103.86 16.46 Favored 'General case' 0 C--O 1.259 1.596 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 29.6 m -110.82 173.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.844 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -72.5 139.64 81.32 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.55 -27.58 41.63 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.936 1.758 . . . . 0.0 111.788 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -85.54 8.39 19.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.459 0.647 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.5 t30 64.06 68.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.457 1.123 . . . . 0.0 111.183 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.455 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.9 mt -139.93 170.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 112.313 -2.221 . . . . 0.0 105.32 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 68' ' ' ILE . 65.7 t30 -86.43 135.72 33.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.342 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.641 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 20.4 mt -108.0 -26.94 10.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.0 tp10 79.09 3.6 2.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.132 -1.394 . . . . 0.0 113.169 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 17.7 mt -89.88 126.05 35.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.406 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 39.8 m -103.96 118.8 37.52 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.063 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.2 102.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 56' ' ' VAL . 13.9 tp -95.42 94.95 8.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.85 -178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -84.17 94.95 8.49 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.958 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' VAL . 83.6 mt -99.29 122.57 42.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.213 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.26 84.7 5.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.406 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.429 HH12 ' CD ' ' A' ' 52' ' ' GLN . 27.9 tpt180 -95.56 133.01 40.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.661 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.22 -44.42 79.51 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 118.11 17.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -87.14 134.51 33.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.331 0.586 . . . . 0.0 111.945 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -68.92 137.47 53.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.438 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -72.91 131.4 42.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.946 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.86 86.07 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 18.5 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -63.56 -28.44 69.94 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.698 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.74 -18.65 74.94 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.531 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 92.5 m-85 -77.43 -22.78 50.96 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HD12 ' A' ' 30' ' ' ILE . 72.9 mt -72.58 123.66 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.6 t -123.37 136.35 54.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -65.92 -42.14 90.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.96 107.01 18.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.72 -76.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HB3' ' NZ ' ' A' ' 155' ' ' LYS . 39.2 tt0 51.43 70.82 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.82 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.02 86.84 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.573 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.61 2.14 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.453 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 24.9 t70 -139.35 124.4 18.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.557 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.36 168.57 19.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.644 0.735 . . . . 0.0 112.545 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 34.2 m -119.67 136.42 54.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.381 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 160' ' ' HIS . 3.1 tm? -99.48 114.11 26.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.12 120.49 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.161 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -113.99 119.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.425 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -129.32 72.8 1.48 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.2 p -121.36 -171.95 2.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.632 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.44 -35.76 71.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.27 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.58 -55.81 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.04 125.35 12.27 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.392 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 1.6 p -88.15 112.58 22.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' THR . 84.0 m-20 76.29 74.48 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 103' ' ' VAL . 23.8 m -142.22 136.37 29.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.195 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.47 137.24 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 109.651 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.78 108.72 13.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.624 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 5.7 pt-20 -75.65 108.2 8.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.08 -29.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.547 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.62 -115.81 4.61 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.945 -1.121 . . . . 0.0 115.735 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 15.4 Cg_exo -60.19 109.35 0.61 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.95 2.434 . . . . 0.0 115.448 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.88 134.94 35.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -134.64 -172.27 2.98 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.86 147.55 48.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.07 -14.19 11.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.49 -111.69 3.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.974 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.2 118.73 32.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.51 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' B' ' 2' ' ' LEU . 49.3 pt -135.32 -179.27 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 5.4 m-20 -96.29 123.7 40.02 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.967 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 53.7 tp -106.12 104.22 13.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 128' ' ' SER . 10.1 t 63.47 28.57 15.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 127' ' ' SER . 93.4 p 80.16 1.23 2.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.873 1.669 . . . . 0.0 112.011 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 m -95.3 114.45 63.85 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.291 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.23 114.06 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.11 1.873 . . . . 0.0 112.718 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -121.3 130.01 53.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.615 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -105.59 164.46 11.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 55.18 50.07 15.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.352 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 35.2 ttm -101.85 134.65 44.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.061 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 70.0 mt -86.78 152.07 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.296 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -129.58 151.03 50.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.45 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -156.32 142.95 18.6 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.584 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.44 99.36 6.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.505 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -171.02 127.9 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.062 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 110.94 3.25 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.529 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.437 HG22 HE22 ' A' ' 145' ' ' GLN . 29.1 p -109.62 156.54 20.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.855 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 143' ' ' THR . 51.0 tttm -143.36 152.41 41.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.016 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 6.3 p -40.59 161.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.481 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 90.65 -28.58 7.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.502 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.437 HE22 HG22 ' A' ' 141' ' ' THR . 24.7 mt-30 -83.09 -11.58 57.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.458 ' HB3' ' H ' ' B' ' 7' ' ' GLN . 25.2 p -72.08 111.95 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.634 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 137.23 -14.71 3.74 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.615 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.75 151.72 52.21 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 124.32 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 112.039 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.0 tp -91.98 109.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 9.3 p -144.59 178.25 8.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.97 0.89 . . . . 0.0 112.13 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.7 174.65 10.46 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.766 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 3' ' ' ASN . 27.9 m -72.45 94.44 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.04 -24.61 9.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.584 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 94.0 mttt -134.65 146.52 49.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.73 0.776 . . . . 0.0 112.507 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 mm -110.1 130.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -101.69 -45.39 5.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.46 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.596 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.0 -170.17 43.0 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.651 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.506 HG23 HD11 ' A' ' 173' ' ' LEU . 30.5 pt -116.68 143.63 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.542 ' HB2' HD21 ' A' ' 101' ' ' LEU . 67.0 t60 -73.52 114.98 12.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.321 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.77 -21.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -176.63 -157.01 16.75 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.886 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.96 165.96 35.82 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.578 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 28.1 t-20 -136.62 85.99 2.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.778 0.799 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.31 -106.99 1.61 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.563 -1.198 . . . . 0.0 115.178 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.14 -17.11 57.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.93 127.31 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.48 142.4 17.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.464 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 66.6 m-85 -119.5 122.06 40.81 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.236 1.018 . . . . 0.0 111.994 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 32.3 t -119.83 149.71 41.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.38 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.39 136.29 35.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -67.46 123.99 21.95 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.596 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 29.6 mt -90.61 84.96 5.97 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -80.75 135.72 36.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.999 0.428 . . . . 0.0 110.37 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.09 -29.14 68.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.401 0.619 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -55.14 -32.12 61.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.536 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.3 -11.64 51.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -111.1 -18.76 12.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.489 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.01 -8.46 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.45 ' OE2' ' HB2' ' A' ' 181' ' ' LYS . 0.7 OUTLIER -72.85 -17.68 61.52 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.43 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.528 ' NZ ' ' HB2' ' A' ' 181' ' ' LYS . 4.4 ttmp? -94.87 89.32 5.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.713 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.381 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' A' ' 124' ' ' ILE . 2.7 mm? -139.27 151.55 46.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.457 0.646 . . . . 0.0 110.768 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 36.2 tt0 -122.49 79.67 1.64 Allowed 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 171.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.59 145.63 30.53 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 33.2 tp -98.59 153.58 18.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.5 m-85 -59.15 142.35 51.82 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.506 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 94.3 mt-30 . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 118.203 -1.399 . . . . 0.0 . -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.747 ' CX7' ' HZ2' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.693 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.69 -60.79 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.564 2.176 . . . . 0.0 115.186 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 152' ' ' ALA . 45.1 t-20 -57.01 -51.07 70.72 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.828 -0.545 . . . . 0.0 112.206 -177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -56.28 -45.29 80.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.698 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.12 -28.35 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 111.224 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.05 -44.66 83.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.82 90.76 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.485 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -57.33 -49.81 74.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.987 0.423 . . . . 0.0 110.193 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.24 -39.55 82.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.972 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.8 tp -62.09 -49.57 75.4 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.509 0.671 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.8 tt -54.6 -43.72 72.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.155 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -64.91 -29.69 70.65 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.6 6.15 13.38 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.953 0.797 . . . . 0.0 112.982 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.8 -38.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.1 mt -86.39 115.89 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.353 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.4 mtt -119.72 161.74 20.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.925 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -92.8 123.67 36.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.92 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -112.84 105.57 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.931 0.872 . . . . 0.0 111.448 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.683 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.1 m -78.0 123.04 26.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.619 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.1 p -126.26 -173.48 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 m -81.03 -9.47 59.83 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -91.46 -43.47 9.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.6 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.66 -169.05 42.18 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.268 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG2' HG23 ' A' ' 19' ' ' THR . 31.4 mt-10 -106.02 107.32 18.26 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -101.98 171.13 7.69 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.423 1.106 . . . . 0.0 113.516 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.7 m -79.9 113.77 18.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.534 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.02 112.49 4.48 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.781 -1.199 . . . . 0.0 110.877 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 tp -94.98 120.0 34.46 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -89.25 129.86 9.88 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.476 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -90.61 -56.85 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.72 0.76 . . . . 0.0 110.426 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -160.33 127.56 4.42 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 12.5 t0 56.89 -78.35 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.486 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 15.2 mmt-85 -120.46 -11.24 9.14 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.851 -0.531 . . . . 0.0 110.666 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 HG13 ' A' ' 74' ' ' VAL . 57.2 t -80.19 99.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.331 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 45.7 t -114.23 141.84 47.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.838 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 173' ' ' LEU . 24.1 m -111.84 137.64 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.712 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.7 tt -142.24 141.7 22.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.36 142.53 16.91 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.253 1.302 . . . . 0.0 111.351 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.539 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 83.7 m -70.82 -34.84 72.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.132 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -65.62 -7.22 13.91 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.389 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.95 60.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.48 0.657 . . . . 0.0 109.672 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 15.6 mm-40 50.1 72.83 1.12 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.893 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.03 156.06 60.94 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.96 2.44 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -153.46 26.14 Favored Glycine 0 N--CA 1.455 -0.062 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.835 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.24 -15.58 35.51 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 2.2 p30 -139.27 156.56 46.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.223 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.23 161.06 17.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 77.3 mt -104.38 108.51 19.96 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 17' ' ' THR . 80.2 t -84.6 85.07 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.352 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 73.82 -10.1 1.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.091 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.82 -33.33 0.57 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.91 111.08 1.16 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.802 -1.199 . . . . 0.0 111.557 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -75.12 96.48 3.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 tt -123.92 148.02 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.661 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 8.4 mpt_? -97.44 165.05 12.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.326 0.584 . . . . 0.0 111.526 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.4 t -90.45 120.65 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.725 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 78' ' ' ASP . 75.9 tttt -79.86 -38.67 32.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.385 0.612 . . . . 0.0 110.152 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -159.29 132.63 7.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.395 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.97 114.57 26.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.185 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -118.06 105.73 12.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.319 -178.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.09 110.11 18.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.543 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 71.2 mt -79.32 120.86 24.38 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.447 ' HA ' ' H ' ' A' ' 70' ' ' LEU . 33.5 m -116.01 154.87 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 12.6 t70 -87.1 143.45 34.85 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 119.034 0.834 . . . . 0.0 112.91 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -43.72 -17.13 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.52 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.633 ' HG2' ' OD1' ' A' ' 64' ' ' ASP . 52.7 mm-40 -71.34 0.9 7.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.316 0.579 . . . . 0.0 109.827 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 64.4 m-80 72.75 18.82 4.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -116.98 145.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.858 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -51.6 135.58 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.106 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.0 tp -104.56 -16.69 14.96 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 68.3 14.76 9.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.122 -1.399 . . . . 0.0 113.648 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 82.1 mt -105.91 105.29 15.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.061 0.457 . . . . 0.0 111.499 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -89.54 110.19 21.06 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.434 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 95.5 t -81.51 108.86 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 tp -101.49 100.34 10.77 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.815 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 14.1 m -74.41 102.76 4.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 33' ' ' ARG . 86.5 mt -104.71 127.81 52.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.619 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 57' ' ' LYS . 14.1 t70 -87.79 89.46 8.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -93.61 133.89 36.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.61 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.91 -28.75 58.21 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.34 118.36 36.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 19.0 pttp -59.89 129.21 40.71 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.211 -0.995 . . . . 0.0 108.842 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -78.97 161.53 26.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.593 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -49.08 122.84 6.33 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -175.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.22 93.76 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.841 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 156' ' ' ILE . 49.0 pt -96.81 19.11 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -56.16 -35.31 67.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.312 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.76 -16.28 79.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.062 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -87.61 -13.13 43.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.55 133.37 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 7.1 m -96.25 130.94 43.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -77.97 -55.1 5.57 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 91' ' ' SER . 29.0 t70 -100.94 131.68 46.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.4 mt -79.39 -67.64 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.827 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 47.04 71.68 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 118' ' ' VAL . . . -167.26 78.32 0.11 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.2 p -71.83 12.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 27.8 t70 -150.31 121.55 7.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.833 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.76 12.6 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.866 0.841 . . . . 0.0 111.591 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 m -120.06 145.96 46.36 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.585 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 9.6 tt -120.56 121.94 39.5 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 112' ' ' ILE . 24.2 m -111.21 121.92 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.061 0.458 . . . . 0.0 111.04 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 4.0 t -100.5 134.48 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.08 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -135.7 70.97 1.42 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 m -127.18 175.43 8.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.764 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 25.8 p-10 -71.42 -20.05 62.16 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.359 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -84.97 -34.16 22.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.423 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.47 97.29 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.421 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 102.85 15.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 60.55 70.83 0.6 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.839 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 28.6 m -117.75 111.87 19.69 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.855 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 102' ' ' VAL . 2.0 mp -87.36 105.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 tt -116.56 127.24 54.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.658 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.71 128.51 34.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.17 -24.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.03 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 79.13 -124.12 6.43 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.852 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 27.9 Cg_endo -62.66 105.11 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.52 2.147 . . . . 0.0 114.495 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 90.6 t -97.2 118.32 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.694 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 p -138.07 167.58 21.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.971 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -104.53 126.04 51.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.61 -49.79 6.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.88 -115.89 4.13 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.476 -0.868 . . . . 0.0 115.114 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 123' ' ' LEU . 3.8 mp -95.96 107.8 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.061 -0.569 . . . . 0.0 112.096 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 42.2 pt -138.98 -177.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.274 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -102.1 136.53 41.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.008 0.432 . . . . 0.0 110.598 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 4.1 mm? -115.07 103.81 11.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' SER . 10.3 t 60.8 31.13 20.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.768 -0.582 . . . . 0.0 109.751 -177.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 127' ' ' SER . 67.0 m 79.96 2.94 2.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.444 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.6 m -99.59 115.68 65.45 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.777 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.05 115.37 2.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.947 1.765 . . . . 0.0 112.368 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.563 ' HB ' HD23 ' A' ' 126' ' ' LEU . 19.7 m -128.69 141.84 51.21 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.014 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 60.3 t30 -117.91 162.8 17.54 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 3.2 mpt_? 77.84 22.94 0.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.659 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.48 129.27 37.62 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.146 0.974 . . . . 0.0 113.303 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 79.6 mt -92.3 132.66 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.278 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -107.25 129.22 54.9 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.515 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 1.3 p90 -133.29 143.44 49.05 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.96 99.49 9.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.636 0.732 . . . . 0.0 112.009 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 141' ' ' THR . 88.8 t80 -170.11 126.16 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.023 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.12 110.97 1.76 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' B' ' 7' ' ' GLN . 36.8 p -112.52 151.68 29.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -143.16 151.52 40.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.334 1.064 . . . . 0.0 110.916 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.403 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.86 156.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.363 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.81 -20.74 45.41 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 121.726 0.625 . . . . 0.0 111.648 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -87.33 2.94 48.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.459 -0.871 . . . . 0.0 112.228 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.551 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 16.6 m -64.8 142.62 58.37 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.621 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 104.5 -23.54 31.24 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.866 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 101' ' ' LEU . . . -49.74 135.92 24.3 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.562 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 47.3 t -88.78 122.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 111.847 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -93.46 108.83 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -146.65 166.18 27.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.193 0.997 . . . . 0.0 113.418 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . . . -128.74 173.25 10.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.485 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -67.53 106.26 2.1 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.885 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.99 6.47 89.44 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.24 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -137.96 112.98 9.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.416 ' CD1' HD12 ' A' ' 86' ' ' ILE . 65.7 mt -103.59 134.73 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.362 0.601 . . . . 0.0 110.596 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -99.53 -55.13 2.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.931 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 176.64 -156.97 21.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.55 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.1 pt -125.94 148.04 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.334 0.588 . . . . 0.0 112.089 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.01 116.55 6.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.195 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 171' ' ' ALA . 46.2 t -104.48 -28.88 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.625 0.726 . . . . 0.0 109.901 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' B' ' 7' ' ' GLN . . . 174.44 -145.84 8.26 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.589 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.62 174.11 44.56 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.4 t-20 -135.26 86.26 2.23 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.733 0.778 . . . . 0.0 109.769 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.05 -103.52 0.73 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.545 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -82.85 -11.49 58.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.68 -177.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.474 ' OE1' ' HB3' ' A' ' 166' ' ' ARG . 1.1 mp0 -112.8 145.99 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.851 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -105.13 150.8 17.11 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.7 m-85 -132.8 119.69 20.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.217 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.7 t -113.59 152.66 30.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.579 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 161' ' ' VAL . . . -90.98 135.19 33.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 133' ' ' ARG . 9.0 tt0 -74.93 113.48 12.28 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.595 HD13 ' HA2' ' A' ' 158' ' ' GLY . 8.4 mp -82.9 83.04 7.92 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -81.06 121.14 25.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.122 0.963 . . . . 0.0 111.249 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -39.67 -39.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.253 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -45.56 -51.21 12.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -69.45 -19.99 63.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -97.59 -29.62 13.33 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.704 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.41 -20.89 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.165 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.24 -23.95 18.35 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.47 114.36 20.15 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.377 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.089 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.8 mm? -136.63 155.19 50.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.273 0.559 . . . . 0.0 109.792 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -121.89 77.32 1.36 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -77.51 147.2 35.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.508 HD12 ' H ' ' B' ' 6' ' ' PHE . 55.1 tp -103.24 142.85 33.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.508 ' H ' HD12 ' B' ' 5' ' ' LEU . 24.6 m-85 -57.78 125.39 22.81 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.06 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.463 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 83.2 mt-30 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 116.525 -0.307 . . . . 0.0 . 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.551 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 112.594 -0.203 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.49 -35.62 81.39 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 121.907 1.738 . . . . 0.0 113.913 -178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.3 -51.81 53.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.296 0.57 . . . . 0.0 110.834 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -67.63 -36.15 80.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.941 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 7.2 tp10 -58.19 -50.53 73.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 110.578 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.19 -48.75 79.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.05 83.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.438 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 3.3 tt -64.28 -40.39 95.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.596 0.236 . . . . 0.0 110.666 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -63.95 -43.71 94.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.38 . . . . 0.0 110.678 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.3 tp -67.51 -43.17 81.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.682 0.754 . . . . 0.0 110.58 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.3 tp -49.77 -50.54 44.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.436 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 78.4 mtp180 -56.9 -40.05 75.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.74 -15.49 8.9 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.9 5.56 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 44.8 mm -119.12 109.48 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.4 mmt -124.78 150.84 45.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.654 0.74 . . . . 0.0 111.211 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -76.33 95.36 3.76 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 27' ' ' GLY . 1.7 mp -87.86 104.5 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 m -95.88 113.57 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.199 1.0 . . . . 0.0 109.987 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 69.4 p -94.44 -162.84 0.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.863 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.6 m -80.15 -7.25 58.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.68 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -100.74 -56.21 2.39 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.255 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.46 -163.59 26.55 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -83.49 123.39 29.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.267 -0.466 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -126.41 159.28 33.72 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 121.189 0.519 . . . . 0.0 109.709 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 14.2 m -90.16 109.23 20.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.141 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -88.23 110.18 3.6 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.368 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.1 120.4 36.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -87.27 138.84 15.66 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.63 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 31' ' ' HIS . 4.1 mp -120.57 -39.8 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 118.447 1.124 . . . . 0.0 110.911 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 36.0 m-70 -135.43 128.61 31.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 18.8 t70 43.72 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 14.3 ptt180 -127.08 21.54 6.78 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.963 0.887 . . . . 0.0 109.253 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.38 112.46 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.064 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 63.2 m -116.76 156.7 26.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.65 139.52 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.176 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 pt -142.01 162.86 43.64 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.0 152.45 71.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 121.212 1.275 . . . . 0.0 111.52 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 61.0 m -70.69 -33.1 70.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -79.13 3.89 16.3 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.64 59.67 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 20' ' ' THR . 12.7 mm100 68.41 72.32 0.36 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.44 117.01 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.985 2.457 . . . . 0.0 110.086 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.35 -138.11 2.81 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.812 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' HG12 ' A' ' 56' ' ' VAL . 24.8 t70 -77.55 -24.67 49.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.515 ' HB3' HH11 ' A' ' 55' ' ' ARG . 4.9 p-10 -142.83 162.63 34.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.881 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -140.79 149.04 21.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 84.6 mt -82.99 99.99 10.17 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.731 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -86.16 96.1 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.156 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 63.91 18.91 11.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.39 -17.81 21.09 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.338 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -90.64 123.54 34.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.11 113.31 14.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.181 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.2 mt -116.75 122.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.5 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 46' ' ' ASP . 2.7 mpt_? -66.84 152.0 46.43 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.368 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 45' ' ' ASP . 7.9 p -94.4 137.25 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 33' ' ' ARG . 67.7 mttm -92.56 -55.52 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' ' HB ' ' A' ' 76' ' ' THR . 29.1 m-20 -128.26 140.14 52.05 Favored 'General case' 0 N--CA 1.46 0.049 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.622 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -132.44 78.93 1.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.567 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 90.6 t80 -88.01 131.33 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.591 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 10.6 mptt -90.1 116.13 27.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.98 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 17.2 mt -82.93 119.08 23.96 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-O 121.608 0.718 . . . . 0.0 110.549 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 70' ' ' LEU . 29.8 m -128.62 158.22 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.147 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.05 145.26 88.57 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.261 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.11 -19.12 3.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.809 1.673 . . . . 0.0 113.218 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.06 5.57 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 109.81 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.76 61.59 0.97 Allowed 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.808 0.813 . . . . 0.0 109.641 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' LEU . 35.9 mm -133.44 145.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.026 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -59.57 128.87 39.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -105.1 -24.36 12.79 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 174.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.629 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 25.6 tp10 75.22 10.31 3.67 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.452 -1.703 . . . . 0.0 113.607 175.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 10.5 mp -95.13 122.2 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.4 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 92.4 m -98.26 112.45 24.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.485 0.659 . . . . 0.0 109.883 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 98.9 t -76.2 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.7 tp -94.25 102.02 14.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.388 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 20.1 m -89.36 100.84 13.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 122.091 0.948 . . . . 0.0 109.178 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.8 mt -74.63 141.25 44.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 19.5 t70 -82.88 72.63 9.95 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.09 133.67 46.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.148 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -81.05 -32.13 34.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.97 98.44 2.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -88.46 150.18 23.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.139 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' HB2' ' H ' ' A' ' 84' ' ' ARG . 5.8 p90 -92.21 -163.9 1.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.528 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 12.5 tpp180 -83.86 117.58 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.598 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 31' ' ' HIS . 4.8 m-20 -66.57 99.46 0.59 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -91.56 27.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 122.037 -0.414 . . . . 0.0 111.544 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -65.1 -15.46 62.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.463 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.6 -16.42 75.66 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.764 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -91.7 -14.41 30.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.06 127.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 155' ' ' LYS . 38.9 m -125.95 132.85 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' OE1' ' HB3' ' A' ' 175' ' ' LYS . 2.3 pm0 -81.93 -27.29 33.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.75 149.08 26.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.4 mt -103.4 -68.61 0.83 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 41.75 37.66 0.8 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.433 0.635 . . . . 0.0 112.31 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.57 73.62 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 118' ' ' VAL . 1.2 p -73.5 20.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.138 -1.531 . . . . 0.0 114.818 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -121.59 130.12 53.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.43 166.32 25.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.476 -0.89 . . . . 0.0 113.1 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 96.4 m -121.55 142.54 49.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.49 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.13 113.41 26.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.6 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.95 97.57 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -87.93 123.01 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.619 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 77.0 t60 -137.64 33.31 2.47 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 20.1 p -109.51 -162.44 0.81 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.024 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 105' ' ' SER . 29.0 t-20 -53.35 -56.58 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.15 -44.25 80.24 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.557 -0.714 . . . . 0.0 112.055 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.55 106.28 7.74 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.416 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 23.9 m -93.91 105.72 17.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.619 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 9.9 t30 79.18 72.42 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.275 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.3 m -141.15 107.86 5.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.37 100.37 11.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.801 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 139' ' ' TYR . 58.1 tp -127.55 128.24 45.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.327 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 8.6 pt-20 -79.19 142.53 36.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.83 -20.07 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.55 -124.78 7.96 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.958 -1.115 . . . . 0.0 114.846 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.25 128.62 12.26 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 114.833 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 97' ' ' VAL . 86.8 t -104.91 157.58 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.764 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 36.7 m -160.21 114.89 2.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -78.01 115.94 18.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 118.668 -1.213 . . . . 0.0 108.059 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.9 -11.88 46.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.612 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.08 -120.64 5.26 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.788 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 68' ' ' ILE . 48.5 tp -94.17 113.66 25.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' ' 2' ' ' LEU . 34.4 pt -138.42 177.83 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.1 m-20 -94.64 128.35 41.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.657 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 68.4 tp -115.36 105.05 12.41 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' SER . 12.5 t 62.24 30.57 17.61 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 127' ' ' SER . 52.7 m 82.1 -1.55 1.48 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.151 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 39.3 m -100.22 123.09 47.98 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.874 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.71 116.37 3.21 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.04 1.827 . . . . 0.0 111.739 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.6 m -126.82 134.25 50.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.279 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -108.93 163.2 13.51 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 177' ' ' TYR . 15.8 mmt180 66.37 24.0 10.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.022 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 tpt -72.24 128.86 36.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.143 0.973 . . . . 0.0 112.034 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 38.2 mm -92.43 126.61 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.899 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' THR . 33.8 ttt-85 -104.75 137.27 42.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.33 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 2.4 p90 -145.63 109.51 4.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -74.01 99.3 3.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.829 1.3 . . . . 0.0 110.914 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 113' ' ' LEU . 85.4 t80 -160.21 137.95 9.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 111.497 -2.592 . . . . 0.0 106.32 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 86.18 1.95 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -101.01 161.84 13.31 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -141.99 168.29 20.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.849 1.309 . . . . 0.0 113.093 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.576 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.03 152.61 0.17 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.763 175.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.494 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 93.5 -19.81 50.38 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.51 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -94.22 7.21 46.12 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.205 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.698 ' HB2' ' OX8' ' B' ' 8' ' ' CA1 . 13.7 m -62.47 136.97 58.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.0 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 103.91 -16.98 50.01 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.829 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.5 142.28 43.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.505 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.13 114.9 29.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.439 0.638 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.7 tp -89.54 106.56 18.53 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.016 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.0 p -149.85 -177.17 5.74 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.039 0.923 . . . . 0.0 111.447 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.99 163.96 35.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.734 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 t -61.12 120.94 11.28 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.717 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.87 -19.39 45.85 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG3' ' OG ' ' A' ' 91' ' ' SER . 24.9 ttmm -144.41 124.59 13.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.878 0.839 . . . . 0.0 111.537 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.33 135.34 38.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.455 ' HA ' HE22 ' A' ' 172' ' ' GLN . 93.1 m-85 -103.06 -71.21 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . -152.56 -169.13 17.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.387 -1.387 . . . . 0.0 114.719 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 161' ' ' VAL . 27.4 pt -119.36 140.67 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.457 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -61.09 120.33 10.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 159' ' ' ILE . 73.2 t -117.08 -28.35 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.491 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -175.09 -151.28 8.4 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.345 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.48 161.16 27.6 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 19.0 t-20 -135.29 107.91 7.43 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.34 -110.18 3.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.872 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -113.06 25.82 11.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.248 1.023 . . . . 0.0 109.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -126.07 135.99 52.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.447 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -94.38 148.39 18.98 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.282 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 46.2 m-85 -128.96 123.42 32.44 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.822 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.8 t -116.07 155.5 28.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.511 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.91 123.8 42.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 174' ' ' LYS . 55.8 tp60 -72.27 124.85 25.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.638 HD13 ' HA2' ' A' ' 158' ' ' GLY . 11.0 mp -88.87 84.17 6.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 172' ' ' GLN . 66.4 mttm -78.43 132.72 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 179' ' ' VAL . 8.1 ttpm? -52.12 -30.81 28.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -53.61 -29.44 37.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.406 ' OH ' ' HG3' ' A' ' 133' ' ' ARG . 7.8 m-85 -72.18 -32.3 66.7 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.722 -0.611 . . . . 0.0 111.362 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.535 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 90.7 m-85 -87.81 -13.72 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.212 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 175' ' ' LYS . 57.4 t -67.15 -11.64 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.5 -24.61 62.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.133 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -111.28 170.54 8.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.519 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.548 178.507 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.054 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.448 ' HG ' ' CZ ' ' A' ' 169' ' ' PHE . 2.9 mm? -138.93 149.21 44.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.185 0.517 . . . . 0.0 110.712 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.6 tt0 -119.43 78.05 1.27 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 171.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -81.74 143.61 31.71 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.536 ' HG ' ' N ' ' B' ' 6' ' ' PHE . 24.2 tp -99.89 153.34 19.23 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.536 ' N ' ' HG ' ' B' ' 5' ' ' LEU . 25.4 m-85 -60.07 130.31 46.08 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.576 ' HB3' ' HA ' ' A' ' 143' ' ' THR . 98.8 mt-30 . . . . . 0 C--N 1.315 -0.928 0 C-N-CA 120.623 -0.431 . . . . 0.0 . 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.698 ' OX8' ' HB2' ' A' ' 146' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.9 -40.51 85.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.795 2.33 . . . . 0.0 115.29 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 12.2 t30 -61.71 -55.64 28.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 m -74.37 -33.6 63.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.91 -24.81 58.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.75 -42.69 97.8 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.48 85.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.76 -50.28 72.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.955 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -71.23 -37.17 72.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.993 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.85 -44.72 95.37 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.5 pp -63.69 -29.95 71.11 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -76.23 -28.53 57.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.13 -45.7 6.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -120.25 6.64 10.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.737 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 46.1 mm -106.22 106.0 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 71.0 mtp -111.84 147.58 35.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.216 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 101.66 12.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.143 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.72 98.87 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 32.5 m -80.66 100.0 8.45 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -170.79 2.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.905 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -74.01 -29.75 62.11 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.586 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.82 -23.71 22.76 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.212 -0.305 . . . . 0.0 111.516 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.27 -164.99 37.54 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.644 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -97.86 107.82 20.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.634 0.731 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -108.97 164.14 12.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.904 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 26.3 m -89.34 118.18 28.83 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.64 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.23 99.1 2.49 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.652 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.92 104.89 14.38 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.51 120.83 5.65 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.446 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.0 mp -81.75 -58.91 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 117.576 0.688 . . . . 0.0 110.581 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -155.04 148.82 25.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 26.0 m-20 51.71 -91.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.776 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -137.22 22.5 3.0 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.29 119.58 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 110.41 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.0 m -114.31 159.17 20.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.2 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.14 140.97 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 73' ' ' THR . 14.0 tt -148.36 141.89 15.85 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.13 143.25 25.81 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 120.604 0.869 . . . . 0.0 110.167 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.576 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 71.5 m -67.74 -35.03 78.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -68.41 -7.57 32.82 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.42 68.24 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.636 0.732 . . . . 0.0 109.663 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 59.46 69.68 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.198 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -77.62 146.24 23.92 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.27 2.647 . . . . 0.0 110.549 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.41 -140.42 8.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.982 -1.104 . . . . 0.0 114.079 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.83 -24.38 38.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.732 -0.734 . . . . 0.0 110.324 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.62 139.83 34.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 27.6 m -124.55 153.47 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.246 0.546 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.3 mt -94.52 101.87 13.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.179 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.99 87.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.61 16.02 8.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.522 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.63 -25.07 6.64 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.034 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.08 108.47 17.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 76.5 mttt -73.8 142.38 46.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.715 0.769 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -136.53 142.17 39.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.85 140.12 33.08 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.854 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.45 155.56 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.408 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -113.72 -46.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.54 134.5 8.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.474 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -124.1 116.01 22.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 87.5 t80 -133.65 123.85 25.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.778 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 61' ' ' LYS . 2.4 mppt? -83.9 112.9 20.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . 6.7 tt -96.49 115.13 26.92 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.174 0.988 . . . . 0.0 109.876 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 27.7 m -111.35 178.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.165 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.6 t70 -70.93 136.56 85.09 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.92 -28.55 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.363 2.042 . . . . 0.0 113.948 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -90.12 20.21 4.48 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.6 0.714 . . . . 0.0 110.742 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.75 62.06 1.56 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.887 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 54.9 mt -133.13 158.29 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -77.94 144.58 36.7 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.14 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.707 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.4 tp -127.48 -35.65 2.14 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 55.4 mm-40 85.96 7.26 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.5 HD13 ' HG ' ' A' ' 70' ' ' LEU . 11.3 mp -78.97 93.66 5.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.164 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.576 ' OG1' ' HA ' ' A' ' 39' ' ' THR . 45.7 m -84.01 106.25 15.52 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 60' ' ' TYR . 70.0 t -71.16 96.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.5 tp -103.04 98.74 8.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 111.304 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.453 ' OG1' ' HE2' ' A' ' 181' ' ' LYS . 3.8 m -92.26 125.51 36.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.463 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.1 mt -114.02 153.43 29.39 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.938 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.62 68.5 8.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.266 -1.373 . . . . 0.0 108.475 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -78.82 117.58 20.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.877 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -76.31 -52.18 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.947 0.403 . . . . 0.0 109.982 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.92 82.98 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 19.5 pttp -73.27 139.16 45.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.641 0.734 . . . . 0.0 112.139 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -82.1 -178.32 6.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -69.64 147.87 50.07 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.565 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 6.6 t70 -88.69 95.98 10.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.848 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 90' ' ' ILE . 39.1 pt -91.49 15.66 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 13.9 ttp180 -62.7 -29.56 70.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.833 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.32 -16.47 80.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.679 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -92.46 -20.17 21.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 56.9 mt -68.74 124.35 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 19.0 m -103.52 120.54 41.06 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.33 -38.07 36.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 91' ' ' SER . 22.1 t70 -101.04 130.62 47.07 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 172.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 mt -90.57 -78.82 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 49.7 70.31 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.42 86.82 0.11 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.6 p -79.41 15.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.123 -0.539 . . . . 0.0 112.272 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 15.2 t70 -141.03 132.14 26.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.965 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.57 31.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.025 0.917 . . . . 0.0 111.031 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.05 135.85 51.37 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.329 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.93 117.97 34.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.256 0.55 . . . . 0.0 111.879 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.31 93.77 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 108' ' ' PHE . 4.9 t -83.04 122.06 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.457 0.646 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 72.5 t60 -145.71 41.65 1.22 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.7 p -108.35 -164.9 0.99 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.18 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.37 -48.92 79.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.79 -17.58 53.04 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' HB2' HG11 ' A' ' 103' ' ' VAL . 20.7 m-85 -150.94 101.39 2.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.507 -0.746 . . . . 0.0 110.742 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 p -85.65 110.02 18.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.519 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 11.5 t30 66.43 71.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.564 0.697 . . . . 0.0 111.655 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 m -139.81 109.31 6.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.08 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.0 tp -82.39 120.87 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 116.05 20.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.579 -176.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 7.6 pt-20 -74.15 128.3 35.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.35 -27.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.067 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 89.45 -131.23 10.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.912 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 39.5 Cg_exo -61.38 115.93 3.07 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.842 2.362 . . . . 0.0 114.19 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -92.46 116.51 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.295 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -123.53 172.08 9.02 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 67.2 mtt -115.75 154.33 29.8 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.0 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.82 -22.92 10.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.02 -111.05 3.23 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.064 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -109.66 111.98 23.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.904 -0.648 . . . . 0.0 109.848 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 46.2 pt -139.35 -177.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 84.5 m-20 -101.43 127.7 47.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.823 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 34.7 tp -107.75 106.58 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 128' ' ' SER . 60.6 p 60.84 30.27 19.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.297 0.57 . . . . 0.0 109.951 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' SER . 63.4 m 85.67 0.52 0.7 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.282 1.033 . . . . 0.0 112.431 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.9 m -110.1 115.27 55.03 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 75.6 Cg_exo -52.05 128.09 25.75 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.529 2.153 . . . . 0.0 114.365 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 p -125.46 145.35 50.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.098 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 65.9 t30 -115.68 160.82 19.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.322 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 5.2 mpt_? 65.83 32.72 8.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.074 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.4 mmm -77.91 127.28 32.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.565 0.698 . . . . 0.0 112.807 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 170' ' ' SER . 71.7 mt -85.41 145.39 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.843 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.85 134.0 44.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 111.675 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -152.94 148.41 27.08 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.54 120.03 36.11 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 122.65 1.214 . . . . 0.0 111.502 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -175.06 129.84 0.3 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.811 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.04 0.79 Allowed 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.151 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.8 t -119.55 138.45 53.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.112 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.43 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 113.455 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.531 ' CG2' ' H2 ' ' B' ' 8' ' ' CA1 . 0.2 OUTLIER -41.19 153.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.276 174.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.561 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 88.16 -20.11 31.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.429 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -90.68 -7.84 51.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.327 -0.437 . . . . 0.0 111.495 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 25.8 p -73.61 135.13 43.81 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.024 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 124.03 -24.14 6.39 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.053 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.48 148.82 25.27 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.142 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.95 121.61 50.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 112.38 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 30.8 tp -92.41 113.42 25.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.283 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -149.26 169.9 19.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.752 0.787 . . . . 0.0 112.823 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.6 169.95 16.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.132 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 1.6 t -62.69 106.11 0.75 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.87 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.12 70.43 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.402 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.87 106.92 9.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.4 mt -95.08 115.96 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.09 -65.37 1.02 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.894 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.501 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . -177.39 -155.6 14.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.103 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.4 pt -119.52 142.76 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.374 0.607 . . . . 0.0 111.236 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.15 115.62 7.83 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.35 -25.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -172.42 -154.84 10.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.564 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.31 161.77 31.89 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.516 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 48.3 t30 -136.2 98.54 3.88 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.86 -119.78 6.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.657 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -103.03 17.38 24.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.821 0.81 . . . . 0.0 111.015 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -113.01 124.65 53.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.74 139.03 15.17 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.404 ' CZ ' ' HG ' ' B' ' 2' ' ' LEU . 73.4 m-85 -119.09 118.03 30.3 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.088 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 135' ' ' ILE . 40.4 t -110.94 154.12 24.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.249 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -101.49 136.21 41.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.991 0.424 . . . . 0.0 110.078 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 133' ' ' ARG . 3.0 mm100 -76.92 117.03 18.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 92.6 mt -89.85 87.19 6.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 177' ' ' TYR . 92.5 mttt -80.52 126.5 31.31 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.325 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 63.0 tttm -43.07 -43.78 4.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.226 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LYS . 3.9 pt20 -57.71 -23.52 52.21 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.489 ' CD2' ' HB2' ' A' ' 174' ' ' LYS . 54.4 m-85 -75.63 -25.99 57.37 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.644 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -84.43 3.66 35.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.203 0.525 . . . . 0.0 110.921 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 179' ' ' VAL . 15.9 t -93.08 -3.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -78.75 -51.35 9.91 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.453 ' HE2' ' OG1' ' A' ' 76' ' ' THR . 63.1 tttp -71.37 136.59 47.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.168 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.603 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.22 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 2.2 mm? -135.11 149.39 50.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 31.4 tt0 -119.74 84.85 2.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 172.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -89.58 146.39 24.6 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 45.9 tp -102.14 151.7 21.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.55 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 22.3 m-85 -57.78 140.87 50.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 93.8 mt-30 . . . . . 0 N--CA 1.441 -0.892 0 C-N-CA 118.353 -1.339 . . . . 0.0 . 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.561 HX51 ' H ' ' A' ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.646 ' O ' ' HG3' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.499 2.85 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -59.61 -33.92 96.7 Favored 'Trans proline' 0 CA--C 1.526 0.09 0 C-N-CA 122.559 2.173 . . . . 0.0 114.073 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 52.6 t30 -70.78 -46.8 62.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.914 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -62.72 -33.65 75.55 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.812 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 44.9 mt-10 -61.15 -47.01 88.2 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.389 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -62.1 -44.38 96.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.233 0.54 . . . . 0.0 109.835 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.71 87.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.705 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 1.6 tt -64.68 -40.07 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.653 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -67.6 -48.1 67.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 -39.72 87.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.879 0.847 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 67.1 tp -54.9 -49.86 70.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.115 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 16.8 mtm180 -72.33 -29.6 63.97 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -91.12 -48.98 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -175.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -118.49 0.06 11.51 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 55.0 mt -106.44 122.99 60.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 80.6 mtp -133.98 165.6 24.66 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.991 0.901 . . . . 0.0 110.584 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.74 111.79 12.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.958 -1.474 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HA3' ' A' ' 27' ' ' GLY . 49.1 mm -104.53 110.38 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 2.0 m -87.31 112.86 22.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.175 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -122.35 -171.93 2.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.32 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.475 ' H ' HG22 ' A' ' 20' ' ' THR . 14.9 m -55.28 -37.09 66.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.622 ' HZ3' ' H4 ' ' B' ' 8' ' ' CA1 . 23.9 ttpp -91.02 0.43 57.54 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.78 -160.16 21.69 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.466 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -89.91 122.85 33.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.136 0.493 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CZ ' ' HE3' ' A' ' 22' ' ' LYS . 66.9 m-85 -113.45 177.6 4.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.233 1.016 . . . . 0.0 112.003 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 49.4 m -91.94 107.18 19.02 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.742 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG12 ' A' ' 18' ' ' ILE . . . -93.3 112.1 4.23 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 tp -95.6 103.9 15.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.418 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.68 125.58 13.63 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.7 mm -89.99 -46.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 117.199 0.5 . . . . 0.0 111.106 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 19.3 p80 -171.83 149.93 2.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.99 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.646 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 31.6 t70 46.49 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.646 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 10.2 ptp85 -125.44 18.86 8.15 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.811 -0.556 . . . . 0.0 111.074 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.51 122.92 58.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.625 0.726 . . . . 0.0 111.71 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.44 141.68 50.97 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.377 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.67 135.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.562 0.696 . . . . 0.0 109.785 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 73' ' ' THR . 8.1 tp -141.04 137.78 17.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.798 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.52 151.53 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.775 0.983 . . . . 0.0 111.196 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 92.0 m -78.35 -34.84 48.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.936 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -72.2 3.8 4.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.759 0.314 . . . . 0.0 111.111 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.33 -24.62 50.78 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.0 0.905 . . . . 0.0 109.336 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 56.9 70.18 1.48 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.817 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.95 152.12 24.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.875 2.383 . . . . 0.0 109.41 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.57 -134.78 7.04 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.91 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.83 -9.14 24.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.499 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 11.6 t70 -136.91 124.43 22.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.082 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.95 172.58 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.697 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.618 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.6 mp -117.03 121.92 42.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.76 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.24 98.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 55.9 58.14 4.64 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.793 -176.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -38.07 1.9 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 118.7 15.63 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 48' ' ' LEU . 4.6 mtmp? -80.71 146.02 31.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.638 0.732 . . . . 0.0 112.166 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -144.58 146.32 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.076 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 24.8 mmm180 -79.89 145.35 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.67 0.271 . . . . 0.0 110.466 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.29 150.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HE3' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -94.65 -58.25 2.24 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.36 117.53 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.277 -1.328 . . . . 0.0 110.454 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 59' ' ' LYS . 38.1 ttpt -107.56 115.67 30.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -121.66 117.46 26.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -77.28 109.36 11.1 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 57.4 tp -85.45 114.36 22.43 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-O 122.475 1.131 . . . . 0.0 110.877 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 34.6 m -123.52 168.36 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 113.092 -1.867 . . . . 0.0 108.786 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 13.3 t70 -63.99 144.16 98.16 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.945 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.75 -19.71 8.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.248 1.965 . . . . 0.0 113.682 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.94 15.75 19.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 109.112 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t30 60.65 64.12 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.08 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -130.87 142.16 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 131' ' ' THR . 65.2 t30 -64.4 127.13 30.18 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 29.0 mt -98.43 -29.21 13.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 70' ' ' LEU . 32.5 tp10 85.81 7.94 0.35 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.785 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 10.8 mp -91.93 107.48 19.24 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.736 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 51.7 m -90.27 105.37 17.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.09 99.78 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.56 100.94 13.6 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.486 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -94.58 98.42 10.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.367 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.0 pt? -122.62 127.93 50.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.457 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.79 86.14 1.7 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.568 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -79.96 141.08 36.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.12 -1.4 . . . . 0.0 107.943 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -68.96 -38.6 79.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -90.59 96.7 10.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.2 152.9 28.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -85.42 159.06 20.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.116 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' HIS . 23.7 mmm180 -72.49 156.54 38.92 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.877 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.41 67.47 8.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.8 pp -75.1 11.41 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.198 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -58.29 -25.94 62.41 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 120.623 0.249 . . . . 0.0 111.255 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.14 -17.68 74.11 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.805 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -95.34 -4.32 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 109.956 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.402 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.8 mt -82.11 131.9 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 174' ' ' LYS . 2.5 m -91.6 122.77 34.47 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -174.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -71.18 -63.33 1.13 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.86 135.17 34.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 172.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.13 -54.91 41.65 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.979 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 46.58 71.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.176 0.512 . . . . 0.0 110.965 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.21 93.25 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 5.9 p -78.04 6.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -119.17 124.81 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.57 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.328 1.061 . . . . 0.0 113.745 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 m -124.28 139.18 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.37 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.89 117.77 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.008 0.432 . . . . 0.0 112.033 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -104.24 105.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.841 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.63 121.74 54.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 111.713 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -126.5 76.99 1.67 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.47 -170.28 2.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.444 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -56.4 -47.29 79.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -98.64 -56.65 2.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.903 0.774 . . . . 0.0 110.099 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.46 90.82 5.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 3.1 m -106.87 114.61 28.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.822 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' THR . 3.5 m-20 71.5 26.85 3.14 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.166 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -84.52 111.66 19.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.375 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.58 99.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.336 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 113' ' ' LEU . 3.6 mp -95.39 137.19 34.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.08 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.59 114.81 26.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -97.82 -19.56 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.422 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.33 -135.81 14.69 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.453 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 19.3 Cg_exo -67.23 142.15 59.66 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.02 2.48 . . . . 0.0 114.063 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.83 171.29 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.639 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 m -148.61 157.68 43.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.13 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 73.9 mtm -100.58 129.26 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -97.63 -17.42 19.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.31 -118.85 4.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.48 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.4 tt -107.5 120.3 41.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.204 0.526 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.42 HG21 HD23 ' B' ' 2' ' ' LEU . 40.3 pt -140.68 -166.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 17.5 m120 -117.17 131.55 56.85 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.235 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 1.6 mm? -110.08 108.1 18.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 128' ' ' SER . 7.2 t 61.39 29.14 18.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 127' ' ' SER . 55.3 m 84.31 -10.49 0.88 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.571 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 m -81.64 126.31 76.13 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.05 117.4 4.51 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.828 1.685 . . . . 0.0 112.14 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.0 p -120.25 142.89 48.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.553 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.11 164.29 15.77 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.358 0.599 . . . . 0.0 111.538 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 62.61 34.27 15.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG3' HG12 ' A' ' 124' ' ' ILE . 10.7 mmt -79.32 137.2 37.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.505 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 65.6 mt -96.25 133.69 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.584 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 37.5 ttt180 -120.43 125.23 47.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.762 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -142.9 139.08 30.63 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.92 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -80.44 96.52 6.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.145 0.974 . . . . 0.0 110.982 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -165.56 131.74 2.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.521 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.67 83.62 0.87 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -89.42 140.24 29.71 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.24 157.63 39.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.996 1.379 . . . . 0.0 114.315 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.77 150.0 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.292 175.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' H ' HX51 ' B' ' 8' ' ' CA1 . . . 92.38 -27.35 10.69 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -93.15 7.37 44.5 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' B' ' 7' ' ' GLN . 12.6 p -79.58 125.7 29.94 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.181 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.571 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 127.93 -16.66 6.1 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.303 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 151.67 33.6 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.653 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.37 119.13 45.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.332 0.587 . . . . 0.0 112.039 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.64 110.04 19.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.7 p -152.85 -170.4 3.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.024 0.916 . . . . 0.0 113.129 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -166.1 178.6 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.989 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 3.0 t -55.44 107.98 0.38 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.471 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 60.11 30.24 70.01 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.557 ' HE2' ' OG ' ' A' ' 91' ' ' SER . 2.5 tpmt? -145.3 91.67 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.713 -0.743 . . . . 0.0 111.453 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 69.0 mt -93.75 122.52 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -92.32 -46.79 7.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.054 0.454 . . . . 0.0 110.351 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 173' ' ' LEU . . . 163.85 -154.73 25.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.125 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.36 146.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.53 0.681 . . . . 0.0 111.234 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -78.9 115.05 18.34 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.644 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.24 -28.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.65 -151.5 8.99 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.209 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -173.18 167.09 39.76 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.489 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' B' ' 4' ' ' ALA . 24.8 t-20 -136.76 94.43 2.98 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.4 -96.43 0.49 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.398 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -108.96 9.88 26.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.19 0.519 . . . . 0.0 110.879 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -121.29 135.67 55.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.98 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.19 139.29 14.41 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 60.9 m-85 -120.59 121.52 38.55 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.93 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.6 m -121.17 167.94 12.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.617 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.49 143.2 37.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.06 116.17 18.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.574 ' HB2' ' HA2' ' A' ' 158' ' ' GLY . 8.7 mp -93.58 86.3 5.15 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 91' ' ' SER . 28.6 mttm -76.3 146.67 38.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -58.34 -31.94 68.04 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 111.695 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -50.9 -42.23 59.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' A' ' 62' ' ' LEU . 9.0 m-85 -64.01 -38.54 91.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -92.47 -22.18 19.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -174.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.84 -14.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.461 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.43 -9.39 20.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.194 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -111.1 99.67 8.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.617 0.723 . . . . 0.0 112.85 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.866 177.015 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 124' ' ' ILE . 2.7 mm? -128.9 149.88 50.59 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.614 0.571 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 35.4 tt0 -118.22 77.11 1.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -78.65 155.37 29.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 51.0 tp -110.46 142.9 41.56 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.544 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 21.3 m-85 -57.16 136.08 56.4 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 146' ' ' CYS . 94.1 mt-30 . . . . . 0 N--CA 1.44 -0.938 0 C-N-CA 119.665 -0.814 . . . . 0.0 . -176.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.622 ' H4 ' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 120.297 -0.168 . . . . 0.0 113.004 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -43.78 -50.3 7.33 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.901 1.734 . . . . 0.0 112.731 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.43 ' HA ' ' HB ' ' A' ' 153' ' ' THR . 38.6 t30 -62.1 -50.99 69.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.553 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -56.86 -53.38 58.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.175 -1.375 . . . . 0.0 112.935 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.553 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.2 mp0 -71.33 -26.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.309 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.56 -45.71 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . -56.89 -45.39 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.403 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 7.5 tt -59.76 -42.33 93.02 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 m -70.3 -36.49 74.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.256 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -70.26 -47.41 61.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.679 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 4.0 pp -64.81 -25.02 67.73 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 8' ' ' LEU . 69.6 mtp180 -70.0 -50.07 45.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.31 -23.99 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -108.51 -4.55 17.15 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 43.4 mm -114.59 117.08 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.816 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -120.79 137.31 54.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.313 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 m -76.71 103.28 6.59 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.97 102.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.686 0.755 . . . . 0.0 111.575 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 63.4 m -71.13 100.01 1.97 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.791 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -107.4 175.7 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.954 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.524 ' H ' HG22 ' A' ' 20' ' ' THR . 3.4 m -55.15 -47.31 75.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.714 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 7.7 mmpt? -89.83 2.11 55.35 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.71 -175.97 27.73 Favored Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.853 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 105' ' ' SER . 30.2 mt-10 -101.48 112.6 25.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -106.93 162.59 13.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.951 0.881 . . . . 0.0 112.951 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.691 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 86.3 m -80.73 106.8 13.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.847 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.27 116.48 4.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.694 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -94.42 108.95 20.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 110.795 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.8 108.08 2.41 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 86' ' ' ILE . 39.6 mm -75.43 -55.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.891 0.377 . . . . 0.0 111.802 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -162.96 138.92 7.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.617 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 13.0 t70 57.32 -94.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.069 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 76' ' ' THR . 79.2 mtt85 -126.28 8.74 7.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.802 0.81 . . . . 0.0 110.163 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 74' ' ' VAL . 96.9 t -92.71 113.18 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.866 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 p -124.06 142.8 50.87 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.11 137.09 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.023 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 tt -144.95 139.95 15.72 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.525 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.2 144.1 72.06 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.457 1.438 . . . . 0.0 112.439 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.816 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 89.7 m -63.9 -37.6 87.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -72.52 6.54 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.17 -19.1 30.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.668 0.747 . . . . 0.0 109.937 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 64.98 69.51 0.66 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.196 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.81 110.49 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.638 1.559 . . . . 0.0 109.48 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -141.84 1.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.546 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.01 -28.32 15.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.952 0.882 . . . . 0.0 109.227 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -136.88 132.4 34.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.039 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.81 153.15 36.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 mp -97.01 104.01 15.98 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.118 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.2 p -82.02 96.03 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.34 10.53 7.3 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.47 -28.76 3.96 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.461 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 54' ' ' ILE . 58.5 tt0 -78.88 118.38 20.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.127 0.489 . . . . 0.0 110.741 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -72.55 107.79 5.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.405 HD12 HG11 ' A' ' 49' ' ' VAL . 8.9 mt -119.39 126.4 75.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.257 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -77.56 146.22 36.42 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 110.084 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.27 138.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -84.46 -45.56 12.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.78 144.48 15.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -136.67 112.67 9.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -112.95 129.35 56.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.339 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.43 110.79 16.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.647 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 36.9 tp -81.19 115.1 20.44 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.44 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.59 167.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.673 -1.603 . . . . 0.0 108.218 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 17.9 t70 -87.0 143.32 34.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.59 -17.05 6.25 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.367 2.045 . . . . 0.0 113.513 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.89 7.18 9.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.86 39.99 2.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.938 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 150.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.846 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -66.4 137.39 56.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 18.6 mt -105.38 -28.38 10.91 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.816 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 35.8 tp10 80.7 9.03 1.18 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.948 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HG ' HD21 ' A' ' 173' ' ' LEU . 2.3 mm? -95.54 133.41 39.58 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.904 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.8 m -105.61 115.56 30.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 34' ' ' VAL . 60.4 t -74.61 96.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -93.28 103.55 15.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.928 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 19.9 m -94.44 100.5 12.49 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.22 156.63 16.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.758 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -83.87 103.53 13.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -129.96 143.1 50.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.459 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -87.34 -59.02 2.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.77 90.64 4.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 32' ' ' ASP . 55.6 pttt -68.07 163.66 21.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -79.23 145.91 33.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.343 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -62.45 130.82 46.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.717 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.94 80.93 0.47 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 122.173 -0.329 . . . . 0.0 111.437 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 86' ' ' ILE . 2.6 pp -87.36 19.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 O-C-N 121.448 -0.782 . . . . 0.0 110.403 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.48 -13.38 62.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.614 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.84 67.43 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.873 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.28 -10.15 50.52 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.86 131.84 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.9 m -105.43 133.68 49.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -81.97 -23.82 35.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -127.31 111.49 13.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.6 mt -52.74 -64.55 0.78 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.7 69.25 0.69 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.28 96.9 0.1 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 8.5 p -86.55 17.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.333 0.587 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -140.35 132.92 28.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.034 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.18 16.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.236 1.017 . . . . 0.0 113.38 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.3 m -128.23 142.1 51.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.389 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.76 110.97 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.142 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 7' ' ' ALA . 27.1 m -103.74 136.19 37.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.16 0.505 . . . . 0.0 110.999 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 105' ' ' SER . 27.4 t -122.54 133.87 67.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.909 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.603 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 64.5 t60 -138.64 45.03 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 m -108.78 -165.42 1.02 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.413 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -83.34 -18.52 38.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.619 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 11.9 p30 -67.49 -50.3 59.55 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -138.49 113.83 9.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.4 m -92.55 96.84 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.808 0.813 . . . . 0.0 112.22 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.603 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 8.0 t30 74.03 70.45 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.054 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 m -134.85 136.67 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.819 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.58 117.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.8 mp -111.91 113.16 25.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.49 120.58 24.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -97.06 -25.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.956 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.73 -129.12 9.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.838 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 25.1 Cg_exo -62.43 130.51 30.37 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.3 2.0 . . . . 0.0 113.231 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 137' ' ' TYR . 15.0 m -121.45 131.66 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.0 p -122.98 144.98 48.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 72.8 mtm -81.31 114.28 19.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.51 -50.27 7.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.864 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.19 -119.95 5.86 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.785 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.45 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.4 tm? -95.68 118.1 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.304 0.574 . . . . 0.0 112.53 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.8 pt -139.98 -174.46 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 91.1 m-20 -113.26 104.28 12.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.757 ' HA ' ' O ' ' B' ' 4' ' ' ALA . 3.6 mm? -79.52 113.36 17.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.45 ' HB3' HD12 ' B' ' 5' ' ' LEU . 59.0 p 52.27 30.81 8.39 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.969 -0.457 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m 70.56 62.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -160.8 115.27 1.35 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.315 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.21 112.12 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.349 1.366 . . . . 0.0 111.6 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.625 ' HB ' HD23 ' A' ' 126' ' ' LEU . 17.7 m -125.79 128.86 48.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.854 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 57.7 t30 -106.86 162.79 13.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.639 ' HG2' ' HB3' ' A' ' 172' ' ' GLN . 19.6 ttm-85 70.88 34.82 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.286 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 94.3 mmm -87.37 139.44 30.55 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 111.68 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.4 mm -97.94 134.49 36.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.442 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -111.82 125.42 54.0 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.438 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 5.8 p90 -137.36 125.82 23.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.67 99.81 3.78 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 122.232 1.015 . . . . 0.0 110.773 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -166.7 128.19 1.71 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.47 91.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.1 p -90.72 162.42 14.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.336 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -132.17 150.33 52.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.971 0.891 . . . . 0.0 111.865 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.648 ' HA ' ' CB ' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -44.22 154.22 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.275 175.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -33.14 5.43 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.497 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 70.8 mt-30 -77.52 9.99 2.92 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.54 139.6 58.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.691 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 108.88 -14.96 34.31 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.951 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.68 145.1 40.11 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.532 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.42 122.19 50.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.645 0.736 . . . . 0.0 112.249 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.38 108.91 20.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.347 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 178.85 8.68 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.904 0.859 . . . . 0.0 112.802 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.417 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . . . -153.12 179.25 8.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.628 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 3' ' ' ASN . 2.0 t -60.63 102.63 0.2 Allowed 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.794 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.95 88.01 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.608 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.08 119.36 16.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.641 0.721 . . . . 0.0 112.768 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.1 mt -99.31 124.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -94.57 -35.03 12.42 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 161.05 -163.15 34.14 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.769 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.5 pt -129.85 152.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.842 0.829 . . . . 0.0 112.11 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -62.27 122.73 16.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.756 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.13 -30.98 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.183 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' B' ' 7' ' ' GLN . . . -174.21 -146.12 5.5 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.583 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -179.42 158.11 21.76 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.322 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 21.4 t30 -131.22 86.56 2.37 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.977 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.13 -99.74 0.81 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 114.995 -1.002 . . . . 0.0 114.973 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -94.25 -2.43 52.39 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 111.929 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -121.46 131.39 54.13 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.759 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.01 151.3 25.83 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -129.28 114.11 15.84 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.765 -1.174 . . . . 0.0 113.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.0 m -108.92 159.27 16.94 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.46 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -96.26 132.35 41.81 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.587 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 133' ' ' ARG . 51.8 tt0 -70.96 107.86 4.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.12 0.486 . . . . 0.0 110.283 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.489 HD21 ' HG ' ' A' ' 72' ' ' LEU . 80.4 mt -85.59 93.83 8.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.556 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.75 125.56 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.726 0.774 . . . . 0.0 109.548 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -40.18 -39.86 1.0 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.4 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.48 -46.23 37.91 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 180' ' ' GLU . 27.8 m-85 -64.06 -17.0 62.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.38 -22.31 30.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 110.626 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.24 -29.46 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 177' ' ' TYR . 19.2 tp10 -65.67 -43.58 88.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.5 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -65.92 135.81 55.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.779 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.414 ' N ' HD12 ' B' ' 2' ' ' LEU . 6.3 mp -111.69 114.28 27.19 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 38.4 tt0 -86.55 79.54 8.9 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.492 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.757 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -82.41 125.08 30.64 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 37.7 tp -86.02 146.75 26.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.516 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 16.2 m-85 -60.17 130.2 45.5 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.648 ' CB ' ' HA ' ' A' ' 143' ' ' THR . 98.3 mt-30 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.647 -0.706 . . . . 0.0 . 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.671 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 120.357 -0.135 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.26 -48.78 4.0 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.969 2.446 . . . . 0.0 114.451 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.67 -40.49 76.39 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.58 0.705 . . . . 0.0 110.694 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -49.78 68.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.535 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 10.1 mm-40 -60.28 -33.82 72.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.388 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -68.81 -58.52 4.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.309 0.576 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 tp -70.46 -33.02 70.8 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -79.79 -34.55 39.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.42 -36.43 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.1 tp -54.94 -59.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.027 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.61 -27.04 61.92 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -81.71 -46.34 14.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.53 -6.06 9.24 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.2 mt -110.25 121.19 62.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.96 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.4 mtt -127.73 147.23 50.4 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.639 0.733 . . . . 0.0 109.817 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -64.92 110.98 2.63 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.009 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG1' ' HA3' ' A' ' 27' ' ' GLY . 39.7 mm -95.57 105.18 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -92.21 96.52 10.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.507 0.67 . . . . 0.0 109.301 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.458 HG23 HG22 ' A' ' 18' ' ' ILE . 1.3 p -102.81 -169.73 1.7 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.341 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -67.32 -32.04 72.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.703 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HZ3' ' CX7' ' B' ' 8' ' ' CA1 . 49.4 tttm -83.03 -35.29 25.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.395 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.43 -151.57 22.64 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 119.479 -1.343 . . . . 0.0 115.34 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.42 120.28 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.306 -0.947 . . . . 0.0 110.531 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.576 ' HZ ' ' HZ2' ' A' ' 22' ' ' LYS . 63.1 m-85 -126.44 159.58 32.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.184 0.992 . . . . 0.0 113.018 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 32.9 m -79.65 100.91 8.07 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.384 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' CG1' ' A' ' 18' ' ' ILE . . . -90.42 112.29 4.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.69 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -101.81 105.72 16.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.28 116.58 5.27 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 46.4 mm -83.53 -60.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.223 0.512 . . . . 0.0 111.946 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -145.51 152.65 40.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.875 0.845 . . . . 0.0 112.678 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 41.6 m-20 45.14 -92.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.781 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 16.9 ptt180 -141.59 25.75 1.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.88 0.848 . . . . 0.0 109.661 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.53 118.61 53.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.548 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 m -117.48 146.07 43.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.869 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.89 122.91 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.062 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 18' ' ' ILE . 57.0 mt -134.76 141.11 37.39 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.243 -177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HB3' ' CE1' ' A' ' 40' ' ' HIS . 45.9 Cg_exo -58.6 144.3 97.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 121.583 1.522 . . . . 0.0 109.915 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.53 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 49.7 m -74.11 -32.44 63.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 38' ' ' PRO . 43.0 p-80 -71.53 -7.27 46.51 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.89 -29.44 66.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.952 0.882 . . . . 0.0 108.754 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 66.61 70.95 0.47 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.662 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.73 118.56 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.223 2.615 . . . . 0.0 108.64 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.52 -111.42 0.74 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.559 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.18 -35.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.558 0.694 . . . . 0.0 109.172 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -117.78 148.64 41.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.561 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 75' ' ' LEU . 86.8 t -131.3 123.81 53.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.744 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.402 HD21 ' HE2' ' A' ' 53' ' ' LYS . 36.0 mt -74.41 88.32 2.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.198 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 54' ' ' ILE . 48.1 t -83.24 98.98 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.5 23.04 12.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 -7.6 56.93 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.597 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -93.76 130.37 39.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.122 0.487 . . . . 0.0 111.665 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HE2' HD21 ' A' ' 48' ' ' LEU . 59.5 mmtt -74.35 88.62 2.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.925 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 49' ' ' VAL . 57.9 mt -102.94 136.07 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -100.67 154.75 18.34 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 117.956 -1.498 . . . . 0.0 113.889 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 59' ' ' LYS . 78.2 t -71.49 133.53 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.522 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 57' ' ' LYS . 11.0 tmtt? -100.95 -56.24 2.37 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -128.02 115.88 19.17 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.649 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HB2' HG11 ' A' ' 56' ' ' VAL . 54.0 tttp -106.88 92.16 3.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -113.22 123.76 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.455 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 5.7 mptt -86.12 103.19 14.54 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 56.2 tp -69.19 114.75 7.74 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 123.376 1.56 . . . . 0.0 112.302 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.9 m -114.62 153.42 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 174.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' A' ' 66' ' ' GLU . 12.3 t70 -74.33 139.92 75.69 Favored Pre-proline 0 C--N 1.306 -1.291 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 31.2 Cg_exo -44.72 -17.62 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.576 1.517 . . . . 0.0 112.086 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 64' ' ' ASP . 12.9 tp10 -68.42 -1.39 6.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.566 0.698 . . . . 0.0 109.161 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' PRO . 10.7 t30 72.21 30.21 2.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.052 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.3 mt -123.39 143.41 36.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.789 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.41 ' HA ' HG12 ' A' ' 63' ' ' VAL . 15.8 m120 -59.84 145.26 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.768 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 59.2 mt -126.26 -30.72 2.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.183 0.516 . . . . 0.0 109.833 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.4 mm-40 87.13 4.35 0.36 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.975 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 66.6 mt -87.92 98.12 11.32 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.014 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 m -76.46 103.45 6.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.033 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 62' ' ' LEU . 99.2 t -77.57 88.05 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 47' ' ' VAL . 15.2 tp -93.76 115.01 27.41 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.109 -175.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -98.32 109.86 22.55 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.632 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.44 151.41 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.92 86.93 6.87 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.353 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 33' ' ' ARG . 29.2 mmm180 -103.81 146.96 27.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.009 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.96 -51.63 3.99 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -76.22 114.02 14.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.58 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 32' ' ' ASP . 11.7 ptpt -84.57 -179.48 7.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.729 0.776 . . . . 0.0 111.938 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.47 163.57 12.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.214 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -67.27 117.04 8.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -66.26 91.55 0.17 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.4 pt -90.18 20.0 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -62.85 -21.48 65.99 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.43 -18.4 71.28 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.542 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 96.7 m-85 -87.88 -1.98 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.103 0.478 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 30' ' ' ILE . 64.4 mt -84.78 125.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.6 m -85.08 129.05 34.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.683 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -55.95 13.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.68 132.99 42.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.9 mt -55.62 -70.18 0.12 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 50.61 71.27 0.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.021 0.439 . . . . 0.0 110.046 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.08 88.27 0.07 OUTLIER Glycine 0 C--N 1.333 0.408 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.447 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 7.7 p -79.77 -0.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.355 0.597 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 12.5 t70 -128.91 114.69 16.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.687 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.03 165.12 20.92 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.961 0.886 . . . . 0.0 111.363 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 7.9 m -119.12 140.53 49.98 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.261 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.7 tp -109.83 124.81 51.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.479 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.43 111.36 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 105' ' ' SER . 10.5 t -103.52 137.85 30.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.34 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.449 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 86.5 t60 -136.41 42.05 2.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.535 ' H ' HG12 ' A' ' 103' ' ' VAL . 54.6 m -107.29 -176.59 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.209 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -44.41 -57.91 3.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -79.83 -47.94 14.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.047 0.839 . . . . 0.0 112.26 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -108.99 96.08 6.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.651 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 3.1 m -98.08 103.58 15.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.808 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 109' ' ' THR . 16.9 t30 73.36 72.2 0.13 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.978 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -140.09 125.09 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.193 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.1 tt -113.07 126.19 70.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 tt -143.0 127.87 18.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 14.0 pt-20 -81.01 108.02 14.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.23 -33.21 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.958 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 93.72 -118.96 5.84 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 26.6 Cg_endo -58.02 107.29 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 116.03 -175.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.8 t -96.47 118.93 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.59 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 24.5 m -137.66 141.23 41.16 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.501 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -81.92 130.19 35.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.313 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.31 -18.38 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.52 -130.18 9.53 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.403 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 123' ' ' LEU . 2.9 tm? -93.5 112.38 24.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' B' ' 2' ' ' LEU . 47.9 pt -135.83 -174.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 1.0 OUTLIER -108.33 106.44 16.58 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.857 -179.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.636 HD12 ' O ' ' B' ' 4' ' ' ALA . 56.3 tp -82.57 111.21 18.35 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.1 p 56.42 37.31 28.72 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.076 0.465 . . . . 0.0 110.991 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.4 m 77.73 11.14 2.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.892 0.877 . . . . 0.0 112.992 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -118.2 118.19 34.4 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.622 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 51.2 Cg_exo -54.05 116.62 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.245 1.964 . . . . 0.0 113.825 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 p -125.09 145.4 49.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.839 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' HB3' HD23 ' A' ' 123' ' ' LEU . 25.2 p-10 -112.9 163.26 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.909 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 80.2 mtt180 58.94 41.86 20.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.642 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -77.63 127.87 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.54 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.528 ' HB ' ' OG ' ' A' ' 170' ' ' SER . 39.4 mm -87.38 120.84 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 24.8 ttt180 -104.88 124.65 49.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.613 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.552 ' CE2' ' HA3' ' A' ' 168' ' ' GLY . 0.6 OUTLIER -117.19 115.86 26.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.879 -1.896 . . . . 0.0 105.879 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -71.55 90.42 1.01 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.016 0.912 . . . . 0.0 112.059 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -166.96 132.12 2.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.328 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.41 0.54 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.518 0.675 . . . . 0.0 111.582 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 131.79 54.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' ' NE2' ' B' ' 7' ' ' GLN . 7.2 mtpm? -122.29 179.3 4.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' B' ' 7' ' ' GLN . 0.2 OUTLIER -38.7 150.75 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.773 177.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.467 ' H ' ' CX7' ' B' ' 8' ' ' CA1 . . . 91.08 -20.22 41.39 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.039 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.28 5.87 40.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.572 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 14.5 p -78.53 140.98 38.49 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.182 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.652 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 116.96 -19.29 12.11 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.16 150.44 29.13 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.098 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.96 124.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.44 0.638 . . . . 0.0 111.967 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.36 108.96 20.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 15.4 p -144.99 -178.72 6.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.927 0.87 . . . . 0.0 112.453 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.2 179.74 7.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.397 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 t -65.17 117.23 7.46 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.559 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.7 76.91 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.618 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 8.7 ptpp? -159.32 138.91 11.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.776 0.788 . . . . 0.0 112.602 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 63.6 mt -113.41 135.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.635 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.03 -39.61 6.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.798 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 175.08 -171.1 44.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.5 pt -125.54 142.83 41.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.871 0.843 . . . . 0.0 111.111 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 146' ' ' CYS . 4.0 t-160 -61.7 112.75 2.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.234 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.87 -25.17 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.265 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -174.36 -145.94 5.46 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.402 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 175.43 164.11 29.43 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.3 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 4' ' ' ALA . 31.1 t30 -136.88 99.98 4.18 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.477 0.656 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 60.56 -110.03 2.71 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 115.014 0.765 . . . . 0.0 115.014 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -92.93 18.96 8.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.447 0.642 . . . . 0.0 111.337 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.411 HE21 ' HB2' ' A' ' 167' ' ' GLN . 14.2 mt-30 -135.1 128.56 32.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -91.05 145.28 17.7 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 136' ' ' ARG . 44.9 m-85 -127.18 126.98 43.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.672 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.528 ' OG ' ' HB ' ' A' ' 135' ' ' ILE . 19.8 p -124.92 169.61 11.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.178 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.88 140.21 41.33 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.6 pt20 -70.3 118.5 13.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.0 mp -97.78 75.9 2.44 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -83.74 142.1 30.96 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -50.98 -22.97 2.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -54.63 -22.54 13.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -97.82 -16.22 19.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.2 -6.2 15.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.3 -18.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.5 -58.6 7.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.522 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -92.04 127.28 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.616 175.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.034 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 124' ' ' ILE . 1.8 mm? -135.31 138.4 43.41 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.243 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ASN . 39.2 tt0 -106.96 90.1 3.2 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 126' ' ' LEU . . . -96.42 126.51 41.67 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.117 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 6' ' ' PHE . 36.0 tp -87.03 158.68 19.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.717 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.576 ' O ' ' HG ' ' B' ' 5' ' ' LEU . 26.0 m-85 -62.58 147.45 49.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 142' ' ' LYS . 97.1 mt-30 . . . . . 0 N--CA 1.434 -1.258 0 C-N-CA 118.402 -1.319 . . . . 0.0 . 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' CA1 . . . . . 0.585 ' CX7' ' HZ3' ' A' ' 22' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_